baid,acvalue,aid,sid,cid,geneid,pmid,aidtype,aidmdate,hasdrc,rnai,activity,protacxn,acname,acqualifier,aidsrcname,aidname,cmpdname,targetname,targeturl,ecs,repacxn,taxid,cellids,targettaxid,anatomyid,anatomy
 380807293,6e-05,1916785,103245522,5291,2064,35696863,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) incubated for 1 hr in presence of ATP by Kinase-Glo Plus luminescence kinase assay,Imatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103286,6e-05,1796167,381752969,132143189,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103126,9e-05,1796167,381752970,132143289,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742004,0.0001,473322,103177459,176870,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629292,0.0001,1274048,103177459,176870,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of EGFR deletion (746 to 750 residues) mutant (unknown origin),Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380807292,0.00014,1916785,482089589,168298900,2064,35696863,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) incubated for 1 hr in presence of ATP by Kinase-Glo Plus luminescence kinase assay,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-(1H-pyrazolo[3,4-b]pyridin-3-ylamino)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103282,0.00014,1796167,381752956,132143236,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indole-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103132,0.00015,1796167,381752955,132162946,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-methoxyindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103136,0.00015,1796167,381752949,132143267,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380767874,0.00016,1905774,482056461,168275910,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 V777L mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,"(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103128,0.00016,1796167,381752960,132143265,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103138,0.00018,1796167,381752972,132143243,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[5-(aminomethyl)indole-1-carbonyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347055770,0.0002,1250405,318392799,78209992,2064,26313252,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon19 deletion mutant (unknown origin) by HTRF assay in presence of Km of ATP,"(R)-4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629276,0.0002,1274048,336869239,127027694,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of EGFR deletion (746 to 750 residues) mutant (unknown origin),"N-(1H-indazol-3-yl)-7,7-dimethyl-2-(1H-pyrazol-4-yl)-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103280,0.0002,1796167,381752957,132143245,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfanylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103131,0.00028,1796167,381752961,132143190,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103433,0.00029,1796168,381752969,132143189,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629437,0.0003,1274047,103177459,176870,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin),Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103283,0.0003,1796167,381752962,132163054,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"2-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1,3-thiazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103436,0.0003,1796168,381752955,132162946,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-methoxyindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640536,0.00031,1309513,336902653,74223816,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4S)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103430,0.00031,1796168,381752970,132143289,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389705955,0.00034,1919057,475727197,166034047,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In vitro kinase inhibition assay from US Patent US11505527: 'Tetrahydroquinoline derivatives and a process of preparation thereof',"(3E)-2-amino-3-[hydroxy(phenyl)methylidene]-7,7-dimethyl-4-[4-(4-methylphenyl)sulfonylphenyl]-6,8-dihydro-4H-quinolin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640769,0.00035,1309513,336903600,127050067,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4S,5R)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-5-methyl-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103427,0.00035,1796168,381752957,132143245,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfanylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640101,0.00038,1309513,336903931,74223711,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4S)-N-[4-(3-bromoanilino)-7-methoxyquinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742016,0.0004,473322,103455939,4709,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629284,0.0004,1274048,336870589,92132732,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of EGFR deletion (746 to 750 residues) mutant (unknown origin),"N-(7-chloro-1H-indazol-3-yl)-7,7-dimethyl-2-(1H-pyrazol-4-yl)-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103125,0.0004,1796167,381752950,132143247,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380779845,0.00042,1905772,482056461,168275910,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 D769H mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,"(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380767924,0.00043,1905773,482056461,168275910,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 D769Y mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,"(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103292,0.00043,1796168,381752949,132143267,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863455,0.0005,260896,103480274,11613187,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-methyl-1-piperazinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864179,0.0005,260899,103480053,11713043,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
155742020,0.0005,473322,103746579,46197128,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,N-(4-(3-Bromophenylamino)quinolin-6-yl)-4-(dimethylamino)-butanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665448,0.0005,1168534,312363556,46865125,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1S)-1-(dimethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629280,0.0005,1274048,336870997,92132733,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,<,ChEMBL,Inhibition of EGFR deletion (746 to 750 residues) mutant (unknown origin),"N-(1H-indazol-3-yl)-7,7-dimethyl-2-(2-methylpyrazol-3-yl)-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629441,0.0005,1274047,336869239,127027694,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin),"N-(1H-indazol-3-yl)-7,7-dimethyl-2-(1H-pyrazol-4-yl)-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629445,0.0005,1274047,336870997,92132733,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,<,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin),"N-(1H-indazol-3-yl)-7,7-dimethyl-2-(2-methylpyrazol-3-yl)-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104278,0.00055,1796169,381752956,132143236,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indole-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380776661,0.00056,1905775,482056461,168275910,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 R896C mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,"(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389705956,0.00056,1919057,46516901,216239,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In vitro kinase inhibition assay from US Patent US11505527: 'Tetrahydroquinoline derivatives and a process of preparation thereof',Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340071105,0.00057,770082,103768626,10184653,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
402103135,0.00058,1796167,381752974,132143285,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]pyrrolo[2,3-b]pyridine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103023,0.00059,1796166,381752957,132143245,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfanylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389711616,0.0006,1919057,475727196,166034050,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In vitro kinase inhibition assay from US Patent US11505527: 'Tetrahydroquinoline derivatives and a process of preparation thereof',"Ethyl 4-[4-(benzenesulfonyl)phenyl]-7,7-dimethyl-5-oxo-2-(trifluoromethyl)-1,4,6,8-tetrahydroquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103030,0.0006,1796166,381752955,132162946,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-methoxyindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104031,0.0006,1796169,381752960,132143265,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340071113,0.00063,770082,174505192,11511120,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,Dacomitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
402102678,0.00063,1796166,381752969,132143189,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355647027,0.000637,1312565,103244983,123631,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic GST-tagged human recombinant EGFR L858R mutant expressed in baculovirus system by z-lyte assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103024,0.00066,1796166,381752970,132143289,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103285,0.00066,1796167,381752973,137554364,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-hydroxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-(1H-pyrrolo[2,3-b]pyridin-5-ylcarbamoyl)pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103130,0.00067,1796167,381752959,132143252,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(4-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340011558,0.00069,748805,174501507,67218825,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"1-[3-(4-Amino-7-cyclopentylpyrrolo[2,3-d]pyrimidine-5-carbonyl)phenyl]-3-(2-methoxy-5-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101862434,0.0007,260896,103480268,11518389,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-methyl-1-piperazinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863467,0.0007,260896,103480053,11713043,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103424,0.0007,1796168,381752962,132163054,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"2-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1,3-thiazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640532,0.00071,1309513,336902657,127049383,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4S)-N-[7-ethoxy-4-[[(1S)-1-phenylethyl]amino]quinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103291,0.00073,1796168,381752961,132143190,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380648047,0.00075,1878102,136940589,24821094,2064,35041943,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to ERBB2 (unknown origin) assessed as dissociation constant by KINOMEscan analysis,Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093325,0.00078,1057929,103768626,10184653,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101862433,0.0008,260896,103480044,11568720,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863510,0.0008,260903,103480268,11518389,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand stimulated erbB2 autophosphorylation in T24 NIH cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-methyl-1-piperazinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,526,"","",""
410147240,0.0008,1798142,433935512,25127713,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',Poziotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103422,0.00081,1796168,381752972,132143243,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[5-(aminomethyl)indole-1-carbonyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640540,0.00083,1309513,336906111,127051866,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4S)-N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102690,0.00083,1796166,381752956,132143236,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indole-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102687,0.00084,1796166,381752949,132143267,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340012328,0.00089,748805,174506712,67219570,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"1-[3-(4-Amino-7-cyclopentylpyrrolo[2,3-d]pyrimidine-5-carbonyl)phenyl]-3-(2-fluoro-5-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
321559059,0.00092,670126,160679732,70686299,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"(2S)-N-[2-[4-[4-(1,2-benzothiazol-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]pyrrolidine-2-carboxamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408018387,0.00096,1951290,494411940,155266923,2064,36804726,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103140,0.00097,1796167,381752953,132143292,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103431,0.00097,1796168,381752974,132143285,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]pyrrolo[2,3-b]pyridine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559052,0.00098,670126,160685087,44229839,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"N-[2-(4-{[4-(1,2-Benzoisothiazol-4-yloxy)-3-chlorophenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-2-methylalaninamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539079,0.001,410944,103441767,9915743,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573540,0.001,320572,103574114,44455194,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(oxazepan-2-yl)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573541,0.001,320572,103574214,11606101,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2,"3-[2-(4-acetylpiperazin-1-yl)ethoxy]-N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573542,0.001,320572,103574403,11620487,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2,"1-(2-{[4-({3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573543,0.001,320572,103574356,11627337,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2,"1-[2-[[4-[4-[(3-fluorophenyl)methoxy]-3-methylanilino]-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573544,0.001,320572,103574217,11634645,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573546,0.001,320572,103574013,11663284,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(3-morpholin-4-ylpropoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574008,0.001,320572,103574071,11619972,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-morpholin-4-ylethoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574009,0.001,320572,103574355,11684684,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2,"1-(2-{[4-({3-chloro-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622133,0.001,404519,103641339,21952114,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,N-(1-benzyl-1H-indazol-5-yl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622139,0.001,404519,103641338,11751635,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,(R)-N-(3-chloro-4-(pyrazin-2-ylmethoxy)phenyl)-5-(1-(dimethylamino)propan-2-yloxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778367,0.001,315250,103574979,11569158,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of ebrB2,"(2R)-2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-5-yl)oxy]-N,N-dimethylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778368,0.001,315250,103561935,11712237,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of ebrB2,"(R)-N,N-dimethyl-2-(4-(3-methyl-4-(6-methylpyridin-3-yloxy)phenylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864176,0.001,260899,103480268,11518389,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-methyl-1-piperazinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
155741653,0.001,473323,103202674,4708,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742008,0.001,473322,103746580,44629538,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,N-[4-(3-bromoanilino)-6-quinazolinyl]-4-(dimethylamino)butanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742024,0.001,473322,103746518,46197015,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,N-[4-(3-bromoanilino)quinolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155743021,0.001,473322,103258685,16045442,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,"N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665459,0.001,1168534,312363550,56640518,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[1-(methylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363852957,0.001,1450721,381837358,137631967,2064,28714692,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant ErbB2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",4-chloro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-isoquinolin-6-ylpyridin-2-yl]phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363852958,0.001,1450721,381880837,137657932,2064,28714692,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant ErbB2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",4-chloro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363852959,0.001,1450721,381866237,137651391,2064,28714692,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant ErbB2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",5-fluoro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103432,0.00102,1796168,381752960,132143265,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769303,0.00106,1905726,482050668,168271684,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-hydroxy-4-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568323,0.0011,68096,103237025,10691652,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,"N-[4-(3-Bromo-4-fluoro-phenylamino)-pyrido[3,4-d]pyrimidin-6-yl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101863466,0.0011,260896,103480257,11566580,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,EGFR/ErbB-2/ErbB-4 Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155741635,0.0011,473322,103202674,4708,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104035,0.0011,1796169,381752955,132162946,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-methoxyindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104282,0.0011,1796169,381752969,132143189,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340012203,0.0012,748805,174516909,71615301,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"1-[3-(4-Amino-7-cyclopentylpyrrolo[2,3-d]pyrimidine-5-carbonyl)phenyl]-3-(2,4-dichlorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
366369535,0.0012,1560827,136940589,24821094,2064,32083858,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to DNA-tagged recombinant ERBB2 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis,Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809779,0.0012,1795310,377003054,87056634,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(E)-N-(7-(((R)-1,4-dioxan-2-yl)methoxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-((R)-2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104041,0.0012,1796169,381752972,132143243,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[5-(aminomethyl)indole-1-carbonyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143061,0.0012,1798142,104048227,9915743,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559060,0.0013,670126,160669074,57415414,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"6-(2-chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino}phenoxy)isoindolin-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629449,0.0013,1274047,336870589,92132732,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin),"N-(7-chloro-1H-indazol-3-yl)-7,7-dimethyl-2-(1H-pyrazol-4-yl)-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408018384,0.00131,1951290,312468004,25127713,2064,36804726,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Poziotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104276,0.00134,1796169,381752957,132143245,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfanylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345670959,0.00138,1171421,312371395,71513822,2064,25409491,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type HER2 (unknown origin) incubated for 5 mins by HTRF assay,(Z)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769562,0.0014,1905726,482052977,137376670,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-3-[(2R)-1-methylpyrrolidin-2-yl]-N-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103137,0.0014,1796167,381752968,132143255,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-2,3-dihydroindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143043,0.0014,1798142,464922071,139378131,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408018386,0.00142,1951290,494406819,171349813,2064,36804726,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),1-[4-[4-(3-chloro-2-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769308,0.00143,1905726,482076065,168290131,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559057,0.0015,670126,160706531,57415536,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"7-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-1,3-dihydroindol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363522782,0.0015,1375530,136940589,24821094,2064,29715023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human ErbB2 using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809753,0.0015,1795310,377003052,87056632,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'",(E)-N-(4-(3-chloro-4-fluorophenylamino)-7-((S)-tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103127,0.0015,1796167,381752954,132143256,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103288,0.0015,1796167,381752967,132162908,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103290,0.0015,1796168,381752959,132143252,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(4-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103426,0.0015,1796168,381752973,137554364,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-hydroxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-(1H-pyrrolo[2,3-b]pyridin-5-ylcarbamoyl)pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104284,0.0015,1796169,381752967,132162908,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559058,0.0016,670126,160679721,25026082,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"4-(2-chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino}phenoxy)-1,3-dihydro-2H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559149,0.0016,670126,160674392,44229775,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"N-[2-(4-{[4-(1,2-benzoisothiazol-4-yloxy)-3-chlorophenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757272,0.0016,1795123,375077064,117685026,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"US9556191, example 28",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757496,0.0016,1795123,375077062,117685022,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"US9556191, example 26",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809747,0.0016,1795310,377003014,87056553,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809752,0.0016,1795310,377003044,87056555,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769296,0.00167,1905726,482063465,137535295,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402435508,0.00169,1920003,486501393,169023559,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"HER2 Kinase Activity Assay from US Patent US20230364079: 'COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF'","US20230364079, Example 145",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559051,0.0017,670126,160674391,25026281,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"2-[4-[3-chloro-4-(1H-indazol-4-yloxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629288,0.0017,1274048,336870998,127028959,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of EGFR deletion (746 to 750 residues) mutant (unknown origin),"N-(7-chloro-1H-indazol-3-yl)-2-[5-(difluoromethyl)-1H-pyrazol-4-yl]-7,7-dimethyl-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769304,0.0017,1905726,482070557,168286132,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-hydroxy-4-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757108,0.0017,1795123,375077060,117685120,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxyquinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143371,0.0017,1798142,464922025,139378130,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143905,0.0017,1798142,464922050,139378041,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4-cyclopropyl-5-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380776662,0.00176,1905775,103441767,9915743,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 R896C mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757489,0.0018,1795123,375077059,117685021,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"US9556191, example 23",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101862437,0.0019,260896,103479423,9907221,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-propynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112807,0.0019,1676531,461550340,162668115,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[5-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-(2-hydroxyethoxy)phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757287,0.0019,1795123,375077058,117685119,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"US9556191, example 22",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809775,0.0019,1795310,377003046,86764908,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102328,0.0019,1796170,381752969,132143189,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769299,0.00193,1905726,482057295,168276509,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250517,0.00196,1804976,104048227,9915743,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408018385,0.00198,1951290,103768626,10184653,2064,36804726,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503828,0.002,361654,103643990,24897043,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,"5-(Dimethyl-hydrazonomethyl)-N-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539085,0.002,410944,103768626,10184653,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573555,0.002,320572,103574167,11561779,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-pyrrolidin-1-ylethoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101613161,0.002,383073,103441767,9915743,2064,18077425,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of human Her2 in SKBR3 cells,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101613162,0.002,383074,103441767,9915743,2064,18077425,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of human Her2 in BT474 cells,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101622129,0.002,404519,103640206,11684096,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,2-(4-(3-Chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)-2-methylpropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755436,0.002,309857,103551491,44442025,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of ErbB2 kinase,(R)-N-(1-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propan-2-yl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755438,0.002,309857,103551494,44442027,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of ErbB2 kinase,(R)-N-(2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propyl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755440,0.002,309857,103551487,11706282,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of ErbB2 kinase,(R)-1-(2-((4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)methyl)pyrrolidin-1-yl)-2-hydroxyethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755441,0.002,309857,103551488,11569903,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,(S)-1-(2-((4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)methyl)pyrrolidin-1-yl)-2-hydroxyethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778366,0.002,315250,103574840,11591222,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2,(2R)-N-(2-Hydroxyethyl)-N-methyl-2-{[4-({3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)quinazolin-5-yl]oxy}propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101827305,0.002,254948,103468863,10162630,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,[3-Chloro-4-(pyrazin-2-ylmethoxy)-phenyl]-[5-(1-methyl-piperidin-4-yloxy)-quinazolin-4-yl]-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101827309,0.002,254948,103468841,10152238,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-[5-(1-methyl-piperidin-4-yloxy)-quinazolin-4-yl]-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101827310,0.002,254948,103468864,10162954,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,[3-Chloro-4-(thiazol-4-ylmethoxy)-phenyl]-[5-(1-methyl-piperidin-4-yloxy)-quinazolin-4-yl]-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101827313,0.002,254948,103468856,10288761,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,4-(3-Chloro-4-(2-pyridylmethoxy)anilino)-5-(1-methylpiperidin-4-yloxy)quinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864191,0.002,260899,103480054,11604864,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(1-piperidinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
204355680,0.002,546552,124958834,49855952,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)-N-hydroxyfuran-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321558858,0.002,670126,160669086,57413593,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"N-[2-(4-{[4-(1,2-benzoisothiazol-4-yloxy)-3-chlorophenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-2-methyl-2-(methylsulfonyl)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326050914,0.002,710623,103712586,10297043,2064,23098265,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR2,"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347032939,0.002,1242284,318385113,118073633,2064,26191356,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR E746-A750 deletion mutant in human PC9 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,"N-[(3R,4R)-4-fluoro-1-[6-[[3-methoxy-1-(1-methylpyrrolidin-3-yl)pyrazol-4-yl]amino]-9-propan-2-ylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355655809,0.002,1315979,374334920,134150417,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355688257,0.002,1330938,160708509,42642648,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Varlitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366340561,0.002,1545487,160708509,42642648,2064,30878832,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His-tagged HER2 (catalytic domain 691 to 1255 residues) using polyglutamic acid/tyrosine as substrate by spectrophotometry,Varlitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102688,0.002,1796166,381752950,132143247,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104036,0.002,1796169,381752964,132143282,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239084,0.002,1804976,441610621,51039094,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',Tucatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
409903349,0.002,1291334,312367128,71496460,2064,26968253,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Del ex19 mutant phosphorylation in human PC9 cells preincubated for 2 hrs by ELISA,N-(5-((4-(1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
101862431,0.0021,260896,103479571,11595844,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,N-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-hydroxy-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863462,0.0021,260896,103480054,11604864,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(1-piperidinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420156,0.0021,632226,136941544,56849703,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[2-(4-{[3-chloro-4-(3-chlorophenoxy)phenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethoxy]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321558859,0.0021,670126,160679731,57415537,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"2-[4-[3-Chloro-4-(1-methylindazol-4-yl)oxyanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559055,0.0021,670126,160690508,44205208,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"2-(4-{[4-(1,2-benzoisothiazol-4-yloxy)-3-chlorophenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366319121,0.0021,1532892,440163067,155543012,2064,30508379,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human N-terminal His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-methoxy-6-[3-(1,4,7,10-tetrazacyclododec-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102431,0.0021,1796170,381752957,132143245,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfanylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104029,0.0021,1796169,381752970,132143289,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142462,0.0021,1798142,464922110,139378042,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-4-methoxy-2-[(1S,5R)-3-methyl-3,6-diazabicyclo[3.2.0]heptan-6-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568317,0.0022,68096,103202152,9995195,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
321558854,0.0022,670126,160706548,57413595,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"N-[2-(4-{[4-(1,2-benzoisothiazol-4-yloxy)-3-chlorophenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-2-hydroxy-2-methylpropanamide methanesulfonate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757101,0.0022,1795123,375077063,117685086,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"US9556191, example 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104039,0.0022,1796169,381752949,132143267,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144639,0.0022,1798142,464922108,139378019,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[[6-(2-hydroxypropan-2-yl)-1H-indol-5-yl]amino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863465,0.0023,260896,103479874,11590557,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-5-(4-morpholinyl)-2-pentynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559049,0.0023,670126,160690493,57496700,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"N-(tert-butyl)-3-(2-chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino}phenoxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863469,0.0024,260896,103480042,18176200,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-(3-Bromo-phenylamino)-pyrido[3,4-d]pyrimidin-6-yl]-propynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347056686,0.0024,1250407,318392799,78209992,2064,26313252,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon19 deletion mutant (unknown origin) by HTRF assay in presence of 2mM of ATP,"(R)-4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380776663,0.0024,1905775,318405845,51039030,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 R896C mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,Pyrotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102339,0.0024,1796170,381752972,132143243,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[5-(aminomethyl)indole-1-carbonyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769556,0.00241,1905726,482067535,168283966,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-hydroxy-4-(3-methyl-4-pyrazolo[1,5-a]pyrimidin-6-yloxyanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559054,0.0025,670126,160690494,57415535,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"7-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-2,3-dihydroisoindol-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559056,0.0025,670126,160695907,25025888,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"2-(4-{[3-chloro-4-(1H-indol-4-yloxy)phenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757498,0.0025,1795123,375077061,117685130,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615741,0.0025,1919643,483622401,146510579,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 45",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102682,0.0025,1796166,381752961,132143190,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102689,0.0025,1796166,381752972,132143243,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[5-(aminomethyl)indole-1-carbonyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103133,0.0025,1796167,381752964,132143282,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769305,0.00255,1905726,482079993,137376541,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"2-methoxy-N-[(E)-3-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]prop-2-enyl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239074,0.00255,1804976,441610608,146251045,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-[(2S,4S)-2-(difluoromethyl)piperidin-4-yl]oxy-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863463,0.0026,260896,103479798,11532242,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,N-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-5-(diethylamino)pent-2-ynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354612054,0.0026,1266268,103244983,123631,2064,26706113,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR tyrosine kinase L858R mutant (unknown origin) assessed as ATP level by luminescence analysis,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102432,0.0026,1796170,381752970,132143289,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102434,0.0026,1796170,381752960,132143265,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144126,0.0026,1798142,464922061,139378015,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778727,0.0027,314965,103561956,16118310,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of erbB2,(R)-1-morpholino-2-(4-(1-(thiazol-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665449,0.0027,1168534,103177479,208908,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102438,0.0027,1796170,381752955,132162946,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-methoxyindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863459,0.0028,260896,103479868,11719423,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(bis-(1-methylethyl)amino)-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155741631,0.0028,473322,103746519,46197127,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,N-(4-(3-Bromophenylamino)quinolin-6-yl)propionamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420063,0.0028,632226,136931878,56849849,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxypropanamide methanesulfonate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112584,0.0028,1676531,103177479,208908,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809748,0.0028,1795310,377003059,87056793,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(E)-N-(7-((1R,5S,6R)-3-oxabicyclo[3.1.0]hexan-6-ylmethoxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-((R)-2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142735,0.0028,1798142,104144352,10184653,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143051,0.0028,1798142,464922111,155164952,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-4-methoxy-2-[(1S,5S)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146519,0.0028,1798142,464922052,151831901,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769559,0.00285,1905726,482051251,137376586,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-4-(dimethylamino)-N-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326008277,0.0029,689677,163337176,11678194,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"N-[2-(4-{[3-chloro-4-(3-chlorophenoxy)phenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-2-(methylsulfonyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665453,0.0029,1168534,312363555,46866616,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,6-[5-[(1S)-1-amino-2-methylsulfonylethyl]furan-2-yl]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102691,0.0029,1796166,381752953,132143292,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103026,0.0029,1796166,381752960,132143265,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindazole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103423,0.0029,1796168,381752956,132143236,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indole-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203199,0.0029,1798359,404345964,130276915,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-3-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232552,0.0029,1803904,404345964,130276915,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-3-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347987,0.0029,1919554,404345964,130276915,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-3-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146781,0.0029,1798142,464922047,139377786,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4-chloro-5-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568322,0.003,68096,103237123,10759828,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,"N-[4-(3-Chloro-4-fluoro-phenylamino)-pyrido[3,4-d]pyrimidin-6-yl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101573548,0.003,320572,103574164,11518627,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-piperazin-1-ylethoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573549,0.003,320572,103574219,11597061,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(methylamino)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573556,0.003,320572,103574264,44455293,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"1-(2-{[4-({4-[(3-fluorobenzyl)oxy]-3-methoxyphenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101584358,0.003,325824,103567541,6918508,2064,18077363,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her1,Falnidamol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780730,0.003,472049,103771162,11557040,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by HTRF assay,Lapatinib Ditosylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340039357,0.003,760330,174507796,11488320,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated HER2 phosphorylation in human MCF7 cells,Sapitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341082160,0.003,1053594,194172520,72712897,2064,24124898,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L851Q mutant (unknown origin),"7-[3-methyl-4-(4-methylpiperazin-1-yl)anilino]-3-phenyl-1-[(3S)-1-prop-2-enoylpyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347069344,0.003,1255210,318396216,72201349,2064,26396685,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR 746 to 750 deletion mutant phosphorylation in human HCC827 cells after 60 mins by mesoscale multiplex assay,"N-(3-(2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-7-oxopyrido[2,3-d]pyrimidin-8(7H)-yl)phenyl)-2-propenamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072431,0.003,1256453,123085234,11620908,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,Tak-285,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355631006,0.003,1305356,336904742,127050882,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[2-[[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]methyl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
366340611,0.003,1545490,174507796,11488320,2064,30878832,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 expressed in baculovirus/Sf21 system by ELISA,Sapitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380602618,0.003,1866989,404686722,121231412,2064,35312319,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human GST-fused EGFR T790M/C797S double mutant expressed in Sf9 insect cells by HTRF assay,"2-(5-fluoro-2-hydroxyphenyl)-2-(3-oxo-1H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380656512,0.003,1880133,103768626,10184653,2064,35439421,Confirmatory,20230629,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of wild-type HER2 phosphorylation in human BT-474 cells,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103428,0.003,1796168,381752967,132162908,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402435506,0.003,1920003,441610621,51039094,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"HER2 Kinase Activity Assay from US Patent US20230364079: 'COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF'",Tucatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144111,0.003,1798142,464922049,151331857,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[(3aR,6aR)-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-1-yl]-5-[[4-[4-cyclopropyl-5-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144409,0.003,1798142,461604657,139378120,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146300,0.0031,1798142,464922112,139377772,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[2-[(2R)-2-(azetidin-1-ylmethyl)pyrrolidin-1-yl]-5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742074,0.0032,473323,103746518,46197015,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,N-[4-(3-bromoanilino)quinolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665550,0.0032,1806610,471698512,155280356,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"1-(3-((4-((3,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)azetidin-1-yl)-prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420066,0.0033,632226,136931760,56849558,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-Chloro-4-(3-chlorophenoxy)phenyl)-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559053,0.0033,670126,160669085,44229840,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"N-[2-(4-{[4-(1,2-benzoisothiazol-4-yloxy)-3-chlorophenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-3-hydroxy-2,2-dimethylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142101,0.0033,1798142,463792094,147097681,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4-chloro-5-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769302,0.00338,1905726,482057379,168276568,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665458,0.0034,1168534,312363549,56640590,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,6-[5-(1-amino-2-methylsulfonylethyl)furan-2-yl]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354629453,0.0034,1274047,336870998,127028959,2064,26639762,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin),"N-(7-chloro-1H-indazol-3-yl)-2-[5-(difluoromethyl)-1H-pyrazol-4-yl]-7,7-dimethyl-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142096,0.0034,1798142,463792094,147097681,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4-chloro-5-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864189,0.0035,260899,103480274,11613187,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-bromo-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-methyl-1-piperazinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
204355378,0.0035,546552,124976269,49855569,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,(E)-3-(5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)thiophen-2-yl)-N-hydroxyacrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355382,0.0035,546552,124966726,49855953,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)-N-hydroxythiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355646782,0.0035,1312565,336893933,127043295,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic GST-tagged human recombinant EGFR L858R mutant expressed in baculovirus system by z-lyte assay,N-(3-chloro-4-fluorophenyl)-6-(1-methylpyrazol-4-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112376,0.0035,1676531,461531104,162654645,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[(2-benzyl-3H-benzimidazol-5-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380763549,0.0035,1904484,482060429,163408815,2064,35259690,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),pan-HER-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757493,0.0035,1795123,375077057,117685153,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145189,0.0035,1798142,464922064,139377682,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769557,0.00351,1905726,482056461,168275910,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665450,0.0036,1168534,312363548,56640520,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[1-(dimethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103287,0.0036,1796167,381752971,132162748,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(1H-indol-5-ylcarbamoyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104034,0.0036,1796169,381752961,132143190,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104281,0.0036,1796169,381752973,137554364,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-hydroxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-(1H-pyrrolo[2,3-b]pyridin-5-ylcarbamoyl)pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440051,0.0036,1920052,486503835,167318668,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 368",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699903,0.00363,1796911,384577256,118900261,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'",Synthesis of (E)-N-(7-(2-ethoxyethoxy)-4-(3-ethynylphenylamino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769300,0.00368,1905726,482052398,168272889,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372362758,0.0037,1730856,461557455,162673188,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,4-[4-[[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]triazol-1-yl]-N-hydroxybutanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372363326,0.0037,1730856,461535503,162657735,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,3-[4-[[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]triazol-1-yl]-N-hydroxypropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757106,0.0037,1795123,375077065,117685025,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"US9556191, example 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102340,0.0037,1796170,381752956,132143236,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]indole-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440364,0.0037,1920053,486503656,166927714,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 183",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101862438,0.0038,260896,103480259,11632391,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-hexynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023761,0.0038,447375,103707768,45487311,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(3S,5S,6S)-5-(hydroxycarbamoyl)-1-methyl-6-(4-phenylpiperazine-1-carbonyl)piperidin-3-yl 2,5-dihydro-1H-pyrrole-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023771,0.0038,447375,103707841,45487373,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenylpiperazine-1-carbonyl)piperidin-3-yl pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347056790,0.0038,1250365,318392787,122192382,2064,26313252,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon19 deletion mutant phosphorylation in human PC9 cells,N-(3-chloro-2-fluorophenyl)-7-methoxy-6-(morpholin-4-ylmethyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
372362760,0.0038,1730856,461535804,162657948,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,5-[4-[[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]triazol-1-yl]-N-hydroxypentanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102335,0.0038,1796170,381752973,137554364,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-hydroxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-(1H-pyrrolo[2,3-b]pyridin-5-ylcarbamoyl)pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142453,0.0038,1798142,463792125,151375040,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-dichloro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568319,0.0039,68096,103236915,5329069,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,"4-Anilinopyrido[3,4-d]pyrimidine 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
340086373,0.0039,776745,174509495,73352568,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,2-[[5-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methylamino]ethanesulfonamide;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112377,0.0039,1676531,461533564,162656366,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-(4-hydroxyanilino)-6-[4-(4-methylpiperazin-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203216,0.0039,1798359,404345935,130277020,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-chlorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232579,0.0039,1803904,404345935,130277020,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-chlorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347905,0.0039,1919554,404345935,130277020,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-chlorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380767876,0.00391,1905774,318405845,51039030,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 V777L mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,Pyrotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402435511,0.00392,1920003,486501397,169023559,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"HER2 Kinase Activity Assay from US Patent US20230364079: 'COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF'","US20230364079, Example 145",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573539,0.004,320572,103574015,11675978,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"2-[(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573550,0.004,320572,103573965,11533556,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[3-(4-methylpiperazin-1-yl)propoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573551,0.004,320572,103574115,44455195,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-methoxypiperidin-1-yl)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622142,0.004,404519,103640207,22011954,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"(5-(4-(4-(Benzyloxy)phenylamino)pyrido[3,4-d]pyrimidin-6-yl)furan-2-yl)methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755442,0.004,309857,103551489,11454712,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,N-(2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)ethyl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742028,0.004,473322,103746650,25000333,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,"N-(3-Ethynylphenyl)-6,7-dimethoxyquinolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780728,0.004,472049,103738337,24782374,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by HTRF assay,"4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-methyl-N-(2-morpholinoethyl)-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365015,0.004,549932,124969752,21874200,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-((4-aminopiperidin-1-yl)methyl)-N-(3-chlorophenyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365021,0.004,549932,124966078,21874410,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-((4-aminopiperidin-1-yl)methyl)-N-(3-bromophenyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655814,0.004,1315979,374350000,134154754,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
367502594,0.004,1667576,442053645,78322298,2064,32139324,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,"(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-pyrrolidin-1-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367502595,0.004,1667576,442062324,78322295,2064,32139324,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,"(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(diethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102337,0.004,1796170,381752949,132143267,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102679,0.004,1796166,381752962,132163054,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"2-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1,3-thiazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102681,0.004,1796166,381752959,132143252,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(4-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203164,0.004,1798359,404345914,130277012,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232613,0.004,1803904,404345914,130277012,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347897,0.004,1919554,404345914,130277012,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769301,0.00405,1905726,482062866,137376693,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoroprop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355677,0.0041,546552,124956213,49855568,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,3-{5-[4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino]quinazolin-6-yl}furan-2-yl)-N-hydroxy-acrylamideHydrochlorideMonohydrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420211,0.0041,632226,136935223,56849563,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[4-[3-Chloro-4-(3-chlorophenoxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326008278,0.0041,689677,163337177,68669354,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"N-[2-[4-[3-chloro-4-(3-chlorophenoxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methylsulfonylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615746,0.0041,1919643,483622403,146448643,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 47",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402435509,0.00419,1920003,486501394,169023647,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"HER2 Kinase Activity Assay from US Patent US20230364079: 'COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF'","US20230364079, Example 152",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100664257,0.0042,91108,103217136,9969008,2064,12039561,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2,1-(5-tert-Butyl-2-methyl-2H-pyrazol-3-yl)-3-(4-pyridin-4-ylmethyl-phenyl)-urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103435,0.0042,1796168,381752954,132143256,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439857,0.0042,1920052,486503645,166927653,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 175",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146093,0.0042,1798142,464922038,139377687,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4-cyclopropyl-5-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355646790,0.00425,1312565,336896929,127045267,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic GST-tagged human recombinant EGFR L858R mutant expressed in baculovirus system by z-lyte assay,N-(3-ethynylphenyl)-6-(1-methylpyrazol-4-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350474,0.0043,68098,103202252,9974694,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,N-[4-(3-Chloro-4-fluoro-phenylamino)-quinazolin-6-yl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568321,0.0043,68096,103202252,9974694,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,N-[4-(3-Chloro-4-fluoro-phenylamino)-quinazolin-6-yl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
106023772,0.0043,447375,103707795,45487332,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(2S,3S)-N-hydroxy-5-(2-oxo-2-(pyrrolidin-1-yl)ethyl)-2-(4-phenyl-1,2,3,6-tetrahydropyridine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747193,0.0043,474114,103749171,46865992,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-(3-(5-(2-(4-(2-(dimethylamino)ethyl)phenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2,6-difluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420212,0.0043,632226,136938449,56849846,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-hydroxyacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147260,0.0043,1798142,464922035,170776257,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[[1-[(dimethylamino)methyl]pyrrolidin-2-yl]methyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147404,0.0043,1798142,464922076,139377704,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402435507,0.00435,1920003,486501366,163420638,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"HER2 Kinase Activity Assay from US Patent US20230364079: 'COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF'","US20230364079, Example 130",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023764,0.0044,447375,103707823,45487359,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(3S,5S,6S)-5-(hydroxycarbamoyl)-1-methyl-6-(4-phenylpiperazine-1-carbonyl)piperidin-3-yl azepane-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380767875,0.0044,1905774,103441767,9915743,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 V777L mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102332,0.0044,1796170,381752961,132143190,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(6-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104028,0.0044,1796169,381752950,132143247,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203211,0.0044,1798359,404345926,130275775,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-5-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232572,0.0044,1803904,404345926,130275775,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-5-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347962,0.0044,1919554,404345926,130275775,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-5-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439866,0.0044,1920052,486503653,166927714,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 183",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142457,0.0044,1798142,464922107,139378018,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[[4-(2-hydroxypropan-2-yl)-1H-indol-5-yl]amino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143356,0.0044,1798142,464922051,150521662,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[(3aR,6aR)-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-1-yl]-5-[[4-[4,5-difluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768204,0.00443,1905793,318405845,51039030,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Pyrotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355384,0.0045,546552,103177479,208908,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112589,0.0045,1676531,461519332,162646427,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-(4-benzhydryloxyanilino)-6-[4-(4-methylpiperazin-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112716,0.0045,1676531,461545295,162664642,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[4-[(1,3-dioxoisoindol-2-yl)methoxy]anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104279,0.0045,1796169,381752962,132163054,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"2-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1,3-thiazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440495,0.0045,1920053,486503786,169552771,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 319",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146778,0.0045,1798142,464922100,139377912,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(2R,4R)-2-[(dimethylamino)methyl]-4-fluoropyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768206,0.00457,1905793,103441767,9915743,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420221,0.0046,632226,136928526,56851592,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(3-methylphenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340012324,0.0046,748805,174491210,67219433,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"1-[3-(4-Amino-7-cyclopentylpyrrolo[2,3-d]pyrimidine-5-carbonyl)phenyl]-3-(4-chlorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
388809778,0.0046,1795310,377003047,87056557,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203219,0.0046,1798359,404345922,130275229,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232548,0.0046,1803904,404345922,130275229,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347991,0.0046,1919554,404345922,130275229,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144400,0.0046,1798142,402358581,152090984,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[2-(1-hydroxycyclopropyl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355381,0.0047,546552,124961477,49855951,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,n-(2-Aminophenyl)-3-(4-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102675,0.0047,1796166,381752967,132162908,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089914,0.0047,1961745,312367127,71496458,2064,37468498,Confirmatory,20240503,0,0,Active,P04626,AC50,=,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147416,0.0047,1798142,464922039,152252426,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3S)-3-[(dimethylamino)methyl]morpholin-4-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747199,0.0048,474114,103749163,46886313,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-(3-(5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112379,0.0048,1676531,312367127,71496458,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439729,0.0048,1920052,486503522,162428888,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 50",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439769,0.0048,1920052,486503560,162428988,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 88",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440546,0.0048,1920053,486503835,167318668,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 368",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355679,0.0049,546552,124961475,49855760,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,N-(2-aminophenyl)-5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)thiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665399,0.0049,1806610,471698515,25127385,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440077,0.0049,1920052,486503861,162428812,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 396",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407927659,0.0049,1928766,494401197,171346428,2064,33226807,Confirmatory,20240503,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to HER2 in human BT-474 cells assessed as dissociation constant by measuring high affinity ligand binding site by LigandTracer technique,"(3S)-4-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-[[(2S)-5-amino-2-[[2-[2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100368718,0.005,69713,103376060,5329089,2064,11462982,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells,"4-Anilinopyrido[3,4-d]pyrimidine 28",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539064,0.005,410944,103771162,11557040,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,Lapatinib Ditosylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573545,0.005,320572,103574404,11698913,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"1-{2-[(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethyl}piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573547,0.005,320572,103574313,44455330,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"1-{2-[(4-{[3-methyl-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethyl}piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573557,0.005,320572,103574309,11670167,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"1-(2-{[4-({3-fluoro-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101827306,0.005,254948,103468834,44403420,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,[3-Chloro-4-(pyridin-2-ylmethoxy)-phenyl]-[7-methoxy-5-(4-methyl-piperidin-1-yloxy)-quinazolin-4-yl]-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864182,0.005,260899,103480044,11568720,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pentynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
151257325,0.005,454329,103717567,46225657,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-3-methoxyphenyl]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365020,0.005,549932,124956505,21874287,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-((4-aminopiperidin-1-yl)methyl)-N-m-tolylpyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456058,0.005,624804,103768626,10184653,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326078560,0.005,719887,103202250,156414,2064,22621397,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655805,0.005,1315979,374265485,134130825,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380658224,0.005,1880127,103441767,9915743,2064,35439421,Confirmatory,20230629,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of HER2 phosphorylation in human BT-474 cells incubated for 3 hrs followed by replacement with fresh medium without compound measured after 5 hrs by immunoblot analysis,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380826208,0.005,1913375,160681951,15606394,2064,"",Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Affinity Biochemical interaction (Competition binding assay (DiscoverX)) EUB0000596aBDA ERBB2,Afatinib Dimaleate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809751,0.005,1795310,377003013,87056475,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'",(E)-N-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-4-(2-(hydroxymethyl)azetidin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809777,0.005,1795310,377003057,87056714,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(E)-N-(7-(((S)-1,4-dioxan-2-yl)methoxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615761,0.005,1919643,483622400,146448661,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 44",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103293,0.005,1796168,381752964,132143282,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203227,0.005,1798359,404345989,130276397,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-5-fluoro-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232578,0.005,1803904,404345989,130276397,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-5-fluoro-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402353779,0.005,1919554,404345989,130276397,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-5-fluoro-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147225,0.005,1798142,464922044,139377792,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3S)-3-[(dimethylamino)methyl]morpholin-4-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420155,0.0051,632226,136928639,11684629,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethoxy)ethan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432834,0.0052,1919984,486499646,168257664,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"Synthesis of (E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-4-(bis(methyl-d3)amino)but-2-en-1-one formic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440335,0.0052,1920053,486503628,166927715,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 156",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018067,0.0052,1920044,486499650,168258054,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363684693,0.0053,1424370,312468004,25127713,2064,28754471,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of GST-tagged human HER2 catalytic domain expressed in insect cells,Poziotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103029,0.0053,1796166,381752954,132143256,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103437,0.0053,1796168,381752953,132143292,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144644,0.0053,1798142,464922040,139378098,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863461,0.0054,260896,103479579,11524106,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-heptynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372339077,0.0054,1718898,461541674,162662079,2064,33314925,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of substrate incubated for 30 mins by ADP-Glo assay,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372362757,0.0054,1730856,461557896,162673495,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,3-[4-[[4-(3-chloro-4-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]triazol-1-yl]-N-hydroxypropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102685,0.0054,1796166,381752973,137554364,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-hydroxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-(1H-pyrrolo[2,3-b]pyridin-5-ylcarbamoyl)pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203218,0.0054,1798359,404345950,130277061,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methoxyphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232567,0.0054,1803904,404345950,130277061,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methoxyphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347951,0.0054,1919554,404345950,130277061,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methoxyphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432857,0.00548,1919984,486499669,168257443,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[2-fluoro-3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018099,0.00548,1920044,486503219,169552743,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[2-fluoro-3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640544,0.00549,1309513,336906113,127051867,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4R)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103139,0.0055,1796167,381752958,132143198,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfonylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432869,0.0055,1919984,486499680,168257936,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018114,0.0055,1920044,486503241,169552736,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142112,0.0055,1798142,459092840,139378118,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142446,0.0055,1798142,459092840,139378118,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147230,0.0055,1798142,464922034,139377695,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxy-2-[methyl-[[(2R)-1-methylpyrrolidin-2-yl]methyl]amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432847,0.00554,1919984,486499659,168257497,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-(3-methyl-4-pyridin-3-yloxyanilino)-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018089,0.00554,1920044,486503209,169552737,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-(3-methyl-4-pyridin-3-yloxyanilino)-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769298,0.00557,1905726,103441767,9915743,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239079,0.00557,1804976,441610600,146250832,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-N-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyphenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023766,0.0056,447375,103707796,45487333,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenyl-1,2,3,6-tetrahydropyridine-1-carbonyl)piperidin-3-yl pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023774,0.0056,447375,103707870,45487398,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(2S,3S)-N-hydroxy-5-(2-oxo-2-(pyrrolidin-1-yl)ethyl)-2-((R)-3-phenylpyrrolidine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439733,0.0056,1920052,486503526,167318585,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 54",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440311,0.0056,1920053,486503604,167318605,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 132",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440342,0.0056,1920053,486503635,167318565,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 165",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640224,0.00562,1309513,336902654,127049380,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4S)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350469,0.0057,68098,103202674,4708,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568313,0.0057,68096,103202674,4708,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
204355383,0.0057,546552,124956215,49855759,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,N-(2-aminophenyl)-5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420065,0.0057,632226,136941656,56849847,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-hydroxy-N-methylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420354,0.0057,632227,136941544,56849703,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[2-(4-{[3-chloro-4-(3-chlorophenoxy)phenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethoxy]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372362761,0.0057,1730856,461537057,162658837,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,4-[4-[[4-(3-chloro-4-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]triazol-1-yl]-N-hydroxybutanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439869,0.0057,1920052,486503656,166927714,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 183",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439816,0.0058,1920052,486503604,167318605,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 132",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440361,0.0058,1920053,486503653,166927714,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 183",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250514,0.00584,1804976,441610618,155926699,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340069402,0.0059,770082,103177459,176870,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
402203233,0.0059,1798359,404345925,130275774,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-bromo-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232574,0.0059,1803904,404345925,130275774,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-bromo-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402353780,0.0059,1919554,404345925,130275774,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-bromo-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440348,0.0059,1920053,486503641,167318565,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 165",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564656,0.006,367174,103610163,25195273,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573554,0.006,320572,103574014,11547991,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"1-{3-[(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]propyl}piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101596685,0.006,331423,103563549,17747343,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,4-Amino-6-{[1-(3-Fluorobenzyl)-1h-Indazol-5-Yl]amino}pyrimidine-5-Carbaldehyde O-(2-Methoxyethyl)oxime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778073,0.006,314962,103561946,16117483,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,"(S)-2-(4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)-N,N-dimethylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
204365014,0.006,549932,124964358,21874248,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-((4-aminopiperidin-1-yl)methyl)-N-(3-fluorophenyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365022,0.006,549932,124956507,11440253,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-[(4-aminopiperidin-1-yl)methyl]-N-(3-chloro-4-fluorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365023,0.006,549932,124956506,21874431,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-((4-aminopiperidin-1-yl)methyl)-N-p-tolylpyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456620,0.006,624804,103441767,9915743,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559061,0.006,670126,160669075,25026085,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"2-[4-[4-(1-Benzothiophen-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347032935,0.006,1242284,318385114,118073630,2064,26191356,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR E746-A750 deletion mutant in human PC9 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,"N-[(3R,4R)-1-[6-[(1-ethyl-3-methoxypyrazol-4-yl)amino]-9-methylpurin-2-yl]-4-fluoropyrrolidin-3-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
347068983,0.006,1255210,318396215,122195059,2064,26396685,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR 746 to 750 deletion mutant phosphorylation in human HCC827 cells after 60 mins by mesoscale multiplex assay,N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[6-(1-methylindol-3-yl)pyrazin-2-yl]amino]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380667925,0.006,1882631,103712586,10297043,2064,35311289,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402178306,0.006,1801898,317227920,71014491,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Time-Resolved Fret (TR-FRET) Assay from US Patent US9187459: 'Quinazoline-7-ether compounds and methods of use',(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(3-oxabicyclo[3.1.0]hexan-6-ylmethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203228,0.006,1798359,404345947,130276395,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-4-(1-(1-acryloylpiperidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido) naphthalen-1-yl dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232564,0.006,1803904,404345947,130276395,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-4-(1-(1-acryloylpiperidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido) naphthalen-1-yl dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347954,0.006,1919554,404345947,130276395,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","(R)-4-(1-(1-acryloylpiperidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido) naphthalen-1-yl dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440190,0.006,1920053,486503489,169552757,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 17",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380779844,0.00609,1905772,103441767,9915743,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 D769H mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321559050,0.0061,670126,160695923,57413597,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"N-[2-[4-[4-(1,2-benzothiazol-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2,2-dimethylpropanamide;methanesulfonic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372339078,0.0061,1718898,461557889,162673490,2064,33314925,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of substrate incubated for 30 mins by ADP-Glo assay,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143364,0.0061,1798142,464922021,139378104,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[(3aR,6aR)-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-1-yl]-5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250510,0.00617,1804976,441610616,146241231,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',Her2-IN-7,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250512,0.00617,1804976,441610595,146240745,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-[[(1S,5R)-8-(2,2-difluoroethyl)-8-azabicyclo[3.2.1]octan-3-yl]oxy]-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347056782,0.0062,1250365,103244983,123631,2064,26313252,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon19 deletion mutant phosphorylation in human PC9 cells,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
372362762,0.0062,1730856,461535527,162657752,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,(E)-N-[4-(3-chloro-4-fluoroanilino)-6-[(3R)-oxolan-3-yl]oxyquinazolin-7-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142737,0.0062,1798142,464922053,139378137,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747202,0.0063,474114,103749161,46886311,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-(3-(5-(2-(phenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326008275,0.0063,689677,163337174,57597166,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-(methylsulfonyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103027,0.0063,1796166,381752974,132143285,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]pyrrolo[2,3-b]pyridine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440352,0.0063,1920053,486503645,166927653,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 175",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769558,0.00631,1905726,482056533,168275958,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350475,0.0064,68098,103202311,9897300,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,N-[4-[(3-Bromophenyl)amino]-7-(3-morpholinopropoxy)quinazoline-6-yl]acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372344341,0.0064,1720526,136940589,24821094,2064,32527559,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant ERBB2 (676 to 1255 residues) expressed in baculovirus expression system using Tyr 06 as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay,Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380622128,0.0064,1871766,136940589,24821094,2064,34839996,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin),Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615743,0.0064,1919643,483622410,146510098,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 68",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103421,0.0064,1796168,381752968,132143255,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-2,3-dihydroindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439840,0.0064,1920052,486503628,166927715,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 156",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769561,0.00642,1905726,482079077,168292331,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-hydroxy-4-(4-imidazo[1,2-a]pyridin-6-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665826,0.0065,1806610,471698527,25128361,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203240,0.0065,1798359,404345943,130277060,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2-chlorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232636,0.0065,1803904,404345943,130277060,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2-chlorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402353782,0.0065,1919554,404345943,130277060,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2-chlorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757275,0.0066,1795123,375077066,117685087,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-7-ethoxyquinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380779170,0.00665,1905772,318405845,51039030,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 D769H mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,Pyrotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615756,0.0067,1919643,483622404,146448652,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 48",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440544,0.0067,1920053,486503833,167318705,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 366",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086369,0.0068,776745,312397805,118738356,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,1-[4-[[5-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methyl]piperazin-1-yl]ethanone;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143359,0.0068,1798142,464922101,155164971,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-4-methoxy-2-[(1R,5R)-6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239081,0.00683,1804976,441610598,146240742,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(4,4-difluoro-1-methylpiperidin-3-yl)oxy-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432868,0.00684,1919984,486499680,168257936,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018087,0.00684,1920044,486503208,169552736,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239075,0.00686,1804976,441610594,146240642,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380688714,0.0069,1887679,374263426,51039094,2064,34624192,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST fused HER2 (679 to 1255 residues) (unknown origin) using poly (Glu-Tyr) E4Y1 peptide as substrate measured after 4 hrs by ADP-Glo reagent method,Tucatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768205,0.0069,1905793,374263426,51039094,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Tucatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250504,0.00692,1804976,441610601,146241576,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)-7-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
40272542,0.007,1433,50100107,208908,2064,"",Other,20170124,0,0,Active,NP_001005862,"","",Ambit Biosciences,Kinase Inhibitor Selectivity Profiling Assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503821,0.007,361654,103643991,24897277,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,"N-[1-(3-Fluoro-benzyl)-1H-indazol-5-yl]-5-[morpholin-4-yliminomethyl]-pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595841,0.007,331423,103563594,17747139,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"5-[(E)-ethoxyiminomethyl]-4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675485,0.007,290549,103523385,11365185,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"N-(2,6-difluorophenyl)-4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
106001750,0.007,435796,103177479,208908,2064,18183025,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780734,0.007,472049,103738238,24786207,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by HTRF assay,"4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2-(diethylamino)ethyl)-3-methyl-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365024,0.007,549932,124969751,11382411,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-((4-aminopiperidin-1-yl)methyl)-N-(3-ethynylphenyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456602,0.007,624804,103177479,208908,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342753077,0.007,1155500,242648958,71556703,2064,24915291,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 1 hr by HTRF assay,2-methyl-N-[2-({3-[2-(prop-2-enamido)acetamido]phenyl}amino)pyrimidin-5-yl]-5-[3-(trifluoromethyl)benzamido]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757679,0.007,1795123,375077068,117685027,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3,4-dichloro-2-fluorophenyl)amino)-7-ethoxyquinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103425,0.007,1796168,381752950,132143247,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203208,0.007,1798359,404345934,130276950,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232617,0.007,1803904,404345934,130276950,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347889,0.007,1919554,404345934,130276950,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439695,0.007,1920052,486503489,169552757,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 17",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147409,0.007,1798142,464922093,139377750,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]-4,4-difluoropyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326008276,0.0071,689677,163313035,57597387,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methylsulfonylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665534,0.0071,1806610,471698512,155280356,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"1-(3-((4-((3,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)azetidin-1-yl)-prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203177,0.0071,1798359,404345915,130277015,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203232,0.0071,1798359,404345911,130276342,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-3-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232538,0.0071,1803904,404345915,130277015,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232624,0.0071,1803904,404345911,130276342,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-3-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347886,0.0071,1919554,483499798,168474839,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347997,0.0071,1919554,404345915,130277015,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440152,0.0071,1920052,486503936,167318873,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 471",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747188,0.0072,474114,103749173,46886322,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"2,6-difluoro-N-(3-(5-(2-(1,2,3,4-tetrahydroisoquinolin-6-ylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420234,0.0072,632227,136931878,56849849,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxypropanamide methanesulfonate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350470,0.0073,68098,103202775,10691590,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,N-[4-(3-Bromo-4-fluoro-phenylamino)-quinazolin-6-yl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568314,0.0073,68096,103202775,10691590,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,N-[4-(3-Bromo-4-fluoro-phenylamino)-quinazolin-6-yl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
106023775,0.0073,447375,103707798,45487335,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(3S,5S,6S)-5-(hydroxycarbamoyl)-1-methyl-6-(4-phenylpiperazine-1-carbonyl)piperidin-3-yl piperidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372363325,0.0073,1730856,461522320,162648529,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,5-[4-[[4-(3-chloro-4-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]triazol-1-yl]-N-hydroxypentanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769307,0.0073,1905726,482049765,168271074,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615734,0.0073,1919643,483622402,146510144,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 46",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440052,0.0073,1920052,486503836,167318909,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 369",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432828,0.00736,1919984,486499640,168257578,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018062,0.00736,1920044,486499641,168258024,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864175,0.0074,260899,103673639,156413,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,Canertinib dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
347056786,0.0074,1250365,318392799,78209992,2064,26313252,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon19 deletion mutant phosphorylation in human PC9 cells,"(R)-4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
366369534,0.0074,1560827,318464585,71226662,2064,32083858,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to DNA-tagged recombinant ERBB2 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis,Acalabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864192,0.0075,260899,103479572,11553647,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(diethylamino)-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
198359656,0.0075,517501,123087720,20817111,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102684,0.0075,1796166,381752964,132143282,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203170,0.0075,1798359,404345920,130276911,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203207,0.0075,1798359,404345919,130275835,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[3-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232561,0.0075,1803904,404345920,130276911,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232614,0.0075,1803904,404345919,130275835,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[3-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347961,0.0075,1919554,404345920,130276911,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347994,0.0075,1919554,404345919,130275835,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[3-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439847,0.0075,1920052,486503635,167318565,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 165",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146786,0.0075,1798142,464922056,139377809,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',Sunvozertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239078,0.00756,1804976,441610605,146240651,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-[(4S)-1-ethyl-3,3-difluoropiperidin-4-yl]oxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568324,0.0076,68096,103237500,9930632,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,N-(4-[4-benzyloxyanilino]quinazolin-6-yl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101864185,0.0076,260899,103479874,11590557,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-5-(4-morpholinyl)-2-pentynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
402102329,0.0076,1796170,381752962,132163054,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"2-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1,3-thiazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439837,0.0076,1920052,486503625,166927674,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 153",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440060,0.0076,1920052,486503844,167318648,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 377",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144121,0.0076,1798142,464922033,151063012,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxy-2-[methyl(2-pyrrolidin-1-ylethyl)amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420154,0.0077,632226,136922139,56850930,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,Egfr/her2-IN-11,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420621,0.0077,632227,136938323,56851594,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112588,0.0077,1676531,103768626,10184653,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203203,0.0077,1798359,404345981,130277074,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-4-(1-(1-acryloylpyrimidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido)-3-methylphenyl methyl(phenyl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232626,0.0077,1803904,404345981,130277074,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-4-(1-(1-acryloylpyrimidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido)-3-methylphenyl methyl(phenyl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347948,0.0077,1919554,483499865,168474848,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 68",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640232,0.00779,1309513,336905673,127051556,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4S)-N-[4-(3-chloro-4-fluoroanilino)-7-(2-piperidin-1-ylethoxy)quinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145457,0.0078,1798142,464922037,139377696,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146083,0.0078,1798142,464922036,139369413,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[[6-(2-hydroxypropan-2-yl)-1-methylindol-5-yl]amino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147414,0.0078,1798142,464922060,139377930,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250513,0.00786,1804976,441610603,146250709,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,7-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112720,0.0079,1676531,461533457,162656290,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[(1-benzylindol-5-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103284,0.0079,1796167,381752965,132163000,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103296,0.0079,1796168,381752971,132162748,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(1H-indol-5-ylcarbamoyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439678,0.0079,1920052,486503474,162428954,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239072,0.00796,1804976,441610597,146241248,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-[[(2R)-4,4-difluoro-1-methylpiperidin-2-yl]methoxy]-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503824,0.008,361654,103643993,24897278,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,"N4-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((4-methylpiperazin-1-ylimino)methyl)pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503830,0.008,361654,103644047,44587569,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,2-(4-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidin-5-yl)methyleneamino)piperazin-1-yl)ethanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622130,0.008,404519,103641276,44586019,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"3-Azabicyclo(3.1.0)hexane-6-methanol, 3-((4-(4-((3-methoxy-4-phenoxyphenyl)amino)-6-quinazolinyl)phenyl)methyl)-, (1alpha,5alpha,6alpha)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622137,0.008,404519,103441682,11342331,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,N-(4-(4-(3-chlorobenzyloxy)-3-chlorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778080,0.008,314962,103561945,16117348,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,"(R)-2-(4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)-N,N-dimethylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101778728,0.008,314965,103561936,16116961,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"(R)-N,N-dimethyl-2-(4-(1-(pyridin-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821637,0.008,248914,103441682,11342331,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,N-(4-(4-(3-chlorobenzyloxy)-3-chlorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420218,0.008,632226,136925311,56851431,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[2-chloro-4-(5H-pyrrolo[3,2-d]pyrimidin-4-ylamino)phenoxy]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347032658,0.008,1242284,318385110,118073591,2064,26191356,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR E746-A750 deletion mutant in human PC9 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,"1-[(3aS,6aR)-2-[6-[4-(4-methylpiperazin-1-yl)anilino]-9-propan-2-ylpurin-2-yl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
354665406,0.008,1289551,103177459,176870,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR deletion mutant autophosphorylation in human HCC827 cells after 2 hrs by sandwich ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354669916,0.008,1291349,318422521,71667668,2064,26968253,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Del ex19 mutant in human HCC827 cells assessed as suppression of cell proliferation,Naquotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354669921,0.008,1291350,318422521,71667668,2064,26968253,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Del ex19 mutant in human PC9 cells assessed as suppression of cell proliferation,Naquotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355630499,0.008,1305356,336906413,127052094,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(2-hydroxyethyl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
372363324,0.008,1730856,461557047,162672887,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,4-[4-[[4-(3-chloro-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]triazol-1-yl]-N-hydroxybutanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615733,0.008,1919643,483622389,146510153,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',Her2-IN-13,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102435,0.008,1796170,381752974,132143285,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]pyrrolo[2,3-b]pyridine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439959,0.008,1920052,486503746,169552767,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 276",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440333,0.008,1920053,486503626,167318894,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 154",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144877,0.008,1798142,464922048,151671673,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxy-2-[methyl-[[(2S)-1-methylpyrrolidin-2-yl]methyl]amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100368719,0.0081,69713,103375950,5329090,2064,11462982,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells,"4-Anilinopyrido[3,4-d]pyrimidine 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023762,0.0081,447375,103707872,45487400,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(2S,3S,5S)-methyl 3-(hydroxycarbamoyl)-2-(4-phenylpiperazine-1-carbonyl)-5-(pyrrolidine-1-carbonyloxy)piperidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363920736,0.0081,1481345,381839686,127264586,2064,28282122,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human IgG1 Fc-tagged ERBB2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus by Z'-LYTE assay,Chmfl-egfr-202,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757282,0.0081,1795123,375077052,117685126,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"US9556191, example 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809774,0.0081,1795310,377003045,87056556,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350479,0.0082,68098,103202774,10673774,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,N-[4-(3-Bromo-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420215,0.0082,632226,136928514,56851432,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"3-[2-chloro-4-(5H-pyrrolo[3,2-d]pyrimidin-4-ylamino)phenoxy]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439879,0.0082,1920052,486503666,167318849,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 196",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440101,0.0082,1920052,486503885,167318704,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 420",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440435,0.0082,1920053,486503727,167318720,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 257",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144887,0.0082,1798142,464922074,139377693,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-[2-(1,1,1-trifluoro-2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420163,0.0083,632226,136932767,56851430,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(3-chlorophenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372339081,0.0083,1718898,461557934,162673523,2064,33314925,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of substrate incubated for 30 mins by ADP-Glo assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203223,0.0083,1798359,404345910,130275832,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-5-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232586,0.0083,1803904,404345910,130275832,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-5-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347908,0.0083,1919554,483499797,168474838,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440049,0.0083,1920052,486503833,167318705,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 366",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432846,0.00838,1919984,486499658,168257936,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018086,0.00838,1920044,486503208,169552736,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840045,0.0084,256662,103202250,156414,2064,15711537,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420064,0.0084,632226,136941654,56849704,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[2-[4-[3-Chloro-4-[3-(trifluoromethoxy)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethoxy]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440115,0.0084,1920052,486503899,167318796,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 434",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147159,0.0084,1798142,464922059,139377746,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432854,0.00841,1919984,486499666,168257746,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-1-[(14S)-5-[3-chloro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]-4-(dimethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018096,0.00841,1920044,486503216,168762333,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-1-[(14R)-5-[3-chloro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]-4-(dimethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106024076,0.0085,447375,103707821,45487357,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"propan-2-yl N-[(5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenyl-3,6-dihydro-2H-pyridine-1-carbonyl)piperidin-3-yl]-N-methylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326008274,0.0085,689677,163313033,71449341,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-ethylsulfonylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340085733,0.0085,776745,174524982,71726907,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfinylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203214,0.0085,1798359,404345962,130276393,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-ethenylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232615,0.0085,1803904,404345962,130276393,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-ethenylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347949,0.0085,1919554,404345962,130276393,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-ethenylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439851,0.0085,1920052,486503639,167318776,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 169",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568320,0.0086,68096,103237501,10547930,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,N-(4-[4-phenoxyanilino]quinazolin-6-yl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
340085732,0.0086,776745,174504389,73351100,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[2-(2,2,2-trifluoroethylsulfonyl)ethylamino]methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104040,0.0086,1796169,381752968,132143255,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-2,3-dihydroindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203215,0.0086,1798359,404345923,130276918,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-(difluoromethoxy)-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232568,0.0086,1803904,404345923,130276918,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-(difluoromethoxy)-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347896,0.0086,1919554,404345923,130276918,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-(difluoromethoxy)-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439681,0.0086,1920052,486503476,162428791,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 4",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440111,0.0086,1920052,486503895,167318597,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 430",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440264,0.0086,1920053,486503560,162428988,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 88",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432865,0.00869,1919984,486499677,168257557,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-1-[(14S)-5-[5-chloro-2-fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]-4-(dimethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018106,0.00869,1920044,486503227,168762272,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-1-[(14R)-5-[5-chloro-2-fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]-4-(dimethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355377,0.0087,546552,124969426,49855761,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,N-(2-aminophenyl)-3-(5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)furan-2-yl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340070336,0.0087,770082,103244983,123631,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
402203192,0.0087,1798359,404345944,130276352,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2-methylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232571,0.0087,1803904,404345944,130276352,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2-methylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347893,0.0087,1919554,404345944,130276352,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2-methylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440081,0.0087,1920052,486503865,167318685,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 400",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100569046,0.0088,68097,103236916,10662351,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB-453 cells.,"N-(4-m-Tolylamino-pyrido[3,4-d]pyrimidin-6-yl)-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
402432875,0.00884,1919984,486499685,168257593,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[4-(5-fluoropyridin-3-yl)oxy-3-methylanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018112,0.00884,1920044,486503234,169552751,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[4-(5-fluoropyridin-3-yl)oxy-3-methylanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104030,0.0089,1796169,381752954,132143256,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439680,0.0089,1920052,486503476,162428791,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 4",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147250,0.0089,1798142,464922082,139377714,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(1-hydroxycyclobutyl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432861,0.00892,1919984,486499673,168258025,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[3-fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018102,0.00892,1920044,486503223,169552745,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350473,0.009,68098,103202250,156414,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100368721,0.009,69713,103673639,156413,2064,11462982,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells,Canertinib dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707258,0.009,68106,103177479,208908,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101565331,0.009,367174,103771162,11557040,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,Lapatinib Ditosylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622131,0.009,404519,103303552,5328967,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-Anilinoquinazoline deriv. 10n,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622134,0.009,404519,103177479,208908,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880672,0.009,263981,103486155,11657332,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,1-((6-(2-(4-(4-(3-Fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)pyridin-2-yl)methyl)-3-(2-(methylsulfonyl)ethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880673,0.009,263981,103177479,208908,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204367026,0.009,549932,124964357,11220978,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-((4-aminopiperidin-1-yl)methyl)-N-phenylpyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402350,0.009,580189,103771162,11557040,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,Lapatinib Ditosylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435412,0.009,638068,103177479,208908,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435416,0.009,638068,103771162,11557040,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,Lapatinib Ditosylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347032943,0.009,1242284,318385109,118073677,2064,26191356,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR E746-A750 deletion mutant in human PC9 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,"N-((3R,4R)-4-fluoro-1-(9-isopropyl-6-((1-methyl-1H-pyrazol-4-yl)amino)-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
347068987,0.009,1255210,318396227,86303858,2064,26396685,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR 746 to 750 deletion mutant phosphorylation in human HCC827 cells after 60 mins by mesoscale multiplex assay,Egfr-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072437,0.009,1256453,103177479,208908,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354669869,0.009,1291348,336877076,72703790,2064,26968253,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant in human H3255 cells assessed as suppression of cell proliferation,Nazartinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630184,0.009,1305356,336906861,127052414,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(1-propan-2-ylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355630503,0.009,1305356,336902537,127049308,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-(1-methylpyrazol-4-yl)pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355631302,0.009,1305356,336905525,127051445,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355654677,0.009,1315425,374297454,134139995,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[3-Chloro-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-chloroacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380639276,0.009,1876118,103202250,156414,2064,33539089,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERbB2 (unknown origin),Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380667929,0.009,1882631,103202250,156414,2064,35311289,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388836056,0.009,1795774,8035064,208908,2064,14684309,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/j.bmcl.2003.10.010: 'Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.',Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388996180,0.009,1798859,8035064,208908,2064,18287036,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Receptor Tyrosine Kinase Inhibition Assay from Article 10.1073/pnas.0708281105: '6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.'",Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103124,0.009,1796167,381752951,132143272,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104280,0.009,1796169,381752965,132163000,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432870,0.009,1919984,486499680,168257936,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018115,0.009,1920044,486503241,169552736,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144405,0.009,1798142,464922045,150895835,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[(3aR,6aR)-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-1-yl]-5-[[4-[4-chloro-5-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145700,0.009,1798142,464922069,139377957,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-dichloro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769297,0.00907,1905726,318405845,51039030,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,Pyrotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112590,0.0091,1676531,123085234,11620908,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,Tak-285,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757484,0.0091,1795123,375077067,86305720,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665732,0.0091,1806610,471698512,155280356,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"1-(3-((4-((3,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)azetidin-1-yl)-prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440374,0.0091,1920053,486503666,167318849,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 196",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420666,0.0092,632227,136931760,56849558,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-Chloro-4-(3-chlorophenoxy)phenyl)-5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355689462,0.0092,1330936,103177479,208908,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) expressed in baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKKCONH2 as substrate and [gamma32]-ATP measured after 10 mins by Topcount scintillation counting method,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363684688,0.0092,1424362,103177479,208908,2064,28754471,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367495711,0.0092,1664189,103177479,208908,2064,32631510,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380667928,0.0092,1882631,103177479,208908,2064,35311289,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615751,0.0092,1919643,483622373,146448693,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',hERG-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203201,0.0092,1798359,404345982,130276350,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-Amino-1-(1-prop-2-enoyl-2,4-dihydropyrimidin-3-yl)pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203222,0.0092,1798359,404345916,130276925,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[3-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232560,0.0092,1803904,404345916,130276925,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[3-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347956,0.0092,1919554,404345982,130276350,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-Amino-1-(1-prop-2-enoyl-2,4-dihydropyrimidin-3-yl)pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347998,0.0092,1919554,404345916,130276925,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[3-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420166,0.0093,632226,136921997,56851427,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(2-fluorophenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112803,0.0093,1676531,461536074,162658142,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[5-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-(3-hydroxypropoxy)phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615867,0.0093,1919643,483622385,162496349,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203229,0.0093,1798359,404345946,130277051,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,3-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232628,0.0093,1803904,404345946,130277051,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,3-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347882,0.0093,1919554,404345946,130277051,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,3-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439903,0.0093,1920052,486503690,166927720,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 220",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147556,0.0093,1798142,464922098,139377846,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3S)-3-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147558,0.0093,1798142,464922042,139377775,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250509,0.00938,1804976,441610594,146240642,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420213,0.0094,632226,136941655,56851051,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-({2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}thio)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363658618,0.0094,1412710,136940589,24821094,2064,30108960,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human ErbB2 using using poly (4:1 Glu, Tyr) as substrate measured after 1 hr in presence of [gamma-33P]ATP",Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363936474,0.0094,1488738,136940589,24821094,2064,28734581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 (unknown origin),Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372334878,0.0094,1714839,136940589,24821094,2064,29324347,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErBB2 (unknown origin),Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389158970,0.0094,1801874,136961336,24821094,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HotSpot kinase assay from US Patent US9181263: 'Inhibitors of bruton's tyrosine kinase',Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103281,0.0094,1796167,381752952,132143259,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440145,0.0094,1920052,486503929,167318897,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 464",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440558,0.0094,1920053,486503847,167318671,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 381",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402435510,0.00944,1920003,486501395,169023528,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"HER2 Kinase Activity Assay from US Patent US20230364079: 'COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF'","US20230364079, Example 155",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420567,0.0095,632227,136935223,56849563,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[4-[3-Chloro-4-(3-chlorophenoxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665544,0.0095,1806610,471698515,25127385,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668120,0.0095,1806610,471698530,155243064,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 30",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615869,0.0095,1919643,483622387,168489963,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145174,0.0095,1798142,464922030,139377722,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxy-2-[methyl(2-piperidin-1-ylethyl)amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239073,0.00956,1804976,441610612,146243560,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-[(2S,4S)-5,5-difluoro-1,2-dimethylpiperidin-4-yl]oxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366319120,0.0096,1532892,440114942,155513959,2064,30508379,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human N-terminal His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-methoxy-6-[3-(1,4,7-triazonan-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757276,0.0096,1795123,375077069,86305721,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3,4-dichloro-2-fluorophenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809755,0.0096,1795310,377003051,87056716,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'",(E)-N-(4-(3-chloro-4-fluorophenylamino)-7-((S)-tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(2-(hydroxymethyl)azetidin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439823,0.0096,1920052,486503611,166927757,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 139",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440572,0.0096,1920053,486503861,162428812,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 396",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112809,0.0097,1676531,103441767,9915743,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440664,0.0097,1920053,486503953,167318881,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 489",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432823,0.00977,1919984,486499637,168258126,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018059,0.00977,1920044,486499638,168258063,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359664,0.0098,517501,123096639,52946371,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-isopropylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366340671,0.0098,1545519,103177479,208908,2064,30878832,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380718916,0.0098,1894160,103177479,208908,2064,33540357,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615754,0.0098,1919643,483622418,146448754,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 79",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439682,0.0098,1920052,486503477,166928114,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 5",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407913630,0.0098,1924192,103177479,208908,2064,33650861,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615856,0.0099,1919643,483622413,146448647,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 74",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432858,0.00992,1919984,486499670,168257664,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"Synthesis of (E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-4-(bis(methyl-d3)amino)but-2-en-1-one formic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018068,0.00992,1920044,486499650,168258054,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100706973,0.01,68106,103592520,5329492,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541193,0.01,410949,103606835,11307581,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541199,0.01,410949,103607072,25263279,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541203,0.01,410949,103606906,11273032,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622140,0.01,404519,103592266,5329480,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,GW583340 dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675437,0.01,290550,103523376,44426278,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"1-(4-(4-(6-(Dimethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675446,0.01,290550,103523392,44426288,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"4-(4-(6-(dimethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675739,0.01,290550,103523377,44426279,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"3,3-Dimethyl-1-(4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidin-1-yl)butan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675741,0.01,290550,103523393,44426289,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"4-(2-methyl-4-(6-(pyrrolidin-1-yl)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821948,0.01,248914,103441723,11227115,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(2-chlorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912902,0.01,270616,103177479,208908,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023779,0.01,447375,103707807,45487343,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(2S,3S)-N-hydroxy-5-(N-methylbenzamido)-2-(4-phenyl-1,2,3,6-tetrahydropyridine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155734505,0.01,463639,103177479,208908,2064,20166671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420571,0.01,632227,136938449,56849846,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-hydroxyacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354665784,0.01,1289555,103177459,176870,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant autophosphorylation in human H3255 cells after 2 hrs by sandwich ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630495,0.01,1305356,336902535,127049306,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,"N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]imidazo[4,5-c]pyridin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355656240,0.01,1315979,374353332,134155700,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355688813,0.01,1330940,103641275,9874913,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human GST-fused HER2 (675 to 1255 residues) assessed as phosphotyrosine formation using poly(Glu:Tyr, 4:1) as substrate and ATP measured after 6 mins",2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363852960,0.01,1450721,381845098,137637094,2064,28714692,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant ErbB2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",4-fluoro-2-[5-[[(1R)-2-hydroxy-1-phenylethyl]amino]-3-(3-methyl-2H-indazol-5-yl)pyridin-2-yl]phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366340497,0.01,1545483,103641275,9874913,2064,30878832,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant GST-tagged HER2 (unknown origin) (catalytic domain 675 to 1225) residues expressed in baculovirus-infected Sf9 cells assessed as reduction of phosphorylation of polyglutamic acid/tyrosine incubated for 25 mins by spectrometery,2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
372117264,0.01,1678845,103641275,9874913,2064,33479663,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown orgin),2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372339365,0.01,1718806,103641275,9874913,2064,33314925,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant HER2 (675 to 1255) (unknown origin) expressed in baculovirus infected Sf9 insect cells using poly-Glu-Tyr as substrate incubated for 5 mins in presence of ATP measured after 25 mins by dye based colorimetric analysis,2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837163,0.01,1795775,8035078,5329492,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388996181,0.01,1798859,57560486,11420697,2064,18287036,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Receptor Tyrosine Kinase Inhibition Assay from Article 10.1073/pnas.0708281105: '6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.'","5-{2-[4-({3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrazin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203176,0.01,1798359,404345927,130275862,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203178,0.01,1798359,404345909,130276921,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-bromo-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203182,0.01,1798359,404345983,130276386,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-Amino-1-(1-prop-2-enoyl-2,4-dihydropyrimidin-3-yl)pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] piperidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203185,0.01,1798359,404345952,130275808,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,5-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203191,0.01,1798359,404345917,130275825,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203238,0.01,1798359,404345924,130276336,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-(fluoromethoxy)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232539,0.01,1803904,404345927,130275862,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232553,0.01,1803904,404345909,130276921,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-bromo-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232562,0.01,1803904,404345952,130275808,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,5-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232584,0.01,1803904,404345917,130275825,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232625,0.01,1803904,404345924,130276336,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-(fluoromethoxy)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232634,0.01,1803904,433917013,130276387,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","US10329300, Example 70",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347877,0.01,1919554,404345927,130275862,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[5-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347888,0.01,1919554,404345917,130275825,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[5-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347890,0.01,1919554,483499796,168474837,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 1",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347957,0.01,1919554,404345983,130276386,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-Amino-1-(1-prop-2-enoyl-2,4-dihydropyrimidin-3-yl)pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] piperidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347993,0.01,1919554,404345952,130275808,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,5-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402353784,0.01,1919554,404345924,130276336,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-(fluoromethoxy)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151278192,0.0101,461252,103729564,24945689,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439861,0.0101,1920052,486503649,167318639,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 179",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439862,0.0101,1920052,486503649,167318639,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 179",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279403,0.0102,461252,103177479,208908,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334046125,0.0102,730878,164149212,71578521,2064,23107515,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to synthetic peptide mimicking HER2 subdomain 4 (unknown origin) by fluorescence spectroscopic analysis,Ac-Gln-Asp-Val-Asn-Thr-Ala-Val-Ala-Trp-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439687,0.0102,1920052,486503481,162428889,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 9",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440610,0.0102,1920053,486503899,167318796,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 434",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433600,0.0103,636385,103177479,208908,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086367,0.0103,776745,103771162,11557040,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,Lapatinib Ditosylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250503,0.0103,1804976,441610619,146250829,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-7-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439838,0.0103,1920052,486503626,167318894,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 154",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372339079,0.0104,1718898,461547108,162624208,2064,33314925,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of substrate incubated for 30 mins by ADP-Glo assay,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-2-(2-hydroxyethylamino)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757269,0.0104,1795123,375077054,86305812,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-(2-methoxyethoxy)quinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440023,0.0104,1920052,486503809,167318546,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 341",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354611854,0.0105,1266268,336889715,124197380,2064,26706113,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR tyrosine kinase L858R mutant (unknown origin) assessed as ATP level by luminescence analysis,1-[4-(Piperidin-1-ylmethyl)phenyl]-3-[4-[3-(trifluoromethyl)anilino]quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279406,0.0106,461252,103729373,24944848,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,3-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxypropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665455,0.0106,1168534,312363560,46866615,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,6-[5-[(1R)-1-amino-2-methylsulfonylethyl]furan-2-yl]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355638978,0.0106,1308940,123092436,44259,2064,27288183,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) incubated for 1 hr by spectrophotometric analysis,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239083,0.0106,1804976,441610609,146250699,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-[(4S)-3,3-difluoropiperidin-4-yl]oxy-7-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432852,0.0106,1919984,486499664,168257749,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E,4S)-4-(dimethylamino)-1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]pent-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018094,0.0106,1920044,486503214,169552739,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E,4S)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]pent-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439773,0.0107,1920052,486503564,167318555,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 92",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769295,0.01077,1905726,482087914,137535296,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[3-cyano-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104283,0.0108,1796169,381752971,132162748,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(1H-indol-5-ylcarbamoyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432850,0.0108,1919984,486499662,168257540,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-3-[(2S)-1-methylpyrrolidin-2-yl]-1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432864,0.0108,1919984,486499676,168257866,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[2-fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432872,0.0108,1919984,486499682,168257872,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-1-[(14S)-5-[2,5-difluoro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]-4-(dimethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439817,0.0108,1920052,486503605,167318899,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 133",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018088,0.0108,1920044,486503208,169552736,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018092,0.0108,1920044,486503212,168762297,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-3-[(2S)-1-methylpyrrolidin-2-yl]-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018105,0.0108,1920044,486503226,168762302,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[2-fluoro-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146295,0.0108,1798142,464922086,139377675,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-cyclopropyl-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699874,0.0109,1796911,384577259,118900294,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'",Synthesis of (E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-ethoxyethoxy)quinazolin-6-yl)-4-(diethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439894,0.0109,1920052,486503681,167318607,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 211",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439953,0.0109,1920052,486503740,169552765,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 270",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440177,0.0109,1920053,486503477,166928114,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 5",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142106,0.0109,1798142,464922057,149085517,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366322628,0.01094,1535505,440226659,118900289,2064,30600209,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(2-ethoxyethoxy)quinazolin-6-yl]-4-(diethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701317,0.011,226585,103407791,44372022,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and ErbB-2 average ratio,"4-[4-(3-chloro-4-phenylmethoxyanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571352,0.011,344457,103628281,44580918,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(3R,5S)-5-((4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidin-3-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573552,0.011,320572,103574308,11712609,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"1-(2-{[4-({3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755923,0.011,309859,103551491,44442025,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Erb2 autophosphorylation by cellular clone 24 assay,(R)-N-(1-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propan-2-yl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755927,0.011,309859,103551494,44442027,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Erb2 autophosphorylation by cellular clone 24 assay,(R)-N-(2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propyl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840039,0.011,256662,103177479,208908,2064,15711537,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106024079,0.011,447375,103707845,45487376,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(5S,6S)-5-(hydroxycarbamoyl)-6-(3-phenyl-2,5-dihydro-1H-pyrrole-1-carbonyl)piperidin-3-yl pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355376,0.011,546552,124974653,42596953,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,(E)-3-(3-(4-(3-chloro-4-(3-fluorobenzyloxy)phen-ylamino)quinazolin-6-yl)phenyl)-N-hydroxy-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420062,0.011,632226,136928527,56849560,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]-5-methylpyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420158,0.011,632226,123085235,16736274,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-{2-[4-({5-Chloro-6-[3-(Trifluoromethyl)phenoxy]pyridin-3-Yl}amino)-5h-Pyrrolo[3,2-D]pyrimidin-5-Yl]ethoxy}ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420217,0.011,632226,136944728,56851429,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(2-chlorophenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326008273,0.011,689677,163319921,71452977,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"N-[2-[4-[3-chloro-4-(3-chlorophenoxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methyl-2-methylsulfonylpropanamide;4-methylbenzenesulfonic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326009981,0.011,689677,163319920,57496699,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"N-[2-(4-{[3-chloro-4-(3-chlorophenoxy)phenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl]-2-methyl-2-(methylsulfonyl)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326009984,0.011,689677,163337175,57597223,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-propan-2-ylsulfonylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354665403,0.011,1289550,103177459,176870,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR deletion mutant autophosphorylation in human PC9 cells after 2 hrs by sandwich ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
354669920,0.011,1291349,336877076,72703790,2064,26968253,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Del ex19 mutant in human HCC827 cells assessed as suppression of cell proliferation,Nazartinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656037,0.011,1315979,374334616,134150331,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-4-(dimethylamino)-N-[4-[4-(pyridin-2-ylmethyl)anilino]pyrido[3,4-d]pyrimidin-6-yl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355656238,0.011,1315979,103673639,156413,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,Canertinib dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355688814,0.011,1330940,374285021,44586019,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human GST-fused HER2 (675 to 1255 residues) assessed as phosphotyrosine formation using poly(Glu:Tyr, 4:1) as substrate and ATP measured after 6 mins","3-Azabicyclo(3.1.0)hexane-6-methanol, 3-((4-(4-((3-methoxy-4-phenoxyphenyl)amino)-6-quinazolinyl)phenyl)methyl)-, (1alpha,5alpha,6alpha)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112378,0.011,1676531,461556894,162672776,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[4-[(1,3-dioxoisoindol-2-yl)methyl]anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112811,0.011,1676531,461549771,162667731,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389037224,0.011,1799771,160844951,70701995,2064,21454582,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Enzyme Assay from Article 10.1074/jbc.M110.206193: 'Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.',"2-[[4-[[5-Chloro-6-[3-(trifluoromethyl)phenoxy]pyridin-3-yl]amino]pyrrolo[3,2-d]pyrimidin-5-yl]methoxy]ethanolate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665904,0.011,1806610,471698527,25128361,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666681,0.011,1806610,471698534,59404878,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615737,0.011,1919643,483622415,146510161,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 76",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615747,0.011,1919643,483622392,146510007,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 36",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615757,0.011,1919643,483622417,146448640,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 78",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203172,0.011,1798359,404345951,130277057,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[8-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]quinolin-5-yl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203175,0.011,1798359,404345984,130275335,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-methyl-4-(2-oxo-2-pyrrolidin-1-ylethyl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203190,0.011,1798359,404345948,130275813,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2-fluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203209,0.011,1798359,404345913,130275882,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]naphthalen-1-yl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203217,0.011,1798359,404345985,130276369,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","methyl (2R)-2-[4-[[4-amino-1-(1-prop-2-enoylpiperidin-3-yl)pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl]-2-(methylamino)acetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203231,0.011,1798359,404345972,130275884,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-4-(1-(1-acryloylpyrrolidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido) naphthalen-1-yl dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232565,0.011,1803904,404345948,130275813,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2-fluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232570,0.011,1803904,404345972,130275884,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-4-(1-(1-acryloylpyrrolidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido) naphthalen-1-yl dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232587,0.011,1803904,404345951,130277057,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[8-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]quinolin-5-yl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232622,0.011,1803904,404345984,130275335,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-methyl-4-(2-oxo-2-pyrrolidin-1-ylethyl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232623,0.011,1803904,404345913,130275882,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]naphthalen-1-yl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232632,0.011,1803904,433917015,130276367,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","US10329300, Example 72",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347879,0.011,1919554,483499800,168474841,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 5",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347885,0.011,1919554,483499833,168474844,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347902,0.011,1919554,483499855,168474846,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 58",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347904,0.011,1919554,404345984,130275335,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-methyl-4-(2-oxo-2-pyrrolidin-1-ylethyl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347990,0.011,1919554,404345948,130275813,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2-fluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402353783,0.011,1919554,404345985,130276369,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","methyl (2R)-2-[4-[[4-amino-1-(1-prop-2-enoylpiperidin-3-yl)pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl]-2-(methylamino)acetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809743,0.0112,1795310,377003058,87056715,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(E)-N-(7-((1R,5S,6R)-3-oxabicyclo[3.1.0]hexan-6-ylmethoxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-(2-(hydroxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809745,0.0112,1795310,377003055,87056712,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(E)-N-(7-(((R)-1,4-dioxan-2-yl)methoxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-((S)-2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440110,0.0112,1920052,486503894,167318868,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 429",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440346,0.0112,1920053,486503639,167318776,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 169",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104033,0.0113,1796169,381752959,132143252,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(4-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440097,0.0113,1920052,486503881,162428785,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 416",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147220,0.0113,1798142,464922024,152377821,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxy-2-[methyl-[[(2R)-1-methylpyrrolidin-2-yl]methyl]amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104277,0.0114,1796169,381752952,132143259,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440224,0.0114,1920053,486503522,162428888,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 50",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144131,0.0114,1798142,464922070,139378134,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4-chloro-5-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023773,0.0115,447375,103707863,45487393,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(3S,5S,6S)-5-(hydroxycarbamoyl)-1-methyl-6-(4-phenylpiperazine-1-carbonyl)piperidin-3-yl pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354612058,0.0115,1266268,336886935,124197376,2064,26706113,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR tyrosine kinase L858R mutant (unknown origin) assessed as ATP level by luminescence analysis,1-[4-(Pyrrolidin-1-ylmethyl)phenyl]-3-[4-[3-(trifluoromethyl)anilino]quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439856,0.0115,1920052,486503644,167318699,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 174",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250506,0.0116,1804976,441610615,146241156,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-N-[4-[(6-fluoro-[1,2,4]triazolo[1,5-a]pyridin-7-yl)oxy]-3-methylphenyl]-7-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440270,0.0116,1920053,486503566,167318863,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 93b",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145467,0.0116,1798142,464922087,139377763,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',(S)-Sunvozertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145868,0.0116,1798142,464922065,139377933,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757270,0.0117,1795123,375077053,86305763,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439867,0.0117,1920052,486503654,167318855,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 184",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439934,0.0117,1920052,486503721,162428947,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 251",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439986,0.0117,1920052,486503772,167318653,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 304",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440042,0.0117,1920052,486503826,167318675,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 359",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440554,0.0117,1920053,486503843,167318537,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 376",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809746,0.0118,1795310,377003048,87056476,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'",(E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(cyclopropylmethoxy)quinazolin-6-yl)-4-(2-(hydroxymethyl)azetidin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440116,0.0118,1920052,486503900,162429001,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 435",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440014,0.0119,1920052,486503800,167318569,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 333",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350471,0.012,68098,103202105,10854884,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,"N-[4-(3-Chloro-4-fluoro-phenylamino)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350478,0.012,68098,103202102,10528818,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,"N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(4-morpholin-4-yl-but-1-enyl)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568318,0.012,68096,103202105,10854884,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,"N-[4-(3-Chloro-4-fluoro-phenylamino)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
100701309,0.012,226585,103407769,44372004,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and ErbB-2 average ratio,"4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701313,0.012,226585,103407771,44372005,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and ErbB-2 average ratio,"4-[4-[(1-benzylindazol-5-yl)amino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503820,0.012,361654,103563898,17747105,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidine-5-carbaldehyde O-methyl oxime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595845,0.012,331423,103563898,17747105,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidine-5-carbaldehyde O-methyl oxime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622146,0.012,404519,103641275,9874913,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778089,0.012,314962,103561957,16118312,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(S)-1-morpholino-2-(4-(1-(thiazol-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101880676,0.012,263981,103486443,11640889,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(2-aminopyrimidin-4-yl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355379,0.012,546552,124956214,49855758,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,(E)-3-(4-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)-N-hydroxyacrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420153,0.012,632226,136938448,56851166,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]-6-methylpyrrolo[3,2-d]pyrimidin-5-yl]ethoxy]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420159,0.012,632226,136925430,56851053,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-({2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}sulfonyl)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420220,0.012,632226,136931761,56849701,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420891,0.012,632226,136925429,56851052,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-({2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}sulfinyl)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321558853,0.012,670126,136931761,56849701,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347069348,0.012,1255210,318396217,72201501,2064,26396685,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR 746 to 750 deletion mutant phosphorylation in human HCC827 cells after 60 mins by mesoscale multiplex assay,"N-(3-(2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8(7H)-yl)phenyl)acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347069352,0.012,1255210,318396226,77461033,2064,26396685,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR 746 to 750 deletion mutant phosphorylation in human HCC827 cells after 60 mins by mesoscale multiplex assay,"N-[3-[2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxyanilino]-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640228,0.012,1309513,336903601,127050068,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4S,5R)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-5-methyl-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656235,0.012,1315979,374292667,134138682,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
367502593,0.012,1667576,174494203,71585671,2064,32139324,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,"(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-morpholin-4-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367502596,0.012,1667576,442058780,78321977,2064,32139324,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,"(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112587,0.012,1676531,461540734,162661416,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[(1-benzylindazol-5-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112591,0.012,1676531,312468004,25127713,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,Poziotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112717,0.012,1676531,461562312,162676593,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[4-[(1,3-dioxoisoindol-2-yl)methoxy]anilino]-6-[4-(4-methylpiperazin-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372339080,0.012,1718898,461544522,162624257,2064,33314925,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of substrate incubated for 30 mins by ADP-Glo assay,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388995922,0.012,1798859,57560483,10309835,2064,18287036,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Receptor Tyrosine Kinase Inhibition Assay from Article 10.1073/pnas.0708281105: '6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.'","N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-ethynylthieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665726,0.012,1806610,471698515,25127385,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615854,0.012,1919643,483622393,146448634,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203169,0.012,1798359,404345912,130276343,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232546,0.012,1803904,404345912,130276343,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347883,0.012,1919554,483499799,168474840,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 4",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432822,0.012,1919984,441610621,51039094,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',Tucatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440579,0.012,1920053,486503868,167318611,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 403",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018056,0.012,1920044,441610621,51039094,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',Tucatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632647,0.0121,1306575,336904293,127050557,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant Her2 (676 to 1255 residues) expressed in baculovirus by fluorescence based assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(3-morpholin-4-ylpropyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439952,0.0121,1920052,486503739,169552764,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 269",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440363,0.0121,1920053,486503655,167318619,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 185",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440398,0.0121,1920053,486503690,166927720,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 220",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440004,0.0122,1920052,486503790,167318806,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 323",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440566,0.0122,1920053,486503855,167318693,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 389",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147235,0.0122,1798142,464922084,139377674,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxy-2-[(3R)-3-(methylamino)pyrrolidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086374,0.0123,776745,312397802,118738353,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-(piperazin-1-ylmethyl)furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279401,0.0124,461252,103729374,24944849,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxybutanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439763,0.0124,1920052,486503555,167318571,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 83",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439812,0.0124,1920052,486503601,162429093,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 129",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439813,0.0124,1920052,486503601,162429093,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 129",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440410,0.0124,1920053,486503702,167318613,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 232",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380763550,0.0125,1904484,103768626,10184653,2064,35259690,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439679,0.0125,1920052,486503475,162428836,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239077,0.0126,1804976,441610611,146240741,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-7-(oxolan-3-yloxy)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250507,0.0126,1804976,441610613,146240649,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-[[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]oxy]-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439889,0.0126,1920052,486503676,162429081,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 206",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440318,0.0126,1920053,486503611,166927757,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 139",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439872,0.0127,1920052,486503659,167318786,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 189",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440001,0.0127,1920052,486503787,167318874,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 320",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440022,0.0127,1920052,486503808,167318546,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 341",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439772,0.0128,1920052,486503563,167318761,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 91",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439895,0.0128,1920052,486503682,167318692,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 212",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440514,0.0128,1920053,486503805,167318721,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 338",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440002,0.0129,1920052,486503788,167318726,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 321",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440356,0.0129,1920053,486503649,167318639,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 179",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440357,0.0129,1920053,486503649,167318639,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 179",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440596,0.0129,1920053,486503885,167318704,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 420",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100368772,0.013,69712,103376061,5329087,2064,11462982,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells,"4-Anilinopyrido[3,4-d]pyrimidine 26",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571798,0.013,344457,103628200,11420204,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-{2-[(2R)-pyrrolidin-2-yl]ethynyl}thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622132,0.013,404519,103640278,44585537,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"Methyl 2-((5-(4-(4-(benzyloxy)phenylamino)pyrido[3,4-d]pyrimidin-6-yl)furan-2-yl)methylamino)acetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622136,0.013,404519,103441785,11365726,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,N-(4-(3-chloro-4-(4-phenylthiazol-2-ylthio)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101639298,0.013,277510,103505685,16108951,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-[(3-phenyl-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101675436,0.013,290550,103523390,44426286,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"4-(2-methyl-4-(6-(methylamino)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751506,0.013,308828,103549790,44441017,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-aminopiperidin-1-yl)methyl]-N-[1-[(5-methylpyridin-3-yl)methyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821800,0.013,248914,103441785,11365726,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,N-(4-(3-chloro-4-(4-phenylthiazol-2-ylthio)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880660,0.013,263981,103486160,11576231,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,{6-[(4-{3-Chloro-4-[(3-fluorobenzyl)oxy]anilino}-5-pyrimidinyl)ethynyl]-2-pyridinyl}methanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880669,0.013,263981,103486315,11656050,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)phenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124298,0.013,418919,103593183,25218693,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"1-{4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl}-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420164,0.013,632226,136938323,56851594,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150767,0.013,1079763,194182113,76332981,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","1-[4-(3-hydroxyanilino)-9H-pyrido[2,3-b]indol-6-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355630491,0.013,1305356,336904295,127050559,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-[1-[2-(dimethylamino)acetyl]piperidin-4-yl]pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
366357358,0.013,1553449,103628200,11420204,2064,30565923,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 (unknown origin),"N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-{2-[(2R)-pyrrolidin-2-yl]ethynyl}thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367502592,0.013,1667576,103177479,208908,2064,32139324,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112374,0.013,1676531,461536696,162658595,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-(4-phenoxyanilino)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112714,0.013,1676531,461527613,162652174,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"[4-[[6-[4-(4-methylpiperazin-1-yl)phenyl]-5-[3-(prop-2-enoylamino)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]phenyl] 2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372363323,0.013,1730856,461536583,162658520,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,3-[4-[[4-(3-chloro-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]triazol-1-yl]-N-hydroxypropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388995928,0.013,1798859,57560485,11420204,2064,18287036,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Receptor Tyrosine Kinase Inhibition Assay from Article 10.1073/pnas.0708281105: '6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.'","N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-{2-[(2R)-pyrrolidin-2-yl]ethynyl}thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389005897,0.013,1798858,57560482,25218693,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"1-{4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl}-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389037225,0.013,1799771,8035064,208908,2064,21454582,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Enzyme Assay from Article 10.1074/jbc.M110.206193: 'Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.',Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615852,0.013,1919643,483622414,146448755,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 75",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615861,0.013,1919643,483622379,146448639,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 11",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203179,0.013,1798359,404345975,135203409,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-1-(1-acryloylpyrrolidin-3-yl)-4-amino-N-(4-(2-(dimethylamino)-2-oxoethyl)naphthalen-1-yl)-H-pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203193,0.013,1798359,404345928,130275831,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2,5-dichloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203196,0.013,1798359,404345921,130275856,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-1-(1-acryloylpiperidin-3-yl)-4-amino-N-(4-(2-(dimethylamino)-2-oxoethyl)-2,3-dimethylphenyl)-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203205,0.013,1798359,404345966,130277037,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-(furan-3-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203220,0.013,1798359,404345918,130275249,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-5-fluoro-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203234,0.013,1798359,404345945,130277050,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-fluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203241,0.013,1798359,404345990,130276927,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2,3-dimethylphenyl]-1-[(3R)-5-fluoro-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232535,0.013,1803904,404345918,130275249,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-5-fluoro-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232540,0.013,1803904,404345975,135203409,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-1-(1-acryloylpyrrolidin-3-yl)-4-amino-N-(4-(2-(dimethylamino)-2-oxoethyl)naphthalen-1-yl)-H-pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232554,0.013,1803904,404345928,130275831,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2,5-dichloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232559,0.013,1803904,404345921,130275856,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-1-(1-acryloylpiperidin-3-yl)-4-amino-N-(4-(2-(dimethylamino)-2-oxoethyl)-2,3-dimethylphenyl)-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232582,0.013,1803904,404345966,130277037,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-(furan-3-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232618,0.013,1803904,404345945,130277050,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-fluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232629,0.013,1803904,404345990,130276927,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2,3-dimethylphenyl]-1-[(3R)-5-fluoro-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347876,0.013,1919554,404345975,135203409,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","(R)-1-(1-acryloylpyrrolidin-3-yl)-4-amino-N-(4-(2-(dimethylamino)-2-oxoethyl)naphthalen-1-yl)-H-pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347898,0.013,1919554,404345966,130277037,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-(furan-3-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347985,0.013,1919554,404345928,130275831,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2,5-dichloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347988,0.013,1919554,404345918,130275249,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-5-fluoro-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347992,0.013,1919554,404345921,130275856,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","(R)-1-(1-acryloylpiperidin-3-yl)-4-amino-N-(4-(2-(dimethylamino)-2-oxoethyl)-2,3-dimethylphenyl)-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402348000,0.013,1919554,404345945,130277050,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-fluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402353786,0.013,1919554,404345990,130276927,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2,3-dimethylphenyl]-1-[(3R)-5-fluoro-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407970419,0.013,1939976,494402531,171347252,2064,36324498,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"2-[4-[4-amino-1-[(3S)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]-2,3-dimethylphenyl]-N,N-dimethylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086370,0.0131,776745,312397800,118738351,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-(morpholin-4-ylmethyl)furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250508,0.0131,1804976,441610604,146250710,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3-fluoro-1-methylpiperidin-4-yl)oxy-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439796,0.0131,1920052,486503585,167318902,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 113",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439958,0.0131,1920052,486503745,169552766,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 275",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432821,0.0132,1919984,104048227,9915743,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439863,0.0132,1920052,486503650,167318888,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 180",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440019,0.0132,1920052,486503805,167318721,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 338",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018055,0.0132,1920044,104048227,9915743,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143674,0.0132,1798142,464922043,149744005,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[3-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440059,0.0133,1920052,486503843,167318537,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 376",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440139,0.0133,1920052,486503923,167318870,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 458",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440513,0.0133,1920053,486503804,167318696,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 337",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809750,0.0135,1795310,377003053,87056633,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(E)-N-(7-(((R)-1,4-dioxan-2-yl)methoxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-(2-(hydroxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439853,0.0135,1920052,486503641,167318565,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 165",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440454,0.0135,1920053,486503746,169552767,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 276",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103295,0.0136,1796168,381752965,132163000,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439686,0.0136,1920052,486503481,162428889,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 9",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440066,0.0136,1920052,486503850,167318915,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 384",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359653,0.0138,517501,123094322,52946372,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-[4-[4-amino-1-[1-[1-(3-methoxypropyl)piperidin-4-yl]piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-1,3-benzoxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102338,0.0139,1796170,381752950,132143247,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144650,0.0139,1798142,461604600,151121820,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[3,4-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359468,0.014,69714,103303391,5328954,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10a,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100368774,0.014,69712,103376034,5329088,2064,11462982,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells,"4-Anilinopyrido[3,4-d]pyrimidine 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701241,0.014,68100,103407769,44372004,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2,"4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701242,0.014,68100,103407791,44372022,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2,"4-[4-(3-chloro-4-phenylmethoxyanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564651,0.014,367174,103610115,44571435,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(furan-2-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742012,0.014,473322,103746581,46197129,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg mutant by HTRF assay,"N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155746563,0.014,474114,103749172,46886321,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-(3-(5-(2-(4-(4-ethylpiperazin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2,6-difluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355380,0.014,546552,124961476,49855949,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,(E)-N-(2-aminophenyl)-3-(3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326009982,0.014,689677,163313034,71449342,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"2-tert-butylsulfonyl-N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326078559,0.014,719887,103768626,10184653,2064,22621397,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340039508,0.014,760336,174507796,11488320,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 kinase domain expressed in baculovirus/Sf21 system by ELISA,Sapitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655464,0.014,1315979,374290183,134137974,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-piperidin-1-ylbut-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355689484,0.014,1330934,174507796,11488320,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 expressed in baculovirus/Sf21 system in presence of ATP by ELISA,Sapitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363684689,0.014,1424370,164149846,10163178,2064,28754471,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of GST-tagged human HER2 catalytic domain expressed in insect cells,Afatinib Impurity C,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366322323,0.014,1535439,103768626,10184653,2064,30600149,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human GST-fused HER2 kinase domain expressed in baculovirus expression system measured after 30 mins by ELISA,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366340179,0.014,1545467,103768626,10184653,2064,30878832,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using pEY as substrate incubated for 30 mins by ELISA,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366365936,0.014,1558401,103768626,10184653,2064,31550151,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of HER2 (unknown origin),Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112373,0.014,1676531,461527121,162651821,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[5-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-(1-methoxypropan-2-yloxy)phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112375,0.014,1676531,461516923,162644681,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112583,0.014,1676531,461532895,162655895,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[5-[4-[(1-benzylindazol-5-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-(2-hydroxyethoxy)phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112721,0.014,1676531,461533540,162656352,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[4-(4-methylpiperazin-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112808,0.014,1676531,461519866,162646814,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-ethoxy-6-[4-(4-methylpiperazin-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380656911,0.014,1880131,103768626,10184653,2064,35439421,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 phosphorylation (unknown origin),Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380718917,0.014,1894160,374263426,51039094,2064,33540357,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Tucatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380719137,0.014,1894154,103768626,10184653,2064,33540357,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using pEY (4:1) as substrate,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757278,0.014,1795123,375077050,117685125,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',Egfr/her2-IN-9,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817743,0.014,1795646,8034231,5328954,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10a,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388836057,0.014,1795774,8035062,5329479,2064,14684309,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/j.bmcl.2003.10.010: 'Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.',6-Thiazolylquinazoline 5,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388836058,0.014,1795774,8035063,5329480,2064,14684309,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/j.bmcl.2003.10.010: 'Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.',GW583340 dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666672,0.014,1806610,471698514,155235880,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"1-(3-((4-((2,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)azetidin-1-yl)-prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615855,0.014,1919643,483622393,146448634,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104658,0.014,1796168,381752951,132143272,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203212,0.014,1798359,404345957,130276939,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,6-difluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203213,0.014,1798359,404345991,145866620,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R,5R)-5-methyl-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203226,0.014,1798359,404345967,130277044,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[7-[2-(dimethylamino)-2-oxoethyl]-1,3-benzodioxol-4-yl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232576,0.014,1803904,404345967,130277044,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[7-[2-(dimethylamino)-2-oxoethyl]-1,3-benzodioxol-4-yl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232583,0.014,1803904,404345957,130276939,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,6-difluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232585,0.014,1803904,433917021,154584240,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","US10329300, Example 78",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347881,0.014,1919554,483499875,168474849,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 78",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347955,0.014,1919554,404345957,130276939,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,6-difluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347958,0.014,1919554,404345967,130277044,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[7-[2-(dimethylamino)-2-oxoethyl]-1,3-benzodioxol-4-yl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439764,0.014,1920052,486503556,167318709,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 84",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439880,0.0141,1920052,486503667,167318830,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 197",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439987,0.0141,1920052,486503773,167318866,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 305",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809744,0.0142,1795310,377003043,87056554,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104038,0.0142,1796169,381752974,132143285,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"methyl 1-[4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]pyrrolo[2,3-b]pyridine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439780,0.0142,1920052,486503570,167318835,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 310",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439781,0.0142,1920052,486503570,167318835,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 310",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440552,0.0142,1920053,486503841,167318658,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 374",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144892,0.0142,1798142,464922058,139377729,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-dichloro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440057,0.0143,1920052,486503841,167318658,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 374",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440302,0.0143,1920053,486503596,167318600,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 124",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086376,0.0144,776745,312397803,118738354,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,Ethyl 4-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methyl]piperazine-1-carboxylate;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432849,0.0144,1919984,486499661,168257615,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-3-[(2R)-1-methylpyrrolidin-2-yl]-1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440007,0.0144,1920052,486503793,169552772,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 326",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018091,0.0144,1920044,486503211,168762337,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-3-[(2R)-1-methylpyrrolidin-2-yl]-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198358932,0.0145,517501,123089476,52943781,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-[4-[4-amino-1-[1-(1-methylpiperidin-4-yl)piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-1,3-benzoxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440569,0.0146,1920053,486503858,167318895,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 392",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440091,0.0147,1920052,486503875,167318858,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 410",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440280,0.0147,1920053,486503574,166927922,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 101",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440555,0.0147,1920053,486503844,167318648,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 377",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102331,0.0148,1796170,381752959,132143252,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(4-aminoindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439902,0.0148,1920052,486503689,166927708,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 219",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440294,0.0148,1920053,486503588,167318841,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 116",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102326,0.0149,1796170,381752968,132143255,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-2,3-dihydroindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440173,0.0149,1920053,486503474,162428954,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440578,0.0149,1920053,486503867,162428835,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 402",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101504953,0.015,361656,103643990,24897043,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,"5-(Dimethyl-hydrazonomethyl)-N-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101675452,0.015,290550,103523391,44426287,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"4-(2-methyl-4-(6-(2-morpholinoethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675742,0.015,290550,103523395,44426291,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"4-(2-methyl-4-(6-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821392,0.015,248914,103441772,11376208,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[(1-benzylindol-5-yl)amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279400,0.015,461252,103729375,24944850,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,5-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxypentanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204355678,0.015,546552,124957901,49855950,2064,21080629,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by flash plate based radioactive enzyme assay,(e)-n-(2-Aminophenyl)-3-(4-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)phenyl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420210,0.015,632226,136922138,56850806,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"5-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]pentan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420266,0.015,632227,136941656,56849847,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-hydroxy-N-methylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420350,0.015,632227,136928639,11684629,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethoxy)ethan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420890,0.015,632226,136944837,56849848,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-hydroxy-2-methylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345661357,0.015,1167102,174503764,73292545,2064,25271963,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-(5-{[4-(1H-Indol-3-yl)pyrimidin-2-yl]amino}-4-methoxy-2-{4-methylpiperazin-1-yl}phenyl)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355630697,0.015,1305356,336906415,127052096,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
372112722,0.015,1676531,461533508,162656328,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[5-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-[2-(dimethylamino)ethoxy]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112805,0.015,1676531,461547733,162666308,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[5-[4-[4-[(1,3-dioxoisoindol-2-yl)methyl]anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-(2-hydroxyethoxy)phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615859,0.015,1919643,483622383,146448697,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 21",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104037,0.015,1796169,381752966,132143184,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440307,0.015,1920053,486503601,162429093,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 129",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440308,0.015,1920053,486503601,162429093,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 129",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198358936,0.0151,517501,123101236,52950017,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-[4-[4-amino-1-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-1,3-benzoxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439748,0.0151,1920052,486503540,166927848,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 67",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439990,0.0151,1920052,486503776,167318540,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 308",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440055,0.0151,1920052,486503839,167318814,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 372",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145878,0.0151,1798142,464922106,139377929,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3S,4R)-3-(dimethylamino)-4-fluoropyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439805,0.0152,1920052,486503594,167318749,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 122",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146529,0.0152,1798142,464922032,152208300,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[(3aR,6aR)-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-1-yl]-5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439915,0.0153,1920052,486503702,167318613,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 232",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440135,0.0153,1920052,486503919,167318632,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 454",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145705,0.0153,1798142,464922069,139377957,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-dichloro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198358933,0.0154,517501,123094542,52946470,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"trans-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-3-chlorophenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439785,0.0154,1920052,486503574,166927922,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 101",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439897,0.0154,1920052,486503684,167318836,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 214",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440063,0.0154,1920052,486503847,167318671,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 381",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440117,0.0154,1920052,486503901,162428919,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 436",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023770,0.0155,447375,103707806,45487342,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(2S,3S)-N-hydroxy-5-(N-methylisobutyramido)-2-(4-phenyl-1,2,3,6-tetrahydropyridine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665446,0.0155,1168534,312363551,56640588,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[1-(ethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809749,0.0155,1795310,377003049,87056630,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(cyclopropylmethoxy)quinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439809,0.0155,1920052,486503598,167318702,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 126",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440286,0.0155,1920053,486503580,167318541,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 107",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809776,0.0156,1795310,377003060,87056794,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(E)-N-(7-((1R,5S,6R)-3-oxabicyclo[3.1.0]hexan-6-ylmethoxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-((S)-2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143056,0.0156,1798142,464922031,147820439,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151278188,0.0157,461252,103729562,24756910,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,Cudc-101,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155734504,0.0157,463639,103729562,24756910,2064,20166671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,Cudc-101,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366332865,0.0157,1542171,103729562,24756910,2064,30418766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Cudc-101,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367471269,0.0157,1652202,442050272,156012318,2064,32435375,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),7-[8-(3-ethynylanilino)-3-methoxynaphthalen-2-yl]oxy-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380800950,0.0157,1915573,103729562,24756910,2064,33077264,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Cudc-101,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440016,0.0157,1920052,486503802,167318813,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 335",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440086,0.0157,1920052,486503870,167318801,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 405",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146995,0.0157,1798142,464922079,152160866,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-[(2S)-2-hydroxybutan-2-yl]anilino]-1,3,5-triazin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757277,0.0158,1795123,375077056,117685125,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',Egfr/her2-IN-9,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432824,0.0158,1919984,486499637,168258126,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018060,0.0158,1920044,486499638,168258063,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146524,0.0158,1798142,463792103,151923834,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4-chloro-3-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086375,0.0159,776745,174509494,73352567,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,N-[2-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methylamino]ethyl]methanesulfonamide;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359510,0.016,69714,103302479,5328968,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10o,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539069,0.016,410944,103606833,25263267,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675444,0.016,290550,103523385,11365185,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"N-(2,6-difluorophenyl)-4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675747,0.016,290550,103523356,44426260,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"N-(3-(4-(4-(1-(3,3-dimethylbutanoyl)piperidin-4-yloxy)-3-methylphenylamino)quinazolin-6-yl)prop-2-ynyl)-2-methoxyacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694374,0.016,295195,103531676,44430034,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"(6S)-1-[[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]-1,4-diazepan-6-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863508,0.016,260903,103673639,156413,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand stimulated erbB2 autophosphorylation in T24 NIH cells,Canertinib dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,526,"","",""
198359651,0.016,517501,123101237,52941514,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420162,0.016,632226,136931748,56851290,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-chloro-4-phenoxyphenyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345598417,0.016,1198817,103203007,6603857,2064,25794791,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2 intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,"N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072435,0.016,1256453,318397011,92045039,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630709,0.016,1305356,336906416,127052097,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(1-ethylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355655951,0.016,1315981,103673639,156413,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of ERBB2 (unknown origin) autophosphorylation transfected in EGF-stimulated mouse T24 NIH/3T3 cells with extracellular binding domain of ERBB1 incubated for 2 hrs followed by stimulation with EGF for 10 mins,Canertinib dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,526,"","",""
372362759,0.016,1730856,461547580,162666199,2064,33493830,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by mobility shift assay,5-[4-[[4-(3-chloro-2-fluoroanilino)-6-(prop-2-enoylamino)quinazolin-7-yl]oxymethyl]triazol-1-yl]-N-hydroxypentanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817761,0.016,1795646,8034245,5328968,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10o,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388996858,0.016,1798900,58097699,25263267,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615745,0.016,1919643,483622391,146510573,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 35",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615866,0.016,1919643,483622388,166890606,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 32",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103134,0.016,1796167,381752966,132143184,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104043,0.016,1796169,381752953,132143292,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203173,0.016,1798359,404345949,130275867,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,3-difluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203202,0.016,1798359,404345988,130276363,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-methyl-4-(pyrrolidine-1-carbonylamino)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232545,0.016,1803904,404345988,130276363,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-methyl-4-(pyrrolidine-1-carbonylamino)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232550,0.016,1803904,404345949,130275867,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,3-difluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347953,0.016,1919554,404345988,130276363,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-methyl-4-(pyrrolidine-1-carbonylamino)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347989,0.016,1919554,404345949,130275867,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,3-difluorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439807,0.016,1920052,486503596,167318600,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 124",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439960,0.016,1920052,486503747,167318770,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 277",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440105,0.016,1920052,486503889,167318731,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 424",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440269,0.016,1920053,486503565,167318576,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 93a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769560,0.01601,1905726,482080846,168293608,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-b]pyridazin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439742,0.0161,1920052,486503534,169552758,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 60b",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439848,0.0161,1920052,486503636,166928147,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 166",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439882,0.0161,1920052,486503669,167318665,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 199",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239085,0.0162,1804976,441610602,146240650,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3,3-difluoro-1-methylpiperidin-4-yl)oxy-N-(3-methyl-4-pyrazolo[1,5-a]pyridin-6-yloxyphenyl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439775,0.0162,1920052,486503566,167318863,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 93b",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440107,0.0162,1920052,486503891,167318763,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 426",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440602,0.0162,1920053,486503891,167318763,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 426",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440182,0.0163,1920053,486503481,162428889,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 9",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440332,0.0163,1920053,486503625,166927674,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 153",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688220,0.0164,1330925,374270101,134132574,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,7-[4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688768,0.0164,1330941,103729562,24756910,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human amino-terminal GST-fused HER2 (Lys676-Val1255) expressed in baculovirus expression system using Biotin-FLT3 (Tyr589) peptide as substrate and ATP by HTScan assay,Cudc-101,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440050,0.0165,1920052,486503834,167318914,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 367",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440453,0.0165,1920053,486503745,169552766,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 275",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147149,0.0165,1798142,464921981,139377678,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4-chloro-3,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440074,0.0166,1920052,486503858,167318895,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 392",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440087,0.0166,1920052,486503871,169552775,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 406",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440285,0.0166,1920053,486503579,167318768,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 106",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389058770,0.0167,1800296,194690240,11511120,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,ELISA-Based Kinase Assay from US Patent US8623883: '4-phenylamino-quinazolin-6-yl-amides',Dacomitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439988,0.0167,1920052,486503774,167318558,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 306",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440000,0.0167,1920052,486503786,169552771,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 319",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440071,0.0167,1920052,486503855,167318693,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 389",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440084,0.0167,1920052,486503868,167318611,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 403",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440447,0.0167,1920053,486503739,169552764,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 269",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239082,0.0168,1804976,441610617,155926698,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-5-[(2R,4S)-1-methyl-2-(trifluoromethyl)piperidin-4-yl]oxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432851,0.0168,1919984,486499663,168257743,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E,4R)-4-(dimethylamino)-1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]pent-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432855,0.0168,1919984,486499667,168762280,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylanilino)-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439790,0.0168,1920052,486503579,167318768,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 106",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440021,0.0168,1920052,486503807,167318764,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 340",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440591,0.0168,1920053,486503880,167318567,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 415",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018093,0.0168,1920044,486503213,168762303,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E,4R)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]pent-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018097,0.0168,1920044,486503217,169552741,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylanilino)-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440096,0.0169,1920052,486503880,167318567,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 415",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101573553,0.017,320572,103574260,11569434,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"1-{2-[(4-{[3-methoxy-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethyl}piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863457,0.017,260896,103303045,2776,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,N-(4-((3-bromophenyl)amino)quinazolin-6-yl)but-2-ynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912915,0.017,270616,103498765,9894581,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfonyl)ethoxy)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124299,0.017,418919,103593181,25218691,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"4-[4-(4-amino-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl]-N,N-dimethylpiperazine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420157,0.017,632226,123085234,11620908,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,Tak-285,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420219,0.017,632226,136928528,56849562,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[3-(trifluoromethoxy)phenoxy]phenyl]-5-methylpyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326009983,0.017,689677,163333768,57597316,2064,22980219,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD tagged HER2 cytoplasmic domain amino acid 676 to 1255 expressed in baculovirus after 5 mins by scintillation counter,"N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-2-methyl-2-methylsulfonylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334072990,0.017,739689,123085234,11620908,2064,23490150,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD-tagged HER2 cytoplasmic domain (676 to 1255) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,Tak-285,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340069866,0.017,770082,174503764,73292545,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-(5-{[4-(1H-Indol-3-yl)pyrimidin-2-yl]amino}-4-methoxy-2-{4-methylpiperazin-1-yl}phenyl)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355655578,0.017,1315425,103177479,208908,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656031,0.017,1315979,374335598,134150618,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-[4-(pyridin-2-ylmethyl)anilino]pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
389005902,0.017,1798858,57560480,25218691,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"4-[4-(4-amino-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl]-N,N-dimethylpiperazine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389032816,0.017,1799771,160844950,70701994,2064,21454582,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Enzyme Assay from Article 10.1074/jbc.M110.206193: 'Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.',"4-[2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethylamino]-2-methyl-4-oxobutan-2-olate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668232,0.017,1806610,471698530,155243064,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 30",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615736,0.017,1919643,483622409,146510148,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 67",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203181,0.017,1798359,404345992,145866621,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2,3-dimethylphenyl]-1-[(3R,5R)-5-methyl-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203186,0.017,1798359,404345965,130275369,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-(furan-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203206,0.017,1798359,404345987,130275840,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-(dimethylcarbamoylamino)-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232577,0.017,1803904,404345965,130275369,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-(furan-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232581,0.017,1803904,404345987,130275840,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-(dimethylcarbamoylamino)-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232589,0.017,1803904,433917022,154584241,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","US10329300, Example 79",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347884,0.017,1919554,483499876,168474850,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 79",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347899,0.017,1919554,404345965,130275369,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-(furan-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347986,0.017,1919554,404345987,130275840,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-(dimethylcarbamoylamino)-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439774,0.017,1920052,486503565,167318576,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 93a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440018,0.017,1920052,486503804,167318696,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 337",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
409903345,0.017,1291334,312367127,71496458,2064,26968253,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Del ex19 mutant phosphorylation in human PC9 cells preincubated for 2 hrs by ELISA,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
402102437,0.0171,1796170,381752954,132143256,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439783,0.0171,1920052,486503572,167318586,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 99",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345670965,0.0173,1171421,103768626,10184653,2064,25409491,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type HER2 (unknown origin) incubated for 5 mins by HTRF assay,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439799,0.0173,1920052,486503588,167318841,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 116",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439878,0.0173,1920052,486503665,167318867,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 195",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439891,0.0173,1920052,486503678,166927661,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 208",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432879,0.0174,1919984,486499689,168762313,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"US11807649, Example S55 Enantiomer 1",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018072,0.0174,1920044,486499689,168762313,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"US11807649, Example S55 Enantiomer 1",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439979,0.0176,1920052,486503765,169552769,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 297",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432856,0.0177,1919984,486499668,168762287,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"Synthesis of (E)-4-(dimethylamino)-1-((10S)-4-((4-(imidazo[1,2-a]pyridin-7-yloxy)-3-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439849,0.0177,1920052,486503637,167318544,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 167",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440169,0.0177,1920052,486503953,167318881,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 489",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018098,0.0177,1920044,486503218,169552742,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"Synthesis of (E)-4-(dimethylamino)-1-((10S)-4-((4-(imidazo[1,2-a]pyridin-7-yloxy)-3-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4,5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757495,0.0178,1795123,375077071,86305719,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3-chloro-2,4-difluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439877,0.0178,1920052,486503664,167318808,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 194",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440009,0.0179,1920052,486503795,167318564,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 328",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453089,0.018,375732,103635361,44583654,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S,5S)-N-hydroxy-5-(2-oxo-2-(piperidin-1-yl)ethyl)-2-(4-phenylpiperazine-1-carbonyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101503822,0.018,361654,103643992,24897276,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,"N-[1-(3-Fluoro-benzyl)-1H-indazol-5-yl]-5-[piperidin-1-yliminomethyl]-pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595843,0.018,331423,103563644,17747134,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101639294,0.018,277510,103505644,16108939,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-[(4-phenyl-3,6-dihydropyridin-1(2H)-yl)carbonyl]-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101675470,0.018,290549,103523388,11752667,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"Cyclopentyl(4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101676429,0.018,290549,103523364,44426268,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,N-tert-butyl-3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742028,0.018,306289,103549494,44440823,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"2-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methoxy]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751504,0.018,308828,103549795,11712721,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-aminopiperidin-1-yl)methyl]-N-[3-chloro-4-[(1-oxidopyridin-1-ium-2-yl)methoxy]phenyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821804,0.018,248914,103441722,11192753,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-(naphthalen-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912906,0.018,270616,103498602,9829680,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,4-((5-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-yl)methyl)thiomorpholine 1-oxide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106010473,0.018,439897,103699338,45483674,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid trans-4-aminocyclohexyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
106010476,0.018,439897,103699482,45483695,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid 2-(piperazin-1-yl)ethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
106014982,0.018,441964,103701239,24883334,2064,19888761,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 by fluorescence polarization assay,"(S)-1-Acryloyl-N-[4-(3-chloro-2,4-difluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yl]pyrrolidine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023767,0.018,447375,103505644,16108939,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(6S,7S)-N-hydroxy-6-[(4-phenyl-3,6-dihydropyridin-1(2H)-yl)carbonyl]-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420452,0.018,632227,136935222,56849555,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435421,0.018,638068,136941420,11955109,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[4-[(propan-2-ylamino)methyl]phenyl]ethynyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321558857,0.018,670126,160679719,57415415,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"5-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-2,3-dihydroisoindol-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334072989,0.018,739689,164133032,25207010,2064,23490150,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD-tagged HER2 cytoplasmic domain (676 to 1255) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,"methyl 4-[4-(1-benzothiophen-4-yloxy)-3-chloroanilino]-8,9-dihydro-7H-pyrimido[4,5-b]azepine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355631457,0.018,1305356,336904294,127050558,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-[1-(2-hydroxyacetyl)piperidin-4-yl]pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
389666764,0.018,1806610,471698537,155242991,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-(3-((7-Methoxy-4-(phenylamino)quinazolin-6-yl)oxy)azetidin-1-yl)prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615750,0.018,1919643,483622390,146448683,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',Her2-IN-14,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203221,0.018,1798359,404345955,130276371,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]quinolin-8-yl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203225,0.018,1798359,404345956,130276943,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232620,0.018,1803904,404345955,130276371,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]quinolin-8-yl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232630,0.018,1803904,404345956,130276943,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347906,0.018,1919554,404345956,130276943,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347952,0.018,1919554,404345955,130276371,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]quinolin-8-yl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440278,0.018,1920053,486503572,167318586,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 99",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439998,0.0181,1920052,486503784,167318757,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 317",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440160,0.0181,1920052,486503944,167318842,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 480",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439703,0.0182,1920052,486503496,164575759,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 24",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440283,0.0182,1920053,486503577,167318629,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 104",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086368,0.0183,776745,174509493,73352566,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfanylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440090,0.0183,1920052,486503874,162428729,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 409",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440304,0.0183,1920053,486503598,167318702,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 126",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439740,0.0184,1920052,486503533,167318670,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 60a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439741,0.0184,1920052,486503533,167318670,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 60a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432853,0.0185,1919984,486499665,168257750,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432862,0.0185,1919984,486499674,168257946,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-3-fluoro-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439684,0.0185,1920052,486503479,162428940,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 7",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440067,0.0185,1920052,486503851,167318684,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 385",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018095,0.0185,1920044,486503215,169552740,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018103,0.0185,1920044,486503224,169552746,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-3-fluoro-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439788,0.0186,1920052,486503577,167318629,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 104",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439883,0.0186,1920052,486503670,166928160,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 200",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407917219,0.0186,1925313,494423619,171358280,2064,34303870,Confirmatory,20240503,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to HER2 (unknown origin) assessed as dissociation constant,H-Cys-Asp-Thr-Phe-Pro-Tyr-Leu-Gly-Trp-Trp-Asn-Pro-Asn-Glu-Tyr-Arg-Tyr-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439795,0.0187,1920052,486503584,167318623,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 112",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440140,0.0187,1920052,486503924,167318825,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 459",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440237,0.0187,1920053,486503534,169552758,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 60b",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440377,0.0187,1920053,486503669,167318665,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 199",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146088,0.0188,1798142,464922090,139377686,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3S,4R)-3-(dimethylamino)-4-fluoropyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432833,0.0189,1919984,486499645,168257532,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440032,0.0189,1920052,486503816,167318854,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 349",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440268,0.0189,1920053,486503564,167318555,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 92",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018063,0.0189,1920044,486499644,168257400,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100706974,0.019,68106,103592046,5329493,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,N-{1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574024,0.019,320574,103574403,11620487,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"1-(2-{[4-({3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622124,0.019,404519,103640205,44585507,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"2-((5-(4-(4-(Benzyloxy)phenylamino)pyrido[3,4-d]pyrimidin-6-yl)furan-2-yl)methylamino)acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675462,0.019,290550,103523374,44426276,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"1-(4-(4-(6-(2-Methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675472,0.019,290549,103523378,11786150,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"N-(2,6-difluorophenyl)-4-(4-(6,7-dimethoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101755437,0.019,309857,103551492,44442026,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,(S)-N-(1-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propan-2-yl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778942,0.019,315244,103575029,11562662,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,N-[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]-5-[(1R)-1-methyl-2-morpholin-4-yl-2-oxoethoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
151279393,0.019,461252,103729449,24944930,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402365,0.019,580189,124962422,51346888,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)-2-fluoro-N-(2-(pyrrolidin-1-yl)ethyl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420161,0.019,632226,136922140,56851288,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]-5-[2-(2-hydroxyethoxy)ethyl]pyrrolo[3,2-d]pyrimidine-6-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342753078,0.019,1155500,242648951,71519693,2064,24915291,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 1 hr by HTRF assay,Blk-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655710,0.019,1315979,374321498,134146699,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355655807,0.019,1315979,374297934,134140108,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355655810,0.019,1315979,374349415,134154596,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-(2-methoxyethoxy)quinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355656036,0.019,1315979,374319110,134146010,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363684687,0.019,1424362,404710263,145988898,2064,28754471,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]quinazolin-6-yl]ethyl]-3-hydroxy-3-methylbutanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363684692,0.019,1424370,242558147,9806229,2064,28754471,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of GST-tagged human HER2 catalytic domain expressed in insect cells,AV-412 free base,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366340227,0.019,1545482,103202250,156414,2064,30878832,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction of phosphorylation of polyglutamic acid/tyrosine incubated for 10 mins by beta scintillation counter,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366479986,0.019,1615366,136940589,24821094,2064,31381333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay,Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380638448,0.019,1875935,103202250,156414,2064,33539089,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2 (unknown origin),Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380667917,0.019,1882625,404710263,145988898,2064,35311289,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 (676 to 1255 residues) preincubated for 5 mins followed by ATP addition measured after 10 mins by microplate reader method,N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]quinazolin-6-yl]ethyl]-3-hydroxy-3-methylbutanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380800955,0.019,1915573,103729449,24944930,2064,33077264,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),7-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837151,0.019,1795775,8035079,5329493,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',N-{1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388995923,0.019,1798859,57560487,25218695,2064,18287036,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Receptor Tyrosine Kinase Inhibition Assay from Article 10.1073/pnas.0708281105: '6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.'","N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-ethynylthieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665402,0.019,1806610,471698516,155235877,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"6-((1-Acryloylpiperidin-4-yl)oxy)-4-((3,4-dichlorophenyl)amino)-7-methoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203171,0.019,1798359,404345979,145866619,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R,E)-4-(4-amino-1-(1-(4-dimethylamino)but-2-enoyl)piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido)naphthalen-1-yl dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232616,0.019,1803904,433917009,154584239,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","US10329300, Example 66",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347875,0.019,1919554,483499863,168474847,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 66",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440298,0.019,1920053,486503592,167318750,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 120",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439875,0.0191,1920052,486503662,166927717,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 192",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440150,0.0191,1920052,486503934,167318610,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 469",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632649,0.0192,1306575,336901227,127048297,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant Her2 (676 to 1255 residues) expressed in baculovirus by fluorescence based assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439677,0.0193,1920052,486503473,156821216,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 1",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439829,0.0193,1920052,486503617,167318779,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 145",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440038,0.0193,1920052,486503822,167318821,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 355",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439739,0.0194,1920052,486503532,166927914,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 60",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439845,0.0194,1920052,486503633,167318682,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 162",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440600,0.0194,1920053,486503889,167318731,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 424",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239076,0.0196,1804976,441610599,146241657,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',CID 146241657,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440324,0.0196,1920053,486503617,167318779,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 145",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145184,0.0196,1798142,464922080,139377681,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-dichloro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239086,0.0197,1804976,441610607,146240627,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-[(4S)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-N-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-7-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439896,0.0197,1920052,486503683,166927670,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 213",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144882,0.0197,1798142,461604564,152088193,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[[2-(2-hydroxypropan-2-yl)-6-methylpyridin-3-yl]amino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145452,0.0197,1798142,464922089,139377685,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[5-chloro-4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086372,0.0198,776745,312397804,118738355,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(4-methylsulfonylpiperazin-1-yl)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439940,0.0198,1920052,486503727,167318720,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 257",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440010,0.0198,1920052,486503796,167318689,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 329",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104042,0.0199,1796169,381752958,132143198,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfonylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146310,0.0199,1798142,464922055,139377955,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4-chloro-5-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503823,0.02,361654,103643927,24897494,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,"4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-(2,2,2-trifluoroethylhydrazinylidene)methyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539065,0.02,410944,103607072,25263279,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539070,0.02,410944,103606910,25263271,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl piperazine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539082,0.02,410944,103606834,25263268,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-methylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541200,0.02,410949,103607073,25263280,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571803,0.02,344457,103606834,25263268,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-methylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675461,0.02,290550,103523384,11203411,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"N-(2,6-difluorophenyl)-4-(4-(6-(dimethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821390,0.02,248914,103441721,11399289,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-(naphthalen-1-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863470,0.02,260896,103673639,156413,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,Canertinib dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864190,0.02,260899,103479579,11524106,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-heptynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101912905,0.02,270616,103498516,9960734,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-(((2-(methylsulfonyl)ethyl)(propyl)amino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106010469,0.02,439897,103699346,45483677,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid cis-4-amino-4-methylcyclohexyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151279402,0.02,461252,103729447,24944851,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyhexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365011,0.02,549932,124959166,53318118,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"(S)-N-(3-ethynylphenyl)-5-((morpholin-2-ylmethoxy)methyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365018,0.02,549932,124967055,21874402,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-((4-aminopiperidin-1-yl)methyl)-N-o-tolylpyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420061,0.02,632226,136925310,56851428,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(3-fluorophenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420342,0.02,632227,136928526,56851592,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(3-methylphenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655812,0.02,1315979,374328591,134148660,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388997004,0.02,1798900,58097700,25263268,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-methylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997006,0.02,1798900,58097706,25263271,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl piperazine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997075,0.02,1798900,58097714,25263279,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665721,0.02,1806610,471698520,155243032,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"6-((1-Acryloylpiperidin-4-yl)oxy)-4-((2,4-dichloro-phenyl)amino)-7-methoxy-quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615868,0.02,1919643,483622386,162496359,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 30",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203163,0.02,1798359,404345974,135203404,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-ethenylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203187,0.02,1798359,404345963,130276411,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-ethylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203236,0.02,1798359,404345978,130276334,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-3-fluorophenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203237,0.02,1798359,404345931,130276357,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-cyano-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232542,0.02,1803904,404345978,130276334,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-3-fluorophenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232556,0.02,1803904,404345974,135203404,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-ethenylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232580,0.02,1803904,404345963,130276411,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-ethylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232633,0.02,1803904,404345931,130276357,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-cyano-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347892,0.02,1919554,404345974,135203404,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-ethenylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347900,0.02,1919554,404345963,130276411,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-ethylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347960,0.02,1919554,404345978,130276334,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]-3-fluorophenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402353785,0.02,1919554,404345931,130276357,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-cyano-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439706,0.02,1920052,486503499,166927896,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439881,0.02,1920052,486503668,167318651,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 198",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440306,0.02,1920053,486503600,166927756,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 128",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440310,0.02,1920053,486503603,167318635,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 131",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440648,0.02,1920053,486503937,167318663,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 473",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151278187,0.0201,461252,103729685,24945368,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,N1-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-N8-hydroxyoctanediamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439852,0.0201,1920052,486503640,167318552,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 170",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388757682,0.0203,1795123,375077070,86305722,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3,4-dichloro-2-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439787,0.0203,1920052,486503576,167318896,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 103",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439844,0.0203,1920052,486503632,166927659,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 160",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439886,0.0203,1920052,486503673,167318775,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 203",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440078,0.0203,1920052,486503862,167318812,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 397",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440143,0.0203,1920052,486503927,167318572,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 462",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440319,0.0203,1920053,486503612,166928145,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 140",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440482,0.0203,1920053,486503773,167318866,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 305",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440015,0.0204,1920052,486503801,167318722,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 334",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440142,0.0205,1920052,486503926,167318754,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 461",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439803,0.0206,1920052,486503592,167318750,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 120",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440267,0.0206,1920053,486503563,167318761,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 91",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440127,0.0207,1920052,486503911,167318711,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 446",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440281,0.0207,1920053,486503575,166927754,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 102",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440517,0.0207,1920053,486503808,167318546,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 341",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440008,0.0208,1920052,486503794,167318871,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 327",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439860,0.0209,1920052,486503648,166928150,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 178",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440358,0.0209,1920053,486503650,167318888,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 180",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101676422,0.021,290549,103523394,44426290,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101676425,0.021,290549,103523384,11203411,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"N-(2,6-difluorophenyl)-4-(4-(6-(dimethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
106010471,0.021,439897,103699483,45483696,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"[(3S)-morpholin-3-yl]methyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethyl-7aH-pyrrolo[2,3-d]pyrimidin-6-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
345598416,0.021,1198817,312385811,9937225,2064,25794791,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2 intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,"N-[4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]pyrido[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354665796,0.021,1289555,336878369,71535003,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant autophosphorylation in human H3255 cells after 2 hrs by sandwich ELISA,"1-((3R,4R)-3-(((5-chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)methyl)-4-methoxypyrrolidin-1-yl)prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655575,0.021,1315425,374334793,134150381,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(3-Chloro-4-morpholin-4-ylanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112719,0.021,1676531,461562420,162676678,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[6-[4-(4-methylpiperazin-1-yl)phenyl]-4-propan-2-yloxy-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665722,0.021,1806610,471698509,155235870,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"1-(4-((4-((2,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666676,0.021,1806610,471698532,74388734,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 32",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615753,0.021,1919643,483622384,146448703,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 22",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203230,0.021,1798359,404345933,130277056,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232544,0.021,1803904,404345933,130277056,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2-fluorophenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347872,0.021,1919554,483499820,168474843,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439811,0.021,1920052,486503600,166927756,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 128",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439815,0.021,1920052,486503603,167318635,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 131",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440375,0.021,1920053,486503667,167318830,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 197",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407923779,0.021,1927648,494416958,171355565,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 1 hrs in presence of ATP by ELISA assay,N-(4-methylphenyl)-2-[4-oxo-3-(4-sulfamoylphenyl)benzo[g]quinazolin-2-yl]sulfanylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407923780,0.021,1927648,494418971,171356652,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 1 hrs in presence of ATP by ELISA assay,N-(2-methylphenyl)-2-[4-oxo-3-(4-sulfamoylphenyl)benzo[g]quinazolin-2-yl]sulfanylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432842,0.0211,1919984,486499654,169550964,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-(1-methylpyridin-1-ium-4-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018082,0.0211,1920044,486503204,169552732,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439876,0.0212,1920052,486503663,167318728,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 193",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440429,0.0212,1920053,486503721,162428947,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 251",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145686,0.0212,1798142,464922087,139377763,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',(S)-Sunvozertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439776,0.0213,1920052,486503567,167318690,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 94",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439824,0.0213,1920052,486503612,166928145,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 140",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439994,0.0213,1920052,486503780,167318882,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 313",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142741,0.0213,1798142,464922023,139378101,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2R)-2-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439693,0.0214,1920052,486503487,166927837,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 15",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359662,0.0215,517501,123099174,52947602,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-(3-methoxypropyl)piperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359665,0.0215,517501,123098952,52948817,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"trans-2-(4-(4-(4-amino-3-(4-(7-chlorobenzo[d]oxazol-2-ylamino)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl)piperazin-1-yl)-N,N-dimethylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439873,0.0215,1920052,486503660,167318878,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 190",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440592,0.0215,1920053,486503881,162428785,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 416",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146977,0.0215,1798142,464922056,139377809,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',Sunvozertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440003,0.0216,1920052,486503789,167318574,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 322",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440153,0.0216,1920052,486503937,167318663,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 473",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440165,0.0217,1920052,486503949,167318730,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 485",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250511,0.0218,1804976,441610606,146241658,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(1-azabicyclo[2.2.2]octan-4-yloxy)-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439855,0.0218,1920052,486503643,167318864,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 173",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440112,0.0218,1920052,486503896,167318707,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 431",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440376,0.0219,1920053,486503668,167318651,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 198",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350225,0.022,68098,103202152,9995195,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101596687,0.022,331423,103563800,17747282,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-(1-benzylindazol-5-yl)-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751924,0.022,308828,103549793,11178756,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-((4-aminopiperidin-1-yl)methyl)-N-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101755439,0.022,309857,103551497,44442028,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,(S)-N-(2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propyl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778071,0.022,314962,103561948,16118179,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(R)-2-(4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)-1-morpholinopropan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101778930,0.022,315244,103574929,44455730,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2R)-2-[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-5-yl]oxy-1-morpholin-4-ylpropan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101864184,0.022,260899,103479806,11539461,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(4-morpholinyl)-2-butynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101912899,0.022,270616,103498916,9872621,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(benzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912910,0.022,270616,103498517,9873849,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,2-(((5-(4-(4-(3-Fluorobenzyloxy)-3-chlorophenylamino)quinazolin-6-yl)furan-2-yl)methyl)(2-(methylsulfonyl)ethyl)amino)acetonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106010470,0.022,439897,124974945,10437018,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
106010477,0.022,439897,103699339,45483675,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"[(3S)-morpholin-3-yl]methyl N-[5-ethyl-4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-7aH-pyrrolo[2,3-d]pyrimidin-6-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
204367025,0.022,549932,103549751,10151881,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"[5-(4-amino-piperidin-1-ylmethyl)-pyrrolo[2,1-f][1,2,4]triazin-4-yl]-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420216,0.022,632226,136935222,56849555,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420346,0.022,632227,136922139,56850930,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,Egfr/her2-IN-11,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355631310,0.022,1305356,336906414,127052095,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355633471,0.022,1306577,103244983,123631,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366350093,0.022,1549565,136940589,24821094,2064,30875504,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 using biotinyl-beta amyloid beta amyloid beta AAEEEEYFELVAKKK measured after 10 mins in the presence of ATP by HTRF assay,Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402178304,0.022,1801898,317227922,71618040,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Time-Resolved Fret (TR-FRET) Assay from US Patent US9187459: 'Quinazoline-7-ether compounds and methods of use',"(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[[(1R,5R)-3-oxabicyclo[3.1.0]hexan-1-yl]methoxy]quinazolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203197,0.022,1798359,404345970,130276937,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203200,0.022,1798359,404345953,130276381,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2,5-dimethylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232590,0.022,1803904,404345970,130276937,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232621,0.022,1803904,404345953,130276381,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2,5-dimethylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347878,0.022,1919554,483499835,168474845,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 39",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347995,0.022,1919554,404345970,130276937,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439961,0.022,1920052,486503748,167318745,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 278",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440079,0.0221,1920052,486503863,167318701,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 398",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146990,0.0221,1798142,464922022,151915644,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxy-2-[methyl(2-pyrrolidin-1-ylethyl)amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440448,0.0222,1920053,486503740,169552765,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 270",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439945,0.0223,1920052,486503732,167318563,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 262",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440329,0.0223,1920053,486503622,167318839,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 150",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321541448,0.0224,664633,160678864,53341082,2064,22372864,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 preincubated for 10 mins followed by incubation for 30 mins by fluorescence polarization assay,"N-[[2-[4-amino-6-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]pyrimidin-5-yl]-1,3-oxazol-4-yl]methyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250515,0.0224,1804976,441610620,146241657,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',CID 146241657,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439890,0.0224,1920052,486503677,166927721,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 207",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440155,0.0224,1920052,486503939,167318716,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 475",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439839,0.0225,1920052,486503627,167318859,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 155",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146305,0.0225,1798142,464922103,139377851,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(2R,4S)-2-[(dimethylamino)methyl]-4-methylpyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439685,0.0227,1920052,486503480,162429013,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 8",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440300,0.0227,1920053,486503594,167318749,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 122",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440058,0.0228,1920052,486503842,167318667,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 375",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440085,0.0228,1920052,486503869,167318550,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 404",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440390,0.0229,1920053,486503682,167318692,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 212",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675443,0.023,290550,103523370,44426274,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675471,0.023,290549,103523377,44426279,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"3,3-Dimethyl-1-(4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidin-1-yl)butan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751500,0.023,308828,103549751,10151881,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"[5-(4-amino-piperidin-1-ylmethyl)-pyrrolo[2,1-f][1,2,4]triazin-4-yl]-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778085,0.023,314962,103561935,11712237,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,"(R)-N,N-dimethyl-2-(4-(3-methyl-4-(6-methylpyridin-3-yloxy)phenylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101778517,0.023,315244,103561935,11712237,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,"(R)-N,N-dimethyl-2-(4-(3-methyl-4-(6-methylpyridin-3-yloxy)phenylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101778933,0.023,315244,103574876,44455701,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2R)-2-[4-[3-methoxy-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-5-yl]oxy-1-morpholin-4-ylpropan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101864177,0.023,260899,103479798,11532242,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,N-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-5-(diethylamino)pent-2-ynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101912914,0.023,270616,103498679,9937660,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,4-((5-(4-((4-(Benzyloxy)-3-chlorophenyl)amino)quinazolin-6-yl)furan-2-yl)methyl)thiomorpholine 1-oxide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106010474,0.023,439897,103699413,45483687,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid piperidin-4-ylmethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
204365019,0.023,549932,124974945,10437018,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420119,0.023,632227,123085234,11620908,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,Tak-285,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340069398,0.023,770082,174514062,73292363,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-(5-{[5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-4-methoxy-2-{4-methylpiperazin-1-yl}phenyl)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
354665410,0.023,1289551,312367127,71496458,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR deletion mutant autophosphorylation in human HCC827 cells after 2 hrs by sandwich ELISA,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630994,0.023,1305356,336903855,127050256,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[6-[1-(1-acetylpiperidin-4-yl)pyrazol-4-yl]-3-aminopyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355656035,0.023,1315979,374296412,134139694,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
372112586,0.023,1676531,461529019,162653183,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[2-[2-(dimethylamino)ethoxy]-5-[4-[4-[(1,3-dioxoisoindol-2-yl)methyl]anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666768,0.023,1806610,471698534,59404878,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402178300,0.023,1801898,317227921,121596254,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Time-Resolved Fret (TR-FRET) Assay from US Patent US9187459: 'Quinazoline-7-ether compounds and methods of use',"(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[[(1S,5S)-3-oxabicyclo[3.1.0]hexan-1-yl]methoxy]quinazolin-6-yl]-5-(dimethylamino)pent-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203165,0.023,1798359,404345954,130275764,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232558,0.023,1803904,404345954,130275764,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347874,0.023,1919554,404345954,130275764,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440176,0.023,1920053,486503476,162428791,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 4",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440291,0.023,1920053,486503585,167318902,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 113",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250518,0.0231,1804976,8035064,208908,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439778,0.0231,1920052,486503569,166927752,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 109",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439779,0.0231,1920052,486503569,166927752,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 109",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363522781,0.0232,1375530,404677845,145967187,2064,29715023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human ErbB2 using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA","N-[(7S)-4-amino-6-methylidene-5-(4-phenoxyphenyl)-7,8-dihydropyrimido[5,4-b]pyrrolizin-7-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439825,0.0232,1920052,486503613,166927956,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 141",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439900,0.0232,1920052,486503687,166927891,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 217",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440509,0.0232,1920053,486503800,167318569,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 333",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102686,0.0233,1796166,381752965,132163000,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440655,0.0233,1920053,486503944,167318842,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 480",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440427,0.0234,1920053,486503719,162428781,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 249",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440372,0.0235,1920053,486503664,167318808,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 194",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086371,0.0237,776745,312397801,118738352,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(4-methylpiperazin-1-yl)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440590,0.0237,1920053,486503879,167318603,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 414",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439786,0.0238,1920052,486503575,166927754,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 102",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439964,0.0238,1920052,486503751,167318734,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 281",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439965,0.0238,1920052,486503751,167318734,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 281",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688214,0.0239,1330925,103177479,208908,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100368720,0.024,69713,103375975,5329092,2064,11462982,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells,"4-Anilinopyrido[3,4-d]pyrimidine 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101444026,0.024,392130,103202674,4708,2064,18667312,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675439,0.024,290550,103523394,44426290,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778078,0.024,314962,103561954,16117623,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,"(S)-N,N-dimethyl-2-(4-(1-(thiazol-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101821953,0.024,248914,103441781,11365342,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(4-chlorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101827307,0.024,254948,103468868,44403436,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,[3-Chloro-4-(pyridin-2-ylmethoxy)-phenyl]-(5-methoxy-quinazolin-4-yl)-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101827312,0.024,254948,103468855,44403429,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,[3-Chloro-4-(pyridin-2-ylmethoxy)-phenyl]-[5-(tetrahydro-pyran-4-yloxy)-quinazolin-4-yl]-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864186,0.024,260899,103480257,11566580,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,EGFR/ErbB-2/ErbB-4 Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101912904,0.024,270616,103498558,9873657,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(isopropylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124195,0.024,418589,103245651,5329009,2064,19211246,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N-(3-chloro-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279394,0.024,461252,103729624,24945204,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-Chloro-4-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334072991,0.024,739689,164130185,71583657,2064,23490150,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD-tagged HER2 cytoplasmic domain (676 to 1255) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,"4-{[4-(1-Benzothiophen-4-Yloxy)-3-Chlorophenyl]amino}-N-(2-Hydroxyethyl)-8,9-Dihydro-7h-Pyrimido[4,5-B]azepine-6-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799243,0.024,1428363,103244983,123631,2064,27987485,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665729,0.024,1806610,471698527,25128361,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666772,0.024,1806610,471698537,155242991,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-(3-((7-Methoxy-4-(phenylamino)quinazolin-6-yl)oxy)azetidin-1-yl)prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615763,0.024,1919643,483622399,146448715,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 43",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440289,0.024,1920053,486503583,167318912,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 111",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440527,0.024,1920053,486503816,167318854,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 349",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103294,0.0241,1796168,381752952,132143259,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440147,0.0241,1920052,486503931,167318725,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 466",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440511,0.0241,1920053,486503802,167318813,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 335",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151278189,0.0242,461252,103729686,45140150,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ylthio)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102341,0.0242,1796170,381752953,132143292,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(5-amino-1,3-dihydroisoindole-2-carbonyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439826,0.0242,1920052,486503614,166927758,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 142",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439832,0.0243,1920052,486503620,167318598,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 148",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439868,0.0243,1920052,486503655,167318619,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 185",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440125,0.0243,1920052,486503909,167318907,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 444",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440654,0.0244,1920053,486503943,167318886,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 479",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432863,0.0245,1919984,486499675,168257832,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"Synthesis of (E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-2-fluoro-5-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-34-((R)-1-methylpyrrolidin-2-yl)prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440533,0.0245,1920053,486503822,167318821,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 355",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018104,0.0245,1920044,486503225,168762279,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"Synthesis of (E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-2-fluoro-5-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-3-((R)-1-methylpyrrolidin-2-yl)prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439683,0.0246,1920052,486503478,162428900,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439835,0.0246,1920052,486503623,167318681,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 151",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440076,0.0246,1920052,486503860,167318877,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 395",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440171,0.0247,1920052,486503955,167318826,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 492",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439808,0.0248,1920052,486503597,167318853,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 125",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440072,0.0248,1920052,486503856,167318618,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 390",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440043,0.0249,1920052,486503827,167318857,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 360",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101596688,0.025,331423,103563591,17747281,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-propan-2-yloxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675478,0.025,290549,103523383,44426283,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"N-(2,6-difluorophenyl)-4-(2-methyl-4-(6-(methylamino)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821399,0.025,248914,103441709,11180905,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-piperidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821635,0.025,248914,103441700,11307866,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(1-benzenesulfonyl-1H-indol-5-ylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912912,0.025,270616,103498945,21952043,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(benzyloxy)-3-bromophenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666670,0.025,1806610,471698513,155280255,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"6-((1-Acryloylpiperidin-4-yl)oxy)-4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxy-quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402178302,0.025,1801898,317227919,121596253,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Time-Resolved Fret (TR-FRET) Assay from US Patent US9187459: 'Quinazoline-7-ether compounds and methods of use',"(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[[(3R,6R)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]quinazolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432843,0.025,1919984,486499655,168258144,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439732,0.025,1920052,486503525,167318633,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 53",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439962,0.025,1920052,486503749,169552768,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 279",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440108,0.025,1920052,486503892,167318751,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 427",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440219,0.025,1920053,486503517,166927915,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 45",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440612,0.025,1920053,486503901,162428919,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 436",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018083,0.025,1920044,486503205,169552733,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089316,0.025,1961745,103244983,123631,2064,37468498,Confirmatory,20240503,0,0,Active,P04626,AC50,=,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440138,0.0251,1920052,486503922,167318772,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 457",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439777,0.0252,1920052,486503568,166927696,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 95",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440095,0.0252,1920052,486503879,167318603,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 414",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440518,0.0253,1920053,486503809,167318546,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 341",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439701,0.0255,1920052,486503494,167318715,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 22",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440538,0.0255,1920053,486503827,167318857,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 360",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440606,0.0255,1920053,486503895,167318597,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 430",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440386,0.0256,1920053,486503678,166927661,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 208",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439885,0.0257,1920052,486503672,167318733,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 202",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440061,0.0257,1920052,486503845,167318765,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 379",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142730,0.0257,1798142,461604599,147746345,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[[2-(2-hydroxypropan-2-yl)pyridin-3-yl]amino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439913,0.0258,1920052,486503700,167318780,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 230",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440093,0.0259,1920052,486503877,166927873,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 412",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440137,0.0259,1920052,486503921,167318901,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 456",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440320,0.0259,1920053,486503613,166927956,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 141",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568315,0.026,68096,103237122,10738988,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,"N-[4-(3-Bromo-4-fluoro-phenylamino)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101751928,0.026,308828,103549794,11590799,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-aminopiperidin-1-yl)methyl]-N-[3-chloro-4-(pyrazin-2-ylmethoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778076,0.026,314962,103561953,16117349,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,"(R)-N,N-dimethyl-2-(4-(1-(thiazol-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101863464,0.026,260896,103479806,11539461,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(4-morpholinyl)-2-butynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912893,0.026,270616,103498735,44416289,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(1-methyl-1H-imidazol-2-ylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912901,0.026,270616,103498557,9960493,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(propylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912917,0.026,270616,103498619,9828336,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(benzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420209,0.026,632226,136945714,56851593,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(3-methoxyphenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345598414,0.026,1198817,312385812,10075664,2064,25794791,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2 intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,"6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-(4-phenylmethoxyphenyl)pyrido[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355631461,0.026,1305356,336905528,127051448,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]-2-fluorophenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
372112380,0.026,1676531,461520227,162647070,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-(4-benzhydryloxyanilino)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112715,0.026,1676531,461529688,162653671,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[6-[4-(4-methylpiperazin-1-yl)phenyl]-4-(2-methylpropoxy)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615744,0.026,1919643,483622380,146510069,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 12",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103429,0.026,1796168,381752958,132143198,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfonylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203168,0.026,1798359,404345929,130277047,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-4-(1-(1-acryloylpiperidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido)phenyldimethyl carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232563,0.026,1803904,404345929,130277047,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-4-(1-(1-acryloylpiperidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamido)phenyldimethyl carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250516,0.026,1804976,441610596,146250831,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(3-fluoro-1-methylpiperidin-4-yl)oxy-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347880,0.026,1919554,483499816,168474842,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US11696917, Example 21",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439694,0.026,1920052,486503488,162428782,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 16",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439757,0.026,1920052,486503549,162428850,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 77",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
409903341,0.026,1291334,312367129,71496459,2064,26968253,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Del ex19 mutant phosphorylation in human PC9 cells preincubated for 2 hrs by ELISA,N-[4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-[methyl-[2-(methylamino)ethyl]amino]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
410146768,0.026,1798142,464922105,139377852,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(1,1,1-trifluoro-2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665452,0.0261,1168534,312363561,46865445,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1R)-1-(dimethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440046,0.0261,1920052,486503830,167318884,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 363",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440131,0.0261,1920052,486503915,167318788,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 450",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439819,0.0262,1920052,486503607,166928146,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 135",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440312,0.0262,1920053,486503605,167318899,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 133",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439715,0.0263,1920052,486503508,162428857,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 36",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439759,0.0263,1920052,486503551,166927699,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 79",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440045,0.0263,1920052,486503829,169552774,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 362",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440092,0.0263,1920052,486503876,167318805,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 411",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440044,0.0264,1920052,486503828,167318589,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 361",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440148,0.0264,1920052,486503932,167318777,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 467",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439806,0.0265,1920052,486503595,166927703,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 123",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440159,0.0265,1920052,486503943,167318886,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 479",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632648,0.0268,1306575,318397010,122195677,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant Her2 (676 to 1255 residues) expressed in baculovirus by fluorescence based assay,[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102677,0.0268,1796166,381752952,132143259,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439802,0.0268,1920052,486503591,167318875,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 119",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595842,0.027,331423,103563697,17747242,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[1-[(3-fluorophenyl)methyl]indol-5-yl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675469,0.027,290549,103523381,44426281,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"N-(2,6-difluorophenyl)-4-(4-(6-(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101694382,0.027,295195,103531669,9825976,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"(5-[1,4]Diazepan-1-ylmethyl-pyrrolo[2,1-f][1,2,4]triazin-4-yl)-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751932,0.027,308828,103531669,9825976,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"(5-[1,4]Diazepan-1-ylmethyl-pyrrolo[2,1-f][1,2,4]triazin-4-yl)-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778934,0.027,315244,103574878,44455702,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2R)-2-[4-[3-chloro-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-5-yl]oxy-1-morpholin-4-ylpropan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101821645,0.027,248914,103441774,11365297,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-[2-hydroxyethyl(methyl)amino]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155745955,0.027,474117,103749171,46865992,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 intracellular phosphorylation in human N87 cells by ELISA,"N-(3-(5-(2-(4-(2-(dimethylamino)ethyl)phenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2,6-difluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
254420230,0.027,632227,136928527,56849560,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]-5-methylpyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420559,0.027,632227,136944728,56851429,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(2-chlorophenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655463,0.027,1315979,374267788,134131929,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388996182,0.027,1798859,57560484,25218694,2064,18287036,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Receptor Tyrosine Kinase Inhibition Assay from Article 10.1073/pnas.0708281105: '6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.'","6-[(3S)-3-aminobut-1-yn-1-yl]-N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615857,0.027,1919643,483622374,146448641,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102333,0.027,1796170,381752971,132162748,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(1H-indol-5-ylcarbamoyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103434,0.027,1796168,381752966,132143184,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440366,0.0271,1920053,486503658,166927677,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 188",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432867,0.0273,1919984,486499679,168258001,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"Synthesis of (E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-3-(1-methylazetidin-3-yl)prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018108,0.0273,1920044,486503229,169552748,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"Synthesis of (E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4,5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-3-(1-methylazetidin-3-yl)prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439907,0.0274,1920052,486503694,167318645,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 224",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440119,0.0274,1920052,486503903,167318617,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 438",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106024077,0.0275,447375,103707833,45101511,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(3S,5S,6S)-5-(hydroxycarbamoyl)-1-methyl-6-(4-phenylpiperazine-1-carbonyl)piperidin-3-yl azocane-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439871,0.0275,1920052,486503658,166927677,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 188",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439916,0.0275,1920052,486503703,167318817,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 233",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440006,0.0275,1920052,486503792,167318787,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 325",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372335266,0.0276,1715358,123092436,44259,2064,29523467,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ERBB2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439749,0.0276,1920052,486503541,166927660,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 69",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440037,0.0276,1920052,486503821,167318601,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 354",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440234,0.0276,1920053,486503532,166927914,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 60",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440397,0.0276,1920053,486503689,166927708,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 219",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146773,0.0276,1798142,464922102,139377843,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[[(2R,4S)-1,4-dimethylpyrrolidin-2-yl]methyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439884,0.0277,1920052,486503671,167318833,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 201",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279397,0.0278,461252,103729782,45140349,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,(R)-N-Hydroxy-7-(7-methoxy-4-(1-phenylethylamino)quinazolin-6-yloxy)heptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440170,0.0278,1920052,486503954,162428867,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 491",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440158,0.0279,1920052,486503942,162429006,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 478",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100702159,0.028,226585,103408038,44372197,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and ErbB-2 average ratio,"N-(2-methylsulfonylethyl)-4-[4-(4-phenylmethoxyanilino)quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100702778,0.028,68100,103407771,44372005,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2,"4-[4-[(1-benzylindazol-5-yl)amino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453098,0.028,375732,103635148,44583601,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(2S,3S,5RS)-N-hydroxy-5-(2-oxo-2-(pyrrolidin-1-yl)ethyl)-2-(4-phenylpiperazine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101821649,0.028,248914,103441771,11157794,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Diisopropylamino-but-2-enoic acid [4-(4-benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821805,0.028,248914,103441742,11455794,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-cyclohexylmethoxy-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912896,0.028,270616,103498514,9917474,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(phenylsulfonyl)ethoxy)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106010480,0.028,439897,103699477,45483693,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid 2-(piperidin-1-yl)ethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
106023763,0.028,447375,104236502,49861327,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"[(5S,6S)-5-(hydroxycarbamoyl)-6-[(3R)-3-phenylpyrrolidine-1-carbonyl]piperidin-3-yl] pyrrolidine-1-carboxylate;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321558855,0.028,670126,160674380,57415416,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"5-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-1,3-dihydroindol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388836051,0.028,1795774,8035060,5329477,2064,14684309,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/j.bmcl.2003.10.010: 'Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.',6-Thiazolylquinazoline 3,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203235,0.028,1798359,404345959,130277023,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,6-dichlorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232627,0.028,1803904,404345959,130277023,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,6-dichlorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402353781,0.028,1919554,404345959,130277023,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,6-dichlorophenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432859,0.028,1919984,486499671,168257502,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"Synthesis of (E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-4-(methylamino)but-2-en-1-one formate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439846,0.028,1920052,486503634,166927938,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 164",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440634,0.028,1920053,486503923,167318870,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 458",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018100,0.028,1920044,486503221,168762282,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"Synthesis of (E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4,5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-4-(methylamino)but-2-en-1-one formate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439697,0.0282,1920052,486503491,166927737,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 163",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439698,0.0282,1920052,486503491,166927737,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 163",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439794,0.0282,1920052,486503583,167318912,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 111",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439929,0.0282,1920052,486503716,167318697,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 246",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440080,0.0282,1920052,486503864,167318634,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 399",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432827,0.0283,1919984,486499639,168257998,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439924,0.0283,1920052,486503711,169552760,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 241",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439989,0.0283,1920052,486503775,167318890,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 307",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018075,0.0283,1920044,486503187,169552725,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440347,0.0286,1920053,486503640,167318552,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 170",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439843,0.0287,1920052,486503631,166927763,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 159",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439722,0.0288,1920052,486503515,162429033,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 43",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439784,0.0288,1920052,486503573,167318797,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 100",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439898,0.0288,1920052,486503685,166927771,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 215",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440113,0.0288,1920052,486503897,167318799,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 432",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440485,0.0288,1920053,486503776,167318540,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 308",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440235,0.0289,1920053,486503533,167318670,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 60a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440236,0.0289,1920053,486503533,167318670,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 60a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675737,0.029,290550,103523387,44426285,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,Cyclopentyl(4-(4-(6-(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821954,0.029,248914,103441792,11354013,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Thiomorpholin-4-yl-but-2-enoic acid [4-(4-benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880659,0.029,263981,103486553,44410716,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,Methyl 5-(3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)phenylamino)-5-oxopentanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106009909,0.029,439897,103699447,45483689,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid piperidin-3-ylmethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
106023778,0.029,447375,103707759,45487302,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(2S,3S)-N-hydroxy-5-(N-methylbenzamido)-2-((R)-3-phenylpyrrolidine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359660,0.029,517501,123096641,52947603,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"trans-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-chlorophenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420152,0.029,632226,136931762,56849702,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[4-[3-Chloro-4-[3-(trifluoromethoxy)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433589,0.029,636385,136937053,56949987,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334072657,0.029,739689,164130184,59484610,2064,23490150,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD-tagged HER2 cytoplasmic domain (676 to 1255) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,"4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-N-(2-hydroxyethyl)-8,9-dihydro-7H-pyrimido[4,5-b]azepine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340069394,0.029,770082,174493356,73294315,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
341150613,0.029,1079763,194140848,76311268,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","3-[(6-bromo-9H-pyrido[2,3-b]indol-4-yl)amino]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
372112804,0.029,1676531,461541672,162662077,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-(4-benzylanilino)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440532,0.029,1920053,486503821,167318601,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 354",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440575,0.029,1920053,486503864,167318634,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 399",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380801466,0.0292,1915714,103177479,208908,2064,33243532,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432871,0.0292,1919984,486499681,168257430,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"Synthesis of (45,E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-2-fluoro-5-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5': 5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-4-(dimethylamino)pent-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432878,0.0292,1919984,486499688,168762332,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.4.1.02,11.04,9]nonadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439892,0.0292,1920052,486503679,166927713,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 209",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440408,0.0292,1920053,486503700,167318780,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 230",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018071,0.0292,1920044,486499688,168762332,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.4.1.02,11.04,9]nonadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018109,0.0292,1920044,486503231,168762276,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"Synthesis of (4S,E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-2-fluoro-5-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4,5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-4-(dimethylamino)pent-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440102,0.0293,1920052,486503886,167318606,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 421",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440114,0.0293,1920052,486503898,167318637,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 433",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380767922,0.02933,1905773,103441767,9915743,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 D769Y mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439842,0.0294,1920052,486503630,167318666,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 158",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440161,0.0294,1920052,486503945,167318706,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 481",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439865,0.0295,1920052,486503652,167318916,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 182",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440542,0.0295,1920053,486503831,162428855,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 364",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440166,0.0296,1920052,486503950,167318584,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 486",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439738,0.0297,1920052,486503531,166927903,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 59",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439888,0.0297,1920052,486503675,166927890,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 205",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439942,0.0297,1920052,486503729,169552761,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 259",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439995,0.0298,1920052,486503781,167318547,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 314",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541204,0.03,410949,103606995,25263274,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101596686,0.03,331423,103563797,17747311,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[1-[(3-chlorophenyl)methyl]indazol-5-yl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675448,0.03,290550,103523364,44426268,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,N-tert-butyl-3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675464,0.03,290549,103523390,44426286,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"4-(2-methyl-4-(6-(methylamino)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778937,0.03,315244,103574792,44455645,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,"(2S)-N,N-Dimethyl-2-[[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-5-quinazolinyl]oxy]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101829708,0.03,254975,103468232,21945968,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"4-[(1-benzylindazol-5-yl)amino]-5-ethyl-N-(3-imidazol-1-ylpropyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101912895,0.03,270616,103498734,44416288,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(pyridin-2-ylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912911,0.03,270616,134457208,9809611,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(phenylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103123565,0.03,418568,103593130,25263246,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by SPA assay,"(3R,5S)-5-[2-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124270,0.03,418567,103593396,25263258,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-{2-[4-({1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106010472,0.03,439897,103699478,45483694,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid piperidin-2-ylmethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
106024075,0.03,447375,103707874,45487402,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(3R,5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenyl-1,2,3,6-tetrahydropyridine-1-carbonyl)piperidin-3-yl pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420214,0.03,632226,136921998,56851589,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435328,0.03,638068,136921864,57390777,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[(E)-2-[4-[(propan-2-ylamino)methyl]phenyl]ethenyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334072988,0.03,739689,164133033,71583658,2064,23490150,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD-tagged HER2 cytoplasmic domain (676 to 1255) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,"4-[4-(1-benzothiophen-4-yloxy)-3-chloroanilino]-N-(2-methylsulfonylethyl)-8,9-dihydro-7H-pyrimido[4,5-b]azepine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342807277,0.03,1128576,242620546,90655145,2064,24565969,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 after 60 mins by ELISA,"(E)-N-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-4-(6-oxo-2-azabicyclo[2.2.2]octan-2-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345598415,0.03,1198817,312385810,9954156,2064,25794791,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2 intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,"2-[[4-[(1-Benzylindazol-5-yl)amino]pyrido[3,4-d]pyrimidin-6-yl]-methylamino]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655711,0.03,1315979,374283644,134136245,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[[1-(benzenesulfonyl)indol-5-yl]amino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355656041,0.03,1315979,374323481,134147234,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-[di(propan-2-yl)amino]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363684691,0.03,1424370,103202250,156414,2064,28754471,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of GST-tagged human HER2 catalytic domain expressed in insect cells,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605544,0.03,1867605,482066547,156768728,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-bromo-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380667927,0.03,1882631,124974945,10437018,2064,35311289,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000799,0.03,1798897,58097678,25263246,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-[2-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000800,0.03,1798897,58097690,25263258,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-{2-[4-({1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666471,0.03,1806610,471698513,155280255,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"6-((1-Acryloylpiperidin-4-yl)oxy)-4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxy-quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666667,0.03,1806610,471698534,59404878,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666767,0.03,1806610,471698514,155235880,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"1-(3-((4-((2,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)azetidin-1-yl)-prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440175,0.03,1920053,486503476,162428791,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 4",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439736,0.0302,1920052,486503529,166927843,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 57",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440388,0.0302,1920053,486503680,166927886,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 210",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440581,0.0303,1920053,486503870,167318801,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 405",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439957,0.0307,1920052,486503744,167318880,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 274",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440297,0.0307,1920053,486503591,167318875,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 119",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439791,0.0308,1920052,486503580,167318541,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 107",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440034,0.0308,1920052,486503818,167318695,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 351",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440353,0.0308,1920053,486503646,167318577,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 176",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101444506,0.031,395891,103334788,6505803,2064,19017562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 in human SKBR3 cells,Tanespimycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101564641,0.031,367174,103610159,44532811,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)thiophen-3-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751931,0.031,308828,103549771,10152514,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"2-(1-{4-[1-(3-Fluoro-benzyl)-1H-indazol-5-ylamino]-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl}-piperidin-4-ylamino)-ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778514,0.031,315244,103575032,44455782,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2R)-2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-5-yl)oxy]-N-(2-hydroxyethyl)-N-methylpropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101912898,0.031,270616,103498662,9893671,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,Deschloro Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023777,0.031,447375,103707873,45487401,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(3S,5S,6S)-5-(hydroxycarbamoyl)-1-methyl-6-(4-phenylpiperazine-1-carbonyl)piperidin-3-yl dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420270,0.031,632227,136925429,56851052,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-({2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}sulfinyl)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347032947,0.031,1242284,318385111,118073699,2064,26191356,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR E746-A750 deletion mutant in human PC9 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,N-[(3S)-1-[9-(2-hydroxyethyl)-6-[4-(4-methylpiperazin-1-yl)anilino]purin-2-yl]pyrrolidin-3-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
388757274,0.031,1795123,375077051,117685164,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-((4aS,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615862,0.031,1919643,483622376,146448689,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203189,0.031,1798359,404345971,130276346,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203198,0.031,1798359,404345968,130276952,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232557,0.031,1803904,404345968,130276952,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232566,0.031,1803904,404345971,130276346,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347903,0.031,1919554,404345968,130276952,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-chloro-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347999,0.031,1919554,404345971,130276346,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-3-fluoro-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439724,0.031,1920052,486503517,166927915,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 45",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439854,0.031,1920052,486503642,167318643,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 172",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440275,0.031,1920053,486503570,167318835,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 310",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440276,0.031,1920053,486503570,167318835,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 310",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440371,0.031,1920053,486503663,167318728,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 193",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440389,0.031,1920053,486503681,167318607,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 211",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440380,0.0311,1920053,486503672,167318733,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 202",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440026,0.0313,1920052,486503812,162428822,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 345",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440027,0.0313,1920052,486503812,162428822,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 345",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440228,0.0313,1920053,486503526,167318585,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 54",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440271,0.0313,1920053,486503567,167318690,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 94",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440098,0.0314,1920052,486503882,167318906,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 417",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440351,0.0314,1920053,486503644,167318699,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 174",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356260,0.0315,517320,123087720,20817111,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432873,0.0315,1919984,486499683,168258177,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-1-[(14S)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]-4-(methylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440088,0.0315,1920052,486503872,167318624,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 407",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440198,0.0315,1920053,486503496,164575759,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 24",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018110,0.0315,1920044,486503232,169552749,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-1-[(14R)-5-[2-fluoro-5-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]-4-(methylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440340,0.0316,1920053,486503633,167318682,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 162",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439943,0.0318,1920052,486503730,169552762,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 260",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440279,0.0318,1920053,486503573,167318797,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 100",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439887,0.0319,1920052,486503674,167318743,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 204",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440637,0.0319,1920053,486503926,167318754,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 461",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539071,0.032,410944,103606912,25263273,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539080,0.032,410944,103606908,25263269,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethyl-N-methylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539083,0.032,410944,103606911,25263272,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"Pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidine, 6j",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539084,0.032,410944,103606996,25263275,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101540184,0.032,410952,103606909,25263270,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by scintillation proximity assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751934,0.032,308828,103549784,11698674,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-((4-aminopiperidin-1-yl)methyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778082,0.032,314962,103561938,16117085,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(R)-2-(4-(1-(pyridin-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101864187,0.032,260899,103479786,11518637,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(dibutylamino)-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101880662,0.032,263981,103486524,44410704,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880679,0.032,263981,103486545,44410710,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)phenyl)-3-(methylsulfonyl)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257332,0.032,454329,103717543,46225640,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-3-methylphenyl]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632844,0.032,1306577,160689339,68196023,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,N-[4-(3-bromoanilino)quinazolin-6-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656038,0.032,1315979,374325856,134147887,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-[di(propan-2-yl)amino]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
372117280,0.032,1678846,103641275,9874913,2064,33479663,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown orgin) by cell-based assay,2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388996859,0.032,1798900,58097704,25263269,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethyl-N-methylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388996864,0.032,1798900,58097710,25263275,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388996866,0.032,1798900,58097707,25263272,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","Pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidine, 6j",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997009,0.032,1798900,58097705,25263270,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997079,0.032,1798900,58097708,25263273,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102683,0.032,1796166,381752971,132162748,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-(1H-indol-5-ylcarbamoyl)-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439834,0.032,1920052,486503622,167318839,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 150",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439920,0.032,1920052,486503707,167318608,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 237",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440503,0.0321,1920053,486503794,167318871,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 327",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440540,0.0321,1920053,486503829,169552774,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 362",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440585,0.0321,1920053,486503874,162428729,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 409",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439822,0.0322,1920052,486503610,167318612,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 138",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439858,0.0322,1920052,486503646,167318577,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 176",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440367,0.0322,1920053,486503659,167318786,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 189",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632651,0.0323,1306575,336902098,127048979,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant Her2 (676 to 1255 residues) expressed in baculovirus by fluorescence based assay,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440582,0.0323,1920053,486503871,169552775,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 406",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439804,0.0324,1920052,486503593,167318746,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 121",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440089,0.0326,1920052,486503873,167318691,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 408",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440502,0.0326,1920053,486503793,169552772,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 326",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366319122,0.0327,1532892,103177479,208908,2064,30508379,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human N-terminal His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440537,0.0327,1920053,486503826,167318675,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 359",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809773,0.0328,1795310,377003050,87056631,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(cyclopropylmethoxy)quinazolin-6-yl)-4-(2-(methoxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432881,0.0328,1919984,486499691,168257584,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,16-pentazatetracyclo[12.4.1.02,11.04,9]nonadeca-2(11),3,5,7,9-pentaen-16-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440047,0.0328,1920052,486503831,162428855,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 364",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440288,0.0328,1920053,486503582,167318804,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 110",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440611,0.0328,1920053,486503900,162429001,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 435",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018074,0.0328,1920044,486499691,168257584,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,16-pentazatetracyclo[12.4.1.02,11.04,9]nonadeca-2(11),3,5,7,9-pentaen-16-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359365,0.033,69714,103302688,5328965,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10l,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675459,0.033,290550,103523381,44426281,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"N-(2,6-difluorophenyl)-4-(4-(6-(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675460,0.033,290550,103523388,11752667,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"Cyclopentyl(4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821642,0.033,248914,103441733,11238512,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420563,0.033,632227,136922138,56850806,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"5-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]pentan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340039503,0.033,760336,174487251,11306338,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 kinase domain expressed in baculovirus/Sf21 system by ELISA,2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-ethylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654692,0.033,1315425,374272916,134133329,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[3-Chloro-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817762,0.033,1795646,8034242,5328965,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10l,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439754,0.033,1920052,486503546,167318911,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 74",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439874,0.033,1920052,486503661,166927676,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 191",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632650,0.0331,1306575,336906410,127052093,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant Her2 (676 to 1255 residues) expressed in baculovirus by fluorescence based assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147245,0.0331,1798142,464922078,152160865,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-[(2R)-2-hydroxybutan-2-yl]anilino]-1,3,5-triazin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439899,0.0332,1920052,486503686,166927889,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 216",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440445,0.0334,1920053,486503737,167318838,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 267",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439714,0.0335,1920052,486503507,166927698,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 35",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439793,0.0335,1920052,486503582,167318804,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 110",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439841,0.0335,1920052,486503629,167318740,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 157",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440317,0.0336,1920053,486503610,167318612,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 138",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439700,0.0337,1920052,486503493,167318893,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 21",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440254,0.0338,1920053,486503551,166927699,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 79",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440391,0.0339,1920053,486503683,166927670,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 213",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410142746,0.0339,1798142,464922046,139378128,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxy-2-[methyl-[2-[(2S)-2-methylpyrrolidin-1-yl]ethyl]amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675744,0.034,290550,103523375,44426277,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,N-(3-methyl-4-(1-methylpiperidin-4-yloxy)phenyl)-6-(3-morpholinopropoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751936,0.034,308828,103549788,44441015,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-aminopiperidin-1-yl)methyl]-N-[1-(pyridin-3-ylmethyl)indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778931,0.034,315244,103574979,11569158,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,"(2R)-2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-5-yl)oxy]-N,N-dimethylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
204367024,0.034,549932,124968158,21874228,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-[(4-aminopiperidin-1-yl)methyl]-N-(3,5-dichlorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420600,0.034,632227,136931761,56849701,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796313,0.034,1426965,123092436,44259,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440327,0.034,1920053,486503620,167318598,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 148",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440553,0.034,1920053,486503842,167318667,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 375",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432830,0.0342,1919984,486499642,168257396,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018076,0.0342,1920044,486503190,169552726,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439950,0.0343,1920052,486503737,167318838,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 267",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440011,0.0343,1920052,486503797,167318755,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 330",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440243,0.0343,1920053,486503540,166927848,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 67",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439905,0.0344,1920052,486503692,162428886,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 222",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440164,0.0344,1920052,486503948,167318703,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 484",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440064,0.0345,1920052,486503848,167318802,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 382",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440258,0.0345,1920053,486503555,167318571,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 83",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440643,0.0345,1920053,486503932,167318777,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 467",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439711,0.0346,1920052,486503504,166927742,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 32",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440344,0.0346,1920053,486503637,167318544,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 167",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440360,0.0347,1920053,486503652,167318916,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 182",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751937,0.035,308828,103549787,44441014,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-aminopiperidin-1-yl)methyl]-N-[1-(pyridin-2-ylmethyl)indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778935,0.035,315244,103574927,11496987,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,N-{3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}-5-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101912903,0.035,270616,103498644,44416243,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,4-((5-(4-((4-(Benzyloxy)-3-fluorophenyl)amino)quinazolin-6-yl)furan-2-yl)methyl)thiomorpholine 1-oxide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124274,0.035,418567,103593397,25263259,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-{2-[4-({1-[(2,5-difluorophenyl)methyl]-1H-indazol-5-yl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747191,0.035,474114,103749160,46886310,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"2-chloro-N-(3-(5-(2-(phenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420207,0.035,632227,136932767,56851430,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(3-chlorophenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420662,0.035,632227,136944837,56849848,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-hydroxy-2-methylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355647023,0.035,1312565,336896687,127045112,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic GST-tagged human recombinant EGFR L858R mutant expressed in baculovirus system by z-lyte assay,6-(1-piperidin-4-ylpyrazol-4-yl)-N-quinolin-6-ylquinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654684,0.035,1315425,374359317,134157345,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(3-Chloro-4-morpholin-4-ylanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-chloroacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655716,0.035,1315979,374354121,134155932,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-morpholin-4-ylbut-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380799238,0.035,1913055,160681951,15606394,2064,"",Confirmatory,20230629,0,0,Active,P04626,EC50,=,ChEMBL,Affinity On-target Cellular interaction (HER2-phosphorylation in BT-474 cells) EUB0000596aBDA ERBB2,Afatinib Dimaleate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000988,0.035,1798897,58097691,25263259,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-{2-[4-({1-[(2,5-difluorophenyl)methyl]-1H-indazol-5-yl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615730,0.035,1919643,483622397,146510016,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 41",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615760,0.035,1919643,483622381,146448650,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 17",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440368,0.035,1920053,486503660,167318878,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 190",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439691,0.0351,1920052,486503485,167318710,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 13",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439827,0.0351,1920052,486503615,166927662,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 143",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439947,0.0351,1920052,486503734,167318573,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 264",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440483,0.0351,1920053,486503774,167318558,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 306",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440349,0.0352,1920053,486503642,167318643,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 172",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440249,0.0355,1920053,486503546,167318911,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 74",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439760,0.0356,1920052,486503552,166927919,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 80",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440536,0.0358,1920053,486503825,169552773,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 358",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439932,0.0359,1920052,486503719,162428781,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 249",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675473,0.036,290549,103523393,44426289,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"4-(2-methyl-4-(6-(pyrrolidin-1-yl)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751511,0.036,308828,103549791,11684098,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-aminopiperidin-1-yl)methyl]-N-[3-chloro-4-(pyridin-3-ylmethoxy)phenyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101864178,0.036,260899,103479878,11496207,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(bis(1-methylethyl)amino)-2-butynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101880668,0.036,263981,103486307,11669455,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(4-aminophenyl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106014983,0.036,441964,103177479,208908,2064,19888761,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 by fluorescence polarization assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402370,0.036,580189,124968178,11955112,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-5-(5-(4-ethylpiperazin-1-yl)pent-1-ynyl)-6-methylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354665788,0.036,1289555,312367127,71496458,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant autophosphorylation in human H3255 cells after 2 hrs by sandwich ELISA,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867966,0.036,1795986,381620334,137529663,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[8-[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]benzoyl]-4,4-dimethyl-1,3-dioxa-8-aza-2-boraspiro[4.5]decan-2-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867975,0.036,1795986,381620336,136666750,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[4-[6-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]benzoyl]amino]hexyl]-4,5,5-trimethyl-1,3,2-dioxaborolan-2-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668240,0.036,1806610,471698530,155243064,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 30",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432866,0.036,1919984,486499678,168257754,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[2-fluoro-4-(5-fluoropyridin-3-yl)oxy-5-methylanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440496,0.036,1920053,486503787,167318874,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 320",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018107,0.036,1920044,486503228,169552747,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[2-fluoro-4-(5-fluoropyridin-3-yl)oxy-5-methylanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440039,0.0361,1920052,486503823,167318778,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 356",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147255,0.0362,1798142,459092841,139377919,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"(E)-N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321541447,0.0363,664633,103177479,208908,2064,22372864,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 preincubated for 10 mins followed by incubation for 30 mins by fluorescence polarization assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440309,0.0363,1920053,486503602,167318688,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 130",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145695,0.0364,1798142,463792102,139377679,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[2-(2-hydroxypropan-2-yl)-4-(trifluoromethyl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440574,0.0365,1920053,486503863,167318701,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 398",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440635,0.0366,1920053,486503924,167318825,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 459",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439836,0.0367,1920052,486503624,167318900,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 152",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440192,0.0368,1920053,486503491,166927737,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 163",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440193,0.0368,1920053,486503491,166927737,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 163",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439743,0.0369,1920052,486503535,167318641,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 61",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440665,0.0369,1920053,486503954,162428867,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 491",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106010475,0.037,439897,103699400,45483685,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid trans-2-piperidin-4-ylethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
198356224,0.037,517320,123101237,52941514,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398249,0.037,1574931,103768626,10184653,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
366415026,0.037,1584366,440149221,155536330,2064,28528303,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant His-tagged human ErbB2 cytoplasmic domain expressed in baculovirus expression system by Z-LYTE assay,N-[5-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867969,0.037,1795986,381620327,137529656,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[(1S,2R,6S,8S)-2-[2-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]benzoyl]amino]ethyl]-9,9-dimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615742,0.037,1919643,483622394,146510014,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 38",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440580,0.037,1920053,486503869,167318550,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 404",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102676,0.0371,1796166,381752968,132143255,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(5-amino-2,3-dihydroindole-1-carbonyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440547,0.0371,1920053,486503836,167318909,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 369",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440035,0.0375,1920052,486503819,156821234,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 352",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440373,0.0375,1920053,486503665,167318867,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 195",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440231,0.0377,1920053,486503529,166927843,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 57",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440505,0.0377,1920053,486503796,167318689,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 329",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439708,0.0378,1920052,486503501,167318562,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440666,0.0378,1920053,486503955,167318826,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 492",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359448,0.038,69714,103303499,5328955,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10b,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571799,0.038,344457,103628279,44580916,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(R)-1-(2-((4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidin-1-yl)ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751933,0.038,308828,103549765,10288920,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[[4-(aminomethyl)piperidin-1-yl]methyl]-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101880664,0.038,263981,103486164,11525434,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,5-{[6-(aminomethyl)-2-pyridinyl]ethynyl}-N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl)-4-pyrimidinamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912913,0.038,270616,103498515,44416188,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(benzyloxy)-3-chlorophenyl)-6-(5-((4-(phenylsulfonyl)butylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257318,0.038,454329,103717510,46225610,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,N-(4-(benzo[d]thiazol-2-yl)-3-chlorophenyl)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420691,0.038,632227,136938448,56851166,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[2-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]-6-methylpyrrolo[3,2-d]pyrimidin-5-yl]ethoxy]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433597,0.038,636385,136920693,56950115,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]-2-cyanoacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655811,0.038,1315979,374276850,134134364,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[[1-(benzenesulfonyl)indol-5-yl]amino]-7-ethoxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388817744,0.038,1795646,8034232,5328955,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10b,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203204,0.038,1798359,404345932,130275865,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-cyano-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203224,0.038,1798359,404345976,130275892,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232575,0.038,1803904,404345932,130275865,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-cyano-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232588,0.038,1803904,404345976,130275892,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347963,0.038,1919554,404345932,130275865,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[5-cyano-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347996,0.038,1919554,404345976,130275892,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3-methylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440362,0.0381,1920053,486503654,167318855,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 184",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279392,0.0382,461252,103729448,24944935,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,6-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyhexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439963,0.0382,1920052,486503750,167318851,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 280",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440151,0.0383,1920052,486503935,167318865,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 470",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279405,0.0384,461252,103729446,24944934,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,5-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxypentanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439792,0.0384,1920052,486503581,167318553,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 108",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439870,0.0384,1920052,486503657,167318809,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 187",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440048,0.0384,1920052,486503832,167318595,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 365",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440120,0.0387,1920052,486503904,167318678,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 439",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440452,0.0388,1920053,486503744,167318880,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 274",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439993,0.0389,1920052,486503779,167318662,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 312",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440287,0.0389,1920053,486503581,167318553,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 108",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503827,0.039,361654,103644048,24897280,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,"(S)-N4-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((2-(methoxymethyl)pyrrolidin-1-ylimino)methyl)pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694384,0.039,295195,103531680,10288918,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"1-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]-1,4-diazepan-6-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821401,0.039,248914,103441757,11180271,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(4-benzyloxy-3-chloro-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342821915,0.039,1119725,242612623,58191997,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant HER2 (unknown origin) using poly-Glu-Tyr peptide as substrate,N-(2-aminophenyl)-4-[[4-(3-bromoanilino)quinazolin-6-yl]oxymethyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665737,0.039,1806610,471698521,155243033,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',6-((1-Acryloylpiperidin-4-yl)oxy)-4-((4-bromo-3-chlorophenyl)amino)-7-methoxyquinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355646786,0.0391,1312565,336896932,127045270,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic GST-tagged human recombinant EGFR L858R mutant expressed in baculovirus system by z-lyte assay,N-(3-chloro-4-fluorophenyl)-6-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439850,0.0391,1920052,486503638,166928148,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 168",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439983,0.0391,1920052,486503769,167318729,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 301",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440149,0.0391,1920052,486503933,167318798,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 468",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440539,0.0392,1920053,486503828,167318589,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 361",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366322626,0.03926,1535505,440149902,118900282,2064,30600209,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,Synthesis of (E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(3-methoxypropoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699906,0.0393,1796911,384577250,118900282,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'",Synthesis of (E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(3-methoxypropoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439996,0.0393,1920052,486503782,167318575,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 315",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388809754,0.0395,1795310,377003056,87056713,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"N87 Assay from US Patent US9714235: 'Quinazoline derivatives, compositions thereof, and use as pharmaceuticals'","(E)-N-(7-(((S)-1,4-dioxan-2-yl)methoxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-(2-(hydroxymethyl)azetidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439766,0.0395,1920052,486503558,167318843,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 283",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439767,0.0395,1920052,486503558,167318843,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 283",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440028,0.0395,1920052,486503813,167318593,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 346",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440156,0.0395,1920052,486503940,167318578,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 476",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440605,0.0396,1920053,486503894,167318868,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 429",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440083,0.0397,1920052,486503867,162428835,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 402",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440343,0.0397,1920053,486503636,166928147,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 166",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439744,0.0398,1920052,486503536,167318908,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 62",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100667843,0.04,81581,103262170,10300451,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"5-{[(5Z)-4-[(3-ethynylphenyl)amino]-6-oxo-5H,6H,7H-pyrrolo[2,3-d]pyrimidin-5-ylidene]methyl}-4-methyl-N-[2-(morpholin-4-yl)ethyl]-1H-pyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
100667848,0.04,81581,103263013,5329252,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28d",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
101539068,0.04,410944,103606997,25263278,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3S,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539076,0.04,410944,103606995,25263274,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571804,0.04,344457,103628364,44580950,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(3R,5S)-5-((4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidin-3-yl methanesulfonate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821639,0.04,248914,103441732,11307602,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-4-(azetidin-1-yl)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829717,0.04,254975,103468240,9871380,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"2-imidazol-1-ylethyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101829719,0.04,254975,103468319,16730263,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"4-(1-benzyl-1H-indazol-5-ylamino)-5-ethylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254420127,0.04,632227,136925430,56851053,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-({2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}sulfonyl)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342807276,0.04,1128576,242620528,86302281,2064,24565969,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 after 60 mins by ELISA,"N-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997007,0.04,1798900,58097713,25263278,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3S,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997012,0.04,1798900,58097709,25263274,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666675,0.04,1806610,471698537,155242991,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-(3-((7-Methoxy-4-(phenylamino)quinazolin-6-yl)oxy)azetidin-1-yl)prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439966,0.04,1920052,486503752,167318596,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 282",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440033,0.04,1920052,486503817,162428983,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 350",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440474,0.04,1920053,486503765,169552769,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 297",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440562,0.04,1920053,486503851,167318684,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 385",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440030,0.0401,1920052,486503815,167318686,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 348",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440031,0.0401,1920052,486503815,167318686,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 348",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439980,0.0402,1920052,486503766,167318616,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 298",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440396,0.0403,1920053,486503688,167318869,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 218",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440489,0.0404,1920053,486503780,167318882,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 313",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439893,0.0405,1920052,486503680,166927886,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 210",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632646,0.0406,1306575,336906855,127052408,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant Her2 (676 to 1255 residues) expressed in baculovirus by fluorescence based assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439926,0.0406,1920052,486503713,167318872,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 243",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439810,0.0407,1920052,486503599,167318674,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 127",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440338,0.0407,1920053,486503631,166927763,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 159",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440576,0.0407,1920053,486503865,167318685,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 400",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440118,0.0408,1920052,486503902,167318758,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 437",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440384,0.0408,1920053,486503676,162429081,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 206",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742031,0.041,306289,103549521,44440843,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(1R)-1-(3-fluorophenyl)ethyl]indazol-5-yl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751503,0.041,308828,103549783,22055262,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-((1,4-diazepan-1-yl)methyl)-N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254420892,0.041,632226,136935221,56851591,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[3-(trifluoromethoxy)phenoxy]phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435331,0.041,638068,136921863,57390776,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[4-(pyrrolidin-1-ylmethyl)phenyl]ethynyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435422,0.041,638068,136925167,57392588,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[2-[4-[(dimethylamino)methyl]phenyl]ethynyl]-6-methylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372344338,0.041,1720526,461532953,162655939,2064,32527559,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant ERBB2 (676 to 1255 residues) expressed in baculovirus expression system using Tyr 06 as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay,4-[7-methoxy-6-(5-morpholin-4-ylpent-2-ynoylamino)quinolin-4-yl]oxy-N-pyridin-2-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668228,0.041,1806610,471698535,90440556,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-(4-((7-Methoxy-4-(phenylamino)quinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439771,0.041,1920052,486503562,167318773,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 90",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432848,0.0411,1919984,486499660,168257966,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(azetidin-1-yl)-1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439730,0.0411,1920052,486503523,167318592,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 51",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440172,0.0411,1920053,486503473,156821216,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 1",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018090,0.0411,1920044,486503210,169552738,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(azetidin-1-yl)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440400,0.0412,1920053,486503692,162428886,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 222",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440516,0.0412,1920053,486503807,167318764,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 340",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440656,0.0412,1920053,486503945,167318706,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 481",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432831,0.0413,1919984,486499643,168257601,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439923,0.0413,1920052,486503710,167318739,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 240",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018077,0.0413,1920044,486503191,169552727,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440411,0.0415,1920053,486503703,167318817,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 233",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440638,0.0415,1920053,486503927,167318572,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 462",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439901,0.0416,1920052,486503688,167318869,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 218",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440653,0.0416,1920053,486503942,162429006,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 478",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439814,0.0417,1920052,486503602,167318688,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 130",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439927,0.0419,1920052,486503714,167318913,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 244",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595850,0.042,331423,103563642,17747415,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,(NE)-N-[[4-amino-6-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]pyrimidin-5-yl]methylidene]hydroxylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106014984,0.042,441964,103701238,24883287,2064,19888761,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 by fluorescence polarization assay,(S)-1-Acryloyl-N-[4-(3-chloro-2-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yl]pyrrolidine-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023776,0.042,447375,103707822,45487358,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenylpiperidine-1-carbonyl)piperidin-3-yl pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433587,0.042,636385,136924002,56950114,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,"4-N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341102817,0.042,1062007,103177479,208908,2064,24355130,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by ADP-Glo assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656042,0.042,1315979,374357541,134156845,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440438,0.042,1920053,486503730,169552762,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 260",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407923782,0.042,1927648,494419010,171356677,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 1 hrs in presence of ATP by ELISA assay,N-(3-ethylphenyl)-2-[4-oxo-3-(4-sulfamoylphenyl)benzo[g]quinazolin-2-yl]sulfanylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699899,0.0421,1796911,384577253,118900298,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'",Egfr/her2-IN-4,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366322625,0.04211,1535505,440149575,118900298,2064,30600209,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,Egfr/her2-IN-4,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439954,0.0422,1920052,486503741,162428794,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 271",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440586,0.0423,1920053,486503875,167318858,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 410",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440442,0.0424,1920053,486503734,167318573,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 264",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440132,0.0427,1920052,486503916,167318766,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 451",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432836,0.0428,1919984,486499648,168257457,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440099,0.0428,1920052,486503883,167318614,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 418",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440455,0.0428,1920053,486503747,167318770,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 277",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018069,0.0428,1920044,486499652,168258011,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439970,0.0429,1920052,486503756,167318719,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 287",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440456,0.0429,1920053,486503748,167318745,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 278",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
40272361,0.043,1433,50100096,9874913,2064,"",Other,20170124,0,0,Active,NP_001005862,"","",Ambit Biosciences,Kinase Inhibitor Selectivity Profiling Assay,2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539073,0.043,410944,103606835,11307581,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564657,0.043,367174,103610164,44571453,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,EGFR/ErbB-2 inhibitor-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571801,0.043,344457,103606835,11307581,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751499,0.043,308828,103549786,44441013,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-aminopiperidin-1-yl)methyl]-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-6-methoxypyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751502,0.043,308828,103549782,22390524,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-amino-4-methylpiperidin-1-yl)methyl]-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101755926,0.043,309859,103551489,11454712,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Erb2 autophosphorylation by cellular clone 24 assay,N-(2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)ethyl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778088,0.043,314962,103561956,16118310,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(R)-1-morpholino-2-(4-(1-(thiazol-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101778515,0.043,315244,103574973,11619909,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,"(2S)-2-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]quinazolin-5-yl]oxy-N,N-dimethylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101864180,0.043,260899,103479571,11595844,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,N-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-hydroxy-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
106001748,0.043,435796,103641275,9874913,2064,18183025,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355631002,0.043,1305356,336905527,127051447,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]-4-fluorophenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
366476694,0.043,1613745,103641275,9874913,2064,30594029,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to wild-type partial length human ERRB2 (K646 to V1225 residues) expressed in mammalian expression system by Kinomescan assay,2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112802,0.043,1676531,461530953,162654542,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[6-[4-(4-methylpiperazin-1-yl)phenyl]-4-[4-[[2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetyl]amino]anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997015,0.043,1798900,58097701,11307581,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440561,0.043,1920053,486503850,167318915,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 384",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440597,0.043,1920053,486503886,167318606,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 421",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440603,0.0431,1920053,486503892,167318751,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 427",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440206,0.0434,1920053,486503504,166927742,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 32",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151278193,0.0435,461252,103729623,24945115,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-Chloro-4-fluorophenylamino)quinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380800952,0.0435,1915573,103729623,24945115,2064,33077264,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),7-(4-(3-Chloro-4-fluorophenylamino)quinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432837,0.0438,1919984,486499649,168257862,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018079,0.0438,1920044,486503198,169552729,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595844,0.044,331423,103563798,17747309,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,3-[[5-[[6-amino-5-[(E)-methoxyiminomethyl]pyrimidin-4-yl]amino]indazol-1-yl]methyl]benzonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675476,0.044,290549,103523387,44426285,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,Cyclopentyl(4-(4-(6-(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821628,0.044,248914,103441857,11342284,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(2-methoxyphenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880667,0.044,263981,103486306,11612021,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,5-[(3-Aminophenyl)ethynyl]-N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124293,0.044,418919,103593178,25218688,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1-[4-(piperazin-1-yl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106010479,0.044,439897,103699460,45483691,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"{4-(1-Benzyl-1H-indazol-5-ylamino)-5-ethyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl}-carbamic acid 2-(1H-imidazol-1-yl)ethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254420448,0.044,632227,136941655,56851051,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-({2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}thio)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340069854,0.044,770082,104245790,44607530,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
388757104,0.044,1795123,375077055,117685121,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Assay from US Patent US9556191: 'Aminoquinazoline derivatives and their salts and methods of use thereof',"(E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-(2,2,2-trifluoroethoxy)quinazolin-6-yl)-4-((4aR,7aS)-tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6(3H)-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388995919,0.044,1798859,57560488,25218696,2064,18287036,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Receptor Tyrosine Kinase Inhibition Assay from Article 10.1073/pnas.0708281105: '6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.'","6-[(3S)-3-aminobut-1-yn-1-yl]-N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389006053,0.044,1798858,57560477,25218688,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1-[4-(piperazin-1-yl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203239,0.044,1798359,404345960,130277049,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,6-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232631,0.044,1803904,404345960,130277049,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,6-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402250505,0.044,1804976,441610610,146241386,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-[(4S)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-7-fluoro-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347894,0.044,1919554,404345960,130277049,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,6-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440290,0.0441,1920053,486503584,167318623,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 112",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440146,0.0443,1920052,486503930,167318816,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 465",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440233,0.0443,1920053,486503531,166927903,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 59",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023768,0.0445,447375,103707767,45487310,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(3S,5S,6S)-5-(hydroxycarbamoyl)-1-methyl-6-(4-phenylpiperazine-1-carbonyl)piperidin-3-yl azetidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440567,0.0446,1920053,486503856,167318618,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 390",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440370,0.0448,1920053,486503662,166927717,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 192",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440645,0.0448,1920053,486503934,167318610,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 469",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880658,0.045,263981,103486517,44410700,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)phenyl)methanesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656033,0.045,1315979,374357458,134156816,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[4-(benzenesulfonamido)anilino]-7-ethoxyquinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380656912,0.045,1880131,174505192,11511120,2064,35439421,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 phosphorylation (unknown origin),Dacomitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203174,0.045,1798359,404345973,130275811,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2,3-dimethylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232549,0.045,1803904,404345973,130275811,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2,3-dimethylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347895,0.045,1919554,404345973,130275811,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]-2,3-dimethylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440385,0.0451,1920053,486503677,166927721,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 207",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440437,0.0453,1920053,486503729,169552761,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 259",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440501,0.0453,1920053,486503792,167318787,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 325",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440326,0.0455,1920053,486503619,167318621,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 147",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440443,0.0456,1920053,486503735,167318561,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 265",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363684690,0.0457,1424370,174505192,11511120,2064,28754471,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of GST-tagged human HER2 catalytic domain expressed in insect cells,Dacomitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366340200,0.0457,1545479,174505192,11511120,2064,30878832,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) expressed in insect cells by ELISA,Dacomitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380718786,0.0457,1894158,174505192,11511120,2064,33540357,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of GST-tagged ERBB2 (unknown origin) expressed in insect cells by ELISA,Dacomitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440314,0.0457,1920053,486503607,166928146,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 135",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440662,0.0457,1920053,486503951,167318883,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 487",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101676419,0.046,290549,103523380,11272368,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"N-(2,6-difluorophenyl)-4-(4-(6-methoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101863468,0.046,260896,103479572,11553647,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(diethylamino)-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326078947,0.046,719890,160698093,70693519,2064,22621397,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of GST-tagged ErbB2 expressed in sf9 cells by ELISA,Dacomitinib monohydrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
340039507,0.046,760336,103499581,10411907,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 kinase domain expressed in baculovirus/Sf21 system by ELISA,6-{[1-(Carbamoylmethyl)piperidin-4-yl]oxy}-4-(3-chloro-2-fluoroanilino)-7-methoxyquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354665792,0.046,1289555,312468158,57335384,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant autophosphorylation in human H3255 cells after 2 hrs by sandwich ELISA,Rociletinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656242,0.046,1315979,174505192,11511120,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,Dacomitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
366322324,0.046,1535439,174505192,11511120,2064,30600149,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human GST-fused HER2 kinase domain expressed in baculovirus expression system measured after 30 mins by ELISA,Dacomitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203188,0.046,1798359,404345936,130275822,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203194,0.046,1798359,404345958,130277027,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3,5-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232569,0.046,1803904,404345958,130277027,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3,5-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232619,0.046,1803904,404345936,130275822,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347873,0.046,1919554,404345936,130275822,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347907,0.046,1919554,404345958,130277027,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-3,5-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439933,0.0463,1920052,486503720,167318794,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 250",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440062,0.0464,1920052,486503846,167318559,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 380",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371389611,0.04645,1671289,441329562,2051,2064,"",Other,20211102,0,0,Active,"",IC50,"",Pistoia Alliance DataFAIRy Bioassay Pilot,"Z'-LYTE: ERBB2 (HER2), Direct Format, kinase activity assay, coupled enzyme activity measurement method, detected via fluorescence resonance energy transfer","N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
402439948,0.0465,1920052,486503735,167318561,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 265",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440392,0.0466,1920053,486503684,167318836,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 214",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439800,0.0467,1920052,486503589,167318660,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 117",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440128,0.0468,1920052,486503912,167318587,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 447",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694371,0.047,295195,103531640,10159833,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"2-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methylamino]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880681,0.047,263981,103486482,11561468,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,(5-(2-(4-(4-(3-Fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)furan-2-yl)methanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257337,0.047,454329,103717610,46225682,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-3-methoxyphenyl]-7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666765,0.047,1806610,471698513,155280255,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"6-((1-Acryloylpiperidin-4-yl)oxy)-4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxy-quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102334,0.047,1796170,381752964,132143282,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439762,0.047,1920052,486503554,166927654,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 82",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440614,0.047,1920053,486503903,167318617,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 438",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440652,0.0471,1920053,486503941,167318860,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 477",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440020,0.0472,1920052,486503806,167318655,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 339",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440259,0.0472,1920053,486503556,167318709,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 84",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439910,0.0474,1920052,486503697,167318781,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 227",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440531,0.0475,1920053,486503820,167318694,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 353",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440133,0.0476,1920052,486503917,167318604,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 452",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440641,0.0476,1920053,486503930,167318816,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 465",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100702777,0.048,68100,103408038,44372197,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2,"N-(2-methylsulfonylethyl)-4-[4-(4-phenylmethoxyanilino)quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101444027,0.048,392130,103202250,156414,2064,18667312,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101676427,0.048,290549,103523392,44426288,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"4-(4-(6-(dimethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388836050,0.048,1795774,8035059,5329476,2064,14684309,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/j.bmcl.2003.10.010: 'Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.',6-Thiazolylquinazoline 2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615758,0.048,1919643,483622427,146448646,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 95",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615858,0.048,1919643,483622382,146448688,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 18",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203183,0.048,1798359,404345930,130276402,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-cyclopropyl-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232536,0.048,1803904,404345930,130276402,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-cyclopropyl-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347950,0.048,1919554,404345930,130276402,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-cyclopropyl-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440630,0.0481,1920053,486503919,167318632,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 454",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440036,0.0482,1920052,486503820,167318694,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 353",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665445,0.0483,1168534,312363553,118717615,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[2-methylsulfonyl-1-(propan-2-ylamino)ethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440284,0.0485,1920053,486503578,167318698,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 105",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440013,0.0486,1920052,486503799,167318891,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 332",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440394,0.0486,1920053,486503686,166927889,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 216",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440481,0.0486,1920053,486503772,167318653,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 304",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440121,0.0487,1920052,486503905,167318742,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 440",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440136,0.0487,1920052,486503920,167318832,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 455",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439944,0.0488,1920052,486503731,162429052,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 261",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440252,0.0489,1920053,486503549,162428850,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 77",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420238,0.049,632227,136941654,56849704,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[2-[4-[3-Chloro-4-[3-(trifluoromethoxy)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethoxy]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093693,0.049,1057929,194179778,72737210,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2-morpholin-4-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203162,0.049,1798359,404345977,130277010,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,3-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203166,0.049,1798359,404345969,130276338,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[3-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232537,0.049,1803904,404345977,130277010,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,3-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232541,0.049,1803904,404345969,130276338,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[3-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347887,0.049,1919554,404345969,130276338,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[3-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methoxyphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347891,0.049,1919554,404345977,130277010,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","[4-[[4-amino-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carbonyl]amino]-2,3-dimethylphenyl] N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439688,0.049,1920052,486503482,162428942,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 10",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145462,0.049,1798142,464922028,139377742,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxy-2-[methyl(2-piperidin-1-ylethyl)amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439939,0.0491,1920052,486503726,167318735,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 256",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440647,0.0494,1920053,486503936,167318873,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 471",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440094,0.0497,1920052,486503878,167318680,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 413",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439981,0.0498,1920052,486503767,166927936,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 299",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100302244,0.05,241491,103460717,9952784,2064,16078851,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 kinase in intact CSH12 cells; Range = 25-50 nM,"N-{4-[(3,4-dichloro-6-fluorophenyl)amino]quinazoline-6-yl}-2-chloroacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100302245,0.05,241491,103460812,21080010,2064,16078851,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 kinase in intact CSH12 cells; Range = 25-50 nM,"(E)-4-Dimethylamino-but-2-enoic acid [4-(4,5-dichloro-2-fluoro-phenylamino)-quinazolin-6-yl]-amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101540185,0.05,410952,103606907,11490270,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by scintillation proximity assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-diethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541195,0.05,410949,103606996,25263275,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541196,0.05,410949,103606912,25263273,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541198,0.05,410949,103593129,11284937,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124284,0.05,418567,103593395,25263257,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-(2-{4-[(1-benzyl-1H-indazol-5-yl)amino]thieno[3,2-d]pyrimidin-6-yl}ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420596,0.05,632227,136928528,56849562,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[3-(trifluoromethoxy)phenoxy]phenyl]-5-methylpyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355742098,0.05,1342637,374275931,67161257,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-6-methylsulfonyl-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742713,0.05,1342637,374297025,57802868,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"Cyclopentyl-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742714,0.05,1342637,374308539,57802550,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,N-(3-bromo-4-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742715,0.05,1342637,374318742,57802560,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4-bromo-2,3-difluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742716,0.05,1342637,374337024,134151034,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(2,3-dichlorophenyl)-7-[(4-ethanimidoyl-1,4-oxazepan-2-yl)methoxy]-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742717,0.05,1342637,374340332,10346203,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3R,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(4,5-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742718,0.05,1342637,374352934,57802817,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-7-[(4-ethylsulfonylmorpholin-2-yl)methoxy]-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742719,0.05,1342637,374295182,57802566,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,N-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742720,0.05,1342637,374315769,57802849,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4-bromo-3,5-difluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742721,0.05,1342637,374336429,134150859,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[(3'aS,5'R,6'aR)-spiro[1,3-dioxolane-2,3'-3a,5,6,6a-tetrahydro-2H-furo[3,2-b]furan]-5'-yl]oxy-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742722,0.05,1342637,374277121,57802878,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N'-cyano-2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholine-4-carboximidamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355742723,0.05,1342637,374322530,57802871,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"[2-[[4-(3,4-Dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-(3,5-dimethyl-1,2-oxazol-4-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743029,0.05,1342637,374284193,57802818,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"6-[[4-(3,4-Dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-3,3,4-trimethylmorpholin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743030,0.05,1342637,374284511,66955051,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 42",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743031,0.05,1342637,374297811,57802853,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4,5-dichloro-2-fluorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743034,0.05,1342637,374316563,53630967,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-(methyloxy)-7-[(4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-ylmethyl)oxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743035,0.05,1342637,374323264,53630923,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(3S,8aS)-3-({[4-[(3,4-dichloro-2-fluorophenyl)amino]-6-(methyloxy)quinazolin-7-yl]oxy}methyl)hexahydropyrrolo[1,2-a]pyrazin-1(2H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743037,0.05,1342637,374330552,66838579,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-methoxy-7-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743038,0.05,1342637,374351610,57802679,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 216",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743504,0.05,1342637,374267592,10346676,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 73",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743506,0.05,1342637,374274671,57802861,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 214",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743507,0.05,1342637,374284086,57802901,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-methoxy-7-[(4-methylsulfonylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743508,0.05,1342637,374269460,11756978,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 74",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743509,0.05,1342637,374274540,53630919,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4,5-dichloro-2-fluorophenyl)-7-{[(3S,8aS)-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-3-ylmethyl]oxy}-6-(methyloxy)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743510,0.05,1342637,374284266,57802650,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3-chloro-2,4-difluorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743511,0.05,1342637,374289213,66954904,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 48",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743513,0.05,1342637,374301998,9937516,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743514,0.05,1342637,374316455,134145312,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-[(3S,3aR,6R,6aS)-6-[4-(4-bromo-3-chloroanilino)-6-methoxyquinazolin-7-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743515,0.05,1342637,374317226,134145518,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(3S,3aR,6R,6aR)-6-[4-(4-bromo-3-chloroanilino)-6-methoxyquinazolin-7-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743726,0.05,1342637,374323540,66838567,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(3-chloro-2,4-difluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743727,0.05,1342637,374336960,57802547,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4,5-dichloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743728,0.05,1342637,374346319,10029284,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3R,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743729,0.05,1342637,374350333,58013796,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 238",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743730,0.05,1342637,374354559,57802889,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-methoxy-7-[2-(4,5,5-trimethylmorpholin-2-yl)ethoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743731,0.05,1342637,374300632,57802678,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 34",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743732,0.05,1342637,374302497,57802556,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-methoxy-7-[(4-methylsulfonyl-1,4-oxazepan-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743734,0.05,1342637,374309240,57802603,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"2-[2-[[4-(3,4-Dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743735,0.05,1342637,374350311,134154844,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,N-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-3-yl)methoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743736,0.05,1342637,374270976,57802680,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3-chloro-2,4-difluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743918,0.05,1342637,374307019,57802660,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743919,0.05,1342637,374329363,57802892,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,(6S)-6-[[4-(4-bromo-3-chloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-4-methylpiperazin-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743920,0.05,1342637,374329606,58013780,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,N-(4-bromo-3-chlorophenyl)-6-methoxy-7-[(3R)-oxolan-3-yl]oxyquinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743921,0.05,1342637,374338096,57802694,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(2-Chloropyridin-3-yl)-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743925,0.05,1342637,374285893,67162380,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(3S,3aR,6S,6aR)-6-[4-(4-bromo-3-chloroanilino)-6-methoxyquinazolin-7-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743926,0.05,1342637,374307378,57802580,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-7-[(6,6-dimethylmorpholin-2-yl)methoxy]-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743927,0.05,1342637,374329786,66838624,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-N-(3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743928,0.05,1342637,374342806,57802582,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 33",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744298,0.05,1342637,374304440,57802643,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 182",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744299,0.05,1342637,374314934,57802916,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4-bromo-2,5-difluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744300,0.05,1342637,374316306,57802695,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-ethoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744301,0.05,1342637,374316792,58013804,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744302,0.05,1342637,374350365,57802793,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 36",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744303,0.05,1342637,374352486,57802576,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-7-(morpholin-2-ylmethoxy)-6-propan-2-yloxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744304,0.05,1342637,374354509,57802910,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-methoxy-7-[[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744305,0.05,1342637,374286940,66838539,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744496,0.05,1342637,374303789,57802656,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[4-(3-chloropropylsulfonyl)morpholin-2-yl]methoxy]-N-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744498,0.05,1342637,374357334,57802623,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 241",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744499,0.05,1342637,374277722,57802591,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744500,0.05,1342637,374280787,57802593,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]-N-(3,4,5-trichlorophenyl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744502,0.05,1342637,374305423,134142184,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(3S,3aR,6S,6aR)-6-[6-methoxy-4-[[(3S,4R)-4-methoxyoxolan-3-yl]amino]quinazolin-7-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744503,0.05,1342637,374325784,57802800,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 194",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744504,0.05,1342637,374341662,57802906,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"1-[2-[[4-(3,4-Dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]propan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744506,0.05,1342637,374351504,134155171,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aS,5R,6aR)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-yl]oxy]-N-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744507,0.05,1342637,312467833,10458325,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,Tesevatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744685,0.05,1342637,374289367,57802842,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,N-(4-bromo-3-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744686,0.05,1342637,374299261,57802611,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 277",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744687,0.05,1342637,374312088,10028639,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3R,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(3-chloro-2,4-difluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744688,0.05,1342637,374312865,57802919,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 219",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744689,0.05,1342637,374320512,57802565,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-cyano-2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-N'-ethylmorpholine-4-carboximidamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744691,0.05,1342637,374326230,53630972,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-(methyloxy)-7-{[(2-piperidin-4-yl-1,3-thiazol-4-yl)methyl]oxy}quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744692,0.05,1342637,374328870,134148740,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6R,6aS)-3-(trifluoromethyl)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744693,0.05,1342637,374335245,66839071,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,8aS)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-3-yl]methoxy]-N-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744694,0.05,1342637,374342756,57802866,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 249",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744695,0.05,1342637,374350371,57802605,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 218",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744696,0.05,1342637,374290590,66838546,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 35",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745010,0.05,1342637,374297713,10253661,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 59",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745011,0.05,1342637,374304433,57802674,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-methoxy-7-[(4,6,6-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745013,0.05,1342637,374343471,57802669,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4-bromo-2,3-dichlorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745014,0.05,1342637,374350022,10030541,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3R,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745015,0.05,1342637,374352045,57802725,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"1-[2-[[4-(3,4-Dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-oxazepan-4-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745018,0.05,1342637,374268858,66838463,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(4,5-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745019,0.05,1342637,374306260,134142438,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"2-[[4-(3-chloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-N'-cyano-1,4-oxazepane-4-carboximidamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745020,0.05,1342637,374306680,10370400,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,C23H23N4O4FClBr,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745021,0.05,1342637,374310641,57802713,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-ethoxy-7-(morpholin-2-ylmethoxy)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745234,0.05,1342637,374330276,57802747,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745237,0.05,1342637,374286016,134136905,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aS,5R,6aR)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-yl]oxy]-N-(4-bromo-2,3-dichlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745238,0.05,1342637,374301705,57802867,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,N-(4-bromo-3-chloro-2-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745240,0.05,1342637,374328763,57802797,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-7-[(4-methylmorpholin-2-yl)methoxy]-6-propan-2-yloxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745242,0.05,1342637,374355069,57802637,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-7-[2-(5,5-dimethylmorpholin-2-yl)ethoxy]-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745243,0.05,1342637,374355085,134156210,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aS,5R,6aR)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-yl]oxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745245,0.05,1342637,374297658,57802833,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[(4-butylmorpholin-2-yl)methoxy]-N-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745395,0.05,1342637,374305289,57802675,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 258",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745396,0.05,1342637,374308254,57802880,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745397,0.05,1342637,374318584,57802801,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]-N-(2,3,4-trichlorophenyl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745399,0.05,1342637,374345656,57802776,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745400,0.05,1342637,374350981,134155029,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6R,6aS)-3-(trifluoromethylamino)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745401,0.05,1342637,374282074,89125605,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,2-[[4-(4-chloro-3-methylanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-N-cyano-N'-methylmorpholine-4-carboximidamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745402,0.05,1342637,374289471,57802607,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-methoxy-7-[[2-(1-methylpiperidin-3-yl)-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745403,0.05,1342637,374294892,57802653,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745404,0.05,1342637,374298025,134140126,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aS,5R,6aR)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-yl]oxy]-N-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745405,0.05,1342637,374298552,58013819,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 38",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745605,0.05,1342637,374299504,10437760,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,C22H19N3O5BrClF2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745608,0.05,1342637,374307576,57802698,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 56",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745609,0.05,1342637,374328884,57802732,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-6-methoxy-7-[2-(4,6,6-trimethylmorpholin-2-yl)ethoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745610,0.05,1342637,374300737,57802722,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 39",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745611,0.05,1342637,374310964,10253774,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 71",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745612,0.05,1342637,374320424,57802736,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"[[2-[[4-(3,4-Dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-piperidin-1-ylmethylidene]cyanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745613,0.05,1342637,374321697,57802766,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,N-(4-bromo-3-chlorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745614,0.05,1342637,374354736,57802905,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745615,0.05,1342637,374361687,57802578,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(4-bromo-2,3-dichlorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745616,0.05,1342637,374270291,57802754,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 193",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745802,0.05,1342637,374304503,66838467,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745803,0.05,1342637,374332129,57802737,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 212",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745804,0.05,1342637,374333322,10412767,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 65",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745805,0.05,1342637,374346599,57802904,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"[[2-[[4-(3,4-Dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-pyrrolidin-1-ylmethylidene]cyanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745808,0.05,1342637,374289252,10345562,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 77",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745809,0.05,1342637,374289318,57802639,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(6S)-6-[[4-(3,4-dichloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-4-methylpiperazin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745810,0.05,1342637,374349711,58013772,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 239",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745811,0.05,1342637,374351740,134155250,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichlorophenyl)-7-[(5-ethyl-4,6,7,7a-tetrahydro-3aH-[1,3]thiazolo[5,4-c]pyridin-2-yl)methoxy]-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
372112372,0.05,1676531,461514806,162643202,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-methoxy-6-[4-(4-methylpiperazin-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890389,0.05,1797499,386053014,10073562,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 15",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890391,0.05,1797499,386053022,57802617,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 23",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890393,0.05,1797499,386053012,10347091,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 13",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388896149,0.05,1797499,386053011,10458326,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 12",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388906801,0.05,1797499,386053006,10369374,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"N-(3,4-dichloro-2-fluorophenyl)-7-({[(3aR,5r,6aS)-2-(1-methylethyl)octahydrocyclopenta[c]pyrrol-5-yl]methyl}oxy)-6-(methyloxy)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388906805,0.05,1797499,386053024,58013804,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913101,0.05,1797499,386053123,10457243,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 119",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913327,0.05,1797499,386053171,10325530,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 167",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913335,0.05,1797499,386053048,10005056,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 58",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913512,0.05,1797499,386053033,57802722,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 39",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913526,0.05,1797499,386053032,58013819,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 38",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388914868,0.05,1797499,386053202,57802647,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 198",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388915520,0.05,1797499,386053057,10482693,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 67",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388919112,0.05,1797499,386053067,57802678,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 34",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388919122,0.05,1797499,386053164,57802811,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 160",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388920152,0.05,1797499,386053049,10253661,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 59",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388920419,0.05,1797499,386053187,57802908,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 183",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388921638,0.05,1797499,386053208,57802862,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 204",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388921960,0.05,1797499,386053081,10345562,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 77",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388922135,0.05,1797499,386053203,57802865,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 199",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388922840,0.05,1797499,386053219,57802714,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"1,1-Dimethylethyl 4-[5-({[4-[(3,4-dichlorophenyl)amino]-6-(methyloxy)quinazolin-7-yl]oxy}methyl)-1,2,4-oxadiazol-3-yl]piperazine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388923007,0.05,1797499,386053249,57802774,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 245",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388923344,0.05,1797499,386053197,57802754,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 193",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388924689,0.05,1797499,386053211,57802907,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 207",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388924936,0.05,1797499,386053191,57802873,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 187",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388924937,0.05,1797499,386053069,57802905,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925104,0.05,1797499,386053074,11755547,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 69",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925208,0.05,1797499,386053200,57802717,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 196",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925365,0.05,1797499,386053230,57802863,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 226",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925487,0.05,1797499,386053248,69026545,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 244",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925490,0.05,1797499,386053158,57802803,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 154",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925496,0.05,1797499,386053206,57802700,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 202",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926417,0.05,1797499,386053240,57802631,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 236",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926676,0.05,1797499,386053241,57802666,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 237",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388927073,0.05,1797499,386053220,57802679,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 216",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388927505,0.05,1797499,386053131,10325099,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 127",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388928162,0.05,1797499,386053179,10347268,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 175",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388929607,0.05,1797499,386053247,76614830,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 243",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388929616,0.05,1797499,386053167,10073317,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 163",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388929884,0.05,1797499,386053174,10455540,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 170",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388930086,0.05,1797499,386053221,139208796,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 217",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388930840,0.05,1797499,386053242,58013796,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 238",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950881,0.05,1798244,404342813,135236905,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 105",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997077,0.05,1798900,58097703,11490270,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-diethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000994,0.05,1798897,58097689,25263257,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-(2-{4-[(1-benzyl-1H-indazol-5-yl)amino]thieno[3,2-d]pyrimidin-6-yl}ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666477,0.05,1806610,471698532,74388734,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 32",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668113,0.05,1806610,471698535,90440556,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-(4-((7-Methoxy-4-(phenylamino)quinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727966,0.05,1919215,476024463,155755967,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 10",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727988,0.05,1919215,476024460,155755902,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 7",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727989,0.05,1919215,476024467,155756004,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 14",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727990,0.05,1919215,476024474,155755888,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 21",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727991,0.05,1919215,476024455,155756017,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727992,0.05,1919215,476024468,155755932,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 15",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727993,0.05,1919215,476024459,155755976,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727994,0.05,1919215,476024457,139474413,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 4",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727995,0.05,1919215,476024483,155755982,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 30",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727996,0.05,1919215,476024456,166638751,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727997,0.05,1919215,476024471,155755912,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 18",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727998,0.05,1919215,476024461,155755964,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 8",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389727999,0.05,1919215,476024511,155756001,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 56",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728000,0.05,1919215,476024464,155755922,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 11",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728001,0.05,1919215,476024454,139474188,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 1",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728002,0.05,1919215,476024469,155755991,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 16",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728024,0.05,1919215,476024458,155756041,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 5",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728025,0.05,1919215,476024476,155755951,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 23",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728027,0.05,1919215,476024504,155756024,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 50",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728028,0.05,1919215,476024466,155756028,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 13",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728029,0.05,1919215,476024500,155756018,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 46",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728030,0.05,1919215,476024477,155756032,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 24",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728032,0.05,1919215,476024462,155755941,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 9",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728034,0.05,1919215,476024482,155755965,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728035,0.05,1919215,476024478,155756014,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728036,0.05,1919215,476024465,155756016,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 12",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728037,0.05,1919215,476024491,155755928,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728038,0.05,1919215,476024488,155755917,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 35",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728060,0.05,1919215,476024501,155755966,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 47",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728061,0.05,1919215,476024479,155755974,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 26",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728062,0.05,1919215,476024495,155755893,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 41",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728063,0.05,1919215,476024537,155755947,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 80",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728067,0.05,1919215,476024494,155756025,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728068,0.05,1919215,476024496,155755931,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 42",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728069,0.05,1919215,476024486,155756003,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 33",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728070,0.05,1919215,476024472,155755955,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 19",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728071,0.05,1919215,476024489,155755943,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 36",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728072,0.05,1919215,476024544,155755948,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 86",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728121,0.05,1919215,476024475,155755958,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 22",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728123,0.05,1919215,476024584,139474336,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 124",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728124,0.05,1919215,476024522,166638753,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 67",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728125,0.05,1919215,476024470,155755921,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 17",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728126,0.05,1919215,476024536,155755986,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 79",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728129,0.05,1919215,476024473,155755988,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 20",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728130,0.05,1919215,476024554,155755909,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 94",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728131,0.05,1919215,476024498,155755899,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 44",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728132,0.05,1919215,476024558,155755999,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 98",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728133,0.05,1919215,476024497,139474449,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 43",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728155,0.05,1919215,476024505,155756034,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 51",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728156,0.05,1919215,476024499,155756026,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 45",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728157,0.05,1919215,476024502,155755907,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 48",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728158,0.05,1919215,476024481,155756035,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 28",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728159,0.05,1919215,476024525,155755939,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 70",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728162,0.05,1919215,476024507,155756015,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 53",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728163,0.05,1919215,476024570,155755889,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 110",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728164,0.05,1919215,476024509,155755938,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 54",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728165,0.05,1919215,476024521,155793616,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 66",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728169,0.05,1919215,476024560,155755954,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 100",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728191,0.05,1919215,476024578,139474454,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 118",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728195,0.05,1919215,476024492,155755990,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 38",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728197,0.05,1919215,476024587,139474123,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 127",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728198,0.05,1919215,476024529,155755929,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 73",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728199,0.05,1919215,476024485,155755977,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 32",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728203,0.05,1919215,476024480,155756009,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728204,0.05,1919215,476024563,155755892,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 103",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728205,0.05,1919215,476024516,155755998,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 61",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728250,0.05,1919215,476024512,155755918,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 57",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728251,0.05,1919215,476024513,155756006,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 58",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728252,0.05,1919215,476024517,166638752,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 62",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728253,0.05,1919215,476024524,155756010,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 69",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728256,0.05,1919215,476024540,155755930,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 83",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728258,0.05,1919215,476024585,139474337,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 125",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728259,0.05,1919215,476024510,155756012,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 55",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728260,0.05,1919215,476024530,155755915,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 74",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728261,0.05,1919215,476024518,155755924,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 63",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728262,0.05,1919215,476024581,139474122,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 121",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728305,0.05,1919215,476024506,155755945,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 52",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728307,0.05,1919215,476024531,155755935,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 75",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728309,0.05,1919215,476024493,155756042,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 39",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728310,0.05,1919215,476024562,155755961,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 102",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728311,0.05,1919215,476024557,155755890,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 97",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728312,0.05,1919215,476024572,139474333,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 112",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728313,0.05,1919215,476024503,155755925,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 49",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728317,0.05,1919215,476024487,155755919,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 34",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728381,0.05,1919215,476024590,139474457,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 130",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728382,0.05,1919215,476024573,139466273,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 113",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728383,0.05,1919215,476024574,139474191,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 114",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728385,0.05,1919215,476024514,155756027,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 59",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728387,0.05,1919215,476024519,155755896,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 64",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728389,0.05,1919215,476024575,139474120,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 115",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728390,0.05,1919215,476024582,139474455,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 122",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728391,0.05,1919215,476024566,155755994,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 106",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728392,0.05,1919215,476024541,155755934,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 84",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728394,0.05,1919215,476024528,155755906,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 72",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728442,0.05,1919215,476024591,139474137,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 131",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728444,0.05,1919215,476024515,155755957,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 60",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728445,0.05,1919215,476024523,155755987,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 68",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728446,0.05,1919215,476024538,155756043,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 81",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728447,0.05,1919215,476024567,155756007,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 107",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728449,0.05,1919215,476024592,139474138,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 132",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728451,0.05,1919215,476024571,155755908,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 111",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728457,0.05,1919215,476024597,139474415,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 137",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728458,0.05,1919215,476024596,139474458,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 136",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728461,0.05,1919215,476024532,155755956,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 76",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728462,0.05,1919215,476024547,155755993,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 88",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728463,0.05,1919215,476024568,155755985,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 108",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728464,0.05,1919215,476024549,155755942,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 90",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728467,0.05,1919215,476024589,139474339,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 129",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728468,0.05,1919215,476024564,139474124,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 104",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728491,0.05,1919215,476024543,155755953,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 85",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728493,0.05,1919215,476024520,155755894,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 65",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728495,0.05,1919215,476024545,155755897,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 87",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728497,0.05,1919215,476024556,155755972,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 96",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728498,0.05,1919215,476024548,155755979,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 89",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728499,0.05,1919215,476024593,139474414,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 133",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728500,0.05,1919215,476024586,139474456,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 126",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728501,0.05,1919215,476024527,155755950,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 71",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728502,0.05,1919215,476024555,155756045,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 95",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728505,0.05,1919215,476024533,155755944,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 77",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731275,0.05,1919215,476024595,139474141,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 135",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731276,0.05,1919215,476024539,155755900,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 82",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731279,0.05,1919215,476024579,139474453,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 119",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731282,0.05,1919215,476024565,155755904,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 105",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731285,0.05,1919215,476024550,139474117,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 91",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731287,0.05,1919215,476024559,155755962,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 99",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731288,0.05,1919215,476024580,139474121,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 120",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731378,0.05,1919215,476024588,139474195,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 128",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731380,0.05,1919215,476024534,155755911,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 78",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731381,0.05,1919215,476024552,155755960,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 92",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731383,0.05,1919215,476024576,139474136,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 116",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731384,0.05,1919215,476024553,155755895,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 93",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731387,0.05,1919215,476024577,139474135,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 117",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731388,0.05,1919215,476024569,155755983,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 109",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731389,0.05,1919215,476024594,139474196,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 134",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389731390,0.05,1919215,476024583,139474192,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 123",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439797,0.0501,1920052,486503586,166927929,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 114",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439928,0.0504,1920052,486503715,167318744,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 245",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023769,0.0505,447375,103707797,45487334,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(3S,5S,6S)-5-(hydroxycarbamoyl)-1-methyl-6-(4-phenylpiperazine-1-carbonyl)piperidin-3-yl 3,3-difluoropyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440350,0.0505,1920053,486503643,167318864,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 173",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440508,0.0505,1920053,486503799,167318891,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 332",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440457,0.0506,1920053,486503749,169552768,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 279",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440321,0.0507,1920053,486503614,166927758,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 142",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440322,0.0507,1920053,486503615,166927662,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 143",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440201,0.0508,1920053,486503499,166927896,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675435,0.051,290550,103523354,44426258,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,N-(3-{4-[4-(1-Cyclobutanecarbonyl-piperidin-4-yloxy)-3-methyl-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-2-methoxy-acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101676420,0.051,290549,103523376,44426278,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"1-(4-(4-(6-(Dimethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778075,0.051,314962,103561941,16036788,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(R)-1-morpholino-2-(4-(1-(pyridin-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
254420592,0.051,632227,136925311,56851431,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[2-chloro-4-(5H-pyrrolo[3,2-d]pyrimidin-4-ylamino)phenoxy]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380552836,0.051,1855770,123092436,44259,2064,35964425,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human HER2 incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615759,0.051,1919643,483622411,146448669,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 72",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432877,0.0511,1919984,486499687,168257414,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-3-(3-fluoro-1-methylazetidin-3-yl)-1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440188,0.0511,1920053,486503487,166927837,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 15",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018113,0.0511,1920044,486503236,169552752,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-3-(3-fluoro-1-methylazetidin-3-yl)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145179,0.0512,1798142,459092836,139377726,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[[6-fluoro-4-(2-hydroxypropan-2-yl)pyridin-3-yl]amino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279391,0.0516,461252,103729847,24944855,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-Ethynylphenylamino)-6-methoxyquinazolin-7-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439755,0.0518,1920052,486503547,162428933,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 75",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143669,0.0518,1798142,464922091,155164959,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-4-methoxy-2-[(3R)-3-(methylamino)pyrrolidin-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453094,0.052,375732,103505643,16108947,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(6S,7S)-N-hydroxy-6-(4-phenylpiperazine-1-carbonyl)-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101638417,0.052,277510,103505643,16108947,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-(4-phenylpiperazine-1-carbonyl)-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101751935,0.052,308828,103549763,44441000,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[[(3S)-3-aminopyrrolidin-1-yl]methyl]-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101880678,0.052,263981,103486529,11605761,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)benzyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106024078,0.052,447375,103707871,45487399,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(2S,3S)-N-hydroxy-5-(N-methylisobutyramido)-2-((R)-3-phenylpyrrolidine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388995918,0.052,1798859,57560490,11260603,2064,18287036,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Receptor Tyrosine Kinase Inhibition Assay from Article 10.1073/pnas.0708281105: '6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.'","5-{2-[4-({3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[2,3-d]pyrimidin-6-yl]ethynyl}pyrazin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668009,0.052,1806610,471698535,90440556,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-(4-((7-Methoxy-4-(phenylamino)quinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203184,0.052,1798359,404345961,130275885,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-(dimethylamino)-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232555,0.052,1803904,404345961,130275885,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[2-(dimethylamino)-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347901,0.052,1919554,404345961,130275885,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[2-(dimethylamino)-4-[2-(dimethylamino)-2-oxoethyl]phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355640236,0.05208,1309513,336907815,127053079,2064,27387355,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,"(4S)-N-[4-[3-chloro-4-(cyclopropylmethoxy)anilino]-7-ethoxyquinazolin-6-yl]-2-oxo-1,3-oxazolidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665451,0.0522,1168534,312363554,118717616,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[2-methylsulfonyl-1-(2-methylsulfonylethylamino)ethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439997,0.0522,1920052,486503783,167318724,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 316",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440341,0.0523,1920053,486503634,166927938,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 164",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440646,0.0523,1920053,486503935,167318865,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 470",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439798,0.0524,1920052,486503587,167318581,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 115",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440174,0.0524,1920053,486503475,162428836,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440196,0.0524,1920053,486503494,167318715,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 22",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440378,0.0526,1920053,486503670,166928160,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 200",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440620,0.0526,1920053,486503909,167318907,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 444",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144114,0.0526,1798142,464922085,139378057,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[5-chloro-4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143897,0.0527,1798142,464922027,150423133,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[3-[(dimethylamino)methyl]azetidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440334,0.0529,1920053,486503627,167318859,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 155",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359459,0.053,69714,103302993,5328961,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10h,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124297,0.053,418919,103550985,25218687,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"3-(2-(2-methoxybenzyl)-1H-benzo[d]imidazol-6-yl)-1-((trans)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632869,0.053,1306577,336907691,127052993,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656233,0.053,1315979,374280281,134135323,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388817747,0.053,1795646,8034238,5328961,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10h,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389006051,0.053,1798858,57560476,25218687,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"3-(2-(2-methoxybenzyl)-1H-benzo[d]imidazol-6-yl)-1-((trans)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439859,0.0532,1920052,486503647,166928149,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 177",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439937,0.0532,1920052,486503724,167318736,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 254",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440041,0.0532,1920052,486503825,169552773,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 358",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340086377,0.0533,776745,312397806,118738357,2064,24121234,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2 (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,[5-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]-(4-methylpiperazin-1-yl)methanone;4-methylbenzenesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440395,0.0533,1920053,486503687,166927891,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 217",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440313,0.0535,1920053,486503606,169552759,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 134",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356272,0.0537,517320,123096639,52946371,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-isopropylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699878,0.0539,1796911,384577258,118900273,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'",Egfr/her2-IN-5,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439747,0.0539,1920052,486503539,167318837,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 66",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701315,0.054,226585,103408013,44372180,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and ErbB-2 average ratio,"4-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503506,0.054,361656,103644047,44587569,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,2-(4-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidin-5-yl)methyleneamino)piperazin-1-yl)ethanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101564234,0.054,371616,103610712,44571820,2064,19101143,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(2,6-difluorophenyl)-3-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571794,0.054,344457,103628199,44580891,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(S)-N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(pyrrolidin-2-ylethynyl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751925,0.054,308828,103549769,10227907,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[[4-(methylamino)piperidin-1-yl]methyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
103124300,0.054,418919,103593182,25218692,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1-{4-[4-(3-methoxypropyl)piperazin-1-yl]cyclohexyl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155734506,0.054,463639,174485413,46881918,2064,20166671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"trans-3-(2-(2-methoxybenzyl)-1H-benzo[d]imidazol-6-yl)-1-(4-(1-methylpiperidin-4-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155734508,0.054,463639,174495446,46881850,2064,20166671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,"3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-6-yl)-1-((1r,4r)-4-(1-(3-methoxypropyl)piperidin-4-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398256,0.054,1574931,440162380,155542715,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[[1-(3-morpholin-4-ylpropyl)triazol-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
366531273,0.054,1633241,440113599,155513061,2064,30826508,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 in human A549 cells by ELISA method,[3-Oxo-3-[3-(pyridine-2-carbonylamino)anilino]propyl] 4-phenylpiperazine-1-carbodithioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,23,"","",""
388995916,0.054,1798859,57560489,25218697,2064,18287036,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Receptor Tyrosine Kinase Inhibition Assay from Article 10.1073/pnas.0708281105: '6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases.'","N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-{2-[(2R)-pyrrolidin-2-yl]ethynyl}thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389006052,0.054,1798858,57560481,25218692,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1-{4-[4-(3-methoxypropyl)piperazin-1-yl]cyclohexyl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665819,0.054,1806610,471698509,155235870,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"1-(4-((4-((2,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440017,0.054,1920052,486503803,167318862,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 336",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439830,0.0541,1920052,486503618,167318615,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 146",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440413,0.0541,1920053,486503705,167318539,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 235",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439801,0.0542,1920052,486503590,166927925,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 118",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440488,0.0542,1920053,486503779,167318662,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 312",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440484,0.0543,1920053,486503775,167318890,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 307",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439689,0.0544,1920052,486503483,162428840,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 11",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102336,0.0545,1796170,381752965,132163000,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aR)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675450,0.055,290550,103523382,44426282,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"N-(2,6-difluorophenyl)-4-(2-methyl-4-(6-(3-morpholinopropoxy)quinazolin-4-ylamino)phenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101676431,0.055,290549,103523382,44426282,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"N-(2,6-difluorophenyl)-4-(2-methyl-4-(6-(3-morpholinopropoxy)quinazolin-4-ylamino)phenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742011,0.055,306289,103549509,10217590,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751497,0.055,308828,103549509,10217590,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101880663,0.055,263981,103486437,11597180,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(pyridin-2-yl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747201,0.055,474114,103749178,46886327,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"2-phenyl-N-(3-(5-(2-(1,2,3,4-tetrahydroisoquinolin-6-ylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365017,0.055,549932,103549509,10217590,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420165,0.055,632226,136941533,56851590,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[2-(trifluoromethoxy)phenoxy]phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398253,0.055,1574931,336872725,74766095,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(prop-2-yn-1-yloxy)quinazolin-6-yl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
372112592,0.055,1676531,461517437,162645045,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[4-[(1,3-dioxoisoindol-2-yl)methyl]anilino]-6-[4-(4-methylpiperazin-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440626,0.055,1920053,486503915,167318788,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 450",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439818,0.0551,1920052,486503606,169552759,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 134",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439728,0.0553,1920052,486503521,162429063,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 49",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439820,0.0553,1920052,486503608,167318819,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 136",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440109,0.0555,1920052,486503893,167318542,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 428",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440303,0.0556,1920053,486503597,167318853,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 125",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440510,0.0557,1920053,486503801,167318722,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 334",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101827308,0.056,254948,103468827,18967573,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,"6,7-Dimethoxy-4-[3-methyl-4-(pyridin-2-ylmethoxy)anilino]quinazoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101828892,0.056,255958,103468841,10152238,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against erbB2 autophosphorylation in MCF-7 breast carcinoma cell line,[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-[5-(1-methyl-piperidin-4-yloxy)-quinazolin-4-yl]-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
254456619,0.056,624804,103202250,156414,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354665177,0.056,1289550,312367127,71496458,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR deletion mutant autophosphorylation in human PC9 cells after 2 hrs by sandwich ELISA,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
389666473,0.056,1806610,471698514,155235880,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"1-(3-((4-((2,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)azetidin-1-yl)-prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439692,0.0562,1920052,486503486,162429004,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 14",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440587,0.0562,1920053,486503876,167318805,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 411",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440065,0.0563,1920052,486503849,162429007,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 383",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439727,0.0566,1920052,486503520,167318889,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 48",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440282,0.0566,1920053,486503576,167318896,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 103",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439789,0.0567,1920052,486503578,167318698,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 105",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440293,0.0567,1920053,486503587,167318581,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 115",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440179,0.0568,1920053,486503479,162428940,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 7",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440336,0.0568,1920053,486503629,167318740,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 157",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778081,0.057,314962,103561947,16118035,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(R)-2-(4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)-N-methylpropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
380767923,0.05736,1905773,318405845,51039030,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 D769Y mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography,Pyrotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439931,0.0574,1920052,486503718,167318892,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 248",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439946,0.0576,1920052,486503733,162428946,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 263",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440571,0.0576,1920053,486503860,167318877,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 395",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440521,0.0578,1920053,486503812,162428822,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 345",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440522,0.0578,1920053,486503812,162428822,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 345",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440053,0.0579,1920052,486503837,167318718,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 370",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440387,0.0579,1920053,486503679,166927713,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 209",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821391,0.058,248914,103441735,11285080,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(4,4-dihydroxypiperidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615762,0.058,1919643,483622398,146448668,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 42",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439721,0.0582,1920052,486503514,166927641,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 42",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440325,0.0582,1920053,486503618,167318615,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 146",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440337,0.0582,1920053,486503630,167318666,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 158",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440103,0.0584,1920052,486503887,166927669,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 422",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440529,0.0584,1920053,486503818,167318695,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 351",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665447,0.0586,1168534,312363552,118717614,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[1-(cyclohexylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101613075,0.059,383072,103441767,9915743,2064,18077425,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human Her2,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778087,0.059,314962,103561939,16116963,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(R)-N-methyl-2-(4-(1-(pyridin-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101821403,0.059,248914,103441791,11192678,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-morpholin-4-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821814,0.059,248914,103441767,9915743,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821961,0.059,248914,103441712,11444623,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880677,0.059,263981,103486476,11627264,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(6-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)pyridin-2-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124296,0.059,418919,103593179,25218689,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"1-{4-[4-(4-amino-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl]piperazin-1-yl}ethan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341094305,0.059,1057941,194172917,71765762,2064,24184076,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,Neratinib impurity QL,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072430,0.059,1256453,103441767,9915743,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366322667,0.059,1535443,440217628,155564719,2064,30600149,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),(E)-N-[3-cyano-7-ethoxy-4-[3-fluoro-4-(pyridin-2-ylmethoxy)anilino]quinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366365937,0.059,1558401,103441767,9915743,2064,31550151,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of HER2 (unknown origin),Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380658223,0.059,1880125,103441767,9915743,2064,35439421,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 phosphorylation (676 to 1255 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 15 mins in presence of ATP measured after 1 hr by DELPHIA,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389005896,0.059,1798858,57560478,25218689,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"1-{4-[4-(4-amino-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl]piperazin-1-yl}ethan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203195,0.059,1798359,404345975,135203409,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","(R)-1-(1-acryloylpyrrolidin-3-yl)-4-amino-N-(4-(2-(dimethylamino)-2-oxoethyl)naphthalen-1-yl)-H-pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232551,0.059,1803904,433917005,130275296,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","US10329300, Example 62",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347959,0.059,1919554,433917005,130275296,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","US10329300, Example 62",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407932635,0.059,1930038,103441767,9915743,2064,34778767,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant HER2 (676 to 1255 residues) (unknown origin) expressed in baculovirus infected sf9 cells autophosphorylation incubated for 1 hrs in presence of ATP by time-resolved fluorometry,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440141,0.0591,1920052,486503925,167318852,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 460",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440315,0.0593,1920053,486503608,167318819,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 136",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440563,0.0594,1920053,486503852,167318815,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 386",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439828,0.0595,1920052,486503616,167318800,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 144",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439726,0.0596,1920052,486503519,166927738,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 47",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439978,0.0596,1920052,486503764,167318673,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 296",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440157,0.0596,1920052,486503941,167318860,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 477",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440217,0.0598,1920053,486503515,162429033,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 43",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99538454,0.06,40021,103407771,44372005,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing BT474 (Breast) tumor cell proliferation,"4-[4-[(1-benzylindazol-5-yl)amino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453097,0.06,375732,103635284,11328571,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S,5RS)-N-hydroxy-5-(2-oxo-2-(piperidin-1-yl)ethyl)-2-(4-phenylpiperazine-1-carbonyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101742022,0.06,306289,103549500,10114464,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-(3-aminopropoxymethyl)-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742029,0.06,306289,103549510,44440833,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[[(2R)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751508,0.06,308828,103549792,22055240,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-aminopiperidin-1-yl)methyl]-N-[3-chloro-4-[(5-methylpyridin-3-yl)methoxy]phenyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101880680,0.06,263981,103486421,11561058,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(pyrimidin-2-yl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103123568,0.06,418568,103593200,25263250,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by SPA assay,"(3R,5S)-5-[2-(4-{[3-chloro-4-(pyridin-2-yloxy)phenyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124272,0.06,418567,103593401,25263263,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-(2-{4-[(1-benzyl-1H-indol-5-yl)amino]thieno[3,2-d]pyrimidin-6-yl}ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124278,0.06,418567,103593324,25263254,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-(2-{4-[(4-benzylphenyl)amino]thieno[3,2-d]pyrimidin-6-yl}ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124286,0.06,418567,103593131,25263247,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-[2-(4-{[3-chloro-4-(1,3-thiazol-4-ylmethoxy)phenyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420222,0.06,632226,136922009,56849556,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-Methyl-4-((6-methylpyridin-3-yl)oxy)phenyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254432702,0.06,634138,103177479,208908,2064,22169601,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326053044,0.06,708988,163331795,54760383,2064,23116168,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant ERBB2 by radiometric kinase assay,"9-cyclopentyl-N2-[4-(4-methylpiperazin-1-yl)phenyl]-N8-phenyl-purine-2,8-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040374,0.06,760335,174507796,11488320,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,Sapitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363627120,0.06,1395848,404701444,9919900,2064,29605809,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human MCF-7 cells after 24 hrs by immunoblotting analysis,"[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[4-[[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-9-carbamoyloxy-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]amino]butylamino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372339076,0.06,1718898,103441767,9915743,2064,33314925,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of substrate incubated for 30 mins by ADP-Glo assay,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000440,0.06,1798897,58097695,25263263,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-(2-{4-[(1-benzyl-1H-indol-5-yl)amino]thieno[3,2-d]pyrimidin-6-yl}ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000638,0.06,1798897,58097686,25263254,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-(2-{4-[(4-benzylphenyl)amino]thieno[3,2-d]pyrimidin-6-yl}ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000989,0.06,1798897,58097679,25263247,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-[2-(4-{[3-chloro-4-(1,3-thiazol-4-ylmethoxy)phenyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000997,0.06,1798897,58097682,25263250,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-[2-(4-{[3-chloro-4-(pyridin-2-yloxy)phenyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666771,0.06,1806610,471698532,74388734,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 32",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632645,0.0601,1306575,103177479,208908,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant Her2 (676 to 1255 residues) expressed in baculovirus by fluorescence based assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440124,0.0601,1920052,486503908,167318538,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 443",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440640,0.0602,1920053,486503929,167318897,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 464",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439758,0.0604,1920052,486503550,166927701,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 78",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440523,0.0604,1920053,486503813,167318593,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 346",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440189,0.0606,1920053,486503488,162428782,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 16",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363687110,0.0608,1404961,123092436,44259,2064,29902719,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821965,0.061,248914,103441755,11203436,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]ethenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101828891,0.061,255958,103468856,10288761,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against erbB2 autophosphorylation in MCF-7 breast carcinoma cell line,4-(3-Chloro-4-(2-pyridylmethoxy)anilino)-5-(1-methylpiperidin-4-yloxy)quinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
254420440,0.061,632227,136921997,56851427,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(2-fluorophenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093485,0.061,1057929,194159081,72737208,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2-pyrrolidin-1-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402239080,0.0613,1804976,441610614,146241627,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Inhibition Assay from US Patent US10822334: 'ErbB receptor inhibitors',"5-(5,5-difluoro-1-methylazepan-4-yl)oxy-N-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylphenyl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440642,0.0613,1920053,486503931,167318725,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 466",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440330,0.0614,1920053,486503623,167318681,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 151",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821803,0.062,248914,103441690,11249776,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-(furan-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359659,0.062,517501,123094321,52946371,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-isopropylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435417,0.062,638068,136925168,56835161,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[2-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]ethynyl]-6-methylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655462,0.062,1315979,374325781,134147869,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-[(1-benzylindazol-5-yl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355656236,0.062,1315979,374322230,134146887,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-[(1-benzylindazol-5-yl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440070,0.0621,1920052,486503854,167318903,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 388",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440167,0.0621,1920052,486503951,167318883,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 487",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440498,0.0621,1920053,486503789,167318574,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 322",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440593,0.0621,1920053,486503882,167318906,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 417",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769306,0.06226,1905726,482050969,168271897,2064,35319895,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis,"(E)-N-[3-cyano-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439737,0.0625,1920052,486503530,166927644,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 58",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432841,0.0628,1919984,486499653,168258119,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018081,0.0628,1920044,486503202,169552731,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100274015,0.063,242383,103442718,11524582,2064,15993060,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibitory concentration against ErbB-2 protein tyrosine kinase by using [gamma-33P]-ATP as radioligand in pH 7.5,"[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-(1,3,8a,9-tetraaza-fluoren-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539066,0.063,410944,103607073,25263280,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539067,0.063,410944,103606998,25263276,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3S,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539075,0.063,410944,103606999,25263277,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3S,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539081,0.063,410944,103607074,25263281,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694013,0.063,295195,103531653,10310843,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"1-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356256,0.063,517320,123096641,52947603,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"trans-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-chlorophenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388996863,0.063,1798900,58097712,25263277,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3S,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997013,0.063,1798900,58097715,25263280,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997014,0.063,1798900,58097711,25263276,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3S,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388997076,0.063,1798900,58097716,25263281,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615752,0.063,1919643,483622396,146448638,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203167,0.063,1798359,225157243,5279,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'",Staurosporine HCl,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232635,0.063,1803904,249871008,91669270,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","US8889696, Staurosporine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440607,0.0631,1920053,486503896,167318707,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 431",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440075,0.0633,1920052,486503859,167318905,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 393",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440627,0.0638,1920053,486503916,167318766,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 451",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821393,0.064,248914,103441694,11399331,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-[4-(1,3-benzothiazol-2-ylmethoxy)-3-chloroanilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366531270,0.064,1633241,103177459,176870,2064,30826508,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 in human A549 cells by ELISA method,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,23,"","",""
366531272,0.064,1633241,440112790,155512535,2064,30826508,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 in human A549 cells by ELISA method,N-[3-(cyclohexylcarbamoylamino)phenyl]pyridine-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,23,"","",""
402440181,0.064,1920053,486503481,162428889,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 9",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440557,0.064,1920053,486503846,167318559,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 380",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439690,0.0642,1920052,486503484,166927839,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 12",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439985,0.0642,1920052,486503771,167318656,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 303",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440005,0.0644,1920052,486503791,167318793,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 324",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440621,0.0645,1920053,486503910,167318602,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 445",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440134,0.0646,1920052,486503918,167318848,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 453",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440210,0.0646,1920053,486503508,162428857,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 36",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440545,0.0647,1920053,486503834,167318914,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 367",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440491,0.0648,1920053,486503782,167318575,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 315",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864194,0.065,260899,103479868,11719423,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(bis-(1-methylethyl)amino)-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
334072658,0.065,739689,164147003,59484694,2064,23490150,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD-tagged HER2 cytoplasmic domain (676 to 1255) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,"4-({3-Chloro-4-[3-(Trifluoromethyl)phenoxy]phenyl}amino)-N-[2-(Methylsulfonyl)ethyl]-8,9-Dihydro-7h-Pyrimido[4,5-B]azepine-6-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354665418,0.065,1289551,312468158,57335384,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR deletion mutant autophosphorylation in human HCC827 cells after 2 hrs by sandwich ELISA,Rociletinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632836,0.065,1306577,336904290,127050554,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(4-Chloroanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440126,0.065,1920052,486503910,167318602,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 445",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440381,0.0654,1920053,486503673,167318775,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 203",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440584,0.0656,1920053,486503873,167318691,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 408",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440497,0.0657,1920053,486503788,167318726,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 321",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439984,0.0659,1920052,486503770,167318687,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 302",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440203,0.0659,1920053,486503501,167318562,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778941,0.066,315244,103574974,11705343,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2R)-2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-5-yl)oxy]-N-methylpropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101880675,0.066,263981,103486442,44410648,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,5-(2-(1H-pyrazol-3-yl)ethynyl)-N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150763,0.066,1079763,194168452,76325760,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","N-(3-chlorophenyl)-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
342821912,0.066,1119725,242612630,58191965,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant HER2 (unknown origin) using poly-Glu-Tyr peptide as substrate,N-(2-aminophenyl)-4-[[4-(3-ethynylanilino)quinazolin-6-yl]oxymethyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380800954,0.066,1915573,242612631,58191950,2064,33077264,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),(E)-N-(2-aminophenyl)-3-[1-[4-(3-ethynylanilino)quinazolin-6-yl]sulfonylpyrrol-3-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439699,0.0661,1920052,486503492,167318898,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 20",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440405,0.0669,1920053,486503697,167318781,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 227",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453102,0.067,375732,103635363,44583656,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S,5S)-N-hydroxy-2-(4-(3-isopropylphenyl)piperidine-1-carbonyl)-5-(2-oxo-2-(piperidin-1-yl)ethyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101675740,0.067,290550,103523378,11786150,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"N-(2,6-difluorophenyl)-4-(4-(6,7-dimethoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863456,0.067,260896,103479799,11634425,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dibutylamino)-2-butynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420629,0.067,632227,136921998,56851589,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340011562,0.067,748805,174522097,67219716,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"1-[3-(4-Amino-7-cyclopentyl-7H-pyrrolo[23-d]pyrimidine-5-carbonyl)-phenyl]-3-(2,6-difluoro-phenyl)-urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
366398243,0.067,1574931,440152182,155538283,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[[1-(3-hydroxypropyl)triazol-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
402440054,0.067,1920052,486503838,167318638,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 371",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440355,0.0671,1920053,486503648,166928150,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 178",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440339,0.0672,1920053,486503632,166927659,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 160",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440617,0.0672,1920053,486503906,167318756,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 441",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439955,0.0673,1920052,486503742,162428815,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 272",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440609,0.0674,1920053,486503898,167318637,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 433",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440428,0.0676,1920053,486503720,167318794,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 250",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539074,0.068,410944,103606906,11273032,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564643,0.068,367174,103610158,44571451,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"2-((5-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)furan-2-yl)methylamino)acetonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564650,0.068,367174,103610162,44528960,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((ethylamino)methyl)-1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571793,0.068,344457,103606906,11273032,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101639297,0.068,277510,103505699,11625778,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"methyl (5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenyl3,6-dihydro-2H-pyridine-1-carbonyl)-7-azaspiro[2.5]octane-7-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
355633479,0.068,1306577,336902095,127048976,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,N-[4-(3-ethynylanilino)quinazolin-6-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388996869,0.068,1798900,58097702,11273032,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439770,0.0681,1920052,486503561,166927921,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 89",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440106,0.0681,1920052,486503890,167318803,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 425",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439707,0.0687,1920052,486503500,167318661,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 28",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440559,0.0689,1920053,486503848,167318802,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 382",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101653915,0.069,283010,104236748,11655791,2064,16279804,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 tyrosine kinase phosphorylation expressed in mouse BaF3 cells,"6,7-diethoxy-N-(3-iodophenyl)quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,147,"","",""
101778928,0.069,315244,103574840,11591222,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2R)-N-(2-Hydroxyethyl)-N-methyl-2-{[4-({3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)quinazolin-5-yl]oxy}propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101821968,0.069,248914,103441864,11410608,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(1H-imidazol-5-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880665,0.069,263981,103486165,11720499,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-({6-[(4-{3-Chloro-4-[(3-fluorobenzyl)oxy]anilino}-5-pyrimidinyl)ethynyl]-2-pyridinyl}methyl)-N'-methylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155745956,0.069,474117,103749172,46886321,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 intracellular phosphorylation in human N87 cells by ELISA,"N-(3-(5-(2-(4-(4-ethylpiperazin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2,6-difluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
355632848,0.069,1306577,336906409,71761647,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(3-Bromoanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102325,0.069,1796170,381752967,132162908,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(12aS)-8-methoxy-6-oxo-12a,13-dihydroindolo[2,1-c][1,4]benzodiazepin-9-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103031,0.069,1796166,381752951,132143272,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440525,0.0691,1920053,486503815,167318686,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 348",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440526,0.0691,1920053,486503815,167318686,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 348",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439768,0.0695,1920052,486503559,167318627,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 87",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440123,0.0695,1920052,486503907,167318620,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 442",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439752,0.0696,1920052,486503544,167318560,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 72",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440180,0.0697,1920053,486503480,162429013,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 8",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440632,0.0698,1920053,486503921,167318901,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 456",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99524147,0.07,42142,103203007,6603857,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 overexpressing BT 474 cell proliferation,"N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
100337216,0.07,69874,103200288,4705,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101741773,0.07,306289,103549504,10195479,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-(piperidin-4-yloxymethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751498,0.07,308828,103549761,10217083,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"(R)-N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((3-aminopyrrolidin-1-yl)methyl)pyrrolo[1,2-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101827311,0.07,254948,103468867,44403435,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,[5-(1-Methyl-piperidin-4-yloxy)-quinazolin-4-yl]-[4-(pyridin-2-ylmethoxy)-phenyl]-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106024073,0.07,447375,103707857,45487387,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(5S,6S)-5-(hydroxycarbamoyl)-6-(isoindoline-2-carbonyl)piperidin-3-yl pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365013,0.07,549932,124967056,53322058,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-[(4-aminopiperidin-1-yl)methyl]-N-(3-chloro-4-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402357,0.07,580189,124957152,53317175,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)propiolaldehyde O-2-morpholinoethyl oxime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432844,0.07,1919984,486499656,168257526,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[4-(6-ethylpyridin-3-yl)oxy-3-methylanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440069,0.07,1920052,486503853,167318789,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 387",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440615,0.07,1920053,486503904,167318678,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 439",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018084,0.07,1920044,486503206,169552734,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[4-(6-ethylpyridin-3-yl)oxy-3-methylanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439751,0.0702,1920052,486503543,166927917,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 71",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440415,0.0702,1920053,486503707,167318608,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 237",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440245,0.0703,1920053,486503542,166927663,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 70",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440588,0.0705,1920053,486503877,166927873,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 412",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440550,0.0707,1920053,486503839,167318814,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 372",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440424,0.0708,1920053,486503716,167318697,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 246",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564648,0.071,367174,103610110,25195274,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402352,0.071,580189,124973823,53325551,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)-2-fluoro-N-(2-(methylsulfonyl)ethyl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407923781,0.071,1927648,103177459,176870,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 1 hrs in presence of ATP by ELISA assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440608,0.0711,1920053,486503897,167318799,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 432",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151278195,0.0712,461252,103729846,24944856,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-chloro-4-fluorophenylamino)-6-methoxyquinazolin-7-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440144,0.0713,1920052,486503928,167318636,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 463",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440515,0.0714,1920053,486503806,167318655,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 339",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439719,0.0715,1920052,486503512,166927739,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145873,0.0716,1798142,464922097,139377706,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-5-cyanopyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440434,0.0717,1920053,486503726,167318735,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 256",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503825,0.072,361654,103644049,24897279,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,"(R,E)-N4-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((2-(methoxymethyl)pyrrolidin-1-ylimino)methyl)pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564233,0.072,371616,103610711,25124150,2064,19101143,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(2,6-difluorophenyl)-3-(3-(2-(2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203180,0.072,1798359,404345980,130275226,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232543,0.072,1803904,404345980,130275226,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[5-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347909,0.072,1919554,404345980,130275226,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[5-chloro-4-[2-(dimethylamino)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432874,0.0724,1919984,486499684,168257849,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"Synthesis of (4R,E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-2-fluoro-5-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-4-(dimethylamino)pent-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440541,0.0724,1920053,486503830,167318884,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 363",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018111,0.0724,1920044,486503233,169552750,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"Synthesis of (4R,E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-2-fluoro-5-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4,5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-4-(dimethylamino)pent-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440506,0.0726,1920053,486503797,167318755,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 330",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359460,0.073,69714,103303393,5328960,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10g,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100568316,0.073,68096,103237399,9820644,2064,10346932,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,"2-Propenamide, N-(4-((3-bromophenyl)amino)-7-quinazolinyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
155747196,0.073,474114,103749174,46886323,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-(3-(5-(2-(3-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435329,0.073,638068,136939793,57400426,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[2-[3-[(dimethylamino)methyl]phenyl]ethynyl]-6-methylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655804,0.073,1315979,374352751,72202607,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[7-methoxy-4-(4-phenoxyanilino)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388817749,0.073,1795646,8034237,5328960,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10g,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699902,0.0737,1796911,104144352,10184653,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'",Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366322629,0.07372,1535505,103768626,10184653,2064,30600209,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440168,0.0738,1920052,486503952,167318713,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 488",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143910,0.0738,1798142,313065691,71496458,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694380,0.074,295195,103531685,44430039,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(6-methyl-1,4-diazepan-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821955,0.074,248914,103441808,11399310,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-[3-chloro-4-[(4-phenyl-1,3-thiazol-2-yl)methyl]anilino]-3-cyano-7-methoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204403335,0.074,580189,124975556,11955434,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-methyl-5-(4-morpholinobut-1-ynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668107,0.074,1806610,471698533,155242948,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-[3-[7-Methoxy-4-[4-(trifluoromethyl)anilino]quinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402203210,0.074,1798359,404345986,130277068,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"In Vitro Inhibitory Activity Assay from US Patent US9920060: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232573,0.074,1803904,404345986,130277068,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","4-amino-N-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402347871,0.074,1919554,404345986,130277068,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"Inhibitory Effect on HER2-Phosphorylating Activity (In Vitro) from US Patent US11696917: 'Agent enhancing antitumor effect using pyrazolo[3,4-d]pyrimidine compound'","4-amino-N-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]-2-methylphenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439831,0.0742,1920052,486503619,167318621,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 147",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439918,0.0745,1920052,486503705,167318539,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 235",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675453,0.075,290550,103523355,44426259,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,N-[3-(4-{4-[1-(3-Chloro-benzoyl)-piperidin-4-yloxy]-3-methyl-phenylamino}-quinazolin-6-yl)-prop-2-ynyl]-2-methoxy-acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675480,0.075,290549,103523375,44426277,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,N-(3-methyl-4-(1-methylpiperidin-4-yloxy)phenyl)-6-(3-morpholinopropoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821801,0.075,248914,103441803,11398461,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[(1-benzylindazol-5-yl)amino]-3-cyano-7-methoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345670964,0.075,1171421,312371392,71512060,2064,25409491,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type HER2 (unknown origin) incubated for 5 mins by HTRF assay,(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380763551,0.0751,1904484,482086360,153253814,2064,35259690,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),pan-HER-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440227,0.0752,1920053,486503525,167318633,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 53",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439992,0.0753,1920052,486503778,167318795,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 311",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440560,0.0753,1920053,486503849,162429007,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 383",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440499,0.0754,1920053,486503790,167318806,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 323",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439982,0.0755,1920052,486503768,167318536,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 300",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439967,0.0756,1920052,486503753,167318590,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 284",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440129,0.0759,1920052,486503913,167318644,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 448",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101565334,0.076,367174,103610161,44528924,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((dimethylamino)methyl)-1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101596689,0.076,331423,103563698,17747339,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[2-[(3-fluorophenyl)methyl]-3H-benzimidazol-5-yl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675479,0.076,290549,103523359,44426263,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"N-(2,6-difluorophenyl)-4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101675738,0.076,290550,103523371,11397750,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"1-(4-(4-(6,7-Dimethoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694383,0.076,295195,103531678,10117051,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"(6R)-1-[[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]-1,4-diazepan-6-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751930,0.076,308828,103549753,10116123,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(piperidin-4-ylamino)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821630,0.076,248914,103441762,11353443,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821647,0.076,248914,103441874,11203886,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(1R)-1-phenylethoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380648045,0.076,1878102,374328055,135565884,2064,35041943,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to ERBB2 (unknown origin) assessed as dissociation constant by KINOMEscan analysis,Zanubrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439974,0.0762,1920052,486503760,167318683,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 291",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440487,0.0763,1920053,486503778,167318795,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 311",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151278190,0.0765,461252,103729563,45140149,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-Ethynyl-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380800956,0.0765,1915573,103729563,45140149,2064,33077264,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),7-(4-(3-Ethynyl-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440163,0.0765,1920052,486503947,167318649,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 483",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440162,0.0767,1920052,486503946,162428845,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 482",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675475,0.077,290549,103523386,44426284,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"(4-(4-(6,7-Bis(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)(cyclopentyl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101676432,0.077,290549,103523389,11477567,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"4-(4-(6,7-dimethoxyquinazolin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101840041,0.077,256662,103730344,6445562,2064,15711537,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Pelitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106010478,0.077,439897,103699495,45483699,2064,19821562,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9 cells by liquid scintillation counting,"2-morpholin-4-ylethyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethyl-7aH-pyrrolo[2,3-d]pyrimidin-6-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
347072433,0.077,1256453,318396855,122195541,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632711,0.077,1306577,336907692,127052994,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654691,0.077,1315425,374268761,134132187,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(3-Chloro-4-piperidin-1-ylanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-chloroacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440660,0.0772,1920053,486503949,167318730,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 485",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440418,0.0777,1920053,486503710,167318739,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 240",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571792,0.078,344457,103628529,44581016,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"ethyl (3R,5S)-5-((4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidin-3-ylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778513,0.078,315244,103574837,11677510,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2S)-N-(2-hydroxyethyl)-N-methyl-2-{[4-({3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)quinazolin-5-yl]oxy}propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101821644,0.078,248914,103441749,11398999,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(4-fluorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402351,0.078,580189,124959810,53318458,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)-2-fluoro-N-(2-morpholinoethyl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093659,0.078,1057924,194172914,72737404,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of ErbB2 (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-[3-(diethylamino)propyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398245,0.078,1574931,440144278,155533092,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[[1-[(2-fluorophenyl)methyl]triazol-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
380552467,0.078,1855770,482054483,165412708,2064,35964425,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human HER2 incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,Egfr/her2-IN-6,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439753,0.078,1920052,486503545,166927902,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 73",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440323,0.0782,1920053,486503616,167318800,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 144",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440458,0.0782,1920053,486503750,167318851,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 280",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440331,0.0787,1920053,486503624,167318900,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 152",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439716,0.0788,1920052,486503509,166927838,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778936,0.079,315244,103575028,11577059,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2S)-2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-5-yl)oxy]-N-(2-hydroxyethyl)-N-methylpropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
254433594,0.079,636385,136943433,56950116,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]-2-phenoxyacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354665169,0.079,1289550,312468158,57335384,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR deletion mutant autophosphorylation in human PC9 cells after 2 hrs by sandwich ELISA,Rociletinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
389666481,0.079,1806610,471698517,155235887,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 9",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666850,0.079,1806610,471698531,155243066,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440225,0.0793,1920053,486503523,167318592,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 51",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440029,0.0796,1920052,486503814,167318654,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 347",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439971,0.0798,1920052,486503757,167318669,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 288",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514796,0.08,364803,103587939,25063262,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"N-(4-Benzyloxy-3-chloro-phenyl)-5-[5-(2-morpholin-4-yl-ethyl)-[1,3,4]oxadiazol-2-yl]-pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539078,0.08,410944,103202250,156414,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778086,0.08,314962,103561937,16116962,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,"(S)-N,N-dimethyl-2-(4-(1-(pyridin-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
103124277,0.08,418567,103593129,11284937,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000629,0.08,1798897,58097677,11284937,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391773,0.08,1804579,104065403,11562562,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"2-Fluoro-8-[(6-Iodo-1,3-Benzodioxol-5-Yl)methyl]-9-[3-(Isopropylamino)propyl]-9h-Purin-6-Amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101613781,0.081,383075,103441767,9915743,2064,18077425,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of human Her2 in A431 cells,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,37,"","",""
101694010,0.081,295195,103531664,10115240,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-(piperazin-1-ylmethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821811,0.081,248914,103441701,11238694,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-[3-chloro-4-[(2,4-difluorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204403334,0.081,580189,124972951,53325049,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)-2-methyl-N-(2-morpholinoethyl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440273,0.0812,1920053,486503569,166927752,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 109",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440274,0.0812,1920053,486503569,166927752,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 109",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439864,0.0815,1920052,486503651,166927913,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 181",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440056,0.0816,1920052,486503840,167318556,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 373",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439930,0.0817,1920052,486503717,162428890,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 247",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440543,0.0818,1920053,486503832,167318595,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 365",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574015,0.082,320574,103574115,44455195,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-methoxypiperidin-1-yl)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796307,0.082,1426965,381851637,71616702,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[4-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxybutoxy]-N-(3-bromophenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615865,0.082,1919643,483622378,146448684,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 5",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439951,0.082,1920052,486503738,169552763,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 268",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440068,0.0821,1920052,486503852,167318815,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 386",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440556,0.0821,1920053,486503845,167318765,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 379",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101504957,0.083,361656,103643991,24897277,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,"N-[1-(3-Fluoro-benzyl)-1H-indazol-5-yl]-5-[morpholin-4-yliminomethyl]-pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101821641,0.083,248914,103441741,11284905,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-(naphthalen-1-ylmethylamino)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821807,0.083,248914,103441856,11203663,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(thiazol-2-ylsulfanyl)-phenylamino]-3-cyano-7-methoxy-quinolin-6-yl}-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389667847,0.083,1806610,471698533,155242948,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-[3-[7-Methoxy-4-[4-(trifluoromethyl)anilino]quinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699905,0.0838,1796911,384577255,118900245,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'",Synthesis of (E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-isopropoxyethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366323032,0.08384,1535505,440127358,118900245,2064,30600209,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,Synthesis of (E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-isopropoxyethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439968,0.0839,1920052,486503754,167318657,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 285",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440247,0.0839,1920053,486503544,167318560,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 72",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440461,0.0839,1920053,486503752,167318596,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 282",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440528,0.0839,1920053,486503817,162428983,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 350",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440633,0.0839,1920053,486503922,167318772,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 457",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503829,0.084,361654,103643926,24897045,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,"4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-(methylhydrazinylidene)methyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539063,0.084,410944,103593129,11284937,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571797,0.084,344457,103593129,11284937,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112713,0.084,1676531,461557118,145945998,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[3-ethyl-6-[4-(4-methylpiperazin-1-yl)phenyl]-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388996868,0.084,1798900,58097677,11284937,2064,19028424,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2008.11.023: 'Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.'","(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389058636,0.08405,1800296,194690242,11721216,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,ELISA-Based Kinase Assay from US Patent US8623883: '4-phenylamino-quinazolin-6-yl-amides',(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440459,0.0842,1920053,486503751,167318734,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 281",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440460,0.0842,1920053,486503751,167318734,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 281",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440402,0.0849,1920053,486503694,167318645,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 224",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359452,0.085,69714,103303243,5328959,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10f,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748790,0.085,308241,103551055,135497854,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"4-(3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)isoquinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124279,0.085,418567,103593399,25263261,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"Alkynyl thienopyrimidine, 15q",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340070344,0.085,770082,174524325,73294506,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,(E)-N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
388817756,0.085,1795646,8034236,5328959,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10f,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000804,0.085,1798897,58097693,25263261,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"Alkynyl thienopyrimidine, 15q",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665540,0.085,1806610,471698509,155235870,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"1-(4-((4-((2,4-Dichlorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439705,0.0856,1920052,486503498,166927906,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 26",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440187,0.0859,1920053,486503486,162429004,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 14",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389058637,0.08598,1800296,194690245,11496734,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,ELISA-Based Kinase Assay from US Patent US8623883: '4-phenylamino-quinazolin-6-yl-amides',(E)-4-(azepan-1-yl)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564640,0.086,367174,103610111,44571432,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-3-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747190,0.086,474114,103749170,46886320,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"2,6-difluoro-N-(3-(5-(2-(3-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747200,0.086,474114,103749164,46886314,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"2,6-difluoro-N-(3-(5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356946,0.086,517320,123094542,52946470,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"trans-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-3-chlorophenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435419,0.086,638068,136941421,57401286,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[(E)-2-[4-[(cyclopropylamino)methyl]phenyl]ethenyl]-6-methylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103028,0.086,1796166,381752966,132143184,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440439,0.0861,1920053,486503731,162429052,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 261",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
40273494,0.087,1433,50100094,156414,2064,"",Other,20170124,0,0,Active,NP_001005862,"","",Ambit Biosciences,Kinase Inhibitor Selectivity Profiling Assay,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571805,0.087,344457,103628530,44581017,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"N-((3R,5S)-5-((4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidin-3-yl)ethanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124276,0.087,418567,103593323,25263253,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-[2-(4-{[(3-phenoxyphenyl)methyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001744,0.087,435796,103202250,156414,2064,18183025,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000808,0.087,1798897,58097685,25263253,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-[2-(4-{[(3-phenoxyphenyl)methyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143900,0.0876,1798142,464922094,155164982,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(7R)-7-(dimethylamino)-5-azaspiro[2.4]heptan-5-yl]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439976,0.0877,1920052,486503762,167318630,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 293",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571802,0.088,344457,103628278,44580915,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(R)-N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-((1-(methylsulfonyl)pyrrolidin-2-yl)ethynyl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694381,0.088,295195,103531637,44430019,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101741769,0.088,306289,103531637,44430019,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380622131,0.088,1871766,482075163,168289495,2064,34839996,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin),"(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-3,3a,4,5,6,7-hexahydropyrazolo[1,5-a]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440494,0.088,1920053,486503785,169552770,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 318",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440490,0.0881,1920053,486503781,167318547,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 314",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439941,0.0883,1920052,486503728,167318625,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 258",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440650,0.0886,1920053,486503939,167318716,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 475",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440296,0.0887,1920053,486503590,166927925,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 118",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440379,0.0888,1920053,486503671,167318833,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 201",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440535,0.0889,1920053,486503824,167318760,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 357",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701304,0.089,215071,103407771,44372005,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and erbB2 overexpressing tumor cell proliferation,"4-[4-[(1-benzylindazol-5-yl)amino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748794,0.089,308241,103551062,135497855,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"N-ethyl-N-((2-(5-(isoquinolin-4-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-1H-benzo[d]imidazol-4-yl)methyl)ethanamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821643,0.089,248914,103441740,11342405,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,N-[4-(4-Benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-2-morpholin-4-ylmethyl-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040381,0.089,760335,174497362,11271821,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,"2-[4-[4-(3-chloro-2,4-difluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655802,0.089,1315979,374296438,134139702,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-(3-chloro-4-fluoroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
389666465,0.089,1806610,471698517,155235887,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 9",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440565,0.0894,1920053,486503854,167318903,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 388",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440636,0.0897,1920053,486503925,167318852,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 460",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701745,0.09,144357,103407771,44372005,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing N87 (Gastric) tumor cell proliferation,"4-[4-[(1-benzylindazol-5-yl)amino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571796,0.09,344457,103628365,44580951,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(3R,5S)-5-((4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidin-3-yl propionate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742021,0.09,306289,103549498,10194801,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-(2-aminoethoxymethyl)-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778083,0.09,314962,103561936,16116961,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,"(R)-N,N-dimethyl-2-(4-(1-(pyridin-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101856320,0.09,259431,103477184,11512802,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,"9-{2-[(2,2-dimethylpropyl)amino]ethyl}-8-[(2-iodo-5-methoxyphenyl)sulfanyl]-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912894,0.09,270616,103498978,9851149,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-methoxyphenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354665414,0.09,1289551,336878369,71535003,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR deletion mutant autophosphorylation in human HCC827 cells after 2 hrs by sandwich ELISA,"1-((3R,4R)-3-(((5-chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)methyl)-4-methoxypyrrolidin-1-yl)prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398252,0.09,1574931,440217712,155564756,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[7-[(1-benzyltriazol-4-yl)methoxy]-4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
389391777,0.09,1804579,104065410,11627094,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"2-Fluoro-8-(6-iodo-benzo[1,3]dioxol-5-ylmethyl)-9-(pent-4-ynyl)adenine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880666,0.091,263981,103486300,44410560,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(2-aminophenyl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340039505,0.091,760336,174487252,11398239,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 kinase domain expressed in baculovirus/Sf21 system by ELISA,2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-(2-methoxyethyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363691138,0.091,1407103,103177459,176870,2064,30096580,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human GST-tagged HER2 (676-end) expressed in baculovirus infected Sf9 insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104027,0.091,1796169,381752951,132143272,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402178305,0.091,1801898,317227923,71014204,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,Time-Resolved Fret (TR-FRET) Assay from US Patent US9187459: 'Quinazoline-7-ether compounds and methods of use',(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(3-oxabicyclo[3.1.0]hexan-1-ylmethoxy)quinazolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440221,0.091,1920053,486503519,166927738,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 47",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440623,0.091,1920053,486503912,167318587,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 447",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439906,0.0916,1920052,486503693,162429087,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 223",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101638420,0.092,277510,103505684,16108943,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-((R)-3-phenylpyrrolidine-1-carbonyl)-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
106023760,0.092,447375,103505684,16108943,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(6S,7S)-N-hydroxy-6-((R)-3-phenylpyrrolidine-1-carbonyl)-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402232547,0.092,1803904,433917012,130276351,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,"HER2-Phosphorylating Activity from US Patent US10329300: 'Pyrazolo[3,4-d]pyrimidine compound or salt thereof'","US10329300, Example 69",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439973,0.0925,1920052,486503759,167318846,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 290",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439909,0.0927,1920052,486503696,162428777,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 226",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440534,0.0928,1920053,486503823,167318778,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 356",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439935,0.0929,1920052,486503722,167318820,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 252",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366428838,0.093,1589888,440159925,135236905,2064,31023512,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of probe binding to HER2 (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,"US10246444, Example 105",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439936,0.093,1920052,486503723,167318810,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 253",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440266,0.0931,1920053,486503562,167318773,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 90",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440598,0.0932,1920053,486503887,166927669,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 422",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440295,0.0933,1920053,486503589,167318660,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 117",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440446,0.0937,1920053,486503738,169552763,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 268",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440040,0.0938,1920052,486503824,167318760,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 357",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675477,0.094,290549,103523356,44426260,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"N-(3-(4-(4-(1-(3,3-dimethylbutanoyl)piperidin-4-yloxy)-3-methylphenylamino)quinazolin-6-yl)prop-2-ynyl)-2-methoxyacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
103124859,0.094,418922,103593182,25218692,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ErbB2 phosphorylation in IGF1 and EGF-stimulated human N87 cells pretreated for 6 hrs before IGF1 and EGF stimulation by ELISA,"3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1-{4-[4-(3-methoxypropyl)piperazin-1-yl]cyclohexyl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
390615860,0.094,1919643,483622395,146448630,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 39",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440209,0.0942,1920053,486503507,166927698,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 35",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440073,0.0943,1920052,486503857,167318652,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 391",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707254,0.095,68106,103177606,5329483,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,N-[4-(benzyloxy)phenyl]-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564653,0.095,367174,103610165,44571454,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)thiophen-2-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595849,0.095,331423,103563551,17747280,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-phenylmethoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402364,0.095,580189,124972952,53325050,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-methyl-5-(5-(pyrrolidin-1-yl)pent-1-ynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345669528,0.095,1170851,103177459,176870,2064,25383627,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of EGFR del746 to 750 mutant (unknown origin) by high-throughput biochemical screening,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112718,0.095,1676531,461555384,162671664,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-[4-(4-methylpiperazin-1-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837162,0.095,1795775,8035069,5329483,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',N-[4-(benzyloxy)phenyl]-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439956,0.095,1920052,486503743,162428917,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 273",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440272,0.0951,1920053,486503568,166927696,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 95",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439725,0.0952,1920052,486503518,162429085,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 46",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372339075,0.0955,1718898,103177479,208908,2064,33314925,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of substrate incubated for 30 mins by ADP-Glo assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101676424,0.096,290549,103523373,11305772,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"1-(4-(4-(6-Methoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363684686,0.096,1424362,404712009,145990017,2064,28754471,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),N-[4-(3-bromoanilino)quinazolin-6-yl]-2-hydroxy-4-(trifluoromethyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380667930,0.096,1882631,404712009,145990017,2064,35311289,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),N-[4-(3-bromoanilino)quinazolin-6-yl]-2-hydroxy-4-(trifluoromethyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440292,0.0963,1920053,486503586,166927929,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 114",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440425,0.0969,1920053,486503717,162428890,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 247",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647233,0.097,79614,103203121,44279343,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,"N*4*-(1-Benzyl-1H-indazol-5-yl)-pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647234,0.097,79617,103203007,6603857,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 overexpressing HB4a.e5.2 cell proliferation,"N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356220,0.097,517320,123101236,52950017,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"N-[4-[4-amino-1-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-1,3-benzoxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112806,0.097,1676531,103244983,123631,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345670962,0.0971,1171421,312371400,71514054,2064,25409491,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type HER2 (unknown origin) incubated for 5 mins by HTRF assay,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145863,0.0973,1798142,459092873,139369414,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[[4-(2-hydroxypropan-2-yl)-6-methylpyridin-3-yl]amino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440184,0.0974,1920053,486503483,162428840,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 11",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439821,0.0977,1920052,486503609,162428914,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 137",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571800,0.098,344457,103628363,44580949,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(((2S,4R)-4-ethoxypyrrolidin-2-yl)ethynyl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439969,0.0981,1920052,486503755,167318650,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 286",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440195,0.0984,1920053,486503493,167318893,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 21",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453096,0.099,375732,103635283,11751106,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S,5RS)-N-hydroxy-5-(2-oxo-2-(pyrrolidin-1-yl)ethyl)-2-(4-phenylpiperazine-1-carbonyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
198356296,0.099,517320,123089476,52943781,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"N-[4-[4-amino-1-[1-(1-methylpiperidin-4-yl)piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-1,3-benzoxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439833,0.099,1920052,486503621,166927712,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 149",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439921,0.0993,1920052,486503708,167318876,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 238",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100667845,0.1,81581,103262822,5329243,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26o",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
100667847,0.1,81581,103263072,5329236,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26h",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
100667849,0.1,81581,103263014,5329251,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28c",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
100667850,0.1,81581,103263015,5329250,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28b",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
101453086,0.1,375732,103635285,11317404,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S,5RS)-N-hydroxy-5-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-2-(4-phenylpiperazine-1-carbonyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101453095,0.1,375732,103635217,44583623,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(5S,6S)-N-hydroxy-6-(4-phenylpiperazine-1-carbonyl)spiro[2.5]octane-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101514789,0.1,364803,103587747,25242463,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,Methyl 4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)pyrimidine-5-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675491,0.1,290549,103523371,11397750,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"1-(4-(4-(6,7-Dimethoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101856323,0.1,259431,103477108,11504234,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,8-(2-Iodo-5-methoxy-phenylsulfanyl)-9-(2-isobutylamino-ethyl)-9H-purin-6-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912907,0.1,270616,103498885,9873631,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-bromobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257327,0.1,454329,103717515,46225612,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,N-(4-(benzo[d]thiazol-2-yl)phenyl)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155745953,0.1,474117,103177479,208908,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 intracellular phosphorylation in human N87 cells by ELISA,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
334072987,0.1,739689,164130186,59484612,2064,23490150,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminal DYKDDDD-tagged HER2 cytoplasmic domain (676 to 1255) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,"methyl 4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-8,9-dihydro-7H-pyrimido[4,5-b]azepine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355631306,0.1,1305356,336902536,127049307,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,"N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]imidazo[4,5-c]pyridin-3-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355656034,0.1,1315979,374293111,134138812,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[[1-(benzenesulfonyl)indol-5-yl]amino]-7-ethoxyquinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355656239,0.1,1315979,374343472,134152887,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-4-(dimethylamino)-N-[4-(4-phenoxyanilino)pyrido[3,4-d]pyrimidin-6-yl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355733374,0.1,1341597,374276620,24945448,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]-N'-hydroxyoctanediamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733375,0.1,1341597,374337002,24900962,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-8-[[1-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methyl]piperidin-4-yl]amino]octanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733376,0.1,1341597,103729779,45140153,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-(4-(Benzylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733377,0.1,1341597,374301261,59756739,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-6-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]anilino]hexanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733378,0.1,1341597,374321715,24900377,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-3-[4-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methyl]piperazin-1-yl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733379,0.1,1341597,374313569,24900575,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N'-hydroxy-N-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]octanediamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733380,0.1,1341597,374356351,24900578,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-[2-[[3-(hydroxyamino)-3-oxopropyl]amino]ethyl]-4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733381,0.1,1341597,374331105,24900643,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-6-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methylamino]hexanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733382,0.1,1341597,374350526,24900966,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-7-[2-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenoxy]ethylamino]heptanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733383,0.1,1341597,103729847,24944855,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-(4-(3-Ethynylphenylamino)-6-methoxyquinazolin-7-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733384,0.1,1341597,374312793,24900509,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-7-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenoxy]heptanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733585,0.1,1341597,374328217,24900642,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-[2-[[7-(hydroxyamino)-7-oxoheptyl]amino]ethyl]-4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733586,0.1,1341597,374341362,24900506,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-4-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenoxy]butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733587,0.1,1341597,374276439,24900644,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-8-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methylamino]octanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733588,0.1,1341597,374325354,24900376,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-2-[4-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methyl]piperazin-1-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733589,0.1,1341597,374280341,24900641,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-[2-[[6-(hydroxyamino)-6-oxohexyl]amino]ethyl]-4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733590,0.1,1341597,374280859,24900508,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-6-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenoxy]hexanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733591,0.1,1341597,374331513,25226957,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-[4-(1-benzofuran-5-ylamino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733592,0.1,1341597,374345985,24900441,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-5-[4-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methyl]piperazin-1-yl]pentanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733594,0.1,1341597,103729564,24945689,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733595,0.1,1341597,103729623,24945115,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-(4-(3-Chloro-4-fluorophenylamino)quinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733596,0.1,1341597,103729846,24944856,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-(4-(3-chloro-4-fluorophenylamino)-6-methoxyquinazolin-7-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733728,0.1,1341597,374274854,24944939,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-[4-(3-chloro-4-fluoroanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxy-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733729,0.1,1341597,374305790,24900963,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-[2-[[7-(hydroxyamino)-7-oxoheptyl]amino]ethyl]-4-[7-methyl-4-[[(1R)-1-phenylethyl]amino]pyrrolo[2,3-d]pyrimidin-6-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733730,0.1,1341597,103729562,24756910,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,Cudc-101,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733732,0.1,1341597,374358841,24945765,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,8-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methylamino]-N-hydroxyoctanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733733,0.1,1341597,103729782,45140349,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,(R)-N-Hydroxy-7-(7-methoxy-4-(1-phenylethylamino)quinazolin-6-yloxy)heptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733734,0.1,1341597,374351850,24900511,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N'-hydroxy-N-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]butanediamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733735,0.1,1341597,374356019,24901025,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-7-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]anilino]heptanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733736,0.1,1341597,374297476,24900574,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N'-hydroxy-N-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]pentanediamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733737,0.1,1341597,374308281,24900715,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733738,0.1,1341597,374290944,59756717,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-4-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]anilino]methyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733739,0.1,1341597,374352497,57721258,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,6-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-N-hydroxyhexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733852,0.1,1341597,103729685,24945368,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,N1-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-N8-hydroxyoctanediamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733853,0.1,1341597,374323423,59803642,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"3-[[2-(hydroxyamino)-2-oxoethyl]amino]-N-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733854,0.1,1341597,374339920,135948797,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-[4-(3-ethynylanilino)-7-hydroxyquinazolin-6-yl]oxy-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733855,0.1,1341597,374353140,134155646,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,8-[4-(3-ethynyl-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyoctanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733856,0.1,1341597,103729624,24945204,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-(4-(3-Chloro-4-fluorophenylamino)-7-(2-methoxyethoxy)quinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733857,0.1,1341597,374269986,134132544,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,8-[4-(3-ethynyl-4-fluoroanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]oxy-N-hydroxyoctanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733858,0.1,1341597,374274330,24944940,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxy-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733859,0.1,1341597,374276971,24900444,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-2-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenoxy]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733860,0.1,1341597,374306468,24900443,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-7-[4-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methyl]piperazin-1-yl]heptanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733861,0.1,1341597,374334261,59756709,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-4-[[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methylamino]methyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733862,0.1,1341597,374357761,24944763,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,5-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]sulfanyl-N-hydroxypentanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733863,0.1,1341597,374359968,24900771,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"4-[4-(benzylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-N-hydroxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733985,0.1,1341597,374271170,24901307,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-3-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methylamino]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733986,0.1,1341597,374343441,57721309,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-[4-(3-ethynyl-4-hydroxyanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733987,0.1,1341597,374276987,24900645,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-7-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methylamino]heptanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733988,0.1,1341597,374282008,24900378,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-4-[4-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methyl]piperazin-1-yl]butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733989,0.1,1341597,374310452,24900712,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"7-[4-[4-[[(1R)-1-(4-fluorophenyl)ethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenoxy]-N-hydroxyheptanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733990,0.1,1341597,374330199,24900442,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-6-[4-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methyl]piperazin-1-yl]hexanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733991,0.1,1341597,103729448,24944935,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,6-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyhexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733992,0.1,1341597,103729449,24944930,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733993,0.1,1341597,374328723,24944607,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,6-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methylamino]-N-hydroxyhexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733994,0.1,1341597,103729686,45140150,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-(4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ylthio)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733995,0.1,1341597,374273837,24944931,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,2-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733996,0.1,1341597,374275795,24900507,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-5-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenoxy]pentanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734113,0.1,1341597,374289080,59756735,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"(E)-N-hydroxy-3-[4-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]anilino]methyl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734114,0.1,1341597,374300028,24900576,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N'-hydroxy-N-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]hexanediamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734115,0.1,1341597,374311928,24900965,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-8-[2-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenoxy]ethylamino]octanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734117,0.1,1341597,374290495,24945690,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-(2-methoxyethoxy)quinazolin-6-yl]oxy-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734118,0.1,1341597,374332427,24945688,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]oxy-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734119,0.1,1341597,374306847,24900714,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"6-[4-[[4-[4-(benzylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methyl]piperazin-1-yl]-N-hydroxyhexanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734120,0.1,1341597,374348010,57721315,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,<=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,N-[4-(3-chloro-4-fluoroanilino)-7-(2-methoxyethoxy)quinazolin-6-yl]-N'-hydroxyoctanediamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734122,0.1,1341597,374358704,24900772,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"4-[4-[[(1R)-1-(4-fluorophenyl)ethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-N-hydroxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739021,0.1,1342329,103610706,44571815,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-(2-(2-methoxy-4-(4-(pyrrolidin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739022,0.1,1342329,103610707,44571816,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"(R)-N-(2,6-difluorophenyl)-3-(3-(2-(4-(4-(3-fluoropyrrolidin-1-yl)piperidin-1-yl)-2-methoxyphenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739023,0.1,1342329,374267756,59452918,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[4-(2-fluoroethyl)-3-oxopiperazin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739024,0.1,1342329,374272167,59452632,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[1-[1-(2-methylsulfonylethyl)piperidin-4-yl]piperidin-4-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739025,0.1,1342329,374272336,59452856,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[1-[1-(2-fluoroethyl)piperidin-4-yl]piperidin-4-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739026,0.1,1342329,374282128,66649736,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[1-(2-methylsulfonylethyl)piperidin-4-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739113,0.1,1342329,374284269,59452736,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-[1-(2-methylsulfonylethyl)piperidin-4-yl]piperazin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739114,0.1,1342329,374298506,59452689,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-[2-[4-[4-[4-(2,2-difluoroethyl)piperazin-1-yl]piperidin-1-yl]-2-ethoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739121,0.1,1342329,374351886,59452760,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-[1-(2-methylsulfonylethyl)piperidin-4-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739222,0.1,1342329,374321791,59452903,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-(3,3-difluoropiperidin-1-yl)piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739224,0.1,1342329,374343649,59452644,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2,5-bis(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739226,0.1,1342329,374349326,59452909,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-3-methyl-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739356,0.1,1342329,374353388,59860249,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[7-fluoro-3-(2-{[4-{4-[4-(2-fluoroethyl)-1-piperazinyl]-1-piperidinyl}-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739357,0.1,1342329,374267648,59452922,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({2-(methyloxy)-4-[1-(2-methylpropyl)-4-piperidinyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739359,0.1,1342329,374281318,59452719,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[4-[4-(dimethylamino)-1-piperidinyl]-2-(methyl-oxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739363,0.1,1342329,374324970,59452950,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739364,0.1,1342329,374327946,59453008,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-[4-(trifluoromethyl)piperidin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739365,0.1,1342329,374345325,59452800,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({2-(methyloxy)-4-[4-(1-piperidinylmethyl)-1-piperidinyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739474,0.1,1342329,103610703,44571813,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739475,0.1,1342329,374272497,59452959,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739479,0.1,1342329,374340185,59452914,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methyloxy)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739482,0.1,1342329,374350245,59452955,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[(3S)-3-fluoropyrrolidin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739607,0.1,1342329,374352001,59452741,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[(3S)-3-hydroxypiperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739608,0.1,1342329,374358251,59452702,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-(4-piperidin-1-ylpiperidin-1-yl)-2-propan-2-yloxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739609,0.1,1342329,103610708,44571817,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-(2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739613,0.1,1342329,374275611,59452992,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-{3-[2-({4-(1,4'-bipiperidin-1'-yl)-2-[(2-methylpropyl)oxy]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739616,0.1,1342329,374292124,59452650,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-5-methyl-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739697,0.1,1342329,374303354,59452563,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-(2-{[5-chloro-4-{4-[4-(2-fluoroethyl)-1-piperazinyl]-1-piperidinyl}-2-(methyl-oxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739698,0.1,1342329,374305374,59452695,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-ethoxy-4-[4-[1-(2-methylsulfonylethyl)piperidin-4-yl]piperazin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739703,0.1,1342329,103610704,25123829,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739772,0.1,1342329,374268134,59452951,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[2-(ethyloxy)-4-(4-propyl-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739773,0.1,1342329,374275240,59452721,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-(2-methylpropyl)-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739777,0.1,1342329,374288826,59452624,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-[2-[5-chloro-2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739778,0.1,1342329,374289646,59452855,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-[2-[4-[4-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739780,0.1,1342329,374305470,59452687,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-(4-methylpiperidin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739859,0.1,1342329,374306599,59860250,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-Difluorophenyl)-3-[8-fluoro-3-[2-[[4-[4-[4-(2-fluoroethyl)-1-piperazinyl]-1-piperidinyl]-2-methoxyphenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739860,0.1,1342329,374311779,59452849,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-ethoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739861,0.1,1342329,374329477,59452766,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-(4-fluoropiperidin-1-yl)piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739862,0.1,1342329,374346032,59452597,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({2-(methyloxy)-4-[3-(1-piperidinyl)-propyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739863,0.1,1342329,374354061,59452745,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[3-[2-(dimethylamino)ethoxy]anilino]pyrimidin-4-yl]-7-methoxyimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739866,0.1,1342329,374360897,59452844,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-methoxypiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739950,0.1,1342329,374277578,59452996,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[4-(2-fluoroethyl)piperazin-1-yl]piperidin-1-yl]-2-methoxy-5-methylanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739953,0.1,1342329,374295233,59452746,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(2-(ethyloxy)-4-{4-[1-(2-fluoroethyl)-4-piperidinyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739954,0.1,1342329,374299295,59452730,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)-7-fluoroimidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739957,0.1,1342329,374333339,59452729,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-propan-2-ylpiperazin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739959,0.1,1342329,374352357,59452645,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-[2-[4-[4-[bis(2-methoxyethyl)amino]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740063,0.1,1342329,374271730,59452732,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-[4-(2-methylsulfonylethyl)piperazin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]-8-methylimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740064,0.1,1342329,374273525,59452857,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-[2-[5-chloro-2-methoxy-4-[4-[4-(2-methylsulfonylethyl)piperazin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740065,0.1,1342329,374281579,59452832,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-[2-[4-[4-(azepan-1-yl)piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740066,0.1,1342329,374283337,59452975,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-3-(3-{2-[(5-methyl-2-(methyloxy)-4-{1-[2-(methylsulfonyl)ethyl]-4-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740067,0.1,1342329,374284387,59452965,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-ethyl-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740068,0.1,1342329,374299102,59452690,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-(4-methyl-1,4-diazepan-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740070,0.1,1342329,374310559,59452564,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methyl-3-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740128,0.1,1342329,374327012,59452572,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-[4-(2-methylsulfonylethyl)piperidin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740132,0.1,1342329,374352175,59452703,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[(3R)-3-hydroxypiperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740133,0.1,1342329,374357539,59452836,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-ethoxy-4-[4-[4-(2-methylsulfonylethyl)piperazin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740194,0.1,1342329,374297277,59452628,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-(2-methylsulfonylethyl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740195,0.1,1342329,374300871,59452875,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-3-[3-(2-{[2-(methyloxy)-4-(1-propyl-4-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740198,0.1,1342329,374328697,25124474,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[4-(2-fluoroethyl)piperazin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740203,0.1,1342329,374357560,59452880,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({2-(methyloxy)-4-[2-(4-methyl-1-piperazinyl)ethyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740252,0.1,1342329,103610709,44571818,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-(2-(4-(4-((2R,6S)-2,6-dimethylmorpholino)piperidin-1-yl)-2-methoxyphenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740255,0.1,1342329,374296051,59452830,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(7-fluoro-3-{2-[(2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740299,0.1,1342329,374338432,59452559,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-3-[3-(2-{[2-(methyloxy)-4-(cis-4-{4-[2-(methylsulfonyl)-ethyl]-1-piperazinyl}cyclohexyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740300,0.1,1342329,374348575,59452559,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-3-[3-(2-{[2-(methyloxy)-4-(cis-4-{4-[2-(methylsulfonyl)-ethyl]-1-piperazinyl}cyclohexyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740301,0.1,1342329,374273011,59452693,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[2-(methyloxy)-4-(4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}-1-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740302,0.1,1342329,374284157,66649729,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-ethoxy-4-[1-(2-methylsulfonylethyl)piperidin-4-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740303,0.1,1342329,374305702,59452674,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({2-(methyloxy)-4-[3-(4-methyl-1-piperazinyl)propyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740304,0.1,1342329,374307757,59452877,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[5-methyl-2-(methyloxy)-4-(1-propyl-4-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740306,0.1,1342329,374318404,59452805,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[3-[2-(dimethylamino)ethoxy]anilino]pyrimidin-4-yl]-7-methylimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740307,0.1,1342329,374336001,59452691,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-[2-[4-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740308,0.1,1342329,374336654,59452879,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[1-(2-fluoroethyl)piperidin-4-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740357,0.1,1342329,374355472,59452594,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[1-(2-methylsulfonylethyl)piperidin-4-yl]-2-propylanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740358,0.1,1342329,374360018,59452677,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[(3S)-3-hydroxypiperidin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740361,0.1,1342329,374279833,59452683,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2-(propyloxy)phenyl]amino}-4-pyrimidinyl)-imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740362,0.1,1342329,374306850,59452926,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[4-(2-fluoroethyl)piperazin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]-8-methylimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740363,0.1,1342329,374315910,59452774,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-5-methyl-4-[4-[4-(2-methylsulfonylethyl)piperazin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740365,0.1,1342329,374267841,59452622,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]-8-methylimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740366,0.1,1342329,374285203,59452566,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-(4-piperidin-1-ylpiperidin-1-yl)-2-propylanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740404,0.1,1342329,374289282,59452900,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,4-difluorophenyl)-3-[3-[2-[3-[2-(dimethylamino)ethoxy]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740412,0.1,1342329,374351903,59452639,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740413,0.1,1342329,374352018,59452701,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,3-difluorophenyl)-3-[3-[2-[3-[2-(dimethylamino)ethoxy]anilino]pyrimidin-4-yl]-7-methoxyimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740450,0.1,1342329,374352322,59452977,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[5-(pyrrolidin-1-ylmethyl)-1,3,4-oxadiazol-2-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740451,0.1,1342329,374359323,59452617,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(5-chloro-2-fluorophenyl)-3-(3-{2-[(3-{[2-(dimethylamino)ethyl]oxy}phenyl)-amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740452,0.1,1342329,374359743,59452881,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[7-methoxy-3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740455,0.1,1342329,374311165,59452740,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[4-(2-fluoroethyl)piperazin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]-7-methoxyimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740457,0.1,1342329,374327242,59452611,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[4-{4-[4-(2-fluoroethyl)-1-piperazinyl]-1-piperidinyl}-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)-7-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740458,0.1,1342329,374331905,59452901,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-{3-[2-({5-fluoro-2-(methyloxy)-4-[2-(1-piperidinyl)ethyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}-N-(2,4,6-trifluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740484,0.1,1342329,374349405,59452949,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]-7-methylimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740485,0.1,1342329,374361121,59452822,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({2-(ethyloxy)-4-[4-(1-methylethyl)-1-piperazinyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740486,0.1,1342329,103610711,25124150,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-(2-(2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740491,0.1,1342329,374291523,59452825,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[2-methyl-4-(4-piperidinyloxy)phenyl]-amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740493,0.1,1342329,374300072,87090176,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-3-[3-(2-{[4-{4-[(1s,4s)-5-(2-fluoroethyl)-2,5-diazabicyclo-[2.2.1]hept-2-yl]-1-piperidinyl}-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740531,0.1,1342329,374306038,59452861,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-(4-ethylpiperazin-1-yl)piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740533,0.1,1342329,374316502,59452767,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)-8-fluoroimidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740535,0.1,1342329,374334209,59453010,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[2-(methyloxy)-4-(4-morpholinyl)phenyl]-amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740537,0.1,1342329,374347861,59452834,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(3-{[2-(dimethylamino)ethyl]oxy}-2-methylphenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740539,0.1,1342329,374354972,59452708,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,4-difluorophenyl)-3-[3-[2-[3-[2-(dimethylamino)ethoxy]anilino]pyrimidin-4-yl]-7-methoxyimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740576,0.1,1342329,374272699,59860284,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[8-fluoro-3-(2-{[2-(methyloxy)-4-(4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}-1-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740579,0.1,1342329,374297167,59452939,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-thiomorpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740582,0.1,1342329,374338438,59452809,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[4-(2-methylsulfonylethyl)piperazin-1-yl]piperidin-1-yl]-2-(2,2,2-trifluoroethoxy)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740583,0.1,1342329,103610705,44571814,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-(2-(2-methoxy-4-(4-morpholinopiperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740585,0.1,1342329,374277827,59452625,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]-8-methylimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740623,0.1,1342329,374293128,25124151,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methylsulfonyl)-ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740625,0.1,1342329,374319754,59452923,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-[(4-methylpiperazin-1-yl)methyl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740626,0.1,1342329,374320863,59452937,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-ethoxy-4-[4-[4-(2-fluoroethyl)piperazin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740627,0.1,1342329,374322035,59452567,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-(4-hydroxypiperidin-1-yl)piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740630,0.1,1342329,374347453,59452681,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[2-(methyloxy)-4-(4-propyl-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740631,0.1,1342329,103610700,44571810,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-(2-(3-(2-(dimethylamino)ethoxy)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740671,0.1,1342329,374294921,59452904,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({2-methyl-4-[(1-methyl-4-piperidinyl)oxy]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740673,0.1,1342329,374295241,59452796,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-ethoxy-4-[4-[4-(3,3,3-trifluoropropyl)piperazin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740675,0.1,1342329,374331490,59452776,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[4-[1-(2-fluoroethyl)piperidin-4-yl]piperazin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740676,0.1,1342329,374334246,59452752,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[2-(ethyloxy)-4-(1-propyl-4-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740678,0.1,1342329,374341133,59452676,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[3-(1-methyl-1H-pyrazol-4-yl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740728,0.1,1342329,374361303,59452694,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-[2-[[3-[2-(Dimethylamino)ethoxy]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-N-(2,4,6-trifluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740729,0.1,1342329,103610712,44571820,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740731,0.1,1342329,374272329,59860246,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(8-fluoro-3-{2-[(2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740732,0.1,1342329,374277170,59452598,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({5-fluoro-2-(methyloxy)-4-[2-(1-piperidinyl)ethyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740735,0.1,1342329,374288659,59452840,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(2-(ethyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740736,0.1,1342329,374289829,59452735,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[4-{4-[4-(2-fluoroethyl)-1-piperazinyl]-1-piperidinyl}-2,5-bis(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740775,0.1,1342329,374300884,59452662,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2-methylphenyl]amino}-4-pyrimidinyl)-imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740779,0.1,1342329,103610710,44571819,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-(3-(2-(4-(4-(4-acetylpiperazin-1-yl)piperidin-1-yl)-2-methoxyphenylamino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-N-(2,6-difluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740782,0.1,1342329,374276645,59452716,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[5-fluoro-2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355741952,0.1,1342329,374318245,59452863,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(2-(ethyloxy)-5-methyl-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355741953,0.1,1342329,374324964,59452885,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-[5-[(dimethylamino)methyl]-1,3,4-oxadiazol-2-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355741954,0.1,1342329,374333936,59860270,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[2-ethoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363627148,0.1,1395846,404703251,145984188,2064,29605809,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human MCF-7 cells,"[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[5-[(8R,9S,13S,14S,16R,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]pent-2-ynylamino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363627149,0.1,1395846,404704478,145985073,2064,29605809,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human MCF-7 cells,"[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[(E)-6-[(8R,9S,13S,14S,16R,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]hex-2-enyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366448412,0.1,1599425,440151011,9811391,2064,31129450,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[(E)-4-[(8R,9S,13S,14S,16R,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]but-2-enyl]amino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867965,0.1,1795986,381620328,137529657,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[(1R,2R,6S,8R)-2-[2-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]benzoyl]-methylamino]ethyl]-9,9-dimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391776,0.1,1804579,104065404,9549213,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"9H-Purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665547,0.1,1806610,471698516,155235877,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"6-((1-Acryloylpiperidin-4-yl)oxy)-4-((3,4-dichlorophenyl)amino)-7-methoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666679,0.1,1806610,471698529,155243065,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389707957,0.1,1919094,475952616,60199101,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,Kinase Assay for ErbB2 from US Patent US11524956: 'Alkyne substituted quinazoline compound and methods of use',"US11524956, Example 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389707958,0.1,1919094,475952620,60199117,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,Kinase Assay for ErbB2 from US Patent US11524956: 'Alkyne substituted quinazoline compound and methods of use',"US11524956, Example 5",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389708069,0.1,1919094,475952621,60199118,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,Kinase Assay for ErbB2 from US Patent US11524956: 'Alkyne substituted quinazoline compound and methods of use',"US11524956, Example 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389708070,0.1,1919094,475952619,60172363,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,Kinase Assay for ErbB2 from US Patent US11524956: 'Alkyne substituted quinazoline compound and methods of use',"rel-(E)-N-(7-(((1R,5S,6s)-3-oxabicyclo[3.1.0]hexan-6-yl)ethynyl)-4-((3-chloro-4-fluorophenyl)amino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389708071,0.1,1919094,475952595,166611548,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,Kinase Assay for ErbB2 from US Patent US11524956: 'Alkyne substituted quinazoline compound and methods of use',"US11524956, Example 1",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389708072,0.1,1919094,475952618,60199102,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,Kinase Assay for ErbB2 from US Patent US11524956: 'Alkyne substituted quinazoline compound and methods of use',"US11524956, Example 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389708073,0.1,1919094,475952622,90117097,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,<,BindingDB,Kinase Assay for ErbB2 from US Patent US11524956: 'Alkyne substituted quinazoline compound and methods of use',"US11524956, Example 7",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439712,0.1,1920052,486503505,167318628,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 33",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439731,0.1,1920052,486503524,166927741,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 52",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440401,0.101,1920053,486503693,162429087,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 223",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440493,0.101,1920053,486503784,167318757,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 317",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453099,0.102,375732,103635215,44583621,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(2S,3S,5RS)-N-hydroxy-1-methyl-5-(2-oxo-2-(piperidin-1-yl)ethyl)-2-(4-phenylpiperazine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
204402353,0.102,580189,124967717,53322414,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,3-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)-1-(4-ethylpiperazin-1-yl)-2-fluoroprop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655813,0.102,1315979,374272883,134133313,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-(4-phenoxyanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440328,0.102,1920053,486503621,166927712,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 149",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440589,0.102,1920053,486503878,167318680,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 413",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821405,0.103,248914,103441747,11489786,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(4-benzylamino-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432835,0.103,1919984,486499647,168257492,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439723,0.103,1920052,486503516,162428770,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 44",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440594,0.103,1920053,486503883,167318614,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 418",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018078,0.103,1920044,486503195,169552728,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407927805,0.103,1928767,494401197,171346428,2064,33226807,Confirmatory,20240503,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to HER2 in human BT474 cells assessed as dissociation constant by measuring low affinity ligand binding site by LigandTracer technique,"(3S)-4-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-[[(2S)-5-amino-2-[[2-[2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821802,0.104,248914,103441805,11422340,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-4-[bis(2-hydroxypropyl)amino]-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366531271,0.104,1633241,440211385,155562216,2064,30826508,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 in human A549 cells by ELISA method,[2-Oxo-2-[3-(pyridine-2-carbonylamino)anilino]ethyl] piperidine-1-carbodithioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,23,"","",""
367495712,0.104,1664189,123092436,44259,2064,32631510,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367495998,0.104,1664189,442057624,135236611,2064,32631510,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,"US10246444, Example 90",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439709,0.104,1920052,486503502,166927840,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 30",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439917,0.104,1920052,486503704,167318622,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 234",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440383,0.104,1920053,486503675,166927890,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 205",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440450,0.104,1920053,486503742,162428815,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 272",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440619,0.104,1920053,486503908,167318538,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 443",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615735,0.105,1919643,483622377,146510145,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 4",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439975,0.105,1920052,486503761,167318807,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 292",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440504,0.105,1920053,486503795,167318564,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 328",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439750,0.106,1920052,486503542,166927663,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 70",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440122,0.106,1920052,486503906,167318756,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 441",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574022,0.107,320574,103574356,11627337,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"1-[2-[[4-[4-[(3-fluorophenyl)methoxy]-3-methylanilino]-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy]ethyl]piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040373,0.107,760335,103499581,10411907,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,6-{[1-(Carbamoylmethyl)piperidin-4-yl]oxy}-4-(3-chloro-2-fluoroanilino)-7-methoxyquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440238,0.107,1920053,486503535,167318641,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 61",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440417,0.107,1920053,486503709,167318844,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 239",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440422,0.107,1920053,486503714,167318913,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 244",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356216,0.108,517320,123099174,52947602,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-(3-methoxypropyl)piperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355647031,0.108,1312565,336896928,127045266,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic GST-tagged human recombinant EGFR L858R mutant expressed in baculovirus system by z-lyte assay,6-(1-methylpyrazol-4-yl)-N-quinolin-6-ylquinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366314272,0.108,1531683,123092436,44259,2064,30384048,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ERBB2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380552464,0.108,1855770,482080784,165412706,2064,35964425,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human HER2 incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,Egfr/her2/dhfr-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440382,0.108,1920053,486503674,167318743,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 204",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439972,0.109,1920052,486503758,167318708,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 289",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440365,0.109,1920053,486503657,167318809,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 187",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99538267,0.11,40021,103407769,44372004,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing BT474 (Breast) tumor cell proliferation,"4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100368775,0.11,69712,103376203,5329085,2064,11462982,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells,6-Substituted 4-Anilinoquinazoline 24,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701308,0.11,215071,103407769,44372004,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and erbB2 overexpressing tumor cell proliferation,"4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571806,0.11,344457,103628201,44580892,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(R)-N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-((1-(2-methoxyethyl)pyrrolidin-2-yl)ethynyl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675457,0.11,290550,103523365,44426269,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694372,0.11,295195,103531642,22390536,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"2-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl-methylamino]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694376,0.11,295195,103531654,22390522,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"1-{4-[1-(3-fluoro-benzyl)-1H-indazol-5-ylamino]-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl}-piperidine-4-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101741771,0.11,306289,103549484,44440815,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-(1-benzylindazol-5-yl)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742018,0.11,306289,103549490,22390542,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"(4-[1-(3-Fluoro-benzyl)-1H-indazol-5-ylamino]-pyrrolo[2,1-f][1,2,4]triazin-5-yl}-methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742032,0.11,306289,103549497,44440826,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"2-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methoxy]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751509,0.11,308828,103549778,22390530,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"[5-(4-Dimethylamino-piperidin-1-ylmethyl)-pyrrolo[2,1-f][1,2,4]triazin-4-yl]-[1-(3-fluoro-benzyl)-1H-indazol-5-yl]-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101829715,0.11,254975,103468324,23646544,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"4-[(1-Benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254420203,0.11,632227,136931748,56851290,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-chloro-4-phenoxyphenyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420687,0.11,632227,136931762,56849702,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-[4-[3-Chloro-4-[3-(trifluoromethoxy)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435418,0.11,638068,136925170,57392590,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[5-(pyrrolidin-1-ylmethyl)-1,3-thiazol-2-yl]ethynyl]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340039506,0.11,760336,174502626,72165162,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 kinase domain expressed in baculovirus/Sf21 system by ELISA,2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-propan-2-ylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363964610,0.11,1503437,103177459,176870,2064,29028534,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867967,0.11,1795986,381620331,137529660,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[4-[6-[[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]phenoxy]benzoyl]amino]hexyl]-4,5,5-trimethyl-1,3,2-dioxaborolan-2-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668003,0.11,1806610,471698533,155242948,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-[3-[7-Methoxy-4-[4-(trifluoromethyl)anilino]quinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439734,0.11,1920052,486503527,167318829,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 55",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440100,0.11,1920052,486503884,167318543,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 419",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440104,0.11,1920052,486503888,167318642,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 423",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440524,0.11,1920053,486503814,167318654,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 347",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564652,0.111,367174,103610117,44571437,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((ethylamino)methyl)-1H-pyrrol-2-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439925,0.111,1920052,486503712,162428821,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 242",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440492,0.111,1920053,486503783,167318724,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 316",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340012002,0.112,748805,174511859,11260323,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"1-[2-(4-amino-7-cyclopentylpyrrolo[2,3-d]pyrimidin-5-yl)-3H-benzimidazol-5-yl]-3-(2,6-difluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
341093660,0.112,1057924,194159081,72737208,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of ErbB2 (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2-pyrrolidin-1-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367496239,0.112,1664197,442060512,135236945,2064,32631510,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal His-tagged HER2 (676 to 1255 residues) expressed in baculovirus expression system by competitive binding assay,"US10246444, Example 92",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440024,0.112,1920052,486503810,167318752,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 343",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440239,0.112,1920053,486503536,167318908,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 62",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359370,0.113,69714,103303133,5328957,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10d,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564649,0.113,367174,103610112,44571433,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(thiophen-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564654,0.113,367174,103610114,44571434,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)-1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817793,0.113,1795646,8034234,5328957,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10d,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439938,0.113,1920052,486503725,162428990,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 255",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440345,0.113,1920053,486503638,166928148,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 168",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359367,0.114,69714,103202674,4708,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817764,0.114,1795646,8034230,4708,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440305,0.114,1920053,486503599,167318674,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 127",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440432,0.114,1920053,486503724,167318736,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 254",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355638531,0.115,1308958,123092436,44259,2064,27288183,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) incubated for 1 hr by spectrophotometric analysis,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439911,0.115,1920052,486503698,167318791,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 228",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439914,0.115,1920052,486503701,167318861,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 231",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439949,0.115,1920052,486503736,162428879,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 266",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439977,0.115,1920052,486503763,167318834,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 295",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440628,0.115,1920053,486503917,167318604,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 452",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359368,0.116,69714,103302531,5328966,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10m,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864193,0.116,260899,103479580,11711590,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(diethylamino)-2-butynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
388817752,0.116,1795646,8034243,5328966,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10m,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440440,0.116,1920053,486503732,167318563,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 262",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144653,0.116,1798142,340134784,72703790,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',Nazartinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359369,0.117,69714,103302663,44325116,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,N-[4-(3-bromoanilino)quinazolin-6-yl]-4-[2-(methoxymethyl)pyrrolidin-1-yl]but-2-ynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707257,0.117,68106,103177379,5329488,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,"N-{4-[(4-{[4-(benzyloxy)phenyl]amino}quinazolin-6-yl)oxy]butyl}-2,2,2-trifluoroacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817745,0.117,1795646,8034240,5328963,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10j,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388843731,0.117,1795775,8035074,5329488,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',"N-{4-[(4-{[4-(benzyloxy)phenyl]amino}quinazolin-6-yl)oxy]butyl}-2,2,2-trifluoroacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867973,0.117,1795986,381620339,137529667,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[(1R,2R,6S,8R)-2-[2-[4-[2-[5-[carbamoyl-(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)amino]indol-1-yl]ethyl]piperidin-1-yl]-2-oxoethyl]-9,9-dimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439710,0.117,1920052,486503503,162428848,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440583,0.117,1920053,486503872,167318624,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 407",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143681,0.117,1798142,464922062,139378052,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[4,5-difluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2S)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503826,0.118,361654,103643928,44587526,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2,"N-[1-(3-Fluoro-benzyl)-1H-indazol-5-yl]-5-{[4-methoxy-phenylimino]-methyl}-pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440301,0.118,1920053,486503595,166927703,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 123",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440465,0.118,1920053,486503756,167318719,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 287",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440500,0.119,1920053,486503791,167318793,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 324",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541197,0.12,410949,103607074,25263281,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3R,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571795,0.12,344457,103628280,44580917,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(R)-methyl 2-((4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675488,0.12,290549,103523374,44426276,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"1-(4-(4-(6-(2-Methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101694011,0.12,295195,103531671,44430032,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(4-methyl-1,4-diazepan-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694014,0.12,295195,103531672,22390479,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(4-methylsulfonyl-1,4-diazepan-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694377,0.12,295195,103531666,10217304,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(4-methylpiperazin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742014,0.12,306289,103549506,44440830,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-(piperidin-4-ylmethoxymethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751501,0.12,308828,103549781,22390495,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"N-(1-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)piperidin-4-yl)-2-hydroxyacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778929,0.12,315244,103574839,44455672,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2R)-N-(2-methoxyethyl)-N-methyl-2-{[4-({3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)quinazolin-5-yl]oxy}propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101778939,0.12,315244,103575078,11533311,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-5-yl)oxy]-N-(2-hydroxyethyl)-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
103123567,0.12,418568,103593400,44564704,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by SPA assay,"[(3R,5S)-5-[2-[4-[(1-thiophen-3-ylsulfonylindol-5-yl)amino]thieno[3,2-d]pyrimidin-6-yl]ethynyl]pyrrolidin-3-yl] morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286467,0.12,456100,103177459,176870,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155745958,0.12,474117,103749178,46886327,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 intracellular phosphorylation in human N87 cells by ELISA,"2-phenyl-N-(3-(5-(2-(1,2,3,4-tetrahydroisoquinolin-6-ylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
254420223,0.12,632226,136938312,56851588,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[2-(trifluoromethyl)phenoxy]phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435413,0.12,638068,136925171,57392591,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[(E)-2-[4-[(2-methylsulfonylethylamino)methyl]phenyl]ethenyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040380,0.12,760335,174487251,11306338,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-ethylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342821916,0.12,1119725,103177459,176870,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant HER2 (unknown origin) using poly-Glu-Tyr peptide as substrate,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630998,0.12,1305356,336904741,127050881,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[4-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
355654125,0.12,1315425,374319677,134146163,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380800951,0.12,1915573,103177459,176870,2064,33077264,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000996,0.12,1798897,58097694,25263262,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-[2-(4-{[1-(thiophene-2-sulfonyl)-1H-indol-5-yl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440393,0.12,1920053,486503685,166927771,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 215",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440519,0.12,1920053,486503810,167318752,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 343",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089617,0.12,1961745,103768137,24826799,2064,37468498,Confirmatory,20240503,0,0,Active,P04626,AC50,=,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Ponatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101565332,0.121,367174,103610160,44571452,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367495713,0.121,1664189,442060512,135236945,2064,32631510,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,"US10246444, Example 92",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380552466,0.121,1855770,482086131,164887604,2064,35964425,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human HER2 incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,Her2-IN-12,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102436,0.121,1796170,381752966,132143184,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-(3-hydroxypropylcarbamoyl)-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylpyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440186,0.121,1920053,486503485,167318710,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 13",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440299,0.121,1920053,486503593,167318746,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 121",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359509,0.122,69714,103303552,5328967,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10n,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564642,0.122,367174,103610157,44571450,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"(5-(4-(3-Chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)furan-2-yl)methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380656513,0.122,1880133,312367127,71496458,2064,35439421,Confirmatory,20230629,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of wild-type HER2 phosphorylation in human BT-474 cells,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817800,0.122,1795646,8034244,5328967,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10n,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439696,0.122,1920052,486503490,167318570,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 18",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439904,0.122,1920052,486503691,167318879,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 221",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440426,0.122,1920053,486503718,167318892,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 248",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440232,0.123,1920053,486503530,166927644,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 58",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440419,0.123,1920053,486503711,169552760,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 241",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359456,0.124,69714,103302708,5328962,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10i,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155779962,0.124,472048,103771162,11557040,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,Lapatinib Ditosylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
355655705,0.124,1315979,374343816,134152991,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-[(1-benzylindol-5-yl)amino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388817742,0.124,1795646,8034239,5328962,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10i,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439713,0.124,1920052,486503506,162428980,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 34",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440659,0.124,1920053,486503948,167318703,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 484",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350472,0.125,68098,103202153,10523411,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,"N-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439999,0.125,1920052,486503785,169552770,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 318",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072443,0.126,1256453,318397014,122195680,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-ethylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103025,0.126,1796166,381752958,132143198,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfonylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432860,0.126,1919984,486499672,168258017,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[4-(6-ethylpyridin-3-yl)oxy-3-methylanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018101,0.126,1920044,486503222,169552744,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[4-(6-ethylpyridin-3-yl)oxy-3-methylanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439922,0.127,1920052,486503709,167318844,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 239",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574016,0.128,320574,103574164,11518627,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-piperazin-1-ylethoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655803,0.128,1315979,374310126,134143525,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-[(2R,6S)-2,6-dimethylpiperidin-1-yl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440404,0.128,1920053,486503696,162428777,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 226",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409339,0.12882,164335,103345780,6447926,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,2-Cyano-3-(4-hydroxy-3-methoxy-5-((phenylthio)methyl)phenyl)-2-propenamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574023,0.129,320574,103574214,11606101,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"3-[2-(4-acetylpiperazin-1-yl)ethoxy]-N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440548,0.129,1920053,486503837,167318718,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 370",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455147,0.13,81560,103345780,6447926,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,2-Cyano-3-(4-hydroxy-3-methoxy-5-((phenylthio)methyl)phenyl)-2-propenamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701744,0.13,144357,103407769,44372004,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing N87 (Gastric) tumor cell proliferation,"4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541194,0.13,410949,103606997,25263278,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3S,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541202,0.13,410949,103606998,25263276,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3S,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675467,0.13,290549,103523365,44426269,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101675474,0.13,290549,103523395,44426291,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"4-(2-methyl-4-(6-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101741770,0.13,306289,103549519,44440841,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-[[(2S)-morpholin-2-yl]methoxymethyl]-N-[1-[(1R)-1-phenylethyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742012,0.13,306289,103549501,10226418,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-(4-aminobutoxymethyl)-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101777719,0.13,314962,103561950,16117891,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,"(S)-N,N-dimethyl-2-(4-(1-(thiazol-4-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101778932,0.13,315244,103574928,11547377,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,N-(2-Hydroxyethyl)-N-methyl-2-{[4-({3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)quinazolin-5-yl]oxy}acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101829479,0.13,254975,103468325,23646545,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"4-[(1-benzylindazol-5-yl)amino]-5-ethyl-N-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
103124281,0.13,418567,103593398,25263260,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-{2-[4-({1-[1-(3-fluorophenyl)ethyl]-1H-indazol-5-yl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257331,0.13,454329,103717511,46225611,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"6-methoxy-N-[4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742062,0.13,473323,103746579,46197128,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,N-(4-(3-Bromophenylamino)quinolin-6-yl)-4-(dimethylamino)-butanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435326,0.13,638068,136931631,57396070,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[3-[4-[(propan-2-ylamino)methyl]phenoxy]prop-1-ynyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321558852,0.13,670126,160679720,57415417,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"6-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-1,3-dihydroindol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000991,0.13,1798897,58097692,25263260,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-{2-[4-({1-[1-(3-fluorophenyl)ethyl]-1H-indazol-5-yl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665822,0.13,1806610,471698528,155243063,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440194,0.13,1920053,486503492,167318898,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 20",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440420,0.13,1920053,486503712,162428821,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 242",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440512,0.13,1920053,486503803,167318862,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 336",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440644,0.13,1920053,486503933,167318798,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 468",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407923638,0.13,1927663,103420820,216239,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755922,0.131,309859,103551492,44442026,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Erb2 autophosphorylation by cellular clone 24 assay,(S)-N-(1-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propan-2-yl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821960,0.131,248914,103441710,11192261,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(thiophen-2-ylmethoxy)-phenylamino]-3-cyano-7-ethoxy-quinolin-6-yl}-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367496238,0.131,1664197,123092436,44259,2064,32631510,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal His-tagged HER2 (676 to 1255 residues) expressed in baculovirus expression system by competitive binding assay,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380552465,0.131,1855770,103420820,216239,2064,35964425,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human HER2 incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440530,0.131,1920053,486503819,156821234,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 352",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366322627,0.1316,1535505,440228225,118900244,2064,30600209,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,Synthesis of (E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-propoxyethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821812,0.132,248914,103441717,11365122,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(3-methylphenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699876,0.132,1796911,384577254,118900244,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'",Synthesis of (E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-propoxyethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440564,0.132,1920053,486503853,167318789,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 387",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440622,0.134,1920053,486503911,167318711,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 446",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279404,0.1345,461252,103177459,176870,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101571807,0.135,344457,103628446,44580971,2064,18842405,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 kinase,"(3R,5S)-5-((4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)thieno[3,2-d]pyrimidin-6-yl)ethynyl)pyrrolidin-3-yl ethyl carbonate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574020,0.135,320574,103574404,11698913,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"1-{2-[(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethyl}piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433601,0.135,636385,136920691,57390198,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453092,0.137,375732,103635146,44583600,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"benzyl 5-(2-((3RS,5S,6S)-5-(hydroxycarbamoyl)-6-(3-phenylpyrrolidine-1-carbonyl)piperidin-3-yl)acetamido)pentylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
402440441,0.137,1920053,486503733,162428946,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 263",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440661,0.138,1920053,486503950,167318584,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 486",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101638415,0.14,277510,103505651,16108940,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-[(4-phenylpiperidin-1-yl)carbonyl]-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101675484,0.14,290549,103523370,44426274,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101675487,0.14,290549,103523362,44426266,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-phenylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101741765,0.14,306289,103549513,44440836,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-(1,4-oxazepan-6-ylmethoxymethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101748797,0.14,308241,103535200,135497851,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"4-(3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)isoquinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778079,0.14,314962,103561951,16117758,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(R)-2-(4-(1-(thiazol-4-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101778084,0.14,314962,103561942,16118034,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(S)-1-morpholino-2-(4-(1-(pyridin-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101778940,0.14,315244,103575079,11547919,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,N-[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]-5-(2-morpholin-4-yl-2-oxoethoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101856325,0.14,259431,103477210,11519125,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,9-(3-tert-Butylamino-propyl)-8-(2-iodo-5-methoxy-phenylsulfanyl)-9H-purin-6-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880671,0.14,263981,103486094,11502887,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(pyridin-3-yl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742058,0.14,473323,103258685,16045442,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,"N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198358518,0.14,517324,103177479,208908,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 phosphorylation in human BT474 cells by ELISA,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
204402356,0.14,580189,124957150,53317173,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-5,6-dimethylpyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435327,0.14,638068,136925169,57392589,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[5-(pyrrolidin-1-ylmethyl)furan-2-yl]ethynyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776626,0.14,649306,103177459,176870,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
340069858,0.14,770082,174519073,73292361,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-{5-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxy-2-[4-methylpiperazin-1-yl]phenyl}prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
340071109,0.14,770082,174498510,73292362,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-[4-Methoxy-2-(4-methylpiperazin-1-yl)-5-[(4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
345661005,0.14,1167102,174519073,73292361,2064,25271963,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-{5-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxy-2-[4-methylpiperazin-1-yl]phenyl}prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
354665173,0.14,1289550,336878369,71535003,2064,26756222,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR deletion mutant autophosphorylation in human PC9 cells after 2 hrs by sandwich ELISA,"1-((3R,4R)-3-(((5-chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)methyl)-4-methoxypyrrolidin-1-yl)prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
389665539,0.14,1806610,471698520,155243032,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"6-((1-Acryloylpiperidin-4-yl)oxy)-4-((2,4-dichloro-phenyl)amino)-7-methoxy-quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089621,0.14,1961745,103194628,3081361,2064,37468498,Confirmatory,20240503,0,0,Active,P04626,AC50,=,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Vandetanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912897,0.141,270616,103498997,9938805,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-[4-[(3-fluorophenyl)methoxy]-3-(trifluoromethyl)phenyl]-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912916,0.141,270616,103498996,9874613,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((benzyl(2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440250,0.141,1920053,486503547,162428933,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 75",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440473,0.141,1920053,486503764,167318673,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 296",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597774,0.142,1865640,381884390,134959408,2064,36518696,Confirmatory,20230629,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 wild type (679 to 1255 residues) expressed in baculovirus infected Sf9 insect cells using AQT0794 measured up to 240 mins by fluorescence assay,N-[3-[[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1H-imidazol-4-yl]pyridin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440423,0.142,1920053,486503715,167318744,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 245",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101653918,0.143,283010,104236654,11246488,2064,16279804,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 tyrosine kinase phosphorylation expressed in mouse BaF3 cells,PD-153035 hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,147,"","",""
402440624,0.143,1920053,486503913,167318644,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 448",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410144414,0.143,1798142,464922072,139378144,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2S)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440183,0.144,1920053,486503482,162428942,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 10",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440573,0.144,1920053,486503862,167318812,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 397",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615864,0.145,1919643,483622412,146448656,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 73",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440214,0.145,1920053,486503512,166927739,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440449,0.145,1920053,486503741,162428794,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 271",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514801,0.146,364803,103587876,44562420,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-Amino-6-(4-(benzyloxy)-3-chlorophenylamino)pyrimidine-5-carbohydrazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564644,0.146,367174,103610155,44571448,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((dimethylamino)methyl)furan-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112810,0.146,1676531,461548149,162666602,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[3-methyl-6-[4-(4-methylpiperazin-1-yl)phenyl]-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380552463,0.146,1855770,482070119,165412709,2064,35964425,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human HER2 incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,Egfr/her2-IN-7,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440476,0.146,1920053,486503767,166927936,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 299",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440613,0.146,1920053,486503902,167318758,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 437",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100706975,0.147,68106,103592519,5329491,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,N-[4-(benzenesulfonyl)phenyl]-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755924,0.147,309859,103551487,11706282,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Erb2 autophosphorylation by cellular clone 24 assay,(R)-1-(2-((4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)methyl)pyrrolidin-1-yl)-2-hydroxyethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124858,0.147,418922,103593183,25218693,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ErbB2 phosphorylation in IGF1 and EGF-stimulated human N87 cells pretreated for 6 hrs before IGF1 and EGF stimulation by ELISA,"1-{4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl}-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
388837160,0.147,1795775,8035077,5329491,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',N-[4-(benzenesulfonyl)phenyl]-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101504958,0.148,361656,103643992,24897276,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,"N-[1-(3-Fluoro-benzyl)-1H-indazol-5-yl]-5-[piperidin-1-yliminomethyl]-pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101574025,0.148,320574,103574114,44455194,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(oxazepan-2-yl)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699908,0.148,1796911,384577251,118900305,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'","Synthesis of (R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-methoxy-1-methylethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366322624,0.1483,1535505,440217240,118900305,2064,30600209,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,"Synthesis of (R,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-methoxy-1-methylethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439908,0.149,1920052,486503695,167318582,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 225",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439919,0.149,1920052,486503706,162428839,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 236",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440082,0.149,1920052,486503866,167318588,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 401",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345670958,0.1494,1171421,312371399,71513157,2064,25409491,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type HER2 (unknown origin) incubated for 5 mins by HTRF assay,(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)-2-fluorobut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100358857,0.15,69715,103291864,16149502,2064,11472210,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Dissociation constant for peptide inhibitor binding to HER2 receptor,Yvdgfyacymdv-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675160,0.15,290549,103523354,44426258,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,N-(3-{4-[4-(1-Cyclobutanecarbonyl-piperidin-4-yloxy)-3-methyl-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-2-methoxy-acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155746561,0.15,474114,103749177,46886326,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-(3-(5-(2-(3-(2-(dimethylamino)ethyl)phenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402361,0.15,580189,124962420,53319790,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-methyl-5-(5-morpholinopent-1-ynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420226,0.15,632227,136925310,56851428,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(3-fluorophenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420633,0.15,632227,136928514,56851432,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"3-[2-chloro-4-(5H-pyrrolo[3,2-d]pyrimidin-4-ylamino)phenoxy]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420658,0.15,632227,136938312,56851588,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[2-(trifluoromethyl)phenoxy]phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321558856,0.15,670126,160701254,57415418,2064,22439974,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,"4-(2-chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino}phenoxy)isoindolin-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340069862,0.15,770082,174493357,73294505,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-[3-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
389665837,0.15,1806610,471698538,155243075,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-[3-[4-[3-Chloro-4-(trifluoromethoxy)anilino]-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666680,0.15,1806610,471698517,155235887,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 9",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440354,0.15,1920053,486503647,166928149,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 177",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398250,0.151,1574931,103244983,123631,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
380522518,0.151,1849107,482050840,168271807,2064,36351049,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,H-Asn-Pro-Asn-Trp-Gly-Arg-Ser-Trp-Tyr-Asn-Gln-Arg-Phe-Lys-Gly-Cys-Gly-Arg-Ile-Lys-Pro-Arg-Lys-Gly-Tyr-Thr-Arg-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665454,0.152,1168534,312363557,118717617,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,[[(1S)-1-[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]-2-methylsulfonylethyl]amino] propanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440625,0.152,1920053,486503914,167318714,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 449",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564646,0.153,367174,103610118,44528930,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)-1H-pyrrol-2-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595852,0.153,331423,103563696,17747138,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-(3-chloro-4-phenylmethoxyphenyl)-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655714,0.153,1315979,374326702,134148137,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-[(1-benzylindazol-5-yl)amino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402439761,0.153,1920052,486503553,166927883,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 81",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632719,0.154,1306577,336906408,127052092,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821810,0.155,248914,103441699,11421443,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,2-{2-Chloro-4-[3-cyano-6-(4-dimethylamino-but-2-enoylamino)-7-methoxy-quinolin-4-ylamino]-phenylsulfanyl}-1-methyl-3H-imidazol-1-ium,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356240,0.156,517320,123096642,52947604,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"trans-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methylphenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439746,0.157,1920052,486503538,167318828,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 64",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440130,0.157,1920052,486503914,167318714,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 449",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398255,0.158,1574931,440203910,155559257,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[[1-[(4-methylphenyl)methyl]triazol-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
402440205,0.158,1920053,486503503,162428848,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665457,0.1582,1168534,312363559,118717619,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,[[(1S)-1-[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]-2-methylsulfonylethyl]amino] heptanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337133,0.16,69874,104235582,49860652,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-[4-Fluoro-3-(trifluoromethyl)anilino]-6,7-dimethoxyquinoline-3-carbonitrile;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101639296,0.16,277510,103505692,16108952,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-5-methyl-6-[(4-phenyl-3,6-dihydropyridin-1(2H)-yl)carbonyl]-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101639300,0.16,277510,103505660,16108949,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-{[4-(2-methyl-4-nitrophenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101675456,0.16,290550,103523363,44426267,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,N-cyclobutyl-3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778077,0.16,314962,103561952,16117890,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(R)-1-morpholino-2-(4-(1-(thiazol-4-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propan-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101880661,0.16,263981,103486477,11583563,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,(4-(2-(4-(4-(3-Fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)thiazol-2-yl)methanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286111,0.16,456091,103177459,176870,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151288067,0.16,460690,103177459,176870,2064,20005116,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155747198,0.16,474114,103749175,46886324,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-(3-(5-(2-(2-methyl-1,2,3,4-tetrahydroisoquinolin-6-ylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120454,0.16,492321,103177459,176870,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
237864966,0.16,620240,103177459,176870,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334019640,0.16,722488,103177459,176870,2064,23245802,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 cytoplasmic domain (amino acids 676 to 1245) expressed in Sf9 cells by DELFIA time resolved fluorometry,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
334040840,0.16,725964,103177459,176870,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796314,0.16,1426965,381844631,137636787,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[5-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypentoxy]-N-(3-bromophenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366428833,0.16,1589888,440133496,135236903,2064,31023512,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of probe binding to HER2 (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,"US10246444, Example 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666854,0.16,1806610,471698531,155243066,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821947,0.161,248914,103441795,11296170,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(3-cyanophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440025,0.161,1920052,486503811,167318676,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 344",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440244,0.161,1920053,486503541,166927660,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 69",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440577,0.161,1920053,486503866,167318588,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 401",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359454,0.162,69714,103303132,5328958,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10e,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453101,0.162,375732,103635147,11363138,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(2S,3S,5RS)-5-(2-(5-aminopentylamino)-2-oxoethyl)-N-hydroxy-2-(3-phenylpyrrolidine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
106024074,0.162,447375,103707858,45487388,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(2S,3S)-5-(2-(4-aminobutylamino)-2-oxoethyl)-N-hydroxy-2-(3-phenylpyrrolidine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817696,0.162,1795646,8034235,5328958,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10e,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440202,0.163,1920053,486503500,167318661,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 28",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440248,0.163,1920053,486503545,166927902,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 73",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345665456,0.1638,1168534,312363558,118717618,2064,25305330,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,[[(1S)-1-[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]-2-methylsulfonylethyl]amino] pentanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372381531,0.165,1734765,461561664,122419211,2064,27739679,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant ERBB2 G778D mutant (676 to end residues) using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis","N-[3-[[4-Amino-1-(4beta-hydroxycyclohexane-1alpha-yl)-1H-pyrazolo[3,4-d]pyrimidine-3-yl]ethynyl]-4-methylphenyl]-4-methyl-3-(trifluoromethyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388951666,0.165,1798403,404338880,122419211,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase Inhibition Assays from US Patent US10266537: '3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof'","N-[3-[[4-Amino-1-(4beta-hydroxycyclohexane-1alpha-yl)-1H-pyrazolo[3,4-d]pyrimidine-3-yl]ethynyl]-4-methylphenyl]-4-methyl-3-(trifluoromethyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440412,0.165,1920053,486503704,167318622,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 234",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688208,0.1655,1330925,374299439,134140501,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,6-[4-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyhexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574021,0.166,320574,103574217,11634645,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(4-methylpiperazin-1-yl)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440316,0.166,1920053,486503609,162428914,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 137",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366428837,0.167,1589888,440158419,135236566,2064,31023512,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of probe binding to HER2 (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,"US10246444, Example 98",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367495710,0.167,1664189,440158419,135236566,2064,32631510,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,"US10246444, Example 98",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440191,0.167,1920053,486503490,167318570,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 18",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821400,0.169,248914,103441734,11410940,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(4-hydroxypiperidin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453090,0.17,375732,103635362,44583655,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S,5R)-N-hydroxy-5-(2-oxo-2-(piperidin-1-yl)ethyl)-2-(4-phenylpiperazine-1-carbonyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101694375,0.17,295195,103531682,44430037,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(6-methoxy-1,4-diazepan-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742019,0.17,306289,103549507,44440831,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[[(3S)-piperidin-3-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751927,0.17,308828,103549785,44441012,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-(1,4-diazepan-1-ylmethyl)-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-6-methoxypyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101829477,0.17,254975,103468206,23646546,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"benzyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101864188,0.17,260899,103480259,11632391,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-2-hexynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101889388,0.17,266066,103238236,5328203,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,"4-N-(3-bromophenyl)-6-N-methylquinazoline-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
155747189,0.17,474114,103749167,46886317,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"1-(3-(5-(2-(4-Morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747192,0.17,474114,103749176,46886325,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-(3-(5-(2-(4-(4-ethylpiperazin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747197,0.17,474114,103749168,46886318,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"Phenyl 3-(5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615740,0.17,1919643,483622428,146510112,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 99",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407923637,0.17,1927663,482076866,155815724,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,N-(4-chlorophenyl)-2-[4-oxo-3-[2-(4-sulfamoylphenyl)ethyl]quinazolin-2-yl]sulfanylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821951,0.171,248914,103441708,44388486,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-[2-(methoxymethyl)pyrrolidin-1-yl]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439912,0.171,1920052,486503699,167318580,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 229",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440359,0.171,1920053,486503651,166927913,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 181",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440369,0.171,1920053,486503661,166927676,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 191",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440431,0.171,1920053,486503723,167318810,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 253",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355706554,0.172,1338270,374361547,134157980,2064,27769032,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to HER2 domain-4 (unknown origin) by SPR assay,"(2S)-2-[[(3S)-3-[[(2S)-5-(diaminomethylideneamino)-2-[[5-[[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]amino]-5-oxopentanoyl]amino]pentanoyl]amino]-3-naphthalen-1-ylpropanoyl]amino]-3-phenylpropanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439704,0.172,1920052,486503497,167318548,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595854,0.173,331423,103563590,17747208,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-2-methylpropoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864181,0.173,260899,103479787,11503073,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(4-morpholinyl)-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
355655709,0.174,1315979,374349889,134154721,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[4-(benzenesulfonamido)anilino]-7-ethoxyquinazolin-6-yl]-4-morpholin-4-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440663,0.174,1920053,486503952,167318713,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 488",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334046126,0.1741,730878,164146315,71578522,2064,23107515,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to synthetic peptide mimicking HER2 subdomain 4 (unknown origin) by fluorescence spectroscopic analysis,Ac-Cys-Gln-Gln-His-Tyr-Thr-Thr-Pro-Pro-Thr-Phe-Gly-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688212,0.1749,1330925,374292238,132495274,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,7-[4-[4-(3-chloro-2-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279395,0.175,461252,103729844,45140350,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,(R)-7-(4-(1-(4-Fluorophenyl)ethylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615755,0.176,1919643,483622405,146448687,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 51",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440216,0.176,1920053,486503514,166927641,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 42",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440616,0.176,1920053,486503905,167318742,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 440",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440631,0.176,1920053,486503920,167318832,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 455",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688219,0.1767,1330925,374354409,134156011,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,7-[4-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359447,0.177,69714,103303392,5328956,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10c,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817765,0.177,1795646,8034233,5328956,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10c,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440436,0.177,1920053,486503728,167318625,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 258",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615731,0.179,1919643,483622423,146510001,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 82",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337016,0.18,69874,103332773,5328841,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Chlorophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398224,0.18,164334,103339168,10906920,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Dimethylamino-but-2-ynoic acid [4-(3-bromo-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675748,0.18,290550,103523383,44426283,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"N-(2,6-difluorophenyl)-4-(2-methyl-4-(6-(methylamino)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751510,0.18,308828,103549780,22390556,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"N-(1-{4-[1-(3-Fluoro-benzyl)-1H-indazol-5-ylamino]-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl}-piperidin-4-yl)-acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778927,0.18,315244,103575122,11503005,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,2-[(4-{[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}quinazolin-5-yl)oxy]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101829713,0.18,254975,103468288,23589545,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"4-[[1-(Phenylmethyl)-1h-indazol-5-yl]amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid ethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101856072,0.18,259431,103477120,11548875,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,8-(2-Iodo-5-methoxy-phenylsulfanyl)-9-(3-isopropylamino-propyl)-9H-purin-6-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124271,0.18,418567,103593322,25263252,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(6-fluoroquinolin-4-yl)oxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124285,0.18,418567,103593403,25263265,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-[2-(4-{[1-(1,3-thiazol-4-ylmethyl)-1H-indol-5-yl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257334,0.18,454329,103717544,46225641,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-3-chlorophenyl]-7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435423,0.18,638068,136935077,57397872,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[5-(pyrrolidin-1-ylmethyl)thiophen-2-yl]ethynyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334019645,0.18,722488,164147423,71508798,2064,23245802,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 cytoplasmic domain (amino acids 676 to 1245) expressed in Sf9 cells by DELFIA time resolved fluorometry,"2-[3-(1,3-Benzodioxol-5-yl)-5-(4-bromophenyl)-3,4-dihydropyrazol-2-yl]-4-(4-bromophenyl)-1,3-thiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355654694,0.18,1315425,374331816,134149577,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796312,0.18,1426965,381860225,71616700,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[2-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxyethoxy]-N-(3-bromophenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000797,0.18,1798897,58097684,25263252,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-{2-[4-({3-chloro-4-[(6-fluoroquinolin-4-yl)oxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000803,0.18,1798897,58097697,25263265,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-[2-(4-{[1-(1,3-thiazol-4-ylmethyl)-1H-indol-5-yl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440242,0.18,1920053,486503539,167318837,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 66",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440618,0.18,1920053,486503907,167318620,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 442",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350477,0.182,68098,103202749,10672994,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,"N-{4-(3-Chloro-4-fluoro-phenylamino)-7-[3-(4-methyl-piperazin-1-yl)-propoxy]-pyrido[3,2-d]pyrimidin-6-yl}-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615739,0.182,1919643,483622406,146510036,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 52",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359366,0.183,69714,103302689,5328964,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 10k,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821949,0.183,248914,103441773,11478925,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-[2-methoxyethyl(methyl)amino]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817757,0.183,1795646,8034241,5328964,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 10k,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439717,0.183,1920052,486503510,162428973,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 38",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574010,0.184,320574,103574355,11684684,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"1-(2-{[4-({3-chloro-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821648,0.184,248914,103441720,11307255,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-phenoxy-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439991,0.184,1920052,486503777,167318551,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 309",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124295,0.186,418919,103550971,25218685,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"3-(2-benzyl-1H-benzo[d]imidazol-6-yl)-1-((trans)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389006054,0.186,1798858,57560473,25218685,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"3-(2-benzyl-1H-benzo[d]imidazol-6-yl)-1-((trans)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354669779,0.187,1291326,312468158,57335384,2064,26968253,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Del ex19 mutant phosphorylation in human HCC827 cells after 1 hr by Western blot analysis,Rociletinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733529,0.188,1341678,103729562,24756910,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged recombinant human HER2 (679 to 1255 residues) expressed in baculovirus infected insect Sf9 cells using poly (Glu:Tyr) 4:1 as substrate after 2 hrs,Cudc-101,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
372112712,0.188,1676531,461541399,162661885,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[5-[4-[(2-benzyl-3H-benzimidazol-5-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-(2-hydroxyethoxy)phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410147551,0.188,1798142,464922073,139377739,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-2-[(2S)-2-[(dimethylamino)methyl]pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350480,0.189,68098,103202805,11799155,2064,10753475,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,"N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101596690,0.189,331423,103563750,17747341,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[1-[(4-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440222,0.189,1920053,486503520,167318889,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 48",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337121,0.19,69874,103332428,5328840,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Bromophenylamino)-6,7-dimethoxy-3-quinolinecarbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675743,0.19,290550,103523359,44426263,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"N-(2,6-difluorophenyl)-4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101751507,0.19,308828,103549774,22390541,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"[1-(3-Fluoro-benzyl)-1H-indazol-5-yl]-{5-[4-(2-methanesulfonyl-ethylamino)-piperidin-1-ylmethyl]-pyrrolo[2,1-f][1,2,4]triazin-4-yl}-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751926,0.19,308828,103549789,44441016,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"5-[(4-aminopiperidin-1-yl)methyl]-N-[1-(pyridin-4-ylmethyl)indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155742066,0.19,473323,103746580,44629538,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,N-[4-(3-bromoanilino)-6-quinazolinyl]-4-(dimethylamino)butanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402359,0.19,580189,124965003,51346887,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-methyl-5-(4-(morpholinomethyl)styryl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457141,0.19,624804,123092436,44259,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363795870,0.19,1426965,381881797,137658341,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[4-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxybutoxy]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796310,0.19,1426965,381865071,137650597,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropoxy]-N-(3-ethynylphenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615853,0.19,1919643,483622407,146448695,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 54",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265050,0.19,1805507,447113336,156905949,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 11",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688215,0.1928,1330925,374335351,134150543,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,6-[4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]triazol-1-yl]-N-hydroxyhexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453093,0.194,375732,103635214,44583620,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(2S,3S,5RS)-N-hydroxy-1-methyl-5-(2-oxo-2-(pyrrolidin-1-yl)ethyl)-2-(4-phenylpiperazine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101821398,0.196,248914,103441684,11238875,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,1-{(E)-3-[4-(4-Benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-ylcarbamoyl]-allyl}-aziridine-2-carboxylic acid methyl ester,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433596,0.196,636385,136920692,57390199,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,ethyl (E)-4-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyanilino]-4-oxobut-2-enoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439720,0.196,1920052,486503513,166927842,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 41",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439745,0.196,1920052,486503537,167318845,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 63",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440204,0.196,1920053,486503502,166927840,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 30",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440595,0.196,1920053,486503884,167318543,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 419",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655706,0.198,1315979,374347319,134153988,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-N-[4-[(1-benzylindazol-5-yl)amino]-7-ethoxyquinazolin-6-yl]-4-[(2S,6R)-2,6-dimethylpiperazin-1-yl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402439718,0.199,1920052,486503511,166927841,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 39",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100274012,0.2,242383,103442649,11625514,2064,15993060,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB-2 protein tyrosine kinase by using [gamma-33P]-ATP as radioligand in pH 7.5,"(4-Benzyloxy-3-chloro-phenyl)-(1,3,8a,9-tetraaza-fluoren-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350468,0.2,68098,103202261,10791534,2064,10753475,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,"N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-pyrido[3,2-d]pyrimidin-6-yl]-N-methyl-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455165,0.2,81560,103346261,44345431,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,3-(3-Benzylsulfanylmethyl-4-hydroxy-5-methoxy-phenyl)-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100667842,0.2,81581,103262865,5329240,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26l",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
100667844,0.2,81581,103262821,5329244,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26p",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
100702779,0.2,68100,103408013,44372180,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2,"4-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622125,0.2,404519,103640389,23149451,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"4-(1-(3-(1H-pyrrol-1-yl)thiophene-2-carbonyl)-5-amino-1H-1,2,4-triazol-3-ylamino)benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694385,0.2,295195,103531667,10227095,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"4-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperazin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778516,0.2,315244,103574877,11619812,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,(2R)-N-(2-hydroxyethyl)-2-{[4-({3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)quinazolin-5-yl]oxy}propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101829476,0.2,254975,103468301,23646541,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"Ethyl 4-[(1-benzylindazol-5-yl)amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101912909,0.2,270616,103498555,9830092,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(benzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359667,0.2,517501,123092901,20817111,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644312,0.2,1162093,312353641,91669170,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"Ethyl 2-amino-5-oxo-1-pyridin-3-yl-4-(tetrazolo[1,5-a]quinolin-4-yl)-4,6,7,8-tetrahydroquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
345644318,0.2,1162093,103177459,176870,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388836060,0.2,1795774,8035058,5329475,2064,14684309,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/j.bmcl.2003.10.010: 'Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.',6-Thiazolylquinazoline 1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666480,0.2,1806610,471698529,155243065,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102433,0.202,1796170,381752958,132143198,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methyl-N-[1-methyl-5-[[1-methyl-5-(5-methylsulfonylindole-1-carbonyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440451,0.202,1920053,486503743,162428917,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 273",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440604,0.202,1920053,486503893,167318542,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 428",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564647,0.203,367174,103610060,44571415,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(1H-pyrrol-2-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595848,0.204,331423,103563852,17747104,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-(3-chloro-4-fluorophenyl)-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439765,0.204,1920052,486503557,166927857,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 85",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440257,0.204,1920053,486503554,166927654,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 82",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391772,0.205,1804579,104065408,6914564,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"8-(6-Bromo-benzo[1,3]dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)-adenine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439735,0.205,1920052,486503528,167318767,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 56",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100368773,0.207,69712,103376171,5329086,2064,11462982,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells,6-Substituted 4-Anilinoquinazoline 25,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615732,0.207,1919643,483622424,146510002,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 84",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453088,0.208,375732,103635286,11271094,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S,5RS)-N-hydroxy-5-(2-morpholino-2-oxoethyl)-2-(4-phenylpiperazine-1-carbonyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
390615749,0.208,1919643,483622425,146448631,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 86",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398244,0.209,1574931,440130748,155524215,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[[1-[(3-fluorophenyl)methyl]triazol-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
402432845,0.209,1919984,486499657,168258028,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"2-fluoro-1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018085,0.209,1920044,486503207,169552735,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"2-fluoro-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707252,0.21,68106,103592518,5329490,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,N-(3-chloro-4-fluorophenyl)-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101676423,0.21,290549,103523355,44426259,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,N-[3-(4-{4-[1-(3-Chloro-benzoyl)-piperidin-4-yloxy]-3-methyl-phenylamino}-quinazolin-6-yl)-prop-2-ynyl]-2-methoxy-acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101829718,0.21,254975,103468302,23646542,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"Ethyl 4-[(1-benzylindazol-5-yl)amino]-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101856070,0.21,259431,103477170,11556271,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,9-[3-(butan-2-ylamino)propyl]-8-[(2-iodo-5-methoxyphenyl)sulfanyl]-9H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101856071,0.21,259431,103477029,11613386,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,8-[(2-iodo-5-methoxyphenyl)sulfanyl]-9-[3-(pentan-3-ylamino)propyl]-9H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124273,0.21,418567,103593404,25263266,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-(2-{4-[(1-benzyl-3-fluoro-1H-indol-5-yl)amino]thieno[3,2-d]pyrimidin-6-yl}ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124855,0.21,418922,103593178,25218688,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ErbB2 phosphorylation in IGF1 and EGF-stimulated human N87 cells pretreated for 6 hrs before IGF1 and EGF stimulation by ELISA,"3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1-[4-(piperazin-1-yl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
254420625,0.21,632227,136941533,56851590,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[2-(trifluoromethoxy)phenoxy]phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837152,0.21,1795775,8035076,5329490,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',N-(3-chloro-4-fluorophenyl)-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000987,0.21,1798897,58097698,25263266,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-(2-{4-[(1-benzyl-3-fluoro-1H-indol-5-yl)amino]thieno[3,2-d]pyrimidin-6-yl}ethynyl)pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391785,0.21,1804579,104065412,11539274,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"2-Fluoro-8-(6-bromo-benzo[1,3]dioxol-5-ylmethyl)-9-(pent-4-ynyl)adenine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354669575,0.211,1291327,312468158,57335384,2064,26968253,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Del ex19 mutant phosphorylation in human PC9 cells after 1 hr by Western blot analysis,Rociletinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
366398246,0.212,1574931,440155645,142735680,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[[1-[(4-fluorophenyl)methyl]triazol-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
366398247,0.212,1574931,440112052,155512047,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[[1-[(4-methoxyphenyl)methyl]triazol-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
389058771,0.21211,1800296,194690243,11554905,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,ELISA-Based Kinase Assay from US Patent US8623883: '4-phenylamino-quinazolin-6-yl-amides',(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(3-fluoropiperidin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102439,0.214,1796170,381752951,132143272,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101653917,0.215,283010,104236685,52946569,2064,16279804,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 tyrosine kinase phosphorylation expressed in mouse BaF3 cells,"N-(3-bromophenyl)-6,7-diethoxyquinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,147,"","",""
402440403,0.218,1920053,486503695,167318582,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 225",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433598,0.219,636385,136933928,57397269,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,Ethyl 2-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyanilino]acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101541201,0.22,410949,103606999,25263277,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ERBb2 by DELFIA assay,"(3S,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912908,0.22,270616,103498556,21951965,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124283,0.22,418567,103593393,25263255,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-[2-(4-{[4-(pyridin-2-ylsulfanyl)phenyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420274,0.22,632227,136935221,56851591,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-[3-(trifluoromethoxy)phenoxy]phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435414,0.22,638068,136935076,57397871,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[4-[(2-methylsulfonylethylamino)methyl]phenyl]ethynyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340039504,0.22,760336,174512934,11375205,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 kinase domain expressed in baculovirus/Sf21 system by ELISA,"2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N,N-dimethylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347069564,0.22,1255235,318396227,86303858,2064,26396685,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Competitive binding affinity to human ERBB2 in presence of immobilized ligand,Egfr-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000802,0.22,1798897,58097687,25263255,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-[2-(4-{[4-(pyridin-2-ylsulfanyl)phenyl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668227,0.22,1806610,471698539,155242963,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 49",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440486,0.223,1920053,486503777,167318551,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 309",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398251,0.225,1574931,440136017,155527677,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[[1-[(4-chlorophenyl)methyl]triazol-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
390615748,0.225,1919643,483622422,146510054,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 81",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279399,0.2252,461252,103729779,45140153,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(Benzylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453084,0.226,375732,103635360,11476645,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S,5RS)-N-hydroxy-5-(2-((R)-3-hydroxypyrrolidin-1-yl)-2-oxoethyl)-2-(4-phenylpiperazine-1-carbonyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101821640,0.227,248914,103441739,44388494,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,N-[4-(4-Benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-3-(1H-imidazol-4-yl)-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440416,0.227,1920053,486503708,167318876,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 238",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337283,0.23,69874,103332757,5328863,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"6,7-Dimethoxy-4-{[4-(propan-2-yl)phenyl]amino}quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453100,0.23,375732,103505691,16108944,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(6S,7S)-N-hydroxy-5-methyl-6-(4-phenylpiperazine-1-carbonyl)-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101639299,0.23,277510,103505691,16108944,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-5-methyl-6-(4-phenylpiperazine-1-carbonyl)-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101675466,0.23,290549,103523363,44426267,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,N-cyclobutyl-3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101676421,0.23,290549,103523379,44426280,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"4-(4-(6,7-bis(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)-N-(2,6-difluorophenyl)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101778072,0.23,314962,103561949,16117347,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,"(R)-N,N-dimethyl-2-(4-(1-(thiazol-4-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101821966,0.23,248914,103441707,11387244,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-[(1-benzyl-2,3-dihydroindol-5-yl)amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420199,0.23,632227,136922140,56851288,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]-5-[2-(2-hydroxyethoxy)ethyl]pyrrolo[3,2-d]pyrimidine-6-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040647,0.23,760335,174507817,72163261,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[3-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341121845,0.23,1068981,194153504,76317765,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,"(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-pyrrolidin-1-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654686,0.23,1315425,374290828,134138134,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-chloroacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605545,0.23,1867605,482049115,156768707,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"3-bromo-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101653916,0.231,283010,104236426,11703561,2064,16279804,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 tyrosine kinase phosphorylation expressed in mouse BaF3 cells,"6,7-diethoxy-N-[(4-fluorophenyl)methyl]quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,147,"","",""
410147154,0.231,1798142,461604616,139377657,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[2-(3-hydroxyoxetan-3-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439782,0.232,1920052,486503571,166927876,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 98",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440178,0.232,1920053,486503478,162428900,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440651,0.232,1920053,486503940,167318578,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 476",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707249,0.234,68106,103177478,5329486,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,N-[4-(benzyloxy)phenyl]-6-{3-[(2-methanesulfonylethyl)amino]propoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707251,0.234,68106,103592466,5329489,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,N-(3-Ethynylphenyl)-6-(4-((2-(methylsulfonyl)ethyl)amino)butoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837148,0.234,1795775,8035072,5329486,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',N-[4-(benzyloxy)phenyl]-6-{3-[(2-methanesulfonylethyl)amino]propoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837157,0.234,1795775,8035075,5329489,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',N-(3-Ethynylphenyl)-6-(4-((2-(methylsulfonyl)ethyl)amino)butoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440215,0.234,1920053,486503513,166927842,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 41",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440475,0.234,1920053,486503766,167318616,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 298",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440570,0.237,1920053,486503859,167318905,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 393",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707255,0.24,68106,103244983,123631,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748780,0.24,308241,103551054,135497853,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"(2-(5-(isoquinolin-4-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-1H-benzo[d]imidazol-4-yl)methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778074,0.24,314962,103561955,16118309,2064,18313293,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human erbB2 autophosphorylation in MCF7 cells,(R)-N-methyl-2-(4-(1-(thiazol-2-ylmethyl)-1H-indazol-5-ylamino)quinazolin-5-yloxy)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
101829474,0.24,254975,103468239,23646550,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"3-Imidazol-1-ylpropyl 4-[(1-benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155734503,0.24,463639,103244983,123631,2064,20166671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747195,0.24,474114,103749076,46886245,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"2-chloro-N-(3-(5-(pyridin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402373,0.24,580189,103244983,123631,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435420,0.24,638068,103244983,123631,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363691136,0.24,1407103,404695587,145979089,2064,30096580,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human GST-tagged HER2 (676-end) expressed in baculovirus infected Sf9 insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,2-cyano-N-[(2-hydroxy-5-morpholin-4-ylsulfonyl-1H-indol-3-yl)imino]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796311,0.24,1426965,381848495,137639383,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",[4-(3-Bromoanilino)quinazolin-6-yl] 4-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxybutanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388836059,0.24,1795774,8035066,123631,2064,14684309,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/j.bmcl.2003.10.010: 'Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.',Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089616,0.24,1961745,103501621,3062316,2064,37468498,Confirmatory,20240503,0,0,Active,P04626,AC50,=,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440223,0.241,1920053,486503521,162429063,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 49",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440478,0.241,1920053,486503769,167318729,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 301",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432839,0.242,1919984,486499651,168257729,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14S)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440430,0.242,1920053,486503722,167318820,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 252",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018080,0.242,1920044,486503200,169552730,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14R)-5-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380552837,0.244,1855770,482059091,164887603,2064,35964425,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human HER2 incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,Egfr/her2-IN-8,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389058638,0.24439,1800296,194690241,11692115,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,ELISA-Based Kinase Assay from US Patent US8623883: '4-phenylamino-quinazolin-6-yl-amides',"(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(2,2-difluoroethoxy)quinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564639,0.246,367174,103610061,44528870,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((dimethylamino)methyl)-1H-pyrrol-2-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821402,0.246,248914,103441789,11249881,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,N-[4-(4-Benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-2-dimethylaminomethyl-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389058635,0.24712,1800296,194690244,11605533,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,ELISA-Based Kinase Assay from US Patent US8623883: '4-phenylamino-quinazolin-6-yl-amides',(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-(4-fluoropiperidin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455139,0.25,81560,103345735,10430383,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,3-[3-(2-Chloro-benzylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100744652,0.25,219061,103216631,9932061,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of neu (erb-B2) HER2 kinase,CID 9932061,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564645,0.25,367174,103610156,44571449,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((4-methylpiperazin-1-yl)methyl)furan-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675746,0.25,290550,103523380,11272368,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"N-(2,6-difluorophenyl)-4-(4-(6-methoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742024,0.25,306289,103549486,44440817,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-methyl-N-[1-(pyridin-3-ylmethyl)indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742026,0.25,306289,103549593,44440874,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-6-methoxy-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751929,0.25,308828,103549593,44440874,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-6-methoxy-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
103124291,0.25,418919,103551024,25218686,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"1-((trans)-4-morpholinocyclohexyl)-3-(2-(thiophen-2-ylmethyl)-1H-benzo[d]imidazol-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040377,0.25,760335,174487252,11398239,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-(2-methoxyethyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040648,0.25,760335,174507818,72163262,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[3-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypyrrolidin-1-yl]-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340071117,0.25,770082,174508905,73291832,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"(E)-4-(dimethylamino)-N-[4-methoxy-3-[(5-methyl-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]phenyl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
341121837,0.25,1068981,194187978,76335961,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,"(E)-4-(diethylamino)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341121840,0.25,1068981,194160470,73053605,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,"(E)-4-(dimethylamino)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630180,0.25,1305356,336904286,127050550,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]-N-methylprop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
366528692,0.25,1632302,440203557,78324481,2064,27524310,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,"(E)-1-[4-(3-chloro-4-fluoroanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-pyrrolidin-1-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380513513,0.25,1846722,482061616,168279644,2064,33992931,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 (unknown origin) pre-incubated for 5 mins followed by substrate addition and measured after 30 mins in presence of ATP by microtitre plate reader analysis,"N-(3-chloro-4-fluorophenyl)-1-(4-fluorophenyl)-3-methylpyrazolo[4,3-d]pyrimidin-7-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605083,0.25,1867605,482069726,168285537,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(3-bromophenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389006055,0.25,1798858,57560474,25218686,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"1-((trans)-4-morpholinocyclohexyl)-3-(2-(thiophen-2-ylmethyl)-1H-benzo[d]imidazol-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388952009,0.251,1798403,404338882,122419381,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase Inhibition Assays from US Patent US10266537: '3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof'","N-[3-[2-[4-amino-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-d]pyrimidin-3-yl]ethynyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409335,0.25119,164335,103345735,10430383,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,3-[3-(2-Chloro-benzylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340012199,0.253,748805,174501506,67219622,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"N-[3-(4-amino-7-cyclopentylpyrrolo[2,3-d]pyrimidine-5-carbonyl)phenyl]-2,6-difluorobenzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
340011998,0.254,748805,174506711,67219498,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"1-[4-(4-Amino-7-cyclopentylpyrrolo[2,3-d]pyrimidine-5-carbonyl)phenyl]-3-(2,6-difluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
372117931,0.254,1679035,461555426,155814900,2064,33479617,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 using Biotin- FLT3 (Tyr589) peptide as substrate preincubated for 5 mins followed by ATP/substrate addition and measured after 30 mins,"N-(3-chloro-4-fluorophenyl)-1-(4-fluorophenyl)-3-methylpyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380621744,0.254,1871594,461555426,155814900,2064,34749202,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) preincubated for 5 mins followed by substrate peptide and ATP addition measured after 30 mins by horseradish peroxidase based microtitre plate reader analysis,"N-(3-chloro-4-fluorophenyl)-1-(4-fluorophenyl)-3-methylpyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440154,0.254,1920052,486503938,167318885,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 474",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595856,0.255,331423,103563695,17747376,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[1-[(3-fluorophenyl)methyl]-2,3-dihydroindol-5-yl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101504950,0.258,361656,103643927,24897494,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,"4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-(2,2,2-trifluoroethylhydrazinylidene)methyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101755925,0.259,309859,103551488,11569903,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Erb2 autophosphorylation by cellular clone 24 assay,(S)-1-(2-((4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)methyl)pyrrolidin-1-yl)-2-hydroxyethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675468,0.26,290549,103523372,44426275,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"1-(4-(4-(6,7-Bis(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
103124533,0.26,418567,103593133,25263249,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-[2-(4-{[5-(pyridin-2-yloxy)naphthalen-2-yl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000805,0.26,1798897,58097681,25263249,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-[2-(4-{[5-(pyridin-2-yloxy)naphthalen-2-yl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665720,0.26,1806610,471698519,155243034,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',6-((1-Acryloylpiperidin-4-yl)oxy)-4-((3-(hydroxy-methyl)phenyl)amino)-7-methoxyquinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103129,0.26,1796167,381752963,132143239,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,SKBR3 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440229,0.26,1920053,486503527,167318829,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 55",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366323031,0.2618,1535505,440123918,118900269,2064,30600209,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,Synthesis of (E) N (4 (4 (3 fluorobenzyloxy)3-chlorophenylamino)-7-(2-ethoxyethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699901,0.262,1796911,384577257,118900269,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'",Synthesis of (E) N (4 (4 (3 fluorobenzyloxy)3-chlorophenylamino)-7-(2-ethoxyethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440466,0.262,1920053,486503757,167318669,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 288",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440658,0.262,1920053,486503947,167318649,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 483",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707256,0.263,68106,103177567,5329481,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,4-Anilinoquinazoline 4a,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837150,0.263,1795775,8035067,5329481,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',4-Anilinoquinazoline 4a,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356208,0.264,517320,123094322,52946372,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"N-[4-[4-amino-1-[1-[1-(3-methoxypropyl)piperidin-4-yl]piperidin-4-yl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-1,3-benzoxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040650,0.264,760335,174492283,20819668,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[4-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440421,0.264,1920053,486503713,167318872,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 243",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093527,0.265,1057929,194166070,72735051,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",methyl (E)-4-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]carbamoylamino]but-2-enoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632723,0.267,1306577,336906410,127052093,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615863,0.267,1919643,483622426,146448756,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 92",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372344340,0.268,1720526,461529348,121273408,2064,32527559,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant ERBB2 (676 to 1255 residues) expressed in baculovirus expression system using Tyr 06 as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay,N-(4-ethylpyridin-2-yl)-4-[6-(prop-2-enoylamino)quinolin-4-yl]oxybenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821633,0.269,248914,103441797,11238293,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-(pyridin-3-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124294,0.27,418919,103593180,25218690,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"ethyl 4-[4-(4-amino-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl]piperazine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340070332,0.27,770082,174488326,73294314,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
389006058,0.27,1798858,57560479,25218690,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"ethyl 4-[4-(4-amino-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl]piperazine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666467,0.27,1806610,471698543,155243124,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 99",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440406,0.272,1920053,486503698,167318791,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 228",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440409,0.274,1920053,486503701,167318861,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 231",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072434,0.275,1256453,318397023,122195689,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,4-(carbamoylamino)-N-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728026,0.275,1919215,476024484,155756008,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389728254,0.275,1919215,476024561,155755959,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Inhibition of EGFR and HER2 Kinase Activity Assay from US Patent US11548900: 'Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof'","US11548900, Example 101",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440185,0.275,1920053,486503484,166927839,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 12",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440639,0.275,1920053,486503928,167318636,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 463",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093747,0.276,1057929,194166071,72737403,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-[3-(dimethylamino)propyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655715,0.278,1315979,374341764,134152401,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[7-ethoxy-4-[4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
99538453,0.28,40021,103407791,44372022,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing BT474 (Breast) tumor cell proliferation,"4-[4-(3-chloro-4-phenylmethoxyanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100716177,0.28,81567,163312479,10390073,2064,15177482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER-2,4-(4-Fluorophenyl)-2-(1-methylpiperidin-4-yl)-5-(2-(1-(S)-Phenylethyl)amino-4-pyridinyl)thiazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101639295,0.28,277510,103505678,16108950,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-(3,4,10,10a-tetrahydropyrazino[1,2-a]indol-2(1H)-ylcarbonyl)-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101676433,0.28,290549,103523391,44426287,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"4-(2-methyl-4-(6-(2-morpholinoethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101741772,0.28,306289,103549495,44440824,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"Methyl 2-[[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methoxy]acetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101856319,0.28,259431,103462743,10183346,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,8-[(2-iodo-5-methoxyphenyl)sulfanyl]-9-(pent-4-yn-1-yl)-9H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341121841,0.28,1068981,103244983,123631,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630701,0.28,1305356,336902112,127048991,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]methyl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
101821816,0.281,248914,103441770,11342107,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-phenethyloxy-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366528691,0.281,1632302,103244983,123631,2064,27524310,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367502597,0.281,1667576,103244983,123631,2064,32139324,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440477,0.284,1920053,486503768,167318536,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 300",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440265,0.285,1920053,486503561,166927921,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 89",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655707,0.286,1315979,374360282,134157614,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-[[1-(benzenesulfonyl)indol-5-yl]amino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
347072441,0.287,1256453,318397010,122195677,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99566316,0.29,51584,103259470,44307008,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,Pentanedioic acid furan-2-ylmethyl ester 4-((E)-2-nitro-vinyl)-phenyl ester,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100647186,0.29,79614,103203241,44279443,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,"(1-Benzyl-1H-indazol-5-yl)-(6,7-dimethoxy-quinazolin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701300,0.29,215071,103407791,44372022,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and erbB2 overexpressing tumor cell proliferation,"4-[4-(3-chloro-4-phenylmethoxyanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420444,0.29,632227,136945714,56851593,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-[3-chloro-4-(3-methoxyphenoxy)phenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341121842,0.29,1068981,194153503,76317764,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,"(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-piperidin-1-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341121846,0.29,1068981,194181132,76332331,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,"(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(2-methylpiperidin-1-yl)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655808,0.29,1315979,374328377,134148588,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[4-[4-(benzenesulfonamido)anilino]-7-ethoxyquinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380639275,0.29,1876118,242169820,17756796,2064,33539089,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERbB2 (unknown origin),"N-(3-chloro-4-fluorophenyl)-6-[4-(diethylaminomethyl)-1-piperidinyl]-4-pyrimido[5,4-d]pyrimidinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666035,0.29,1806610,471698538,155243075,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-[3-[4-[3-Chloro-4-(trifluoromethoxy)anilino]-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101755928,0.291,309859,103551497,44442028,2064,17869514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Erb2 autophosphorylation by cellular clone 24 assay,(S)-N-(2-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)quinazolin-5-yloxy)propyl)-2-hydroxy-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151278194,0.2954,461252,103729780,45140347,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(4-Fluorobenzylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150612,0.298,1079763,194175281,76329343,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","3-[(6-morpholin-4-ylsulfonyl-9H-pyrido[2,3-b]indol-4-yl)amino]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440568,0.298,1920053,486503857,167318652,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 391",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101565333,0.299,367174,103610059,44571414,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)thiophen-3-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863509,0.299,260903,103177459,176870,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand stimulated erbB2 autophosphorylation in T24 NIH cells,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,526,"","",""
402440246,0.299,1920053,486503543,166927917,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 71",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398122,0.3,164334,103339805,10884588,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-[4-[(3-Bromophenyl)amino]-3-cyano-6-quinolinyl]-4-methoxy-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100667126,0.3,226205,103262784,5329232,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26d",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
101638418,0.3,277510,103505677,16108942,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-{[4-(2-methyl-4-nitrophenyl)-3,6-dihydropyridin-1(2H)-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101862432,0.3,260896,103479787,11503073,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(4-morpholinyl)-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257335,0.3,454329,103717577,46225663,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,N-(4-(benzo[d]thiazol-2-yl)-3-fluorophenyl)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254432701,0.3,634138,103177459,176870,2064,22169601,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363964607,0.3,1503437,404684831,145971962,2064,29028534,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,"N-(2,4-dinitrophenyl)-2-[4-oxo-3-(4-sulfamoylphenyl)benzo[g]quinazolin-2-yl]sulfanylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391779,0.3,1804579,104050833,11407809,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"8-((6-Bromobenzo[d][1,3]dioxol-5-yl)thio)-9-(pent-4-yn-1-yl)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391782,0.3,1804579,104065407,11661053,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"2-Fluoro-8-(6-chloro-benzo[1,3]dioxol-5-ylmethyl)-9-(pent-4-ynyl)adenine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665548,0.3,1806610,471698523,155243035,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',6-((1-Acryloylpiperidin-4-yl)oxy)-4-((4-chloro-3-(hydroxymethyl)phenyl)-amino)-7-methoxy-quinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668630,0.3,1806610,471698542,155242979,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 54",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102330,0.3,1796170,381752963,132143239,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102680,0.3,1796166,381752963,132143239,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402103289,0.3,1796168,381752963,132143239,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,NCI-N87 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402104032,0.3,1796169,381752963,132143239,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,JIMT1 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[[4-[[4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-1-methylimidazole-2-carbonyl]amino]-1-methylpyrrole-2-carbonyl]amino]-1-methylpyrrole-2-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402264137,0.3,1805507,447113332,156905947,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 7",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359453,0.301,69714,103302478,5328969,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,(2e)-N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}-4-(Dimethylamino)but-2-Enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101504952,0.301,361656,103563898,17747105,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)-6-aminopyrimidine-5-carbaldehyde O-methyl oxime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
366322363,0.301,1535440,103302478,5328969,2064,30600149,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His6-tagged HER2 cytoplasmic domain (676 to 1245 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in autophosphorylation preincubated for 10 mins followed by ATP-MgCl2 addition and measured,(2e)-N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}-4-(Dimethylamino)but-2-Enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388817808,0.301,1795646,8034246,5328969,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,(2e)-N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}-4-(Dimethylamino)but-2-Enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440261,0.301,1920053,486503558,167318843,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 283",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440262,0.301,1920053,486503558,167318843,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 283",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146986,0.303,1798142,464922092,170776255,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[4-[5-chloro-4-fluoro-2-(1-hydroxyethyl)anilino]-5-methoxypyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432880,0.304,1919984,486499690,168762324,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.4.1.02,11.04,9]nonadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018073,0.304,1920044,486499690,168762324,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.4.1.02,11.04,9]nonadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440208,0.307,1920053,486503506,162428980,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 34",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440551,0.307,1920053,486503840,167318556,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 373",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707247,0.309,68106,103177568,5329484,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,6-methoxy-N-(4-phenylmethoxyphenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837161,0.309,1795775,8035070,5329484,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',6-methoxy-N-(4-phenylmethoxyphenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675451,0.31,290550,103523389,11477567,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"4-(4-(6,7-dimethoxyquinazolin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694370,0.31,295195,103531660,44430030,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"1-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742015,0.31,306289,103549485,44440816,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-methyl-N-[1-(pyridin-2-ylmethyl)indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155745954,0.31,474117,103749176,46886325,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 intracellular phosphorylation in human N87 cells by ELISA,"N-(3-(5-(2-(4-(4-ethylpiperazin-1-yl)phenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
341150616,0.31,1079763,194182116,76332984,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","N-(4-chlorophenyl)-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402439702,0.313,1920052,486503495,166928116,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 23",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632707,0.315,1306577,336903064,127049689,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,[4-(4-Bromoanilino)quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440218,0.315,1920053,486503516,162428770,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 44",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632865,0.316,1306577,336906407,127052091,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440226,0.317,1920053,486503524,166927741,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 52",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204403331,0.318,580189,124962864,53320059,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,3-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidin-5-yl)-N-(2-morpholinoethyl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410145690,0.318,1798142,402358564,152187859,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[(3R)-3-(dimethylamino)piperidin-1-yl]-5-[[4-[2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366528696,0.319,1632302,174525207,71585566,2064,27524310,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,"(E)-1-[4-(3-chloro-4-fluoroanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(dimethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100358851,0.32,69715,103292758,16149965,2064,11472210,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Dissociation constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdv-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398233,0.32,164334,103339415,10973186,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Diisopropylamino-but-2-ynoic acid [4-(3-bromo-phenylamino)-3-cyano-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701311,0.32,226585,103408188,44372283,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and ErbB-2 average ratio,"N-(2-methylsulfonylethyl)-4-[4-[4-[[3-(trifluoromethyl)phenyl]methoxy]anilino]quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101864183,0.32,260899,103479799,11634425,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER stimulated human erbB autophosphorylation in MDA-MB-453 cells,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dibutylamino)-2-butynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
389668111,0.32,1806610,471698539,155242963,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 49",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112585,0.321,1676531,461518006,162645452,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[6-[4-(4-methylpiperazin-1-yl)phenyl]-3-(2-methylpropyl)-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356252,0.322,517320,123094321,52946371,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-isopropylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345671192,0.3244,1171421,312371393,71244643,2064,25409491,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type HER2 (unknown origin) incubated for 5 mins by HTRF assay,(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-2-fluoro-4-piperidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440199,0.329,1920053,486503497,167318548,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341121838,0.33,1068981,194187980,76335963,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,"(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(4-methylpiperidin-1-yl)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522514,0.33,1849107,482086698,168297032,2064,36351049,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,CID 168297032,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665735,0.33,1806610,471698540,155242964,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-(3-((7-Methoxy-4-(phenylamino)quinazolin-6-yl)oxy)pyrrolidin-1-yl)prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359663,0.334,517501,123094615,52946503,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"trans-N-(4-(4-amino-1-(4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440399,0.334,1920053,486503691,167318879,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 221",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366528695,0.337,1632302,440144894,78324478,2064,27524310,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,"(E)-1-[4-(3-chloro-4-fluoroanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(4-methylpiperidin-1-yl)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402439756,0.337,1920052,486503548,166927854,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 76",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440599,0.337,1920053,486503888,167318642,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 423",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198358517,0.34,517324,123087720,20817111,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 phosphorylation in human BT474 cells by ELISA,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101862435,0.343,260896,103244983,123631,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655717,0.343,1315979,103244983,123631,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
367480750,0.343,1656984,103244983,123631,2064,32031378,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR2 (unknown origin),Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432838,0.343,1919984,486499650,168258054,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018065,0.343,1920044,486499646,168257664,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"Synthesis of (E)-1-((10S)-4-((4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)-7,8,10,11-tetrahydro-9H-6,10-methanopyrimido[4',5':5,6]pyrido[3,2-b][1,4,7]oxadiazonin-9-yl)-4-(bis(methyl-d3)amino)but-2-en-1-one formic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366528694,0.344,1632302,440120068,90322858,2064,27524310,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,"(E)-1-[4-(3-chloro-4-fluoroanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-piperidin-1-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373828718,0.346,1757233,469810920,164617795,2064,33667849,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to HER2 domain IV (unknown origin) by SPR analysis,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440263,0.346,1920053,486503559,167318627,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 87",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409354,0.34674,164335,103346293,6091659,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin AG 825,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707253,0.347,68106,103177505,5329485,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,N-[4-(benzyloxy)phenyl]-6-(prop-2-en-1-yloxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355633703,0.347,1306577,336904291,127050555,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(3-Bromoanilino)quinazolin-6-yl]-3-(3-morpholin-4-ylpropyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837159,0.347,1795775,8035071,5329485,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',N-[4-(benzyloxy)phenyl]-6-(prop-2-en-1-yloxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821632,0.348,248914,103441794,11478340,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-pyrimidin-2-ylsulfanylanilino)-3-cyano-7-methoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99529126,0.35,3366,103262822,5329243,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26o",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100337131,0.35,69874,103332485,135402848,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Bromophenylamino)-6,7-dihydroxy-3-quinolinecarbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100358854,0.35,69715,103292706,16151367,2064,11472210,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Dissociation constant for peptide inhibitor binding to HER2 receptor,dFCDGFYACdYMDV-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455175,0.35,81560,103346293,6091659,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,Tyrphostin AG 825,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647232,0.35,79614,103203612,44279655,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,"(1-Benzyl-1H-indol-5-yl)-(6,7-dimethoxy-quinazolin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101778938,0.35,315244,103575075,11562650,2064,18061446,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ebrB2 expressed in human MCF7 cells by autophosphorylation assay,N-[3-Chloro-4-(pyridin-2-ylmethoxy)phenyl]-5-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
151286895,0.35,456100,103723984,46200951,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Chloro-2-hydroxybenzyl)-1-(4-hydroxybenzyl)-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151288070,0.35,460690,103724585,46207042,2064,20005116,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(1-naphthyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155734507,0.35,463639,103177459,176870,2064,20166671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605091,0.35,1867605,160682577,6444692,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,Mubritinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380648050,0.35,1878102,318464585,71226662,2064,35041943,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to ERBB2 (unknown origin) assessed as dissociation constant by KINOMEscan analysis,Acalabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665403,0.35,1806610,471698523,155243035,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',6-((1-Acryloylpiperidin-4-yl)oxy)-4-((4-chloro-3-(hydroxymethyl)phenyl)-amino)-7-methoxy-quinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665719,0.35,1806610,471698540,155242964,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-(3-((7-Methoxy-4-(phenylamino)quinazolin-6-yl)oxy)pyrrolidin-1-yl)prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440414,0.352,1920053,486503706,162428839,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 236",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380552838,0.357,1855770,482046728,165412710,2064,35964425,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human HER2 incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,Dhfr-IN-4,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106023765,0.358,447375,103560256,44446843,2064,19635666,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,"(6S,7S)-N-hydroxy-6-(3-phenylpyrrolidine-1-carbonyl)-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440213,0.358,1920053,486503511,166927841,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 39",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453087,0.359,375732,103560256,44446843,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(6S,7S)-N-hydroxy-6-(3-phenylpyrrolidine-1-carbonyl)-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
100337224,0.36,69874,103332784,5328864,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(2-Isopropylphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701292,0.36,144357,103407791,44372022,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing N87 (Gastric) tumor cell proliferation,"4-[4-(3-chloro-4-phenylmethoxyanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694012,0.36,295195,103531646,22390502,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-(pyrrolidin-1-ylmethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101856068,0.36,259431,103477162,10140801,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,2-fluoro-8-[(2-iodo-5-methoxyphenyl)sulfanyl]-9-(pent-4-yn-1-yl)-9H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101912900,0.36,270616,103498857,9808725,2064,16777410,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-(trifluoromethyl)benzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365016,0.36,549932,124959165,53318117,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-[(4-aminopiperidin-1-yl)methyl]-N-(1-methylindazol-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040375,0.36,760335,174512935,72163258,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[4-[4-(3-chloroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101504956,0.361,361656,103643926,24897045,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,"4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-(methylhydrazinylidene)methyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
198358519,0.362,517324,123101237,52941514,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 phosphorylation in human BT474 cells by ELISA,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101821806,0.363,248914,103441790,11237508,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(4-benzyloxy-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355633178,0.364,1306577,336903065,127049690,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,[4-(3-Ethynylanilino)quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391787,0.365,1804579,104050833,11407809,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"8-((6-Bromobenzo[d][1,3]dioxol-5-yl)thio)-9-(pent-4-yn-1-yl)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366528693,0.369,1632302,103177459,176870,2064,27524310,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367502591,0.369,1667576,103177459,176870,2064,32139324,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99529125,0.37,3366,103262821,5329244,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26p",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99529131,0.37,3366,103262865,5329240,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26l",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100398234,0.37,164334,103339596,11733863,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-{4-[(3-Bromophenyl)amino]-3-cyano-6-quinolinyl}-4-dipropylamino-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101856321,0.37,259431,103477119,10277546,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,8-(2-Iodo-5-methoxy-phenylsulfanyl)-9-(4-methyl-pent-3-enyl)-9H-purin-6-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124275,0.37,418567,103593321,25263251,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(5-methyl-1,2-oxazol-3-yl)oxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155746562,0.37,474114,103749169,46886319,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-[3-(5-{2-[(4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}imidazo[2,1-B][1,3]thiazol-6-Yl)phenyl]-2-Phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341121839,0.37,1068981,103177459,176870,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630705,0.37,1305356,336904285,127050549,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[5-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]-2-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
389000798,0.37,1798897,58097683,25263251,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-{2-[4-({3-chloro-4-[(5-methyl-1,2-oxazol-3-yl)oxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665537,0.37,1806610,471698540,155242964,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-(3-((7-Methoxy-4-(phenylamino)quinazolin-6-yl)oxy)pyrrolidin-1-yl)prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355633467,0.371,1306577,336902097,127048978,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,N-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440207,0.371,1920053,486503505,167318628,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 33",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093723,0.374,1057929,194166069,72735050,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-prop-2-ynylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150614,0.376,1079763,194147661,76314858,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","3-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-9H-pyrido[2,3-b]indol-4-yl]amino]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440407,0.376,1920053,486503699,167318580,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 229",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359451,0.378,69714,103303045,2776,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,N-(4-((3-bromophenyl)amino)quinazolin-6-yl)but-2-ynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817750,0.378,1795646,8034229,2776,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,N-(4-((3-bromophenyl)amino)quinazolin-6-yl)but-2-ynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398118,0.38,164334,103407703,44371971,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]-3-(methoxymethoxy)prop-2-ynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398131,0.38,164334,103339325,10161969,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Methoxy-but-2-ynoic acid [4-(3-bromo-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101743217,0.38,306289,103549516,44440839,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-[[(2S)-morpholin-2-yl]methoxymethyl]-N-[1-(pyridin-2-ylmethyl)indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
340071505,0.38,770082,174503766,73291831,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"(E)-4-(dimethylamino)-N-[3-[(5-fluoro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxyphenyl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
410146982,0.382,1798142,464922054,139377814,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[(3aS,6aS)-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-1-yl]-5-[[4-[4,5-difluoro-2-(2-hydroxybutan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366528433,0.384,1632302,440135269,78324177,2064,27524310,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,"(E)-1-[4-(3-chloro-4-fluoroanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(2-methylpiperidin-1-yl)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522520,0.385,1849107,482049278,168270738,2064,36351049,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,H-Asn-Pro-Asn-Trp-Gly-Arg-Ser-Trp-Tyr-Asn-Gln-Arg-Phe-Lys-Gly-Cys-Gly-Cys-Gly-Arg-Ile-Lys-Pro-Arg-Lys-Gly-Tyr-Thr-Arg-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688210,0.3861,1330925,374291131,134138227,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,6-[4-[4-(3-chloro-2-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyhexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821967,0.388,248914,103441764,11786660,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-[3-chloro-4-[(3,5-difluorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345660773,0.388,1167102,174493358,73294507,2064,25271963,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"(E)-N-[3-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxyphenyl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
402440507,0.389,1920053,486503798,167318545,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 331",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99539689,0.39,40020,103592046,5329493,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 overexpressing BT474 (breast carcinoma) cell line proliferation,N-{1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829711,0.39,254975,103468296,23646540,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"Ethyl 4-[(1-benzylindazol-5-yl)amino]pyrrolo[2,1-f][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
340070340,0.39,770082,174519075,73291830,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"(E)-4-(dimethylamino)-N-[4-methoxy-3-[(4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]phenyl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
341150617,0.39,1079763,194140847,76311267,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","N-(3-methoxyphenyl)-6-piperazin-1-ylsulfonyl-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363964609,0.39,1503437,404656549,145952676,2064,29028534,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,2-[4-oxo-3-(4-sulfamoylphenyl)benzo[g]quinazolin-2-yl]sulfanyl-N-quinolin-3-ylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615729,0.39,1919643,483622421,146510109,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 80",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440479,0.391,1920053,486503770,167318687,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 302",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093535,0.392,1057929,194152107,72737575,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",3-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-1-[2-(diethylamino)ethyl]-1-methylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356284,0.393,517320,123092901,20817111,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440211,0.393,1920053,486503509,166927838,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 37",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359655,0.397,517501,123096640,52947602,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-(3-methoxypropyl)piperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100667852,0.4,81581,103263082,5329239,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26k",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
340069406,0.4,770082,174493358,73294507,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"(E)-N-[3-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxyphenyl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
341093400,0.4,1057929,194186579,72737402,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA","1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(3,3-dimethoxypropyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666464,0.4,1806610,471698529,155243065,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355633463,0.401,1306577,336902096,127048977,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440212,0.403,1920053,486503510,162428973,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 38",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440230,0.403,1920053,486503528,167318767,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 56",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440480,0.403,1920053,486503771,167318656,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 303",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656234,0.404,1315979,374291394,134138310,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[7-methoxy-4-(4-phenylmethoxyanilino)quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821646,0.406,248914,103441801,11296256,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"4-Dimethylamino-but-2-enoic acid [4-(4-benzyloxy-3,5-dichloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656030,0.406,1315979,374293917,134139047,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440012,0.406,1920052,486503798,167318545,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"Biochemical Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 331",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632522,0.407,1306577,318397010,122195677,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867976,0.407,1795986,381620340,137529668,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[4-[4-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenoxy]methyl]piperidine-1-carbonyl]phenyl]-4,5,5-trimethyl-1,3,2-dioxaborolan-2-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742023,0.41,306289,103549517,44440840,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-[[(2S)-morpholin-2-yl]methoxymethyl]-N-[1-(pyridin-3-ylmethyl)indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151288062,0.41,460690,103724389,46229773,2064,20005116,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(4-methoxyphenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
340040378,0.41,760335,174502626,72165162,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-propan-2-ylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616869,0.41,1268283,103177459,176870,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821952,0.412,248914,103441758,44388499,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(2,6-dimethylpiperidin-1-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655712,0.413,1315979,374292257,134138566,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[7-methoxy-4-[4-(pyridin-2-ylmethyl)anilino]quinazolin-6-yl]-4-pyrrolidin-1-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100359449,0.414,69714,103302834,5328978,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 16r,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817767,0.414,1795646,8034255,5328978,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 16r,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574014,0.415,320574,103574308,11712609,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"1-(2-{[4-({3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656244,0.419,1315979,374318161,134145751,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[7-methoxy-4-(4-phenoxyanilino)quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
99566326,0.42,51584,103259394,10405907,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,Pentanedioic acid 4-((E)-2-nitro-vinyl)-phenyl ester phenyl ester,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100337273,0.42,69874,103332909,5328838,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Bromophenylamino)-6,7-diethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742017,0.42,306289,103549492,44440821,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-(2-methoxyethoxymethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742027,0.42,306289,103549491,44440820,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-(methoxymethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286113,0.42,456091,103724200,135488525,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,(E)-2-(2-(5-bromo-2-hydroxybenzylidene)hydrazinyl)thiazol-4(5H)-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254420123,0.42,632227,123085235,16736274,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"2-{2-[4-({5-Chloro-6-[3-(Trifluoromethyl)phenoxy]pyridin-3-Yl}amino)-5h-Pyrrolo[3,2-D]pyrimidin-5-Yl]ethoxy}ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432825,0.422,1919984,486499638,168258063,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440253,0.422,1920053,486503550,166927701,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 78",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018057,0.422,1920044,486499637,168258126,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101503505,0.426,361656,103644048,24897280,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,"(S)-N4-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((2-(methoxymethyl)pyrrolidin-1-ylimino)methyl)pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101741766,0.43,306289,103549482,22055269,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101567608,0.431,367181,103610114,44571434,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 intracellular autophosphorylation of ErbB2 in human BT474 cells by DELFIA assay,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)-1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
402440255,0.431,1920053,486503552,166927919,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 80",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093689,0.432,1057929,194159082,72737033,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2-hydroxyethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440433,0.434,1920053,486503725,162428990,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 255",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595847,0.435,331423,103563548,17747279,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-(2-methoxyphenyl)methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522511,0.437,1849107,482049106,168270628,2064,36351049,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,CID 168270628,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597773,0.437,1865640,440199298,121269225,2064,36518696,Confirmatory,20230629,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 wild type (679 to 1255 residues) expressed in baculovirus infected Sf9 insect cells using AQT0794 measured up to 240 mins by fluorescence assay,Lazertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574018,0.44,320574,103574013,11663284,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(3-morpholin-4-ylpropoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402362,0.44,580189,124962421,51346878,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-methyl-5-((4-(morpholinomethyl)phenyl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457137,0.44,624804,103526391,10427712,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,"6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605541,0.44,1867605,482084340,156768722,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"2-methyl-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665724,0.44,1806610,471698538,155243075,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',1-[3-[4-[3-Chloro-4-(trifluoromethoxy)anilino]-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440469,0.446,1920053,486503760,167318683,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 291",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440657,0.446,1920053,486503946,162428845,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 482",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334046124,0.4462,730878,164143589,71578587,2064,23107515,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to synthetic peptide mimicking HER2 subdomain 4 (unknown origin) by fluorescence spectroscopic analysis,"(2S)-2-[[(2S,3R)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-acetamidopropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]amino]-N-[2-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethyl]butanediamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409353,0.44668,164335,103346025,44345336,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,2-[5-(2-Carbamoyl-2-cyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093396,0.447,1057929,194186578,72737209,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2-piperidin-1-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398248,0.448,1574931,440222080,155566440,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[[1-(2-phenylethyl)triazol-4-yl]methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
100398124,0.45,164334,103339595,11005320,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,3-(2-Methoxy-ethoxy)-propynoic acid [4-(3-bromo-phenylamino)-3-cyano-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455171,0.45,81560,103346025,44345336,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,2-[5-(2-Carbamoyl-2-cyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124280,0.45,418567,103593132,25263248,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-{2-[4-({6-[(3-fluorophenyl)methoxy]pyridin-3-yl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389000639,0.45,1798897,58097680,25263248,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-{2-[4-({6-[(3-fluorophenyl)methoxy]pyridin-3-yl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668007,0.45,1806610,471698539,155242963,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 49",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359374,0.458,69714,103303565,5328985,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 23,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656241,0.458,1315979,374351155,134155078,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388829373,0.458,1795646,8034262,5328985,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 23,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829523,0.46,255868,103468240,9871380,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against Sal2 (salivary gland carcinoma) cell line expressing active HER2,"2-imidazol-1-ylethyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334019642,0.46,722488,164139692,71508889,2064,23245802,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 cytoplasmic domain (amino acids 676 to 1245) expressed in Sf9 cells by DELFIA time resolved fluorometry,"4-(4-Bromophenyl)-2-[5-(4-bromophenyl)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)-3,4-dihydropyrazol-2-yl]-1,3-thiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101862436,0.464,260896,103479786,11518637,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,N-[4-[(3-chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(dibutylamino)-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440464,0.468,1920053,486503755,167318650,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 286",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453085,0.47,375732,103635216,44583622,2064,19457660,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S)-N-hydroxy-2-(4-phenylpiperazine-1-carbonyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101514795,0.47,364803,103587875,17747535,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-Amino-6-(4-(benzyloxy)-3-chlorophenylamino)pyrimidine-5-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665404,0.47,1806610,471698524,155243031,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',6-((1-Acryloylpiperidin-4-yl)oxy)-7-methoxy-4-((3-(oxazol-5-yl)phenyl)-amino)quinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366398254,0.471,1574931,440185869,155552106,2064,30554954,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human C-terminal His6-tagged ERBB2 (676 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",N-[4-(3-chloro-4-fluoroanilino)-7-[(1-phenyltriazol-4-yl)methoxy]quinazolin-6-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,490,"","",""
402440629,0.474,1920053,486503918,167318848,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 453",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359654,0.478,517501,123087387,52942747,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"trans-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-3-methylphenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151278191,0.4782,461252,103729688,46233390,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,7-(4-(3-Chloro-4-fluorobenzylamino)-7-methoxyquinazolin-6-yloxy)-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389668922,0.48,1806610,471698542,155242979,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 54",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388699898,0.482,1796911,384577252,118900306,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"HTRF kinEASE TK from US Patent US10196365: 'Quinazoline derivative, preparation method therefor, and pharmaceutical composition and application thereof'","Synthesis of (S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-methoxy-1-methylethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366322623,0.4821,1535505,440118534,118900306,2064,30600209,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,"Synthesis of (S,E)-N-(4-(3-chloro-4-fluorophenylamino)-7-(2-methoxy-1-methylethoxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829092,0.487,1757232,469810920,164617795,2064,33667849,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to HER2 ECD (unknown origin) by SPR analysis,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257105,0.49,454329,103717617,46225688,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,N-(4-(benzo[d]thiazol-2-yl)-2-methylphenyl)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440549,0.492,1920053,486503838,167318638,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 371",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440601,0.495,1920053,486503890,167318803,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 425",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821964,0.498,248914,103441738,11168387,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(4-benzyloxy-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
40274281,0.5,1433,50100098,6445562,2064,"",Other,20170124,0,0,Active,NP_001005862,"","",Ambit Biosciences,Kinase Inhibitor Selectivity Profiling Assay,Pelitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99529124,0.5,3366,103262170,10300451,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"5-{[(5Z)-4-[(3-ethynylphenyl)amino]-6-oxo-5H,6H,7H-pyrrolo[2,3-d]pyrimidin-5-ylidene]methyl}-4-methyl-N-[2-(morpholin-4-yl)ethyl]-1H-pyrrole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100039979,0.5,240906,103460627,10385997,2064,16078851,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 kinase in intact CSH12 cells,"N-{4-[(4,5-dichloro-2-fluoro-phenyl)amino]quinazolin-6-yl}-2-methoxyacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100667057,0.5,81580,103263075,5329245,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26q",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
101133764,0.5,328043,103442094,11282791,2064,18343125,Confirmatory,20181023,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of Her2 expressed in CSH12 cells by Western blot analysis,"1-(2,4-Difluoro-phenyl)-3-[4-(6,7-dimethoxy-quinolin-4-yloxy)-3-fluoro-phenyl]-urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101133765,0.5,328043,103570147,44452543,2064,18343125,Confirmatory,20181023,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of Her2 expressed in CSH12 cells by Western blot analysis,"1-[4-(6,7-Dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-(4-fluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101133766,0.5,328043,103570148,44452544,2064,18343125,Confirmatory,20181023,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of Her2 expressed in CSH12 cells by Western blot analysis,"1-[4-(6,7-Dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-(2-fluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101597736,0.5,331537,103564772,44449577,2064,18395443,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"6-(5-methyl-1,3,4-oxadiazol-2-yl)-5-propan-2-yl-N-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829706,0.5,254975,103468205,21945841,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"4-[(1-benzylindazol-5-yl)amino]-5-ethyl-N,N-dimethylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101920044,0.5,271972,103454583,11153014,2064,17154512,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2,"N-(2-Chloro-6-methylphenyl)-2-((2,6-dimethyl-4-pyrimidinyl)amino)-5-thiazolecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001438,0.5,435796,103730344,6445562,2064,18183025,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Pelitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632873,0.5,1306577,336904293,127050557,2064,27288180,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(3-morpholin-4-ylpropyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355633186,0.5,1306577,336901227,127048297,2064,27288180,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355633475,0.5,1306577,336901226,127048296,2064,27288180,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355633699,0.5,1306577,336906855,127052408,2064,27288180,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408007183,0.5,1948926,381864366,24756034,2064,26629594,Confirmatory,20240503,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin) autophosphorylation expressed in human BT-474 cells by ELISA-based assay,"1-Naphthalenecarboxamide, 6-((6-(hydroxymethyl)-4-pyrimidinyl)oxy)-N-(3-(trifluoromethyl)phenyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408007184,0.5,1948926,381881408,16004702,2064,26629594,Confirmatory,20240503,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin) autophosphorylation expressed in human BT-474 cells by ELISA-based assay,Nvp-baw2881,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440200,0.507,1920053,486503498,166927906,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 26",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101504951,0.509,361656,103643993,24897278,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,"N4-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((4-methylpiperazin-1-ylimino)methyl)pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
355656396,0.509,1315979,374351652,134155220,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
99529128,0.51,3366,103263075,5329245,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26q",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101742020,0.51,306289,103549522,44440844,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(1S)-1-(3-fluorophenyl)ethyl]indazol-5-yl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354616870,0.51,1268283,336888580,127039277,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-[2-acetyl-5-[4-(trifluoromethyl)phenyl]-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666469,0.51,1806610,471698536,155242989,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101862430,0.511,260896,103177459,176870,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632840,0.513,1306577,336904292,127050556,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]-3-(3-morpholin-4-ylpropyl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367480751,0.513,1656984,103177459,176870,2064,32031378,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR2 (unknown origin),Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340011994,0.518,748805,174501508,11352718,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"N-[2-(4-amino-7-cyclopentylpyrrolo[2,3-d]pyrimidin-5-yl)-3H-benzimidazol-5-yl]-2,6-difluorobenzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
155742430,0.52,473323,103746519,46197127,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,N-(4-(3-Bromophenylamino)quinolin-6-yl)propionamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666666,0.52,1806610,471698543,155243124,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 99",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265724,0.52,1805507,447113331,156905946,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890379,0.525,1797499,386053068,66838546,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 35",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890381,0.525,1797499,386045968,57802847,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 272",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890384,0.525,1797499,386053017,70946765,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 18",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890385,0.525,1797499,386053008,10458325,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',Tesevatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890387,0.525,1797499,386053023,57802554,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 24",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890392,0.525,1797499,386053010,10073622,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 11",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890599,0.525,1797499,386053013,10392846,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 14",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388894348,0.525,1797499,386045973,57802611,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 277",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388894360,0.525,1797499,386053050,10321951,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 60",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388896144,0.525,1797499,386053019,70946714,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 20",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388896145,0.525,1797499,386053018,70795120,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 19",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388896153,0.525,1797499,386053026,57802649,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388896157,0.525,1797499,386053052,10480937,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 62",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388901535,0.525,1797499,386053030,70795231,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 32",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388901539,0.525,1797499,386053040,57802612,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 49",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388903118,0.525,1797499,386053028,70946716,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388903119,0.525,1797499,386053029,70795293,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 30",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388903125,0.525,1797499,386053060,10076584,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388907781,0.525,1797499,386053028,70946716,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 29",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388907786,0.525,1797499,386053020,70946733,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 21",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388907787,0.525,1797499,386053032,58013819,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 38",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388911599,0.525,1797499,386053101,66838678,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 97",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388911605,0.525,1797499,386053042,53630924,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"(3S,8aR)-3-({[4-[(3,4-dichloro-2-fluorophenyl)amino]-6-(methyloxy)quinazolin-7-yl]oxy}methyl)hexahydropyrrolo[1,2-a]pyrazin-1(2H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388912559,0.525,1797499,386053009,10256639,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 10",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388912568,0.525,1797499,386053020,70946733,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 21",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388912873,0.525,1797499,386053039,66954887,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 46",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913518,0.525,1797499,386053043,57802807,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 53",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913521,0.525,1797499,386053063,9986023,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913744,0.525,1797499,386053035,57802812,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 41",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913745,0.525,1797499,386053021,57802840,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 22",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913749,0.525,1797499,386053027,57802768,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 28",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388914156,0.525,1797499,386053047,10480595,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 57",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388914310,0.525,1797499,386053057,10482693,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 67",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388914491,0.525,1797499,386053025,57802705,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 26",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388914865,0.525,1797499,386053129,10460027,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 125",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388917009,0.525,1797499,386053152,57802888,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 148",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388917862,0.525,1797499,386053270,57802655,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 267",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388917869,0.525,1797499,386053015,9985010,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 16",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388919445,0.525,1797499,386053082,10075455,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 78",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388919793,0.525,1797499,386053045,10413710,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 55",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388920139,0.525,1797499,386053055,10412767,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 65",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388920796,0.525,1797499,386053051,10325018,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 61",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388921964,0.525,1797499,386053066,57802582,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 33",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388921968,0.525,1797499,386053227,57802553,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 223",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388922289,0.525,1797499,386053225,139208797,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 221",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388922299,0.525,1797499,386053051,10325018,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 61",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388922660,0.525,1797499,386053264,57802778,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 261",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388923209,0.525,1797499,386053053,10392528,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 63",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388923212,0.525,1797499,386053115,10365561,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 111",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388923346,0.525,1797499,386053273,57802594,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 270",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388923359,0.525,1797499,386053244,57802663,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 240",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388923563,0.525,1797499,386053231,57802595,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 227",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388924016,0.525,1797499,386053274,57802758,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 271",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388924691,0.525,1797499,386053054,10369165,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 64",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388924935,0.525,1797499,386053236,57802646,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 232",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925120,0.525,1797499,386053046,57802698,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 56",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925214,0.525,1797499,386053228,57802559,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 224",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925486,0.525,1797499,386053252,57802753,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 248",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925493,0.525,1797499,386053246,57802563,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 242",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925639,0.525,1797499,386053257,57802734,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 254",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925645,0.525,1797499,386053121,10050178,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 117",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925761,0.525,1797499,386053224,57802773,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 220",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925870,0.525,1797499,386053207,57802769,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 203",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926030,0.525,1797499,386053233,57802826,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 229",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926583,0.525,1797499,386053234,57802839,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 230",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926585,0.525,1797499,386053271,57802781,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 268",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926684,0.525,1797499,386053232,57802770,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 228",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388927084,0.525,1797499,386053251,57802891,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 247",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388927507,0.525,1797499,386053239,57802731,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 235",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388928163,0.525,1797499,386053238,139208798,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 234",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388928953,0.525,1797499,386053168,121323685,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 164",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388928959,0.525,1797499,386053245,57802623,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 241",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388929604,0.525,1797499,386053250,57802673,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 246",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388930093,0.525,1797499,386053263,57802616,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 260",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388930095,0.525,1797499,386053176,10320305,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 172",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388930096,0.525,1797499,386053235,121323686,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 231",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388930835,0.525,1797499,386053226,57802718,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 222",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100671763,0.529,91107,103202250,156414,2064,12270171,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 autophosphorylation,Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675458,0.53,290550,103523372,44426275,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"1-(4-(4-(6,7-Bis(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675463,0.53,290550,103523386,44426284,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"(4-(4-(6,7-Bis(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)(cyclopentyl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356228,0.53,517320,123087387,52942747,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"trans-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-3-methylphenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366479987,0.53,1615366,374328055,135565884,2064,31381333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay,Zanubrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380822900,0.53,1913719,374328055,135565884,2064,"",Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Selectivity interaction (33P-ATP and filter-binding assay (Reaction Biology)) EUB0000646a ERBB2,Zanubrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410146100,0.534,1798142,464922029,150622911,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',"N-[2-[(3aS,6aS)-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-1-yl]-5-[[4-[4,5-difluoro-2-(2-hydroxypropan-2-yl)anilino]-1,3,5-triazin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688218,0.5374,1330925,374330964,134149339,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,"6-[4-[4-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)anilino]quinazolin-6-yl]triazol-1-yl]-N-hydroxyhexanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337129,0.54,69874,103332222,5328851,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Chloro-4-fluorophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100710600,0.54,92132,103592046,5329493,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro efficacy (average) against HN5 (EGFR) and BT474 (erbB2) tumor cell proliferation,N-{1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821950,0.54,248914,103441683,11238864,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456598,0.54,624804,103583785,16038120,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,"5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616877,0.54,1268283,103177479,208908,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432832,0.547,1919984,486499644,168257400,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018064,0.547,1920044,486499645,168257532,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100702776,0.55,68100,103408188,44372283,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB-2,"N-(2-methylsulfonylethyl)-4-[4-[4-[[3-(trifluoromethyl)phenyl]methoxy]anilino]quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675465,0.55,290549,103523358,44426262,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,2-methoxy-N-[3-(4-{3-methyl-4-[1-(tetrahydro-furan-2-carbonyl)-piperidin-4-yloxy]-phenylamino}-quinazolin-6-yl)-prop-2-ynyl]-acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
340040379,0.55,760335,174507798,72163260,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,3-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylpropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388836054,0.55,1795774,8035061,5329478,2064,14684309,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/j.bmcl.2003.10.010: 'Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.',6-Thiazolylquinazoline 4,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950013,0.55,1798244,404342800,135236483,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950140,0.55,1798244,404342798,135236945,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 92",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950141,0.55,1798244,404342792,135236450,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 82",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950280,0.55,1798244,404342809,135236611,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 90",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950287,0.55,1798244,404342812,135236597,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 104",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950400,0.55,1798244,404342798,135236945,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 92",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950538,0.55,1798244,404342803,135236756,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 43",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950540,0.55,1798244,404342811,135236566,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 98",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950729,0.55,1798244,404342785,135251923,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 34",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950733,0.55,1798244,404342787,135236457,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 36",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950735,0.55,1798244,404342795,135236536,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 86",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950736,0.55,1798244,404342791,135237001,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 81",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950871,0.55,1798244,404342797,135236903,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950878,0.55,1798244,404342794,135236518,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 85",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389453650,0.552,1805069,442074304,135177281,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Z′-LYTE assay from US Patent US10858364: 'Imidazopyrazine inhibitors of Bruton's tyrosine kinase',"4-[8-Amino-3-[4-(but-2-ynoylamino)butanoyl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440472,0.552,1920053,486503763,167318834,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 295",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655806,0.556,1315979,374283101,134136098,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"N-[4-[(1-benzyl-2,3-dihydroindol-5-yl)amino]-7-methoxyquinazolin-6-yl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151279396,0.5569,461252,103729845,45140351,2064,20143778,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,(R)-7-(4-(1-(4-Chlorophenyl)ethylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101595846,0.557,331423,103563853,17747243,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-(3-bromophenyl)-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440470,0.558,1920053,486503761,167318807,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 292",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433593,0.559,636385,136920690,57390197,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,6-(3-aminophenoxy)-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101638414,0.56,277510,103505626,44418977,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(2S,3S)-N-hydroxy-2-((R)-3-phenylpyrrolidine-1-carbonyl)piperidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101741768,0.56,306289,103549514,44440837,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742013,0.56,306289,103549503,22390490,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-[3-(dimethylamino)propoxymethyl]-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101751505,0.56,308828,103549514,44440837,2064,17606372,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in insect Sf9 cells,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440471,0.568,1920053,486503762,167318630,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 293",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150760,0.576,1079763,194154585,76318469,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","N-(3-ethoxyphenyl)-6-piperazin-1-ylsulfonyl-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254456055,0.58,624804,104246801,42642645,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Foretinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440467,0.584,1920053,486503758,167318708,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 289",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742030,0.59,306289,103549512,44440835,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[[(3R)-morpholin-3-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254420195,0.59,632227,136931749,56851433,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"4-[2-chloro-4-(5H-pyrrolo[3,2-d]pyrimidin-4-ylamino)phenoxy]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326060499,0.59,711546,163332492,23546055,2064,21413808,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"7-(4-Bromophenyl)-7lambda4,9lambda6-dithia-3,8-diazabicyclo[4.3.0]nona-1(6),2,4,7-tetraene 9,9-dioxide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355646914,0.59,1312567,336896929,127045267,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic His-tagged human ErbB2 expressed in baculovirus system by z-lyte assay,N-(3-ethynylphenyl)-6-(1-methylpyrazol-4-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366428835,0.59,1589888,440229356,135236597,2064,31023512,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of probe binding to HER2 (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,"US10246444, Example 104",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265226,0.59,1805507,447113334,156905948,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 9",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372112593,0.592,1676531,461536005,162658093,2064,32931277,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of C-terminal His6-tagged HER2 (703 to 1029 residues) (unknown origin) expressed in Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 60 mins in presence of XL665-labeled streptavi,"N-[3-[6-[4-(4-methylpiperazin-1-yl)phenyl]-4-oxo-3-propan-2-yl-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863458,0.597,260896,103479580,11711590,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(diethylamino)-2-butynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863511,0.599,260903,103244983,123631,2064,16480284,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand stimulated erbB2 autophosphorylation in T24 NIH cells,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,526,"","",""
345661009,0.6,1167102,312367125,78357783,2064,25271963,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,Mutant EGFR inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
389666846,0.6,1806610,471698531,155243066,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 31",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440468,0.601,1920053,486503759,167318846,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 290",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821820,0.603,248914,103441711,11422548,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(1,4,7-trioxa-10-azacyclododec-10-yl)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694379,0.61,295195,103531668,22390480,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"1-[4-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799245,0.61,1428363,381878123,137656751,2064,27987485,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(4-chlorophenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366369533,0.61,1560827,381849777,54755438,2064,32083858,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to DNA-tagged recombinant ERBB2 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis,Tirabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574011,0.613,320574,103574264,44455293,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"1-(2-{[4-({4-[(3-fluorobenzyl)oxy]-3-methoxyphenyl}amino)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]oxy}ethyl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337279,0.62,69874,103332519,5328870,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(4-Bromo-3-methylphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155779966,0.62,472048,103737177,46879474,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,"7-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrrolo[2,3-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101821629,0.625,248914,103441693,11180494,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,2-{2-Chloro-4-[3-cyano-6-(4-dimethylamino-but-2-enoylamino)-7-ethoxy-quinolin-4-ylamino]-phenoxymethyl}-1-methyl-3H-imidazol-1-ium,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072445,0.625,1256453,318397012,122195678,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,1-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]quinazolin-6-yl]-3-ethylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372364052,0.6337,1731398,461535100,162657456,2064,33545637,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"6-[2-[(5E)-5-[(4-chlorophenyl)methylidene]-3-(4-methylphenyl)-6-oxo-1H-1,2,4-triazin-2-yl]-2-oxoethyl]-3-methyl-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359372,0.634,69714,103302863,5328977,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 16q,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817795,0.634,1795646,8034254,5328977,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 16q,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432876,0.635,1919984,486499686,168257392,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"(E)-4-(dimethylamino)-1-[5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,16-pentazatetracyclo[13.3.1.02,11.04,9]nonadeca-2(11),3,5,7,9-pentaen-16-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018070,0.635,1920044,486499686,168257392,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"(E)-4-(dimethylamino)-1-[5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,16-pentazatetracyclo[13.3.1.02,11.04,9]nonadeca-2(11),3,5,7,9-pentaen-16-yl]but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356236,0.639,517320,123098951,20817096,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-5,7-dichlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656039,0.642,1315979,374338040,134151327,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[7-methoxy-4-[[1-(pyridin-2-ylmethyl)indol-5-yl]amino]quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100358850,0.65,69715,103291865,16148913,2064,11472210,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Dissociation constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355632877,0.653,1306577,336906856,127052409,2064,27288180,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,"1-[4-(3,4-Dichloroanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)thiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124856,0.66,418922,103593179,25218689,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ErbB2 phosphorylation in IGF1 and EGF-stimulated human N87 cells pretreated for 6 hrs before IGF1 and EGF stimulation by ELISA,"1-{4-[4-(4-amino-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl]piperazin-1-yl}ethan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
151286884,0.66,456100,103723985,46229517,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Bromo-2-hydroxybenzyl)-1-(4-hydroxybenzyl)-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
103124292,0.664,418919,103550977,24180536,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-6-yl)-1-((trans)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389005904,0.664,1798858,57560475,24180536,2064,19217287,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Kinase Inhibition Assay from Article 10.1016/j.bmcl.2009.01.086: 'Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.',"3-(2-(2-chlorobenzyl)-1H-benzo[d]imidazol-6-yl)-1-((trans)-4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101639302,0.67,277510,103380360,10829071,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,N-hydroxy-1-(4-methoxyphenylsulfonyl)piperidine-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101889378,0.67,266066,103237764,5328042,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,"N4-(3-Bromophenyl)quinazoline-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
340040651,0.67,760335,174512934,11375205,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,"2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N,N-dimethylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093313,0.672,1057929,194172916,72737035,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2-methylsulfonylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366528434,0.674,1632302,440181432,78324176,2064,27524310,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,"(E)-1-[4-(3-chloro-4-fluoroanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440520,0.675,1920053,486503811,167318676,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 344",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355646915,0.676,1312567,336893933,127043295,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic His-tagged human ErbB2 expressed in baculovirus system by z-lyte assay,N-(3-chloro-4-fluorophenyl)-6-(1-methylpyrazol-4-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093697,0.677,1057929,194138370,72737405,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",3-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-1-[2-(dimethylamino)ethyl]-1-methylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829716,0.68,254975,103468231,23644675,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"2-[4-[(1-Benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazin-6-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101889385,0.68,266066,103490185,11683171,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,1-[4-(3-Chloroanilino)quinazolin-6-yl]-3-(2-chloroethyl)-1-methyl-3-nitrosourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
155745957,0.68,474117,103749174,46886323,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 intracellular phosphorylation in human N87 cells by ELISA,"N-(3-(5-(2-(3-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
402440462,0.681,1920053,486503753,167318590,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 284",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150765,0.689,1079763,194147660,76314857,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","2-[4-[[4-(3-methoxyanilino)-9H-pyrido[2,3-b]indol-6-yl]sulfonyl]piperazin-1-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101613314,0.69,383076,103441767,9915743,2064,18077425,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of human Her2 in SW620 cells,Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,519,"","",""
389668622,0.69,1806610,471698542,155242979,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 54",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574019,0.695,320574,103574313,44455330,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"1-{2-[(4-{[3-methyl-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethyl}piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455110,0.7,81560,103345973,44345316,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,2-Cyano-3-[4-hydroxy-3-methoxy-5-(pyridin-2-ylsulfanylmethyl)-phenyl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072427,0.706,1256453,318396856,122195542,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,"[4-[3-Chloro-4-(3,4-dichlorophenoxy)anilino]quinazolin-6-yl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688216,0.7067,1330925,374280555,134135414,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,"7-[4-[4-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)anilino]quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409204,0.70795,164335,103345973,44345316,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,2-Cyano-3-[4-hydroxy-3-methoxy-5-(pyridin-2-ylsulfanylmethyl)-phenyl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101565330,0.709,367174,103610109,44571431,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(furan-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101651772,0.71,282237,103501621,3062316,2064,15615512,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 kinase,Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101920045,0.71,271972,103501621,3062316,2064,17154512,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2,Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372303660,0.71,1699719,103647215,9934347,2064,33119295,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of GST-tagged recombinant HER2 (unknown origin) expressed in baculovirus expression system incubated for 15-45 mins in presence of [gamma32P]-ATP by radiometric assay,2-({5-Chloro-2-[(2-Methoxy-4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}amino)-N-Methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867972,0.71,1795986,381620330,137529659,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[4-[4-[4-[[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]methyl]piperazine-1-carbonyl]phenyl]-4,5,5-trimethyl-1,3,2-dioxaborolan-2-yl]-3-methylbutyl]amino]-1-hydroxy-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665725,0.71,1806610,471698528,155243063,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420160,0.72,632226,136931749,56851433,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged HER2 expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"4-[2-chloro-4-(5H-pyrrolo[3,2-d]pyrimidin-4-ylamino)phenoxy]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440260,0.726,1920053,486503557,166927857,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 85",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440649,0.727,1920053,486503938,167318885,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 474",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100358852,0.73,69715,103292576,16157462,2064,11472210,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Dissociation constant for peptide inhibitor binding to HER2 receptor,Gfcdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829714,0.73,254975,103468207,21945809,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"[4-[(1-Benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazin-6-yl]methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
366428834,0.73,1589888,440131517,135236457,2064,31023512,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of probe binding to HER2 (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,"US10246444, Example 36",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366428836,0.73,1589888,440121433,135236809,2064,31023512,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of probe binding to HER2 (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,"US10246444, Example 62",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821394,0.732,248914,103441727,11421783,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(2-fluorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359463,0.733,69714,103302210,5328976,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622126,0.733,404519,103640390,44585573,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,N-(4-phenoxyphenyl)quinolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817751,0.733,1795646,8034253,5328976,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337226,0.74,69874,103332884,5328844,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Fluorophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402366,0.74,580189,124972950,53325048,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidine-5-carbaldehyde O-2-morpholinoethyl oxime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101694373,0.75,295195,103531674,10288917,2064,17368025,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2,"1-[[4-[[1-[(3-Fluorophenyl)methyl]indazol-5-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]-1,4-diazepan-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435330,0.75,638068,136941419,57401285,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-(2-phenylethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337014,0.76,69874,104235520,49860592,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"6,7-Dimethoxy-4-(3-methylsulfanylanilino)quinoline-3-carbonitrile;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100358853,0.76,69715,103292675,16150666,2064,11472210,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Dissociation constant for peptide inhibitor binding to HER2 receptor,Fcgdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707246,0.76,68106,103177459,176870,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402354,0.76,580189,103177459,176870,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254435415,0.76,638068,103177459,176870,2064,22101132,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her-2 by time-resolved fluorescence assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363964608,0.76,1503437,404667587,145960317,2064,29028534,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,"2-[4-oxo-3-(4-sulfamoylphenyl)benzo[g]quinazolin-2-yl]sulfanyl-N-(2,4,5-trichlorophenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388836048,0.76,1795774,8035065,176870,2064,14684309,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/j.bmcl.2003.10.010: 'Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.',Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665552,0.76,1806610,471698511,155235871,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666328,0.76,1806610,471698543,155243124,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 99",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440220,0.76,1920053,486503518,162429085,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 46",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340012320,0.769,748805,174491208,67219629,2064,23566514,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"N-[4-(4-amino-7-cyclopentylpyrrolo[2,3-d]pyrimidine-5-carbonyl)phenyl]-2,6-difluorobenzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101514791,0.776,364803,103587697,25271178,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-Amino-6-(4-(benzyloxy)-3-chlorophenylamino)pyrimidine-5-carboxylic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514800,0.776,364803,103587749,25271517,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N-phenylpyrimidine-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880670,0.78,263981,103486358,11502866,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-phenylethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257102,0.78,454329,103717566,135428921,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"2-(1,3-Benzothiazol-2-yl)-5-[[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656237,0.782,1315979,374333312,134149963,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-[[1-(furan-2-ylmethyl)indol-5-yl]amino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
402440463,0.787,1920053,486503754,167318657,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 285",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440444,0.796,1920053,486503736,162428879,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 266",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656040,0.798,1315979,374344826,134153313,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-[4-(benzenesulfonamido)anilino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821815,0.8,248914,103441783,11202869,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-imidazol-1-yl-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124282,0.8,418567,103593394,25263256,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by HTRF assay,"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)sulfanyl]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644319,0.8,1162093,312353643,118710987,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"Ethyl 2-amino-4-(7-methoxytetrazolo[1,5-a]quinolin-4-yl)-5-oxo-1-pyridin-3-yl-4,6,7,8-tetrahydroquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355656245,0.8,1315979,374337429,134151152,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-(1H-indol-5-ylamino)-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
389000990,0.8,1798897,58097688,25263256,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)sulfanyl]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204403333,0.81,580189,124959811,53318459,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,5-(4-(benzylamino)but-1-ynyl)-N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-methylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655708,0.815,1315979,374300071,134140680,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[7-methoxy-4-[4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101574012,0.818,320574,103574167,11561779,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-(2-pyrrolidin-1-ylethoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337087,0.82,69874,103332292,5328848,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Aminophenylamino)-6,7-dimethoxy-3-quinolinecarbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829705,0.82,254975,103468295,23646539,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"Ethyl 5-ethyl-4-[(4-phenoxyphenyl)amino]pyrrolo[1,2-a][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380605548,0.82,1867605,482077427,168291117,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(3-methylphenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101567607,0.826,367181,103610160,44571452,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 intracellular autophosphorylation of ErbB2 in human BT474 cells by DELFIA assay,"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
100358855,0.83,69715,103292578,16148480,2064,11472210,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Dissociation constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdvk-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666330,0.83,1806610,471698536,155242989,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433590,0.834,636385,136924004,57391988,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,"N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]-2-(2,4,5-trifluorophenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337012,0.84,69874,103333080,5328869,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Bromo-2-methylphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675438,0.84,290550,103523379,44426280,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,"4-(4-(6,7-bis(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)-N-(2,6-difluorophenyl)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155779965,0.843,472048,103738336,24782621,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,"4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-methyl-N-(2-(4-methylpiperazin-1-yl)ethyl)-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
402440256,0.847,1920053,486503553,166927883,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 81",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337275,0.85,69874,104235531,49860603,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-[3-(Dimethylamino)anilino]-6,7-dimethoxyquinoline-3-carbonitrile;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101742025,0.85,306289,103549520,44440842,2064,17270437,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"5-[[(2S)-morpholin-2-yl]methoxymethyl]-N-[1-[(1S)-1-phenylethyl]indazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
334019643,0.85,722488,164128349,71508797,2064,23245802,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 cytoplasmic domain (amino acids 676 to 1245) expressed in Sf9 cells by DELFIA time resolved fluorometry,"2-[3-(1,3-Benzodioxol-5-yl)-5-(4-bromophenyl)-3,4-dihydropyrazol-2-yl]-4-(4-methoxyphenyl)-1,3-thiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
198356292,0.852,517320,123085108,52941514,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072447,0.855,1256453,318397024,122195690,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,N-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-4-(ethylcarbamoylamino)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99538455,0.86,40021,103408038,44372197,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing BT474 (Breast) tumor cell proliferation,"N-(2-methylsulfonylethyl)-4-[4-(4-phenylmethoxyanilino)quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101831243,0.86,255842,103468240,9871380,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against BT474 (breast carcinoma) cells expressing HER2,"2-imidazol-1-ylethyl N-[4-[(1-benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040382,0.86,760335,174507797,72163259,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[4-[4-(5-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605093,0.86,1867605,482066550,156768725,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"3-methyl-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440240,0.862,1920053,486503537,167318845,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 63",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372364050,0.8657,1731398,461530261,162654057,2064,33545637,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"6-[2-[(5E)-3-(4-chlorophenyl)-5-[(4-methoxyphenyl)methylidene]-6-oxo-1H-1,2,4-triazin-2-yl]-2-oxoethyl]-3-methyl-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337095,0.87,69874,103332248,5328850,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Nitrophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101613095,0.87,383063,103177459,176870,2064,18077425,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Erbb2,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372364051,0.8723,1731398,461555295,162671604,2064,33545637,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"6-[2-[(5E)-5-benzylidene-6-oxo-3-phenyl-1H-1,2,4-triazin-2-yl]-2-oxoethyl]-3-methyl-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356232,0.874,517320,123096640,52947602,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-(3-methoxypropyl)piperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355646918,0.874,1312567,336896928,127045266,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic His-tagged human ErbB2 expressed in baculovirus system by z-lyte assay,6-(1-methylpyrazol-4-yl)-N-quinolin-6-ylquinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363686411,0.879,1404961,404709296,145988274,2064,29902719,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay","N-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204367027,0.88,549932,124967054,53322057,2064,21177105,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-[(4-aminopiperidin-1-yl)methyl]-N-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040855,0.88,725964,164148501,71525006,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(3,4-Dichlorophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889389,0.89,266066,103489550,11558284,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,4-[(3-Chlorophenyl)amino]-6-(methylamino)quinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
363795869,0.89,1426965,381838512,71616701,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropoxy]-N-(3-bromophenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355656032,0.897,1315979,374351494,134155167,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"N-[7-methoxy-4-[[1-(pyridin-2-ylmethyl)-2,3-dihydroindol-5-yl]amino]quinazolin-6-yl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101564655,0.898,367174,103610116,44571436,2064,19111461,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"6-(5-((benzylamino)methyl)furan-2-yl)-N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363798913,0.91,1428363,381859102,137646549,2064,27987485,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(4-methoxyphenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665543,0.91,1806610,471698528,155243063,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
390615738,0.912,1919643,483622408,146510035,2064,"",Confirmatory,20231208,0,0,Active,P04626,IC50,"",BindingDB,BT474 Cellular Assay (HER2 Inhibition) from US Patent US11723908: 'Quinazoline derivatives as antitumor agents',"US11723908, Example 55",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341121844,0.93,1068981,194160474,76321482,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,"(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-morpholin-4-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155779961,0.934,472048,103737175,46879472,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,"ethyl 4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-7-methyl-6H-pyrrolo[3,4-d]pyridazine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
355655465,0.958,1315979,374300980,134140949,2064,27491023,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,N-[4-[[6-(benzenesulfonamido)pyridin-3-yl]amino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101499225,0.96,341698,103624361,442514,2064,18610999,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by ELISA,Haematoxylin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155779964,0.96,472048,103738238,24786207,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,"4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2-(diethylamino)ethyl)-3-methyl-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101821958,0.966,248914,163326329,71456241,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-(3-chloro-4-phenylmethoxyanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-[methyl-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]amino]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321533858,0.97,661573,160683985,46831432,2064,22280453,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time-resolved fluorometry,N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-3-(dimethylamino)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100707250,0.977,68106,103177588,5329482,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,"N-{4-[(4-{[4-(benzyloxy)phenyl]amino}quinazolin-6-yl)oxy]butyl}-2,2,2-trifluoro-N-(2-methanesulfonylethyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388837158,0.977,1795775,8035068,5329482,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',"N-{4-[(4-{[4-(benzyloxy)phenyl]amino}quinazolin-6-yl)oxy]butyl}-2,2,2-trifluoro-N-(2-methanesulfonylethyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150762,0.978,1079763,194175280,76329342,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","N-(2-methylphenyl)-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
341150773,0.978,1079763,194168451,76325759,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","1-[4-(3-nitroanilino)-9H-pyrido[2,3-b]indol-6-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100337285,0.98,69874,103332878,5328839,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Chloro-4-fluorophenylamino)-6,7-diethoxy-3-quinolinecarbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321533859,0.98,661573,160700163,46831433,2064,22280453,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time-resolved fluorometry,N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-3-piperidin-1-ylpropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665536,0.98,1806610,471698511,155235871,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366528432,0.996,1632302,174514873,73354112,2064,27524310,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,"(E)-1-[4-(3-chloro-4-fluoroanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-morpholin-4-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99566306,1,51584,103259467,44307006,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,Pentanedioic acid 4-methoxy-phenyl ester 4-((E)-2-nitro-vinyl)-phenyl ester,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99653114,1,68101,103305338,135402983,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 11c",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653115,1,68101,103305367,5330119,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 17",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653116,1,68101,103305234,5330124,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 20e",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653117,1,68101,103305179,5330122,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 20c",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653118,1,68101,103305247,5330121,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 20b",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653119,1,68101,103305231,135402981,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 11a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653120,1,68101,103305267,5330123,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 20d",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653121,1,68101,103305292,135402984,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"8-(3,4,5-Trimethoxyanilino)-3H-imidazo[4,5-g]quinoline-7-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653122,1,68101,103305372,135402982,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 11b",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653123,1,68101,103305321,5330117,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 14a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653124,1,68101,103305323,5330118,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 14b",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99653125,1,68101,103305337,5330120,2064,12217371,Confirmatory,20180930,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"Anilinoimidazo[4,5-g]quinoline 20a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100037864,1,235920,103454562,9844320,2064,15317463,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 kinase,"Imidazo(1,5-a)pyrido(3,2-E)pyrazin-6-amine, N-(2-chloro-6-methylphenyl)-2-((3S)-3-methyl-1-piperazinyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409355,1,164335,103383761,136130281,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,(E)-3-[3-tert-butyl-4-hydroxy-5-[(2-methylpropan-2-yl)oxy]phenyl]-2-cyanoprop-2-enethioamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574017,1,320574,103574219,11597061,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-3-[2-(methylamino)ethoxy]-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622138,1,404519,103441784,11786930,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,N-(4-(3-chloro-4-(5-phenylthiazol-2-ylthio)phenylamino)-3-cyano-7-methoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101639301,1,277510,103505652,16108948,2064,17256836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-[(5-methyl-4-phenyl-3,6-dihydropyridin-1(2H)-yl)carbonyl]-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101694378,1,295195,103531657,44430027,2064,17368025,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human HER2,"1-{4-[1-(3-fluoro-benzyl)-1H-indazol-5-ylamino]-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl}-piperidine-4-carboxylic acid methyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101741767,1,306289,103549480,44440812,2064,17270437,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"N-(1H-indazol-5-yl)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101742016,1,306289,103454111,11357877,2064,17270437,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant cytoplasmic HER2 kinase expressed in Sf9 cells,"(3-Chloro-4-fluoro-phenyl)-(5-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101748526,1,308241,103551053,135497852,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"4-(3-(4-methyl-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)isoquinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101863460,1,260896,103479878,11496207,2064,16480284,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 fusion protein expressed in baculovirus by ELISA,"N-[4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(bis(1-methylethyl)amino)-2-butynamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106014981,1,441964,103177459,176870,2064,19888761,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of Her2 by fluorescence polarization assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742422,1,473323,103455939,4709,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,N-{4-[(3-Bromophenyl)amino]quinazolin-6-Yl}propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742426,1,473323,103177459,176870,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204365012,1,549932,124973892,53325588,2064,21177105,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N-(1-methylindazol-5-yl)-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326060496,1,711546,136920913,23546056,2064,21413808,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"Methyl 7-(4-bromophenyl)-9,9-dioxo-7lambda4,9lambda6-dithia-8-azabicyclo[4.3.0]nona-1(6),2,4,7-tetraene-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339849222,1,743669,174506036,71579696,2064,23474386,Confirmatory,20180926,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin),"5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-(4-methylpiperazin-1-yl)phenyl]-2-oxo-1H-pyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537307,1,1117571,103401044,6398883,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,2-(Pyridin-4-Ylmethylamino)-~{n}-[3-(Trifluoromethyl)phenyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537308,1,1117571,242614156,90666405,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,[3-[[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537309,1,1117571,103177459,176870,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537310,1,1117571,242614147,23729145,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,"N-(3-chlorophenyl)-7-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537311,1,1117571,242614153,90666402,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537605,1,1117571,242614151,90666400,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537606,1,1117571,242614152,90666401,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,[4-(3-Chloroanilino)-7-methoxyquinazolin-6-yl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537607,1,1117571,242614154,90666403,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,"[3-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenyl]boronic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537608,1,1117571,242614148,90666397,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,"N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537609,1,1117571,242614150,90666399,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,"N-(3-chloro-4-fluorophenyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537610,1,1117571,242614157,90666406,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,"[4-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenyl]boronic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537611,1,1117571,242614159,90666408,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,[4-[[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537612,1,1117571,242614158,90666407,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,"[4-[[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]boronic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537613,1,1117571,242614155,90666404,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,"[3-[[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]boronic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537614,1,1117571,242613059,90665697,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,[4-(3-Chloroanilino)quinazolin-6-yl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537615,1,1117571,242614149,90666398,2064,"",Confirmatory,20181002,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,"N-(3-chlorophenyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345660769,1,1167102,312367123,86677270,2064,25271963,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-(5-{[5-Cyano-4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}-2-{2-dimethylaminoethyl-methylamino}-4-methoxyphenyl)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
345670960,1,1171421,103244983,123631,2064,25409491,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type HER2 (unknown origin) incubated for 5 mins by HTRF assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
346893382,1,1234628,318378202,59292007,2064,26071372,Confirmatory,20181008,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),"4-[[(3S,4R)-1-(5-cyanopyridin-2-yl)-3-fluoropiperidin-4-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072438,1,1256453,318397016,122195682,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,Diethyl 2-[[[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]quinazolin-6-yl]amino]methylidene]propanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353440608,1,1274924,103728028,11626560,2064,26698536,Confirmatory,20180905,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant human ErbB2 using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA",Crizotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353440609,1,1274924,336866609,127025843,2064,26698536,Confirmatory,20180905,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant human ErbB2 using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA",6-(1-Methylpyrazol-4-yl)-2-[[3-[[5-(1-methylpyrazol-4-yl)pyrimidin-2-yl]amino]phenyl]methyl]pyridazin-3-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353622344,1,1298218,336897929,127045929,2064,27106711,Confirmatory,20180906,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin) by Z-LYTE assay,N-[1-(3-chlorophenyl)ethyl]-3-pyridin-4-yl-1H-indazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353622345,1,1298218,336900280,127047591,2064,27106711,Confirmatory,20180906,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin) by Z-LYTE assay,"N-[1-(3,5-dichloropyridin-4-yl)ethyl]-3-(2-methylpyridin-4-yl)-1H-indazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354707463,1,1312475,336879882,127034802,2064,27131066,Confirmatory,20180906,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of human ErbB2 using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA","6,6-dimethyl-8-[1-(oxan-4-ylmethyl)piperidin-4-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354709013,1,1313623,336897453,136211077,2064,27348537,Confirmatory,20180906,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant human ErbB2 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA","2-[5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-1H-indazol-3-yl]-6-(4-methylpiperazin-1-yl)-1H-benzimidazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354715260,1,1325433,374353424,134146628,2064,27769623,Confirmatory,20180907,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant ErbB2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA","9-ethyl-8-[4-[(4-hydroxyoxan-4-yl)methyl]piperazin-1-yl]-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655713,1,1315979,374295832,134139548,2064,27491023,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,(E)-N-[7-ethoxy-4-[4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355656243,1,1315979,374295734,134139534,2064,27491023,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,"(E)-4-(4-methylpiperazin-1-yl)-N-[4-[4-(pyridin-2-ylmethyl)anilino]pyrido[3,4-d]pyrimidin-6-yl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355687995,1,1330925,374289495,134137789,2064,27769671,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,N-hydroxy-6-[4-[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-6-yl]triazol-1-yl]hexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688209,1,1330925,374357599,134156856,2064,27769671,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,N-hydroxy-7-[4-[4-(3-methoxy-4-phenoxyanilino)quinazolin-6-yl]triazol-1-yl]heptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688217,1,1330925,374288318,134137500,2064,27769671,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,N-hydroxy-7-[4-[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-6-yl]triazol-1-yl]heptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688221,1,1330925,374296452,134139706,2064,27769671,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,N-hydroxy-6-[4-[4-(3-methoxy-4-phenoxyanilino)quinazolin-6-yl]triazol-1-yl]hexanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355707435,1,1338271,242613167,90665778,2064,27769032,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to HER2 extracellular domain (unknown origin) by SPR assay,H-Arg-bAla(3R-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733731,1,1341597,374333180,45140152,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,7-[4-[(3-chloro-4-fluorophenyl)methylamino]-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734116,1,1341597,374268637,24901306,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"N-hydroxy-2-[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methylamino]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355734121,1,1341597,374356399,24900713,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"7-[4-[4-(benzylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenoxy]-N-hydroxyheptanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739115,1,1342329,374315152,59452990,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,4-difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739116,1,1342329,374316238,59452725,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[7-methoxy-3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739117,1,1342329,374326918,59452765,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[4-[4-[1-(2-fluoroethyl)piperidin-4-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739118,1,1342329,374331147,59452986,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(2-(methyloxy)-4-{4-[2-(methyloxy)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739119,1,1342329,374346373,59452945,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[2-ethoxy-5-ethyl-4-[4-(2-methylsulfonylethyl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739120,1,1342329,374348275,59452616,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-5-methyl-4-[4-(2-methylsulfonylethyl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739122,1,1342329,374353858,59452859,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(2-(ethyloxy)-5-methyl-4-[4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739217,1,1342329,374358656,59452921,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-(4-methoxypiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739218,1,1342329,374271819,59860248,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739219,1,1342329,374281479,59452801,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739220,1,1342329,374301560,59452663,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(2-(ethyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739221,1,1342329,374313642,59452713,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methyloxy)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739223,1,1342329,374333932,59452612,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(2-(ethyloxy)-5-methyl-4-{4-[2-(methylsulfonyl)ethyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-[(1-methylethyl)oxy]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739225,1,1342329,374344376,59452987,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(2-(ethyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739358,1,1342329,374280664,59452889,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-(2-{[4-{5-[(dimethylamino)methyl]-1,3,4-oxadiazol-2-yl}-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739360,1,1342329,374294070,59452920,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-(2-{[4-{(3S)-3-(1-methylethyl)-4-[2-(methylsulfonyl)-ethyl]-1-piperazinyl}-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739361,1,1342329,374305198,59452848,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[4-[1-(2-methylsulfonylethyl)piperidin-4-yl]-2-propylanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739362,1,1342329,374308509,134143062,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"5-[3-[2-[5-chloro-2-ethoxy-4-[4-(2-methylsulfonylethyl)piperazin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)-2-ethoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739473,1,1342329,374353048,59452957,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-[3-(2-{[2-(methyloxy)-4-(4-propyl-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739476,1,1342329,374281362,59452791,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({2-(methyloxy)-4-[4-(methylsulfonyl)-1-piperazinyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739477,1,1342329,374317730,59452954,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]hexahydro-1H-1,4-diazepin-1-yl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739478,1,1342329,374322712,59452936,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"5-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)-7-fluoroimidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739480,1,1342329,374340524,59452636,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-5-(7-fluoro-3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739481,1,1342329,374345338,59452656,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(methyloxy)-5-{3-[2-({2-(methyloxy)-4-[2-(4-methyl-1-piperazinyl)ethyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739610,1,1342329,374266801,59452850,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-(2-{[4-[1-(2-fluoroethyl)-4-piperidinyl]-2-(methyloxy)-phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739611,1,1342329,374270280,59452827,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(5-ethyl-2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739612,1,1342329,374275025,59452843,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-{3-[2-({5-methyl-2-(methyloxy)-4-[4-(methylsulfonyl)-1-piperazinyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739614,1,1342329,374287761,59453007,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-{3-[2-({5-fluoro-2-(methyloxy)-4-[2-(1-piperidinyl)ethyl]-phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739615,1,1342329,374290817,59452613,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(5-ethyl-2-(ethyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(ethyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739694,1,1342329,374294963,66649875,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[2-ethoxy-4-[1-(2-methylsulfonylethyl)piperidin-4-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739695,1,1342329,374295032,59452667,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739696,1,1342329,374296633,59452790,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-{3-[2-({2-(methyloxy)-4-[2-(4-methyl-1-piperazinyl)ethyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739699,1,1342329,374316789,59452764,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-ethoxy-5-methyl-4-[4-(2-methylsulfonylethyl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739700,1,1342329,374345151,59452698,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739701,1,1342329,374347106,59452642,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[2-methoxy-4-[4-[4-(2-methylsulfonylethyl)piperazin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739702,1,1342329,374361060,59452671,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-5-methyl-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739774,1,1342329,374275245,25124152,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739775,1,1342329,374282969,59452833,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(methyloxy)-5-(3-{2-[(2-(methyloxy)-4-{4-[2-(methyloxy)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739776,1,1342329,374288217,59452803,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(2-(methyloxy)-4-{4-[2-(methyloxy)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739779,1,1342329,374290582,59860279,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-ethoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739781,1,1342329,374305933,59452867,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-{3-[2-({2-(methyloxy)-4-[1-(2-methylpropyl)-4-piperidinyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739864,1,1342329,374355792,59452902,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-5-(3-{2-[(5-ethyl-2-(ethyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(ethyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739865,1,1342329,374357396,59452657,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[2-methoxy-3-methyl-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739867,1,1342329,103610713,25124816,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739868,1,1342329,374269356,59452673,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[3-[2-(dimethylamino)ethoxy]anilino]pyrimidin-4-yl]-7-methylimidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739951,1,1342329,374281590,59452810,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[2-methoxy-4-[4-[4-(2-methylsulfonylethyl)piperidin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739952,1,1342329,374282517,59453013,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(5-ethyl-2-(ethyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(ethyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739955,1,1342329,374326830,59452842,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-[4-[4-(2-methylsulfonylethyl)piperidin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739956,1,1342329,374330138,59452561,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-5-{3-[2-({2-(ethyloxy)-4-[4-(1-methylethyl)-1-piperazinyl]phenyl}-amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355739958,1,1342329,374339934,66649880,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[2-ethoxy-4-[1-(2-methylsulfonylethyl)piperidin-4-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740061,1,1342329,374360463,59452680,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-5-(3-{2-[(5-ethyl-2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(ethyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740062,1,1342329,374361390,25125160,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(2-(ethyloxy)-5-methyl-4-{4-[2-(methylsulfonyl)ethyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740069,1,1342329,374304450,59452576,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[3-[2-(dimethylamino)ethoxy]anilino]pyrimidin-4-yl]-7-methoxyimidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740126,1,1342329,374315941,59452995,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-[4-[1-(2-methylsulfonylethyl)piperidin-4-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740127,1,1342329,374319921,59452794,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[5-fluoro-2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740129,1,1342329,374329113,59452784,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-5-[3-(2-{[5-methyl-2-(methyloxy)-4-(1-propyl-4-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)-benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740130,1,1342329,374348072,25124475,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(5-methyl-2-(methyloxy)-4-{1-[2-(methylsulfonyl)ethyl]-4-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740131,1,1342329,374350653,59452646,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(methyloxy)-5-(3-{2-[(2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl]phenyl)amino}-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740134,1,1342329,374357732,59453012,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[4-[4-[(3S)-3-hydroxypiperidin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740135,1,1342329,374284712,59452906,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-5-(3-{2-[(5-ethyl-2-(ethyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740196,1,1342329,374311935,59452652,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[2-methoxy-5-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740197,1,1342329,374326527,59452780,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"5-[3-[2-[5-chloro-2-methoxy-4-[4-(2-methylsulfonylethyl)piperazin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740199,1,1342329,374334546,66649718,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[2-ethoxy-4-[1-(2-methylsulfonylethyl)piperidin-4-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-propan-2-yloxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740200,1,1342329,374340280,59452586,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(methyloxy)-5-[3-(2-{[2-(methyloxy)-4-(4-propyl-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740201,1,1342329,374346631,59452890,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-[3-(2-{[2-(ethyloxy)-4-(1-propyl-4-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740202,1,1342329,374351160,59452894,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-5-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740253,1,1342329,374281359,59452637,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[4-(4-hydroxypiperidin-1-yl)-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740254,1,1342329,374295581,59452831,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(3-{[2-(dimethylamino)ethyl]oxy}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740256,1,1342329,374297138,59452679,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-isopropoxy-5-{3-[2-({2-methoxy-4-[2-(4-methylpiperazin-1-yl)ethyl]phenyl}amino)pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740257,1,1342329,374312127,59452798,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[2-methoxy-5-methyl-4-[4-(2-methylsulfonylethyl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740258,1,1342329,374314267,59860259,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-2-[(1-methylethyl)oxy]-5-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740259,1,1342329,374322607,59452723,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-[1-(2-methylpropyl)piperidin-4-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740260,1,1342329,374323106,59452696,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(2-(ethyloxy)-4-{4-[2-(methylsulfonyl)ethyl)-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740261,1,1342329,374324176,59452787,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-(2-{[2-(ethyloxy)-4-(4-propyl-1-piperazinyl)phenyl]-amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740305,1,1342329,374314242,59452697,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-5-[7-fluoro-3-(2-{[4-{4-[4-(2-fluoroethyl)-1-piperazinyl]-1-piperidinyl}-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740359,1,1342329,374266608,59452869,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-3-methyl-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740360,1,1342329,374268780,59452744,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[4-[4-[4-(2-fluoroethyl)piperazin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740364,1,1342329,374322583,59452743,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-[3-(2-{[2-(ethyloxy)-4-(4-propyl-1-piperazinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740405,1,1342329,374301847,59452777,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]-7-methylimidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740406,1,1342329,374311407,59452958,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[2-(methyloxy)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740407,1,1342329,374312061,59452718,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"5-[3-[2-[4-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740408,1,1342329,374315352,66649809,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-[1-(2-methylsulfonylethyl)piperidin-4-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740409,1,1342329,374330226,59452714,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-[4-(2-methylsulfonylethyl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740410,1,1342329,374331462,59452786,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[4-[4-(4-hydroxypiperidin-1-yl)piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740411,1,1342329,374345270,59452808,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-{3-[2-({2-(methyloxy)-4-[4-(methylsulfonyl)-1-piperazinyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740453,1,1342329,374291514,59452793,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-Difluorophenyl)-5-[3-[2-[[4-[4-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-1-piperidinyl]-2-methoxyphenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740454,1,1342329,374293466,59452806,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-5-(3-{2-[(2-(ethyloxy)-5-methyl-4-{4-[2-(methylsulfonyl)ethyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}-7-fluoroimidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740456,1,1342329,374325537,66649842,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[2-methoxy-4-[1-(2-methylsulfonylethyl)piperidin-4-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740459,1,1342329,374348769,59452968,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"5-[3-[2-[5-chloro-2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740487,1,1342329,374274947,59452726,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-(2-{[2-methyl-4-({1-[2-(methylsulfonyl)ethyl]-4-piperidinyl}oxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740488,1,1342329,374283078,59452720,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(5-methyl-2-(methyloxy)-4-{1-[2-(methylsulfonyl)ethyl]-4-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740489,1,1342329,374285641,59452607,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-[(1-methylethyl)oxy]-5-(3-{2-[(2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740490,1,1342329,374287320,59452797,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(7-fluoro-3-{2-[(2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740492,1,1342329,374292870,59452933,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(2-(ethyloxy)-5-methyl-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-[(1-methylethyl)oxy]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740532,1,1342329,374311531,59452893,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(2-(ethyloxy)-4-{4-[2-(methylsulfonyl)ethyl)-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740534,1,1342329,374324799,59452962,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[4-[4-[4-(2-fluoroethyl)piperazin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740536,1,1342329,374346509,59452811,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-2-(ethyloxy)-5-[3-(2-{[4-[4-(1-methylethyl)-1-piperazinyl]-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740538,1,1342329,374348029,59452707,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-[4-[4-(2-methylsulfonylethyl)piperazin-1-yl]piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740540,1,1342329,374271997,59452929,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-4-[5-(pyrrolidin-1-ylmethyl)-1,3,4-oxadiazol-2-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740577,1,1342329,374280746,59452938,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2-chloro-4-fluorophenyl)-3-[3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740578,1,1342329,374292885,59452573,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(methyloxy)-5-[3-(2-{[2-(methyloxy)-4-(1-propyl-4-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740580,1,1342329,374306032,59452823,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-(2-{[4-[4-(1-methylethyl)-1-piperazinyl]-2-(methyloxy)phenyl]-amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740581,1,1342329,374325243,59452943,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(2-methylsulfonylethyl)piperazin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740584,1,1342329,374271520,59860265,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(4-chloro-2-fluorophenyl)-3-[3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740624,1,1342329,374295504,59452742,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-[3-[2-[5-[2-(dimethylamino)ethoxy]-2-methylanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740628,1,1342329,374332152,59452865,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-{3-[2-({5-fluoro-2-(methyloxy)-4-[2-(4-morpholinyl)ethyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740629,1,1342329,374333131,59452731,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(2-methylsulfonylethyl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740632,1,1342329,374275968,59452887,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-[3-(2-{[5-methyl-2-(methyloxy)-4-(1-propyl-4-piperidinyl)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740670,1,1342329,374279413,59452792,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}-imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740672,1,1342329,374295156,59860278,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[4-[1-(2-methylsulfonylethyl)piperidin-4-yl]-2-propylanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740674,1,1342329,374326424,59452946,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(5-methyl-2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740677,1,1342329,374338573,59452944,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"5-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740679,1,1342329,374356406,59452705,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"3-[3-[2-[3-[2-(dimethylamino)ethoxy]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-[2-fluoro-5-(trifluoromethyl)phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740730,1,1342329,374270668,59452582,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(3-{2-[(5-ethyl-2-(methyloxy)-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl]phenyl)amino}-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740733,1,1342329,374280494,59452739,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methyl-3-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740734,1,1342329,374283652,59452581,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(methyloxy)-5-{3-[2-({2-(methyloxy)-4-[3-(4-methyl-1-piperazinyl)propyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740737,1,1342329,374295584,59452913,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-methoxy-5-[3-[2-[2-methoxy-5-methyl-4-[4-(2-methylsulfonylethyl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740776,1,1342329,374316142,59452983,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(methyloxy)-5-{3-[2-({2-(methyloxy)-4-[4-(methylsulfonyl)-1-piperazinyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740777,1,1342329,374320754,59452768,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(methyloxy)-5-{3-[2-({2-(methyloxy)-4-[3-(1-piperidinyl)propyl]phenyl}amino)-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740778,1,1342329,374322687,59452578,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-ethoxy-5-[3-[2-[2-ethoxy-5-methyl-4-[4-(2-methylsulfonylethyl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740780,1,1342329,374267306,59452991,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"n-(2,6-Difluorophenyl)-5-[3-(2-{[2-(ethyloxy)-4-(1-propyl-4-piperidinyl)phenyl]-amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740781,1,1342329,374270866,59860271,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-[3-[2-[2-ethoxy-5-methyl-4-(4-methylsulfonylpiperazin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740783,1,1342329,374288029,59452648,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-2-(ethyloxy)-5-(3-{2-[(2-(ethyloxy)-5-methyl-4-{4-[2-(methylsulfonyl)ethyl]-1-piperazinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355740784,1,1342329,374292139,59452813,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-3-(3-{2-[(2-(ethyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355741951,1,1342329,374307782,25124476,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of recombinant human full length ErbB2 expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate a,"N-(2,6-difluorophenyl)-5-(7-fluoro-3-{2-[(2-(methyloxy)-4-{4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355742712,1,1342637,374287933,67162108,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-N-[2,3-dichloro-4-(4-methylpiperazin-1-yl)phenyl]-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743028,1,1342637,374347399,67162684,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-3-(4-methylpiperazin-1-yl)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743032,1,1342637,374300036,67161690,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-6-methoxy-N-[4-(4-methylpiperazin-1-yl)phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743033,1,1342637,374300655,67163141,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-3-pyrrolidin-1-yl-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743036,1,1342637,374324287,67162563,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-6-methylsulfanyl-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743039,1,1342637,374356959,53630920,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(3S,8aS)-3-[[4-(3,4-dichloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-2-methyl-3,4,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743505,1,1342637,374271979,67163520,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-3-(diethylamino)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743512,1,1342637,374292740,67161844,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"[(3S,3aR,6S,6aR)-3-[4-(4-bromo-3-chloroanilino)-6-methoxyquinazolin-7-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] acetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743725,1,1342637,374319980,53630924,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(3S,8aR)-3-({[4-[(3,4-dichloro-2-fluorophenyl)amino]-6-(methyloxy)quinazolin-7-yl]oxy}methyl)hexahydropyrrolo[1,2-a]pyrazin-1(2H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743733,1,1342637,374307886,57802762,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"Tert-butyl 2-[2-[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxyethyl]-5,5-dimethylmorpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743922,1,1342637,374344560,57802786,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,N-(4-bromo-3-chlorophenyl)-6-methoxy-7-(1-methylpyrrolidin-3-yl)oxyquinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743923,1,1342637,374352750,134155539,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aS,5R,6aR)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-yl]oxy]-6-methoxy-N-(2,3,4-trichlorophenyl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743924,1,1342637,374354867,10095656,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 76",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355743929,1,1342637,374264596,134130257,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-N-[4-(3-fluoro-4-methylpiperazin-1-yl)phenyl]-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744294,1,1342637,374273085,57802634,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 50",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744295,1,1342637,374285055,57802779,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(2,3-dichloro-4-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744296,1,1342637,374293511,10075455,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 78",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744297,1,1342637,374301733,134141167,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aS,5R,6aR)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-yl]oxy]-N-(4,5-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744497,1,1342637,374335793,91512858,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[(3'aS,4R,6'aR)-2,2-dimethylspiro[1,3-dioxolane-4,3'-3a,6a-dihydro-2H-furo[3,2-b]furan]-6'-yl]oxy-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744501,1,1342637,374291742,66954887,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 46",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744505,1,1342637,374347496,134154041,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-3-(methylamino)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355744690,1,1342637,374322834,134147051,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aS,5R,6aR)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-yl]oxy]-N-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745012,1,1342637,374314058,134144653,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aS,5R,6aR)-3-methoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-5-yl]oxy]-N-(3-chloro-2,4-difluorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745016,1,1342637,374357445,134156813,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"[(3R,3aR,6S,6aS)-3-[4-(4-bromo-3-chloroanilino)-6-methoxyquinazolin-7-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] methanesulfonate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745017,1,1342637,374358447,67161450,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-6-fluoro-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]oxy]-N-[3,4-dichloro-2-(4-methylpiperazin-1-yl)phenyl]-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745235,1,1342637,374354341,67161635,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-[(3S,3aR,6S,6aS)-6-[4-(4-bromo-3-chloroanilino)-6-methoxyquinazolin-7-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745236,1,1342637,374282840,66838558,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,9aS)-3,4,6,7,9,9a-hexahydro-1H-[1,4]oxazino[3,4-c][1,4]oxazin-3-yl]methoxy]-N-(4-bromo-2,3-dichlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745239,1,1342637,374316246,57802612,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 49",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745241,1,1342637,374336635,134150926,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3R,9aS)-1,3,4,6,7,8,9,9a-octahydropyrido[2,1-c][1,4]oxazin-3-yl]methoxy]-N-(4-bromo-2,3-dichlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745244,1,1342637,374361604,57802807,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 53",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745394,1,1342637,374297808,57802584,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"N-(3,4-dichloro-2-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745398,1,1342637,374340651,67163182,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-3-amino-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745606,1,1342637,374299604,57802862,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 204",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745607,1,1342637,374304727,67161560,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-3-piperidin-1-yl-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745800,1,1342637,374288073,10029004,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"US9796704, Entry 75",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745801,1,1342637,374299180,67161532,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"7-[[(3S,3aR,6S,6aS)-3-morpholin-4-yl-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-N-(4-bromo-3-chlorophenyl)-6-methoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745806,1,1342637,374268589,57802574,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(6S)-6-[[4-(3,4-dichloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-dimethylpiperazin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355745807,1,1342637,374284029,57802721,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused ErbB2 kinase domain (Q679 to V1255 residues) expressed in baculovirus infected insect Sf9 cells using biotinylated poly-EY as substrate after 60 mins by alphascreen as,"(6S)-6-[[4-(4-bromo-3-chloro-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-dimethylpiperazin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363111864,1,1404620,404707090,145351804,2064,29775937,Confirmatory,20200619,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant ERBB2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method",N-methyl-6-[2-[[4-(4-methylpiperazin-1-yl)benzoyl]amino]pyridin-4-yl]oxynaphthalene-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
364909947,1,1516674,440184251,145945978,2064,31335138,Confirmatory,20210302,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of human ERbb2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control","N-[[4-[4-amino-3-(3,5-dimethyl-1-benzofuran-2-yl)-7-oxo-6H-pyrazolo[3,4-d]pyridazin-2-yl]phenyl]methyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
364910686,1,1516674,440121664,138547901,2064,31335138,Confirmatory,20210302,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of human ERbb2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control","N-{4-[4-amino-3-(3,5-dimethyl-1-benzofuran-2-yl)-7-oxo-6,7-dihydro-2H-pyrazolo[3,4-d]pyridazin-2-yl]phenyl}prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365429928,1,1584392,440150765,138617501,2064,29522671,Confirmatory,20210302,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant ERBB2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA","(S)-1-(3-(4-amino-5-(7-methoxy-5-methylbenzo[b]thiophen-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)pyrrolidin-1-yl)prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366350092,1,1549565,440123359,155519537,2064,30875504,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant HER2 using biotinyl-beta amyloid beta amyloid beta AAEEEEYFELVAKKK measured after 10 mins in the presence of ATP by HTRF assay,"7-[[(2R)-1-[[(2R)-oxiran-2-yl]methyl]pyrrolidin-2-yl]methyl]-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366548156,1,1637076,440207042,59603842,2064,27491711,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged cytoplasmic ERBB2 expressed in baculovirus expression system by Z'-LYTE assay,"N-[(1R,2S)-2-aminocyclohexyl]-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372344339,1,1720526,318464585,71226662,2064,32527559,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human recombinant ERBB2 (676 to 1255 residues) expressed in baculovirus expression system using Tyr 06 as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay,Acalabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372344342,1,1720526,461544546,121273567,2064,32527559,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of His-tagged human recombinant ERBB2 (676 to 1255 residues) expressed in baculovirus expression system using Tyr 06 as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay,4-[6-(but-2-ynoylamino)-7-(2-morpholin-4-ylethoxy)quinolin-4-yl]oxy-N-pyridin-2-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373943513,1,1778614,469814425,164620325,2064,33957388,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin) by ELISA,"N-[4-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,5-difluorophenyl]-5-(4-fluorophenyl)-4-oxo-1-propan-2-ylpyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373957459,1,1781603,469826562,162640599,2064,34477384,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 (unknown origin),Cdk9-IN-12,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380622129,1,1871766,482062040,168279948,2064,34839996,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin),"4-[4-amino-1-[(2R)-1-but-2-ynoylpyrrolidin-2-yl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-pyridin-2-ylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380622130,1,1871766,381849777,54755438,2064,34839996,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin),Tirabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380638295,1,1875881,103686626,135419190,2064,33539089,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2/ErbB-2 (unknown origin),Tyrphostin AG 879,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380835629,1,1913678,318464585,71226662,2064,"",Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Selectivity interaction (Z’-LYTE assay) EUB0000638a ERBB2,Acalabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389037223,1,1799771,8035065,176870,2064,21454582,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Enzyme Assay from Article 10.1074/jbc.M110.206193: 'Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.',Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389603223,1,1805909,461601439,129126091,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,Z-LYTE Assay from US Patent US11110088: 'Imidazopyrazine inhibitors of Bruton's tyrosine kinase',"4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-2-methoxy-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389771204,1,1919455,482596636,156038227,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,"Enzyme-linked immunosorbent assay (ELISA) from US Patent US11655239: 'Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof'",4-cyclopropyl-3-[2-[(1-cyclopropylpyrazol-4-yl)amino]quinazolin-6-yl]-N-[1-[3-(trifluoromethyl)phenyl]ethyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389771206,1,1919455,482596638,156038252,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,"Enzyme-linked immunosorbent assay (ELISA) from US Patent US11655239: 'Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof'",4-cyclopropyl-3-[2-[(1-cyclopropylpyrazol-4-yl)amino]quinazolin-6-yl]-N-[1-[3-(trifluoromethyl)phenyl]propyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389771211,1,1919455,482596635,156038305,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,"Enzyme-linked immunosorbent assay (ELISA) from US Patent US11655239: 'Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof'",4-cyclopropyl-3-[2-[(1-cyclopropylpyrazol-4-yl)amino]quinazolin-6-yl]-N-[3-(trifluoromethyl)phenyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389771319,1,1919455,482596628,156038221,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,"Enzyme-linked immunosorbent assay (ELISA) from US Patent US11655239: 'Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof'",N-[1-[4-cyclopropyl-3-[2-[(1-cyclopropylpyrazol-4-yl)amino]quinazolin-6-yl]phenyl]ethyl]-3-(trifluoromethyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389771323,1,1919455,482596632,156038229,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,"Enzyme-linked immunosorbent assay (ELISA) from US Patent US11655239: 'Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof'",N-[1-[4-ethyl-3-[2-[(1-methylpyrazol-4-yl)amino]quinazolin-6-yl]phenyl]ethyl]-3-(trifluoromethyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402102327,1,1796170,381752952,132143259,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,MCF7 Cell Viability Assay for Antibody-Polymer-Drug Conjugates from US Patent US10143695: 'Pyrrolobenzodiazepines and conjugates thereof',"4-[4-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]butanoylamino]-N-[5-[[5-[(4-aminophenyl)methylcarbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-1-methylimidazole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821636,1.007,248914,103441784,11786930,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,N-(4-(3-chloro-4-(5-phenylthiazol-2-ylthio)phenylamino)-3-cyano-7-methoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455143,1.02,81560,103346264,44345433,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,"3-(3-Benzylsulfanylmethyl-4,5-dihydroxy-phenyl)-2-cyano-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356268,1.02,517320,123094615,52946503,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"trans-N-(4-(4-amino-1-(4-morpholinocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040851,1.02,725964,164148503,71525009,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(3,4-Dichlorophenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409416,1.02329,164335,103346264,44345433,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"3-(3-Benzylsulfanylmethyl-4,5-dihydroxy-phenyl)-2-cyano-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093317,1.024,1057929,103177459,176870,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363684685,1.036,1424362,404717524,76900440,2064,28754471,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"2-Amino-4-(4-bromophenyl)-6-[4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenyl]pyridine-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380667926,1.036,1882631,404717524,76900440,2064,35311289,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"2-Amino-4-(4-bromophenyl)-6-[4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenyl]pyridine-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389257568,1.036,1803399,341104395,129627020,2064,23402383,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Tyrosine Kinase Enzyme Assay from Article 10.3109/14756366.2013.765417: 'Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents.',"HER2/EGFR dual kinase inhibitor, 5e",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398126,1.04,164334,103339517,11762902,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Thiomorpholin-4-yl-but-2-ynoic acid [4-(3-bromo-phenylamino)-3-cyano-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040848,1.04,725964,164137305,71524965,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Methylphenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432840,1.05,1919984,486499652,168258011,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018066,1.05,1920044,486499648,168257457,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]but-2-yn-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821396,1.055,248914,103441878,11398437,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-imidazol-1-ylmethyl-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841340,1.0575,625186,103266539,3191,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ebastine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748781,1.07,308241,103551075,135510524,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"N-((5-(3-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)methyl)ethanamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776625,1.07,649306,136943960,57345615,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Bromophenyl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380605547,1.07,1867605,482066949,156768724,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"2-bromo-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380526796,1.081,1850191,381890603,73438222,2064,35302767,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,Atuzabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337218,1.1,69874,103332098,5328882,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-[(3-Bromophenyl)amino]-6,7-bis(2-methoxyethoxy)quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647227,1.1,79614,103203152,44279364,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,"(2-Benzyl-1H-benzoimidazol-5-yl)-(6,7-dimethoxy-quinazolin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100716175,1.1,81567,103347713,44346053,2064,15177482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER-2,4-[5-(2-Cyclohexylamino-pyridin-4-yl)-4-(4-fluoro-phenyl)-oxazol-2-yl]-piperidin-4-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821638,1.1,248914,103441716,44388487,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(phenylaminomethyl-amino)-phenylamino]-3-cyano-7-methoxy-quinolin-6-yl}-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101827304,1.1,254948,103468842,44403425,2064,16055332,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against erbB2 kinase phosphorylation using synthetic peptide as a substrate,(3-Chloro-4-methoxy-phenyl)-[5-(1-methyl-piperidin-4-yloxy)-quinazolin-4-yl]-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840042,1.1,256662,103244983,123631,2064,15711537,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124186,1.1,418589,103593407,44564706,2064,19211246,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,4-(4-(benzo[d]thiazol-2-yl)phenylamino)-N-methylpicolinamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040376,1.1,760335,174512953,72163263,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[3-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxyazetidin-1-yl]-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654681,1.1,1315425,374271928,134133060,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(3-Chloro-4-fluoroanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796306,1.1,1426965,381879211,71616807,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropoxy]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-methoxyquinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666668,1.1,1806610,471698536,155242989,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341121843,1.11,1068981,194160469,76321478,2064,24411123,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 10 mins,"(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(4-methylpiperazin-1-yl)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605098,1.11,1867605,482057860,168276912,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(4-methoxyphenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356244,1.13,517320,123085109,52941515,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chloro-5-methylbenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040836,1.13,725964,164137331,14246200,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Methylphenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821808,1.134,248914,103441704,11157041,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(4-benzyloxy-3-cyano-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821957,1.134,248914,103441865,11456360,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,N-[4-(4-Benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-3-quinolin-8-yl-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889383,1.15,266066,103489939,11683816,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,3-[4-(3-Bromoanilino)quinazolin-6-yl]-1-(2-chloroethyl)-1-nitrosourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
341150611,1.15,1079763,194175278,76329340,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","6-bromo-N-(3-chlorophenyl)-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
341150771,1.15,1079763,194161521,76322137,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","1-[4-(3-chloroanilino)-9H-pyrido[2,3-b]indol-6-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363660909,1.16,1414228,404702549,145983688,2064,30314880,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to HER2 extracellular domain (unknown origin) by SPR analysis,stearoyl-Arg-bAla(3R-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359464,1.164,69714,103303028,5328970,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 16b,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817791,1.164,1795646,8034247,5328970,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 16b,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821959,1.184,248914,103441695,11296411,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-(quinolin-4-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829475,1.2,254975,103468310,23589555,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"Ethyl 4-[(1-benzylindazol-5-yl)amino]-5-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254456618,1.2,624804,136922080,10074640,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Masitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326062534,1.2,715335,163318585,25206346,2064,22883026,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"2-Chloro-3-[(2-Cyanopropan-2-Yl)oxy]-N-{5-[{2-[(Cyclopropylcarbonyl)amino][1,3]thiazolo[5,4-B]pyridin-5-Yl}(Methyl)amino]-2-Fluorophenyl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363687109,1.2,1404961,404714888,145991881,2064,29902719,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay","1-[4-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]-3-(2-morpholin-4-ylethyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363795867,1.2,1426965,381864981,137650532,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxy-N-(3-bromophenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265729,1.2,1805507,447113333,135157072,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 8",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402268167,1.2,1805507,447113326,135157175,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 1",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432829,1.2,1919984,486499641,168258024,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018061,1.2,1920044,486499640,168257578,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,6,8,15-tetrazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355646916,1.202,1312567,336896932,127045270,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic His-tagged human ErbB2 expressed in baculovirus system by z-lyte assay,N-(3-chloro-4-fluorophenyl)-6-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99529129,1.21,3366,103263082,5329239,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26k",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100398219,1.21,164334,103338981,10972694,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-[4-(3-Chloro-4-fluoro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-2-dimethylaminomethyl-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040834,1.21,725964,164148464,71524963,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Bromophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398223,1.22,164334,103407059,21697320,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]-4-[2-(methoxymethyl)pyrrolidin-1-yl]but-2-ynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100671762,1.229,91107,103730344,6445562,2064,12270171,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 autophosphorylation,Pelitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398228,1.23,164334,103730344,6445562,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,Pelitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821809,1.23,248914,103730344,6445562,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,Pelitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286899,1.23,456100,103723987,46229519,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(3,5-Dichloro-2-hydroxybenzyl)-1-(4-hydroxybenzyl)-3-phenylthiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
366365938,1.23,1558401,103730344,6445562,2064,31550151,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Irreversible inhibition of HER2 (unknown origin),Pelitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407923762,1.23,1927652,103177459,176870,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) incubated for 1 hrs by ELISA assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433459,1.234,636385,136937831,57399346,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,"(E)-N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]-3-(3,4-dimethoxyphenyl)prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99529134,1.24,3366,103263072,5329236,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26h",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
341150768,1.24,1079763,194140846,76311266,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","N-(3-methoxyphenyl)-6-morpholin-4-ylsulfonyl-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
334040844,1.28,725964,164148502,71525007,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Bromophenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605092,1.29,1867605,482063581,156768727,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-chloro-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101504955,1.291,361656,103643928,44587526,2064,18653333,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,"N-[1-(3-Fluoro-benzyl)-1H-indazol-5-yl]-5-{[4-methoxy-phenylimino]-methyl}-pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
254433591,1.293,636385,136928029,57394107,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,(E)-N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]-3-(4-fluorophenyl)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440241,1.298,1920053,486503538,167318828,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 64",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647185,1.3,79614,103203006,44279279,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,(1-Benzyl-1H-indol-5-yl)-quinazolin-4-yl-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647228,1.3,79614,103203166,44279376,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,N-(2-Benzyl-1H-benzimidazole-5-yl)quinazoline-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155746565,1.3,474114,103749166,46886316,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"2-cyclopentyl-N-(3-(5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340068917,1.3,770082,174508906,73291833,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"(E)-4-(dimethylamino)-N-[4-methoxy-3-[(5-methylsulfinyl-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]phenyl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
341150764,1.3,1079763,194182115,76332983,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting",Tilfrinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355654680,1.3,1315425,374282893,134136044,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(3,4-Difluoroanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796309,1.3,1426965,381860986,71616704,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropoxy]-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391789,1.3,1804579,104050842,11751343,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"8-(2-Chloro-3,4,5-trimethoxy-phenylsulfanyl)-2-fluoro-9-pent-4-ynyl-9H-purin-6-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665541,1.3,1806610,471698524,155243031,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',6-((1-Acryloylpiperidin-4-yl)oxy)-7-methoxy-4-((3-(oxazol-5-yl)phenyl)-amino)quinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701298,1.32,215071,103408038,44372197,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and erbB2 overexpressing tumor cell proliferation,"N-(2-methylsulfonylethyl)-4-[4-(4-phenylmethoxyanilino)quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163946888,1.32,488718,103764065,46906826,2064,20466555,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,Ethyl 5-(6-methoxy-7-(3-(4-methylpiperidin-1-yl)propoxy)-quinazolin-4-ylamino)benzo[b]thiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334019646,1.32,722488,164139691,71508888,2064,23245802,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 cytoplasmic domain (amino acids 676 to 1245) expressed in Sf9 cells by DELFIA time resolved fluorometry,"2-[5-(4-Bromophenyl)-3-(2,3-dihydro-1,4-benzodioxin-6-yl)-3,4-dihydropyrazol-2-yl]-4-(4-methoxyphenyl)-1,3-thiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
407923763,1.32,1927652,494397703,171344236,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) incubated for 1 hrs by ELISA assay,"N-(2-methyl-1,3-dioxoisoindol-5-yl)-2-[4-oxo-3-(4-sulfamoylphenyl)benzo[g]quinazolin-2-yl]sulfanylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858743,1.329,625186,103323115,5281787,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Caffeic acid phenethyl ester,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821631,1.331,248914,103441763,11444862,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[3-cyano-4-[3,5-dichloro-4-[(3-fluorophenyl)methoxy]anilino]-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440197,1.34,1920053,486503495,166928116,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 23",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889376,1.35,266066,103489670,11675213,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,1-(2-Chloroethyl)-3-{[4-(3-chlorophenyl)amino]quinazolin-6-yl}urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
198358935,1.35,517501,123085108,52941514,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355646917,1.35,1312567,336896687,127045112,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of cytoplasmic His-tagged human ErbB2 expressed in baculovirus system by z-lyte assay,6-(1-piperidin-4-ylpyrazol-4-yl)-N-quinolin-6-ylquinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363937668,1.35,1488747,381868460,137652864,2064,28734581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human C-terminal 6His-tagged Her2 (676 to end) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by biotinyl-beta Abeta Abeta AAEEEEYFELVAKKK substrate addition after 30 to 60 mins in presence of ATP by fluorescence,"5-(1,3-benzodioxol-5-yl)-7-[[(2R)-1-ethenylsulfonylpyrrolidin-2-yl]methyl]pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99539691,1.38,40020,103592518,5329490,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 overexpressing BT474 (breast carcinoma) cell line proliferation,N-(3-chloro-4-fluorophenyl)-6-{4-[(2-methanesulfonylethyl)amino]butoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072444,1.39,1256453,318397015,122195681,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,1-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]-3-ethylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821818,1.391,248914,103441888,11490477,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,N-[4-(4-Benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-3-(2-dimethylamino-phenyl)-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
40274032,1.4,1433,50100097,3062316,2064,"",Other,20170124,0,0,Active,NP_001005862,"","",Ambit Biosciences,Kinase Inhibitor Selectivity Profiling Assay,Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100966069,1.4,266093,103490067,11624601,2064,16759099,Confirmatory,20181020,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,JNK Inhibitor VIII,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100966070,1.4,266093,103489747,11715520,2064,16759099,Confirmatory,20181020,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,"Acetamide, N-(4-amino-5-cyano-6-ethoxy-2-pyridinyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100966071,1.4,266093,103490551,11640926,2064,16759099,Confirmatory,20181020,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,"N-(4-amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100966072,1.4,266093,103490498,11590363,2064,16759099,Confirmatory,20181020,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,"N-(4-amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100966073,1.4,266093,103490381,11539329,2064,16759099,Confirmatory,20181020,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,"Benzeneacetamide, N-(4-amino-5-cyano-6-ethoxy-2-pyridinyl)-2,5-dimethoxy-4-(methylsulfonyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100966753,1.4,266093,103489761,11658882,2064,16759099,Confirmatory,20181020,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100968815,1.4,266924,103494043,16007116,2064,16854050,Confirmatory,20181020,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,4-Amino-5-chloro-6-ethoxy-N-(4-(methylsulfonyl)benzyl)picolinamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829720,1.4,254975,103468214,23646548,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"N-(1-benzylindazol-5-yl)-6-(ethoxymethyl)-5-ethylpyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
106001757,1.4,435796,103501621,3062316,2064,18183025,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747194,1.4,474114,103749165,46886315,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"2-cyclohexyl-N-(3-(5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456614,1.4,624804,103501621,3062316,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325993693,1.4,719075,163325554,71455860,2064,23103095,Confirmatory,20200625,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of recombinant ERBB2 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP,"3-(Tert-butylamino)-4-[[2-(4-pyridin-4-ylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286898,1.41,456100,103723949,46229498,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Chloro-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
341093539,1.419,1057929,194172915,72737577,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-hydroxyazetidine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359450,1.428,69714,103303027,5328971,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 16c,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817802,1.428,1795646,8034248,5328971,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 16c,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380824190,1.437,1912866,160681951,15606394,2064,"",Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Affinity Phenotypic Cellular interaction (Alamar Blue™ assay (growth inhibition of H3255 cells expressing both EGFR and HER2)) EUB0000596aBDA ERBB2,Afatinib Dimaleate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101097291,1.438,310411,103555722,44444843,2064,17935989,Confirmatory,20181022,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ERBB2,Pmid17935989C25,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337089,1.45,69874,103332883,5328842,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-[(3-Trifluoromethylphenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356288,1.45,517320,123101234,52950015,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"N-(4-(4-amino-7-((1s,4s)-4-(4-methylpiperazin-1-yl)cyclohexyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-5,7-dimethylbenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040876,1.45,725964,164137330,71525008,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Methoxyphenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040849,1.46,725964,164137329,14246203,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Chlorophenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356264,1.47,517320,123087386,52942746,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl)-5-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733528,1.473,1341678,103177459,176870,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of N-terminal GST-tagged recombinant human HER2 (679 to 1255 residues) expressed in baculovirus infected insect Sf9 cells using poly (Glu:Tyr) 4:1 as substrate after 2 hrs,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821963,1.477,248914,103441688,11376079,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-pentyloxy-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337183,1.48,69874,103332724,5328861,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-[(3-Chloro-4-methylphenyl)amino]-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101574013,1.48,320574,103574260,11569434,2064,18182285,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erB2 autophosphorylation in clone 24 cells,"1-{2-[(4-{[3-methoxy-4-(pyridin-2-ylmethoxy)phenyl]amino}-1H-pyrazolo[3,4-d]pyrimidin-3-yl)oxy]ethyl}piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455159,1.5,81560,103346683,44345647,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,3-[3-(Benzooxazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701293,1.5,144357,103408038,44372197,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing N87 (Gastric) tumor cell proliferation,"N-(2-methylsulfonylethyl)-4-[4-(4-phenylmethoxyanilino)quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742054,1.5,473323,103746650,25000333,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,"N-(3-Ethynylphenyl)-6,7-dimethoxyquinolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155742070,1.5,473323,103746581,46197129,2064,20222733,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR Leu858Arg and Thr790Met mutant by HTRF assay,"N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340040649,1.5,760335,174497390,72163401,2064,24900741,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of full-length HER2 phosphorylation transfected in in human MCF-7 cl.24 cells after 4 hrs by laser scanning fluorescence microplate cytometry,2-[2-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxyethyl-methylamino]-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363686410,1.5,1404961,404697087,145980052,2064,29902719,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay","6-(4-aminophenyl)-N-[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402264927,1.5,1805507,447113330,156905945,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 5",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265887,1.5,1805507,447113328,156905943,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 3",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409343,1.51356,164335,103346683,44345647,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,3-[3-(Benzooxazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780732,1.52,472049,103737259,176871,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by HTRF assay,Erlotinib Hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514797,1.53,364803,103587748,25271179,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,2-Morpholinoethyl 4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)pyrimidine-5-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865064,1.53,620240,134441201,54754343,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(4-fluorophenyl)sulfonyl-2-(2-methyl-5-nitroimidazol-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345670961,1.536,1171421,312371401,71244644,2064,25409491,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type HER2 (unknown origin) incubated for 5 mins by HTRF assay,(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-2-fluoro-4-morpholin-4-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389160018,1.536,1801874,164038916,24821881,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HotSpot kinase assay from US Patent US9181263: 'Inhibitors of bruton's tyrosine kinase',"2-PropenaMide, N-[cis-4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]cyclohexyl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
410143684,1.556,1798142,464922096,149803485,2064,"",Confirmatory,20240513,0,0,Active,P04626,IC50,"",BindingDB,Potency Assessment EGFR (WT) and EGFR Mutants from US Patent US11896597: 'ErbB/BTK inhibitors',N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359364,1.559,69714,103303477,5328972,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 16g,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817801,1.559,1795646,8034249,5328972,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 16g,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99529132,1.56,3366,103263013,5329252,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28d",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
345670963,1.574,1171421,312371397,71244639,2064,25409491,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of wild type HER2 (unknown origin) incubated for 5 mins by HTRF assay,(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-2-fluoro-4-morpholin-4-ylbut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100274011,1.58,242383,103442707,11581908,2064,15993060,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB-2 protein tyrosine kinase by using [gamma-33P]-ATP as radioligand in pH 7.5,"(2-Benzyl-1H-benzoimidazol-5-yl)-(1,3,8a,9-tetraaza-fluoren-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124857,1.58,418922,103593181,25218691,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ErbB2 phosphorylation in IGF1 and EGF-stimulated human N87 cells pretreated for 6 hrs before IGF1 and EGF stimulation by ELISA,"4-[4-(4-amino-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl]-N,N-dimethylpiperazine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
100359371,1.592,69714,103302730,5328979,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 16s,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817739,1.592,1795646,8034256,5328979,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 16s,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093267,1.594,1057929,194166067,72735047,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-pyrrolidin-1-ylpiperidine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455173,1.6,81560,103346173,44345383,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,2-Cyano-3-[4-hydroxy-3-(4-hydroxy-phenylsulfanylmethyl)-5-methoxy-phenyl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829524,1.6,255868,103468239,23646550,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against Sal2 (salivary gland carcinoma) cell line expressing active HER2,"3-Imidazol-1-ylpropyl 4-[(1-benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124191,1.6,418589,103593537,44564790,2064,19211246,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N-(4-(benzo[d]thiazol-2-yl)-3-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124860,1.6,418922,103593180,25218690,2064,19217287,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of ErbB2 phosphorylation in IGF1 and EGF-stimulated human N87 cells pretreated for 6 hrs before IGF1 and EGF stimulation by ELISA,"ethyl 4-[4-(4-amino-3-{2-[(2-methoxyphenyl)methyl]-1H-1,3-benzodiazol-6-yl}-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl]piperazine-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
355654678,1.6,1315425,374327569,134148374,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(3-Chloro-4-fluoroanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-chloroacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100671764,1.604,91107,103244983,123631,2064,12270171,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 autophosphorylation,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398222,1.63,164334,103203438,9930439,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-[4-(3-Bromo-phenylamino)-3-cyano-quinolin-6-yl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150615,1.64,1079763,194182114,76332982,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","1-[4-(3-aminoanilino)-9H-pyrido[2,3-b]indol-6-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100455149,1.65,81560,103346684,44345648,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,2-Cyano-3-(4-hydroxy-3-methoxy-5-p-tolylsulfanylmethyl-phenyl)-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093735,1.659,1057929,194179779,72737401,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(3-methoxypropyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409340,1.65959,164335,103346684,44345648,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,2-Cyano-3-(4-hydroxy-3-methoxy-5-p-tolylsulfanylmethyl-phenyl)-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356248,1.66,517320,123090493,20817086,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)benzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843118,1.669,625186,103249489,1548953,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Enclomiphene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99539690,1.68,40020,103592466,5329489,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 overexpressing BT474 (breast carcinoma) cell line proliferation,N-(3-Ethynylphenyl)-6-(4-((2-(methylsulfonyl)ethyl)amino)butoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100672263,1.692,91107,103312556,10006530,2064,12270171,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 autophosphorylation,N-[4-(3-Chloro-4-fluoro-phenylamino)-3-cyano-7-(3-morpholin-4-yl-propoxy)-quinolin-6-yl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622143,1.7,404519,103640391,44585574,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"5-Chloro-2-(4-(6,7-dimethoxyquinolin-4-ylamino)-2-methylphenyl)isoindoline-1,3-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101856322,1.7,259431,103462417,11751343,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,"8-(2-Chloro-3,4,5-trimethoxy-phenylsulfanyl)-2-fluoro-9-pent-4-ynyl-9H-purin-6-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796308,1.7,1426965,381883978,137659669,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropoxy]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665734,1.7,1806610,471698511,155235871,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040837,1.75,725964,164140104,71524915,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Fluorophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889380,1.77,266066,103489698,11611500,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,1-(2-Chloroethyl)-3-{[4-(3-bromophenyl)amino]quinazolin-6-yl}urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100707248,1.778,68106,103177504,5329487,2064,14684309,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against ERBB2 receptor kinase,N-[4-(benzyloxy)phenyl]-6-{3-[(2-methanesulfonylethyl)(methyl)amino]propoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388843730,1.778,1795775,8035073,5329487,2064,12639547,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1016/s0960-894x(02)01047-8: 'Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.',N-[4-(benzyloxy)phenyl]-6-{3-[(2-methanesulfonylethyl)(methyl)amino]propoxy}quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151285897,1.78,456091,103724199,136066071,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"(2E)-2-[(E)-(5-chloro-2-hydroxyphenyl)methylidenehydrazinylidene]-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100336874,1.79,69874,103332211,5328856,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Bromo-4-methylphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402372,1.8,580189,124968177,53322690,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-methylpyrimidine-5-carbaldehyde O-3-morpholinopropyl oxime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340069870,1.8,770082,174519074,73294504,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]-2-cyanoacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
402265043,1.8,1805507,447113329,156905944,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 4",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880657,1.82,263981,103486316,44410574,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)phenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093731,1.824,1057929,194179777,72734869,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-fluoropiperidine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355647603,1.83,1312556,103244983,123631,2064,27132165,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 (unknown origin),Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605099,1.83,1867605,482062227,156768713,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-methyl-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356276,1.84,517320,123098952,52948817,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"trans-2-(4-(4-(4-amino-3-(4-(7-chlorobenzo[d]oxazol-2-ylamino)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl)piperazin-1-yl)-N,N-dimethylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605095,1.84,1867605,482081759,156768718,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-methoxy-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647230,1.86,79614,103203120,44279342,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,"4-N-(2-benzyl-3H-benzimidazol-5-yl)pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286725,1.87,456100,103723950,46229499,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Bromo-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254822330,1.878,625186,103345443,8816,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cetylpyridinium bromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288064,1.88,460690,103724388,46207013,2064,20005116,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-p-tolylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155779967,1.89,472048,103737259,176871,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,Erlotinib Hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
334040884,1.89,725964,164145692,11617204,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(2-Naphthalenyl)-1,3-diphenyl-2-pyrazoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093489,1.891,1057929,194138368,72734871,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA","N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3,3-difluoropiperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254420654,1.9,632227,136922009,56849556,2064,22003817,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human N-terminus peptide (DYKDDDD)-tagged EGFR expressed in baculovirus infected insect cells using [gamma-32P]ATP as substrate after 60 mins by scintillation counting,"N-(3-Methyl-4-((6-methylpyridin-3-yl)oxy)phenyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644316,1.9,1162093,312353637,118710982,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"Methyl 2-amino-5-oxo-1-pyridin-3-yl-4-(tetrazolo[1,5-a]quinolin-4-yl)-4,6,7,8-tetrahydroquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
372304449,1.9,1699946,103723950,46229499,2064,33130288,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by ELISA,1-(5-Bromo-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040847,1.91,725964,164134472,2725645,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Methylphenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359466,1.912,69714,163326254,5328975,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817766,1.912,1795646,8034252,5328975,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-[(2S)-2-(methoxymethyl)pyrrolidin-1-yl]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402432826,1.93,1919984,486499638,168258063,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,Detection of Phosphorylated ERBB2 (pERBB2) from US Patent US11807649: 'Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2',"1-[(14R)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
403018058,1.93,1920044,486499637,168258126,2064,"",Confirmatory,20240403,0,0,Active,P04626,IC50,"",BindingDB,Enzyme-linked immunosorbent assays (ELISA) from US Patent US20230382923: 'FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2',"1-[(14S)-5-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]-12-oxa-1,3,6,8,15-pentazatetracyclo[12.3.1.02,11.04,9]octadeca-2(11),3,5,7,9-pentaen-15-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605551,1.94,1867605,482050019,168271249,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(3-fluorophenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398221,1.95,164334,103339582,9954075,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440277,1.951,1920053,486503571,166927876,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 98",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040843,1.98,725964,164145691,71524960,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(3,4-Dichlorophenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409346,1.99526,164335,103383688,44361668,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,(Z)-3-[3-[(4-chlorophenyl)methylsulfanylmethyl]-4-hydroxy-5-methoxyphenyl]-2-cyanoprop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99566308,2,51584,242581715,90662817,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,"Pentanedioic acid (2R,5R)-5-(6-amino-purin-9-yl)-3,4-diisopropoxy-tetrahydro-furan-2-ylmethyl ester 4-((E)-2-nitro-vinyl)-phenyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100455167,2,81560,103345885,44345288,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,"2-Cyano-3-[3-(4,5-dihydro-thiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279390,2,461252,103729781,45140348,2064,20143778,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,(S)-N-hydroxy-7-(7-methoxy-4-(1-phenylethylamino)quinazolin-6-yloxy)heptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151279398,2,461252,103729687,45140151,2064,20143778,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,7-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ylsulfonyl)-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326060492,2,711546,103727811,16757526,2064,21413808,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"3-(4-Bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium-ylide 1,1-dioxide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345660470,2,1167102,312367121,101884762,2064,25271963,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"2-Propenamide, N-[5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-yl-2-pyrimidinyl)amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
345660777,2,1167102,312367126,86677253,2064,25271963,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-(2-{2-Dimethylaminoethyl-methylamino}-4-methoxy-5-{[5-methyl-4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
345661001,2,1167102,312367128,71496460,2064,25271963,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-(5-((4-(1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
345661666,2,1167102,312367124,86677265,2064,25271963,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-(5-{[5-Chloro-4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}-2-{2-dimethylaminoethyl-methylamino}-4-methoxyphenyl)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
372068916,2,1741605,461563235,154573766,2064,32717530,Confirmatory,20220318,0,0,Unspecified,P04626,IC50,>=,ChEMBL,Inhibition of HER2 (unknown origin),1-(3-Fluorophenyl)-3-(3-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665542,2,1806610,471698518,155242960,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 11",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040854,2.01,725964,164140101,71524961,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Fluorophenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605100,2.01,1867605,482060486,156768708,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"3-chloro-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853767,2.0352,625186,103167833,4212,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mitoxantrone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616512,2.06,1268283,336889427,127039935,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-[2-acetyl-5-(4-nitrophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889481,2.07,266066,103489538,10106867,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,4-[(3-Methylphenyl)amino]-6-(methylamino)quinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
341093531,2.077,1057929,194138369,72737206,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-[2-(dimethylamino)ethyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849910,2.084,625186,103507191,8478,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzethonium Chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821397,2.1,248914,103441879,11421877,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-[3-chloro-4-[[(1R)-2,3-dihydro-1H-inden-1-yl]oxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821817,2.1,248914,103441887,11180599,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(2E)-N-[4-[[3-Chloro-4-[methyl(phenylmethyl)amino]phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889382,2.1,266066,103489487,11717370,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,1-(2-Chloroethyl)-3-{[4-(3-methylphenyl)amino]quinazolin-6-yl}urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
334048472,2.1,735371,103599792,15282555,2064,23249297,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin),(2Z)-3-[3-bromo-5-[3-bromo-5-[(2Z)-3-[2-(3-bromo-4-hydroxyphenyl)ethylamino]-2-hydroxyimino-3-oxopropyl]-2-hydroxyphenyl]-4-hydroxyphenyl]-N-[2-(3-bromo-4-hydroxyphenyl)ethyl]-2-hydroxyiminopropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334048473,2.1,735371,164148942,71524406,2064,23249297,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin),(2E)-3-[3-bromo-5-[3-bromo-5-[(2E)-3-[2-[3-bromo-4-[3-bromo-5-[(2E)-3-[2-(3-bromo-4-hydroxyphenyl)ethylamino]-2-hydroxyimino-3-oxopropyl]-2-hydroxyphenoxy]phenyl]ethylamino]-2-hydroxyimino-3-oxopropyl]-2-hydroxyphenyl]-4-hydroxyphenyl]-N-[2-(3-bromo-4-hydroxyphenyl)ethyl]-2-hydroxyiminopropanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644314,2.1,1162093,312353639,118710984,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"Methyl 2-amino-4-(7-methoxytetrazolo[1,5-a]quinolin-4-yl)-5-oxo-1-pyridin-3-yl-4,6,7,8-tetrahydroquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363796305,2.1,1426965,381869299,137653430,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[4-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxybutoxy]-N-(3-ethynylphenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867978,2.118,1795986,381620335,137529664,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[8-[3-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]propanoyl]-4,4-dimethyl-1,3-dioxa-8-aza-2-boraspiro[4.5]decan-2-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398121,2.12,164334,103339351,9803006,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-[4-[(3-bromophenyl)amino]-3-cyano-7-methoxy-6-quinolinyl]-2-butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433599,2.138,636385,136944294,57402866,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,"N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]-2-(3,4,5-trifluorophenoxy)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835463,2.147,625186,103206701,2406,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bithionol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120221,2.15,492321,103770015,46912936,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(4-phenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
237865903,2.15,620242,103770015,46912936,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER-2,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(4-phenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093392,2.165,1057929,194166072,72737578,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-fluoroazetidine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605096,2.17,1867605,482069465,156768720,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-fluoro-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257328,2.2,454329,103717538,46225635,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)phenyl]-7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337085,2.21,69874,103332716,5328871,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Azidophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286891,2.21,456100,103723846,46229407,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(3,5-Dichloro-2-hydroxybenzyl)-1-(4-hydroxybenzyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380605088,2.21,1867605,482049117,168270633,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(2-methoxyphenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849451,2.227,625186,194161898,76322320,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxybutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide;N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxybutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334019644,2.23,722488,164145270,71508839,2064,23245802,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 cytoplasmic domain (amino acids 676 to 1245) expressed in Sf9 cells by DELFIA time resolved fluorometry,"2-[3-(1,3-Benzodioxol-5-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-4-(4-bromophenyl)-1,3-thiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
341093271,2.235,1057929,194159080,72737207,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-[2-(diethylamino)ethyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286723,2.24,456100,103724016,46229535,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(3,5-Dibromo-2-hydroxybenzyl)-1-(4-hydroxybenzyl)-3-phenylthiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155779968,2.24,472048,103738335,24782622,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,"4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-methyl-N-(3-(4-methylpiperazin-1-yl)propyl)-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
254776734,2.24,649306,136937522,57399196,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Methylphenyl)-3-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380605089,2.25,1867605,482059293,168277954,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(3-chlorophenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286730,2.27,456100,103723808,46229381,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Chloro-2-hydroxybenzyl)-1-(4-hydroxybenzyl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
198356950,2.27,517320,123101233,20817080,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl)-5,7-dimethylbenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366467498,2.28,1609523,440157826,155540854,2064,31493743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay","4-[2-[3-(4-Chlorophenyl)-5-(4-morpholin-4-ylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-yl]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
163946889,2.29,488718,103764064,46846074,2064,20466555,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,Ethyl 5-(7-(3-(diethylamino)propoxy)-6-methoxyquinazolin-4-ylamino)benzo[b]thiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257330,2.3,454329,103717578,46225664,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(6-chloro-1,3-benzothiazol-2-yl)phenyl]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257336,2.3,454329,103717608,46225680,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"5-(1,3-Benzothiazol-2-yl)-2-[[7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265047,2.3,1805507,447113327,156905942,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 2",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288053,2.32,460690,103724390,46207441,2064,20005116,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(4-isopropylphenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
334040838,2.32,725964,164140100,71524918,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Bromophenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402440251,2.337,1920053,486503548,166927854,2064,"",Confirmatory,20240212,0,0,Active,P04626,IC50,"",BindingDB,"ErbB Enzyme Assay from US Patent US11834453: 'Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors'","US11834453, Example 76",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334019641,2.38,722488,164148068,71508796,2064,23245802,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 cytoplasmic domain (amino acids 676 to 1245) expressed in Sf9 cells by DELFIA time resolved fluorometry,"2-[3-(1,3-Benzodioxol-5-yl)-5-(4-chlorophenyl)-3,4-dihydropyrazol-2-yl]-4-(4-bromophenyl)-1,3-thiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
99538268,2.4,40021,103408013,44372180,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing BT474 (Breast) tumor cell proliferation,"4-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829707,2.4,254975,103468223,23646549,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"2-[4-[(1-Benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazin-6-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151257316,2.4,454329,103717534,46225634,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-2-fluorophenyl]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363795873,2.4,1426965,381853117,137642481,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[4-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxybutoxy]-N-(3-chloro-4-fluorophenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433460,2.421,636385,136943432,57402440,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-(3-nitrophenoxy)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286118,2.43,456091,103724153,135444060,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"4-Bromobenzaldehyde (4-oxo-4,5-dihydro-1,3-thiazol-2-yl)hydrazone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100701302,2.45,215071,103408013,44372180,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and erbB2 overexpressing tumor cell proliferation,"4-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856608,2.468,625186,103173154,42574,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Closantel,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846840,2.485,625186,123097261,31703,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxorubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99529127,2.5,3366,103262784,5329232,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26d",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100455155,2.5,81560,103346333,44345469,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,2-(4-Hydroxy-3-methoxy-5-phenylsulfanylmethyl-benzylidene)-malononitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101834359,2.5,254834,103469976,5330437,2064,16161995,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,nhibitory concentrations against ErbB-2,"4-(2,4-Dichloro-5-methoxyanilino)-7-methoxy-8-[2-(4-morpholinyl)ethoxy]benzo[g]quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456057,2.5,624804,103220856,5328940,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Bosutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363795872,2.5,1426965,381885710,137660836,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl] 4-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxybutanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799242,2.5,1428363,381861233,137648004,2064,27987485,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-[(6-chloro-1H-benzimidazol-2-yl)methyl]-5-(4-chlorophenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389251024,2.5,1803154,340131706,118090792,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,Inhibition Assay from US Patent US9388165: 'Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase',1-amino-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)isoquinoline-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409347,2.51189,164335,103346333,44345469,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,2-(4-Hydroxy-3-methoxy-5-phenylsulfanylmethyl-benzylidene)-malononitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776741,2.52,649306,136921164,57390436,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3,5-Bis(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151288068,2.58,460690,103724457,46207009,2064,20005116,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(4-bromophenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
40274170,2.6,1433,50100123,3081361,2064,"",Other,20170124,0,0,Active,NP_001005862,"","",Ambit Biosciences,Kinase Inhibitor Selectivity Profiling Assay,Vandetanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100366947,2.6,70241,103220856,5328940,2064,11689083,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,Bosutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821821,2.6,248914,103441730,11307161,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-morpholin-4-yl-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001751,2.6,435796,103194628,3081361,2064,18183025,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Vandetanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456603,2.6,624804,103194628,3081361,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Vandetanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103123566,2.66,418568,103593402,25263264,2064,19208477,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by SPA assay,"(3R,5S)-5-[2-(4-{[1-(2-phenylethyl)-1H-indol-5-yl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286731,2.66,456100,103723844,46229405,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Bromo-2-hydroxybenzyl)-1-(4-hydroxybenzyl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
389000635,2.66,1798897,58097696,25263264,2064,19208477,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Homogeneous Time Resolved Fluorescence (HTRF) Assay from Article 10.1016/j.bmcl.2009.01.080: 'Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.',"(3R,5S)-5-[2-(4-{[1-(2-phenylethyl)-1H-indol-5-yl]amino}thieno[3,2-d]pyrimidin-6-yl)ethynyl]pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539077,2.7,410944,103244983,123631,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363795871,2.7,1426965,381883319,137659218,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropoxy]-N-(3-chloro-4-fluorophenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072436,2.72,1256453,318397021,122195687,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,2-[[[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]amino]methylidene]propanedinitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337097,2.73,69874,103332278,5328854,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(4-Methylphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286117,2.75,456091,103724152,135461369,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"(2E)-2-[(E)-(4-chlorophenyl)methylidenehydrazinylidene]-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776829,2.75,649306,136924467,57392220,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Bromophenyl)-5-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354617096,2.75,1268283,336890725,127040941,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-[2-acetyl-5-(4-iodophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040845,2.77,725964,103769191,46842884,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"3-(3,4-Dimethylphenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1h-pyrazole-1-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359458,2.776,69714,103303487,5328973,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,(E)-N-(4-(3-bromophenylamino)quinazolin-6-yl)-4-morpholinobut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388829369,2.776,1795646,8034250,5328973,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,(E)-N-(4-(3-bromophenylamino)quinazolin-6-yl)-4-morpholinobut-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99529133,2.78,3366,103262069,5329249,2064,12127526,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
380605550,2.79,1867605,482061048,156768717,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"2-chloro-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829478,2.8,254975,103468272,23646535,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"Ethyl 4-[(3-chloro-4-fluorophenyl)amino]-5-ethylpyrrolo[1,2-a][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
334048475,2.8,735371,103454127,10396070,2064,23249297,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin),Bastadin 7,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340071101,2.8,770082,174503765,73294503,2064,23930994,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"1-[6-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-5-methoxy-2,3-dihydroindol-1-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
100359511,2.808,69714,103303515,5328974,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 16i,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817693,2.808,1795646,8034251,5328974,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 16i,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198356280,2.81,517320,123101235,52950016,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-2-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenylamino)benzo[d]oxazole-7-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409357,2.88403,164335,103383599,44361640,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"(E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-[(4-hydroxyphenyl)methyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675455,2.9,290550,103523358,44426262,2064,17398092,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB2 in NH3T3 cells,2-methoxy-N-[3-(4-{3-methyl-4-[1-(tetrahydro-furan-2-carbonyl)-piperidin-4-yloxy]-phenylamino}-quinazolin-6-yl)-prop-2-ynyl]-acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402371,2.9,580189,124967716,53322413,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-ethyl-5-methylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456048,2.9,624804,103177459,176870,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456050,2.9,624804,123092542,135565635,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321582514,2.9,678135,160675461,70684700,2064,22868229,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to full-lenght/His-tagged ERBB2 UV-vis emission spectroscopy,N-benzyl-6-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342821913,2.9,1119725,242612631,58191950,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant HER2 (unknown origin) using poly-Glu-Tyr peptide as substrate,(E)-N-(2-aminophenyl)-3-[1-[4-(3-ethynylanilino)quinazolin-6-yl]sulfonylpyrrol-3-yl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359462,2.921,69714,163312548,5328989,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 27,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817788,2.921,1795646,8034266,5328989,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 27,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093493,2.937,1057929,194166068,72735048,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(2-hydroxyethyl)piperidine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854185,2.949,625186,103170100,2733526,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tamoxifen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398220,2.97,164334,103339363,9913648,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,(E)-4-Dimethylamino-but-2-enoic acid [4-(3-bromo-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455116,3,81560,103346653,44345633,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,3-[3-(4-Chloro-benzylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622432,3,68095,103244961,5328765,2064,1676428,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 33,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829712,3,254975,103468279,23646536,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"Ethyl 4-[(3-bromophenyl)amino]-5-ethylpyrrolo[1,2-a][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254456609,3,624804,103592924,9933475,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Cediranib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326060494,3,711546,163325508,71455836,2064,21413808,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"7-(4-Bromophenyl)-9,9-dioxo-7lambda4,9lambda6-dithia-8-azabicyclo[4.3.0]nona-1(6),2,4,7-tetraene-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040850,3.01,725964,164142895,71524919,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Methoxyphenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409336,3.01995,164335,103244961,5328765,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 33,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749760,3.03,308515,103548558,135723775,2064,17574416,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,N-((5-(2-(3-(6-methoxy-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)vinyl)pyridin-3-yl)methyl)ethanamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776836,3.05,649306,136929359,57394877,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Bromophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
341093739,3.058,1057929,194172914,72737404,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-[3-(diethylamino)propyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889387,3.06,266066,103490210,11554463,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,1-[4-(3-Bromoanilino)quinazolin-6-yl]-3-(2-chloroethyl)-1-methyl-3-nitrosourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
334040882,3.07,725964,164128796,71524917,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Chlorophenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605085,3.07,1867605,482053340,156768715,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"2-methoxy-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647184,3.1,79614,103203613,44279656,2064,11378364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,"(2-Benzyl-2H-indazol-5-yl)-(6,7-dimethoxy-quinazolin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101831242,3.1,255842,103468239,23646550,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against BT474 (breast carcinoma) cells expressing HER2,"3-Imidazol-1-ylpropyl 4-[(1-benzylindazol-5-yl)amino]-5-ethylpyrrolo[2,1-f][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124468,3.1,418589,103593536,44564789,2064,19211246,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N-(4-(benzo[d]thiazol-2-yl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321582987,3.1,678136,160675461,70684700,2064,22868229,Confirmatory,20220830,0,0,Active,P04626,Ki,=,ChEMBL,Inhibition of ERBB2 autophosphorylation Thr 1139 residue in human BT474 cells at 2 to 14 uM after 12 hrs by fluorescence assay,N-benzyl-6-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
254776838,3.11,649306,136934404,57397513,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Chlorophenyl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
341093743,3.121,1057929,194145275,72737579,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA","N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3,3-difluoropyrrolidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337093,3.15,69874,103332209,5328858,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3,5-Dichloro-4-hydroxyphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655577,3.2,1315425,374278446,134134811,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(3,4-Difluoroanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-chloroacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363796304,3.2,1426965,381844365,137636607,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl] 4-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxybutanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665834,3.2,1806610,471698521,155243033,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',6-((1-Acryloylpiperidin-4-yl)oxy)-4-((4-bromo-3-chlorophenyl)amino)-7-methoxyquinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605540,3.25,1867605,482075399,168289663,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(3-methoxyphenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040881,3.28,725964,164148465,71524964,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Methoxyphenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889482,3.29,266066,103373271,11807783,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,"N4-(3-chlorophenyl)quinazoline-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
347072432,3.29,1256453,318397019,122195685,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,Diethyl 2-[[[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]amino]methylidene]propanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455153,3.3,81560,103346268,44345439,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,3-[3-(2-Acetylamino-phenylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829709,3.3,254975,103468280,23646537,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"ethyl 5-ethyl-4-(1H-indazol-5-ylamino)pyrrolo[1,2-a][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100409418,3.31131,164335,103346268,44345439,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,3-[3-(2-Acetylamino-phenylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839685,3.3188,625186,103171247,3598,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hexachlorophene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288060,3.33,460690,103724456,46207442,2064,20005116,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(4-chlorophenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100337010,3.37,69874,103332696,5328877,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Bromophenylamino)-6,7-dimethoxyquinoline-3-carbaldehyde",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101583584,3.4,325576,103567541,6918508,2064,18077363,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,Falnidamol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342821914,3.4,1119725,242612632,58191961,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant HER2 (unknown origin) using poly-Glu-Tyr peptide as substrate,(E)-3-[1-[4-(3-ethynylanilino)quinazolin-6-yl]sulfonylpyrrol-3-yl]-N-hydroxyprop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380800953,3.4,1915573,242612632,58191961,2064,33077264,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),(E)-3-[1-[4-(3-ethynylanilino)quinazolin-6-yl]sulfonylpyrrol-3-yl]-N-hydroxyprop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265632,3.4,1805507,447113390,156905960,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 73",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865154,3.41,620240,134448919,56670197,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(4-chlorophenyl)sulfonyl-2-(2-methyl-5-nitroimidazol-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286739,3.45,456100,103723775,46229355,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Chloro-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354616880,3.45,1268283,336888578,127039275,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-[2-acetyl-5-(4-bromophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120216,3.46,492321,103770016,49799768,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(4-(benzyloxy)phenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
40273711,3.5,1433,50100103,123631,2064,"",Other,20170124,0,0,Inactive,NP_001005862,"","",Ambit Biosciences,Kinase Inhibitor Selectivity Profiling Assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101539072,3.5,410944,103177459,176870,2064,19028424,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 by HTRF assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101856317,3.5,259431,103477144,11574041,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,"9-butyl-8-[(2,5-dimethoxyphenyl)sulfanyl]-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001764,3.5,435796,103244983,123631,2064,18183025,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456060,3.5,624804,103244983,123631,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333958347,3.5,732197,164148981,59604787,2064,23394126,Confirmatory,20180926,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin),"(7-(6-aminopyridin-3-yl)-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)(3-fluoro-2-methyl-4-(methylsulfonyl)phenyl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776744,3.53,649306,136927737,57393973,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Fluorophenyl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354616879,3.53,1268283,336889428,127039936,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"1-(2-Methyl-5-nitroimidazol-1-yl)propan-2-yl 4-[2-acetyl-5-(4-nitrophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301327900,3.54,650683,103163815,5281855,2064,22377675,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant ERBB2 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",Ellagic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100358849,3.56,69715,103291865,16148913,2064,11472210,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Dissociation constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093701,3.564,1057929,194159083,72737034,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-3-(2-methoxyethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605546,3.58,1867605,482052291,168272818,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(4-chlorophenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286112,3.59,456091,103724198,136066070,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"(2E)-2-[(E)-(5-fluoro-2-hydroxyphenyl)methylidenehydrazinylidene]-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
198356212,3.59,517320,123087624,52942861,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR L858 mutant,"cis-methyl 2-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenylamino)benzo[d]oxazole-7-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865146,3.59,620240,134460387,56680356,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(4-bromophenyl)sulfonyl-2-(2-methyl-5-nitroimidazol-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040877,3.59,725964,164134471,71524916,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Fluorophenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748800,3.6,308241,103551077,135497850,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"N-((5-(3-(5,6-difluoro-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)methyl)ethanamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257321,3.6,454329,103717488,46225596,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"5-(1,3-Benzothiazol-2-yl)-2-[[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776740,3.65,649306,136921163,57390435,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3,5-Bis(4-bromophenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
355688717,3.7,1330932,103244983,123631,2064,27769671,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) expressed in baculovirus infected insect cells after 20 mins in presence of ATP by ELISA,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402267776,3.7,1805507,447113335,135157150,2064,"",Confirmatory,20240109,0,0,Active,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 10",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286115,3.73,456091,103724202,135648558,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"(2E)-2-[(2E)-(3,5-dibromo-2-hydroxybenzylidene)hydrazinylidene]-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254433588,3.74,636385,136924003,57391987,2064,22182581,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,(E)-N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]-3-phenylprop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402358,3.75,580189,124957151,53317174,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-methyl-5-(3-(morpholinomethyl)phenyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821956,3.775,248914,103441858,11193143,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(4-phenylmethoxyphenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821819,3.781,248914,103441696,11249521,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,2-{[4-(4-Benzyloxy-3-chloro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-ylamino]-methyl}-acrylic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100768062,3.8,164336,103259470,44307008,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cell lines,Pentanedioic acid furan-2-ylmethyl ester 4-((E)-2-nitro-vinyl)-phenyl ester,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101880674,3.8,263981,103486093,44410414,2064,16483772,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-ethynylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748801,3.82,308241,103551079,135497834,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"N-methyl(5-(3-(5-(trifluoromethoxy)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)methanamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040842,3.83,725964,164137328,2802451,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(1-Naphthalenyl)-1,3-diphenyl-2-pyrazoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155779960,3.84,472048,103737176,46879473,2064,19815412,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,"7-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2-(diethylamino)ethyl)-1H-pyrrolo[2,3-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
254776747,3.84,649306,136930924,57395705,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Bromophenyl)-5-(4-chlorophenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100398116,3.87,164334,103203457,9887521,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-[4-[(3-Bromophenyl)amino]-3-cyano-6-quinolinyl]butynamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040846,3.87,725964,164131599,71524962,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Chlorophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286116,3.89,456091,103724151,135631924,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"4-Fluorobenzaldehyde (4-oxo-4,5-dihydro-1,3-thiazol-2-YL)hydrazone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151288054,3.89,460690,103724455,46207010,2064,20005116,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(4-fluorophenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101821962,3.9,248914,103441687,44388483,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-(pyridin-3-ylmethylamino)anilino]-3-cyano-7-methoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654679,3.9,1315425,374358887,134157236,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[4-[(4-Methoxyphenyl)methoxy]anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389257829,3.981,1803399,341104394,129627019,2064,23402383,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,In Vitro Tyrosine Kinase Enzyme Assay from Article 10.3109/14756366.2013.765417: 'Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents.',"HER2/EGFR dual kinase inhibitor, 5d",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198358934,4.03,517501,123101233,20817080,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl)-5,7-dimethylbenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616516,4.07,1268283,336889863,127040288,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-[2-acetyl-5-(4-fluorophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644317,4.1,1162093,312353642,118710986,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"Ethyl 2-amino-4-(7-methyltetrazolo[1,5-a]quinolin-4-yl)-5-oxo-1-pyridin-3-yl-4,6,7,8-tetrahydroquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354616874,4.1,1268283,336889437,127039945,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-[2-acetyl-5-(4-chlorophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776839,4.12,649306,136930959,57395723,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Methoxyphenyl)-3-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101595851,4.123,331423,103563799,44448969,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-(1H-indazol-5-yl)-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398231,4.13,164334,103339433,10951285,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,(E)-4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-trifluoromethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398229,4.16,164334,103203475,10253204,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,(E)-4-Dimethylamino-but-2-enoic acid [4-(3-bromo-phenylamino)-3-cyano-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748525,4.17,308241,103551080,135497841,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"N-((5-(3-(5-methoxy-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)methyl)ethanamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337020,4.18,69874,103332709,5328867,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(2-Bromophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040839,4.18,725964,164140102,71524871,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Methoxyphenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359363,4.182,69714,103303503,5328987,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-3-(morpholin-4-yl)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817807,4.182,1795646,8034264,5328987,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-3-(morpholin-4-yl)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865070,4.21,620240,134444965,56666765,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(benzenesulfonyl)-2-(2-methyl-5-nitroimidazol-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093263,4.212,1057929,194145274,72735049,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(2-hydroxyethyl)piperazine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
40273000,4.3,1433,50100089,16007391,2064,"",Other,20170124,0,0,Inactive,NP_001005862,"","",Ambit Biosciences,Kinase Inhibitor Selectivity Profiling Assay,Azd-1152hqpa,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001766,4.3,435796,103502389,16007391,2064,18183025,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Azd-1152hqpa,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456062,4.3,624804,103502389,16007391,2064,22037378,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Binding constant for ERBB2 kinase domain,Azd-1152hqpa,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380526798,4.346,1850191,482064864,73294997,2064,35302767,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,"(E)-2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-(4-methylpiperazin-1-yl)pent-2-enenitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398230,4.39,164334,103338982,10885120,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-[4-(3-Chloro-4-fluoro-phenylamino)-3-cyano-quinolin-6-yl]-2-morpholin-4-ylmethyl-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701743,4.4,144357,103408013,44372180,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing N87 (Gastric) tumor cell proliferation,"4-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100768063,4.4,164336,103259394,10405907,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cell lines,Pentanedioic acid 4-((E)-2-nitro-vinyl)-phenyl ester phenyl ester,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100398225,4.49,164334,103339504,9890154,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Dimethylamino-but-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398120,4.5,164334,103339024,10223065,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,(E)-but-2-enoic acid [4-(3-bromophenylamino)-3-cyanoquinolin-6-yl]amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100768064,4.5,164336,242581715,90662817,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cell lines,"Pentanedioic acid (2R,5R)-5-(6-amino-purin-9-yl)-3,4-diisopropoxy-tetrahydro-furan-2-ylmethyl ester 4-((E)-2-nitro-vinyl)-phenyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
334048474,4.5,735371,164140567,15965448,2064,23249297,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin),Bastadin 16,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372304448,4.5,1699946,103723847,46229408,2064,33130288,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by ELISA,"1-(3,5-Dibromo-2-hydroxybenzyl)-1-(4-hydroxybenzyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665538,4.5,1806610,471698519,155243034,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',6-((1-Acryloylpiperidin-4-yl)oxy)-4-((3-(hydroxy-methyl)phenyl)amino)-7-methoxyquinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286114,4.51,456091,103724201,135458958,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"3,5-Dichloro-2-hydroxybenzaldehyde (4-oxo-1,3-thiazolidin-2-ylidene)hydrazone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286735,4.53,456100,103723847,46229408,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(3,5-Dibromo-2-hydroxybenzyl)-1-(4-hydroxybenzyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100409341,4.57088,164335,103761322,44361710,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"2-[5-(2,2-Dicyanoethenyl)-2-hydroxy-3-methoxyphenyl]sulfanylacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409348,4.57088,164335,103383352,44361553,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,(E)-2-cyano-3-[4-hydroxy-3-methoxy-5-(naphthalen-1-ylsulfanylmethyl)phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455161,4.6,81560,103346685,44345649,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,2-Cyano-3-[4-hydroxy-3-methoxy-5-(naphthalen-2-ylsulfanylmethyl)-phenyl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776830,4.64,649306,136942398,57401881,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
169120453,4.65,492321,103770006,49799764,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(4-bromophenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100398128,4.68,164334,103339057,10295839,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-[4-(3-Bromo-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654685,4.7,1315425,374284401,134136450,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[4-(Cyclohexylcarbamoylamino)anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799233,4.7,1428363,381864693,137650330,2064,27987485,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(2,4-dichlorophenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865078,4.76,620240,134448918,56670196,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(2-methyl-5-nitroimidazol-1-yl)-N-(4-methylphenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120224,4.77,492321,103770035,49799778,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(4-chlorophenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
99566312,4.8,51584,103259928,44307269,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,[4-[(E)-2-nitroethenyl]phenyl] 5-(benzylamino)-5-oxopentanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
321583370,4.8,678510,160691443,70690935,2064,22901387,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant HER2 expressed in baculovirus infected Sf9 cells using [32P]ATP incubated for 30 mins prior to ATP addition measured after 20 mins by liquid scintillation counting,"4-N-(3-bromophenyl)-6-N-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylmethyl)quinazoline-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776735,4.83,649306,136932623,57396640,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Chlorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380605084,4.86,1867605,482058404,168277304,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(4-bromophenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776738,4.87,649306,136930926,57395707,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Bromophenyl)-3-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100409209,4.89779,164335,103244042,1838043,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin AG 528,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622428,4.9,68095,103244042,1838043,2064,1676428,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin AG 528,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100350476,5,68098,103202065,10838598,2064,10753475,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells,"N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(4-morpholin-4-yl-butyl)-pyrido[3,2-d]pyrimidin-6-yl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100667846,5,81581,103262069,5329249,2064,12127526,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28a",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
100667851,5,81581,103263149,5329234,2064,12127526,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26f",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
101105818,5,314705,103561608,21081523,2064,18289854,Confirmatory,20181022,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N-{[4-({5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}oxy)-3-fluorophenyl]carbamoyl}-2-(4-fluorophenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101597735,5,331537,103564712,22273644,2064,18395443,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101850572,5,258046,103475594,11517688,2064,16249085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,"3-(5-(3-amino-3-methylbut-1-ynyl)-2-methoxyphenyl)-N-(2,4-difluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101856069,5,259431,103477143,11676469,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,9-Butyl-8-(2-iodo-5-methoxy-benzyl)-9H-purin-6-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155779959,5,472048,103737174,46879471,2064,19815412,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,"4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-methyl-N-(2-morpholinoethyl)-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
155779963,5,472048,103738337,24782374,2064,19815412,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 in human SKBR3 cells by HTRF assay,"4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-methyl-N-(2-morpholinoethyl)-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
363090229,5,1396516,404705177,145985555,2064,29921474,Confirmatory,20200619,0,0,Unspecified,P04626,Kd,>=,ChEMBL,Binding affinity to human ERBB2 (K646 to V1225 residues) expressed in mammalian expression system by KINOMEscan assay,"N-(2-methylpropyl)-N-(11-oxo-5H-benzimidazolo[1,2-b]isoquinolin-6-yl)pyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366291649,5,1627749,440204884,145925651,2064,27460209,Confirmatory,20220329,0,0,Unspecified,P04626,IC50,>=,ChEMBL,Inhibition of ERBB2 (unknown origin),"2-[1-[2-(5-Chloro-2-fluorophenyl)-5-methylpyridin-4-yl]-2-oxoimidazo[4,5-c]pyridin-3-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380526797,5,1850191,482062888,86297191,2064,35302767,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,"(Z)-2-[(2R)-2-[[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]pyrrolidine-1-carbonyl]-4-methyl-4-morpholin-4-ylpent-2-enenitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867968,5,1795986,381620337,137529665,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[8-[4-[(2,4-dihydroxy-5-propan-2-ylbenzenecarboximidoyl)-[2-(ethylamino)-2-oxoethanimidoyl]amino]benzoyl]-4,4-dimethyl-1,3-dioxa-8-aza-2-boraspiro[4.5]decan-2-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867970,5,1795986,381620329,137529658,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[4-[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidine-1-carbonyl]phenyl]-4,5,5-trimethyl-1,3,2-dioxaborolan-2-yl]-3-methylbutyl]amino]-1-hydroxy-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867971,5,1795986,381620333,137529662,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[4-[4-[7-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-4,5,5-trimethyl-1,3,2-dioxaborolan-2-yl]-3-methylbutyl]amino]-1-hydroxy-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867974,5,1795986,381620338,137529666,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[4-[4-[4-[2-[5-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-(ethylcarbamoyl)-1,2,4-triazol-4-yl]indol-1-yl]ethyl]piperidine-1-carbonyl]phenyl]-4,5,5-trimethyl-1,3,2-dioxaborolan-2-yl]-3-methylbutyl]amino]-1-hydroxy-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388867977,5,1795986,381620332,137529661,2064,"",Confirmatory,20231017,0,0,Unspecified,P04626,IC50,>,BindingDB,HER2 Degradation Assay with BT-474 Cell Line from US Patent US10117944: 'Targeted therapeutics',"N-[(2S)-1-[[(1R)-1-[4-[4-[4-[4-[3-(2,4-dihydroxy-5-propan-2-ylphenyl)-5-oxo-1H-1,2,4-triazol-4-yl]phenyl]piperazine-1-carbonyl]phenyl]-4,5,5-trimethyl-1,3,2-dioxaborolan-2-yl]-3-methylbutyl]amino]-1-hydroxy-3-phenylpropan-2-yl]pyrazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120456,5.03,492321,103768215,49798860,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 3-(naphthalen-1-yl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100359461,5.042,69714,103302740,5328984,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 20,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817737,5.042,1795646,8034261,5328984,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 20,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072440,5.05,1256453,318397018,122195684,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,Diethyl 2-[[[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]amino]methylidene]propanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630487,5.06,1305356,336902534,127049305,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[4-[[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]methyl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
101840032,5.1,256662,103177459,176870,2064,15711537,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748798,5.12,308241,103551078,135497849,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"N-((5-(3-(5-fluoro-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)methyl)ethanamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776737,5.12,649306,136932622,57396639,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-(3,5-Diphenyl-3,4-dihydropyrazol-2-yl)-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100337119,5.15,69874,103332513,5328884,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Bromophenylamino)-3,4-dihydro-2H-[1,4]dioxepino[2,3-g]quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286736,5.17,456100,103723776,46229356,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Bromo-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
341093481,5.187,1057929,194152106,72734872,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA","N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-1,4-dioxa-8-azaspiro[4.5]decane-8-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100267678,5.2,240554,103454583,11153014,2064,15546730,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2 kinase,"N-(2-Chloro-6-methylphenyl)-2-((2,6-dimethyl-4-pyrimidinyl)amino)-5-thiazolecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155745952,5.2,474117,103177459,176870,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 intracellular phosphorylation in human N87 cells by ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
345644309,5.2,1162093,312353638,118710983,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"Methyl 2-amino-4-(7-methyltetrazolo[1,5-a]quinolin-4-yl)-5-oxo-1-pyridin-3-yl-4,6,7,8-tetrahydroquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
345644310,5.2,1162093,312355347,118712118,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"2-Amino-5-oxo-1-pyridin-3-yl-4-(tetrazolo[1,5-a]quinolin-4-yl)-4,6,7,8-tetrahydroquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101595853,5.22,331423,103563847,44448995,2064,18508264,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"4-N-[(3-chloro-4-fluorophenyl)methyl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359657,5.23,517501,123085109,52941515,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-7-chloro-5-methylbenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605553,5.26,1867605,482063330,168280880,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(4-fluorophenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093259,5.261,1057929,194138371,72737576,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",3-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-1-[3-(dimethylamino)propyl]-1-methylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100296192,5.3,240497,103464635,9893493,2064,15943473,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition against human HER2 kinase,"[4-(2,4-Difluoro-5-methoxycarbamoyl-phenylamino)-5-isopropyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]-carbamic acid 3-methanesulfonyl-propyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622145,5.3,404519,103640446,44585594,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"3-methylsulfonylpropyl N-[4-[2-fluoro-5-(methoxycarbamoyl)anilino]-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605543,5.3,1867605,482082399,156768711,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093321,5.311,1057929,194138367,72734870,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA","N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4,4-difluoropiperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402355,5.38,580189,124975557,53326342,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-methyl-5-(3-morpholinoprop-1-ynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889384,5.4,266066,103489938,11589515,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,1-(2-Chloroethyl)-1-nitroso-3-{[4-(3-chlorophenyl)amino]quinazolin-6-yl}urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
363605721,5.4,1394744,103200288,4705,2064,29549836,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant human HER2 expressed in insect cells using biotinyl-betaAbetaAbetaAAEEEEYFELVAKKK as substrate after 30 mins by HTRF method,"N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407923711,5.4,1927694,494399040,171345087,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) incubated for 1 hrs in presence of ATP by ELISA assay,"N-(3,4-dimethylphenyl)-2-[4-oxo-3-(4-sulfamoylphenyl)benzo[g]quinazolin-2-yl]sulfanylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040880,5.46,725964,164142897,71524869,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Chlorophenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341093727,5.578,1057929,194179780,72734868,2064,24183742,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of EGFR T790M/L858M double mutant (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-methylpiperazine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616871,5.62,1268283,336888998,127039599,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,CID 127039599,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398125,5.66,164334,103338726,10322889,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Dimethylamino-but-2-enoic acid [4-(3-bromo-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040835,5.69,725964,164134473,71524914,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"3-Naphthalen-2-yl-5-phenyl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100358856,5.7,69715,103292577,16151138,2064,11472210,Confirmatory,20220830,0,0,Active,P04626,Kd,=,ChEMBL,Dissociation constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacykdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514792,5.7,364803,103587938,44562431,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N''-(3-morpholinopropanoyl)pyrimidine-5-carbohydrazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101561175,5.7,371184,103277283,667601,2064,17981366,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 tyrosine kinase activity,Tyrphostin 47,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522519,5.7,1849107,482051052,168271958,2064,36351049,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,H-Asn-Pro-Asn-Trp-Gly-Arg-Ser-Trp-Tyr-Asn-Gln-Arg-Phe-Lys-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605094,5.79,1867605,482080408,156768716,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"2-fluoro-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829459,5.8,255868,103468232,21945968,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against Sal2 (salivary gland carcinoma) cell line expressing active HER2,"4-[(1-benzylindazol-5-yl)amino]-5-ethyl-N-(3-imidazol-1-ylpropyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286108,5.83,456091,103724154,135536623,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"2-[(2E)-2-(4-methylbenzylidene)hydrazinyl]-1,3-thiazol-4(5H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
169120217,5.84,492321,103770034,49799777,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(4-fluorophenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776739,5.87,649306,136934376,57397498,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Bromophenyl)-3-(4-chlorophenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151257323,5.9,454329,103717568,46225658,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-2-methylphenyl]-7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822771,5.9472,625186,103271913,2541,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Candesartan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831107,5.97,625186,103188801,14868,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tribromsalan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101548743,6,365240,103606196,135441202,2064,18763755,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of GST-tagged HER2,"2(1H)-Pyridinone, 4-((2-(4-chloro-1H-pyrazol-1-yl)ethyl)amino)-3-(5-(1-(3-fluoropropyl)-4-piperidinyl)-7-methyl-1H-benzimidazol-2-yl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155747203,6,474114,103749162,46886312,2064,20346655,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"4-(6-(3-nitrophenyl)imidazo[2,1-b]thiazol-5-yl)-N-phenylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363795868,6,1426965,381866396,71616703,2064,28092860,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",6-[3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropoxy]-N-(3-bromophenyl)-7-methoxyquinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665728,6,1806610,471698541,155242975,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 53",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345572821,6.029,1191002,242176229,135461535,2064,25619636,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human full length HER2 assessed as phosphorylation state by ELISA assay,"2-[(4,7-dimethylquinazolin-2-yl)amino]-6-{[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]methyl}pyrimidin-4(1H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455114,6.1,81560,103346680,44345644,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,3-[3-(1H-Benzoimidazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409199,6.16595,164335,103346680,44345644,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,3-[3-(1H-Benzoimidazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455112,6.2,81560,103345619,44345182,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,"3-(3-Benzylsulfanylmethyl-4-hydroxy-5-methoxy-phenyl)-2-(3,4-dihydroxy-benzoyl)-acrylonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654695,6.2,1315425,374307601,134142809,2064,27187856,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(4-Tert-butylanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089625,6.2,1961745,160676622,25102847,2064,37468498,Confirmatory,20240503,0,0,Active,P04626,AC50,=,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Cabozantinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776619,6.21,649306,136942399,42604758,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Methoxyphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776620,6.23,649306,136921165,57390437,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Methoxyphenyl)-5-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776745,6.24,649306,136932625,57396642,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Bromophenyl)-5-(4-fluorophenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
204403330,6.3,580189,124972948,53325046,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-phenylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776736,6.35,649306,136936045,57398416,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100337099,6.36,69874,103332280,5328853,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Hydroxyphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889386,6.39,266066,103373342,10220590,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,6-Amino-4-[(3-methylphenyl)amino]quinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100622439,6.4,68095,103227581,5328768,2064,1676428,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin A46,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409203,6.45654,164335,103227581,5328768,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin A46,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286883,6.49,456100,103723952,44481081,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(3,5-Dichloro-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylthiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
204403336,6.5,580189,124959809,53318457,2064,21334203,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-methylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321583368,6.5,678510,160685941,70688851,2064,22901387,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of recombinant HER2 expressed in baculovirus infected Sf9 cells using [32P]ATP incubated for 30 mins prior to ATP addition measured after 20 mins by liquid scintillation counting,"6-N-(1,3-benzodioxol-5-ylmethyl)-4-N-(3-chlorophenyl)quinazoline-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363799236,6.5,1428363,381869126,137653308,2064,27987485,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(2-chlorophenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748796,6.51,308241,103551063,135497876,2064,17532631,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"4-(3-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)isoquinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150770,6.53,1079763,194168453,76325761,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","2-[4-[[4-(3-ethoxyanilino)-9H-pyrido[2,3-b]indol-6-yl]sulfonyl]piperazin-1-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
334040853,6.58,725964,103769006,49799240,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"3-(3,4-Dichlorophenyl)-5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100768061,6.6,164336,103259467,44307006,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cell lines,Pentanedioic acid 4-methoxy-phenyl ester 4-((E)-2-nitro-vinyl)-phenyl ester,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101740892,6.6,305799,103545048,16216595,2064,17174554,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"4-(3-phenoxylphenyl)-5-cyano-2H-1,2,3-triazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
100337008,6.65,69874,103332679,5328866,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(4-Bromophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347032662,6.651,1242284,318385112,118073729,2064,26191356,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR E746-A750 deletion mutant in human PC9 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,"N-[(3R,4R)-1-[6-[(1,3-dimethylpyrazol-4-yl)amino]-9-propan-2-ylpurin-2-yl]-4-fluoropyrrolidin-3-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
334040878,6.68,725964,164140103,71524872,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(Naphthalene-1-yl)-3-p-tolyl-4,5-dihydro-1h-pyrazole-1-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286893,6.73,456100,103723953,44481332,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(3,5-Dibromo-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylthiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
198358521,6.73,517324,103177459,176870,2064,20817523,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBb2 phosphorylation in human BT474 cells by ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
100337220,6.75,69874,103332459,5328881,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Bromophenylamino)-6,7-bis(methoxymethoxy)-quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337193,6.79,69874,103332539,5328883,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"8-(3-Bromophenylamino)[1,3]dioxolo[4,5-g]quinoline-7-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040841,6.84,725964,164131628,71524873,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(3,4-Dichlorophenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889381,6.88,266066,103490184,10200918,2064,16759097,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,1-(2-Chloroethyl)-1-nitroso-3-methyl-3-{[4-(3-methylphenyl)amino]quinazolin-6-yl}urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
151286380,6.93,456091,103724197,135886854,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"2-[(2E)-2-(4-hydroxybenzylidene)hydrazinyl]-1,3-thiazol-4(5H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151257317,6.95,454329,103717552,46225647,2064,19692247,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(6-fluoro-1,3-benzothiazol-2-yl)phenyl]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366467499,6.96,1609523,440157832,155540856,2064,31493743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay","4-[4-[3-(4-Chlorophenyl)-2-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]-3,4-dihydropyrazol-5-yl]phenyl]morpholine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100547930,7,81574,103294796,10426229,2064,9651163,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(4-Hydroxy-3,5-diisopropylbenzylidene)indolin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101831244,7,255842,103468232,21945968,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against BT474 (breast carcinoma) cells expressing HER2,"4-[(1-benzylindazol-5-yl)amino]-5-ethyl-N-(3-imidazol-1-ylpropyl)pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334048476,7,735371,103599794,9833337,2064,23249297,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin),"(12E,25E)-5,16,21,32,33,36-hexabromo-4,20-dihydroxy-12,25-bis(hydroxyimino)-2,18-dioxa-10,27-diazapentacyclo[28.2.2.214,17.13,7.119,23]octatriaconta-1(32),3,5,7(38),14,16,19,21,23(35),30,33,36-dodecaene-11,26-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865080,7.02,620240,134464194,56683687,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(4-fluorophenyl)-N-(4-fluorophenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776840,7.04,649306,136924466,57392219,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Bromophenyl)-3-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776627,7.05,649306,136940722,57400944,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Chlorophenyl)-3-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286885,7.13,456100,103723986,46229518,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(2-Hydroxy-5-methylbenzyl)-1-(4-hydroxybenzyl)-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101829710,7.2,254975,103468287,44403081,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"4-Benzylamino-5-ethyl-pyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid ethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
334040852,7.24,725964,164148504,71524867,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"3-Naphthalen-1-yl-5-phenyl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776624,7.35,649306,136927738,57393974,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Methoxyphenyl)-3-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100337191,7.38,69874,103332268,5328847,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Acetylphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701294,7.4,144357,103408188,44372283,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing N87 (Gastric) tumor cell proliferation,"N-(2-methylsulfonylethyl)-4-[4-[4-[[3-(trifluoromethyl)phenyl]methoxy]anilino]quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100701306,7.4,215071,103408188,44372283,2064,12639547,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR and erbB2 overexpressing tumor cell proliferation,"N-(2-methylsulfonylethyl)-4-[4-[4-[[3-(trifluoromethyl)phenyl]methoxy]anilino]quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363972556,7.4,1507119,336897123,135464244,2064,28494255,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of c-erbbeta2 (unknown origin),[4-hydroxy-5-[(Z)-(6-hydroxyindol-3-ylidene)methyl]-1H-imidazol-2-yl]-(1H-indol-3-yl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373893114,7.491,1769055,469819849,150237192,2064,34515481,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 (unknown origin) by mobility shift assay,Mnk/pim-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237864965,7.56,620240,134452786,56673721,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(4-chlorophenyl)sulfonyl-2-(4-fluorophenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776742,7.59,649306,136943961,57402711,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Chlorophenyl)-5-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380605086,7.59,1867605,482058656,168277469,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[(5-phenylindol-1-yl)methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522512,7.595,1849107,482060416,168278768,2064,36351049,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,H-Arg-Ile-Lys-Pro-Arg-Lys-Gly-Tyr-Thr-Arg-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337189,7.69,69874,103332254,5328855,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"3-[(3-Cyano-6,7-dimethoxyquinolin-4-yl)amino]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101533392,7.7,409438,103590012,25178539,2064,19053831,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human ERBB2,"3-(12,14-Dioxo-10,13,16-triazahexacyclo[14.6.1.02,10.04,9.011,15.019,23]tricosa-1(22),2,4,6,8,11(15),17,19(23),20-nonaen-13-yl)propyl carbamimidothioate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398227,7.8,164334,103339473,9934935,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Diethylamino-but-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372326608,7.8,1711468,318410324,44467827,2064,26750252,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"N6-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)-3-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101740893,7.9,305799,103545047,6411478,2064,17174554,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"4-(4-Bromophenyl)-1H-1,2,3-triazole-5-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
100296195,8,240497,103464324,10478569,2064,15943473,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition against human HER2 kinase,"2,4-Difluoro-5-[5-isopropyl-6-(5-methyl-[1,3,4]oxadiazol-2-yl)-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino]-N-methoxy-benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455151,8,81560,103345945,44345309,2064,7902440,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,"2-[5-(2,2-Dicyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101856324,8,259431,103477208,11567291,2064,16420067,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,8-[(2-bromo-5-methoxyphenyl)methyl]-9-butyl-9H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072428,8,1256453,318397022,122195688,2064,26475520,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,2-[[[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]quinazolin-6-yl]amino]methylidene]propanedinitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354688040,8,1298204,336900731,137210056,2064,27106709,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of EGFR (746 to 750) deletion mutant (unknown origin) using peptide substrate incubated for 30 mins by europium donor dye-based plate reader analysis,Antiproliferative agent-40,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355631298,8.01,1305356,336905526,127051446,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
254776746,8.04,649306,136930960,57395724,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Fluorophenyl)-5-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100455141,8.1,81560,103346003,44345327,2064,7902440,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,"3-[3-(Benzothiazol-2-ylsulfanylmethyl)-4,5-dihydroxy-phenyl]-2-cyano-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821404,8.1,248914,103441807,11168731,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(pyridin-4-yloxy)-phenylamino]-3-cyano-7-ethoxy-quinolin-6-yl}-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776835,8.13,649306,136927712,57393966,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Chlorophenyl)-3-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776743,8.14,649306,136921133,57390422,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Bromophenyl)-3-(4-fluorophenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
237865074,8.18,620240,134452787,56673722,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(4-bromophenyl)sulfonyl-2-(4-fluorophenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548013,8.2,81574,103294646,44321317,2064,9651163,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"5-Chloro-3-(4-hydroxy-3,5-diisopropyl-benzylidene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616876,8.27,1268283,336888579,127039276,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"1-(2-Methyl-5-nitroimidazol-1-yl)propan-2-yl 4-[2-acetyl-5-(4-bromophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865068,8.41,620240,134460388,47108695,2064,21920766,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(benzenesulfonyl)-2-(4-fluorophenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286104,8.46,456091,103724156,135458975,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"2-[(2E)-2-(4-nitrobenzylidene)hydrazinyl]-1,3-thiazol-4(5H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151289917,8.48,458722,103726439,46231219,2064,20031417,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 after 80 mins by radiometric protein kinase assay,"3-(5-Fluoro-1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616515,8.54,1268283,336890724,127040940,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"1-(2-Methyl-5-nitroimidazol-1-yl)propan-2-yl 4-[2-acetyl-5-(4-fluorophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842177,8.577,625186,103293005,3728,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Iodoquinol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605549,8.63,1867605,482060839,156768710,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"3-fluoro-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409337,8.70964,164335,103345885,44345288,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"2-Cyano-3-[3-(4,5-dihydro-thiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408010374,8.73,1949833,494397687,47012217,2064,27559828,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant ERBB2 expressed in Escherichia coli,"N-[2-(2-fluorophenoxy)ethyl]-6,7-dimethoxyquinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398232,8.74,164334,103339581,10983483,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,(E)-4-Morpholin-4-yl-but-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363798919,8.8,1428363,381839500,137633367,2064,27987485,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(naphthalen-1-ylmethyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150766,8.83,1079763,194175279,76329341,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","6-bromo-N-(3-nitrophenyl)-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100359457,8.832,69714,103302728,5328983,2064,11495584,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 19,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388829371,8.832,1795646,8034260,5328983,2064,11495584,Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 19,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644307,8.9,1162093,312353635,118710980,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"2-Amino-4-(7-methoxytetrazolo[1,5-a]quinolin-4-yl)-5-oxo-1-pyridin-3-yl-4,6,7,8-tetrahydroquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380522513,8.9,1849107,482058870,168277628,2064,36351049,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,H-Asn-Pro-Asn-Trp-Gly-Trp-Ser-Trp-Tyr-Asn-Gln-Arg-Phe-Lys-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665821,8.9,1806610,471698518,155242960,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 11",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644311,9,1162093,312353640,118710985,2064,25172421,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"Methyl 2-amino-4-(7-chlorotetrazolo[1,5-a]quinolin-4-yl)-5-oxo-1-pyridin-3-yl-4,6,7,8-tetrahydroquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100337187,9.04,69874,103332237,5328857,2064,10966743,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Chloro-4-hydroxyphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389665546,9.1,1806610,471698541,155242975,2064,"",Confirmatory,20231017,0,0,Active,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 53",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355630990,9.13,1305356,336904287,127050551,2064,27190603,Confirmatory,20220830,0,0,Active,P04626,EC50,=,ChEMBL,Inhibition of EGFR exon19 deletion activating mutant autophosphorylation in human PC9 cells incubated for 2 hrs by ELISA,N-[3-[2-[3-amino-6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]pyrazin-2-yl]benzimidazol-1-yl]phenyl]-2-methylprop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
254846841,9.148,625186,103188875,2157,2064,"",Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amiodarone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334040883,9.15,725964,164131627,71524870,2064,23391364,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Bromophenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286101,9.17,456091,103724155,135419868,2064,19914835,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"(2E)-2-[(2E)-(4-methoxybenzylidene)hydrazinylidene]-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
169120223,9.24,492321,103768216,49798861,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 3-(naphthalen-2-yl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776828,9.27,649306,136937521,56968794,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Bromophenyl)-3-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380605542,9.28,1867605,482071244,168286628,2064,35452936,Confirmatory,20230629,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(2-bromophenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622128,9.3,404519,103339583,11102890,2064,18500794,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,N-(4-(3-bromophenylamino)-3-cyano-8-methoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749764,9.3,308515,103548559,135620675,2064,17574416,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,6-(4-methylpiperazin-1-yl)-2-(4-(2-(pyridin-3-yl)vinyl)-1H-pyrazol-3-yl)-1H-benzo[d]imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398130,9.35,164334,103339583,11102890,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,N-(4-(3-bromophenylamino)-3-cyano-8-methoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407923710,9.42,1927694,103244983,123631,2064,32739648,Confirmatory,20240503,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) incubated for 1 hrs in presence of ATP by ELISA assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286886,9.47,456100,103724017,46229536,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(2-Hydroxy-3,5-dimethylbenzyl)-1-(4-hydroxybenzyl)-3-phenylthiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
99566324,9.5,51584,103260015,44307314,2064,"",Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,5-O-(3-methoxyphenyl) 1-O-[4-[(E)-2-nitroethenyl]phenyl] pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101535796,9.5,410050,103588738,135524085,2064,18945615,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,"Pyrrolo-pyrimidone, 17",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398226,9.58,164334,103339391,10973080,2064,12502359,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Diethylamino-pent-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286722,9.64,456100,103723805,46229378,2064,19914837,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(3,5-Dichloro-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
169120218,9.65,492321,103770008,49799765,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-p-tolylacrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101829481,9.7,254975,103468213,23646547,2064,16111887,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"N-(1-benzylindazol-5-yl)-5-ethyl-6-(ethylaminomethyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363489345,9.71,1359300,404660031,145955071,2064,29730188,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-His6-fused erbB2 expressed in Sf9 insect cells using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method",N-[2-(3-fluorophenyl)ethyl]-3-(trifluoromethyl)-5-[2-[[3-(trifluoromethyl)phenoxy]methyl]phenyl]benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821813,9.8,248914,103441731,11410634,2064,15715478,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,"(E)-N-[4-[3-chloro-4-[[(1S)-2,3-dihydro-1H-inden-1-yl]oxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522515,9.89,1849107,482057958,168276977,2064,36351049,Confirmatory,20230629,0,0,Active,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,H-Asn-Pro-Asn-Trp-Gly-Trp-Ser-Arg-Tyr-Asn-Gln-Arg-Phe-Lys-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288059,9.95,460690,103724454,46207008,2064,20005116,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(2-bromophenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776832,9.96,649306,136940723,57400945,2064,22361272,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3,5-Bis(4-chlorophenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354616875,9.96,1268283,336889438,127039946,2064,26652482,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"1-(2-Methyl-5-nitroimidazol-1-yl)propan-2-yl 4-[2-acetyl-5-(4-chlorophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120457,9.97,492321,103770010,49799767,2064,20594859,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(4-isopropylphenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
99566310,10,51584,103259386,44306962,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,[4-[(E)-2-nitroethenyl]phenyl] 5-anilino-5-oxopentanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99566314,10,51584,103259387,44306963,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,1-O-benzyl 5-O-[4-[(E)-2-nitroethenyl]phenyl] pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99566318,10,51584,103259505,44307028,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,5-O-(2-methoxyphenyl) 1-O-[4-[(E)-2-nitroethenyl]phenyl] pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99566320,10,51584,103259457,10248755,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,5-O-(4-fluorophenyl) 1-O-[4-[(E)-2-nitroethenyl]phenyl] pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99566322,10,51584,103260013,44307312,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ligand-stimulated autophosphorylation of EGFR/HER2 chimeric receptor expressed in NIH3T3 cells,5-O-[4-[(E)-2-nitroethenyl]phenyl] 1-O-(2-phenylethyl) pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99909352,10,218938,103296559,10061448,2064,8064792,Confirmatory,20181014,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 receptor,"6,7-Dimethoxy-3-pyridin-4-yl-quinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99909353,10,218938,103296361,135469328,2064,8064792,Confirmatory,20181014,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 receptor,"3-Pyridin-4-yl-quinoline-6,7-diol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99909354,10,218938,103296593,10354294,2064,8064792,Confirmatory,20181014,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 receptor,7-Chloro-3-pyridin-4-yl-quinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99909355,10,218938,103264949,3139,2064,8064792,Confirmatory,20181014,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 receptor,"5,7-Dimethoxy-3-(4-pyridinyl)quinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100024622,10,164340,103198425,9869943,2064,12672234,Confirmatory,20181017,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of Protein kinase HER-2,"2-(2,6-Dichloro-phenylamino)-7-(3-diethylamino-propenyl)-1,6-dimethyl-1,8-dihydro-imidazo[4,5-h]isoquinolin-9-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100274013,10,242383,103442782,11681189,2064,15993060,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibitory concentration against ErbB-2 protein tyrosine kinase by using [gamma-33P]-ATP as radioligand in pH 7.5,"(3-Chloro-4-fluoro-phenyl)-(1,3,8a,9-tetraaza-fluoren-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100274014,10,242383,103442761,11542889,2064,15993060,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibitory concentration against ErbB-2 protein tyrosine kinase by using [gamma-33P]-ATP as radioligand in pH 7.5,"1,3,8a,9-Tetraaza-fluoren-4-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100296194,10,240497,103464665,10073832,2064,15943473,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition against human HER2 kinase,"5-[6-(5-Difluoromethyl-[1,3,4]oxadiazol-2-yl)-5-isopropyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino]-2,4-difluoro-N-methoxy-benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100296196,10,240497,103464252,11477626,2064,15943473,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition against human HER2 kinase,"[4-(2,4-Difluoro-5-methoxycarbamoyl-phenylamino)-5-isopropyl-pyrrolo[2,1-f][1,2,4]triazin-6-yl]-carbamic acid tetrahydro-furan-2-ylmethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409213,10,164335,103346261,44345431,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,3-(3-Benzylsulfanylmethyl-4-hydroxy-5-methoxy-phenyl)-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409334,10,164335,103345945,44345309,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"2-[5-(2,2-Dicyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409349,10,164335,103243580,5328762,2064,14561085,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 28,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547883,10,81574,103295300,44321686,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"5-Bromo-3-(4-morpholin-4-yl-benzylidene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547928,10,81574,103295341,2396126,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"5-Chloro-3-(4-morpholin-4-yl-benzylidene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622437,10,68095,103243580,5328762,2064,1676428,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 28,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100716179,10,81567,103347016,10005638,2064,15177482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human HER-2,4-[1-[2-(Cyclopentylamino)pyrimidin-4-yl]-2-[3-(trifluoromethyl)phenyl]imidazol-4-yl]-1-methylpiperidin-4-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100716181,10,81567,103346971,9826083,2064,15177482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human HER-2,"Cyclopentyl-{4-[2-(4-fluoro-phenyl)-5-(4-methyl-piperazin-1-yl)-imidazo[4,5-b]pyridin-1-yl]-pyrimidin-2-yl}-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100847223,10,349121,103648509,9857146,2064,18818075,Confirmatory,20180910,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2,"2-(4-Fluorophenyl)-3-(4-pyridinyl)pyrazolo[1,5-a]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100850446,10,393230,103650140,42629114,2064,19200745,Confirmatory,20180910,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"3-[[[5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazol-2-yl]thio]methyl]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100886645,10,397044,103654447,135444754,2064,19522465,Confirmatory,20180910,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human HER2,2-hydroxy-3-[C-phenyl-N-[4-(piperidin-1-ylmethyl)phenyl]carbonimidoyl]-1H-indole-6-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100886646,10,397044,103654448,135837837,2064,19522465,Confirmatory,20180910,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human HER2,methyl 3-[N-[4-[[dimethylcarbamoyl(methyl)amino]methyl]phenyl]-C-phenylcarbonimidoyl]-2-hydroxy-1H-indole-6-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100886647,10,397044,103654502,135423438,2064,19522465,Confirmatory,20180910,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human HER2,Nintedanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100923557,10,244158,103465297,4369497,2064,15743202,Confirmatory,20181018,0,0,Unspecified,P04626,Selectivity,>,ChEMBL,Selectivity for ERBB2 receptor kinase by scintillation proximity assay,"N-[5-(Ethylsulfonyl)-2-methoxyphenyl]-5-[3-(2-pyridinyl)phenyl]-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100923558,10,244158,103465361,5329875,2064,15743202,Confirmatory,20181018,0,0,Unspecified,P04626,Selectivity,>,ChEMBL,Selectivity for ERBB2 receptor kinase by scintillation proximity assay,2-Anilino-5-aryloxazole 44,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100932778,10,256709,103472640,9797370,2064,16366598,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibitory activity against HER2,"N-(3-fluorophenyl)-6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101001618,10,281191,103510022,11362471,2064,17352464,Confirmatory,20181021,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,"7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetraazatricyclo[16.3.1.0^{5,10}]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101001619,10,281191,103509983,11293798,2064,17352464,Confirmatory,20181021,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,"7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetraazatricyclo[16.3.1.0^{5,10}]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101001620,10,281191,103509986,11397177,2064,17352464,Confirmatory,20181021,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ErbB2,"N-{7-chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetraazatricyclo[16.3.1.0^{5,10}]docosa-1(21),5(10),6,8,18(22),19-hexaen-8-yl}methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101063408,10,298750,103534538,766949,2064,17194588,Confirmatory,20181022,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2,TCS JNK 5a,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101063409,10,298750,103534555,16664858,2064,17194588,Confirmatory,20181022,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2,"1-Naphthalenecarboxamide, N-[3-cyano-7-(cyclopropylcarbonyl)-4,5,6,7-tetrahydrothieno[2,3-b]pyridin-2-yl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101081639,10,304938,103546381,11281930,2064,17027260,Confirmatory,20181022,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2,"3-(4-Amino-3-(3-chloro-4-fluorophenyl)thieno[3,2-c]pyridin-7-yl)benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101081640,10,304938,103546384,9938299,2064,17027260,Confirmatory,20181022,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2,"3-(4-Amino-3-{4-[3-(2-fluoro-5-trifluoromethyl-phenyl)-ureido]-phenyl}-furo[3,2-c]pyridin-7-yl)-benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514793,10,364803,103587809,25271515,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N-(2-morpholinoethyl)pyrimidine-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514798,10,364803,103587750,25271514,2064,18678484,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N-(2-(piperidin-1-yl)ethyl)pyrimidine-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101535795,10,410050,103588737,135524168,2064,18945615,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"6-[2-[(E)-2-[4-(morpholin-4-ylmethyl)phenyl]ethenyl]pyridin-4-yl]-1,7-dihydropyrrolo[3,2-e]pyrimidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101564232,10,371616,103610713,25124816,2064,19101143,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2,"N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101583585,10,325576,103472640,9797370,2064,18077363,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N-(3-fluorophenyl)-6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101583586,10,325576,103567618,3385203,2064,18077363,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>=,ChEMBL,Inhibition of HER2,"3-Phenyl-1H-benzofuro[3,2-c]pyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101637317,10,276915,103508251,11626927,2064,16997559,Confirmatory,20220830,0,0,Active,P04626,IC50,<,ChEMBL,Inhibition of ErB2,IKK-3 Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675481,10,290549,103523352,44426256,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,2-methoxy-N-(3-(4-(3-methyl-4-(1-methylpiperidin-4-yloxy)phenylamino)quinazolin-6-yl)prop-2-ynyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101675482,10,290549,103523367,44426271,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N,N-dimethylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101675483,10,290549,103523368,44426272,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-phenylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101675486,10,290549,103523361,44426265,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,"3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N,N-dimethylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101675489,10,290549,103523351,44426255,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,2-methoxy-N-(3-(4-(3-methyl-4-(piperidin-4-yloxy)phenylamino)quinazolin-6-yl)prop-2-ynyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101675490,10,290549,103523353,44426257,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,N-(3-(4-(4-(1-acetylpiperidin-4-yloxy)-3-methylphenylamino)quinazolin-6-yl)prop-2-ynyl)-2-methoxyacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101676418,10,290549,103523357,44426261,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,2-methoxy-N-(3-(4-(4-(1-(2-methoxyacetyl)piperidin-4-yloxy)-3-methylphenylamino)quinazolin-6-yl)prop-2-ynyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101676426,10,290549,103523360,44426264,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101676428,10,290549,103523369,44426273,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,N-tert-butyl-4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101676430,10,290549,103523366,44426270,2064,17398092,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of erbB2 expressed in Sf9 cells,4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101748782,10,308241,103551069,135497870,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N,N-diethyl-2-(5-(isoquinolin-4-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-1H-benzo[d]imidazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748789,10,308241,103551074,135497814,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N-((5-(3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)methyl)propan-1-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748792,10,308241,103551067,135497869,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N-isopropyl-2-(5-(isoquinolin-4-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-1H-benzo[d]imidazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749759,10,308515,103548549,135794286,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,6-methoxy-2-(4-(2-(pyridin-3-yl)vinyl)-1H-pyrazol-3-yl)-1H-benzo[d]imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101750416,10,308515,103548550,135620673,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,6-methoxy-2-(4-(2-(4-methylpyridin-3-yl)vinyl)-1H-pyrazol-3-yl)-1H-benzo[d]imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103083166,10,430636,103693688,45273507,2064,19610618,Confirmatory,20180910,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"5-(3-(benzyloxy)phenyl)-7-(3-(pyrrolidin-1-yl)cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124185,10,418589,103593535,44564788,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N2-(4-(benzo[d]thiazol-2-yl)-3-methoxyphenyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124187,10,418589,103593598,44564817,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,N-(4-(benzo[d]thiazol-2-yl)-3-methoxyphenyl)-2-methoxy-9H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124188,10,418589,103593666,44564861,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N-[4-(1,3-Benzothiazol-2-yl)-2-fluorophenyl]thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124189,10,418589,103593538,44564791,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N-(4-(benzo[d]thiazol-2-yl)phenyl)-2-methoxy-7H-pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124190,10,418589,103593469,44564747,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N4-(4-(benzo[d]thiazol-2-yl)phenyl)-N2-(5-methyl-1H-pyrazol-3-yl)pyridine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124192,10,418589,103593602,44564821,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N-(4-(benzo[d]thiazol-2-yl)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124193,10,418589,103593473,44564751,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,N-(4-(benzo[d]thiazol-2-yl)phenyl)-4-(4-methylpiperazin-1-yl)pyrimidin-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124194,10,418589,103593600,44564819,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,N-(4-(benzo[d]thiazol-2-yl)-3-methoxyphenyl)-9H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124196,10,418589,103593470,44564748,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N4-(4-(benzo[d]thiazol-2-yl)phenyl)-N2-methylpyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124467,10,418589,103593471,44564749,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N2-(4-(benzo[d]thiazol-2-yl)phenyl)-N4-methylpyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124469,10,418589,103593601,44564820,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N-[4-(1,3-Benzothiazol-2-yl)phenyl]thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124470,10,418589,103593406,44564705,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N4-(4-(benzo[d]thiazol-2-yl)phenyl)-N2-methylpyridine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124473,10,418589,103593665,44564860,2064,19211246,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N-(4-(benzo[d]thiazol-2-yl)-3-chlorophenyl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105935054,10,440618,103696812,45482750,2064,19775160,Confirmatory,20180911,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of N-terminal peptide-tagged ERBB2 cytoplasmic domain by [gamma-33-P]ATP based assay,(S)-3-(4-(ethylsulfinyl)phenyl)-5-(5-methylfuran-2-yl)benzofuran,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105935055,10,440618,103696748,45482700,2064,19775160,Confirmatory,20180911,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of N-terminal peptide-tagged ERBB2 cytoplasmic domain by [gamma-33-P]ATP based assay,(S)-5-(5-methylfuran-2-yl)-3-(4-(methylsulfinyl)phenyl)benzofuran,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105960083,10,445189,103708826,10296883,2064,19827831,Confirmatory,20180911,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant HER2,Sotrastaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001436,10,435796,103163932,4521392,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001437,10,435796,103420820,216239,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001439,10,435796,103734272,9829523,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Midostaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001440,10,435796,103177459,176870,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001441,10,435796,103320031,156422,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Doramapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001442,10,435796,103181324,5169,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001443,10,435796,103245522,5291,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Imatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001743,10,435796,103459325,5330790,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"4-({5-Amino-1-[(2,6-Difluorophenyl)carbonyl]-1h-1,2,4-Triazol-3-Yl}amino)benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001745,10,435796,103506979,9926791,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Tofacitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001746,10,435796,103573134,5494449,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Tozasertib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001747,10,435796,103229612,3025986,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001749,10,435796,103694305,11667893,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Motesanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001752,10,435796,131277755,10138259,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"1H-Pyrrole-3-carboxamide, 5-((5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-N-((2S)-2-hydroxy-3-(4-morpholinyl)propyl)-2,4-dimethyl-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001753,10,435796,103354744,3038522,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Tandutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001754,10,435796,103565670,11712649,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001755,10,435796,103163913,176155,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001756,10,435796,103175813,5329102,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Sunitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001758,10,435796,103298456,153999,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Ruboxistaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001759,10,435796,103176908,160355,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Seliciclib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001760,10,435796,103344166,3038525,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Neflamapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001761,10,435796,103567703,11617559,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001762,10,435796,103623548,10113978,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Pazopanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001763,10,435796,123092436,44259,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001765,10,435796,103317292,151194,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Vatalanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001767,10,435796,103510213,11485656,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Linifanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001768,10,435796,103628628,135398510,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Dovitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001769,10,435796,103694306,11409972,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,1-(4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106001770,10,435796,103694308,9884685,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,PI-103,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106002060,10,435796,104234154,5287969,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Alvocidib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
106002061,10,435796,103694307,11656518,2064,18183025,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151224154,10,455910,103716041,46224684,2064,19926477,Confirmatory,20180912,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2,"5-(2-aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257100,10,454329,103717490,46225598,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-2-(trifluoromethoxy)phenyl]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257101,10,454329,103717516,135971426,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"2-(1,3-Benzothiazol-2-yl)-5-[[7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257103,10,454329,103717584,46225666,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]-N-[4-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257104,10,454329,103717585,46225667,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,N-(4-(6-chlorobenzo[d]thiazol-2-yl)-2-fluorophenyl)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257319,10,454329,103717609,46225681,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-2-methoxyphenyl]-7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257320,10,454329,103717530,46225632,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-3-fluorophenyl]-7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257322,10,454329,103717554,46225649,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]-N-[4-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]phenyl]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257324,10,454329,103717489,46225597,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-2-methoxyphenyl]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257326,10,454329,103717583,46225665,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(5-chloro-1,3-benzothiazol-2-yl)phenyl]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257329,10,454329,103717553,46225648,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(5-chloro-1,3-benzothiazol-2-yl)phenyl]-7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151257333,10,454329,103717493,46225599,2064,19692247,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 by microplate scintillation counting,"N-[4-(1,3-benzothiazol-2-yl)-2-fluorophenyl]-7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155658490,10,470892,103740844,44138048,2064,19303774,Confirmatory,20180912,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2,"7-Chloro-1-(3,4-dichlorophenyl)-6-methoxy-3,4-dihydroisoquinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155658491,10,470892,103740864,44138049,2064,19303774,Confirmatory,20180912,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2,"7-Chloro-1-(3-chlorophenyl)-6-methoxy-3,4-dihydroisoquinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155717118,10,484565,103758714,24762205,2064,20483608,Confirmatory,20180913,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of Her2,"Isobutyl4-(7-amino-3-(4-(4-methylpiperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-6-yl)phenylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155745959,10,474117,103749228,11640390,2064,20346655,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 intracellular phosphorylation in human N87 cells by ELISA,Linsitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
169119229,10,491924,103768671,46898022,2064,20570525,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition ErbB2,n-(4-Aminosulfonylphenyl)-2-morpholino-9h-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
178265315,10,503767,103517284,11715767,2064,18469809,Confirmatory,20200702,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR-1,"2-Pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237397,10,507932,103175813,5329102,2064,19654408,Confirmatory,20180914,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to ERBB2,Sunitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237398,10,507932,123092829,52945601,2064,19654408,Confirmatory,20180914,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to ERBB2,(S)-3-Hydroxy Midostaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237399,10,507932,103699058,24889392,2064,19654408,Confirmatory,20180914,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to ERBB2,Quizartinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237400,10,507932,103722924,126565,2064,19654408,Confirmatory,20180914,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to ERBB2,Lestaurtinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237401,10,507932,103734272,9829523,2064,19654408,Confirmatory,20180914,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to ERBB2,Midostaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237402,10,507932,103354744,3038522,2064,19654408,Confirmatory,20180914,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to ERBB2,Tandutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237403,10,507932,103420820,216239,2064,19654408,Confirmatory,20180914,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to ERBB2,Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198240929,10,511825,123090740,24960018,2064,20188579,Confirmatory,20180914,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by immunoprecipitation assay,(E)-4-(2-(4-Bromobenzylthio)-3-(4-fluoro-3-nitrophenyl)acryloyl)benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198253316,10,515895,123084702,15949613,2064,20833055,Confirmatory,20180914,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"1-{2-Fluoro-4-[(5-Methyl-5h-Pyrrolo[3,2-D]pyrimidin-4-Yl)oxy]phenyl}-3-[3-(Trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198317495,10,526050,123088777,24809764,2064,20873740,Confirmatory,20200626,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR1,5-(2-aminopyrimidin-4-yl)-2-phenyl-1H-pyrrole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204229908,10,553107,124971673,53324451,2064,24900250,Confirmatory,20180916,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 by TR-FRET based LanthaScreen assay,"(3S,5Z,9S)a9,16aDihydroxya14amethoxya3amethyla3,4,7,8,9,10,11,12aoctahydroa1Ha2abenzoxacyclotetradecinea1,7adione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204229909,10,553107,160704414,10498988,2064,24900250,Confirmatory,20180916,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 by TR-FRET based LanthaScreen assay,Desepoxyhypothemycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
224450506,10,592966,131275907,50997096,2064,21405128,Confirmatory,20180918,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2,3-(4-Acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7-(trifluoromethyl)quinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
224485962,10,597116,124976466,49792852,2064,21470862,Confirmatory,20200629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR1 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting,Onvansertib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
224496617,10,601845,131272945,53257410,2064,21517068,Confirmatory,20210802,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR2 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA,"Ethyl 8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237740687,10,612123,134442074,53357848,2064,21665484,Confirmatory,20180919,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2,"1-(4-fluorophenyl)-N-[3-fluoro-4-(5-phenylthieno[2,3-d]pyrimidin-4-yl)oxyphenyl]-2-oxopyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237760637,10,623493,134447688,56669626,2064,21936542,Confirmatory,20180919,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant ERBB2,Infigratinib Phosphate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254357249,10,637258,136941547,56835147,2064,22169262,Confirmatory,20180920,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"Urea, N-(3-fluorophenyl)-N'-[4-[[7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinyl]amino]phenyl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254383880,10,637639,136946051,25210579,2064,22154349,Confirmatory,20200626,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR1,"1-Methyl-2-(2-{[5-(4-Methylpiperazin-1-Yl)-2-(Trifluoromethoxy)phenyl]amino}pyrimidin-4-Yl)-1,5,6,7-Tetrahydro-4h-Pyrrolo[3,2-C]pyridin-4-One",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384316,10,637639,136942814,54759168,2064,22154349,Confirmatory,20200626,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR1,1-Methyl-5-(2-{[5-(4-Methylpiperazin-1-Yl)-2-(Trifluoromethoxy)phenyl]amino}pyrimidin-4-Yl)-1h-Pyrrole-3-Carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433458,10,636385,136934735,57397677,2064,22182581,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,"N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]-2-(3,4-dimethoxyphenoxy)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433592,10,636385,136930421,57395424,2064,22182581,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,6-[3-(benzylamino)phenoxy]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254433595,10,636385,136920694,57390200,2064,22182581,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human ErbB2 preincubated for 2 hrs prior addition of ATP by HTRF assay,N-[3-[6-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-4-yl]oxyphenyl]-4-nitrobenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456046,10,624804,103624610,11364421,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456047,10,624804,123098392,6450551,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Axitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456049,10,624804,103320031,156422,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Doramapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456051,10,624804,136941612,44551653,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"5-Cyano-N-(5-(1-(2-(dimethylamino)acetyl)piperidin-4-yl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-2-yl)-1H-imidazole-2-carboxamide hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456052,10,624804,103420820,216239,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456053,10,624804,103499403,447077,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"6-(2,6-dichlorophenyl)-8-methyl-2-((3-(methylthio)phenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456054,10,624804,103728028,11626560,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Crizotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456056,10,624804,136925373,15983966,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,(R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456059,10,624804,124963590,10127622,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Selumetinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456061,10,624804,103317292,151194,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Vatalanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456063,10,624804,103510213,11485656,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Linifanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456064,10,624804,103604655,16725726,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456065,10,624804,103628628,135398510,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Dovitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456066,10,624804,103694306,11409972,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,1-(4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456067,10,624804,103694308,9884685,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,PI-103,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456068,10,624804,103725901,9929127,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"N-(6-chloro-7-methoxy-9H-pyrido[3,4-b]indol-8-yl)-2-methylnicotinamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456069,10,624804,104234154,5287969,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Alvocidib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456070,10,624804,103354744,3038522,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Tandutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456071,10,624804,103565670,11712649,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456072,10,624804,103229612,3025986,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456073,10,624804,103483726,11234052,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Brivanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456599,10,624804,103694305,11667893,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Motesanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456600,10,624804,123089189,16722836,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Fedratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456601,10,624804,136931825,9869779,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"1-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)-2-methoxyphenyl)-3-(1-(thiazol-2-yl)ethyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456604,10,624804,131277755,10138259,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"1H-Pyrrole-3-carboxamide, 5-((5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-N-((2S)-2-hydroxy-3-(4-morpholinyl)propyl)-2,4-dimethyl-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456605,10,624804,103563888,644241,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Nilotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456606,10,624804,103643222,11717001,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"(E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456607,10,624804,103654502,135423438,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Nintedanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456608,10,624804,103699058,24889392,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Quizartinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456610,10,624804,136944791,11427553,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,(E)-(4-(2-(1H-indazol-3-yl)vinyl)phenyl)(piperazin-1-yl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456611,10,624804,103694307,11656518,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456612,10,624804,103163913,176155,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456613,10,624804,103175813,5329102,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Sunitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456615,10,624804,103245522,5291,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Imatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456616,10,624804,103551463,9813758,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,BMS-345541 free base,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456617,10,624804,134449640,25126798,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Ruxolitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456621,10,624804,103501363,6918852,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"(4-Amino-2-((1-(methylsulfonyl)piperidin-4-yl)amino)pyrimidin-5-yl)(2,3-difluoro-6-methoxyphenyl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456622,10,624804,103506979,9926791,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Tofacitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456623,10,624804,103573134,5494449,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Tozasertib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456624,10,624804,103629211,25182616,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"2-((2-((1-(2-(Dimethylamino)acetyl)-5-methoxyindolin-6-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluoro-N-methylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254456625,10,624804,103298456,153999,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Ruboxistaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457126,10,624804,103643679,11338033,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457127,10,624804,104252247,24779724,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Sgx-523,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457128,10,624804,103491101,11314340,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,(2s)-1-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}-3-Phenylpropan-2-Amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457129,10,624804,103596121,11213558,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Tamatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457130,10,624804,103605815,17755052,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Pictilisib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457131,10,624804,103240316,176167,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Enzastaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457132,10,624804,103583760,10461815,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Pha-665752,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457133,10,624804,103722924,126565,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Lestaurtinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457134,10,624804,103734272,9829523,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Midostaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457135,10,624804,103320975,6918454,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457136,10,624804,103344166,3038525,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Neflamapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457138,10,624804,103567703,11617559,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457139,10,624804,103623548,10113978,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,Pazopanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254457140,10,624804,104246213,24180719,2064,22037378,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding constant for ERBB2 kinase domain,"N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254753290,10,643943,136925460,54613583,2064,22136433,Confirmatory,20200626,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 using ATP as substrate,"Spiro[piperidine-4,3'-[3H]pyrido[3,4-b]indole]-4'-carbonitrile, 7',8'-dichloro-1',2',4',9'-tetrahydro-9'-methyl-1'-oxo-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254753291,10,643944,136925460,54613583,2064,22136433,Confirmatory,20200626,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER4 using ATP as substrate,"Spiro[piperidine-4,3'-[3H]pyrido[3,4-b]indole]-4'-carbonitrile, 7',8'-dichloro-1',2',4',9'-tetrahydro-9'-methyl-1'-oxo-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321487968,10,678111,160670122,66553589,2064,22863529,Confirmatory,20200630,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2,"2-amino-N-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethyl]-5-[1-(oxan-4-yl)pyrazol-4-yl]pyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321583369,10,678510,160696866,70693079,2064,22901387,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant HER2 expressed in baculovirus infected Sf9 cells using [32P]ATP incubated for 30 mins prior to ATP addition measured after 20 mins by liquid scintillation counting,"4-N-(3-chlorophenyl)-6-N-(2,3,4,5-tetrahydro-1,6-benzodioxocin-8-ylmethyl)quinazoline-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
333956830,10,731105,164140524,71575642,2064,23362959,Confirmatory,20180926,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin),"1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333993916,10,731218,164146106,71568837,2064,23414845,Confirmatory,20200626,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),"8-(4-Ethylphenyl)-5-Methyl-2,5-Dihydropyrazolo[4,3-C][2,1]benzothiazine 4,4-Dioxide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333993917,10,731218,164148989,71567006,2064,23414845,Confirmatory,20200626,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),"8-(4-Ethylphenyl)-1,5-dimethylpyrazolo[4,3-c][2,1]benzothiazine 4,4-dioxide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333993918,10,731218,164146105,70698427,2064,23414845,Confirmatory,20200626,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),"N-(4-Tert-Butylbenzyl)-1,5-Dimethyl-1,5-Dihydropyrazolo[4,3-C][2,1]benzothiazin-8-Amine 4,4-Dioxide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339876519,10,761266,174518172,25123227,2064,23755884,Confirmatory,20180927,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) in presence of [gamma-32P]-ATP,"N-[5-({2-[(cyclopropylcarbonyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}oxy)-2-fluorophenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339923456,10,749393,174511716,71658998,2064,23602524,Confirmatory,20200629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant ErbB-2 (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-6-methyl-5-[(E)-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]ethenyl]pyridine-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339923457,10,749393,174491078,71658995,2064,23602524,Confirmatory,20200629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant ErbB-2 (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]ethynyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339923458,10,749393,174496130,71658878,2064,23602524,Confirmatory,20200629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant ErbB-2 (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-methyl-5-[(E)-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]ethenyl]pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339923459,10,749393,174516790,71658997,2064,23602524,Confirmatory,20200629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant ErbB-2 (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,(E)-N-[3-[(E)-2-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-5-cyano-2-methylpyridin-3-yl]ethenyl]phenyl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339923460,10,749393,174501361,71658877,2064,23602524,Confirmatory,20200629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant ErbB-2 (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,(E)-N-[3-[(E)-2-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-methylpyrimidin-5-yl]ethenyl]phenyl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340980765,10,1073263,194147251,46209401,2064,23906342,Confirmatory,20180929,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of N-terminal peptide (DYKDDDD)-tagged HER2 (unknown origin) expressed in baculovirus system using biotinylated poly-Glu-Tyr (4:1) as substrate preincubated for 5 mins measured after 12 hrs by scintillation counting,"N-{7-Cyano-6-[4-Fluoro-3-({[3-(Trifluoromethyl)phenyl]acetyl}amino)phenoxy]-1,3-Benzothiazol-2-Yl}cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342678394,10,1155098,242647319,86302541,2064,24900886,Confirmatory,20200618,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of human ErbB2 expressed in baculovirus expression system using poly (4 Glu, Tyr) as substrate after 60 mins by ELISA","6-(4-aminothieno[2,3-d]pyrimidin-5-yl)-N-phenylnaphthalene-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345269111,10,1181816,312346695,51037948,2064,24980703,Confirmatory,20181005,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR1 (unknown origin),"5-Benzo[1,3]dioxol-5-ylmethyl-10-fluoro-8-(4-methyl-piperazin-1-yl)-[1,2,4]triazolo[1,5-c]quinazolin-2-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345269115,10,1181816,312346535,51037112,2064,24980703,Confirmatory,20181005,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR1 (unknown origin),"5-(1,3-Benzodioxol-5-Ylmethyl)-10-Fluoro[1,2,4]triazolo[1,5-C]quinazolin-2-Amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345269216,10,1181816,312346543,50938552,2064,24980703,Confirmatory,20181005,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR1 (unknown origin),"2-{[2-Amino-5-(1,3-Benzodioxol-5-Ylmethyl)[1,2,4]triazolo[1,5-C]quinazolin-8-Yl]amino}ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345269220,10,1181816,312346540,51036677,2064,24980703,Confirmatory,20181005,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR1 (unknown origin),"5-(1,3-Benzodioxol-5-ylmethyl)-[1,2,4]triazolo[1,5-c]quinazoline-2,8-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345269224,10,1181816,312346542,118706214,2064,24980703,Confirmatory,20181005,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR1 (unknown origin),"3-[[5-(1,3-Benzodioxol-5-yl)-[1,2,4]triazolo[1,5-c]quinazolin-8-yl]amino]propan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
346964347,10,1250750,318392885,122192466,2064,26342867,Confirmatory,20200624,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant ErbB2,"6-[4-[(5-tert-butyl-1,2-oxazol-3-yl)carbamoylamino]phenyl]-N-[3-(dimethylamino)propyl]imidazo[2,1-b][1,3]thiazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072429,10,1256453,318397025,122195691,2064,26475520,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,Diethyl 2-[[[4-[[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]carbamoyl]phenyl]carbamoylamino]methylidene]propanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072439,10,1256453,318397017,122195683,2064,26475520,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,"Diethyl 2-[[[4-[3-chloro-4-(3,4-dichlorophenoxy)anilino]quinazolin-6-yl]amino]methylidene]propanedioate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072442,10,1256453,318397020,122195686,2064,26475520,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,"2-[[[4-[3-Chloro-4-(3,4-dichlorophenoxy)anilino]quinazolin-6-yl]amino]methylidene]propanedinitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
347072446,10,1256453,318397013,122195679,2064,26475520,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) after 120 mins by HotSpot assay,"1-[4-[3-Chloro-4-(3,4-dichlorophenoxy)anilino]quinazolin-6-yl]-3-ethylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353426618,10,1263970,336887549,127038480,2064,"",Confirmatory,20180904,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of human recombinant ErbB2 expressed in baculovirus using Poly (Glu,Tyr) as substrate after 60 mins by ELISA",6-[2-[3-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]oxy-N-phenylnaphthalene-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353426619,10,1263970,336886675,127037812,2064,"",Confirmatory,20180904,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of human recombinant ErbB2 expressed in baculovirus using Poly (Glu,Tyr) as substrate after 60 mins by ELISA",6-[2-[3-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]oxy-N-pyridin-3-ylnaphthalene-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353426620,10,1263970,336891883,127041777,2064,"",Confirmatory,20180904,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of human recombinant ErbB2 expressed in baculovirus using Poly (Glu,Tyr) as substrate after 60 mins by ELISA",N-(3-fluorophenyl)-6-[2-[3-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]oxynaphthalene-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353427955,10,1264811,336891849,46872626,2064,26509640,Confirmatory,20180904,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin),"1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353429760,10,1266551,318410437,44814409,2064,26505898,Confirmatory,20180904,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),"N-{4-[(1r,3s,5s)-3-Amino-5-Methylcyclohexyl]pyridin-3-Yl}-6-(2,6-Difluorophenyl)-5-Fluoropyridine-2-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353433920,10,1269788,336890297,67240318,2064,26762835,Confirmatory,20180904,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human ERBB2 using poly[Glu:Tyr] (4:1) as substrate,"2-((1H-indol-5-yl)amino)-6-((2,4-difluorophenyl)sulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353455897,10,1291017,336877197,68293660,2064,26951753,Confirmatory,20180905,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) in presence of [gamma33P]ATP,"1-{4-[cis-3-(4-Amino-5-{2-fluoro-3-[(S)-1-(tetrahydro-furan-2-yl)methoxy]-phenyl}-pyrrolo[2,3-d]pyrimidin-7-yl)-cyclobutyl]-piperazin-1-yl}-ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353455898,10,1291017,336874132,67035556,2064,26951753,Confirmatory,20180905,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) in presence of [gamma33P]ATP,"7-[3-(azetidin-1-ylmethyl)cyclobutyl]-5-[3-[[(2S)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353455899,10,1291017,242405913,11476171,2064,26951753,Confirmatory,20180905,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) in presence of [gamma33P]ATP,Nvp-aew541,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353455900,10,1291017,336874133,67035106,2064,26951753,Confirmatory,20180905,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) in presence of [gamma33P]ATP,"7-(3-azetidin-1-ylmethyl-cyclobutyl)-5-[3-(7-oxa-bicyclo[2.2.1]hept-1-ylmethoxy)-phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353455901,10,1291017,336878033,68293638,2064,26951753,Confirmatory,20180905,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) in presence of [gamma33P]ATP,"1-{4-[cis-3-(4-Amino-5-{2-fluoro-5-[(S)-1-(tetrahydro-furan-2-yl)methoxy]-phenyl}-pyrrolo[2,3-d]pyrimidin-7-yl)-cyclobutyl]-piperazin-1-yl}-ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354688032,10,1298204,336900732,136175114,2064,27106709,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR (746 to 750) deletion mutant (unknown origin) using peptide substrate incubated for 30 mins by europium donor dye-based plate reader analysis,Drak2-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354688036,10,1298204,103653286,135520135,2064,27106709,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR (746 to 750) deletion mutant (unknown origin) using peptide substrate incubated for 30 mins by europium donor dye-based plate reader analysis,"N-[2-hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-2,2-dimethylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654682,10,1315425,374287264,134137211,2064,27187856,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-chloroacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654683,10,1315425,374307443,134142769,2064,27187856,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[4-[(4-Chlorophenyl)methoxy]anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654688,10,1315425,374357090,134156713,2064,27187856,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"Ethyl 4-[[1-[2-(2-bromoacetyl)oxyethyl]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-8-yl]amino]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655576,10,1315425,374353947,134155874,2064,27187856,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[2-Oxo-8-[4-(piperidine-1-carbonylamino)anilino]-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355655579,10,1315425,374349372,134154580,2064,27187856,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(3-Chloro-4-piperidin-1-ylanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355700741,10,1336033,374264784,69036886,2064,27816515,Confirmatory,20220830,0,0,Active,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His-tagged ERBB2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system,"2-anilino-7-[(1S)-4-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethylpyrrolo[2,3-d]pyrimidin-6-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355733593,10,1341597,374348411,24900835,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>=,ChEMBL,Inhibition of N-terminal GST-tagged human HER2 (Lys676 to Val1255 residues) expressed in baculovirus expression system using biotinylated FLT3 at Tyr589 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA m,"(E)-N-hydroxy-3-[4-[[[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]methylamino]methyl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363139228,10,1419164,404696560,145979714,2064,30423248,Confirmatory,20200619,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) in presence of 1 mM ATP concentration,"[(1S)-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]cyanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363139229,10,1419164,404704923,137321159,2064,30423248,Confirmatory,20200619,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) in presence of 1 mM ATP concentration,JAK3 covalent inhibitor-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363139695,10,1419164,404710363,145988956,2064,30423248,Confirmatory,20200619,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) in presence of 1 mM ATP concentration,"[(1S)-6-[5-[3-(hydroxymethyl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2,3-dihydro-1H-inden-1-yl]cyanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365319450,10,1533590,440221839,137321162,2064,30503936,Confirmatory,20210302,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER-2 (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay,"1-[2-(2,6-Difluorophenyl)-4-oxo-1,3-thiazolidin-3-yl]-3-[4-[7-[3-(4-ethylpiperazin-1-yl)propoxy]-6-methoxyquinolin-4-yl]oxy-3,5-difluorophenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365340559,10,1542839,440151211,132156633,2064,30987781,Confirmatory,20210302,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),"N-[5-cyano-4-[[(2R)-1-methoxypropan-2-yl]amino]pyridin-2-yl]-7-formyl-6-[(2-oxo-1,3-oxazepan-3-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365423487,10,1580962,440113793,155513187,2064,31693351,Confirmatory,20210302,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant human ERBB2 G778D (676 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis",4-(Dimethylamino)-N-(3-(2-((4-oxo-4H-chromen-7-yl)oxy)acetamido)phenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366369536,10,1560827,404719200,121293929,2064,32083858,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to DNA-tagged recombinant ERBB2 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis,Branebrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366369537,10,1560827,440157246,118107483,2064,32083858,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to DNA-tagged recombinant ERBB2 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis,Remibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366369538,10,1560827,381847098,71479709,2064,32083858,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,>,ChEMBL,Binding affinity to DNA-tagged recombinant ERBB2 (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis,Evobrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366428839,10,1589888,440202130,135236676,2064,31023512,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of probe binding to HER2 (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,"US10246444, Example 55",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372334879,10,1714839,461532651,162655720,2064,29324347,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErBB2 (unknown origin),"1-[4-[[4-Amino-5-(1,3-benzodioxol-5-yl)pyrrolo[2,3-d]pyrimidin-7-yl]methyl]piperidin-1-yl]prop-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380317475,10,1823796,475990295,166631440,2064,34333981,Confirmatory,20230314,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant human ERBB2 (676 to 1255 residues) using poly(Glu:Tyr) as substrate incubated for 40 mins in presence of [gamma-33P-ATP] by radiometric scintillation assay,4-[[[2-[3-(Morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]methyl]benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380593321,10,1864440,440132743,131839646,2064,36066182,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),"N-(tert-Butyl)-2-((6,6-dimethyl-8-(methylsulfonamido)-11-oxo-6,11-dihydronaphtho[2,3-b]benzofuran-3-yl)ethynyl)-6-methylisonicotinamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380593534,10,1864440,482065742,168282662,2064,36066182,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),"3-[2-[4-(Cyclopropylmethoxy)pyridin-2-yl]ethynyl]-6,6-dimethyl-8-(2-morpholin-4-ylethoxy)naphtho[3,2-b][1]benzofuran-11-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380776702,10,1908700,194168492,66577038,2064,35439002,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin),{(2R)-1-[4-({3-Methyl-5-[(phenylsulfonyl)methyl]phenoxy}methyl)benzyl]pyrrolidin-2-YL}methanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380776703,10,1908700,482058469,164887502,2064,35439002,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 (unknown origin),SphK1-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388950541,10,1798244,404342805,135236676,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,>,BindingDB,"Kinase assay from US Patent US10246444: '1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions'","US10246444, Example 55",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407910307,10,1923077,494418062,171356152,2064,36793426,Confirmatory,20240503,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),"6-(1-acetylpiperidin-4-yl)-4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-2,8-dimethylpyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605090,10.23,1867605,482048796,168270408,2064,35452936,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(2-chlorophenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151285898,10.26,456091,103724238,135641774,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"2-[(2E)-2-(3-bromobenzylidene)hydrazinyl]-1,3-thiazol-4(5H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776833,10.26,649306,136921131,57390420,2064,22361272,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Fluorophenyl)-3-(4-methylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776841,10.34,649306,136930925,57395706,2064,22361272,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Chlorophenyl)-3-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363488420,10.4,1359300,404655654,145952066,2064,29730188,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-His6-fused erbB2 expressed in Sf9 insect cells using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method",N-[2-(3-fluorophenyl)ethyl]-3-thianthren-1-yl-5-(trifluoromethyl)benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776834,10.48,649306,136940745,57400955,2064,22361272,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3,5-Bis(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
388889928,10.5,1797499,386045969,57802635,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 273",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890596,10.5,1797499,386053038,57802690,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 44",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388890943,10.5,1797499,386045972,57802790,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 276",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388892034,10.5,1797499,386045970,57802850,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 274",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388892048,10.5,1797499,386045971,57802703,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 275",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388901536,10.5,1797499,386053007,10369818,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 8",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388903110,10.5,1797499,386053031,57802793,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 36",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388903111,10.5,1797499,386053058,10390394,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 68",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388903115,10.5,1797499,386053016,10393395,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 17",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388911601,10.5,1797499,386053048,10005056,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 58",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388912555,10.5,1797499,386053033,57802722,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 39",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388912561,10.5,1797499,386053024,58013804,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 25",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388913522,10.5,1797499,386053055,10412767,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 65",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388914487,10.5,1797499,386053056,10347695,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 66",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388914492,10.5,1797499,386053041,53630923,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"(3S,8aS)-3-({[4-[(3,4-dichloro-2-fluorophenyl)amino]-6-(methyloxy)quinazolin-7-yl]oxy}methyl)hexahydropyrrolo[1,2-a]pyrazin-1(2H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388917010,10.5,1797499,386053037,57802681,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 43",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388918659,10.5,1797499,386053049,10253661,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 59",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388919116,10.5,1797499,386053034,53630919,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"N-(4,5-dichloro-2-fluorophenyl)-7-{[(3S,8aS)-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-3-ylmethyl]oxy}-6-(methyloxy)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388920797,10.5,1797499,386053036,66955051,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 42",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388920801,10.5,1797499,386053044,10436695,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"(3S,8aS)-3-({[4-[(3,4-dichloro-2-fluorophenyl)amino]-6-(methyloxy)quinazolin-7-yl]oxy}methyl)-2-methylhexahydropyrrolo[1,2-a]pyrazin-1(2H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388922673,10.5,1797499,386053229,57802665,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 225",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388922843,10.5,1797499,386053261,57802675,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 258",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388922993,10.5,1797499,386053268,57802624,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 265",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388924024,10.5,1797499,386053256,57802667,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 253",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388924685,10.5,1797499,386053265,57802771,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 262",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388924690,10.5,1797499,386053262,57802751,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 259",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925762,10.5,1797499,386053259,76614846,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 256",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388925863,10.5,1797499,386053266,57802670,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 263",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926026,10.5,1797499,386053253,57802866,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 249",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926029,10.5,1797499,386053237,57802564,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 233",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926039,10.5,1797499,386053254,57802760,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 250",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926401,10.5,1797499,386053255,57802894,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 251",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926411,10.5,1797499,386053269,57802581,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 266",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388926678,10.5,1797499,386053272,57802841,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 269",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388928956,10.5,1797499,386053243,58013772,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 239",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388929882,10.5,1797499,386053260,57802859,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 257",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388930980,10.5,1797499,386053258,69667119,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 255",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388930985,10.5,1797499,386053267,57802597,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,AlphaScreen Assay from US Patent US9796704: 'Substituted quinazolines as receptor-type kinase inhibitors',"US9796704, Entry 264",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865147,10.53,620240,134460389,56680357,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(4-fluorophenyl)-N-(4-methylphenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776622,10.53,649306,136939182,57400072,2064,22361272,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Fluorophenyl)-3-phenyl-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
334040879,10.63,725964,164142896,71524868,2064,23391364,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER-2 cytoplasmic domain (676 to 1245) autophosphorylation after 1 hr,"5-(4-Fluorophenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120450,10.78,492321,103770007,10614224,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethylcinnamate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
341102816,10.8,1062007,194148013,331313,2064,24355130,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by ADP-Glo assay,CID 331313,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101740890,11,305799,103545046,11183327,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"5-(4-Chloro-phenyl)-3H-[1,2,3]triazole-4-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
402266261,11,1805507,447113382,135157199,2064,"",Confirmatory,20240109,0,0,Inactive,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 14",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865149,11.05,620240,134460391,56680358,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(4-chlorophenyl)-N-(4-fluorophenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889379,11.08,266066,103489908,44412244,2064,16759097,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,3-[4-(3-Bromoanilino)quinazolin-6-yl]-1-(2-chloroethyl)-1-methylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
254856602,11.108,625186,124974065,36314,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Paclitaxel,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372364049,11.2114,1731398,461544210,162663842,2064,33545637,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin),"6-[(5Z)-5-[(4-chlorophenyl)methylidene]-3-(4-methylphenyl)-6-oxo-1H-1,2,4-triazine-2-carbonyl]-3-methyl-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341102819,11.4,1062007,194168807,313371,2064,24355130,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by ADP-Glo assay,"5,8-Dihydroxy-2,3-bis(hydroxymethyl)naphthoquinone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100671760,11.75,91107,103312577,9979362,2064,12270171,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 autophosphorylation,"4-(3-Ethynyl-phenylamino)-6,7-bis-(2-methoxy-ethoxy)-quinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889377,11.8,266066,103489699,44412177,2064,16759097,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,1-(2-Chloroethyl)-1-methyl-3-[4-(3-methylanilino)quinazolin-6-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100398117,11.82,164334,103339416,10928765,2064,12502359,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Dimethylamino-pent-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622430,12,68095,103244892,5328764,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 30,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749755,12,308515,103548555,135620677,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2,6-methoxy-2-(4-(2-(5-methoxypyridin-3-yl)vinyl)-1H-pyrazol-3-yl)-1H-benzo[d]imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101856318,12,259431,103334009,448969,2064,16420067,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,"9-Butyl-8-(2,5-dimethoxy-benzyl)-9H-purin-6-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389666336,12,1806610,471698526,155243046,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 20",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409211,12.0226,164335,103244892,5328764,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 30,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616513,12.05,1268283,336889008,127039609,2064,26652482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"1-(2-Methyl-5-nitroimidazol-1-yl)propan-2-yl 4-[2-acetyl-5-(4-methoxyphenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605101,12.14,1867605,482071146,168286556,2064,35452936,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(2-fluorophenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889480,12.18,266066,103489909,10156890,2064,16759097,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,1-(2-Chloroethyl)-1-nitroso-3-{[4-(3-methylphenyl)amino]quinazolin-6-yl}urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
380522516,12.3,1849107,482068216,168284444,2064,36351049,Confirmatory,20230629,0,0,Unspecified,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,H-Asn-Pro-Pro-Trp-Gly-Arg-Ser-Arg-Tyr-Asn-Gln-Arg-Phe-Lys-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345572822,12.37,1191002,312377564,118725950,2064,25619636,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human full length HER2 assessed as phosphorylation state by ELISA assay,1-(3-bromopyridin-2-yl)-3-[[2-(1H-indol-3-yl)acetyl]amino]thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286897,12.42,456100,103723806,46229379,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(3,5-Dibromo-2-hydroxybenzyl)-1-(4-fluorobenzyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254776621,12.43,649306,136937506,57399188,2064,22361272,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Fluorophenyl)-3-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
155746564,12.5,474114,103749075,46886244,2064,20346655,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2 by time resolved fluorescence assay,"N-(3-(5-(2-amino-1H-benzo[d]imidazol-6-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-chlorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616884,12.66,1268283,336890726,127040942,2064,26652482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"1-(2-Methyl-5-nitroimidazol-1-yl)propan-2-yl 4-[2-acetyl-5-(4-iodophenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288065,12.87,460690,103724453,46207011,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(2-chlorophenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100409207,12.8825,164335,103244563,5328761,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 25,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821395,13,248914,103441779,44388501,2064,15715478,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(4-benzylamino-3-chloro-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402267295,13,1805507,447113388,135157112,2064,"",Confirmatory,20240109,0,0,Inactive,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 71",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865069,13.07,620240,134460390,47108694,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(benzenesulfonyl)-2-(4-chlorophenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840563,13.084,625186,103224052,2247,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Astemizole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151289914,13.1,458722,103479297,11530963,2064,20031417,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 after 80 mins by radiometric protein kinase assay,"3-(1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776837,13.16,649306,136932624,57396641,2064,22361272,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3-(4-Chlorophenyl)-5-(4-fluorophenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354616873,13.16,1268283,336890727,127040943,2064,26652482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-[2-acetyl-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547937,13.2,81574,103294795,9995374,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"2H-Indol-2-one, 3-[[3-(1,1-dimethylethyl)-4-methoxyphenyl]methylene]-1,3-dihydro-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101822295,13.2,248914,103441863,11341400,2064,15715478,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,4-Dimethylamino-but-2-enoic acid [4-(3-benzyloxy-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151289915,13.316,458722,103726441,46231221,2064,20031417,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 after 80 mins by radiometric protein kinase assay,"3-(5-Bromo-1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865153,13.32,620240,134464195,24179332,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,4-chloro-N-[2-(4-chlorophenyl)acetyl]benzene-sulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605087,13.34,1867605,482060466,168278802,2064,35452936,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(2-methylphenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409206,13.4896,164335,103244043,5328779,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin B42,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100316266,13.5,68103,103244043,5328779,2064,10464027,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 receptor autophosphorylation,Tyrphostin B42,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622150,13.5,68095,103244043,5328779,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin B42,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101739459,13.5,305799,103545040,44437844,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"4-(4-isopropylphenyl)-5-cyano-2H-1,2,3-triazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
237865067,13.56,620240,134437290,56659875,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(4-bromophenyl)sulfonyl-2-(4-chlorophenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622151,13.6,68095,103244563,5328761,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 25,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100336870,13.85,69874,103332247,5328852,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(4-Chloro-2-fluorophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839686,13.904,625186,103212333,3198,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Econazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616872,14.04,1268283,336889009,127039610,2064,26652482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-(2-acetyl-5-phenyl-3,4-dihydropyrazol-3-yl)benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337006,14.18,69874,103332427,5328845,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Cyanophenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522517,14.3,1849107,482072428,168287496,2064,36351049,Confirmatory,20230629,0,0,Unspecified,P04626,Kd,=,ChEMBL,Binding affinity to recombinant HER2 (unknown origin) assessed as dissociation constant by SPR analysis,H-Asn-Pro-Asn-Trp-Gly-Tyr-Ser-Trp-Tyr-Asn-Gln-Arg-Phe-Lys-al,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120449,14.32,492321,103770009,49799766,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(4-methoxyphenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286110,14.34,456091,103724204,136066073,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"(2E)-2-[(E)-(3-chlorophenyl)methylidenehydrazinylidene]-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100672264,14.7,91107,103312074,22466767,2064,12270171,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 autophosphorylation,4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644313,14.8,1162093,312353634,118710979,2064,25172421,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"2-Amino-4-(7-methyltetrazolo[1,5-a]quinolin-4-yl)-5-oxo-1-pyridin-3-yl-4,6,7,8-tetrahydroquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354616883,14.93,1268283,336889436,127039944,2064,26652482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-[2-acetyl-5-(4-ethoxyphenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99538269,15,40021,103408188,44372283,2064,12639547,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of erbB-2 overexpressing BT474 (Breast) tumor cell proliferation,"N-(2-methylsulfonylethyl)-4-[4-[4-[[3-(trifluoromethyl)phenyl]methoxy]anilino]quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455157,15,81560,103346198,44345396,2064,7902440,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,3-[3-(5-Chloro-benzothiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409342,15.1356,164335,103346198,44345396,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,3-[3-(5-Chloro-benzothiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-2-cyano-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337018,15.17,69874,103332182,5328879,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-[(3-Bromophenyl)amino]-6,7-dimethoxy-3-quinolinecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151289916,15.18,458722,103726440,46231220,2064,20031417,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 after 80 mins by radiometric protein kinase assay,"3-(5-Iodo-1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547933,15.2,81574,103294794,44321395,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(3-Bromo-5-tert-butyl-4-methoxy-benzylidene)-5-chloro-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359508,15.238,69714,103303563,5328981,2064,11495584,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,N-[4-[(3-bromophenyl)amino]quinazolin-6-yl]-2-methylacrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817794,15.238,1795646,8034258,5328981,2064,11495584,Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,N-[4-[(3-bromophenyl)amino]quinazolin-6-yl]-2-methylacrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288056,15.39,460690,103724391,46207012,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(2-fluorophenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
237864963,15.57,620240,134441202,56663333,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(4-chlorophenyl)-N-(4-methylphenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359467,15.624,69714,103302705,5328980,2064,11495584,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 16t,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817790,15.624,1795646,8034257,5328980,2064,11495584,Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 16t,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286726,15.66,456100,103723951,46229500,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(4-Fluorobenzyl)-1-(2-hydroxy-5-methylbenzyl)-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100383141,15.8,81584,104234154,5287969,2064,12190313,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 kinase,Alvocidib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409202,15.8489,164335,103761320,44361706,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,4-[5-[(E)-3-amino-2-cyano-3-oxoprop-1-enyl]-2-hydroxy-3-methoxyphenyl]sulfanylbutanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455145,16,81560,103346022,44345334,2064,7902440,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,4-[5-(2-Carbamoyl-2-cyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-butyric acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622123,16,404519,103640447,9906303,2064,18500794,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2,"2-cyano-3-(3,4-dihydroxyphenyl)-N-(3-(trifluoromethyl)phenyl)acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345660454,16,1167102,312367120,86677234,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-{5-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-2-[(3R)-3-dimethylaminopyrrolidin-1-yl]-4-methoxyphenyl}prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
151286890,16.12,456100,103723848,46229409,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(2-Hydroxy-3,5-dimethylbenzyl)-1-(4-hydroxybenzyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100548005,16.2,81574,103294697,10783444,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(3-tert-Butyl-4-methoxy-benzylidene)-5-chloro-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865072,16.26,620240,134456567,56677027,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(4-bromophenyl)-N-(4-fluorophenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776831,16.42,649306,136921132,57390421,2064,22361272,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[5-(4-Chlorophenyl)-3-(4-fluorophenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101739457,16.6,305799,103545049,44437849,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"4-(4-fluoro-3-phenoxylphenyl)-5-cyano-2H-1,2,3-triazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
169120455,16.75,492321,103770050,49799787,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 3-(3-fluorophenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100548010,16.9,81574,103230338,1538822,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(E)-3-(4-Isopropylbenzylidene)indolin-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409210,16.9824,164335,103244133,5328760,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin AG 538,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409344,16.9824,164335,103243649,2385464,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"2-cyano-N-cyclohexyl-3-(3,4-dihydroxyphenyl)prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622433,17,68095,103243649,2385464,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,"2-cyano-N-cyclohexyl-3-(3,4-dihydroxyphenyl)prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345660997,17,1167102,312367127,71496458,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
354616882,17,1268283,336889087,127039662,2064,26652482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"1-(2-Methyl-5-nitroimidazol-1-yl)propan-2-yl 4-(2-acetyl-5-phenyl-3,4-dihydropyrazol-3-yl)benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337277,17.02,69874,103332137,5328859,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-[(5-Chloro-2-hydroxyphenyl)amino]-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101832404,17.1,254920,103561723,135440466,2064,16134929,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibitory concentration against HER2 with ATP concentration at 1/2Km,4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354616881,17.25,1268283,336889007,127039608,2064,26652482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"2-(2-Methyl-5-nitroimidazol-1-yl)ethyl 4-[2-acetyl-5-(4-methoxyphenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409338,17.378,164335,103346035,44345342,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,2-[4-Hydroxy-3-methoxy-5-(toluene-4-sulfonylmethyl)-benzylidene]-malononitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455169,17.4,81560,103346035,44345342,2064,7902440,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,2-[4-Hydroxy-3-methoxy-5-(toluene-4-sulfonylmethyl)-benzylidene]-malononitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622149,18,68095,103243552,5328763,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,"(E)-2-benzoyl-3-(3,4-dihydroxyphenyl)prop-2-enenitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622429,18,68095,103244133,5328760,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin AG 538,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101891033,18,266440,103488503,3417197,2064,16530412,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,Cambridge id 6612972,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363489347,18,1359300,404667100,145959984,2064,29730188,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-His6-fused erbB2 expressed in Sf9 insect cells using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method",N-[2-(3-fluorophenyl)ethyl]-3-(trifluoromethyl)-5-[4-[[3-(trifluoromethyl)phenoxy]methyl]phenyl]benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254776623,18.12,649306,136926160,57393146,2064,22361272,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged human recombinant cytoplasmic domain of HER2 expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,"2-[3,5-Bis(4-fluorophenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354616878,18.12,1268283,336889411,127039915,2064,26652482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"1-(2-Methyl-5-nitroimidazol-1-yl)propan-2-yl 4-[2-acetyl-5-(4-ethoxyphenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409417,18.197,164335,103243552,5328763,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"(E)-2-benzoyl-3-(3,4-dihydroxyphenyl)prop-2-enenitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286737,18.43,456100,103723845,46229406,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(2-Hydroxy-5-methylbenzyl)-1-(4-hydroxybenzyl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
407971044,18.46,1940264,440180859,135494293,2064,36496202,Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of c-ErbB-2 (unknown origin),"(4E)-4-(2-amino-5-oxo-1H-imidazol-4-ylidene)-3-bromo-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100671761,18.52,91107,103177459,176870,2064,12270171,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 autophosphorylation,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120225,18.82,492321,103770051,49799788,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 3-(3-methoxyphenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354616514,18.89,1268283,336887748,127038628,2064,26652482,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of His-tagged human HER-2 cytoplasmic domain (676-1245 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,"1-(2-Methyl-5-nitroimidazol-1-yl)propan-2-yl 4-[2-acetyl-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850466,18.896,625186,103163913,176155,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865079,18.94,620240,134448920,56670198,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(4-bromophenyl)-N-(4-chlorophenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547926,19,81574,103294612,44321301,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(3Z)-3-[(3-bromo-5-tert-butyl-4-methoxyphenyl)methylidene]-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340068913,19,770082,174508890,73294502,2064,23930994,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-[4-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
402265051,19,1805507,447113383,156905957,2064,"",Confirmatory,20240109,0,0,Inactive,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 15",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402266460,19,1805507,447113387,135156994,2064,"",Confirmatory,20240109,0,0,Inactive,P04626,IC50,"",BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 70",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865148,19.05,620240,134452788,47108713,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(benzenesulfonyl)-2-(4-bromophenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363687108,19.2,1404961,404699666,145981733,2064,29902719,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay","N-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644308,19.3,1162093,312353636,118710981,2064,25172421,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"2-Amino-4-(7-chlorotetrazolo[1,5-a]quinolin-4-yl)-5-oxo-1-pyridin-3-yl-4,6,7,8-tetrahydroquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
169120222,19.34,492321,103770049,49799786,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 3-(3-nitrophenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254832807,19.366,625186,103169389,2726,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorpromazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254821809,19.57,625186,103197648,3372,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluphenazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865152,19.83,620240,134448921,56670199,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(4-bromophenyl)-N-(4-bromophenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100007086,20,81724,103320031,156422,2064,12086485,Confirmatory,20181017,0,0,Unspecified,P04626,IC50,>,ChEMBL,Selectivity against HER2 kinase,Doramapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100012867,20,68105,103660586,23133323,2064,11881999,Confirmatory,20181017,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase at ATP concentration <Km,Vandetanib hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101856067,20,259431,103477094,11581013,2064,16420067,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,9-Butyl-8-(2-chloro-5-methoxy-benzyl)-9H-purin-6-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380648048,20,1878102,482066416,163196471,2064,35041943,Confirmatory,20230629,0,0,Unspecified,P04626,Kd,=,ChEMBL,Binding affinity to ERBB2 (unknown origin) assessed as dissociation constant by KINOMEscan analysis,Btk-IN-8,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237864967,20.33,620240,134437291,56659876,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(4-bromophenyl)-N-(4-methylphenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865077,20.45,620240,134464235,56683697,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(3-bromophenyl)-N-(4-fluorophenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409205,20.893,164335,103383759,44361703,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"(E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-(2,4,6-trimethylphenyl)prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407971043,20.99,1940264,440171089,135531249,2064,36496202,Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of c-ErbB-2 (unknown origin),"(4E)-4-(2-amino-5-oxo-1H-imidazol-4-ylidene)-2,3-dibromo-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647229,21,79614,103202908,44279217,2064,11378364,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,(3-Benzyl-3H-benzoimidazol-5-yl)-quinazolin-4-yl-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622135,21,404519,103265405,9858558,2064,18500794,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2,"2-(Bromomethyl)-6,7-dimethyl-3-phenylquinoxaline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101880656,21,263981,103486091,44410411,2064,16483772,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ErbB2,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345661662,21,1167102,312367122,101884761,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-{5-[(5-Chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-2-[3-dimethylaminoazetidin-1-yl]-4-methoxyphenyl}prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
100337125,21.19,69874,103333314,5328873,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,4-(3-Bromophenylamino)-6-ethoxy-7-methoxyquinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398127,21.51,164334,103339022,11037303,2064,12502359,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,(E)-But-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359455,21.657,69714,103303581,5328988,2064,11495584,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,(2Z)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817746,21.657,1795646,8034265,5328988,2064,11495584,Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,(2Z)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286109,21.75,456091,103724203,136066072,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"(2E)-2-[(E)-(3-fluorophenyl)methylidenehydrazinylidene]-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
389665401,22,1806610,471698541,155242975,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,Cell Viability Assay and IC50 Estimation from US Patent US11365189: 'Heterocyclic inhibitors of tyrosine kinase',"US11365189, Ex. No. 53",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547925,22.5,81574,103295033,5427224,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-[1-(4-Bromo-phenyl)-meth-(Z)-ylidene]-1-methyl-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345644315,22.7,1162093,312353644,118710988,2064,25172421,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"Ethyl 2-amino-4-(7-chlorotetrazolo[1,5-a]quinolin-4-yl)-5-oxo-1-pyridin-3-yl-4,6,7,8-tetrahydroquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151288072,22.75,460690,103724515,46207041,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-methyl-N-phenylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100409201,22.9087,164335,103244185,5328773,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin AG 698,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100316267,23,68103,103244185,5328773,2064,10464027,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 receptor autophosphorylation,Tyrphostin AG 698,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622436,23,68095,103244185,5328773,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin AG 698,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101889375,23.03,266066,103489732,44412181,2064,16759097,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of serum-stimulated proliferation of mouse ERBB2 transfected NIH3T3 cell line after 24 hrs,3-[4-(3-Chloroanilino)quinazolin-6-yl]-1-(2-chloroethyl)-1-methylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
237865076,23.45,620240,134444966,56666766,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(4-fluorophenyl)sulfonyl-2-(4-methoxyphenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865150,23.46,620240,134437331,56659883,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(3-bromophenyl)-N-(4-chlorophenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398132,23.59,164334,103339559,10029703,2064,12502359,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Morpholin-4-yl-but-2-enoic acid [4-(3-bromo-phenylamino)-3-cyano-8-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254750572,24,648952,103567703,11617559,2064,16249345,Confirmatory,20180921,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human His-tagged ERBB2 using biotin-amino hexanoic acid-RAHEEIYHFFFAKKK-NH2 as substrate after 15 mins by scintillation proximity assay,"5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366336830,24,1543479,440121836,155518524,2064,30763817,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of recombinant human wild-type N-terminal GST-His6-fused ERBB2 C-terminal domain (Q679 to V1255 residues) expressed in Sf9 insect cells using Poly(Glu:Tyr)4:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation c,N-(4-fluorophenyl)-1-methyl-3-[[methyl-[2-(4-phenylphenyl)ethyl]amino]methyl]indole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
99664447,25,81723,103363438,9927718,2064,14592495,Confirmatory,20181001,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 kinase,"N-(2-chloro-6-methylphenyl)-2-[(cyclopropylcarbonyl)amino]-1,3-thiazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100031447,25,81579,103229612,3025986,2064,15027863,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of HER2, Erb-B2 receptor","N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100296193,25,240497,103464548,11432911,2064,15943473,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition against human HER2 kinase,"5-{6-[5-(Difluoro-methanesulfonyl-methyl)-[1,3,4]oxadiazol-2-yl]-5-isopropyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino}-2,4-difluoro-N-methoxy-benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100382506,25,81584,103359881,5329663,2064,12190313,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 kinase,N-[5-[[(5-ethyl-2-oxazolyl)methyl]thio]-2-thiazolyl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100383142,25,81584,103230532,5282335,2064,12190313,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 kinase,"Benzeneacetamide, N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-(((2-hydroxy-1-(hydroxymethyl)ethyl)amino)methyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101518483,25,406970,103585491,24894992,2064,18529047,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant ERBB2,"4-[1-(tert-Butoxymethyl)-1H-indol-3-yl]-3-(3,4,5-trimethoxyphenyl)-1,5-dihydro-2H-pyrrole-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101829480,25,254975,103468318,23646543,2064,16111887,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,In vitro inhibitory concentration against HER2 cytoplasmic sequence expressed in Sf9 cells,"Ethyl 5-benzyl-4-[(1-benzylindazol-5-yl)amino]pyrrolo[2,1-f][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
204402367,25,580189,103486091,44410411,2064,21334203,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237776010,25,608488,134444730,10048045,2064,21705217,Confirmatory,20200629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"3-[(6-Benzoyl-5-Methylpyrrolo[2,1-F][1,2,4]triazin-4-Yl)amino]-N-Cyclopropyl-4-Methylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325958724,25,695968,163327278,71456750,2064,23025996,Confirmatory,20200625,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"(4-Chloro-2-hydroxyphenyl)-[3-(4-chlorophenyl)-5-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365552756,25,1637542,440207966,132601725,2064,27515719,Confirmatory,20210302,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin),N-[(2-fluorophenyl)methoxy]-3-(4-methylphenyl)-1-phenylpyrazole-4-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865065,25.03,620240,134441203,56663334,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(4-bromophenyl)sulfonyl-2-(4-methoxyphenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363489346,25.4,1359300,404665978,145959197,2064,29730188,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-His6-fused erbB2 expressed in Sf9 insect cells using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method",N-[2-(3-fluorophenyl)ethyl]-3-[4-[[4-(2-methoxyethyl)phenoxy]methyl]phenyl]-5-(trifluoromethyl)benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359373,25.71,69714,103303551,5328986,2064,11495584,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-3-(dimethylamino)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817803,25.71,1795646,8034263,5328986,2064,11495584,Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-3-(dimethylamino)prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151289437,25.87,460690,103724584,46207043,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,N-Benzyl-4-(bis(2-chloroethyl)amino)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101518482,26,406970,103479297,11530963,2064,18529047,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant ERBB2,"3-(1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101821634,26,248914,103441894,11226874,2064,15715478,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor-2 (HER-2) autophosphorylation,(E)-N-[4-[3-chloro-4-[(1S)-1-phenylethoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345660202,26,1167102,312367129,71496459,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,N-[4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-2-[methyl-[2-(methylamino)ethyl]amino]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
237865066,26.33,620240,134464233,56683695,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(benzenesulfonyl)-2-(3-bromophenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100647231,27,79614,103203212,44279421,2064,11378364,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation,(1-Benzyl-1H-benzoimidazol-5-yl)-quinazolin-4-yl-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288071,27.19,460690,103724458,46207062,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(4-nitrophenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
237865073,27.38,620240,134464236,56683698,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(3-bromophenyl)-N-(4-bromophenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824503,27.43,625186,103171942,4189,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Miconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286379,27.83,456091,103724242,135504330,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"2-[(2E)-2-(3-hydroxybenzylidene)hydrazinyl]-1,3-thiazol-4(5H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
237865151,27.89,620240,134464234,56683696,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,2-(3-bromophenyl)-N-(4-methylphenyl)sulfonylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345660458,28,1167102,312367113,86677242,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"(S)-N-{2-[4-(2-Aminopropanoyl)piperazin-1-yl]-5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxyphenyl}prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
341150769,28.3,1079763,194154584,76318468,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","6-morpholin-4-ylsulfonyl-N-(3-phenylmethoxyphenyl)-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100403086,29,68102,103314980,76146,2064,12825933,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 receptor kinase,"2-Methoxycyclohexa-2,5-diene-1,4-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237865075,29.07,620240,134452789,56673723,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,N-(benzenesulfonyl)-2-(4-methoxyphenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198358520,30,517324,103550968,16214946,2064,20817523,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBb2 phosphorylation in human BT474 cells by ELISA,"3-[cis-3-(4-Methylpiperazin-1-yl)cyclobutyl]-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
198395799,30,507754,123097406,10484995,2064,19483697,Confirmatory,20220830,0,0,Unspecified,P04626,Ki,=,ChEMBL,Binding affinity to ErbB-2,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-sulfanylpropanoyl]amino]-3-sulfanylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355638530,30,1308958,336906560,86302574,2064,27288183,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 (unknown origin) incubated for 1 hr by spectrophotometric analysis,Dalmelitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355638982,30,1308940,336906560,86302574,2064,27288183,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) incubated for 1 hr by spectrophotometric analysis,Dalmelitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366467496,30,1609523,103177459,176870,2064,31493743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay",Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
366467497,30,1609523,440191857,155554426,2064,31493743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay","4-[2-[3-(4-Chlorophenyl)-5-(4-piperidin-1-ylphenyl)-3,4-dihydropyrazol-2-yl]-1,3-thiazol-4-yl]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
380648046,30,1878102,440157246,118107483,2064,35041943,Confirmatory,20230629,0,0,Unspecified,P04626,Kd,=,ChEMBL,Binding affinity to ERBB2 (unknown origin) assessed as dissociation constant by KINOMEscan analysis,Remibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380648049,30,1878102,381837518,86567260,2064,35041943,Confirmatory,20230629,0,0,Unspecified,P04626,Kd,=,ChEMBL,Binding affinity to ERBB2 (unknown origin) assessed as dissociation constant by KINOMEscan analysis,"10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2R)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391775,30,1804579,104065411,11704110,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"8-(2-Chloro-4,5-dimethoxybenzyl)-2-fluoro-9-(pent-4-ynyl)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265225,30,1805507,447113381,156905956,2064,"",Confirmatory,20240109,0,0,Inactive,P04626,IC50,>,BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 13",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265491,30,1805507,447113390,156905960,2064,"",Confirmatory,20240109,0,0,Inactive,P04626,IC50,>,BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 73",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402265734,30,1805507,447113338,156905950,2064,"",Confirmatory,20240109,0,0,Inactive,P04626,IC50,>,BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 12",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402266268,30,1805507,447113387,135156994,2064,"",Confirmatory,20240109,0,0,Inactive,P04626,IC50,>,BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 70",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
402267287,30,1805507,447113388,135157112,2064,"",Confirmatory,20240109,0,0,Inactive,P04626,IC50,>,BindingDB,TR-FRET Assay for ERBB Kinases from US Patent US10994015: 'EGFR proteolysis targeting chimeric molecules and associated methods of use',"US10994015, Example 71",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408088934,30,1961745,103164549,445643,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Tacrolimus,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408088935,30,1961745,103290097,5486971,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Pregabalin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089304,30,1961745,103307946,60795,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Aripiprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089305,30,1961745,103469419,5833,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Spironolactone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089306,30,1961745,103471545,170361,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method","6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089308,30,1961745,103578669,31401,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Ursodiol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089309,30,1961745,160692925,637568,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Dimethyl Fumarate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089310,30,1961745,242549783,21772,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Butriptyline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089311,30,1961745,103164546,1775,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Phenytoin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089312,30,1961745,103542516,10133,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Chenodiol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089313,30,1961745,104234203,6018,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Tetrabenazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089314,30,1961745,123083191,1201549,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Benztropine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089315,30,1961745,103194022,2284,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Baclofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089317,30,1961745,103170197,31101,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Bromocriptine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089614,30,1961745,103175813,5329102,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Sunitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089615,30,1961745,103213079,5394,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Temozolomide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089618,30,1961745,174510187,50905713,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Duvelisib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089619,30,1961745,103178666,104850,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Rimonabant,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089620,30,1961745,103181541,5095,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Ropinirole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089622,30,1961745,103267575,4066,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Mequitazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089623,30,1961745,103274161,4746,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Perhexiline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089624,30,1961745,103594774,11561674,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Apremilast,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089626,30,1961745,242645606,71731823,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Lorlatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089627,30,1961745,103170825,5073,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Risperidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089906,30,1961745,103304259,2381,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Biperiden,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089907,30,1961745,160671857,2782,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Clemizole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089908,30,1961745,160704047,4850,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Piribedil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089910,30,1961745,103376383,15250,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Ibufenac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089911,30,1961745,103510783,21319,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Flucloxacillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089912,30,1961745,103562109,151166,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Lumiracoxib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089915,30,1961745,103460177,644019,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Cannabidiol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089916,30,1961745,103594731,53025,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Cefotetan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089917,30,1961745,242590378,9903970,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method","5-Chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089918,30,1961745,103420820,216239,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089919,30,1961745,103728028,11626560,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Crizotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090236,30,1961745,103752013,443872,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Eplerenone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090237,30,1961745,104253152,213046,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Lurasidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090238,30,1961745,123086332,45138674,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Letermovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090239,30,1961745,103177124,6167,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Colchicine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090240,30,1961745,103210741,4046,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Lariam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090241,30,1961745,103391142,3474,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Glafenine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090242,30,1961745,103728954,11504295,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Olodaterol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090243,30,1961745,242590736,10288191,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Binimetinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090244,30,1961745,103403788,59227,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Rotigotine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090246,30,1961745,103167216,3559,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Haloperidol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090247,30,1961745,103208531,54675769,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Novobiocin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090248,30,1961745,103245064,3446,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Gabapentin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090249,30,1961745,103443775,11658860,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Lorcaserin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090530,30,1961745,163319882,11949652,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Teneligliptin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090531,30,1961745,103189247,4205,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Mirtazapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090532,30,1961745,103237245,3655,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Velnacrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090533,30,1961745,103523408,26879,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Levamisole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090535,30,1961745,103195284,5736,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Zotepine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090537,30,1961745,312387361,66558664,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Tazemetostat,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090538,30,1961745,103303946,3748,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Iproniazid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090539,30,1961745,104234146,62959,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Trovafloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090540,30,1961745,104240364,6915744,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Rulide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090541,30,1961745,123098392,6450551,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Axitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090542,30,1961745,103511444,54682461,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Tipranavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090543,30,1961745,103648919,444972,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Fumaric Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090805,30,1961745,160671425,65700,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Metapramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090806,30,1961745,312468035,71481097,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Selinexor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090808,30,1961745,103175312,12560,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Erythromycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090809,30,1961745,103189918,5453,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Thiotepa,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090810,30,1961745,103219116,5803,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Tiratricol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090812,30,1961745,103328173,25382,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Melitracen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090814,30,1961745,194141200,91562,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Cefacetrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090815,30,1961745,242651810,46220502,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Abemaciclib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288058,30.06,460690,103724516,46207040,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-butylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
341102818,30.8,1062007,103222017,10205,2064,24355130,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 (unknown origin) by ADP-Glo assay,Plumbagin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101892435,31,266440,103488483,800888,2064,16530412,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,N-(4-chloro-2-hydroxyphenyl)benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286107,31,456091,103724277,136066076,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,(2E)-2-(cyclooctylidenehydrazono)thiazolidin-4-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100398119,31.43,164334,103339471,9891993,2064,12502359,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Morpholin-4-yl-but-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363489344,31.5,1359300,404666285,145959430,2064,29730188,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-His6-fused erbB2 expressed in Sf9 insect cells using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method",N-[2-(3-fluorophenyl)ethyl]-3-(5-thiophen-2-ylthiophen-2-yl)-5-(trifluoromethyl)benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101739462,31.6,305799,103545045,44437848,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"4-(4-fluorophenyl)-5-cyano-2H-1,2,3-triazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
151286102,31.78,456091,103724239,135547320,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"3-Methylbenzaldehyde (4-oxo-1,3-thiazolidin-2-ylidene)hydrazone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286896,32.54,456100,103724018,46229537,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-Butyl-1-(5-chloro-2-hydroxybenzyl)-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101749757,32.73,308515,103548564,135922389,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2,4-(2-(3-(4-(trifluoromethyl)-1H-imidazol-2-yl)-1H-pyrazol-4-yl)vinyl)isoquinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337212,33.02,69874,103332586,5328874,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,4-(3-Bromophenylamino)-7-ethoxy-6-methoxyquinoline-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409351,33.8844,164335,103244012,5328781,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 70,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398129,33.95,164334,103339421,9984664,2064,12502359,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,(E)-4-Morpholin-4-yl-but-2-enoic acid [4-(3-bromo-phenylamino)-3-cyano-7-ethoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398133,33.95,164334,103339361,10918242,2064,12502359,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Morpholin-4-yl-pent-2-enoic acid [4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622154,34,68095,103244012,5328781,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 70,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100398123,34.13,164334,103338725,10098235,2064,12502359,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to inhibit autophosphorylation of cytoplasmic domain of human epidermal growth factor receptor-2,4-Morpholin-4-yl-but-2-enoic acid [4-(3-bromo-phenylamino)-3-cyano-7-methoxy-quinolin-6-yl]-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337123,34.22,69874,103332695,5328878,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Bromophenylamino)-6,7-dimethoxyquinoline-3-carboxylic Acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409345,34.6737,164335,103244842,5328770,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin AG 555,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409356,34.6737,164335,103244926,5328766,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 36,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605552,34.72,1867605,482053193,168273468,2064,35452936,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"4-[[5-(4-methylphenyl)indol-1-yl]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100316264,35,68103,103244842,5328770,2064,10464027,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 receptor autophosphorylation,Tyrphostin AG 555,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622426,35,68095,103244926,5328766,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 36,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622434,35,68095,103244842,5328770,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin AG 555,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622144,35,404519,103244926,5328766,2064,18500794,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2,Tyrphostin deriv. 36,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301327901,35,650683,136929262,24764502,2064,22377675,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of human recombinant ERBB2 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting","5-propan-2-yl-7,8-dihydro-6H-indeno[1,2-b]indole-9,10-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
366548155,35,1637076,440181619,24759534,2064,27491711,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of recombinant human His-tagged cytoplasmic ERBB2 expressed in baculovirus expression system by Z'-LYTE assay,"4-[6-[4-(2-piperidin-1-ylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-N-(2,2,2-trifluoroethyl)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101518485,36,406970,103585558,24894993,2064,18529047,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant ERBB2,"4-{1-[(Benzyloxy)methyl]-1H-indol-3-yl}-3-(3,4,5-trimethoxyphenyl)-1,5-dihydro-2H-pyrrole-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402363,36,580189,124972949,53325047,2064,21334203,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(thiophen-3-yl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120220,36.45,492321,103770044,49799782,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(2-chlorophenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101740895,36.5,305799,103545039,44437843,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"4-(4-methylphenyl)-5-cyano-2H-1,2,3-triazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
363799229,36.9,1428363,381868875,137653143,2064,27987485,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-benzyl-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622156,37,68095,103244564,5353388,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,"(E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-(1-phenylethyl)prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101518484,37,406970,103585492,24894997,2064,18529047,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant ERBB2,"4-[1-(Phenoxymethyl)-1H-indol-3-yl]-3-(3,4,5-trimethoxyphenyl)-1,5-dihydro-2H-pyrrole-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101750417,37,308515,103548557,135620678,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2,N-ethyl-5-(2-(3-(6-methoxy-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)vinyl)nicotinamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363686409,37.1,1404961,404712376,145990245,2064,29902719,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay","1-[4-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]-3-cyclopropylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409352,37.1535,164335,103244564,5353388,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"(E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-(1-phenylethyl)prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286103,37.64,456091,103724241,135411778,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,(E)-2((E)-(3-nitrobenzylidene)hydrazono)thiazolidin-4-one (8),ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286894,37.82,456100,103723983,46229516,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(4-Fluorobenzyl)-1-(2-hydroxy-3,5-dimethylbenzyl)-3-phenylthiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
237865071,37.93,620240,134444967,56666767,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,4-chloro-N-[2-(4-methoxyphenyl)acetyl]benzene-sulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407971045,37.93,1940264,103750753,135546247,2064,36496202,Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of c-ErbB-2 (unknown origin),tauroacidin A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407971046,37.93,1940264,440215186,135430346,2064,36496202,Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of c-ErbB-2 (unknown origin),2-[[(5Z)-2-amino-5-[3-[(4-bromo-1H-pyrrole-2-carbonyl)amino]-2-hydroxypropylidene]-1H-imidazol-4-ylidene]amino]ethanesulfonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286734,38.23,456100,103723804,46229377,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(4-Fluorobenzyl)-1-(2-hydroxy-5-methylbenzyl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286887,39.51,456100,103724019,46229538,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Bromo-2-hydroxybenzyl)-1-butyl-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151288061,39.64,460690,103724513,46207036,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,"4-(Bis(2-chloroethyl)amino)-N,N-dipropylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286727,39.78,456100,103724051,46229565,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-Butyl-1-(3,5-dichloro-2-hydroxybenzyl)-3-phenylthiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
101856073,40,259431,103333767,448965,2064,16420067,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity against HER2,"9-Butyl-8-(3,4,5-trimethoxybenzyl)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120219,40,492321,103770023,49799770,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 3-(2-nitrophenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
326060493,40,711546,163328930,71457630,2064,21413808,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N-[7-(4-bromophenyl)-9,9-dioxo-7lambda4,9lambda6-dithia-8-azabicyclo[4.3.0]nona-1(6),2,4,7-tetraen-3-yl]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326060495,40,711546,163318662,23546054,2064,21413808,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"9-(4-Bromophenyl)-4-(trifluoromethyl)-7lambda6,9lambda4-dithia-8-azabicyclo[4.3.0]nona-1(6),2,4,8-tetraene 7,7-dioxide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326060497,40,711546,136940477,57400808,2064,21413808,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"7-(4-Bromophenyl)-9,9-dioxo-7lambda4,9lambda6-dithia-8-azabicyclo[4.3.0]nona-1(6),2,4,7-tetraene-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326060498,40,711546,163332491,71459522,2064,21413808,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N-[7-(4-bromophenyl)-9,9-dioxo-7lambda4,9lambda6-dithia-8-azabicyclo[4.3.0]nona-1(6),2,4,7-tetraen-3-yl]methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
326060500,40,711546,163328929,71457629,2064,21413808,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"9-(4-Bromophenyl)-4-fluoro-7lambda6,9lambda4-dithia-8-azabicyclo[4.3.0]nona-1(6),2,4,8-tetraene 7,7-dioxide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363798912,40,1428363,381840184,14738184,2064,27987485,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-phenyl-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380829782,40,1916708,103333767,448965,2064,35691175,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of Her2 in human MCF7 cells by SDS-PAGE analysis,"9-Butyl-8-(3,4,5-trimethoxybenzyl)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169120452,41.26,492321,103770043,49799781,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(2-fluorophenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
254839280,41.503,625186,103203986,2336,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzo[a]pyrene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409350,41.6869,164335,103244877,5328771,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin B48,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100316263,42,68103,103244877,5328771,2064,10464027,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ERBB2 receptor autophosphorylation,Tyrphostin B48,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622438,42,68095,103244877,5328771,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin B48,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288057,44.51,460690,103724514,46229856,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,"4-(Bis(2-chloroethyl)amino)-N,N-dibutylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
169120226,44.85,492321,103770045,49799783,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl3-(2-bromophenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100520006,45,68099,103176929,10085225,2064,9089334,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human erbB-2 receptor tyrosine kinase,2'-Thioadenosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286381,45.51,456091,103724240,135981156,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"3-methoxybenzaldehyde [(2E)-4-oxo-1,3-thiazolidin-2-ylidene]hydrazone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363798917,45.7,1428363,381859409,137646754,2064,27987485,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-[(6-chloro-1H-benzimidazol-2-yl)methyl]-5-(2-chlorophenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288066,46.1,460690,103724517,46207014,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-tert-butylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
363799239,46.8,1428363,381864772,137650383,2064,27987485,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(2-methylphenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151286106,47,456091,103724246,136066075,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,(2E)-2-(cycloheptylidenehydrazono)thiazolidin-4-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
389391793,47.8,1804579,440826829,11302426,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"8-(2,4,5-Trichloro-phenylsulfanyl)-9H-purin-6-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337181,47.94,69874,103332394,5328846,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-[(4-Fluorophenyl)amino]-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151288063,48.35,460690,103724582,46207039,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-cyclopentylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100622155,49,68095,103244013,5328780,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 68,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99529130,49.3,3366,103263149,5329234,2064,12127526,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26f",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100548062,50,81574,103295392,44321734,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"4-[4-(5-Bromo-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-phenyl]-piperazine-1-carbaldehyde",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622152,50,68095,103244925,5328767,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 39,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100931101,50,254695,103469728,11235063,2064,16190753,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibitory concentration against HER2 (ErbB2),3-{[5-cyano-6-(cyclopentylamino)pyrimidin-4-yl]amino}-N-isoxazol-3-yl-4-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100969101,50,267202,103492546,11632737,2064,16789733,Confirmatory,20181020,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of Her2,"N-Cyclopropyl-2,4-difluoro-5-[[[2-(2-pyridinylamino)-5-thiazolyl]methyl]amino]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100985026,50,273804,103479297,11530963,2064,17149885,Confirmatory,20181021,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human ERbB2,"3-(1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101739460,50,305799,103545042,44437845,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"4-(2,3-dimethoxyphenyl)-5-cyano-2H-1,2,3-triazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101739461,50,305799,103545043,44437846,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"4-(3,4-dimethoxyphenyl)-5-cyano-2H-1,2,3-triazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101740891,50,305799,103545041,5076757,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"5-(4-Methoxyphenyl)-2H-1,2,3-triazole-4-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
101740894,50,305799,103545044,44437847,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"4-(3,4,5-trimethoxyphenyl)-5-cyano-2H-1,2,3-triazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
151285899,50,456091,103724243,136066074,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"(2E)-2-(cyclobutylidenehydrazinylidene)-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286100,50,456091,103724245,135735513,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,(2E)-2-(cyclohexylidenehydrazono)thiazolidin-4-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286105,50,456091,103724244,135472788,2064,19914835,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"(2E)-2-(cyclopentylidenehydrazono)-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286724,50,456100,103723911,46229462,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-Butyl-1-(3,5-dichloro-2-hydroxybenzyl)-3-phenylturea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286728,50,456100,103723913,46229464,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-Butyl-1-(2-hydroxy-3,5-dimethylbenzyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286729,50,456100,103723909,46229460,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-(5-Bromo-2-hydroxybenzyl)-1-butyl-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286732,50,456100,103723910,46229461,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-Butyl-1-(2-hydroxy-5-methylbenzyl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286733,50,456100,103723807,46229380,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-(4-Fluorobenzyl)-1-(2-hydroxy-3,5-dimethylbenzyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286738,50,456100,103724053,46229567,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-Butyl-1-(2-hydroxy-3,5-dimethylbenzyl)-3-phenylthiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286740,50,456100,103723908,46229459,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-Butyl-1-(5-chloro-2-hydroxybenzyl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286888,50,456100,103724020,46229539,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,1-Butyl-1-(2-hydroxy-5-methylbenzyl)-3-phenylthiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286889,50,456100,103724052,46229566,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-Butyl-1-(3,5-dibromo-2-hydroxybenzyl)-3-phenylthiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151286892,50,456100,103723912,46229463,2064,19914837,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human cloned HER2 autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,"1-Butyl-1-(3,5-dibromo-2-hydroxybenzyl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151288055,50,460690,103724518,46207037,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-dodecylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
151288069,50,460690,103724583,46207015,2064,20005116,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant HER2 expressed in Sf9-baculovirus system by ELISA,4-(Bis(2-chloroethyl)amino)-N-(3-morpholinopropyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
169120451,50,492321,103770048,49799785,2064,20594859,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant His6x-tagged HER2 autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,(E)-2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 3-(2-methoxyphenyl)acrylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
198236060,50,507198,103654502,135423438,2064,18559524,Confirmatory,20180914,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human HER2,Nintedanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
224459614,50,598840,131287802,53357328,2064,21561771,Confirmatory,20180918,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 assessed as biotin-HEQEDEPEGDYFEWLEPE peptide phosphorylation by TR-FRET assay,"6,6-Dimethyl-8-(1-oxetan-3-yl-piperidin-4-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237748219,50,616950,134445201,49806721,2064,21823617,Confirmatory,20180919,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 activity by TR-FRET assay,"9-ethyl-6,6-dimethyl-8-[4-(oxetan-3-yl)piperazin-1-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237748220,50,616950,131287802,53357328,2064,21823617,Confirmatory,20180919,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 activity by TR-FRET assay,"6,6-Dimethyl-8-(1-oxetan-3-yl-piperidin-4-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237864964,50,620240,134448922,56670200,2064,21920766,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant (His)6-tagged HER-2 autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,4-Methoxy-N-[(4-methylphenyl)sulfonyl]benzeneacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363192435,50,1438344,381861956,118115473,2064,28139931,Confirmatory,20200620,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human N-terminal His-tagged HER2 expressed in baculovirus expression system in presence of 1 mM ATP,Ritlecitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389188547,50,1802325,328082845,118115473,2064,27791347,Confirmatory,20231017,0,0,Inactive,P04626,IC50,>,BindingDB,JAK Enzyme Assay from Article 10.1021/acschembio.6b00677: 'Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition.',Ritlecitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391784,50,1804579,104065405,11598450,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,>,BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"2-Fluoro-8-(2-iodo-4,5-dimethoxybenzyl)-9-(pent-4-ynyl)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391786,50,1804579,104065406,11568559,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,>,BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"8-(2-Bromo-4,5-dimethoxybenzyl)-2-fluoro-9-(pent-4-ynyl)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409198,50.1187,164335,103244925,5328767,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 39,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337179,50.49,69874,103286437,5328843,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-[(3,4-Dimethoxyphenyl)amino]-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99973388,52,105058,103238181,4707,2064,9513602,Confirmatory,20181016,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of heregulin-dependent autophosphorylation of ErbB2 receptor in MDA-MB-453 cells,"N4-(3-bromophenyl)-N6-methylpyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
363799235,52.4,1428363,381853130,137642492,2064,27987485,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(phenoxymethyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799483,52.6,1428363,381877439,137656424,2064,27987485,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-[(6-chloro-1H-benzimidazol-2-yl)methyl]-5-(2,4-dichlorophenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101739458,53.5,305799,103545038,12175099,2064,17174554,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 tyrosine kinase phosphorylation in human MDA-MB-453 cells by Western blot assay,"5-Phenyl-3H-[1,2,3]triazole-4-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
341150761,54.8,1079763,194154583,76318467,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","N-(3-ethoxyphenyl)-6-morpholin-4-ylsulfonyl-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100622153,57,68095,103244158,5328774,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 54,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409333,57.544,164335,103244158,5328774,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 54,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799234,57.6,1428363,381887071,137661754,2064,27987485,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-benzhydryl-5-(1H-benzimidazol-2-ylmethyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391791,58,1804579,104050876,11223683,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"9-(Pent-4-yn-1-yl)-8-((2,4,5-trichlorophenyl)thio)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389391774,58.3,1804579,104050874,11281786,2064,"",Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,biochemical assay from US Patent US10676476: 'Small-molecule HSP90 inhibitors',"8-(2,4-Dichloro-5-methoxy-phenylsulfanyl)-9-(2-isopropoxy-ethyl)-9H-purin-6-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409212,58.8844,164335,103346038,9899125,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,"2-(3,4-Dihydroxy-5-methylbenzylidene)malononitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455163,59,81560,103346038,9899125,2064,7902440,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,"2-(3,4-Dihydroxy-5-methylbenzylidene)malononitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101892434,61,266440,103488821,2883337,2064,16530412,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,"11-(2,3-dihydroxyphenyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337214,62.32,69874,103332710,5328865,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Isopropylphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359668,62.5,517501,123101234,52950015,2064,20817523,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ErbB2,"N-(4-(4-amino-7-((1s,4s)-4-(4-methylpiperazin-1-yl)cyclohexyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-5,7-dimethylbenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547936,64.8,81574,103295444,9884745,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(3,5-Di-tert-butyl-4-hydroxybenzylidene)indolin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622127,65,404519,103295444,9884745,2064,18500794,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2,"3-(3,5-Di-tert-butyl-4-hydroxybenzylidene)indolin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204403332,65,580189,124971154,53324200,2064,21334203,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-5-methyl-6-phenylpyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839278,66.405,625186,103176241,2812,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,=,ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clotrimazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548009,66.6,81574,103295374,10663503,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(Z)-4-methyl-3-(4-morpholinobenzylidene)indolin-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337127,69.4,69874,103333315,5328872,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(3-Acetamidophenylamino)-6,7-dimethoxy-3-quinolinecarbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337185,70.84,69874,104235541,49860613,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"1-(3-Bromoanilino)-6,7-dimethoxyisoquinoline-4-carbonitrile;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345661353,73,1167102,312367112,118719574,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-[5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-2-[4-[2-(dimethylamino)acetyl]piperazin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
100337091,81.3,69874,103333078,5328837,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"Ethyl 4-[(3-bromophenyl)amino]-6,7-dimethoxyquinoline-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337281,88.29,69874,103332954,5328886,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"6,7-Dimethoxyisoquinoline-4-carbonitrile deriv. 62",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548064,90.2,81574,103295395,5941540,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(Z)-4-(4-((2-Oxoindolin-3-ylidene)methyl)phenyl)piperazine-1-carbaldehyde,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455177,91,81560,103346743,44345676,2064,7902440,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,"[5-(2,2-Dicyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337287,91.2,69874,104235553,49860624,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"4-(4-Bromo-2-fluoroanilino)-6,7-dimethoxyquinoline-3-carbonitrile;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341150772,91.2,1079763,194154586,76318470,2064,"",Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting","6-bromo-N-(3-methoxyphenyl)-9H-pyrido[2,3-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100020476,91.2011,164339,103761321,44361708,2064,14561085,Confirmatory,20181017,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER-2 ErbB2 receptor,3-[5-[(E)-3-amino-2-cyano-3-oxoprop-1-enyl]-2-hydroxy-3-methoxyphenyl]sulfanylpropanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100359465,91.325,69714,103303564,5328982,2064,11495584,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of human epidermal growth factor receptor (HER-2) using enzyme assay,4-Anilinoquinazoline deriv. 18,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
388817789,91.325,1795646,8034259,5328982,2064,11495584,Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,Kinase Inhibition Assay from Article 10.1021/jm0005555: '6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinase,4-Anilinoquinazoline deriv. 18,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548065,91.4,81574,103294959,10779668,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"4-Methyl-3-(5-methylsulfanyl-thiophen-2-ylmethylene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548055,92.6,81574,103295232,9948410,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-[1-(4-Piperidin-1-yl-phenyl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100880140,95,372683,103633948,42603880,2064,18524423,Confirmatory,20180910,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of ERBB2,2-(6-Amino-9H-purine-9-yl)-1-(1H-indole-3-yl)ethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
389257830,98.77,1803399,341104396,76900441,2064,23402383,Confirmatory,20231017,0,0,Inactive,P04626,IC50,"",BindingDB,In Vitro Tyrosine Kinase Enzyme Assay from Article 10.3109/14756366.2013.765417: 'Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents.',"HER2/EGFR dual kinase inhibitor, 7e",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100012868,100,68105,103194651,5329032,2064,11881999,Confirmatory,20181017,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase at ATP concentration <Km,N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[2-(triazol-1-yl)ethoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100037363,100,240635,103467121,5330832,2064,15837297,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,>,ChEMBL,In vitro inhibitory concentration against HER2,"3-Acyl-2,6-diaminopyridine deriv. 2r",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100037364,100,240635,163326343,5330847,2064,15837297,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,>,ChEMBL,In vitro inhibitory concentration against HER2,"3-Acyl-2,6-diaminopyridine deriv. 11",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100037365,100,240635,103466761,5330830,2064,15837297,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,>,ChEMBL,In vitro inhibitory concentration against HER2,"3-Acyl-2,6-diaminopyridine deriv. 2p",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100403085,100,68102,103314949,11075591,2064,12825933,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"(2S)-3-hydroxy-2-[(4-methoxy-3,6-dioxocyclohexa-1,4-dien-1-yl)amino]propanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100403087,100,68102,103314526,11129889,2064,12825933,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor kinase,"2-Methoxy-6-(octahydro-naphthalen-1-ylidenemethyl)-[1,4]benzoquinone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547882,100,81574,103294885,10215023,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),methyl 3-[4-methyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547884,100,81574,103295352,10593765,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(Z)-4-(4-((4-methyl-2-oxoindolin-3-ylidene)methyl)phenyl)piperazine-1-carbaldehyde,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547885,100,81574,103295353,44321717,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(3Z)-3-[[4-(dimethylamino)phenyl]methylidene]-6-fluoro-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547886,100,81574,103294670,10562306,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"5-Chloro-3-(1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547923,100,81574,103295231,727518,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(3Z)-3-[(4-methoxyphenyl)methylidene]-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547924,100,81574,103294000,6419834,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),VEGF Receptor 2 Kinase Inhibitor I,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547927,100,81574,103294671,10489322,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"(3Z)-4-methyl-3-(1H-pyrrol-2-ylmethylidene)-2,3-dihydro-1H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547929,100,81574,103294394,10636005,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(3Z)-3-[(5-methylsulfanylthiophen-2-yl)methylidene]-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547931,100,81574,103294914,5713379,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-Furan-2-ylmethylene-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547932,100,81574,103294674,10663368,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-[1-(4-Piperidin-1-yl-phenyl)-ethylidene]-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547934,100,81574,103294958,10682457,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-[1-(5-Ethyl-thiophen-2-yl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547935,100,81574,103294994,10236164,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-[1-(3,4-Dimethyl-1H-pyrrol-2-yl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547938,100,81574,103295078,964113,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),3-(4-Bromobenzylidene)indolin-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547939,100,81574,103293999,10635478,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"(3Z)-3-[(3-ethyl-4,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547940,100,81574,103294884,10613858,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"4-Methyl-5-[2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-1H-pyrrole-3-carboxylic acid ethyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547998,100,81574,103295233,5427216,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-[1-(4-Pyrrolidin-1-yl-phenyl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100547999,100,81574,103294554,10537949,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(5-Ethyl-furan-2-ylmethylene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548000,100,81574,103294672,5908088,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548001,100,81574,103294840,2379240,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),3-(4-Morpholinobenzylidene)indolin-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548002,100,81574,103294435,6036100,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),3-[(Z)-(4-bromo-2-thienyl)methylidene]-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548003,100,81574,103294395,10562777,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(3,5-Dimethyl-1H-pyrrol-2-ylmethylene)-5-methyl-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548004,100,81574,103294436,5707304,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),3-[(Z)-(3-bromo-2-thienyl)methylidene]-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548006,100,81574,103294779,10753550,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-6-fluoro-1H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548007,100,81574,103295031,6536705,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(3Z)-3-[(1-methylpyrrol-2-yl)methylidene]-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548008,100,81574,103295074,10264222,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(3,5-Dimethyl-1H-pyrrol-2-ylmethylene)-4-methyl-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548011,100,81574,103294035,10728035,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"6-Fluoro-3-[1-(1H-pyrrol-2-yl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548012,100,81574,103294514,135536640,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-[1-(4-Chloro-1H-pyrazol-3-yl)-meth-(Z)-ylidene]-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548014,100,81574,103295416,5293755,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-[1-(4-Dimethylamino-phenyl)-meth-(Z)-ylidene]-1-methyl-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548015,100,81574,103294553,136026516,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),(3Z)-3-[(4-chloro-1-methylpyrazol-3-yl)methylidene]-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548053,100,81574,103294555,2358462,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(5-Methyl-furan-2-ylmethylene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548054,100,81574,103295032,10658651,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"5-Nitro-3-(1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548056,100,81574,103293995,10755069,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(4-Dimethylamino-benzylidene)-4-methyl-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548057,100,81574,103294831,5289418,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-YL)methylene]-2-indolinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548058,100,81574,103295281,5874584,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"(3Z)-3-(4-hydroxybenzylidene)-1,3-dihydro-2H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548059,100,81574,103175684,5329098,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),Semaxanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548060,100,81574,103294242,10587839,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"(3Z)-3-[(4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548061,100,81574,103294573,2365265,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"4-[2-Oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100548063,100,81574,103295445,6450842,2064,9651163,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Her-2 receptor tyrosine kinase (HER-2 RTK),"3-(4-(Dimethylamino)benzylidene)-1,3-dihydro-2H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514788,100,364803,103587812,25271181,2064,18678484,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N,N-diethylpyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514790,100,364803,103587810,25271516,2064,18678484,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,N-(4-methoxyphenethyl)-4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)pyrimidine-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514794,100,364803,103587873,25271180,2064,18678484,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,3-Fluorobenzyl 4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)pyrimidine-5-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514799,100,364803,103587811,25271513,2064,18678484,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N-(2-methoxyethyl)pyrimidine-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101514802,100,364803,103587874,25271518,2064,18678484,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,4-amino-6-(4-(benzyloxy)-3-chlorophenylamino)-N-(4-methoxyphenyl)pyrimidine-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748522,100,308241,103551056,135497877,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"4-(3-(4-(isopropoxymethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)isoquinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748523,100,308241,103551065,136118032,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"2-(5-isoquinolin-4-yl-1H-pyrazolo[3,4-b]pyridin-3-yl)-1H-benzoimidazole-4-carboxylic acid methyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748524,100,308241,103551057,135497878,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"3-(3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)quinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748783,100,308241,103551070,136118031,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"4-(3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-1-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)isoquinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748784,100,308241,103551082,135497794,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N-((5-(3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)-4-methylpyridin-3-yl)methyl)ethanamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748785,100,308241,103551072,135497791,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"(5-(3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-N-methylmethanamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748786,100,308241,103551081,136118035,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"(5-(3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-N,N-dimethylmethanamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748787,100,308241,103551059,135497800,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-5-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748788,100,308241,103551064,135497787,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"4-(3-(5-morpholino-1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)isoquinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748791,100,308241,103551066,136118033,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"2-(5-isoquinolin-4-yl-1H-pyrazolo[3,4-b]pyridin-3-yl)-1H-benzoimidazole-4-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748793,100,308241,103551060,136118034,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-5-(pyrimidin-5-yl)-1H-pyrazolo[3,4-b]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748795,100,308241,103551058,135497879,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"3-(4-(methoxymethyl)-1H-benzo[d]imidazol-2-yl)-5-(pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101748799,100,308241,103551061,135497865,2064,17532631,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,"N-((2-(5-(isoquinolin-4-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-1H-benzo[d]imidazol-4-yl)methyl)propan-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749756,100,308515,103548553,135620674,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,5-(2-(3-(6-methoxy-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)vinyl)nicotinonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749758,100,308515,103548556,135620676,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,methyl 5-(2-(3-(6-methoxy-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)vinyl)nicotinate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749761,100,308515,103548561,136104460,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,3-(2-(3-(4-(trifluoromethyl)-1H-imidazol-2-yl)-1H-pyrazol-4-yl)vinyl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749762,100,308515,103548562,135922390,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,2-(4-(2-(pyridin-3-yl)vinyl)-1H-pyrazol-3-yl)-1H-imidazole-4-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749763,100,308515,103548552,135620680,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,4-(2-(3-(6-methoxy-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)vinyl)isoquinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101749765,100,308515,103548566,135823061,2064,17574416,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2,N-((5-(2-(3-(4-(trifluoromethyl)-1H-imidazol-2-yl)-1H-pyrazol-4-yl)vinyl)pyridin-3-yl)methyl)ethanamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402360,100,580189,124970816,53324027,2064,21334203,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(pyridin-3-yl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402368,100,580189,124957149,53317172,2064,21334203,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(pyrrolidin-1-yl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
204402369,100,580189,124965002,53321087,2064,21334203,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HER2 by homogeneous time-resolved fluorescence assay,N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-phenoxypyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345435180,100,1182832,312372737,118723185,2064,25007344,Confirmatory,20200623,0,0,Unspecified,P04626,IC50,>,ChEMBL,"Inhibition of human recombinant ERBB2 using poly(Glu,Tyr) substrate","5-(1H-indol-3-yl)-3-(3,4,5-trimethoxyphenyl)-1H-pyrazin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799231,100,1428363,381839169,137633149,2064,27987485,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(2,3-dimethoxyphenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
364058718,100,1376037,123091512,50908681,2064,"",Confirmatory,20230629,0,0,Unspecified,P04626,INH,>,ChEMBL,"Inhibition of recombinant human GST-tagged HER2 expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method","N-(4-methoxybenzyl)benzofuro[2,3-b]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366548153,100,1637076,440196392,89735655,2064,27491711,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant human His-tagged cytoplasmic ERBB2 expressed in baculovirus expression system by Z'-LYTE assay,Mark-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366548154,100,1637076,440193526,59603829,2064,27491711,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of recombinant human His-tagged cytoplasmic ERBB2 expressed in baculovirus expression system by Z'-LYTE assay,"4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-N-(2,2,2-trifluoroethyl)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367394551,100,1646626,442046326,145704650,2064,31757666,Confirmatory,20210802,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human recombinant ERBB2 (537 to 636 residues) expressed in Escherichia coli using Tyr 06 as substrate after 1 hr in presence of ATP by Z'-LYTE assay,PI3K-IN-9,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605097,100,1867605,482075712,156768712,2064,35452936,Confirmatory,20230629,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of human HER2 incubated for 25 mins by ADP-Glo reagent based microplate reader analysis,"3-methoxy-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100913271,101,248902,103453892,10198953,2064,15267243,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGF-stimulated human umbilical vein endothelial cell proliferation,"2-Methyl-5-(7-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100336872,102.2,69874,103332583,5328876,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"[4-(3-Bromophenylamino)-6,7-dimethoxyquinolin-3-yl]-methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100337222,104.7,69874,103332584,5328875,2064,10966743,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Concentration needed to inhibit the autophosphorylation of the cytoplasmic domain of Epidermal growth factor receptor using DELFIA/time-resolved fluorimetry.,"9-(3-Bromophenylamino)-2,3-dihydro[1,4]dioxino[2,3-g]quinoline-8-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100455108,112,81560,103346026,44345337,2064,7902440,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory concentration against ErbB2/neu (HER-2) by autophosphorylation,2-(4-Hydroxy-3-methoxy-5-methyl-benzylidene)-malononitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409419,112.202,164335,103346026,44345337,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,2-(4-Hydroxy-3-methoxy-5-methyl-benzylidene)-malononitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622122,120,404519,103462655,11289919,2064,18500794,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2,"8-(2,5-dichlorophenylthio)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345660781,156,1167102,312367116,118719577,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-[5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxy-2-[4-[2-(methylamino)acetyl]piperazin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
100409200,165.959,164335,103243619,5328778,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 64,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622435,166,68095,103243619,5328778,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 64,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345660466,179,1167102,312367117,118719578,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-[5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-2-[4-[(2S)-2-hydroxypropanoyl]piperazin-1-yl]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
345661013,211,1167102,312367114,118719575,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-[5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxy-2-[4-[(2S)-piperidine-2-carbonyl]piperazin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
99973389,219,105058,103416901,5328360,2064,9513602,Confirmatory,20181016,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of heregulin-dependent autophosphorylation of ErbB2 receptor in MDA-MB-453 cells,"4-N-(3-bromophenyl)-6-N-[2-(morpholin-4-yl)ethyl]pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
345660462,220,1167102,312367115,118719576,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-[5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxy-2-[4-[(2R)-piperidine-2-carbonyl]piperazin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
345661361,247,1167102,312367118,118719579,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-[5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxy-2-[4-(piperazine-1-carbonyl)piperazin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
100913263,270,248902,103454257,9859850,2064,15267243,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGF-stimulated human umbilical vein endothelial cell proliferation,"2-Methyl-5-(5-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089307,300,1961745,103510684,33255,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Cefazolin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089909,300,1961745,103204227,104838,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Imipenem,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408089913,300,1961745,103596434,73303,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Doripenem,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090245,300,1961745,103511405,5479537,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Cefepime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090534,300,1961745,103188146,441130,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Meropenem,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090807,300,1961745,160682477,5481173,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Ceftazidime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090813,300,1961745,103358253,72015,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Panipenem,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101622141,310,404519,103462520,44399994,2064,18500794,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of HER2,"9-Butyl-8-(3,4,5-trimethoxybenzene-1-sulfonyl)-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409208,331.131,164335,103243683,5328776,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin deriv. 58,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622427,333,68095,103243683,5328776,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin deriv. 58,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100913267,345,248902,103454049,11817879,2064,15267243,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGF-stimulated human umbilical vein endothelial cell proliferation,"(3-Chloro-4-fluoro-phenyl)-pyrrolo[2,1-f][1,2,4]triazin-4-yl-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345661365,351,1167102,312367119,118719580,2064,25271963,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGFR exon 19 deletion activating mutant phosphorylation in human PC9 cells after 2 hrs by fluorescence assay,"N-[2-[4-[(2R)-2-aminopropanoyl]piperazin-1-yl]-5-[(5-chloro-4-pyrazolo[1,5-a]pyridin-3-ylpyrimidin-2-yl)amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45732,"","",""
99973387,379,105058,103417088,5328354,2064,9513602,Confirmatory,20181016,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of heregulin-dependent autophosphorylation of ErbB2 receptor in MDA-MB-453 cells,"4-[(3-Bromophenyl)amino]-6-[[2-(dimethylamino)-ethyl]amino]pyrido[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
408090811,400,1961745,103220466,5742832,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Aztreonam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100316265,500,68103,103244184,5328775,2064,10464027,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of ERBB2 receptor autophosphorylation,Tyrphostin B56,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100622431,500,68095,103244184,5328775,2064,1676428,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,>,ChEMBL,In vitro inhibition of ERBB2 receptor kinase autophosphorylation.,Tyrphostin B56,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408090536,500,1961745,123099069,6540466,2064,37468498,Confirmatory,20240503,0,0,Unspecified,P04626,AC50,>,ChEMBL,"Compound was evaluated for inhibition of human ERBB2 in an in vitro cell free assay measured by Caliper microfluidic capillary electrophoresis, time-resolved fluorescence resonance energy transfer method",Carumonam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100409358,501.187,164335,103244184,5328775,2064,14561085,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibitory activity tested against protein kinase HER-2,Tyrphostin B56,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100913269,509,248902,103454172,11380375,2064,15267243,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGF-stimulated human umbilical vein endothelial cell proliferation,"(3-Chloro-4-fluoro-phenyl)-(6-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100913261,602,248902,103454111,11357877,2064,15267243,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGF-stimulated human umbilical vein endothelial cell proliferation,"(3-Chloro-4-fluoro-phenyl)-(5-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100913265,644,248902,103453887,10131256,2064,15267243,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of EGF-stimulated human umbilical vein endothelial cell proliferation,"2-Methyl-5-(6-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325965137,1000,697298,163320635,51000510,2064,23039927,Confirmatory,20200625,0,0,Unspecified,P04626,Ki,>,ChEMBL,Inhibition of ERBB2,"4-Phenyl-[1]benzofuro[2,3-b]pyridine-3,6-diol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99973390,1100,105058,103417500,5328357,2064,9513602,Confirmatory,20181016,0,0,Unspecified,P04626,IC50,=,ChEMBL,Inhibition of heregulin-dependent autophosphorylation of ErbB2 receptor in MDA-MB-453 cells,"4-[(3-Bromophenyl)amino]-6-[[3-(diethylamino)-2-hydroxypropyl]amino]pyrido[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,395,"","",""
100520007,1600,68099,103168984,60961,2064,9089334,Confirmatory,20220830,0,0,Unspecified,P04626,IC50,~,ChEMBL,Inhibition of human erbB-2 receptor tyrosine kinase,Adenosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100913273,2500,248902,103454075,11288910,2064,15267243,Confirmatory,20181018,0,0,Unspecified,P04626,IC50,>,ChEMBL,Inhibition of EGF-stimulated human umbilical vein endothelial cell proliferation,"(3-Chloro-4-fluoro-phenyl)-(7-methyl-pyrrolo[2,1-f][1,2,4]triazin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355706555,11000,1338270,123097261,31703,2064,27769032,Confirmatory,20220830,0,0,Unspecified,P04626,Kd,=,ChEMBL,Binding affinity to HER2 domain-4 (unknown origin) by SPR assay,Doxorubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
68876674,"",1982,48409448,2858522,2064,"",Other,20110103,0,0,Inactive,NP_001005862,"","",Burnham Center for Chemical Genomics,Kinase inhibition selectivity assay for compound SID-48409448,"1-(3,5-Ditert-butyl-4-hydroxyphenyl)-2-[2-(3-hydroxypropylamino)-5,6-dimethylbenzimidazol-1-yl]ethanone;hydrobromide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99357219,"",3367,103263014,5329251,2064,12127526,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28c",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99357220,"",3367,103262071,5329248,2064,12127526,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26t",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99357221,"",3367,103263015,5329250,2064,12127526,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 28b",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
99625412,"",87018,103402093,10084407,2064,9871562,Literature-derived,20180909,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Her2, ErbB2 receptor tyrosine kinase at 10 uM","(6aR,10aS)-4-Methoxy-7,9-dimethyl-4,6,6a,7,8,10a-hexahydro-indolo[4,3-fg]quinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997055,"",69716,103292577,16151138,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacykdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997056,"",69716,103292576,16157462,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Gfcdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997275,"",69716,103292675,16150666,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcgdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997276,"",69716,103291865,16148913,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997277,"",69716,103291865,16148913,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997278,"",69716,103292758,16149965,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdv-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997279,"",69716,103291864,16149502,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Yvdgfyacymdv-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997280,"",69716,103292578,16148480,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdvk-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997281,"",69716,103292706,16151367,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,dFCDGFYACdYMDV-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997282,"",69717,103292706,16151367,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,dFCDGFYACdYMDV-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997283,"",69717,103292578,16148480,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdvk-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997284,"",69717,103291864,16149502,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Yvdgfyacymdv-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997285,"",69717,103291865,16148913,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997286,"",69717,103291865,16148913,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997287,"",69717,103292758,16149965,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacymdv-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997288,"",69717,103292675,16150666,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcgdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997289,"",69717,103292576,16157462,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Gfcdgfyacymdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
99997290,"",69717,103292577,16151138,2064,11472210,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Kinetic constant for peptide inhibitor binding to HER2 receptor,Fcdgfyacykdv-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100016686,"",68104,103314525,44330534,2064,12825933,Literature-derived,20181017,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 receptor kinase (No effect),"2-[[2-(1,2,3,4,4a,5,6,7,8,8a-Decahydronaphthalen-1-ylmethyl)-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-hydroxybutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100016687,"",68104,103314950,44330742,2064,12825933,Literature-derived,20181017,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 receptor kinase (No effect),"2-[[4-[(1-Carboxy-2-hydroxypropyl)amino]-3,6-dioxocyclohexa-1,4-dien-1-yl]amino]-3-hydroxybutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100016688,"",68104,103314913,11775935,2064,12825933,Literature-derived,20181017,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 receptor kinase (No effect),"2-Benzyl-6-methoxy-[1,4]benzoquinone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100016689,"",68104,103314765,10252189,2064,12825933,Literature-derived,20181017,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 receptor kinase (No effect),"(2S)-2-[[5-[[(1R,2R,4aS,8aS)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-hydroxypropanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100017008,"",164338,103298924,447682,2064,12801229,Literature-derived,20181017,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of protein kinase HER-2 at 10 uM,"(5-Oxo-5,6-dihydro-indolo[1,2-A]quinazolin-7-YL)-acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095555,"",235147,103203006,44279279,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and erbB2,(1-Benzyl-1H-indol-5-yl)-quinazolin-4-yl-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095680,"",235148,103203152,44279364,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and c-erbB-2,"(2-Benzyl-1H-benzoimidazol-5-yl)-(6,7-dimethoxy-quinazolin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095682,"",235148,103203166,44279376,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and c-erbB-2,N-(2-Benzyl-1H-benzimidazole-5-yl)quinazoline-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095684,"",235148,103203121,44279343,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and c-erbB-2,"N*4*-(1-Benzyl-1H-indazol-5-yl)-pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095686,"",235148,103203212,44279421,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and c-erbB-2,(1-Benzyl-1H-benzoimidazol-5-yl)-quinazolin-4-yl-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095688,"",235148,103203612,44279655,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and c-erbB-2,"(1-Benzyl-1H-indol-5-yl)-(6,7-dimethoxy-quinazolin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095690,"",235148,103203120,44279342,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and c-erbB-2,"4-N-(2-benzyl-3H-benzimidazol-5-yl)pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095692,"",235148,103203613,44279656,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and c-erbB-2,"(2-Benzyl-2H-indazol-5-yl)-(6,7-dimethoxy-quinazolin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095694,"",235148,103202908,44279217,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and c-erbB-2,(3-Benzyl-3H-benzoimidazol-5-yl)-quinazolin-4-yl-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100095696,"",235148,103203241,44279443,2064,11378364,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for EGF receptor and c-erbB-2,"(1-Benzyl-1H-indazol-5-yl)-(6,7-dimethoxy-quinazolin-4-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100102684,"",81575,134443588,56666047,2064,14505676,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Ratio of HER-2 inhibition by diastereomers,"methyl 1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-ethoxy-2-methyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptane-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100102685,"",81575,134443589,56666048,2064,14505676,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Ratio of HER-2 inhibition by diastereomers,"methyl (1R)-1-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(phenylmethoxycarbonylamino)purin-9-yl]oxolan-2-yl]methyl]-5-ethoxy-2-methyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptane-4-carboxylate;methyl 1-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(phenylmethoxycarbonylamino)purin-9-yl]oxolan-2-yl]methyl]-5-ethoxy-2-methyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptane-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100102686,"",81575,174484707,73345250,2064,14505676,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Ratio of HER-2 inhibition by diastereomers,"methyl (1R)-2-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(phenylmethoxycarbonylamino)purin-9-yl]oxolan-2-yl]methyl]-5-ethoxy-1-methyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptane-4-carboxylate;methyl 2-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(phenylmethoxycarbonylamino)purin-9-yl]oxolan-2-yl]methyl]-5-ethoxy-1-methyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptane-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100103266,"",81583,103363438,9927718,2064,14592495,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity against HER2 kinase,"N-(2-chloro-6-methylphenyl)-2-[(cyclopropylcarbonyl)amino]-1,3-thiazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100103924,"",81575,103347091,44345831,2064,14505676,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Ratio of HER-2 inhibition by diastereomers,"[(1S)-4-carbamoyl-1,2-dimethyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptan-5-yl] N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]carbamate;[(1R)-4-carbamoyl-1,2-dimethyl-6-oxo-7-oxa-2-azabicyclo[2.2.1]heptan-5-yl] N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100103925,"",81575,134435839,56659086,2064,14505676,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Ratio of HER-2 inhibition by diastereomers,"methyl 2-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-ethoxy-1-methyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptane-4-carboxylate;methyl 2-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-ethoxy-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptane-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100103926,"",81575,134451400,56672966,2064,14505676,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Ratio of HER-2 inhibition by diastereomers,"N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-ethoxy-1,2-dimethyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptane-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100103940,"",227709,103408038,44372197,2064,12639547,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selective inhibition of EGFR/erbB2 tumor cell proliferation over normal HFF cells,"N-(2-methylsulfonylethyl)-4-[4-(4-phenylmethoxyanilino)quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,128878,"","",""
100103942,"",227709,103407771,44372005,2064,12639547,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selective inhibition of EGFR/erbB2 tumor cell proliferation over normal HFF cells,"4-[4-[(1-benzylindazol-5-yl)amino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,128878,"","",""
100103944,"",227709,103408188,44372283,2064,12639547,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selective inhibition of EGFR/erbB2 tumor cell proliferation over normal HFF cells,"N-(2-methylsulfonylethyl)-4-[4-[4-[[3-(trifluoromethyl)phenyl]methoxy]anilino]quinazolin-6-yl]-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,128878,"","",""
100103946,"",227709,103408013,44372180,2064,12639547,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selective inhibition of EGFR/erbB2 tumor cell proliferation over normal HFF cells,"4-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,128878,"","",""
100104109,"",227709,103407769,44372004,2064,12639547,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selective inhibition of EGFR/erbB2 tumor cell proliferation over normal HFF cells,"4-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,128878,"","",""
100104111,"",227709,103407791,44372022,2064,12639547,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Selective inhibition of EGFR/erbB2 tumor cell proliferation over normal HFF cells,"4-[4-(3-chloro-4-phenylmethoxyanilino)quinazolin-6-yl]-N-(2-methylsulfonylethyl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,128878,"","",""
100235017,"",81561,103346072,44345353,2064,7902440,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ErbB2/neu (HER-2) autophosphorylation (Not determined),2-Cyano-3-[3-(6-ethoxy-benzothiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxy-phenyl]-acrylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100235019,"",81561,103346742,44345675,2064,7902440,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ErbB2/neu (HER-2) autophosphorylation (Not determined),3-[5-(2-Carbamoyl-2-cyano-vinyl)-2-hydroxy-3-methoxy-benzylsulfanyl]-propionic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100235040,"",219060,103295808,11776270,2064,8064792,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of erbB2 receptor (Not determined),7-Methoxy-3-pyridin-4-yl-quinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100235041,"",219060,103296592,10444797,2064,8064792,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of erbB2 receptor (Not determined),6-Methoxy-4-methyl-3-pyridin-4-yl-quinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100235042,"",219060,103296594,9994707,2064,8064792,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of erbB2 receptor (Not determined),"5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100235043,"",219060,103296195,135449022,2064,8064792,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of erbB2 receptor (Not determined),3-Pyridin-4-yl-quinolin-7-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100235044,"",219060,103296362,10332346,2064,8064792,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of erbB2 receptor (Not determined),7-Methoxy-4-methyl-3-pyridin-4-yl-quinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100235045,"",219060,103296360,135474209,2064,8064792,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of erbB2 receptor (Not determined),"3-Pyridin-4-yl-quinoline-5,7-diol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100235046,"",219060,103296243,10081720,2064,8064792,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of erbB2 receptor (Not determined),3-Pyridin-4-yl-quinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100235047,"",219060,103296277,10354094,2064,8064792,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of erbB2 receptor (Not determined),6-Methoxy-3-pyridin-4-yl-quinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100246229,"",79615,103203242,44279444,2064,11378364,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation (Not tested),(1-Benzyl-1H-indazol-5-yl)-quinazolin-4-yl-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100246230,"",79615,103203122,44279345,2064,11378364,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of c-erbB-2 overexpressing HB4a cell proliferation (Not tested),"4-N-(1-benzylindol-5-yl)pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100247674,"",81582,103262071,5329248,2064,12127526,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of autophosphorylation of human Her (p185erbB) tyrosine kinase expressed in SKOV-3 cells (Not tested),"Pyrrolo[2,3-d]pyrimidin-6-one deriv. 26t",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
100255259,"",164337,103259928,44307269,2064,"",Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cells (Not determined),[4-[(E)-2-nitroethenyl]phenyl] 5-(benzylamino)-5-oxopentanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100255260,"",164337,103259457,10248755,2064,"",Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cells (Not determined),5-O-(4-fluorophenyl) 1-O-[4-[(E)-2-nitroethenyl]phenyl] pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100255261,"",164337,103259387,44306963,2064,"",Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cells (Not determined),1-O-benzyl 5-O-[4-[(E)-2-nitroethenyl]phenyl] pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100255262,"",164337,103259505,44307028,2064,"",Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cells (Not determined),5-O-(2-methoxyphenyl) 1-O-[4-[(E)-2-nitroethenyl]phenyl] pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100255263,"",164337,103259386,44306962,2064,"",Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cells (Not determined),[4-[(E)-2-nitroethenyl]phenyl] 5-anilino-5-oxopentanoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100255730,"",164337,103260013,44307312,2064,"",Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cells (Not determined),5-O-[4-[(E)-2-nitroethenyl]phenyl] 1-O-(2-phenylethyl) pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100255731,"",164337,103260015,44307314,2064,"",Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of autophosphorylation of HER-2 expressed in NIH3T3 cells (Not determined),5-O-(3-methoxyphenyl) 1-O-[4-[(E)-2-nitroethenyl]phenyl] pentanedioate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
100869160,"",392552,103651549,44591356,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,4-(pyridin-2-ylmethylamino)-N-(3-(trifluoromethyl)phenyl)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869161,"",392552,103650909,44590993,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,"4-(3,4-difluorobenzylamino)-N-(3-(trifluoromethyl)phenyl)isothiazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869162,"",392552,103650910,44590994,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,"4-(2-(benzo[d][1,3]dioxol-5-yl)ethylamino)-N-(3-(trifluoromethyl)phenyl)isothiazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869163,"",392552,103650911,44590995,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,"4-(2-(benzo[d][1,3]dioxol-5-yl)ethylamino)-N-(3-bromophenyl)isothiazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869164,"",392552,103651611,44591374,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,4-(pyridin-4-ylmethylamino)-N-(3-(trifluoromethoxy)phenyl)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869165,"",392552,103651680,44591404,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(3-bromophenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869166,"",392552,103651094,44591117,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,4-(quinolin-4-ylmethylamino)-N-(3-(trifluoromethyl)phenyl)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869167,"",392552,103651612,44591375,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,4-(pyridin-4-ylmethylamino)-N-(4-(trifluoromethoxy)phenyl)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869168,"",392552,103651613,44591376,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(3-tert-butylphenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869169,"",392552,103651096,44591119,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(3-bromophenyl)-4-(quinolin-2-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869170,"",392552,103651548,44591355,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,4-(pyridin-3-ylmethylamino)-N-(3-(trifluoromethyl)phenyl)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869171,"",392552,103651740,44591443,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(3-methyl-4-(trifluoromethyl)phenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869172,"",392552,103650907,44590991,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(2-fluoro-4-methylphenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869173,"",392552,103651682,44591406,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(2-bromophenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869174,"",392552,103651498,5147149,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,"3-Isothiazolecarboxamide, 4-[(4-pyridinylmethyl)amino]-N-[3-(trifluoromethyl)phenyl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869175,"",392552,103651550,44591357,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,4-(pyridin-4-ylmethylamino)-N-(4-(trifluoromethyl)phenyl)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869784,"",392552,103650972,44591030,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(3-bromophenyl)-4-(quinolin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869785,"",392552,103651615,44591378,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(4-chlorophenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869786,"",392552,103651681,44591405,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(4-bromophenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869787,"",392552,103651683,44591407,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,4-(pyridin-4-ylmethylamino)-N-(quinolin-2-yl)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869788,"",392552,103651739,44591442,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(4-methyl-3-(trifluoromethyl)phenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869789,"",392552,103651737,44591440,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(3-chloro-4-(trifluoromethyl)phenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869790,"",392552,103651614,44591377,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(4-tert-butylphenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869791,"",392552,103651684,44591408,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,"N-(3a,7a-dihydro-1H-indazol-5-yl)-4-(pyridin-4-ylmethylamino)-1,2-thiazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869792,"",392552,103650908,44590992,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,"N-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869793,"",392552,103651095,44591118,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(3-bromophenyl)-4-(isoxazol-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869794,"",392552,103651551,44591358,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,4-(pyridin-3-ylmethylamino)-N-(4-(trifluoromethyl)phenyl)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869795,"",392552,103651736,44591439,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,N-(4-chloro-3-(trifluoromethyl)phenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869796,"",392552,103651552,44591359,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,4-(pyridin-2-ylmethylamino)-N-(4-(trifluoromethyl)phenyl)isothiazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100869797,"",392552,103651738,44591441,2064,19124243,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by HTRF assay,"N-(3,4-dichlorophenyl)-4-(pyridin-4-ylmethylamino)isothiazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100880133,"",372683,103634021,44583170,2064,18524423,Confirmatory,20180910,0,0,Inactive,P04626,Inhibition,"",ChEMBL,Inhibition of ERBB2,2-(6-Methoxypurin-7-yl)-1-phenylethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100880134,"",372683,103633951,12814945,2064,18524423,Confirmatory,20180910,0,0,Inactive,P04626,Inhibition,"",ChEMBL,Inhibition of ERBB2,2-(6-Amino-7H-purin-7-yl)-1-phenylethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100880135,"",372683,103634019,42603881,2064,18524423,Confirmatory,20180910,0,0,Inactive,P04626,Inhibition,"",ChEMBL,Inhibition of ERBB2,2-(6-Amino-9H-purine-9-yl)-1-(pyridine-3-yl)ethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100880136,"",372683,103633952,42604009,2064,18524423,Confirmatory,20180910,0,0,Inactive,P04626,Inhibition,"",ChEMBL,Inhibition of ERBB2,2-(6-Amino-9H-purine-9-yl)-1-(pyridine-2-yl)ethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100880137,"",372683,103633949,42604008,2064,18524423,Confirmatory,20180910,0,0,Inactive,P04626,Inhibition,"",ChEMBL,Inhibition of ERBB2,2-(6-Amino-7H-purine-7-yl)-1-(1H-indole-3-yl)ethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100880138,"",372683,103634020,42604010,2064,18524423,Confirmatory,20180910,0,0,Inactive,P04626,Inhibition,"",ChEMBL,Inhibition of ERBB2,2-(6-Methoxy-9H-purine-9-yl)-1-phenylethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100880139,"",372683,103634022,42603882,2064,18524423,Confirmatory,20180910,0,0,Inactive,P04626,Inhibition,"",ChEMBL,Inhibition of ERBB2,2-[6-(dimethylamino)purin-9-yl]-1-(1H-indol-3-yl)ethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100891261,"",350695,103596588,42628077,2064,19402633,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,4-{[2-({4-[2-(4-Acetylpiperazin-1-Yl)-2-Oxoethyl]phenyl}amino)-5-Fluoropyrimidin-4-Yl]amino}-N-(2-Chlorophenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100924715,"",244178,103465155,5329876,2064,15743202,Literature-derived,20181018,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for ERBB2 receptor kinase by scintillation proximity assay; No data,2-Anilino-5-aryloxazole 45,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100938115,"",258045,103475128,11568224,2064,16249085,Literature-derived,20181019,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,"3-(5-(3-amino-3-methylbut-1-ynyl)-2-methoxyphenyl)-N-(2,4-difluorophenyl)-1H-pyrazolo[3,4-b]pyridin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100938116,"",258045,103475456,11697791,2064,16249085,Literature-derived,20181019,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,"4-(3-(6-(2,4-difluorophenylamino)-1H-pyrazolo[3,4-b]pyrazin-3-yl)-4-methoxyphenyl)-2-methylbut-3-yn-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100945239,"",260444,103479222,11501547,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(4-Methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945240,"",260444,103479338,11612199,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(2-phenyl-1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945241,"",260444,103356748,11161961,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"benzo(a)pyrrolo(3,4-c)carbazole-1,3(2H,8H)-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945242,"",260444,103479240,11675829,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"9,10,11,18-Tetramethoxy-4,14-diazapentacyclo[11.7.0.02,6.07,12.015,20]icosa-1(13),2(6),7,9,11,15(20),16,18-octaene-3,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945243,"",260444,103479923,11610703,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"4-(3-hydroxy-4-methoxyphenyl)-3-(3,4,5-trimethoxyphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945244,"",260444,103479319,11536864,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(3,4-Dimethoxyphenyl)-4-phenylpyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945245,"",260444,103479328,10946795,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945246,"",260444,103479248,11589199,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"9,10,11-Trimethoxy-14-methyl-4,14-diazapentacyclo[11.7.0.02,6.07,12.015,20]icosa-1(13),2(6),7,9,11,15,17,19-octaene-3,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945247,"",260444,103479297,11530963,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945248,"",260444,103479313,11681623,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-Phenyl-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945249,"",260444,103479298,44407451,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(1H-pyrrole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945250,"",260444,103479314,44407457,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(indole-2-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945251,"",260444,103478960,11494006,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(indole-3-yl)-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945252,"",260444,103479236,44407428,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(1-Methylindole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945253,"",260444,103479321,2752461,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3,4-diphenyl-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945254,"",260444,103479447,15422870,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(1H-indol-3-yl)-4-(4-methoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945255,"",260444,103478967,11631174,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(4-chlorophenyl)-4-(1H-indol-3-yl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945545,"",260443,103356748,11161961,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"benzo(a)pyrrolo(3,4-c)carbazole-1,3(2H,8H)-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945546,"",260443,103479222,11501547,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(4-Methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945547,"",260443,103479338,11612199,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(2-phenyl-1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945548,"",260443,103479298,44407451,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(1H-pyrrole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945549,"",260443,103479314,44407457,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(indole-2-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945550,"",260443,103479319,11536864,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(3,4-Dimethoxyphenyl)-4-phenylpyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945551,"",260443,103479328,10946795,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"1H-Pyrrole-2,5-dione, 3,4-bis(4-methoxyphenyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945552,"",260443,103479447,15422870,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(1H-indol-3-yl)-4-(4-methoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945553,"",260443,103479320,11572699,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(4-Methoxyphenyl)-4-phenylpyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945554,"",260443,103479240,11675829,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"9,10,11,18-Tetramethoxy-4,14-diazapentacyclo[11.7.0.02,6.07,12.015,20]icosa-1(13),2(6),7,9,11,15(20),16,18-octaene-3,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945555,"",260443,103479923,11610703,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"4-(3-hydroxy-4-methoxyphenyl)-3-(3,4,5-trimethoxyphenyl)-2,5-dihydro-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945556,"",260443,103479236,44407428,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(1-Methylindole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945557,"",260443,103478967,11631174,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(4-chlorophenyl)-4-(1H-indol-3-yl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945558,"",260443,103479069,11575072,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(5-methoxyindole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945559,"",260443,103478975,44407326,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"5,6,7-Trimethoxy-1,2,3,8-tetrahydro-benzo[a]pyrrolo[3,4-c]-carbazol-1,3-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945560,"",260443,103479248,11589199,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"9,10,11-Trimethoxy-14-methyl-4,14-diazapentacyclo[11.7.0.02,6.07,12.015,20]icosa-1(13),2(6),7,9,11,15,17,19-octaene-3,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945561,"",260443,103479297,11530963,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945562,"",260443,103479313,11681623,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-Phenyl-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945563,"",260443,103479223,11151910,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(1H-indol-3-yl)-4-naphthalen-1-ylpyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945564,"",260443,103478960,11494006,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(indole-3-yl)-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945565,"",260443,103479321,2752461,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3,4-diphenyl-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945803,"",260443,103479304,15422868,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(3-indolyl)-4-phenyl-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100945804,"",260443,103479329,11545624,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 10 uM,"3-(2-methyl-1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100946450,"",260444,103479069,11575072,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(5-methoxyindole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100946451,"",260444,103479320,11572699,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(4-Methoxyphenyl)-4-phenylpyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100946452,"",260444,103479223,11151910,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(1H-indol-3-yl)-4-naphthalen-1-ylpyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100946453,"",260444,103478975,44407326,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"5,6,7-Trimethoxy-1,2,3,8-tetrahydro-benzo[a]pyrrolo[3,4-c]-carbazol-1,3-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100946454,"",260444,103479304,15422868,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(3-indolyl)-4-phenyl-1H-pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100946455,"",260444,103479329,11545624,2064,16480264,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in Sf9 cells at 100 uM,"3-(2-methyl-1H-indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
100952143,"",262079,103482296,44408869,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-(chlorodifluoromethoxy)phenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952144,"",262079,103482398,44408930,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-bromophenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952145,"",262079,103481817,44408663,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-N-m-tolyl-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952486,"",262079,103481824,44408666,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(3-methoxyphenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952487,"",262079,103483030,44409207,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"5-(4-(2-(benzo[d][1,3]dioxol-5-yl)ethylamino)-1-methyl-1H-imidazol-5-yl)-N-(4-chlorophenyl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952488,"",262079,103482931,44409176,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"5-(4-((1H-indazol-5-yl)methylamino)-1-methyl-1H-imidazol-5-yl)-N-(4-chlorophenyl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952489,"",262079,103481825,44408667,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(2-methoxyphenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952490,"",262079,103483020,44409203,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-chlorophenyl)-5-(1-methyl-4-(pyridin-2-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952491,"",262079,103482295,44408868,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-isopropylphenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952492,"",262079,103482375,11611374,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-N-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952493,"",262079,103482374,44408916,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-N-(4-(trifluoromethoxy)phenyl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952494,"",262079,103482389,44408923,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(2-fluoro-4-methylphenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952495,"",262079,103481874,44408690,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-N-o-tolyl-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952496,"",262079,103482254,44408850,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-chlorophenyl)-5-(1-methyl-4-(quinolin-5-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952497,"",262079,103482489,44408975,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-benzylphenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952498,"",262079,103483013,44409200,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-chlorophenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952499,"",262079,103482314,44408879,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-chloro-3-(trifluoromethyl)phenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952500,"",262079,103482399,44408931,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"biphenyl-4-yl-(5-{3-methyl-5-[(pyridin-4-ylmethyl)-amino]-3H-imidazol-4-yl}-[1,3,4]oxadiazol-2-yl)-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952501,"",262079,103481880,44408694,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(3,4-dichlorophenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952502,"",262079,103482390,44408924,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(benzo[d][1,3]dioxol-5-ylmethyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952503,"",262079,103482930,44409175,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"5-(4-(3,4-difluorobenzylamino)-1-methyl-1H-imidazol-5-yl)-N-(4-chlorophenyl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952504,"",262079,103483019,44409202,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-chlorophenyl)-5-(1-methyl-4-(pyridin-3-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952505,"",262079,103482286,44408863,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-tert-butylphenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952506,"",262079,103481881,44408695,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(3,4-dimethoxyphenyl)-5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952507,"",262079,103482480,44408972,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-N-(4-phenoxyphenyl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952508,"",262079,103482247,44408845,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"N-(4-chlorophenyl)-5-(1-methyl-4-(quinolin-2-ylmethylamino)-1H-imidazol-5-yl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100952509,"",262079,103481816,44408662,2064,16321531,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Protective index against ErbB2 at 10 uM by HTRF method,"5-(1-methyl-4-(pyridin-4-ylmethylamino)-1H-imidazol-5-yl)-N-(3-(trifluoromethoxy)phenyl)-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100958023,"",263614,103486039,44410388,2064,16464582,Literature-derived,20181020,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM in presence of 0.1 uM ATP,"(1S,3R,3aS,10aR)-1-(3-chlorophenyl)-3-hydroxy-3-phenyl-2,3a,5,10a-tetrahydro-1H-cyclopenta[c][1]benzazepine-4,10-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
100993774,"",277521,103505699,11625778,2064,17256836,Literature-derived,20181021,0,0,Active,P04626,"","",ChEMBL,Decrease of HER2 ECD level in plasma of CD1 mouse xenografted with BT474 cells overexpressing HER2 at 30 mg/kg/day after 28 days,"methyl (5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenyl3,6-dihydro-2H-pyridine-1-carbonyl)-7-azaspiro[2.5]octane-7-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"",1969,Plasma
100994171,"",277520,103505699,11625778,2064,17256836,Literature-derived,20181021,0,0,Active,P04626,"","",ChEMBL,Decrease of tumor volume in CD1 mouse xenografted with BT474 cells overexpressing HER2 at 30 mg/kg/day after 28 days,"methyl (5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenyl3,6-dihydro-2H-pyridine-1-carbonyl)-7-azaspiro[2.5]octane-7-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101064250,"",299191,103534649,44431891,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,"N-(4-chlorophenyl)-1-(2-(6-methyl-5,6-dihydrobenzo[d][1,3]dioxol-4-yl)ethyl)-1H-pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064251,"",299191,103534651,44431893,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,"1-(3,4-dimethoxyphenethyl)-N-(4-chlorophenyl)-1H-pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064252,"",299191,103534656,44431898,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-ethylphenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064253,"",299191,103534658,44431900,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(3-(trifluoromethoxy)phenyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064254,"",299191,103534676,44431918,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chlorophenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-indole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064255,"",299191,103534693,44431932,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(3-chloro-4-(trifluoromethyl)phenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-benzo[d]imidazole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064256,"",299191,103534706,44431941,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(3-chloro-4-(trifluoromethyl)phenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-tetrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064257,"",299191,103534650,44431892,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,"1-(3,4-difluorophenethyl)-N-(4-chlorophenyl)-1H-pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064258,"",299191,103534665,44431907,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(quinolin-3-yl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064259,"",299191,103534685,44431925,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-tert-butylphenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-imidazole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064260,"",299191,103534666,44431908,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(1H-indazol-5-yl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064261,"",299191,103534667,44431909,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(1H-indazol-6-yl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064262,"",299191,103534672,44431914,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chlorophenyl)-5-methyl-2-(2-pyridin-4-ylethyl)pyrazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064263,"",299191,103534677,44431919,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)phenyl)-1H-indole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064264,"",299191,103534704,44431940,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-tert-butylphenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-tetrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064265,"",299191,103534646,44431888,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chlorophenyl)-1-(2-(pyridin-2-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064266,"",299191,103534662,44431904,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,2-(2-pyridin-4-yl-ethyl)-2H-pyrazole-3-carboxylic acid biphenyl-4-ylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064267,"",299191,103534671,44431913,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,"N-(3,4-dimethoxyphenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064268,"",299191,103534687,44431927,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(3-chloro-4-(trifluoromethyl)phenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-imidazole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064269,"",299191,103534689,44431928,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chlorophenyl)-1-(2-pyridin-4-ylethyl)benzimidazole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064270,"",299191,103534647,44431889,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chlorophenyl)-1-(2-(pyridin-3-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064271,"",299191,103534653,44431895,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(benzo[d]isoxazol-3-yl)ethyl)-N-(4-chlorophenyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064272,"",299191,103534660,44431902,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-tert-butylphenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064273,"",299191,103534680,44431922,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)phenyl)-1H-imidazole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064274,"",299191,103534673,44431915,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,3-methyl-1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)phenyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064505,"",299191,103534675,44431917,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,"3,4-dimethyl-1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)phenyl)-1H-pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064506,"",299191,103534648,44431890,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chlorophenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064507,"",299191,103534664,44431906,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-(benzyloxy)phenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064508,"",299191,103534669,44431911,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(3-chloro-4-(trifluoromethyl)phenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064509,"",299191,103534703,44431939,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)phenyl)-1H-tetrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064510,"",299191,103534655,44431897,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethyl)phenyl)-1Hpyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064511,"",299191,103534696,44431935,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chlorophenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-tetrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064512,"",299191,103534659,44431901,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-(chlorodifluoromethoxy)phenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064513,"",299191,103534674,44431916,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,"N-(4-chlorophenyl)-3,4-dimethyl-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064514,"",299191,103534657,44431899,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)phenyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064515,"",299191,103534691,44431930,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)phenyl)-1H-benzo[d]imidazole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064516,"",299191,103534670,44431912,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,"N-(3,4-dichlorophenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064517,"",299191,103534697,44431936,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethyl)phenyl)-1H-tetrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064518,"",299191,103534678,44431920,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chlorophenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-imidazole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064519,"",299191,103534654,44431896,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(1H-imidazol-4-yl)ethyl)-N-(4-chlorophenyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064520,"",299191,103534661,44431903,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-isopropylphenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064521,"",299191,103534663,44431905,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-phenoxyphenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064522,"",299191,103534652,44431894,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chlorophenyl)-1-(2-(isoxazol-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064523,"",299191,103534679,44431921,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethyl)phenyl)-1H-imidazole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101064524,"",299191,103534668,44431910,2064,17481893,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2/Her2 at 10 uM,N-(4-chloro-3-(trifluoromethyl)phenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101085341,"",306294,103549509,10217590,2064,17270437,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human N87 cells,"N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[[(2S)-morpholin-2-yl]methoxymethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
101088841,"",307492,103555870,135800271,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(2-Fluorophenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088842,"",307492,103555863,135800262,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(4-Methoxyphenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088843,"",307492,103555865,135800264,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-[4-(Trifluoromethyl)phenyl]-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088844,"",307492,103555866,135745742,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(3,5-Dichlorophenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088845,"",307492,103555868,135800266,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(2-Chlorophenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088846,"",307492,103555867,135800265,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(4-Tert-butylphenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088847,"",307492,103555861,135800260,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(4-Chlorophenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088848,"",307492,103555872,135800273,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(2,4-Difluorophenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088849,"",307492,103555860,135800259,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(4-Bromophenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088850,"",307492,103555862,135800261,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(2-Methylphenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088851,"",307492,103555871,135800272,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(2-Bromophenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088852,"",307492,103555859,135800258,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-Phenyl-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088853,"",307492,103555873,135800274,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(4-Nitrophenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088854,"",307492,103555864,135800263,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(4-Methylphenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101088855,"",307492,103555869,135800267,2064,17448574,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"1-(3-Chlorophenyl)-4,6-dihydropyrazolo[4,3-d][1]benzazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101090164,"",308303,103551496,20823975,2064,17540562,Literature-derived,20181022,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of Her2,"12-methyl-4-phenyl-N-[2-(piperidin-1-yl)ethyl]-3-thia-1,7,10-triazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),4,7,9,11-pentaen-8-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101090165,"",308303,103551466,10215156,2064,17540562,Literature-derived,20181022,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of Her2,Ikk-IN-3,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101090166,"",308303,103551483,20823960,2064,17540562,Literature-derived,20181022,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of Her2,"N,12-dimethyl-4-phenyl-3-thia-1,7,10-triazatricyclo[7.3.0.0^{2,6}]dodeca-2(6),4,7,9,11-pentaen-8-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101103773,"",313403,103560502,136036544,2064,17983745,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,"1-(4-aminophenyl)-3-[3-(3,4-dihydroxyphenyl)-4-oxo-1H-indeno[1,2-c]pyrazol-5-yl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101103774,"",313403,103560495,135867275,2064,17983745,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,"1-(4-Amino-phenyl)-3-[3-(4-hydroxy-phenyl)-4-oxo-2,4-dihydro-indeno[1,2-c]pyrazol-5-yl]-urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101103775,"",313403,103560469,24936075,2064,17983745,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,"1-(4-aminophenyl)-3-[3-(4-methoxyphenyl)-4-oxo-1H-indeno[1,2-c]pyrazol-5-yl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101103776,"",313403,103560490,24936082,2064,17983745,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,"1-(3-Benzo[1,3]dioxol-5-yl-4-oxo-2,4-dihydro-indeno[1,2-c]pyrazol-5-yl)-3-(4-hydroxy-phenyl)-urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101103777,"",313403,103560483,44446966,2064,17983745,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,"1-(4-hydroxyphenyl)-3-[3-(4-methoxyphenyl)-4-oxo-1H-indeno[1,2-c]pyrazol-5-yl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101103778,"",313403,103560479,44446962,2064,17983745,Literature-derived,20181022,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,"1-(4-Amino-phenyl)-3-(3-benzo[1,3]dioxol-5-yl-4-oxo-2,4-dihydro-indeno[1,2-c]pyrazol-5-yl)-urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101139073,"",331436,103563645,44448864,2064,18508264,Literature-derived,20181023,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"4-N-[2-(3-fluorophenyl)-1-benzofuran-5-yl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101139074,"",331436,103563753,17747492,2064,18508264,Literature-derived,20181023,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"4-N-[3-chloro-4-[(3,5-difluorophenyl)methoxy]phenyl]-5-[(E)-methoxyiminomethyl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101139075,"",331436,103563851,44448999,2064,18508264,Literature-derived,20181023,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"4-N-[1-[(3-fluorophenyl)methyl]indazol-5-yl]-5-[(E)-methoxyiminomethyl]-6-N-methylpyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101146323,"",401056,103617247,10634145,2064,9599282,Literature-derived,20181024,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of c-erbB-2,spongiacidin C,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101146324,"",401056,103617248,10805953,2064,9599282,Literature-derived,20181024,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of c-erbB-2,spongiacidin D,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101146325,"",401056,103617235,44575454,2064,9599282,Literature-derived,20181024,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of c-erbB-2,spongiacidin A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101146326,"",401056,103617236,44575455,2064,9599282,Literature-derived,20181024,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of c-erbB-2,spongiacidin B,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101162630,"",332101,103637009,10789656,2064,"",Literature-derived,20181024,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 overexpressed in mouse 3T3 cells by ELISA,"2-methyl-2-[(3E,7E,11E)-4,8,12,16-tetramethylheptadeca-3,7,11,15-tetraenyl]chromen-6-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101162631,"",332101,103637005,21774110,2064,"",Literature-derived,20181024,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 overexpressed in mouse 3T3 cells by ELISA,"sodium;[4-hydroxy-3-[(2E,6E,10E,14E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]phenyl] sulfate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101162632,"",332101,103637007,44593674,2064,"",Literature-derived,20181024,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 overexpressed in mouse 3T3 cells by ELISA,Sodium 2-Heptaprenylhydroquinone Salt,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101162633,"",332101,103637022,21773340,2064,"",Literature-derived,20181024,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 overexpressed in mouse 3T3 cells by ELISA,"2-[(3E,7E,11E,15E,19E)-4,8,12,16,20,24-hexamethylpentacosa-3,7,11,15,19,23-hexaenyl]-2-methylchromen-6-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101162634,"",332101,103637006,23427375,2064,"",Literature-derived,20181024,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 overexpressed in mouse 3T3 cells by ELISA,"sodium;[3-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl]-4-hydroxyphenyl] sulfate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101162635,"",332101,103637021,11800039,2064,"",Literature-derived,20181024,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 overexpressed in mouse 3T3 cells by ELISA,"2-methyl-2-[(3E,7E,11E,15E)-4,8,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]chromen-6-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101162636,"",332101,103637008,10507839,2064,"",Literature-derived,20181024,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 overexpressed in mouse 3T3 cells by ELISA,"2-[(2Z,6E,10E,14E,18E,22E)-3-(hydroxymethyl)-7,11,15,19,23,27-hexamethyloctacosa-2,6,10,14,18,22,26-heptaenyl]benzene-1,4-diol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
101194986,"",358468,103440754,10039361,2064,17562705,Literature-derived,20181025,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 5 uM,"2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101224252,"",341721,103624361,442514,2064,18610999,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 autophosphorylation in human SK-OV-3 cells by Western blot,Haematoxylin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
101224419,"",341718,103624361,442514,2064,18610999,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 phosphorylation in human SK-OV-3 cells assessed as inhibition of EGF-induced AKT activation by Western blot,Haematoxylin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
101224792,"",341708,103624361,442514,2064,18610999,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM by ELISA,Haematoxylin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101224793,"",341719,103624361,442514,2064,18610999,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 phosphorylation in human SK-OV-3 cells assessed as inhibition of EGF-induced STAT3 activation by Western blot,Haematoxylin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
101225048,"",341717,103624361,442514,2064,18610999,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 phosphorylation in human SKOV3 cells assessed as inhibition of EGF-induced ERK1/2 activation by Western blot,Haematoxylin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,504,"","",""
101230517,"",362297,103642900,44586960,2064,18676149,Literature-derived,20181026,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2,Nakijiquinone H,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101230518,"",362297,103642845,44586931,2064,18676149,Literature-derived,20181026,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2,Nakijiquinone G,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101230519,"",362297,103642901,44586961,2064,18676149,Literature-derived,20181026,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2,Nakijiquinone I,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236591,"",405906,103641390,104860,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Altertoxin I,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236592,"",405906,103641331,5360741,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Alternariol monomethyl ether,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236593,"",405906,103568726,14824655,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Talaroflavone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236681,"",405906,103640363,24900161,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Alternarienonic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236682,"",405906,103641387,6918469,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Altenusin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236683,"",405906,103641330,24899915,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Alternariol 5-O-sulfate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236684,"",405906,103641388,24900160,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Desmethylaltenusin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236685,"",405906,103641329,5359485,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Alternariol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236686,"",405906,103641389,24899917,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Alterlactone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101236687,"",405906,103641333,24899916,2064,18494522,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,4-Hydroxyalternariol 9-methyl ether,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101248156,"",390483,103646952,25093235,2064,18834107,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 3 uM,"N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101255333,"",390052,136929408,57394915,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,"[1,1'-Biphenyl]-4-carboxamide, N-(cyclopropylmethyl)-2'-methyl-5'-[[3-(1-piperidinyl)benzoyl]amino]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256018,"",390052,103624571,44593646,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,"N3-(3-tert-butylphenyl)-N4''-(cyclopropylmethyl)-6-methylbiphenyl-3,4''-dicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256019,"",390052,103645413,9925594,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,"3-acetyl-4-methyl-2,5-di(4-pyridyl)-1H-pyrrole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256020,"",390052,103573134,5494449,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,Tozasertib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256021,"",390052,103645207,16047143,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,2-Amino-5-(4-carbamoylphenyl)-3-(4-sulfamoylphenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256022,"",390052,103566350,6539569,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,"N-[6-(3-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256023,"",390052,103645414,44588220,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,4-(5-(4-fluorophenyl)-1H-pyrazol-3-ylamino)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256024,"",390052,103645415,18792927,2064,19035792,Literature-derived,20181026,0,0,Active,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,"3-(4-Amino-7-piperidin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256025,"",390052,103204722,10308737,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,"N1-(7-(4-(dimethylamino)phenyl)-1,6-naphthyridin-5-yl)butane-1,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256026,"",390052,103294672,5908088,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256027,"",390052,103645273,135421442,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,Hesperadin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256028,"",390052,103565851,447966,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,4-(3-Pyridin-2-YL-1H-pyrazol-4-YL)quinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256029,"",390052,103534540,290221,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,"N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256030,"",390052,103562358,9903786,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,5-(4-Fluorophenyl)-2-ureidothiophene-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256031,"",390052,103645206,44588117,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,"N-[5-(4-cyanophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256032,"",390052,103624217,24856363,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,"N~3~-Cyclopropyl-N~4~'-(Cyclopropylmethyl)-6-Methylbiphenyl-3,4'-Dicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101256033,"",390052,103551373,25138012,2064,19035792,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 10 uM relative to control,Lck inhibitor 2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101281730,"",347287,103592684,25223978,2064,19140666,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM relative to control,N-[3-(acetylamino)phenyl]-5-{(2E)-2-[(4-methoxyphenyl)methylidene]hydrazino}-3-methyl-1H-pyrazole-4-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101283476,"",371171,103591923,24863865,2064,17981366,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human HER2 tyrosine kinase activity at 100 nM,"4-(5-Chloro-6-fluoroindole-3-yl)-6,7-dimethoxyquinazoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101283477,"",371171,103590743,11619763,2064,17981366,Literature-derived,20181026,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human HER2 tyrosine kinase activity at 100 nM,4-(5-Chloro-6-fluoroindole-3-yl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101306657,"",390491,103646952,25093235,2064,18834107,Literature-derived,20200703,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 3 uM,"N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101306773,"",390494,103646952,25093235,2064,18834107,Literature-derived,20200703,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del,A750P mutant at 3 uM","N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101306807,"",388111,103646952,25093235,2064,18834107,Literature-derived,20200703,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del,P753S mutant at 3 uM","N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101307126,"",388115,103646952,25093235,2064,18834107,Literature-derived,20200703,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 3 uM,"N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101307328,"",388112,103646952,25093235,2064,18834107,Literature-derived,20200703,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del,Sins mutant at 3 uM","N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387265,"",290551,103523351,44426255,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,2-methoxy-N-(3-(4-(3-methyl-4-(piperidin-4-yloxy)phenylamino)quinazolin-6-yl)prop-2-ynyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387267,"",290551,103523353,44426257,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,N-(3-(4-(4-(1-acetylpiperidin-4-yloxy)-3-methylphenylamino)quinazolin-6-yl)prop-2-ynyl)-2-methoxyacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387269,"",290551,103523374,44426276,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"1-(4-(4-(6-(2-Methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387271,"",290551,103523361,44426265,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N,N-dimethylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387273,"",290551,103523362,44426266,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-phenylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387275,"",290551,103523376,44426278,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"1-(4-(4-(6-(Dimethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387277,"",290551,103523379,44426280,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"4-(4-(6,7-bis(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)-N-(2,6-difluorophenyl)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387279,"",290551,103523394,44426290,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387281,"",290551,103523377,44426279,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"3,3-Dimethyl-1-(4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidin-1-yl)butan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387283,"",290551,103523378,11786150,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"N-(2,6-difluorophenyl)-4-(4-(6,7-dimethoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387285,"",290551,103523393,44426289,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"4-(2-methyl-4-(6-(pyrrolidin-1-yl)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387287,"",290551,103523395,44426291,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"4-(2-methyl-4-(6-(4-methylpiperazin-1-yl)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387289,"",290551,103523354,44426258,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,N-(3-{4-[4-(1-Cyclobutanecarbonyl-piperidin-4-yloxy)-3-methyl-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-2-methoxy-acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387291,"",290551,103523390,44426286,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"4-(2-methyl-4-(6-(methylamino)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387293,"",290551,103523371,11397750,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"1-(4-(4-(6,7-Dimethoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387295,"",290551,103523364,44426268,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,N-tert-butyl-3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387297,"",290551,103523366,44426270,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387348,"",290551,103523382,44426282,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"N-(2,6-difluorophenyl)-4-(2-methyl-4-(6-(3-morpholinopropoxy)quinazolin-4-ylamino)phenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387350,"",290551,103523389,11477567,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"4-(4-(6,7-dimethoxyquinazolin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387352,"",290551,103523391,44426287,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"4-(2-methyl-4-(6-(2-morpholinoethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387354,"",290551,103523386,44426284,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"(4-(4-(6,7-Bis(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)(cyclopentyl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387356,"",290551,103523387,44426285,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,Cyclopentyl(4-(4-(6-(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387358,"",290551,103523359,44426263,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"N-(2,6-difluorophenyl)-4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387360,"",290551,103523375,44426277,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,N-(3-methyl-4-(1-methylpiperidin-4-yloxy)phenyl)-6-(3-morpholinopropoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387362,"",290551,103523357,44426261,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,2-methoxy-N-(3-(4-(4-(1-(2-methoxyacetyl)piperidin-4-yloxy)-3-methylphenylamino)quinazolin-6-yl)prop-2-ynyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387364,"",290551,103523380,11272368,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"N-(2,6-difluorophenyl)-4-(4-(6-methoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387366,"",290551,103523360,44426264,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387368,"",290551,103523392,44426288,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"4-(4-(6-(dimethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387370,"",290551,103523358,44426262,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,2-methoxy-N-[3-(4-{3-methyl-4-[1-(tetrahydro-furan-2-carbonyl)-piperidin-4-yloxy]-phenylamino}-quinazolin-6-yl)-prop-2-ynyl]-acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387372,"",290551,103523363,44426267,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,N-cyclobutyl-3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387374,"",290551,103523365,44426269,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387376,"",290551,103523372,44426275,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"1-(4-(4-(6,7-Bis(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387378,"",290551,103523381,44426281,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"N-(2,6-difluorophenyl)-4-(4-(6-(2-methoxyethoxy)quinazolin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387380,"",290551,103523388,11752667,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"Cyclopentyl(4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387382,"",290551,103523356,44426260,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"N-(3-(4-(4-(1-(3,3-dimethylbutanoyl)piperidin-4-yloxy)-3-methylphenylamino)quinazolin-6-yl)prop-2-ynyl)-2-methoxyacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387384,"",290551,103523383,44426283,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"N-(2,6-difluorophenyl)-4-(2-methyl-4-(6-(methylamino)pyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387758,"",290551,103523355,44426259,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,N-[3-(4-{4-[1-(3-Chloro-benzoyl)-piperidin-4-yloxy]-3-methyl-phenylamino}-quinazolin-6-yl)-prop-2-ynyl]-2-methoxy-acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387760,"",290551,103523373,11305772,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"1-(4-(4-(6-Methoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387762,"",290551,103523369,44426273,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,N-tert-butyl-4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387764,"",290551,103523352,44426256,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,2-methoxy-N-(3-(4-(3-methyl-4-(1-methylpiperidin-4-yloxy)phenylamino)quinazolin-6-yl)prop-2-ynyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387766,"",290551,103523367,44426271,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N,N-dimethylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387768,"",290551,103523368,44426272,2064,17398092,Literature-derived,20200704,0,0,Inconclusive,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-phenylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387770,"",290551,103523370,44426274,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-neopentylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387772,"",290551,103523385,11365185,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"N-(2,6-difluorophenyl)-4-(2-methyl-4-(6-morpholinopyrido[3,4-d]pyrimidin-4-ylamino)phenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101387774,"",290551,103523384,11203411,2064,17398092,Literature-derived,20200704,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for erbB2 over EGFR,"N-(2,6-difluorophenyl)-4-(4-(6-(dimethylamino)pyrido[3,4-d]pyrimidin-4-ylamino)-2-methylphenoxy)piperidine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101412578,"",372684,103633950,12814948,2064,18524423,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 up to 100 uM,2-(6-Amino-9H-purine-9-yl)-1-phenylethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101416945,"",248969,103453859,10199254,2064,15267243,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of EGF-stimulated human umbilical vein endothelial cell proliferation; ND= not determined,"5-(5,6-Dimethyl-pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-2-methyl-phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101416947,"",248969,103454256,9794758,2064,15267243,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of EGF-stimulated human umbilical vein endothelial cell proliferation; ND= not determined,"2-Methyl-5-(pyrrolo[2,1-f][1,2,4]triazin-4-ylamino)-phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101453091,"",375732,103635427,44583672,2064,19457660,Confirmatory,20220830,0,0,Inactive,P04626,IC50,"",ChEMBL,Inhibition of HER2 extracellular domain sheddase activity in human BT474 cells after 72 hrs by ELISA,"(1S,2S,5R)-N-hydroxy-2-(4-(3-isopropylphenyl)piperidine-1-carbonyl)-5-(2-oxo-2-(piperidin-1-yl)ethyl)cyclohexanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101504954,"",361656,103644049,24897279,2064,18653333,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of human ErB2 phosphorylation in human SKBR3 cells,"(R,E)-N4-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-5-((2-(methoxymethyl)pyrrolidin-1-ylimino)methyl)pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
101595855,"",331423,103563752,44448938,2064,18508264,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2,"5-[(E)-methoxyiminomethyl]-4-N-[1-[(3-methoxyphenyl)methyl]indazol-5-yl]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101638416,"",277510,103505627,16108938,2064,17256836,Confirmatory,20220830,0,0,Inactive,P04626,Activity,"",ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-6-N-butan-2-yl-7-N-hydroxy-5-methyl-5-azaspiro[2.5]octane-6,7-dicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101638419,"",277510,103505659,16108941,2064,17256836,Confirmatory,20220830,0,0,Inactive,P04626,Activity,"",ChEMBL,Inhibition of Her2 sheddase activity in BT474 cell line,"(6S,7S)-N-hydroxy-6-{[4-(2-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
101675210,"",290550,103523351,44426255,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,2-methoxy-N-(3-(4-(3-methyl-4-(piperidin-4-yloxy)phenylamino)quinazolin-6-yl)prop-2-ynyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675211,"",290550,103523353,44426257,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,N-(3-(4-(4-(1-acetylpiperidin-4-yloxy)-3-methylphenylamino)quinazolin-6-yl)prop-2-ynyl)-2-methoxyacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675440,"",290550,103523352,44426256,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,2-methoxy-N-(3-(4-(3-methyl-4-(1-methylpiperidin-4-yloxy)phenylamino)quinazolin-6-yl)prop-2-ynyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675441,"",290550,103523367,44426271,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,"4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N,N-dimethylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675442,"",290550,103523368,44426272,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-phenylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675445,"",290550,103523360,44426264,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675447,"",290550,103523369,44426273,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,N-tert-butyl-4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675449,"",290550,103523366,44426270,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,4-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675454,"",290550,103523373,11305772,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,"1-(4-(4-(6-Methoxyquinazolin-4-ylamino)-2-methylphenoxy)piperidin-1-yl)-3,3-dimethylbutan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675745,"",290550,103523357,44426261,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,2-methoxy-N-(3-(4-(4-(1-(2-methoxyacetyl)piperidin-4-yloxy)-3-methylphenylamino)quinazolin-6-yl)prop-2-ynyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675749,"",290550,103523361,44426265,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,"3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N,N-dimethylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101675750,"",290550,103523362,44426266,2064,17398092,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of erbB2 in NH3T3 cells,3-(4-(6-(3-(2-methoxyacetamido)prop-1-ynyl)quinazolin-4-ylamino)-2-methylphenoxy)-N-phenylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840027,"",256662,103181324,5169,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840028,"",256662,103298456,153999,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Ruboxistaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840029,"",256662,103176908,160355,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Seliciclib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840030,"",256662,103344166,3038525,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Neflamapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840031,"",256662,123092436,44259,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840033,"",256662,103320031,156422,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Doramapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840034,"",256662,103163913,176155,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840035,"",256662,103175813,5329102,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Sunitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840036,"",256662,103354744,3038522,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Tandutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840037,"",256662,103420820,216239,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840038,"",256662,103245522,5291,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Imatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840040,"",256662,103194628,3081361,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Vandetanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840043,"",256662,103317292,151194,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Vatalanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840044,"",256662,104234154,5287969,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,Alvocidib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101840046,"",256662,174515438,8515,2064,15711537,Confirmatory,20220830,0,0,Inactive,P04626,Kd,"",ChEMBL,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,"1,9-Pyrazoloanthrone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101891028,"",266440,103488426,2861706,2064,16530412,Confirmatory,20220830,0,0,Inactive,P04626,IC50,"",ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,"1-Benzyl-3-((4-morpholinophenyl)amino)pyrrolidine-2,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101891029,"",266440,103488493,871702,2064,16530412,Confirmatory,20220830,0,0,Inactive,P04626,IC50,"",ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,"1-(3-Chlorophenyl)pyrazolidine-3,5-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101891030,"",266440,103488504,2867228,2064,16530412,Confirmatory,20220830,0,0,Inactive,P04626,IC50,"",ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,"4'-Methyl-N2-(pyridin-2-yl)-[4,5'-bithiazole]-2,2'-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101891031,"",266440,103488492,674305,2064,16530412,Confirmatory,20220830,0,0,Inactive,P04626,IC50,"",ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,4-methoxy-2-[3-(2-thienyl)-1H-pyrazol-4-yl]phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101891032,"",266440,103488437,5408619,2064,16530412,Confirmatory,20220830,0,0,Inactive,P04626,IC50,"",ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,"3-(4-fluorophenoxy)-7,8-dihydroxy-4H-chromen-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101892436,"",266440,103488491,885304,2064,16530412,Confirmatory,20220830,0,0,Inactive,P04626,IC50,"",ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,N-(4-hydroxy-3-methylphenyl)-3-methoxybenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
101892437,"",266440,103488438,135444536,2064,16530412,Confirmatory,20220830,0,0,Inactive,P04626,IC50,"",ChEMBL,Inhibition of Her2 in SKBr3 cells by ELISA,"1-(3,4-Dihydroxyphenyl)-2-[(4-hydroxy-6-methylpyrimidin-2-YL)thio]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048154,"",417897,103593104,44564576,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(3,4-dichlorophenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048155,"",417897,103593976,44565091,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(3-chlorophenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-2-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048156,"",417897,103594042,44565142,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048157,"",417897,103594117,44565197,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(1H-indazol-5-yl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048158,"",417897,103594114,44565194,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(3-tert-butylphenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048159,"",417897,103593300,44564653,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(benzo[d][1,3]dioxol-5-ylmethyl)-2-(1-(3-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048160,"",417897,103594044,44565144,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(pyridin-4-ylmethyl)-2-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,3-triazol-4-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048161,"",417897,103594113,44156905,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(3-isopropylphenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048162,"",417897,103593105,44156906,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(4-methyl-3-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048163,"",417897,103593371,44156908,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(quinolin-4-ylmethyl)-2-(1-(3-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048164,"",417897,103594041,44156904,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(pyridin-4-ylmethyl)-2-(1-(3-(trifluoromethoxy)phenyl)-1H-1,2,3-triazol-4-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048165,"",417897,103594116,44565196,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(pyridin-4-ylmethyl)-2-(1-(quinolin-2-yl)-1H-1,2,3-triazol-4-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048166,"",417897,103593172,44564600,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(3-methyl-4-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048167,"",417897,103593372,44564688,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-((1H-imidazol-4-yl)methyl)-2-(1-(3-chlorophenyl)-1H-1,2,3-triazol-4-yl)benzenamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048168,"",417897,103593102,44564574,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(4-chloro-3-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048169,"",417897,103593974,44157074,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(3-Chlorophenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)benzenamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048170,"",417897,103593299,44564652,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(benzo[d][1,3]dioxol-5-ylmethyl)-2-(1-(3-chlorophenyl)-1H-1,2,3-triazol-4-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048171,"",417897,103594040,44565141,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(pyridin-2-ylmethyl)-2-(1-(3-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048172,"",417897,103594115,44565195,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(4-tert-butylphenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048173,"",417897,103593975,44565090,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(3-chlorophenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-3-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048174,"",417897,103593103,44564575,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(3-chloro-4-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)-N-(pyridin-4-ylmethyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048175,"",417897,103593301,44156907,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"(1-(3-Chlorophenyl)-1H-1,2,3-triazol-4-yl)-N-(quinolin-4-ylmethyl)benzenamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048176,"",417897,103594043,44565143,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(pyridin-4-ylmethyl)-2-(1-(4-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048177,"",417897,103593977,44156915,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(Pyridin-4-ylmethyl)-2-(1-(3-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)benzenamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048178,"",417897,103593978,44565092,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"N-(pyridin-3-ylmethyl)-2-(1-(3-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103048392,"",417897,103593298,44564651,2064,19188066,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"2-(1-(3-chlorophenyl)-1H-1,2,3-triazol-4-yl)-N-(3,4-difluorobenzyl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103070070,"",423604,103691271,42639664,2064,19271717,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,alterporriol G/H,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103070071,"",423604,103693093,177458,2064,19271717,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,"1,2,8-Trihydroxy-6-methoxy-3-methylanthraquinone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103070072,"",423604,103600249,159926,2064,19271717,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Macrosporin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103070073,"",423604,103600248,89644,2064,19271717,Literature-derived,20180910,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2,Altersolanol A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124184,"",418589,103593534,44564787,2064,19211246,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N2-(4-(benzo[d]thiazol-2-yl)phenyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124471,"",418589,103593599,44564818,2064,19211246,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2 by virtual HTS assay,N-(4-(benzo[d]thiazol-2-yl)phenyl)-9H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
103124472,"",418589,103593472,44564750,2064,19211246,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2 by virtual HTS assay,"N2-(4-(benzo[d]thiazol-2-yl)phenyl)-N4,N4-dimethylpyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105923627,"",435512,103298924,447682,2064,12816539,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Percent residual Her-2 activity in the presence of 10uM inhibitor,"(5-Oxo-5,6-dihydro-indolo[1,2-A]quinazolin-7-YL)-acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105935450,"",437900,103697953,44478401,2064,19788238,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to ERBB2 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay,"1H-Imidazo[2,1-f]purine-2,4(3H,8H)-dione, 7-(5-hydroxy-2-methylphenyl)-8-(2-methoxyphenyl)-1-methyl-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105946430,"",439473,242610731,90664306,2064,19764794,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 assessed as enzyme activity at 1 uM relative to untreated control,"1-N-(4-chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine;trihydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105959703,"",444992,103708897,45102725,2064,19822424,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 at 20 uM by FRET assay,4-(4-fluorophenyl)-5-(4-pyridyl)-1-(ethynyl)-2-(but-3-yn-1-ol)-1H-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105972399,"",436057,103641275,9874913,2064,18183025,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity for ERBB2 as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0,2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105976385,"",439280,242610731,90664306,2064,19764794,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant assessed as enzyme activity at 1 uM relative to untreated control","1-N-(4-chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine;trihydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105976940,"",439284,242610731,90664306,2064,19764794,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant assessed as enzyme activity at 1 uM relative to untreated control,"1-N-(4-chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine;trihydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105977176,"",439279,242610731,90664306,2064,19764794,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR L747-E749del A750P assessed as enzyme activity at 1 uM relative to untreated control,"1-N-(4-chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine;trihydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105977226,"",439276,242610731,90664306,2064,19764794,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant assessed as enzyme activity at 1 uM relative to untreated control,"1-N-(4-chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine;trihydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105977254,"",439281,242610731,90664306,2064,19764794,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del,Sins mutant assessed as enzyme activity at 1 uM relative to untreated control","1-N-(4-chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine;trihydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105989986,"",440204,124974945,10437018,2064,19821562,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER1/HER2-mediated MAPK phosphorylation in human GEO cells by Western blot,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
105990098,"",440205,124974945,10437018,2064,19821562,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of epidermal growth factor-induced HER1/HER2 heterodimer formation in human AU565 cells at 1 uM by immunoprecipitation,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3537,"","",""
105990297,"",440202,124974945,10437018,2064,19821562,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER1/HER2 phosphorylation in human N87 cells by Western blot,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,4063,"","",""
105990300,"",440203,124974945,10437018,2064,19821562,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER1/HER2-mediated AKT phosphorylation in human GEO cells by Western blot,"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151214497,"",451417,103720034,46227150,2064,19674907,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT,"N-[3-[[3-[[3-[[3-[[3-[[3-[[3-[[(4R,10S,13S,16S,19S,22S,25R)-4-[(2-amino-2-oxoethyl)carbamoyl]-10,19-dibenzyl-16-(3-carbamimidamidopropyl)-6,9,12,15,18,21,24-heptaoxo-13,22-di(propan-2-yl)-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacos-25-yl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]-N'-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N'-methylbutanediamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151214579,"",451597,103720036,46227152,2064,19674907,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT,"N-[3-[[3-[(3-amino-3-oxopropyl)amino]-3-oxopropyl]amino]-3-oxopropyl]-N'-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N'-methylbutanediamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151214652,"",451507,103720037,46227153,2064,19674907,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to human ERBB2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT,"N-[3-[[3-[[3-[[3-[[3-[[3-[[3-[[(6S,9S,12S,15S,18S,21S,26S)-6,15-dibenzyl-12-(3-carbamimidamidopropyl)-26-carbamoyl-2,5,8,11,14,17,20,24-octaoxo-9,18-di(propan-2-yl)-1,4,7,10,13,16,19,23-octazacyclohexacos-21-yl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]amino]-3-oxopropyl]-N'-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N'-methylbutanediamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151215463,"",450369,103717491,12000646,2064,19692247,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Residual activity of ERBB2 at 0.1 uM by microplate scintillation counting,2-(4-(6-Methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinazolin-4-yloxy)phenyl)benzo[d]thiazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151215464,"",450369,103717492,44552562,2064,19692247,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Residual activity of ERBB2 at 0.1 uM by microplate scintillation counting,2-(4-(6-Methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-yloxy)phenyl)benzo[d]thiazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151215465,"",450369,103717618,44552561,2064,19692247,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Residual activity of ERBB2 at 0.1 uM by microplate scintillation counting,"2-[3-Fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]oxyphenyl]-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151215718,"",450767,103717618,44552561,2064,19692247,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Residual activity of ERBB2 at 10 uM by microplate scintillation counting,"2-[3-Fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]oxyphenyl]-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151215719,"",450767,103717491,12000646,2064,19692247,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Residual activity of ERBB2 at 10 uM by microplate scintillation counting,2-(4-(6-Methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinazolin-4-yloxy)phenyl)benzo[d]thiazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151215720,"",450767,103717492,44552562,2064,19692247,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Residual activity of ERBB2 at 10 uM by microplate scintillation counting,2-(4-(6-Methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-yloxy)phenyl)benzo[d]thiazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151216304,"",451019,103717492,44552562,2064,19692247,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Residual activity of ERBB2 at 1 uM by microplate scintillation counting,2-(4-(6-Methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-yloxy)phenyl)benzo[d]thiazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151216305,"",451019,103717491,12000646,2064,19692247,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Residual activity of ERBB2 at 1 uM by microplate scintillation counting,2-(4-(6-Methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinazolin-4-yloxy)phenyl)benzo[d]thiazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151216306,"",451019,103717618,44552561,2064,19692247,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Residual activity of ERBB2 at 1 uM by microplate scintillation counting,"2-[3-Fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]oxyphenyl]-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151219178,"",453331,103721610,135859914,2064,19783149,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,1-(Phenpropyl)-isoindigo,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151219179,"",453331,103721758,126274,2064,19783149,Literature-derived,20180911,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,Meisoindigo,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
151254196,"",457037,103722223,45141138,2064,20151670,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 autophosphorylation in human NCI-H1975 cells by Western blot,"(2R,3S)-N-(4-(3-Bromoanilino)quinazolin-6-yl)-3-(piperidin-1-ylmethyl)oxirane-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3971,"","",""
151254527,"",457039,103244983,123631,2064,20151670,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of ERBB2 autophosphorylation in human NCI-H1975 cells up to 10 uM by Western blot,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3971,"","",""
155662257,"",467375,103742945,22050722,2064,19751974,Literature-derived,20180912,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"3-bromo-4-(2,4-difluorobenzyloxy)-1-(4-((dimethylamino)methyl)benzyl)-6-methylpyridin-2(1H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155662258,"",467375,103742719,46882408,2064,19751974,Literature-derived,20180912,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"3-bromo-4-(2,4-difluorobenzyloxy)-1-(5-(hydroxymethyl)pyrazin-2-yl)-6-methylpyridin-2(1H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155664092,"",469697,103743270,46882744,2064,19783434,Literature-derived,20180912,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 5 uM,Ldn-211904 oxalate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155674364,"",463709,103739611,45380088,2064,20028027,Literature-derived,20180912,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 mM,Nakijiquinone O,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155674365,"",463709,103739668,45380090,2064,20028027,Literature-derived,20180912,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 at 1 mM,Nakijiquinone Q,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155674366,"",463709,103739522,45380085,2064,20028027,Literature-derived,20180912,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 at 1 mM,Nakijiquinone L,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155674367,"",463709,103739612,45380089,2064,20028027,Literature-derived,20180912,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 at 1 mM,Nakijiquinone P,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155674368,"",463709,103739609,45380086,2064,20028027,Literature-derived,20180912,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 at 1 mM,Nakijiquinone M,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155674369,"",463709,103739520,45379968,2064,20028027,Literature-derived,20180912,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 at 1 mM,Nakijiquinone J,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155674370,"",463709,103739521,45379969,2064,20028027,Literature-derived,20180912,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 at 1 mM,Nakijiquinone K,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155674371,"",463709,103739669,45380207,2064,20028027,Literature-derived,20180912,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 mM,Nakijiquinone R,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155674372,"",463709,103739610,45380087,2064,20028027,Literature-derived,20180912,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 mM,Nakijiquinone N,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780729,"",472049,103737175,46879472,2064,19815412,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HER2 by HTRF assay,"ethyl 4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-7-methyl-6H-pyrrolo[3,4-d]pyridazine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780731,"",472049,103737177,46879474,2064,19815412,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HER2 by HTRF assay,"7-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrrolo[2,3-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780733,"",472049,103738335,24782622,2064,19815412,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HER2 by HTRF assay,"4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-methyl-N-(3-(4-methylpiperazin-1-yl)propyl)-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780735,"",472049,103738336,24782621,2064,19815412,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HER2 by HTRF assay,"4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-3-methyl-N-(2-(4-methylpiperazin-1-yl)ethyl)-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780736,"",472049,103737174,46879471,2064,19815412,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HER2 by HTRF assay,"4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-methyl-N-(2-morpholinoethyl)-1H-pyrrolo[3,2-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
155780737,"",472049,103737176,46879473,2064,19815412,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HER2 by HTRF assay,"7-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-N-(2-(diethylamino)ethyl)-1H-pyrrolo[2,3-d]pyridazine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930627,"",488716,103763984,46906755,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930628,"",488716,103763808,46906603,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[7-methoxy-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930629,"",488716,103763924,46906701,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[7-methoxy-6-[3-(4-phenylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930630,"",488716,103763809,46906604,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[7-methoxy-6-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930631,"",488716,103763868,46906651,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[7-methoxy-6-[3-(4-methylpiperidin-1-yl)propoxy]quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930632,"",488716,103764119,46906889,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[6-methoxy-7-[3-(4-phenylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930633,"",488716,103763985,46906756,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930634,"",488716,103177459,176870,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930635,"",488716,103764065,46906826,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-(6-methoxy-7-(3-(4-methylpiperidin-1-yl)propoxy)-quinazolin-4-ylamino)benzo[b]thiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930636,"",488716,103764118,46906888,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[7-[3-(4-ethylpiperazin-1-yl)propoxy]-6-methoxyquinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930637,"",488716,103763921,46906698,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[7-methoxy-6-[3-(2-methylpiperidin-1-yl)propoxy]quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930638,"",488716,103763986,46906757,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930639,"",488716,103763866,46906649,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[7-methoxy-6-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930640,"",488716,103764116,46846075,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[6-methoxy-7-[3-(2-methylpiperidin-1-yl)propoxy]quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930641,"",488716,103763923,46906700,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[6-[3-(4-ethylpiperazin-1-yl)propoxy]-7-methoxyquinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930642,"",488716,103244983,123631,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930643,"",488716,103763807,46906602,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930644,"",488716,103764064,46846074,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-(7-(3-(diethylamino)propoxy)-6-methoxyquinazolin-4-ylamino)benzo[b]thiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930645,"",488716,103763867,46906650,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[6-[3-(diethylamino)propoxy]-7-methoxyquinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930646,"",488716,103764063,46906825,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930647,"",488716,103763922,46906699,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[6-[3-(dimethylamino)propoxy]-7-methoxyquinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163930648,"",488716,103764117,46906887,2064,20466555,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,Ethyl 5-[[7-[3-(dimethylamino)propoxy]-6-methoxyquinazolin-4-yl]amino]-1-benzothiophene-2-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936492,"",485616,103763887,46906669,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"1-(2-Chloro-3,6-difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936493,"",485616,103763831,24853329,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"1-(2,5-Difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936494,"",485616,103763941,46906718,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-7-yl}benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936495,"",485616,103764027,46906792,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"{1-[(5-Chloro-2-trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}piperidin-1-yl-methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936496,"",485616,103764028,46906793,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-methoxypiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936497,"",485616,103764029,46871638,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936498,"",485616,103764030,46871653,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936499,"",485616,103764031,46906794,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"1-[4-(4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}pyridin-2-yl)piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936500,"",485616,103763834,46906624,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"1-[(2,5-dichlorophenyl)methyl]-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163936501,"",485616,103763832,46871637,2064,20483621,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"1-(5-Chloro-2-(trifluoromethyl)benzyl)-7-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163938052,"",486358,103764542,135957045,2064,20488718,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting,5-{N-[4-(4-Methylpiperazino)-phenyl]-aminocarbonyl}-indirubin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163938564,"",486359,103764542,135957045,2064,20488718,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting,5-{N-[4-(4-Methylpiperazino)-phenyl]-aminocarbonyl}-indirubin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940903,"",485513,103764031,46906794,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","1-[4-(4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}pyridin-2-yl)piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940907,"",485513,103764027,46906792,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","{1-[(5-Chloro-2-trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}piperidin-1-yl-methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940936,"",485510,103763834,46906624,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"1-[(2,5-dichlorophenyl)methyl]-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940940,"",485510,103764027,46906792,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"{1-[(5-Chloro-2-trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}piperidin-1-yl-methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940944,"",485510,103764028,46906793,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-methoxypiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940948,"",485510,103764029,46871638,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940952,"",485510,103764031,46906794,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"1-[4-(4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}pyridin-2-yl)piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940956,"",485510,103763831,24853329,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"1-(2,5-Difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940970,"",485514,103763834,46906624,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","1-[(2,5-dichlorophenyl)methyl]-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940974,"",485514,103764030,46871653,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940978,"",485514,103764031,46906794,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","1-[4-(4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}pyridin-2-yl)piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940982,"",485514,103763831,24853329,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","1-(2,5-Difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940986,"",485514,103764027,46906792,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","{1-[(5-Chloro-2-trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}piperidin-1-yl-methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940994,"",485515,103763831,24853329,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","1-(2,5-Difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163940998,"",485515,103763832,46871637,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","1-(5-Chloro-2-(trifluoromethyl)benzyl)-7-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941002,"",485515,103764027,46906792,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","{1-[(5-Chloro-2-trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}piperidin-1-yl-methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941006,"",485515,103764028,46906793,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-methoxypiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941010,"",485515,103764029,46871638,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941014,"",485515,103764031,46906794,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","1-[4-(4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}pyridin-2-yl)piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941018,"",485515,103763941,46906718,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-7-yl}benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941020,"",485513,103764028,46906793,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-methoxypiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941024,"",485513,103764029,46871638,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941028,"",485513,103764030,46871653,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941032,"",485513,103763834,46906624,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","1-[(2,5-dichlorophenyl)methyl]-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941036,"",485513,103763831,24853329,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","1-(2,5-Difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941040,"",485513,103763941,46906718,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-7-yl}benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941044,"",485513,103763832,46871637,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","1-(5-Chloro-2-(trifluoromethyl)benzyl)-7-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941048,"",485513,103763887,46906669,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 1 uM","1-(2-Chloro-3,6-difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941059,"",485602,103764031,46906794,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"1-[4-(4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}pyridin-2-yl)piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941063,"",485602,103764027,46906792,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"{1-[(5-Chloro-2-trifluoromethyl)benzyl]-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-7-yl}piperidin-1-yl-methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941067,"",485602,103764028,46906793,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-methoxypiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941071,"",485602,103764029,46871638,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941075,"",485602,103764030,46871653,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941079,"",485602,103763887,46906669,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"1-(2-Chloro-3,6-difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941301,"",485514,103764028,46906793,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-methoxypiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941305,"",485514,103764029,46871638,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","[4-[1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazin-7-yl]phenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941309,"",485514,103763887,46906669,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","1-(2-Chloro-3,6-difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941313,"",485514,103763941,46906718,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-7-yl}benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941317,"",485514,103763832,46871637,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 1 uM","1-(5-Chloro-2-(trifluoromethyl)benzyl)-7-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941356,"",485602,103763941,46906718,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-7-yl}benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941360,"",485602,103763831,24853329,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"1-(2,5-Difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941364,"",485602,103763832,46871637,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"1-(5-Chloro-2-(trifluoromethyl)benzyl)-7-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941368,"",485602,103763834,46906624,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 1 uM,"1-[(2,5-dichlorophenyl)methyl]-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941382,"",485510,103763887,46906669,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"1-(2-Chloro-3,6-difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941386,"",485510,103764030,46871653,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941390,"",485510,103763832,46871637,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"1-(5-Chloro-2-(trifluoromethyl)benzyl)-7-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941394,"",485510,103763941,46906718,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 1 uM,"4-{1-[5-Chloro-2-(trifluoromethyl)benzyl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazin-7-yl}benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941670,"",485515,103764030,46871653,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","1-[[5-chloro-2-(trifluoromethyl)phenyl]methyl]-7-(2-piperazin-1-ylpyridin-4-yl)-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941674,"",485515,103763834,46906624,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","1-[(2,5-dichlorophenyl)methyl]-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-3,4-dihydro-2H-pyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
163941678,"",485515,103763887,46906669,2064,20483621,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 1 uM","1-(2-Chloro-3,6-difluorobenzyl)-7-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169099750,"",490708,103766074,49797851,2064,20541934,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(2-pyridin-3-ylethynyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169099751,"",490708,103766182,49797901,2064,20541934,Literature-derived,20180913,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 10 uM,"N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(1H-pyrrolo[2,3-b]pyridin-5-yl)ethynyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169108392,"",490688,103766182,49797901,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 10 uM","N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(1H-pyrrolo[2,3-b]pyridin-5-yl)ethynyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169108396,"",490688,103766074,49797851,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant at 10 uM",N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(2-pyridin-3-ylethynyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169108520,"",490686,103766182,49797901,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 10 uM","N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(1H-pyrrolo[2,3-b]pyridin-5-yl)ethynyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169108524,"",490686,103766074,49797851,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant at 10 uM",N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(2-pyridin-3-ylethynyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169108562,"",490683,103766182,49797901,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 10 uM,"N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(1H-pyrrolo[2,3-b]pyridin-5-yl)ethynyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169108566,"",490683,103766074,49797851,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant at 10 uM,N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(2-pyridin-3-ylethynyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169109407,"",490692,103766182,49797901,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 10 uM,"N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(1H-pyrrolo[2,3-b]pyridin-5-yl)ethynyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169109411,"",490692,103766074,49797851,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant at 10 uM,N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(2-pyridin-3-ylethynyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169109805,"",490687,103766074,49797851,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 10 uM",N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(2-pyridin-3-ylethynyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169109809,"",490687,103766182,49797901,2064,20541934,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant at 10 uM","N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(1H-pyrrolo[2,3-b]pyridin-5-yl)ethynyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
169110148,"",491925,103768671,46898022,2064,20570525,Literature-derived,20200702,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition ErbB2 at 10 uM,n-(4-Aminosulfonylphenyl)-2-morpholino-9h-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
173413385,"",493040,103904329,9950716,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"n-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-n'-(4-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173413546,"",493040,103904338,11710853,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(3-Amino-1-methylpyrazolo[3,4-c]pyridin-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173413641,"",493040,103904339,11588815,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[4-(3-amino-1-methyl-1H-pyrazolo[3,4-c]pyridin-4-yl)phenyl]-N'-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173413653,"",493040,103904275,10043997,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173413759,"",493040,103904284,49830349,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"n-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-n'-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173413889,"",493040,103904300,18451149,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(3-aminoprop-1-ynyl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173414009,"",493040,103904307,18451208,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(3-morpholin-4-ylprop-1-ynyl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173414134,"",493040,103904310,49830357,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"4-amino-3-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenyl]-N-methylthieno[3,2-c]pyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173414292,"",493040,103904314,49830359,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(1-methylpyrazol-4-yl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-fluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173414391,"",493040,103904334,49830370,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[4-(3-amino-7-methyl-1H-indazol-4-yl)phenyl]-3-(3-bromophenyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173414598,"",493040,103904313,49830358,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(1-methylpyrazol-4-yl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173414710,"",493040,103904328,16125042,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,N-[4-(1H-indazol-4-yl)-phenyl]-N''-(3-methylphenyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173414803,"",493040,103904346,16043242,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-(4-Aminoisothiazolo[5,4-d]pyrimidin-3-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173414946,"",493040,103904327,18451363,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(4-Aminothieno[3,2-c]pyridin-3-yl)phenyl]-3-[2-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173415124,"",493040,103904350,49830376,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[4-(5-Aminoquinoxalin-6-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173415300,"",493040,103904316,49830361,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Methyl 4-amino-7-methyl-5-[4-(phenylcarbamoylamino)phenyl]pyrrolo[2,1-f][1,2,4]triazine-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173415390,"",493040,103904359,18450541,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-(4-Aminothieno[3,2-c]pyridin-3-yl)phenyl)-3-(3-chlorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173415531,"",493040,103904351,11463885,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(3-Amino-7-methoxy-1,2-benzoxazol-4-yl)phenyl]-3-(4-fluoro-3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173415725,"",493040,103904353,49830378,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-amino-N-[4-[(3,5-dimethylphenyl)carbamoylamino]phenyl]thieno[2,3-d]pyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173415906,"",493040,103904340,11485656,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Linifanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173416128,"",493040,103904212,49830289,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]propan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173416332,"",493040,103904288,24894620,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-{4-[7-Amino-3-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl]phenyl}-3-m-tolyl-urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173416641,"",493040,103904337,5329880,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(3-methylphenyl)-3-[4-(1-oxo-2,3-dihydro-1H-isoindol-4-yl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173416753,"",493040,103904287,49830350,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(6-methylpyridin-3-yl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-fluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173417099,"",493040,103904286,18451197,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(furan-3-yl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(2-fluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173417318,"",493040,103904294,6540003,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Thienopyrimidine deriv. 26,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173417449,"",493040,103904296,49830354,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3,4-dimethylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173417508,"",493040,103904335,11856204,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[4-(3-Amino-7-methoxy-1,2-benzoxazol-4-yl)phenyl]-1-(3-bromophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173417618,"",493040,103904302,18451135,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(3-amino-3-ethylpent-1-ynyl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173417879,"",493040,103904352,49830377,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-amino-N-[4-(phenylcarbamoylamino)phenyl]thieno[2,3-d]pyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173418112,"",493040,103904364,49830383,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-Phenyl-1,3-dihydroimidazo[4,5-b]pyridin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173418244,"",493040,103904379,49830386,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(1,2-Benzothiazol-4-yl)phenyl]-3-[4-fluoro-3-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173418348,"",493040,103904367,11292807,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[4-(3-amino-1H-indazol-6-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173418510,"",493040,103904384,49830388,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(1,2-Benzothiazol-4-yl)phenyl]-3-(3,5-dimethylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173418647,"",493040,103904402,49830398,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Aurora kinase inhibitor as703569,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173418671,"",493040,103904371,49830384,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[4-(5-Aminoquinoxalin-6-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173418843,"",493040,103904349,49830375,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(16-Amino-11-thia-13,15-diazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),3,5,12,14,16-heptaen-5-yl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173418905,"",493040,103904347,18451372,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-(4-Aminothieno[3,2-c]pyridin-3-yl)phenyl)-3-(3-fluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173419065,"",493040,103904361,49830381,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(16-Amino-11-thia-13,15-diazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),3,5,12,14,16-heptaen-5-yl)-3-(3-ethylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173419285,"",493040,103904360,5329902,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[2-methyl-4-(1-oxo-2,3-dihydro-1H-isoindol-4-yl)phenyl]-1-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173419523,"",493040,103904358,49830380,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[4-(3-methyl-2H-indazol-4-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173419647,"",493040,103904368,10338500,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-(2-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173419840,"",493040,103904355,16122934,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-amino-N-[4-[(3-methylphenyl)carbamoylamino]phenyl]thieno[2,3-d]pyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173420037,"",493040,103904377,5329895,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(3,4-dimethylphenyl)-3-[4-(1-oxo-2,3-dihydro-1H-isoindol-4-yl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173420211,"",493040,103904356,49830379,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(16-Amino-11-thia-13,15-diazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),3,5,12,14,16-heptaen-5-yl)-3-(2-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173420563,"",493040,103904320,49830364,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[4-amino-3-[4-[(3-methylphenyl)carbamoylamino]phenyl]thieno[3,2-c]pyridin-7-yl]-N-[2-(diethylamino)ethyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173420829,"",493040,103904383,49830387,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-[4-[(3-Methylphenyl)carbamoylamino]phenyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173420963,"",493040,103904419,49830407,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"2,6-difluoro-N-[3-[5-[2-[3-(2-oxopyrrolidin-1-yl)anilino]pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173421453,"",493040,103904363,49830382,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(2,4-Diaminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173421577,"",493040,103904357,10409523,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-(4-Aminoisoxazolo[5,4-d]pyrimidin-3-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173421630,"",493040,103904370,11244819,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(4-(3-amino-1H-indazol-4-yl)phenyl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173421978,"",493040,103904451,44520205,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-amino-N-[4-[(3-fluorophenyl)carbamoylamino]phenyl]pyrrolo[2,1-f][1,2,4]triazine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173422019,"",493040,103904420,46886323,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"N-(3-(5-(2-(3-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173422462,"",493040,103904478,22607266,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-[5-[2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl]-3H-1,3-benzoxazol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173422838,"",493040,103904210,49830287,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-methoxy-N-(3-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173423015,"",493040,103904197,49830279,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-Chloro-N-cyclohexyl-6-(1H-pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173423162,"",493040,103904202,49830281,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-yl]cyclohexane-1,2-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173423310,"",493040,103904191,49830274,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(4-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173423463,"",493040,103904193,49830272,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[[4-chloro-6-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-yl]amino]cyclohexan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173423531,"",493040,103904195,49830277,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(3-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173423658,"",493040,103904189,49830272,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[[4-chloro-6-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-yl]amino]cyclohexan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173423770,"",493040,103904204,49830282,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-chloro-N-cyclohexyl-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173423889,"",493040,103904196,49830278,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2,6-difluoro-N-(3-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173423987,"",493040,103904192,49830275,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-benzyl-6-chloro-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173424862,"",493040,103904203,44415997,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"trans-N1-(4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-yl)cyclohexane-1,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173424991,"",493040,103904215,49830292,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-bromo-3-phenyl-1H-pyrrolo[2,3-b]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173425149,"",493040,103904216,49830293,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"4-[[6-chloro-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]cyclohexan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173425221,"",493040,103904205,44415977,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-cyclohexyl-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173425313,"",493040,103904209,49830286,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[(5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]propane-1,3-diol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173425407,"",493040,103904211,49830288,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-methoxy-N-(3-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173425585,"",493040,103904206,49830283,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(2-hydroxy-1-phenylethyl)-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-3,6-dihydro-2H-pyridine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173425767,"",493040,103904289,24894081,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Urea, N-[4-[7-amino-3-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl]phenyl]-N'-[3-(trifluoromethyl)phenyl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173426094,"",493040,103904297,11442914,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(2-pyridin-3-ylethynyl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173426229,"",493040,103904321,18450667,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Thieno[3,2-c]pyridin-4-amine, 3-(2-methyl-1H-indol-5-yl)-7-[3-(methylsulfonyl)phenyl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173426333,"",493040,103904285,18451199,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(furan-3-yl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-fluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173426520,"",493040,103904309,49830356,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"4-amino-3-[4-[(3-chlorophenyl)carbamoylamino]phenyl]-N-methylthieno[3,2-c]pyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173426555,"",493040,103904295,18451374,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-(4-Aminothieno[3,2-c]pyridin-3-yl)phenyl)-3-m-tolylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173426709,"",493040,103904293,49830353,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[4-[4-amino-3-[4-[(4-methylphenyl)carbamoylamino]phenyl]thieno[3,2-c]pyridin-7-yl]pyrazol-1-yl]-N-methylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173426758,"",493040,103904281,18451223,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(3-pyrrolidin-1-ylprop-1-ynyl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173426991,"",493040,103904308,18451073,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-amino-7-(1H-pyrazol-4-yl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173427140,"",493040,103904303,18451141,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(3-amino-3-methylbut-1-ynyl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173427198,"",493040,103904292,49830352,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(1-methylpyrazol-4-yl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-[4-(difluoromethoxy)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173427304,"",493040,103904283,49830348,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[4-[4-amino-3-[4-[(4-methylphenyl)carbamoylamino]phenyl]thieno[3,2-c]pyridin-7-yl]pyrazol-1-yl]-N,N-dimethylpropanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173427442,"",493040,103904279,11156716,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"n-{4-[4-Amino-7-(4-pyridinyl)thieno[3,2-c]pyridin-3-yl]phenyl}-n'-[2-fluoro-5-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173427488,"",493040,103904280,18451176,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-[3-(dimethylamino)prop-1-ynyl]thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173427697,"",493040,103904319,11306240,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"n-(4-{4-Amino-7-[3-(diethylamino)-1-propynyl]thieno[3,2-c]pyridin-3-yl}phenyl)-n'-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173428004,"",493040,103904278,21907506,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(3,5-Dimethylphenyl)-3-[3-methyl-4-(1-oxo-2,3-dihydroisoindol-4-yl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173428209,"",493040,103904304,18450918,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-[3-(methanesulfonamido)prop-1-ynyl]thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173428380,"",493040,103904214,49830291,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173428609,"",493040,103904272,46207586,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Ilorasertib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173428669,"",493040,103904194,49830276,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2,3-difluoro-N-(3-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173428825,"",493040,103904201,11565683,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-Benzyl-6-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173429060,"",493040,103904277,9868229,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(4-Aminothieno[2,3-D]pyrimidin-5-Yl)phenyl]-3-[2-Fluoro-5-(Trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173429069,"",493040,103904276,6539985,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173429332,"",493040,103904290,49830351,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-Amino-7-(1-methylpyrazol-4-yl)thieno[3,2-c]pyridin-3-yl]phenyl]-3-(4-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173429631,"",493040,103904362,18451366,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(4-Aminothieno[3,2-c]pyridin-3-yl)phenyl]-3-(3-bromophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173429840,"",493040,103904331,49830369,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-amino-N-[4-[(4-methylphenyl)carbamoylamino]phenyl]thieno[2,3-d]pyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173429973,"",493040,103904348,6540027,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Thienopyrimidine deriv. 94,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173430078,"",493040,103904330,49830368,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(16-Amino-11-thia-13,15-diazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),3,5,12,14,16-heptaen-5-yl)-3-(3,5-dimethylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173430335,"",493040,103904332,11189864,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(3,5-Dimethylphenyl)-3-[4-(1-oxo-2,3-dihydroisoindol-4-yl)-3-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173430651,"",493040,103904479,20744829,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(3-chlorophenyl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173430785,"",493040,103904469,49830436,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxyethanamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173430923,"",493040,103904487,49830444,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[4-(3-amino-1H-indazol-5-yl)phenyl]methanesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173431113,"",493040,103904422,49830408,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[2-[3-(4-Methylpiperazin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173431280,"",493040,103904472,49830437,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[4-(3-amino-1H-indazol-5-yl)phenyl]propane-1-sulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173431399,"",493040,103904474,22607531,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-(dimethylamino)-N-[1-(1H-indol-3-yl)-3-(5-isoquinolin-6-ylpyridin-3-yl)oxypropan-2-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173431483,"",493040,103904470,22607336,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-benzyl-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan-1-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173431559,"",493040,103904471,25164469,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(1-Benzyl-1h-1,2,3-triazol-4-yl)-1h-indazol-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173431710,"",493040,103904448,2797247,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-Chloro-2-methylphenyl)-3-[(2-hydroxy-2,2-diphenylacetyl)amino]thiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173431911,"",493040,103904450,14983992,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-Chlorophenyl)-3-[(2-hydroxy-2,2-diphenylacetyl)amino]thiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173432003,"",493040,103904473,49830438,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,[2-amino-5-[5-[2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl]phenyl]-phenylmethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173432125,"",493040,103904468,20744853,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,(2S)-1-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxy-3-phenylpropan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173432399,"",493040,103904477,22607499,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[5-[2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl]-1,3-dihydroindol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173432498,"",493040,103904484,20744821,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,(R)-1-(1H-Indol-3-yl)-3-((5-(3-methyl-1H-indazol-5-yl)pyridin-3-yl)oxy)propan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173432610,"",493040,103904463,49830431,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxy-3-[3-(trifluoromethoxy)phenyl]propan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173432721,"",493040,103904504,49830456,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(5-methylsulfanyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]propan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173432840,"",493040,103904449,2797246,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"1-(4-Fluorophenyl)-3-[(2-hydroxy-2,2-diphenylacetyl)amino]thiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173432998,"",493040,103904511,25164676,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[5-(1-benzyltriazol-4-yl)-1H-indazol-3-yl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173433215,"",493040,103904464,49830432,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-(1-benzyl-5-phenyltriazol-4-yl)-1H-indazol-3-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173433330,"",493040,103904381,11338239,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(3-Amino-1,2-benzothiazol-4-yl)phenyl]-3-(3,5-dimethylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173433443,"",493040,103904476,49830440,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,[2-amino-5-[5-[2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl]phenyl]-(2-fluorophenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173433549,"",493040,103904418,49830406,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"3-[3-[2-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2-fluorophenyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173433674,"",493040,103904489,49830445,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[4-(3-amino-1H-indazol-5-yl)phenyl]ethanesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173433842,"",493040,103904517,25164884,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-[1-(oxan-4-ylmethyl)triazol-4-yl]-1H-indazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173433847,"",493040,103904369,44560751,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(4-(5-Aminoquinoxalin-6-yl)phenyl)-3-m-tolylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173434037,"",493040,103904501,49830454,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,[2-amino-5-[5-[2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl]phenyl]-(3-chlorophenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173434224,"",493040,103904443,49830423,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(3-Amino-7-methoxy-1,2-benzoxazol-4-yl)phenyl]-3-(3,5-difluorophenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173434566,"",493040,103904525,25164675,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-benzyl-5-(1H-indazol-5-yl)isoxazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173434656,"",493040,103904527,16661285,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173434710,"",493040,103904411,49830404,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"N-[3-[5-[2-[3-(2-oxopyrrolidin-1-yl)anilino]pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173434972,"",493040,103904529,49830468,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173435053,"",493040,103904515,49830461,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-benzyl-5-(1H-indazol-5-yl)-N-methyl-N-propan-2-yltriazole-4-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173435237,"",493040,103904524,49830467,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"(3-hydroxypiperidin-1-yl)-[5-(1H-indazol-5-yl)-1,2-oxazol-3-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173435319,"",493040,103904530,25166655,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[1-[(2,4-dimethylphenyl)methyl]triazol-4-yl]-1H-indazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173435595,"",493040,103904547,25164470,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,[3-Amino-5-(1-benzyltriazol-4-yl)indazol-1-yl]-(1-methylpiperidin-4-yl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173435829,"",493040,103904520,25167075,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-(1H-indazol-5-yl)-N-phenylthiazol-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173436342,"",493040,103904502,49830455,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-butoxy-5-phenyl-7H-pyrrolo[2,3-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173436343,"",493040,103904483,49830442,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-(1-benzyl-5-methyltriazol-4-yl)-1H-indazol-3-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173436454,"",493040,103904526,25165085,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(4-benzyl-1H-1,2,3-triazol-1-yl)-1H-indazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173436531,"",493040,103904508,25165861,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(1-Benzyl-1h-1,2,3-triazol-4-yl)-1h-indazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173436608,"",493040,103904480,49830441,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(3,4-dichlorophenyl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173436789,"",493040,103904465,49830433,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-(1-benzyl-5-iodotriazol-4-yl)-1H-indazol-3-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173436945,"",493040,103904550,25165481,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,4-(2-(4-(4-fluorophenyl)-5-(1H-indazol-5-yl)-1H-imidazol-1-yl)ethyl)morpholine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173437321,"",493040,103904512,25164882,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-(1-benzyl-5-cyclopropyltriazol-4-yl)-1H-indazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173437405,"",493040,103904514,49830460,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[5-(1-benzyltriazol-4-yl)-1H-indazol-3-yl]-3-fluorobenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173437641,"",493040,103904546,25166868,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[1-[[2,4-bis(trifluoromethyl)phenyl]methyl]triazol-4-yl]-1H-indazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173438157,"",493040,103904333,11314310,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(4-(3-amino-1H-indazol-4-yl)phenyl)-3-m-tolylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173438350,"",493040,103904560,49830486,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-Phenyl-3-[(6-pyridin-4-yl-1,3-benzothiazol-2-yl)amino]propan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173438477,"",493040,103904574,49830497,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[1-(4-chlorophenyl)-3-hydroxypropan-2-yl]-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173438622,"",493040,103904555,49830481,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(2-amino-1-phenylethyl)-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173438911,"",493040,103904592,15605335,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,3-[[5-Bromo-4-[4-(cyanomethoxy)anilino]pyrimidin-2-yl]amino]benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173438974,"",493040,103904519,25164472,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[5-(1-benzyltriazol-4-yl)-1H-indazol-3-yl]butanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173439157,"",493040,103904558,49830484,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-fluoro-N-[1-(3-methoxyphenyl)ethyl]-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173439218,"",493040,103904545,25167078,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-benzyl-4-(1H-indazol-5-yl)thiazol-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173439607,"",493040,103904556,49830482,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[2-amino-1-(3-methoxyphenyl)ethyl]-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173439813,"",493040,103904559,49830485,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[1-(3-methoxyphenyl)ethyl]-3-methyl-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173439926,"",493040,103904597,11712649,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173440039,"",493040,103904598,16038120,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173440470,"",493040,103904518,49830463,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-benzyl-5-(1H-indazol-5-yl)-N,N-dimethyltriazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173440594,"",493040,103904543,25164677,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-(1H-indazol-5-yl)-3-propylisoxazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173440759,"",493040,103904646,712193,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(3-methoxyphenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173441242,"",493040,103904557,49830483,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[1-(3-methoxyphenyl)ethyl]-4-(3-methylpyridin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173441520,"",493040,103904603,49830512,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,2-[4-[[5-fluoro-2-(4-methyl-3-sulfamoylanilino)pyrimidin-4-yl]amino]phenoxy]-N-methylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173441672,"",493040,103904643,24765714,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[(1-cyclopentyl-2-ethyl-4-methyl-3-oxopyrimido[5,4-e][1,2,4]triazin-7-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173441709,"",493040,103904565,49830489,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[1-(3-methoxyphenyl)ethyl]-4-(pyridin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173442021,"",493040,103904594,23647251,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,2-({2-[(3-Hydroxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173442151,"",493040,103904683,49830556,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-amino-3-(1H-indol-3-yl)-N-[5-(2-pyridin-4-ylethenyl)pyridin-3-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173442191,"",493040,103904516,49830462,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-benzyl-5-(1H-indazol-5-yl)-N-(2-methoxyethyl)-N-methyltriazole-4-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173442300,"",493040,103904604,23647264,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-((2-((1H-Indazol-6-yl)amino)pyrimidin-4-yl)amino)benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173442557,"",493040,103904403,6420138,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-Methyl-5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)thiazol-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173442650,"",493040,103904528,25167280,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(1h-Indazol-5-yl)imidazo[1,2-a]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173442780,"",493040,103904600,11213558,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Tamatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173442935,"",493040,103904659,49830545,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[(3,4-dichlorophenyl)methyl]-3-(1H-indazol-5-yl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173443069,"",493040,103904666,24768216,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[(4-bromophenyl)methyl]-3-1H-indazol-5-ylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173443127,"",493040,103904601,9934347,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,2-({5-Chloro-2-[(2-Methoxy-4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}amino)-N-Methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173443343,"",493040,103904638,11577250,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-[(8-Cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173443417,"",493040,103904649,11210054,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-Ethyl-5-[2-(3-methoxyanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173443557,"",493040,103904657,23570850,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-amino-2-(3,4-dichlorophenyl)-N-(1H-indazol-5-yl)butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173443671,"",493040,103904662,49830547,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(2,4-dichlorophenyl)methylamino]-4-(1H-indazol-5-ylamino)cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173443747,"",493040,103904602,49830511,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,2-[[2-[5-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-4-yl]amino]-N-methylbenzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173443879,"",493040,103904561,49830487,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-(3-aminopropylamino)-N-[1-(3-methoxyphenyl)ethyl]-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173443995,"",493040,103904595,9891182,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[[5-Nitro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173444113,"",493040,103904664,17163635,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-chloro-N-(1H-indazol-5-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173444206,"",493040,103904580,49830502,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-fluoro-N-(1-hydroxy-3-phenylpropan-2-yl)-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173444444,"",493040,103904564,44237411,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-benzyl-6-pyridin-4-yl-1,3-benzothiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173444595,"",493040,103904641,49830534,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-cyclohexyl-4-[(8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl)amino]-3-methoxybenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173445050,"",493040,103904581,49830503,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(1-hydroxy-3-phenylpropan-2-yl)-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173445215,"",493040,103904591,49830508,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"2-[[5-chloro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-N-methylbenzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173445321,"",493040,103904652,5209964,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,N-(4-phenylmethoxyphenyl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173445392,"",493040,103904673,49830552,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"1-Methoxy-9-(pyridin-4-ylamino)-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173445606,"",493040,103904596,49830509,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,2-[4-[[5-Methyl-2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenoxy]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173445689,"",493040,103904634,448014,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173445911,"",493040,103904342,11710853,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(3-Amino-1-methylpyrazolo[3,4-c]pyridin-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173446068,"",493040,103904366,11676233,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[4-(3-amino-1-methyl-1H-pyrazolo[3,4-c]pyridin-4-yl)phenyl]-N'-[3-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173446266,"",493040,103904466,49830434,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-[1-benzyl-5-(4-fluorophenyl)triazol-4-yl]-1H-indazol-3-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173446405,"",493040,103904365,10067064,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-(4-Aminoisoxazolo[5,4-d]pyrimidin-3-yl)phenyl)-3-m-tolylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173446513,"",493040,103904475,49830439,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[2-(5-isoquinolin-6-ylpyridin-3-yl)oxyethyl]methanesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173446647,"",493040,103904482,25165277,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[3-(2-methylpropyl)-1,2-oxazol-5-yl]-1H-indazol-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173446801,"",493040,103904417,46886319,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"N-[3-(5-{2-[(4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}imidazo[2,1-B][1,3]thiazol-6-Yl)phenyl]-2-Phenylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173447191,"",493040,103904658,49830544,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[3-[[[2-(1H-indazol-5-ylamino)-3,4-dioxocyclobuten-1-yl]amino]methyl]phenyl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173447374,"",493040,103904684,135398510,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Dovitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173447682,"",493040,103904655,49830543,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(1H-indazol-5-ylamino)-4-[(4-methoxyphenyl)methylamino]cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173447904,"",493040,103904688,9905711,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-pyridin-4-yl-1H-benzimidazole-4-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173448144,"",493040,103904705,49830566,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-amino-N-[4-[(2-methylphenyl)carbamoylamino]phenyl]thieno[2,3-d]pyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173448319,"",493040,103904677,49830554,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4,5-Dichloro-3-[(4-chlorobenzoyl)amino]-1-benzothiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173448523,"",493040,103904656,44586040,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1H-Indazole-7-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173448601,"",493040,103904721,49830576,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[2-[6-oxo-3-(3,4,5-trimethoxyphenyl)-5,11-dihydrobenzo[b][1,4]benzodiazepin-9-yl]phenyl]methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173448738,"",493040,103904737,49830588,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-(4-hydroxy-3-methoxyphenyl)-N-phenyl-1H-indazole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173448858,"",493040,103904687,23433004,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-[6-[3-(4-methylpiperazin-1-yl)propylamino]pyridin-2-yl]-1H-benzimidazole-4-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173449280,"",493040,103904742,15941246,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(4-amino-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepin-6-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173449639,"",493040,103904702,49830565,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[(3-methoxyphenyl)methyl]-3-phenyl-2H-thieno[2,3-c]pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173449766,"",493040,103904754,49830601,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,5-[5-[2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl]-3-(furan-2-ylmethylidene)-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173449804,"",493040,103904713,10317442,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"9-(4-Hydroxy-3-methoxyphenyl)-3-nitro-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173450073,"",493040,103904751,49830599,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(1H-indol-3-yl)-3-(5-thieno[3,2-c]pyridin-2-ylpyridin-3-yl)oxypropan-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173450196,"",493040,103904744,49830593,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-[4-(methylamino)-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepin-6-yl]phenyl]-3-[3-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173450303,"",493040,103904725,49830579,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"9-[4-(2,3-Dihydroxypropoxy)-3-methoxyphenyl]-3-[2-(4-morpholin-4-ylphenoxy)ethyl]-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173450478,"",493040,103904727,19934548,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"8-methyl-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173450605,"",493040,103904709,201327,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173450804,"",493040,103904723,49830577,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[2-Methoxy-4-[3-[2-(4-morpholin-4-ylphenoxy)ethyl]-6-oxo-5,11-dihydrobenzo[b][1,4]benzodiazepin-9-yl]phenyl]acetonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173451349,"",493040,103904760,16050449,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-{4-[8-Cyclopropylmethyl-2-(4-fluorophenyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-2-ylamino}-2,2-dimethylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173451482,"",493040,103904745,49830594,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(4,5-dichloro-2-cyano-1-benzothiophen-3-yl)-4-methylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173451662,"",493040,103904762,16050453,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[[4-[2-(2,4-Difluorophenyl)-8-methylimidazo[1,2-a]pyrazin-3-yl]pyrimidin-2-yl]amino]-2-methylpropan-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173451799,"",493040,103904711,49830569,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"N-[(3-fluorophenyl)methyl]-9-(4-hydroxy-3-methoxyphenyl)-6-oxo-5,11-dihydrobenzo[b][1,4]benzodiazepine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173452159,"",493040,103904752,22607792,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(1H-indol-3-yl)-3-(5-thieno[2,3-c]pyridin-2-ylpyridin-3-yl)oxypropan-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173452299,"",493040,103904736,49830587,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-[(6-Pyridin-3-ylisoquinolin-3-yl)amino]ethanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173452483,"",493040,103904712,9981692,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(2-acetamidoethyl)-9-(4-hydroxy-3-methoxyphenyl)-6-oxo-5,11-dihydrobenzo[b][1,4]benzodiazepine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173452627,"",493040,103904739,49830590,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Acetamide, N-[2-[6-[[4-(cyclobutylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-1,2,3,4-tetrahydronaphthalen-1,4-imin-9-yl]-2-oxoethyl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173452672,"",493040,103904759,49830606,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[[4-[2-(4-Fluorophenyl)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-2-yl]amino]-2,2-dimethylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173452994,"",493040,103904775,49830616,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[[4-[2-(2,4-Difluorophenyl)-8-methylimidazo[1,2-a]pyrazin-3-yl]pyrimidin-2-yl]amino]-2,2-dimethylpropanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173453297,"",493040,103904778,15981404,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-{4-[2-(4-Fluorophenyl)-8-methylimidazo[1,2-a]pyrazin-3-yl]-pyrimidin-2-ylamino}-2,2-dimethylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173453456,"",493040,103904749,49830597,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(1H-indol-3-yl)-3-[5-(2-pyridin-4-ylethenyl)pyridin-3-yl]oxypropan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173453558,"",493040,103904444,216239,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173454052,"",493040,103904729,49830582,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(2-Fluorophenyl)methylamino]-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173454244,"",493040,103904510,25167074,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(1h-Indazol-5-yl)-n-isopropylimidazo[1,2-a]pyrimidin-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173454905,"",493040,103904787,49830623,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"N-[4-[1-[4-(4-acetylpiperazin-1-yl)cyclohexyl]-4-aminopyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-1-methylindole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173455027,"",493040,103904788,49830623,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"N-[4-[1-[4-(4-acetylpiperazin-1-yl)cyclohexyl]-4-aminopyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-1-methylindole-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173455166,"",493040,103904777,49830618,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[[4-[2-(4-Fluorophenyl)-8-(2-methylpropoxy)imidazo[1,2-a]pyrazin-3-yl]pyrimidin-2-yl]amino]-2,2-dimethylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173455556,"",493040,103904796,49830628,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"3-[4-amino-3-(4-bromophenyl)thieno[3,2-c]pyridin-7-yl]-N-(3-imidazol-1-ylpropyl)prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173455688,"",493040,103904797,135451585,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"8-chloro[1]benzofuro[3,2-d]pyrimidin-4(3H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173455823,"",493040,103904798,136027062,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-(cyclohexylamino)-4-pyridin-4-yl-1H-pyrimidin-6-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173456057,"",493040,103904784,49830620,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[4-[4-amino-1-[4-(2-methoxyethoxy)cyclohexyl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-5,7-dimethyl-1,3-benzoxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173456116,"",493040,103904789,49830624,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"trans-4-(4-Amino-3-iodo-pyrazolo[3,4-d]pyrimidin-1-yl)-cyclohexanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173456524,"",493040,103904509,25167072,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"n-Cyclohexyl-2-(1h-indazol-5-yl)imidazo[1,2-a]pyrimidin-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173456577,"",493040,103904753,49830600,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[2-chloro-5-(2-pyridin-4-ylethenyl)pyridin-3-yl]oxy-3-(1H-indol-3-yl)propan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173456779,"",493040,103904552,49830479,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(2-hydroxy-1-phenylethyl)-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173456911,"",493040,103904566,49830490,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[1-(3-propoxyphenyl)ethyl]-4-pyridin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173457037,"",493040,103904813,24180596,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(7-(4-Morpholinobutoxy)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)picolinonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173457317,"",493040,103904776,49830617,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[[4-[2-(4-Fluorophenyl)-8-methoxyimidazo[1,2-a]pyrazin-3-yl]pyrimidin-2-yl]amino]-2,2-dimethylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173457623,"",493040,103904738,49830589,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[1-(3-methoxyphenyl)ethyl]-4-methyl-5-(3-methyl-2H-indazol-5-yl)thiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173457648,"",493040,103904819,49830641,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"2-Amino-3-(4-phenyl-1,3-thiazol-2-yl)benzimidazole-5-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173457933,"",493040,103904806,22665513,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-[(2-Aminocyclohexyl)amino]-3-(3-methylanilino)pyrazine-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173458245,"",493040,103904786,49830622,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[3-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173458621,"",493040,103904773,25016360,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-{4-[8-Cyclopropylmethyl-2-(2,4-difluorophenyl)-imidazo[1,2-a]pyrazin-3-yl]-pyrimidin-2-ylamino}-2-methylpropan-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173458782,"",493040,103904817,44442347,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(7-(2-Morpholinoethoxy)-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)picolinonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173458869,"",493040,103904859,49830673,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,ABT-869 acid metabolite A-849529,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173458984,"",493040,103904779,16050450,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-{4-[2-(2,4-Difluorophenyl)-8-methylimidazo[1,2-a]pyrazin-3-yl]-pyrimidin-2-ylamino}-2,2-dimethylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173459119,"",493040,103904812,16220223,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(5-(3-(2-methoxyethoxy)prop-1-ynyl)thiophen-3-yl)-6-((4-methylpiperazin-1-yl)methyl)indeno[1,2-c]pyrazol-4(1H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173459191,"",493040,103904746,49830595,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4,5-Dichloro-3-[(4-methylbenzoyl)amino]-1-benzothiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173459334,"",493040,103904783,1400,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"1-(tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173459452,"",493040,103904855,49830670,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-[2-fluoro-5-(hydroxymethyl)phenyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173459542,"",493040,103904857,11407183,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[4-(3-Amino-1,2-benzoxazol-4-yl)phenyl]-1-(3-chloro-4-methoxyphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173459551,"",493040,103904816,49830639,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[3-[[3-(6-cyanopyridin-3-yl)-1,4-dihydroindeno[1,2-c]pyrazol-7-yl]oxy]propyl]-N-methylpiperazine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173459783,"",493040,103904828,156422,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Doramapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173460792,"",493040,103904567,49830491,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-benzyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173461014,"",493040,103904810,49830635,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[7-[3-(Diethylamino)prop-1-ynyl]-1,4-dihydroindeno[1,2-c]pyrazol-3-yl]pyridine-2-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173461166,"",493040,103904610,667926,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-fluoro-N,N'-diphenylpyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173461649,"",493040,103904889,24772168,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(Pyrazin-2-yl)-3-(quinolin-4-yl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173461719,"",493040,103904872,49830684,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(7-Methoxyquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173461895,"",493040,103904891,49830695,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(6-Bromopyridin-2-yl)-3-(7-methoxyquinolin-4-yl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173461980,"",493040,103904887,24859296,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(8-Fluoroquinolin-4-yl)-3-pyrazin-2-ylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173462213,"",493040,103904886,45269554,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,6-{[(5-Cyanopyrazin-2-Yl)carbamoyl]amino}naphthalene-2-Carboxylic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173462399,"",493040,103904896,49830698,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(7-Methoxyquinolin-4-yl)-3-[4-(trifluoromethyl)pyridin-2-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173462692,"",493040,103904882,49830693,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(8-Fluoroquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173462894,"",493040,103904873,49830685,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(6-Methylquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173463070,"",493040,103904888,24859013,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-Pyrazin-2-yl-3-[8-(trifluoromethyl)quinolin-4-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173463181,"",493040,103904904,136027064,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,6-tert-butyl-2-(1H-indazol-3-yl)-1H-benzimidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173463281,"",493040,103904890,24858860,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-Pyrazin-2-yl-3-[7-(trifluoromethyl)quinolin-4-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173463489,"",493040,103904703,135533388,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[(3-Methoxyphenyl)methylidene]-2-phenylimino-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173463702,"",493040,103904593,23647265,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,2-{[2-(1H-indazol-5-ylamino)pyrimidin-4-yl]amino}benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173463834,"",493040,103904897,49830699,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(5-Cyanopyridin-2-yl)-3-[7-(trifluoromethyl)quinolin-4-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173464139,"",493040,103904892,49830696,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(5-Chloro-2-methoxy-4-methylphenyl)-3-(5-cyanopyrazin-2-yl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173464482,"",493040,103904895,24859161,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(6-Morpholin-4-ylpyridin-2-yl)-3-[8-(trifluoromethyl)quinolin-4-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173464809,"",493040,103904901,49830703,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[6-(Trifluoromethyl)pyridin-2-yl]-3-[8-(trifluoromethyl)quinolin-4-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173464967,"",493040,103904906,136027064,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,6-tert-butyl-2-(1H-indazol-3-yl)-1H-benzimidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173465088,"",493040,103904856,49830671,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[4-(4-amino-6-bromothieno[2,3-d]pyrimidin-5-yl)phenyl]-2-(3-chlorophenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173465195,"",493040,103904899,49830701,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(8-Chloroquinolin-4-yl)-3-[6-(trifluoromethyl)pyridin-2-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173465358,"",493040,103904937,49830729,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(3,3-Dimethylbutan-2-ylamino)-4-[[2-(3-methylanilino)pyrimidin-4-yl]amino]cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173465624,"",493040,103904913,45273796,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"7-((2-oxopyrrolidin-1-yl)methyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173466208,"",493040,103904926,2858224,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-(1H-benzimidazol-2-yl)-3-(2-bromo-4-hydroxy-5-methoxyphenyl)prop-2-enenitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173466322,"",493040,103904884,24858859,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-Pyrazin-2-yl-3-(6-trifluoromethyl-quinolin-4-yl)-urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173466797,"",493040,103904950,49830739,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-amino-N-(2,3-dimethylquinoxalin-6-yl)benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173467045,"",493040,103904815,49830638,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(6-Ethynyl-7-methoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)pyridine-2-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173467188,"",493040,103904938,49830730,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[[2-(3,4-Dimethoxyanilino)pyrimidin-4-yl]amino]-4-(3,3-dimethylbutan-2-ylamino)cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173467279,"",493040,103904940,49830731,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(2-fluorophenyl)-N-methyl-2H-thieno[2,3-c]pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173467439,"",493040,103904954,5711,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-(1-aminoethyl)-N-pyridin-4-yl-1-cyclohexanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173467568,"",493040,103904955,25205762,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(4-Methylphenyl)methylamino]-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173468089,"",493040,103904963,623415,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-Bromo-3-phenyl-1H-indazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173468391,"",493040,103904898,49830700,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[6-(Trifluoromethyl)pyridin-2-yl]-3-[7-(trifluoromethyl)quinolin-4-yl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173468552,"",493040,103904785,49830621,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[4-[4-amino-1-[4-(2-methoxyethoxy)cyclohexyl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-5-methyl-1,3-benzoxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173468631,"",493040,103904794,11846126,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-amino-5-cyano-6-ethoxy-N-(pyridin-3-ylmethyl)pyridine-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173468710,"",493040,103904885,23646813,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(5-Chloro-4-formyl-2-methoxyphenyl)-3-(5-cyanopyrazin-2-yl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173468798,"",493040,103904908,49830708,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[1-(3-methoxyphenyl)ethyl]-2-pyridin-4-yl-1,3-thiazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173468945,"",493040,103904912,49830711,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"n-Cyclopropyl-n-[(4-oxo4,5-dihydropyrrolo[1,2-a]quinoxalin-8-yl)methyl]methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173469005,"",493040,103904741,49830591,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-methyl-4-(4-(3-(3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173469126,"",493040,103904743,136027061,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-N,3-N-bis[3,5-bis(N-carbamimidamido-C-methylcarbonimidoyl)phenyl]benzene-1,3-dicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173469217,"",493040,103904750,49830598,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(1H-indol-3-yl)-3-[5-(2-pyridin-4-ylethenyl)pyridin-3-yl]oxypropan-2-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173469628,"",493040,103904939,9881974,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(3,3-Dimethylbutan-2-ylamino)-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173469743,"",493040,103904988,24809834,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-(2-aminopyrimidin-4-yl)-2-(4-chloro-2-fluorophenyl)-1H-pyrrole-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173469899,"",493040,103904991,6539952,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"7-[trans-4-(4-Methylpiperazin-1-Yl)cyclohexyl]-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173470007,"",493040,103904989,176155,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173470117,"",493040,103904962,49830742,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"2-[2-amino-7-[7-(1-benzothiophen-2-yl)-1H-indazol-5-yl]pyrrolo[3,2-d]pyrimidin-5-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173470372,"",493040,103904987,18516237,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(4-Fluorophenyl)thieno[2,3-c]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173470571,"",493040,103905001,49830762,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[[4-(dimethylamino)phenyl]methyl]-3-phenyl-2H-thieno[2,3-c]pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173470718,"",493040,103904969,49830746,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-amino-3-naphthalen-1-yl-N-[5-(2-pyridin-4-ylethenyl)pyridin-3-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173470734,"",493040,103904965,11992146,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[2-(2-fluorophenyl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173470938,"",493040,103904985,24809803,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(2-aminopyrimidin-4-yl)-2-(2,4-dichlorophenyl)-1H-pyrrole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173471141,"",493040,103904961,46224684,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(2-aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173471350,"",493040,103904968,49830745,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-Phenylmethoxy-3-[5-(2-pyridin-4-ylethenyl)pyridin-3-yl]oxypropan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173471469,"",493040,103904995,10073297,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(3-Phenylmethoxyphenyl)-7-(4-pyrrolidin-1-ylcyclohexyl)pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173471596,"",493040,103904978,136027068,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-Phenyl-8,9,10,11-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173471914,"",493040,103904993,49830757,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"trans-5-(3-Benzyloxy-phenyl)-6-methyl-7-(3-pyrrolidin-1-ylmethyl-cyclobutyl)-7h-pyrrolo[2,3-d]pyrimidin-4-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173471927,"",493040,103904980,136027069,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-Pyridin-4-yl-10-thia-3,5,6,8-tetrazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,11-tetraen-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173472063,"",493040,103904946,49830736,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"3-[4-[3-[4-Propan-2-yloxy-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]anilino]cyclopentane-1-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173472127,"",493040,103904999,49830760,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[(4-chlorophenyl)methyl]-3-phenyl-2H-thieno[2,3-c]pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173472568,"",493040,103904761,16050452,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[[[4-[2-(2,4-Difluorophenyl)-8-methylimidazo[1,2-a]pyrazin-3-yl]pyrimidin-2-yl]amino]methyl]cyclopropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173472822,"",493040,103904809,4982682,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-Cyclopentylidene-1,2-dihydrocyclopenta[b]quinoline-9-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173472954,"",493040,103904811,49830636,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[5-[3-(Cyclopropylmethoxy)prop-1-ynyl]thiophen-3-yl]-6-[(4-methylpiperazin-1-yl)methyl]-1,4-dihydroindeno[1,2-c]pyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173473197,"",493040,103904900,49830702,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-Chloro-4-[(5-cyanopyrazin-2-yl)carbamoylamino]-5-methoxybenzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173473450,"",493040,103905036,49830787,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[5-(2,3-difluorophenyl)-1H-indazol-3-yl]butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173473828,"",493040,103904996,9825149,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(3-Phenylmethoxyphenyl)-7-[3-(pyrrolidin-1-ylmethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173473920,"",493040,103904997,49830758,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(cyclohexylmethyl)-3-phenyl-2H-thieno[2,3-c]pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173474167,"",493040,103905043,49830790,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(4-Bromo-2,3-difluorophenyl)thieno[2,3-c]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173474255,"",493040,103905041,18516349,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-Phenylthieno[2,3-c]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173474343,"",493040,103905055,135543617,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(9-oxo-3,10,11-triazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaen-6-yl)-2-phenylcyclopropane-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173474494,"",493040,103905056,10296883,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Sotrastaurin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173474559,"",493040,103905024,9952773,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Tak-715,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173474773,"",493040,103905060,136027072,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[(6-hydroxy-5-methyl-3,4-dihydro-2H-naphthalen-1-ylidene)amino]-2-naphthalen-1-ylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173474937,"",493040,103904979,135515045,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(Pyridin-4-yl)-8,9,10,11-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173475091,"",493040,103904967,49830744,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-Phenyl-3-[5-(2-pyridin-4-ylethenyl)pyridin-3-yl]oxypropan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173475197,"",493040,103905063,49830799,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"4-Fluoro-6-[6-(4-fluorophenyl)imidazo[2,1-b][1,3]thiazol-5-yl]-1-(2-methylpropyl)benzimidazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173475721,"",493040,103904998,49830759,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(1-methylpiperidin-4-yl)-3-phenyl-2H-thieno[2,3-c]pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173475744,"",493040,103905050,49830794,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-Phenylthieno[2,3-c]pyridine-2-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173475834,"",493040,103905077,44588881,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-cyano-N-(1-methyl-5-(N-methylcyclohexanecarboxamido)-1H-benzo[d]imidazol-2-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173476038,"",493040,103905062,24952854,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"6-[6-(4-Fluorophenyl)imidazo[2,1-b][1,3]thiazol-5-yl]-1-(2-methylpropyl)benzimidazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173476542,"",493040,103905047,49830791,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(4-Methylsulfonylphenyl)thieno[2,3-c]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173476666,"",493040,103905046,9906347,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(4-Bromo-phenoxy)-thieno[2,3-c]pyridine-2-carboxylic acid amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173476711,"",493040,103905075,44593713,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(1-(3-amino-3-oxopropyl)-5-(N-methylcyclohexanecarboxamido)-1H-benzo[d]imidazol-2-yl)-4-cyanobenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173476834,"",493040,103905044,18516214,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(2,4-Difluorophenyl)thieno[2,3-c]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173477043,"",493040,103905002,16007116,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-Amino-5-chloro-6-ethoxy-N-(4-(methylsulfonyl)benzyl)picolinamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173477226,"",493040,103904952,25206387,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(4-Chlorophenyl)methylamino]-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173477479,"",493040,103905069,49830803,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[6-[6-(2,4-Difluorophenyl)imidazo[2,1-b][1,3]oxazol-5-yl]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]-2-methylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173477543,"",493040,103905081,11987888,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(3-Hydroxypropyl)-2-[(3-Nitrobenzoyl)amino]-1h-Benzimidazol-5-Yl Pivalate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173477975,"",493040,103905007,11950170,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Belumosudil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173477995,"",493040,103905053,136027071,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(3-chlorophenyl)-8-iodo-6H-imidazo[1,2-c]pyrimidin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173478168,"",493040,103905074,49830805,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-Thiophen-2-ylpyrazolo[1,5-a]pyrimidine-5-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173478226,"",493040,103905091,49830813,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[4-amino-3-(2-methyl-1,3-benzothiazol-5-yl)thieno[3,2-c]pyridin-7-yl]-N-methylprop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173478286,"",493040,103905032,49830785,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-(4-bromophenyl)-1H-indazol-3-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173478397,"",493040,103905092,49830814,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(4-aminophenyl)-7-[2-(1H-benzimidazol-2-yl)ethenyl]thieno[3,2-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173478606,"",493040,103905076,49830806,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[1-butyl-5-[cyclohexanecarbonyl(methyl)amino]benzimidazol-2-yl]-3-cyanobenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173478753,"",493040,103905048,49830792,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[3,5-Bis(trifluoromethyl)phenyl]thieno[2,3-c]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173478972,"",493040,103905100,3453573,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(2-fluorophenyl)-3,7,7-trimethyl-4,6,8,9-tetrahydro-2H-pyrazolo[3,4-b]quinolin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173479208,"",493040,103905120,49830825,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-(3-fluoropyridin-4-yl)-2-methoxy-N-[1-(3-methoxyphenyl)ethyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173479417,"",493040,103905123,324081,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,4-Anilinoquinazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173479718,"",493040,103905119,49830824,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[1-(3-methoxyphenyl)ethyl]-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-3,6-dihydro-2H-pyridine-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173479848,"",493040,103905064,24952851,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"1-(Cyclopropylmethyl)-6-[6-(4-fluorophenyl)imidazo[2,1-b][1,3]thiazol-5-yl]benzimidazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173479961,"",493040,103905121,49830826,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[1-(3-methoxyphenyl)ethyl]-4-pyrimidin-4-ylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173480169,"",493040,103905094,49830816,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"3-[4-amino-3-(7-fluoro-2-methyl-1H-indol-5-yl)thieno[3,2-c]pyridin-7-yl]-N-methylprop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173480353,"",493040,103905103,3155438,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-Amino-3-tert-butyl-4-(2-fluorophenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173480472,"",493040,103905112,123015,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173480608,"",493040,103905144,25205759,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(Pyridin-4-ylamino)-4-[[3-(trifluoromethyl)phenyl]methylamino]cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173480727,"",493040,103905117,24906268,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-(1H-imidazol-5-ylmethylidene)-5-methoxy-1H-indol-2-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173480977,"",493040,103905033,11164136,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(3-methylphenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173481066,"",493040,103905096,49830818,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-(2-aminoethylsulfamoyl)-N-[4-(4-oxo-3H-phthalazin-1-yl)phenyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173481192,"",493040,103905097,49830819,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-(3-aminopropylsulfamoyl)-N-[4-(4-oxo-3H-phthalazin-1-yl)phenyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173481334,"",493040,103905082,3541,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173481429,"",493040,103905114,49830823,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(Indol-3-ylidenemethyl)-5-propan-2-yloxy-1,2-dihydropyrazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173481539,"",493040,103904984,24809803,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(2-aminopyrimidin-4-yl)-2-(2,4-dichlorophenyl)-1H-pyrrole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173481688,"",493040,103904953,3536,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methylamino]-N-(2-pyridinyl)benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173481844,"",493040,103905113,206042,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173482210,"",493040,103905136,49830832,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[5-[4-(propylsulfonylamino)phenyl]-1H-indazol-3-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173482294,"",493040,103905095,49830817,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[4-amino-3-(1,3-benzodioxol-5-yl)thieno[3,2-c]pyridin-7-yl]-N-methylprop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173482469,"",493040,103905140,3133620,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,N-(furan-2-ylmethylideneamino)-6-(3-methyl-5-phenylpyrazol-1-yl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173482602,"",493040,103905155,49830838,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-(5-Chloro-2-cyclopentyloxy-4-methylphenyl)-3-(5-cyanopyrazin-2-yl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173482675,"",493040,103905151,44444843,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Pmid17935989C25,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173482844,"",493040,103905149,11430448,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-Chloro-8-(2-hydroxyethoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetraazatricyclo[16.3.1.0^{5,10}]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173482924,"",493040,103905154,49830837,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-[[4-Chloro-2-[(5-cyanopyrazin-2-yl)carbamoylamino]-5-methylphenoxy]methyl]cyclopentane-1-carboxylic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173483070,"",493040,103905163,135564570,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-hydroxy-3-(5-(morpholinomethyl)pyridin-2-yl)-1H-indole-5-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173483332,"",493040,103905180,49830854,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-[3-(4-Fluorophenyl)-1-methylpyrazol-4-yl]pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173483462,"",493040,103905182,24755603,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(4-(7-Ethyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenyl)propan-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173483539,"",493040,103905168,15745956,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-chloro-N-phenylthieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173483769,"",493040,103905152,11397177,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-{7-chloro-19-cyano-3-oxo-11,17-dioxa-2,4,20,22-tetraazatricyclo[16.3.1.0^{5,10}]docosa-1(21),5(10),6,8,18(22),19-hexaen-8-yl}methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173483837,"",493040,103905137,49830833,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-[5-[4-(propylsulfonylamino)phenyl]-1H-indazol-3-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173483959,"",493040,103905106,10286133,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-Benzyl-N'-(5-nitro-1,3-thiazol-2-yl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173484143,"",493040,103905172,49830850,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"3-[3-(2,3-dichlorophenoxy)propyl]-7-(3-methylbut-2-en-2-yl)-1H-indole-2-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173484293,"",493040,103905189,11624601,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,JNK Inhibitor VIII,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173484632,"",493040,103905156,49830839,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-Chloro-13,14-dihydroxy-3-oxo-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5(10),6,8,17(21),18-hexaene-18-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173484775,"",493040,103905192,49830859,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(4-amino-5-cyano-6-thiophen-3-ylpyridin-2-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173484997,"",493040,103905034,11268820,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(4-fluoro-3-methylphenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173485203,"",493040,103905079,44412343,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(1-(3-hydroxypropyl)-1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173485287,"",493040,103905061,24952850,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"6-[6-(4-Fluorophenyl)imidazo[2,1-b][1,3]thiazol-5-yl]-1-propan-2-ylsulfonylbenzimidazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173485427,"",493040,103905141,2044508,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-amino-1,2,5-oxadiazol-3-yl)-5-thiophen-2-yl-N-(thiophen-2-ylmethylideneamino)triazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173485570,"",493040,103905084,15745966,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(5-Chlorothieno[2,3-d]pyrimidin-4-yl)amino]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173485767,"",493040,103905102,2813676,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-Amino-4-(2-chlorophenyl)-3-methyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173485931,"",493040,103905145,10391182,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(2-aminoethyl)-5-(dimethylamino)-N-(5-isoquinolin-6-ylpyridin-3-yl)naphthalene-1-sulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173486115,"",493040,103904960,46224697,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(3-aminopropyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173486291,"",493040,103904994,9956874,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-Methyl-5-(3-phenylmethoxyphenyl)-7-(4-pyrrolidin-1-ylcyclohexyl)pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173486381,"",493040,103905148,11293798,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-Chloro-8-(3-hydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetraazatricyclo[16.3.1.0^{5,10}]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173486755,"",493040,103905206,2868675,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-amino-5-[1-cyano-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-1H-pyrazole-4-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173486915,"",493040,103905208,135444250,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[(3-Hydroxy-4-methoxyphenyl)methylidene]-2-phenylimino-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173486984,"",493040,103905204,4306353,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(Imidazo[1,2-a]pyridin-2-ylmethylsulfanyl)-5-methyl-[1,2,4]triazolo[4,3-a]quinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173487188,"",493040,103905197,11590363,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(4-amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173487306,"",493040,103905153,11784520,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-Chloro-8-(2,3-dihydroxypropoxy)-3-oxo-11,17-dioxa-2,4,20,22-tetraazatricyclo[16.3.1.0^{5,10}]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173487414,"",493040,103905167,11715767,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-Pyridin-4-yl-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173487552,"",493040,103905219,15941392,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[4-(4-amino-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepin-6-yl)phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173487720,"",493040,103905042,49830789,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(3-Fluorophenyl)thieno[2,3-c]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173487798,"",493040,103905215,21060786,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N2-(3,4,5-Trimethoxyphenyl)-N4-(3-cyclohexylisoxazol-5-yl)-2,4-pyrimidinediamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173488037,"",493040,103905051,49830795,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(4-Ethylsulfonylphenyl)thieno[2,3-c]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173488224,"",493040,103905187,44611456,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-amino-5-cyano-6-ethoxy-N-[(4-sulfamoylphenyl)methyl]pyridine-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173488341,"",493040,103905205,2831603,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-(4-Hydroxy-3-methoxybenzylidene)rhodanine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173488531,"",493040,103905231,10200390,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,BAY-61-3606 free base,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173488785,"",493040,103905248,11221493,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[4-(1H-benzimidazol-2-ylamino)phenyl]-2,3-dihydroisoindol-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173489031,"",493040,103905237,49830874,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-(1-Methylindol-3-yl)-2-[5-(2-pyridin-4-ylethenyl)pyridin-3-yl]ethanamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173489427,"",493040,103905078,44588915,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(1-butyl-5-(N-methylcyclohexanecarboxamido)-1H-benzo[d]imidazol-2-yl)-4-cyanobenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173489602,"",493040,103905193,11539329,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Benzeneacetamide, N-(4-amino-5-cyano-6-ethoxy-2-pyridinyl)-2,5-dimethoxy-4-(methylsulfonyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173489745,"",493040,103905250,49830876,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"3-[(7-Phenylpyrrolo[2,3-d]pyrimidin-2-yl)amino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173489780,"",493040,103905191,11846124,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-Pyridinecarboxamide, 4-amino-5-cyano-6-ethoxy-N-[[4-(methylsulfonyl)phenyl]methyl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173490206,"",493040,103905247,11597571,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173490301,"",493040,103905233,10110877,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[[7-(3,4-Dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-yl]amino]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173490723,"",493040,103905253,5164,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-(4-Fluorophenyl)-1-(4-piperidinyl)-5-(2-amino-4-pyrimidinyl)-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173491020,"",493040,103905265,49830883,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"3-[(2,4-Dimethoxyphenyl)methylamino]-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173491158,"",493040,103905266,49830884,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Tert-butyl 5-[[2-[(2,4-dichlorophenyl)methylamino]-3,4-dioxocyclobuten-1-yl]amino]indazole-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173491232,"",493040,103905150,11362471,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-Chloro-8-(3-hydroxypropyl)-3-oxo-11,17-dioxa-2,4,20,22-tetraazatricyclo[16.3.1.0^{5,10}]docosa-1(21),5(10),6,8,18(22),19-hexaene-19-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173491560,"",493040,103905186,49830857,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-amino-5-cyano-6-ethoxy-N-(pyridin-4-ylmethyl)pyridine-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173491661,"",493040,103905263,49830881,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(3,4-Dichlorophenyl)methylamino]-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173491700,"",493040,103905255,5166,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Cyclohexanol, 4-(4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl)-, trans-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173491849,"",493040,103905256,9863367,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)-2-methoxypyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173492236,"",493040,103905252,49830878,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-[4-(4-Fluorophenyl)-5-pyridin-4-ylimidazol-1-yl]propan-1-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173492763,"",493040,103905067,49830801,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"1-(6-(6-(2,4-Difluorophenyl)imidazo[2,1-b]oxazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)-2-methylpropan-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173492987,"",493040,103905277,5466794,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(2-Chlorophenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methylpiperidin-4-yl)chromen-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173493198,"",493040,103905287,49830890,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-chloro-7-methylsulfanyl-3,4-dihydro-2H-benzo[b][1,7]naphthyridin-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173493242,"",493040,103905284,24203040,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"8-Thia-3,5,10,12-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),3,5,9,11-hexaene-6,13-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173493554,"",493040,103905296,44186884,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-[[1-(1H-indazol-5-yl)triazol-4-yl]methyl]benzotriazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173493632,"",493040,103905202,49830863,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-(2-Fluoro-5-methylphenyl)-[1,2,4]triazolo[4,3-a]pyridin-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173493724,"",493040,103905209,135435475,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[(4-Hydroxy-3-methoxyphenyl)methylidene]-2-phenylimino-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173493928,"",493040,103905238,16219401,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(1-methyl-3-indolyl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173494240,"",493040,103905329,49830907,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-Phenylimidazo[1,5-c]pyrimidin-5-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173494376,"",493040,103905343,123631,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173494505,"",493040,103905300,135465267,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-Formyl-3-methyl-1-oxo-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173494563,"",493040,103905318,3449643,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"ethyl 5-amino-6-cyano-7-(furan-2-yl)-2-(furan-2-ylmethylidene)-3-oxo-7H-[1,3]thiazolo[3,2-a]pyridine-8-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173494696,"",493040,103905386,49830930,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[5-(2,3-difluorophenyl)-1H-pyrazolo[3,4-c]pyridazin-3-yl]butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173494927,"",493040,103905388,49830932,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-amino-5-chloro-6-ethoxy-N-[(2-sulfamoylphenyl)methyl]pyridine-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173495191,"",493040,103905259,49830880,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[2-(2-Phenylethenyl)pyridin-4-yl]-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173495344,"",493040,103905267,49830885,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Tert-butyl 5-[[3,4-dioxo-2-[(4-sulfamoylphenyl)methylamino]cyclobuten-1-yl]amino]indazole-1-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173495730,"",493040,103905339,176870,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173495892,"",493040,103905288,49830891,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-[3-(aminomethyl)pyrrolidin-1-yl]-6-chloro-5-methyl-4-oxo-1H-1,8-naphthyridine-3-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173496434,"",493040,103905407,49830944,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Ethyl 1-oxo-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173496746,"",493040,103905309,135566504,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6,9-dichloro[1]benzothieno[3,2-d]pyrimidin-4(3H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173496856,"",493040,103905283,404051,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-Phenylimidazo[1,2-c]pyrimidin-7-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173496914,"",493040,103905260,10389239,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(2-Quinolin-3-Ylpyridin-4-Yl)-1,5,6,7-Tetrahydro-4h-Pyrrolo[3,2-C]pyridin-4-One",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173497202,"",493040,103905382,49830927,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(1H-pyrazolo[3,4-b]quinolin-3-yl)butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173497723,"",493040,103905315,49830900,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-Amino-3-[4-[(5,7-dimethyl-1,3-benzoxazol-2-yl)amino]-3-fluorophenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173497808,"",493040,103905345,16007391,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Azd-1152hqpa,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173497969,"",493040,103905340,9933475,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Cediranib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173498126,"",493040,103905352,613127,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"6-Chloro-3-(2,4-dichlorophenyl)-3,4-dihydro-1,9(2H,10H)-acridinedione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173498219,"",493040,103905370,18516203,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-Methyl-5-[4-[4-(trifluoromethyl)phenoxy]thieno[2,3-c]pyridin-2-yl]-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173498391,"",493040,103905383,49830928,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(1-propanoylpyrazolo[3,4-b]quinolin-3-yl)butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173498599,"",493040,103905308,49830895,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-Amino-7-bromo-4-chloro-1-benzothiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173498984,"",493040,103905342,3038522,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Tandutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173499070,"",493040,103905344,123631,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173499263,"",493040,103905372,9946124,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[4-(4-Chlorophenoxy)thieno[2,3-c]pyridin-2-yl]-1,3,4-oxadiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173499338,"",493040,103905360,2727417,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-cyclopropyl-3-(4-(trifluoromethyl)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173499518,"",493040,103905391,23647201,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-chloro-9-hydroxy-1-methyl-3-(trifluoromethyl)-1H,4H,9H-pyrazolo[3,4-b]quinolin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173499609,"",493040,103905371,136027078,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(4-(4-iodophenoxy)thieno[2,3-c]pyridin-2-yl)-1,2,4-oxadiazol-5(2H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173500324,"",493040,103905185,11846125,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-amino-5-cyano-6-ethoxy-N-[(2-sulfamoylphenyl)methyl]pyridine-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173500660,"",493040,103905316,9549184,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"1H-Indole-2-carboxamide, N-(4-(1-(trans-4-(4-acetyl-1-piperazinyl)cyclohexyl)-4-amino-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-2-methoxyphenyl)-1-methyl-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173500781,"",493040,103905310,49830896,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-Bromo-9-chloro-2-methyl-[1]benzothiolo[3,2-d][1,3]oxazin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173500859,"",493040,103905413,49830947,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-Chloro-5,10-dihydro-3,4,5,10-tetraaza-dibenzo[a,d]cyclohepten-11-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173500948,"",493040,103905420,22282869,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Pfe-pkis 34,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173501100,"",493040,103905358,49830917,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Ethyl 1-(4-hydroxy-2-methylphenyl)-4-oxo-7-pyridin-4-ylquinoline-3-carboxylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173501203,"",493040,103905390,3547,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Fasudil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173501295,"",493040,103905424,49830951,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[5-(3,4-dichlorophenyl)-1H-pyrazol-4-yl]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173501490,"",493040,103905427,49830953,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[2-(4-Morpholin-4-ylphenoxy)ethyl]-9-[1-[(3,4,5-trifluorophenyl)methyl]pyrrolo[2,3-c]pyridin-3-yl]-5,11-dihydrobenzo[b][1,4]benzodiazepin-6-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173501561,"",493040,103905378,49830925,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-Amino-4-(4-amino-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)butane-2,3-diol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173501813,"",493040,103905428,25263111,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-3-{[2-(trifluoromethyl)phenyl]methoxy}thiophene-2-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173501994,"",493040,103905437,447873,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"Cyclohexyl-{4-[5-(3,4-dichlorophenyl)-2-piperidin-4-YL-3-propyl-3H-imidazol-4-YL]-pyrimidin-2-YL}amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173502059,"",493040,103905429,9826308,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"5-(5,6-Dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173502170,"",493040,103905398,49830938,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-methyl-4-phenyl-2H-pyrazolo[3,4-b]pyridine-5-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173502382,"",493040,103905449,49830963,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,2-[(6-Thiophen-3-ylisoquinolin-3-yl)amino]ethanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173502402,"",493040,103905385,6539560,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[5-(2,3-difluorophenyl)-1H-pyrazolo[3,4-c]pyridazin-3-yl]-4-(dimethylamino)butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173502874,"",493040,103905409,2744272,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[2-[(2-Chlorophenoxy)methyl]-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173503039,"",493040,103905455,16730109,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-(4-Morpholinylamino)benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173503251,"",493040,103905453,49830966,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-[5-(3-methyl-2H-pyrazolo[3,4-c]pyridin-5-yl)pyridin-3-yl]oxy-3-[3-(trifluoromethyl)phenyl]propan-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173503370,"",493040,103905356,19959069,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-Hydroxy-2-methyl-phenyl)-4-oxo-7-pyridin-4-yl-1,4-dihydro-quinoline-3-carboxylic acid amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173503464,"",493040,103905414,11993789,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-Iodo-6,11-dihydropyridazino[3,4-b][1,5]benzodiazepin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173503769,"",493040,103905430,10409707,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,5-(1H-Benzimidazol-1-yl)-3-{[2-(trifluoromethyl)benzyl]oxy}thiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173504026,"",493040,103905419,9818231,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,racemic-Tasocitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173504182,"",493040,103905447,3392643,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2,4-Dihydroindeno[1,2-c]pyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173504232,"",493040,103905515,49830994,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-tert-butyl-6H-indolo[2,3-b]quinoxaline-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173504610,"",493040,103905196,11640926,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(4-amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173504781,"",493040,103905425,695484,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7,9-Dimethylpyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173505119,"",493040,103905492,6263849,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4,5-diphenyl-2H-pyrazolo[3,4-c]pyridazin-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173505132,"",493040,103905441,6538897,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,1-Azakenpaullone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173505426,"",493040,103905384,49830929,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[5-(2,3-difluorophenyl)-1H-pyrazolo[3,4-c]pyridazin-3-yl]-4-(4-ethylpiperazin-1-yl)butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173505528,"",493040,103905472,16727123,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N2-(2-chlorobenzyl)-N4-((4-(aminomethyl)cyclohexyl)methyl)-5-nitropyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173505695,"",493040,103905464,11442386,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"cis-3-(3-Pyrrolidin-1-ylmethylcyclobutyl)-1-(3-benzyloxyphenyl)-imidazo[1,5-a]pyrazin-8-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173505740,"",493040,103905471,44440493,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N2-(2-(methylthio)benzyl)-N4-((4-(aminomethyl)cyclohexyl)methyl)-5-nitropyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173506177,"",493040,103905485,22402079,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(pyrazolo[1,5-a]pyridin-2-yl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173506207,"",493040,103905509,4121107,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(2,1,3-Benzothiadiazol-4-yl)-3-[(2,4-dihydroxyphenyl)methylideneamino]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173506389,"",493040,103905487,3820,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Kenpaullone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173506622,"",493040,103905482,136027083,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-Chloro-4-phenyl-3-(5-phenyl-4,5-dihydro-1H-pyrazol-3-yl)quinolin-2(1H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173506717,"",493040,103905481,1268887,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"(3Z)-5-bromo-3-(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)-1,3-dihydro-2H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173506965,"",493040,103905539,3086685,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-methyl-2-[[3-[2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173507371,"",493040,103905531,49831000,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Antibiotic AM-2282;STS;AM-2282,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173507482,"",493040,103905463,11640390,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Linsitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173507604,"",493040,103905210,233113,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-[(4-Hydroxy-3-methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173507653,"",493040,103905443,49830959,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,6-(3-Aminophenyl)quinoline-8-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173507795,"",493040,103905496,49830987,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[[5-[(4-amino-1,3,5-triazin-2-yl)amino]-3-(4-chlorophenyl)-2-hydroxyphenyl]methyl]-2,2,2-trifluoroacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173507920,"",493040,103905488,135398504,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-{[2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[4-methyl-6-(morpholin-4-yl)-3H-1,3-benzodiazol-2-yl]-1H-pyridin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173508094,"",493040,103905212,49830865,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(1H-indazol-6-yl)-1H-pyrrolo[2,3-b]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173508213,"",493040,103905548,151194,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Vatalanib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173508447,"",493040,103905550,15314616,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7,8-Dimethoxypyrrolo[3,4-c]isoquinoline-1,3-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173508649,"",493040,103905543,3062316,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173508769,"",493040,103905525,49830998,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[(3,4-dimethoxyphenyl)methylideneamino]-5H-pyrimido[5,4-b]indol-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173508918,"",493040,103905558,49831008,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(5-Methyl-1H-pyrazol-3-YL)-6-(4-methylpiperazin-1-YL)-2-(2-phenylethenyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173509025,"",493040,103905547,25190453,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-Chloro-9-Ethyl-6-fluoroisoxazolo[3,4-b]quinoline-3,4(1H,9H)-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173509096,"",493040,103905510,9814156,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(4-chlorophenyl)-N-(1,4,5,6-tetrahydrocyclopenta[c]pyrazol-3-yl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173509533,"",493040,103905551,23829003,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-Ethyl-7,8-dimethoxy-pyrrolo[3,4-c]isoquinoline-1,3-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173509661,"",493040,103905532,3501,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Go-6976,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173509822,"",493040,103905536,49831002,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(5-methylpyridin-2-yl)-6-nitro-1H-benzimidazol-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173509940,"",493040,103905546,25032704,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-chloro-9-ethyl-6-hydroxy-1H,3H,4H,9H-quinolino[2,3-c][1,2]oxazole-3,4-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173510353,"",493040,103905579,49831015,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(3-Amino-1,2-benzoxazol-4-yl)phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173510410,"",493040,103905567,208908,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173510550,"",493040,103905562,49831009,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,2-[(2-Amino-3-phenylpropyl)amino]-3-methyl-5-naphthalen-2-yl-6-pyridin-4-ylpyrimidin-4-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173510758,"",493040,103905540,49831004,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-[3-(4-Chlorophenyl)-1-(2-methoxyethyl)pyrazol-4-yl]pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173511535,"",493040,103905577,136027088,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,4-[3-(3-chloroanilino)-5-(4-hydroxyphenyl)-1H-pyrazol-4-yl]phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173511572,"",493040,103905578,135566832,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4,4'-{3-[(4-Hydroxyphenyl)amino]-1h-Pyrazole-4,5-Diyl}diphenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173512046,"",493040,103905581,49831016,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-Bromo-1,4-dihydroindeno[1,2-c]pyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173512244,"",493040,103905585,1568886,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"11,12-dihydro-10H-cyclopenta[4,5]thieno[3,2-e]bis[1,2,4]triazolo[4,3-a:4',3'-c]pyrimidine-3,7-dithiol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173512441,"",493040,103905583,49831017,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"7-(Benzylamino)-9-cyclopropyl-6,8-difluoro-[1,2]thiazolo[5,4-b]quinoline-3,4-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173512513,"",493040,103905605,49831025,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-Acetamido-4,5-dichloro-1-benzothiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173512814,"",493040,103905576,49831012,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-methylsulfanyl-1H-1,8-phenanthrolin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173512863,"",493040,103905570,25002232,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-[[4-fluoro-3-(4-pyrimidin-2-ylpiperazine-1-carbonyl)phenyl]methyl]-5,6,7,8-tetrahydro-2H-phthalazin-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173513024,"",493040,103905590,23882428,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"(4-Chloropyrido[4,3-b][1,4]benzothiazin-10-yl)-(4-methoxyphenyl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173513120,"",493040,103905580,13452859,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1H,4H,5H-thieno[2,3-g]indazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173513199,"",493040,103905596,5291,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Imatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173513399,"",493040,103905593,10364560,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,p38 MAPK-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173513503,"",493040,103905594,135497772,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"9-chloro-4-hydroxy-5-imino-2-oxo-3H-chromeno[3,4-c]pyridine-1-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173513724,"",493040,103905586,24995524,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(3-Chlorophenyl)-3-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173513914,"",493040,103905597,23642173,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,N-(5-Methyl-isoxazol-3-yl)-3-{3-[4-methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-propionamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173514253,"",493040,103905568,208908,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173514392,"",493040,103905648,5494449,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Tozasertib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173514453,"",493040,103905566,22557045,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,[3-[[4-[4-(3-Methoxy-4-phenoxyanilino)quinazolin-6-yl]phenyl]methyl]-3-azabicyclo[3.1.0]hexan-6-yl]methanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173514661,"",493040,103905622,9811611,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173514944,"",493040,103905442,49830958,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-Phenyl-1,2-dihydroindazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173515003,"",493040,103905650,22413670,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[2-(3,3-dimethylbutan-2-ylamino)-3,4-dioxocyclobuten-1-yl]-N-pyridin-4-ylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173515126,"",493040,103905665,136027090,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-(4-amino-1,2,5-oxadiazol-3-yl)-N-[1-(2,4-dihydroxyphenyl)ethylideneamino]-5-(methoxymethyl)triazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173515233,"",493040,103905684,11713159,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,PF-00562271 free base,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173515254,"",493040,103905598,24809769,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(2-aminopyrimidin-4-yl)-2-(2,3-dimethylphenyl)-1H-pyrrole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173515395,"",493040,103905614,9820195,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-(1-Aminoethyl)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)cyclohexane-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173515746,"",493040,103905608,21874004,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(5-(2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173515879,"",493040,103905649,11524200,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,"6-Chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173515955,"",493040,103905607,135398512,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"5-(2-Chlorophenyl)-7-fluoro-1,2-dihydro-8-methoxy-3-methylpyrazolo(3,4-b)(1,4)benzodiazepine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173516275,"",493040,103905674,16095342,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173516457,"",493040,103905636,15986273,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-Chloro-11-oxo-10,11-dihydro-5H-3,4,5,10-tetraaza-dibenzo[a,d]cycloheptene-6-carboxylic acid amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173516620,"",493040,103905670,3086686,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173516692,"",493040,103905628,3662552,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(2-ethoxyphenyl)methylideneamino]-5-pyrrolidin-1-yltriazole-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173516863,"",493040,103905619,49831031,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-(trifluoromethyl)-3,4-dihydro-2H-xanthene-1,9-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173517197,"",493040,103905640,9956119,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173517308,"",493040,103905632,24771867,2064,21336281,Literature-derived,20111202,0,0,Active,"","","",Abbott Labs,Navigating the Kinome,Alisertib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173517663,"",493040,103905621,5005498,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Alsterpaullone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173517858,"",493040,103905653,49831041,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(4-Amino-3-iodopyrazolo[3,4-d]pyrimidin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173517992,"",493040,103905618,2858816,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,3-(2-bromo-4-hydroxy-5-methoxyphenyl)-2-(6-methyl-1H-benzimidazol-2-yl)prop-2-enenitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173518177,"",493040,103905625,11406590,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173518287,"",493040,103905651,49831039,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"4-Amino-1,3-dimethylthieno[2,3-c]pyrazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173518422,"",493040,103905641,49831037,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2,4-Diamino-8-chloro-10-(4-hydroxy-2-methylphenyl)pyrimido[4,5-b]quinolin-5-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173518696,"",493040,103905251,49830877,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-[(7-Benzylpyrrolo[2,3-d]pyrimidin-2-yl)amino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173518960,"",493040,103905444,49830960,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-(6-(2-(2,4-Difluorophenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)-2-methylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173519314,"",493040,103905569,47001891,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"3-amino-N-[(2E)-4-methyl-1,3-thiazol-2(3H)-ylidene]-6-(pyridin-4-yl)thieno[2,3-b]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173519444,"",493040,103905603,49831024,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"8H-Purin-8-one, 2-(6-fluoro-1H-benzimidazol-1-yl)-9-[(4R)-8-fluoro-3,4-dihydro-2H-1-benzopyran-4-yl]-7,9-dihydro-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173519595,"",493040,103905630,3038525,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,Neflamapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173519667,"",493040,103905676,9885023,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,(S)-(+)-2-Methyl-1-[(4-methyl-5-isoquinolynyl)sulfonyl]homopiperazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173520742,"",493040,103905667,13084523,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"2-[[6-(Dimethylamino)-1,2-benzothiazol-5-yl]amino]-2-oxoacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
173520869,"",493040,103905662,794531,2064,21336281,Literature-derived,20111202,0,0,Inactive,"","","",Abbott Labs,Navigating the Kinome,"1-benzyl-2,3-dimethyl-N-(1H-1,2,4-triazol-5-yl)indole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"","",9606,"","","",""
178253644,"",500006,104241407,46847552,2064,20681538,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM by radiometric method,"ethyl 3-[2-[(Z)-[5-(benzenesulfonamido)-2-oxo-1H-indol-3-ylidene]methyl]-4-oxo-1,5,6,7-tetrahydroindol-3-yl]propanoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
178253645,"",500006,104241537,46913878,2064,20681538,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM by radiometric method,"(Z)-N-[3-({3-[3-(Dimethylamino)propyl]-4-oxo-4,5,6,7-tetrahydro-1H-indol-2-yl}methylene)-2-oxoindolin-5-yl]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198234586,"",512414,103245522,5291,2064,16415863,Literature-derived,20180914,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of HER-2 activity at 10 uM by radiometric assay,Imatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198234587,"",512414,103619538,5311510,2064,16415863,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER-2 activity at 10 uM by radiometric assay,3-(6-((4-(Trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237210,"",507532,104250968,24905144,2064,18849971,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,"1-Methyl-3-Naphthalen-2-Yl-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237211,"",507532,123094844,24905145,2064,18849971,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,"5-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-bromophenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237212,"",507532,123092542,135565635,2064,18849971,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,"2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237213,"",507532,103742055,24905142,2064,18849971,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237214,"",507532,104250045,24905153,2064,18849971,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237215,"",507532,104246981,24905143,2064,18849971,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,"3-[4-Amino-1-(1-Methylethyl)-1h-Pyrazolo[3,4-D]pyrimidin-3-Yl]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198237216,"",507532,104250046,24905152,2064,18849971,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,"1-(1-Methylethyl)-3-Quinolin-6-Yl-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198249738,"",514046,123100925,25243801,2064,19465931,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,"3-Bromo-4-(4-(2-methoxyphenyl)piperazin-1-yl)-1H-pyrazolo[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198249739,"",514046,103694293,10077147,2064,19465931,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198249740,"",514046,103491159,10172943,2064,19465931,Literature-derived,20180914,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,(2s)-1-(1h-Indol-3-Yl)-3-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}propan-2-Amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198301797,"",537798,123093524,44187005,2064,20961062,Literature-derived,20180915,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"7-(2,6-difluoro-4-((1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenyl)-3-(1H-indazol-4-yl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198358930,"",517501,123096642,52947604,2064,20817523,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2,"trans-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methylphenyl)-7-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198358931,"",517501,123098951,20817096,2064,20817523,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-5,7-dichlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359652,"",517501,123087386,52942746,2064,20817523,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl)-5-chlorobenzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359658,"",517501,123090493,20817086,2064,20817523,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2,"cis-N-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)benzo[d]oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359661,"",517501,123087624,52942861,2064,20817523,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2,"cis-methyl 2-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenylamino)benzo[d]oxazole-7-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
198359666,"",517501,123101235,52950016,2064,20817523,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of ErbB2,"cis-2-(4-(4-amino-1-(4-(4-methylpiperazin-1-yl)cyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenylamino)benzo[d]oxazole-7-carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
219900396,"",588725,117686865,51003603,2064,"",Other,20111030,0,0,Inactive,NP_001005862,"","",The Scripps Research Institute Molecular Screening Center,Late stage counterscreen results from the probe development effort to identify inhibitors of kruppel-like factor 5 (KLF5): Radioactivity-based biochemical assay to identify modulators of a panel of 48 kinases,"(E)-3-(3-chlorophenyl)-N-(2-((1,1-dioxidotetrahydro-2H-thiopyran-4-yl)(methyl)amino)-2-oxoethyl)acrylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
224487047,"",598164,131287619,24963588,2064,20634068,Literature-derived,20200629,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752 deletion mutant, P753S mutant at 1 uM by Ambit competition binding assay","2-{3-Pyridin-3-yl-1-[(5-pyridin-2-yl-2-thienyl)carbonyl]-4,5-dihydro-1h-pyrazol-5-yl}phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
224487493,"",598165,131287619,24963588,2064,20634068,Literature-derived,20200629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759 deletion mutant at 1 uM by Ambit competition binding assay,"2-{3-Pyridin-3-yl-1-[(5-pyridin-2-yl-2-thienyl)carbonyl]-4,5-dihydro-1h-pyrazol-5-yl}phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
224498890,"",599705,103744992,11552706,2064,19772287,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of human ErbB2,Losmapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237727284,"",603819,134444646,53482132,2064,21632243,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"N-[(1R,2R)-2-[[5-chloro-2-[[7-methoxy-3-(2-methoxyethyl)-1,2,4,5-tetrahydro-3-benzazepin-8-yl]amino]pyrimidin-4-yl]amino]cyclohexyl]methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237727285,"",603819,134456249,56676869,2064,21632243,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"N-((1R,2R)-2-{5-Chloro-2-[8-methoxy-3-(2-methoxy-ethyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ylamino]-pyrimidin-4-ylamino}-cyclohexyl)-N-methyl-methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742291,"",613155,134457594,241369,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,"1H-pyrazolo[3,4-b]pyridin-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742292,"",613155,134457595,20825615,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,"7-Phenylimidazo[1,2-B][1,2,4]Triazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742293,"",613155,134453776,2787267,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,1-(4-Tolyl)-3-(3-trifluoromethylphenyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742294,"",613155,103426002,7595,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,"1,3-Diphenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742295,"",613155,103215230,11487,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,Diphenylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742296,"",613155,103254861,2813558,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,1-(5-(tert-Butyl)isoxazol-3-yl)-3-phenylurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742297,"",613155,134445989,56668397,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,"3-Phenylimidazo[1,2-b]pyridazin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742298,"",613155,134438307,2409198,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,1-(5-Tert-butyl-2-phenylpyrazol-3-yl)-3-(4-methylphenyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742299,"",613155,103516429,9222,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,7-Azaindole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742300,"",613155,134437894,265996,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,1-Phenyl-3-[3-(trifluoromethyl)phenyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742301,"",613155,134445990,25591404,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,N-cyclopropyl-3-fluoro-4-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742484,"",613155,124963567,13399,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,1H-Indazol-3-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742485,"",613155,103296196,9221,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,Indazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742486,"",613155,103465592,90334,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,2-Amino-3-benzyloxypyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742487,"",613155,124961552,11643997,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,N-phenylpyrimidin-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742488,"",613155,103517679,190,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,Adenine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237742489,"",613155,134453775,75317,2064,21699136,Literature-derived,20180919,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by TR-FRET assay,"4,5,6,7-Tetrahydro-1H-indazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
237790341,"",615008,134457829,44124863,2064,21714526,Literature-derived,20200629,0,0,Unspecified,P04626,"","",ChEMBL,Activity of ERBB2 kinase at 1 uM,"N-(6-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254343396,"",629932,136928999,57394653,2064,21958547,Literature-derived,20180920,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 relative to control,"2-Butenamide, 4-(dimethylamino)-N-[7-fluoro-4-[(2-methylphenyl)amino]imidazo[1,5-a]quinoxalin-8-yl]-N-methyl-, (2E)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254357456,"",637320,136938332,56835062,2064,22169263,Literature-derived,20180920,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"2-[4-[4-[[5-Chloro-7-[2-[methyl(methylsulfonyl)amino]phenyl]pyrrolo[2,1-f][1,2,4]triazin-2-yl]amino]phenyl]piperidin-1-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381100,"",634137,136943282,57402377,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-chloro-4-fluoroanilino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381101,"",634137,136920541,57390121,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","(5-hydroxy-1H-indol-2-yl)-(7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381102,"",634137,136920543,57390123,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(4-hydroxyanilino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381103,"",634137,136943287,57402380,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","1-Benzothiophen-2-yl-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381104,"",634137,136943285,57402379,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(benzylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381105,"",634137,136940076,56839588,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-(5-hydroxy-1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381106,"",634137,136920542,57390122,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","1H-indol-2-yl-[4-(3-iodoanilino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381107,"",634137,136920544,57390124,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","1H-indol-2-yl-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381108,"",634137,136930254,57395351,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","1H-indol-2-yl-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381109,"",634137,136936889,57398880,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-ethynylanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381110,"",634137,136930253,57395350,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-[2-chloro-4-[(3-fluorophenyl)methoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381111,"",634137,136927087,57393636,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","Methanone, [4-[(4-chlorophenyl)amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-1H-indol-2-yl-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381112,"",634137,136927089,56839589,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-(5-methoxy-1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381113,"",634137,136943283,56839587,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381114,"",634137,136923839,57391900,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-ethynylanilino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381115,"",634137,136927088,57393637,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-iodoanilino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-(5-methoxy-1H-pyrrolo[2,3-b]pyridin-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381116,"",634137,136933758,57397176,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(4-bromo-2-fluoroanilino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381203,"",634137,136943284,57402378,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-[2-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381204,"",634137,136943286,56839586,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-chloroanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381205,"",634137,136930256,57395353,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","1-Benzofuran-2-yl-[4-(3-chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381206,"",634137,136933757,57397175,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-iodoanilino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-(5-methoxy-1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381207,"",634137,136940077,57400568,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(3-chloro-4-fluoro-N-methylanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381208,"",634137,136933756,57397174,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(4-chloroanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381209,"",634137,136923841,57391902,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(benzylamino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381210,"",634137,136933759,57397177,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381211,"",634137,136923840,57391901,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","1H-indol-2-yl-[4-(3-iodoanilino)thieno[2,3-d]pyrimidin-6-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381212,"",634137,136936890,57398881,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","1H-indol-2-yl-[4-[4-(trifluoromethyl)anilino]thieno[2,3-d]pyrimidin-6-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381213,"",634137,136940075,57400567,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","[4-(4-bromo-2-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-(1H-indol-2-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254381214,"",634137,136930255,57395352,2064,22169601,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of Erbb2 using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP at 1 uM after 60 mins by scintillation counting","1H-indol-2-yl-[4-[3-(trifluoromethyl)anilino]thieno[2,3-d]pyrimidin-6-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254383267,"",638917,136938647,57399764,2064,22130133,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"[3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] butanoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254383268,"",638917,136945018,56834970,2064,22130133,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"[3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] 2-propylpentanoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254383269,"",638917,103244133,5328760,2064,22130133,Literature-derived,20200626,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,Tyrphostin AG 538,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384193,"",638917,103566217,9549297,2064,22130133,Literature-derived,20200626,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,Met Kinase Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384194,"",638917,103175813,5329102,2064,22130133,Literature-derived,20200626,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,Sunitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384195,"",638917,103501621,3062316,2064,22130133,Literature-derived,20200626,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384196,"",638917,136941847,56834968,2064,22130133,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384197,"",638917,103294831,5289418,2064,22130133,Literature-derived,20200626,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-YL)methylene]-2-indolinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384198,"",638917,136941848,56834969,2064,22130133,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"[3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] acetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384199,"",638917,136938648,56834971,2064,22130133,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"[3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] prop-2-enoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384200,"",638917,103177479,208908,2064,22130133,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384201,"",638917,136935515,57398107,2064,22130133,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"[3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] pyridine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384202,"",638917,136945017,57403282,2064,22130133,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"[3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] propanoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254384203,"",638917,136922351,57391047,2064,22130133,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM,"[3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] furan-2-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254385935,"",637117,103737728,44249772,2064,22189274,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 10 uM after 1 hr by competitive binding assay,"1-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(methylcarbamoylamino)methyl]oxolan-2-yl]purin-6-yl]-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254392793,"",640259,103233114,3194,2064,22204902,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,Ebselen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254392794,"",640259,136932417,57327913,2064,22204902,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,"4-(3-oxo-1,2-benzoselenazol-2-yl)-N-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]butanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254392795,"",640259,136942211,57327769,2064,22204902,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,"[(2R,3R,4S,5R,6R)-4,5-diacetyloxy-6-(3-oxo-1,2-benzoselenazol-2-yl)-3-[(2S,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl acetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254392796,"",640259,136942212,57327842,2064,22204902,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 1 uM,"[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[4-(3-oxo-1,2-benzoselenazol-2-yl)butanoylamino]oxan-2-yl]methyl acetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254750331,"",649362,136934302,9911652,2064,16476733,Literature-derived,20180921,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 1 uM,"[4-Amino-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-5-thiazolyl](2,3-dihydro-1,4-benzodioxin-6-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254821810,"",625186,103197648,3372,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluphenazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254821811,"",625186,103164944,338,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salicylic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254821812,"",625186,103164944,338,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salicylic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822326,"",625186,104247713,71651,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betamipron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822327,"",625186,104247713,71651,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betamipron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822328,"",625186,103213015,68617,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sertraline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822329,"",625186,103213015,68617,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sertraline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822331,"",625186,103345443,8816,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cetylpyridinium bromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822332,"",625186,103165858,237,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Quinacrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822333,"",625186,103165858,237,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Quinacrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822334,"",625186,136935047,168088,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pipethanate ethylbromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822335,"",625186,136935047,168088,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pipethanate ethylbromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822338,"",625186,103198693,2361,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",beta-Naphthoflavone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822339,"",625186,103198693,2361,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",beta-Naphthoflavone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822340,"",625186,103308477,6623,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bisphenol A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822341,"",625186,103308477,6623,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bisphenol A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822342,"",625186,163315720,3823,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822343,"",625186,163315720,3823,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822344,"",625186,103339676,15541,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Spectinomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822761,"",625186,103339676,15541,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Spectinomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822762,"",625186,103493432,2749,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ciclopirox,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822763,"",625186,103493432,2749,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ciclopirox,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822764,"",625186,103235190,4601,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Orphenadrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822765,"",625186,103235190,4601,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Orphenadrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822766,"",625186,103216609,39042,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bezafibrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822767,"",625186,103216609,39042,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bezafibrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822768,"",625186,103164769,5333,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfanilamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822769,"",625186,103703382,36294,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tobramycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822770,"",625186,103703382,36294,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tobramycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822772,"",625186,103271913,2541,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Candesartan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822773,"",625186,103236900,8246,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Neostigmine bromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822774,"",625186,103236900,8246,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Neostigmine bromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822775,"",625186,103173718,2578,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carmustine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822776,"",625186,103173718,2578,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carmustine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822777,"",625186,103173925,3698,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amrinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822778,"",625186,103173925,3698,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amrinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822779,"",625186,103630533,15938,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Paraquat dichloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822780,"",625186,103630533,15938,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Paraquat dichloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254822781,"",625186,103557049,4594,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Omeprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823147,"",625186,103557049,4594,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Omeprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823148,"",625186,103437141,3383,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823149,"",625186,103437141,3383,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823150,"",625186,103579966,54670067,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ascorbic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823151,"",625186,103579966,54670067,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ascorbic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823152,"",625186,103178542,4178,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mexiletine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823153,"",625186,103178542,4178,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mexiletine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823154,"",625186,103771122,11683,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Megestrol Acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823155,"",625186,103771122,11683,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Megestrol Acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823156,"",625186,103581295,44093,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Captopril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823157,"",625186,103581295,44093,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Captopril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823158,"",625186,104234148,8223,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ergotamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823159,"",625186,104234148,8223,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ergotamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823160,"",625186,103166767,14985,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alpha-Tocopherol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823161,"",625186,103166767,14985,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alpha-Tocopherol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823162,"",625186,136923736,6319,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","N,N'-Diphenyl-p-phenylenediamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823163,"",625186,136923736,6319,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","N,N'-Diphenyl-p-phenylenediamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823164,"",625186,103184855,3965,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Loxoprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823165,"",625186,103184855,3965,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Loxoprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823166,"",625186,103387432,311,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Citric Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823167,"",625186,103387432,311,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Citric Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823577,"",625186,103359097,2482,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Butyl 4-aminobenzoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823578,"",625186,103359097,2482,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Butyl 4-aminobenzoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823579,"",625186,103520216,31307,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Triamcinolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823580,"",625186,103520216,31307,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Triamcinolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823581,"",625186,103372397,6112,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lipoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823582,"",625186,103372397,6112,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lipoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823583,"",625186,103238871,3348,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fexofenadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823584,"",625186,103238871,3348,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fexofenadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823585,"",625186,103163870,123630,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tazobactam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823586,"",625186,103163870,123630,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tazobactam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823587,"",625186,104234147,3779,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Isoproterenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823588,"",625186,104234147,3779,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Isoproterenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823589,"",625186,103191448,4044,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mefenamic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823590,"",625186,103191448,4044,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mefenamic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823591,"",625186,103188539,2206,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Antipyrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823592,"",625186,103188539,2206,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Antipyrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823593,"",625186,104234226,37768,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amikacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823594,"",625186,104234226,37768,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amikacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823595,"",625186,103292984,4614,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxaprozin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823596,"",625186,103292984,4614,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxaprozin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254823597,"",625186,104234238,5754,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydrocortisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824087,"",625186,104234238,5754,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydrocortisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824088,"",625186,103171472,2907,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyclophosphamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824089,"",625186,103171472,2907,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyclophosphamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824090,"",625186,103196411,244,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzyl Alcohol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824091,"",625186,103196411,244,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzyl Alcohol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824092,"",625186,103189939,3339,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fenofibrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824093,"",625186,103189939,3339,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fenofibrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824094,"",625186,104234156,64143,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nelfinavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824095,"",625186,104234156,64143,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nelfinavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824096,"",625186,103459872,114864,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(R)-(-)-Ibuprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824097,"",625186,103459872,114864,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(R)-(-)-Ibuprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824098,"",625186,160698338,16051930,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",CID 16051930,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824099,"",625186,160698338,16051930,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",CID 16051930,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824100,"",625186,103234593,10219,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Emetine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824101,"",625186,103234593,10219,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Emetine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824102,"",625186,103329864,7456,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methylparaben,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824103,"",625186,103329864,7456,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methylparaben,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824104,"",625186,103224720,1547484,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cinnarizine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824105,"",625186,103224720,1547484,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cinnarizine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824106,"",625186,103166269,6758,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rotenone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824107,"",625186,103166269,6758,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rotenone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824494,"",625186,103589984,20469,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Beclomethasone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824495,"",625186,103589984,20469,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Beclomethasone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824496,"",625186,103220983,3955,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Loperamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824497,"",625186,103220983,3955,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Loperamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824498,"",625186,103171565,2727,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorpropamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824499,"",625186,103171565,2727,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorpropamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824500,"",625186,163312394,5311497,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vinorelbine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824501,"",625186,163312394,5311497,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vinorelbine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824502,"",625186,103171942,4189,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Miconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824504,"",625186,103341726,124087,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Desloratadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824505,"",625186,103341726,124087,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Desloratadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824506,"",625186,103269962,55652,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Spiradoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824507,"",625186,103269962,55652,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Spiradoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824510,"",625186,123085230,4098,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methapyrilene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824511,"",625186,123085230,4098,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methapyrilene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824512,"",625186,103311042,42890,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Idarubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824513,"",625186,103311042,42890,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Idarubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824514,"",625186,136921836,7043232,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(2S)-2-amino-3-(benzylcarbamothioylsulfanyl)propanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824928,"",625186,103357947,4906,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prilocaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824929,"",625186,103357947,4906,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prilocaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824930,"",625186,103218566,1674,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",3-Methylcholanthrene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824931,"",625186,103218566,1674,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",3-Methylcholanthrene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824932,"",625186,103194022,2284,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Baclofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824933,"",625186,103194022,2284,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Baclofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824934,"",625186,123085521,8226,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methylergonovine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824935,"",625186,123085521,8226,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methylergonovine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824936,"",625186,103707689,2724385,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Digoxin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824937,"",625186,103707689,2724385,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Digoxin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824938,"",625186,103326781,936,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Niacinamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824939,"",625186,103326781,936,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Niacinamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824940,"",625186,103179606,441243,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Saquinavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824941,"",625186,103179606,441243,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Saquinavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824942,"",625186,104251392,716312,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-Fluoro-L-phenylalanine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824943,"",625186,104251392,716312,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-Fluoro-L-phenylalanine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824944,"",625186,103343350,4723,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pemoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824945,"",625186,103343350,4723,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pemoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824946,"",625186,103165766,4543,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nortriptyline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824947,"",625186,103165766,4543,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nortriptyline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254824948,"",625186,103169414,2995,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Desipramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825345,"",625186,103169414,2995,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Desipramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825346,"",625186,103508547,4091,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metformin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825347,"",625186,103508547,4091,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metformin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825348,"",625186,136923751,35802,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flubendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825349,"",625186,136923751,35802,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flubendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825350,"",625186,103267861,2141,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amifostine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825351,"",625186,103267861,2141,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amifostine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825352,"",625186,103179099,7961,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromobenzene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825353,"",625186,103179099,7961,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromobenzene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825354,"",625186,103170845,4168,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metoclopramide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825355,"",625186,103170845,4168,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metoclopramide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825356,"",625186,103619997,37542,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ribavirin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825357,"",625186,103619997,37542,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ribavirin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825358,"",625186,103250293,5071,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rimantadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825359,"",625186,103250293,5071,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rimantadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825360,"",625186,103199488,3821,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ketamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825361,"",625186,103199488,3821,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ketamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825362,"",625186,103340993,4649,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-Aminosalicylic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825363,"",625186,103340993,4649,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-Aminosalicylic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825364,"",625186,103770389,10660,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dimenhydrinate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825365,"",625186,103770389,10660,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dimenhydrinate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825869,"",625186,103166970,2477,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Buspirone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825870,"",625186,103166970,2477,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Buspirone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825871,"",625186,136928380,6761,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pipamazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825872,"",625186,136928380,6761,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pipamazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825873,"",625186,103274495,3690,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ifosfamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825874,"",625186,103274495,3690,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ifosfamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825875,"",625186,103170825,5073,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Risperidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825876,"",625186,103170825,5073,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Risperidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825877,"",625186,103164769,5333,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfanilamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825878,"",625186,103211461,3334,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fenbendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825879,"",625186,103211461,3334,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fenbendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825880,"",625186,103346479,443884,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ergometrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825881,"",625186,103346479,443884,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ergometrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825882,"",625186,103227310,276389,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Harringtonine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825883,"",625186,103227310,276389,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Harringtonine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825884,"",625186,103292815,60846,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valsartan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825885,"",625186,103292815,60846,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valsartan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825886,"",625186,103239458,25444,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,6R)-2-[(2R,3R,4R,5R,6R)-6-[(1R,2S,3S,4R,5'R,6R,7S,8R,9S,12S,13S,15R,16R,18S)-3,15-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825887,"",625186,103239458,25444,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,6R)-2-[(2R,3R,4R,5R,6R)-6-[(1R,2S,3S,4R,5'R,6R,7S,8R,9S,12S,13S,15R,16R,18S)-3,15-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825888,"",625186,103194399,6209,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Choline Chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254825889,"",625186,103194399,6209,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Choline Chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826268,"",625186,103567551,6479523,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azlocillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826269,"",625186,103567551,6479523,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azlocillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826270,"",625186,123087788,2882,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cromolyn,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826271,"",625186,123087788,2882,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cromolyn,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826274,"",625186,103217374,56208,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sarafloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826275,"",625186,103217374,56208,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sarafloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826276,"",625186,103202919,4636,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxymetazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826277,"",625186,103202919,4636,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxymetazoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826278,"",625186,103166276,38409,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tienilic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826279,"",625186,103166276,38409,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tienilic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826286,"",625186,123083185,77999,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rosiglitazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826287,"",625186,123083185,77999,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rosiglitazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826711,"",625186,103258899,56069,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(R)-Bicalutamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826712,"",625186,103258899,56069,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(R)-Bicalutamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826713,"",625186,103292864,4235,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Moclobemide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826714,"",625186,103292864,4235,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Moclobemide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826717,"",625186,103179577,72474,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Grepafloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826718,"",625186,103179577,72474,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Grepafloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826719,"",625186,103770828,443943,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Halcinonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826720,"",625186,103770828,443943,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Halcinonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826721,"",625186,103192563,5991,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethinyl Estradiol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826722,"",625186,103192563,5991,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethinyl Estradiol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826723,"",625186,103194727,57363,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Finasteride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826724,"",625186,103194727,57363,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Finasteride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826725,"",625186,103585278,444254,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Precose,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826726,"",625186,103585278,444254,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Precose,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826727,"",625186,103712397,657255,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826728,"",625186,103712397,657255,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826729,"",625186,103175225,4781,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenylbutazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254826730,"",625186,103175225,4781,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenylbutazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827139,"",625186,103556901,2723,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chloroxylenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827140,"",625186,103556901,2723,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chloroxylenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827141,"",625186,103621816,5745,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cortisone Acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827142,"",625186,103621816,5745,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cortisone Acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827143,"",625186,103388855,5353853,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxiconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827144,"",625186,103388855,5353853,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxiconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827145,"",625186,103306370,5335,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfaphenazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827146,"",625186,103306370,5335,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfaphenazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827147,"",625186,103176121,243,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzoic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827148,"",625186,103176121,243,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzoic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827149,"",625186,123087792,42008,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cefmetazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827150,"",625186,123087792,42008,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cefmetazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827155,"",625186,103318474,1367,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-Aminobenzotriazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827156,"",625186,103318474,1367,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-Aminobenzotriazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827157,"",625186,104240364,6915744,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rulide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827158,"",625186,104240364,6915744,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rulide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827159,"",625186,104234229,5743,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexamethasone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827566,"",625186,104234229,5743,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexamethasone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827567,"",625186,103519121,4197,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Milrinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827568,"",625186,103519121,4197,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Milrinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827569,"",625186,103193678,2366,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betahistine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827570,"",625186,103193678,2366,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betahistine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827571,"",625186,103203672,59768,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Esmolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827572,"",625186,103203672,59768,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Esmolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827573,"",625186,103292969,4409,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nabumetone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827574,"",625186,103292969,4409,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nabumetone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827575,"",625186,103189284,2118,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alprazolam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827576,"",625186,103189284,2118,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alprazolam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827577,"",625186,123089405,444034,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dihydroergocristine mesylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827578,"",625186,123089405,444034,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dihydroergocristine mesylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827579,"",625186,134437966,5039,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ranitidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827580,"",625186,134437966,5039,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ranitidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827583,"",625186,242610449,9920327,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Agri-Mek,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827584,"",625186,242610449,9920327,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Agri-Mek,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827585,"",625186,103391063,6518171,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(S)-2-(2-benzoylphenylamino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827586,"",625186,103391063,6518171,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(S)-2-(2-benzoylphenylamino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827992,"",625186,103164209,4184,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mianserin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827993,"",625186,103164209,4184,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mianserin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827994,"",625186,103598676,451415,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aclarubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827995,"",625186,103598676,451415,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aclarubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827996,"",625186,103165751,5329,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfamethoxazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827997,"",625186,103165751,5329,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfamethoxazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827998,"",625186,124960987,9576413,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Naloxonazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254827999,"",625186,124960987,9576413,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Naloxonazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828000,"",625186,103353725,5328,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfamethizole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828001,"",625186,103353725,5328,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfamethizole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828004,"",625186,103457055,2733,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorzoxazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828005,"",625186,103457055,2733,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorzoxazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828006,"",625186,160692461,444008,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tibolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828007,"",625186,160692461,444008,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tibolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828008,"",625186,103344166,3038525,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Neflamapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828009,"",625186,103344166,3038525,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Neflamapimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828010,"",625186,103197484,2585,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carvedilol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828493,"",625186,103197484,2585,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carvedilol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828494,"",625186,103309971,3973,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828495,"",625186,103309971,3973,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828496,"",625186,103235689,5702160,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Famotidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828497,"",625186,103235689,5702160,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Famotidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828498,"",625186,103399308,2132,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ambroxol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828499,"",625186,103399308,2132,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ambroxol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828500,"",625186,103524762,2123,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Altretamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828501,"",625186,103524762,2123,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Altretamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828502,"",625186,103396795,57469,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Imiquimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828503,"",625186,103396795,57469,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Imiquimod,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828504,"",625186,103301299,4062,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mepivacaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828505,"",625186,103301299,4062,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mepivacaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828506,"",625186,103163909,4539,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Norfloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828507,"",625186,103163909,4539,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Norfloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828508,"",625186,103770845,441350,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metyrosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828509,"",625186,103770845,441350,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metyrosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828510,"",625186,103163904,2764,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ciprofloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828511,"",625186,103163904,2764,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ciprofloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828512,"",625186,103630897,135403821,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rifapentine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828513,"",625186,103630897,135403821,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rifapentine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828832,"",625186,103252877,23662354,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mesna,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828833,"",625186,103252877,23662354,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mesna,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828834,"",625186,103189283,2130,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amantadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828835,"",625186,103189283,2130,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amantadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828836,"",625186,103177753,2554,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carbamazepine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828837,"",625186,103185057,5401,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terazosin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828838,"",625186,103185057,5401,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terazosin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828839,"",625186,103171578,33624,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Timolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828840,"",625186,103171578,33624,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Timolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828841,"",625186,103555996,3354,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flavoxate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828842,"",625186,103555996,3354,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flavoxate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828843,"",625186,103590513,2577,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carmofur,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828844,"",625186,103234269,6098,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cloxacillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828845,"",625186,103234269,6098,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cloxacillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828846,"",625186,103216085,2723949,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thioacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828847,"",625186,103216085,2723949,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thioacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828848,"",625186,103200240,135445761,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pralidoxime Chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828849,"",625186,103200240,135445761,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pralidoxime Chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828850,"",625186,103458417,2467,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Buflomedil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254828851,"",625186,103458417,2467,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Buflomedil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829273,"",625186,104234256,441306,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Netilmicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829274,"",625186,104234256,441306,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Netilmicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829275,"",625186,103330746,5282230,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tranilast,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829276,"",625186,103330746,5282230,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tranilast,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829279,"",625186,160687250,68595,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Maduramicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829280,"",625186,160687250,68595,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Maduramicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829281,"",625186,103164420,4171,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metoprolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829282,"",625186,103164420,4171,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metoprolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829283,"",625186,103510607,54671203,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxycycline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829284,"",625186,103510607,54671203,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxycycline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829285,"",625186,103305076,3332,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Felbinac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829286,"",625186,103305076,3332,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Felbinac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829287,"",625186,103164854,323,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Coumarin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829288,"",625186,103164854,323,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Coumarin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829289,"",625186,103210646,156391,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Naproxen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829290,"",625186,103210646,156391,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Naproxen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829291,"",625186,103196138,289,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Catechol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829292,"",625186,103196138,289,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Catechol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829712,"",625186,103532096,3366,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flucytosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829713,"",625186,103532096,3366,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flucytosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829718,"",625186,103401163,3342,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fenoprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829719,"",625186,103401163,3342,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fenoprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829724,"",625186,136939978,9128,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzo[e]pyrene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829725,"",625186,136939978,9128,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzo[e]pyrene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829728,"",625186,104234242,444041,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betadex,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254829729,"",625186,104234242,444041,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betadex,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830190,"",625186,103590513,2577,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carmofur,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830195,"",625186,103177753,2554,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carbamazepine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830196,"",625186,136931594,19592,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nafenopin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830197,"",625186,136931594,19592,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nafenopin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830202,"",625186,160671910,5282181,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alfacalcidol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830203,"",625186,160671910,5282181,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alfacalcidol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830204,"",625186,103296891,33613,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amoxicillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830205,"",625186,103296891,33613,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amoxicillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830206,"",625186,174525699,9898639,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gentamicinsulfate salt,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830207,"",625186,103229487,13342,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vinblastine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830208,"",625186,103229487,13342,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vinblastine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830209,"",625186,103189534,4173,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metronidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830210,"",625186,103189534,4173,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metronidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830602,"",625186,103186411,5386,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tegafur,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830603,"",625186,103186411,5386,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tegafur,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830604,"",625186,103642911,135403648,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Leucovorin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830605,"",625186,103642911,135403648,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Leucovorin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830606,"",625186,103179427,3958,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lorazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830607,"",625186,103179427,3958,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lorazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830614,"",625186,103600468,16129778,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gallotannin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830615,"",625186,103600468,16129778,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gallotannin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830618,"",625186,103234592,444,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bupropion,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830619,"",625186,103234592,444,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bupropion,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830620,"",625186,103179145,938,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nicotinic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830621,"",625186,103179145,938,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nicotinic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254830622,"",625186,103222497,40854,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxfendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831101,"",625186,103222497,40854,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxfendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831102,"",625186,103169165,60838,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Irinotecan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831103,"",625186,103169165,60838,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Irinotecan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831104,"",625186,174525699,9898639,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gentamicinsulfate salt,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831105,"",625186,164144498,71277,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Erythromycin propionate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831106,"",625186,164144498,71277,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Erythromycin propionate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831108,"",625186,103188801,14868,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tribromsalan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831109,"",625186,103406649,3406,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fomepizole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831110,"",625186,103406649,3406,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fomepizole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831111,"",625186,103239041,637511,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cinnamaldehyde,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831112,"",625186,103239041,637511,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cinnamaldehyde,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831113,"",625186,160698611,5472495,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulindac sulfone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831114,"",625186,160698611,5472495,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulindac sulfone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831115,"",625186,103226073,6574,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","1,1,2-Trichloroethane",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831116,"",625186,103226073,6574,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","1,1,2-Trichloroethane",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831117,"",625186,194134279,3793,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Canditral,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831118,"",625186,194134279,3793,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Canditral,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831119,"",625186,103168790,3488,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glyburide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831120,"",625186,103168790,3488,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glyburide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831121,"",625186,103311080,3496,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glyphosate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831480,"",625186,103311080,3496,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glyphosate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831481,"",625186,194134381,25249,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Stanozolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831482,"",625186,194134381,25249,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Stanozolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831483,"",625186,103447888,6249,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ampicillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831484,"",625186,103164270,3373,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flumazenil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831485,"",625186,103164270,3373,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flumazenil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831486,"",625186,103165869,2164,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amobarbital,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831487,"",625186,103165869,2164,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amobarbital,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831488,"",625186,103338617,6230,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Norethindrone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831489,"",625186,103338617,6230,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Norethindrone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831490,"",625186,103458965,4236,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Modafinil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831491,"",625186,103458965,4236,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Modafinil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831492,"",625186,103199552,5070,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Riluzole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831493,"",625186,103199552,5070,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Riluzole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831494,"",625186,103183095,5087,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831495,"",625186,103183095,5087,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831496,"",625186,103176321,5746,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mitomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831497,"",625186,103176321,5746,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mitomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831498,"",625186,103223867,460612,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Melphalan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831499,"",625186,103223867,460612,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Melphalan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831500,"",625186,103689672,2763,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ciprofibrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831933,"",625186,103689672,2763,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ciprofibrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831934,"",625186,103469378,7638,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Monobenzone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831935,"",625186,103469378,7638,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Monobenzone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831936,"",625186,103267492,2972,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Deferiprone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831937,"",625186,123097009,5742673,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cefotaxime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831938,"",625186,123097009,5742673,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cefotaxime,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831939,"",625186,160671354,5282322,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Leucomycin A1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831940,"",625186,103178022,60021,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Temafloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831941,"",625186,103178022,60021,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Temafloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831942,"",625186,103173303,4908,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Primaquine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831943,"",625186,103173303,4908,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Primaquine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831944,"",625186,103306510,4922,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Proglumide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831945,"",625186,103306510,4922,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Proglumide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831946,"",625186,103292787,34312,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxcarbazepine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831947,"",625186,103292787,34312,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxcarbazepine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831948,"",625186,103183748,5090,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rofecoxib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831949,"",625186,103183748,5090,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rofecoxib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831950,"",625186,103173872,2913,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyproheptadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831951,"",625186,103173872,2913,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyproheptadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831952,"",625186,103198694,11790,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",alpha-Naphthoflavone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254831953,"",625186,103198694,11790,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",alpha-Naphthoflavone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832342,"",625186,103266319,3957,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Loratadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832343,"",625186,103266319,3957,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Loratadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832344,"",625186,104234246,2162,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amlodipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832345,"",625186,104234246,2162,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amlodipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832346,"",625186,103193982,637566,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Geraniol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832347,"",625186,103193982,637566,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Geraniol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832348,"",625186,103189004,5959,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chloramphenicol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832349,"",625186,103189004,5959,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chloramphenicol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832350,"",625186,103194771,4760,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenindione,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832351,"",625186,103194771,4760,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenindione,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832352,"",625186,103477782,30323,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Daunorubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832353,"",625186,103477782,30323,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Daunorubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832354,"",625186,103261079,6215,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluocinolone Acetonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832355,"",625186,103261079,6215,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluocinolone Acetonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832356,"",625186,103166621,4595,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ondansetron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832357,"",625186,160671354,5282322,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Leucomycin A1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832358,"",625186,136923740,5104,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Roxarsone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832359,"",625186,136923740,5104,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Roxarsone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832360,"",625186,103243148,4174,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metyrapone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832361,"",625186,103243148,4174,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metyrapone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832362,"",625186,103447888,6249,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ampicillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832789,"",625186,103179760,65016,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amprenavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832790,"",625186,103179760,65016,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amprenavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832791,"",625186,103307981,2170,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amoxapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832792,"",625186,103307981,2170,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amoxapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832793,"",625186,103197669,2723601,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thioguanine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832794,"",625186,103197669,2723601,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thioguanine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832795,"",625186,163312392,174174,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Atropine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832796,"",625186,163312392,174174,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Atropine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832797,"",625186,136921836,7043232,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(2S)-2-amino-3-(benzylcarbamothioylsulfanyl)propanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832798,"",625186,103165722,4763,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenobarbital,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832799,"",625186,103165722,4763,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenobarbital,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832800,"",625186,103165769,5327,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfamethazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832801,"",625186,103165769,5327,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfamethazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832802,"",625186,103267492,2972,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Deferiprone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832803,"",625186,103165247,5379,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gatifloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832804,"",625186,103165247,5379,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gatifloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832805,"",625186,103535182,135415564,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rifabutin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832806,"",625186,103535182,135415564,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rifabutin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832808,"",625186,103169389,2726,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorpromazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254832809,"",625186,103234890,5360696,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dextromethorphan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833192,"",625186,103234890,5360696,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dextromethorphan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833193,"",625186,103487489,3475,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gliclazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833194,"",625186,103487489,3475,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gliclazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833195,"",625186,103210760,6253,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cytarabine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833196,"",625186,103210760,6253,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cytarabine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833197,"",625186,103261258,2484,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Butenafine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833198,"",625186,103261258,2484,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Butenafine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833199,"",625186,103759736,32798,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clobetasol Propionate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833200,"",625186,103759736,32798,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clobetasol Propionate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833201,"",625186,103169484,2145,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aminoglutethimide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833202,"",625186,103169484,2145,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aminoglutethimide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833203,"",625186,160698676,134551,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",alpha-Ergocryptine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833204,"",625186,160698676,134551,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",alpha-Ergocryptine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833205,"",625186,103770616,9812710,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ivomec,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833206,"",625186,103770616,9812710,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ivomec,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833207,"",625186,124971543,36324,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amitraz,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833208,"",625186,124971543,36324,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amitraz,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833209,"",625186,103523408,26879,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levamisole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833210,"",625186,103523408,26879,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levamisole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833211,"",625186,103173774,3950,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lomustine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833212,"",625186,103458646,65359,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxiglutatione,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833640,"",625186,103458646,65359,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxiglutatione,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833641,"",625186,103164254,3702,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Indapamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833642,"",625186,103164254,3702,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Indapamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833643,"",625186,103164619,2801,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clomipramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833644,"",625186,103164619,2801,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clomipramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833645,"",625186,103291866,4156,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methyl methanesulfonate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833646,"",625186,103291866,4156,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methyl methanesulfonate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833647,"",625186,103507642,3385,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluorouracil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833648,"",625186,103507642,3385,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluorouracil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833649,"",625186,103178857,3394,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flurbiprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833650,"",625186,103178857,3394,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flurbiprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833651,"",625186,103370789,5479,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tinidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833652,"",625186,103370789,5479,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tinidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833653,"",625186,103367920,39941,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benoxaprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833654,"",625186,103367920,39941,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benoxaprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833655,"",625186,103178995,2519,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Caffeine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833656,"",625186,103178995,2519,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Caffeine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833657,"",625186,103178852,441140,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Griseofulvin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833658,"",625186,103178852,441140,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Griseofulvin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833659,"",625186,103189265,3100,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diphenhydramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254833660,"",625186,103189265,3100,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diphenhydramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834086,"",625186,103770976,6172,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gallamine Triethiodide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834087,"",625186,103770976,6172,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gallamine Triethiodide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834088,"",625186,103167682,4463,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nevirapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834089,"",625186,103167682,4463,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nevirapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834090,"",625186,103173774,3950,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lomustine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834091,"",625186,103188146,441130,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Meropenem,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834092,"",625186,103188146,441130,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Meropenem,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834093,"",625186,103221477,2435,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Brimonidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834094,"",625186,103221477,2435,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Brimonidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834095,"",625186,103245381,14385,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","3,3',4',5-Tetrachlorosalicylanilide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834096,"",625186,103245381,14385,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","3,3',4',5-Tetrachlorosalicylanilide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834097,"",625186,103483583,5870,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Estrone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834098,"",625186,103483583,5870,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Estrone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834099,"",625186,103209992,452261,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Genaconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834100,"",625186,103209992,452261,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Genaconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834101,"",625186,103195019,60825,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lamivudine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834102,"",625186,103195019,60825,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lamivudine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834103,"",625186,103166621,4595,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ondansetron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834104,"",625186,103555936,2442,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromhexine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834105,"",625186,103555936,2442,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromhexine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834106,"",625186,103770731,38101,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lodosyn,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834510,"",625186,103770731,38101,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lodosyn,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834511,"",625186,103546496,3961,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Losartan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834512,"",625186,103546496,3961,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Losartan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834513,"",625186,123094714,2140,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diatrizoic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834514,"",625186,123094714,2140,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diatrizoic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834515,"",625186,103597669,34001,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cetraxate hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834516,"",625186,103597669,34001,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cetraxate hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834517,"",625186,104234352,33036,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexchlorpheniramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834518,"",625186,104234352,33036,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexchlorpheniramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834519,"",625186,103195621,6279,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Medroxyprogesterone acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834520,"",625186,103195621,6279,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Medroxyprogesterone acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834521,"",625186,103168363,3826,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ketorolac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834522,"",625186,103168363,3826,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ketorolac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834523,"",625186,103590321,91536,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834524,"",625186,103590321,91536,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834525,"",625186,103174429,1221,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",alpha-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834526,"",625186,103174429,1221,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",alpha-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834527,"",625186,242084574,19649,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Streptomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834528,"",625186,242084574,19649,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Streptomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834529,"",625186,103165728,3386,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluoxetine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834530,"",625186,103165728,3386,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluoxetine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834956,"",625186,103459707,39912,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexibuprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834957,"",625186,103459707,39912,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexibuprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834958,"",625186,103577988,5353432,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834959,"",625186,103577988,5353432,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834960,"",625186,104234145,2520,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Verapamil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834961,"",625186,104234145,2520,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Verapamil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834962,"",625186,103709193,5403,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terbutaline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834963,"",625186,103709193,5403,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terbutaline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834964,"",625186,103554720,60823,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Atorvastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834965,"",625186,103554720,60823,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Atorvastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834966,"",625186,103567215,5280793,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ergocalciferol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834967,"",625186,103567215,5280793,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ergocalciferol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834968,"",625186,103173870,2708,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorambucil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834969,"",625186,103173870,2708,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorambucil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834970,"",625186,103234668,5311304,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nalbuphine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834971,"",625186,103234668,5311304,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nalbuphine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834972,"",625186,103216314,3229,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Enoxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834973,"",625186,103216314,3229,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Enoxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834974,"",625186,103188772,2160,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amitriptyline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834975,"",625186,103188772,2160,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amitriptyline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254834976,"",625186,104234271,448042,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Y-27632 dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835446,"",625186,104234271,448042,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Y-27632 dihydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835447,"",625186,103189005,4913,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Procainamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835448,"",625186,103189005,4913,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Procainamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835449,"",625186,103188188,3308,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Etodolac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835450,"",625186,103188188,3308,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Etodolac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835451,"",625186,160703999,14982,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glycyrrhizin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835452,"",625186,160703999,14982,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glycyrrhizin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835453,"",625186,103243329,3055,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diphenidol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835454,"",625186,103243329,3055,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diphenidol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835455,"",625186,103164490,448537,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diethylstilbestrol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835456,"",625186,103164490,448537,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diethylstilbestrol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835457,"",625186,442046374,156009462,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium;bromide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835458,"",625186,442046374,156009462,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium;bromide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835459,"",625186,103215824,2478,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Busulfan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835460,"",625186,103215824,2478,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Busulfan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835461,"",625186,103179008,4748,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Perphenazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835462,"",625186,103179008,4748,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Perphenazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835464,"",625186,103206701,2406,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bithionol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835465,"",625186,103168962,135398738,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dacarbazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835466,"",625186,103168962,135398738,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dacarbazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835864,"",625186,103411217,4915,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Procarbazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835865,"",625186,103411217,4915,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Procarbazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835866,"",625186,103178920,4926,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Promazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835867,"",625186,103178920,4926,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Promazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835868,"",625186,103234908,4911,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Probenecid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835869,"",625186,103234908,4911,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Probenecid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835870,"",625186,103282650,1645,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",3-Aminobenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835871,"",625186,103282650,1645,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",3-Aminobenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835872,"",625186,124966219,15032,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pregnenolone carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835873,"",625186,103179088,6604200,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nitrofurantoin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835874,"",625186,103179088,6604200,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nitrofurantoin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835875,"",625186,103172948,679,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dimethyl Sulfoxide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835876,"",625186,103172948,679,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dimethyl Sulfoxide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835877,"",625186,103235071,3059,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diflunisal,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835878,"",625186,103235071,3059,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diflunisal,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835879,"",625186,103207410,445858,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ferulic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835880,"",625186,103207410,445858,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ferulic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835881,"",625186,136941379,1379258,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)(2-methylphenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835882,"",625186,136941379,1379258,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)(2-methylphenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835883,"",625186,103178942,2796,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clofibrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254835884,"",625186,104234183,656665,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tropisetron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836353,"",625186,104234183,656665,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tropisetron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836354,"",625186,103556970,441207,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Digitoxin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836355,"",625186,103556970,441207,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Digitoxin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836356,"",625186,103177124,6167,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Colchicine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836357,"",625186,103177124,6167,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Colchicine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836358,"",625186,103178831,3948,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lomefloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836359,"",625186,103178831,3948,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lomefloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836360,"",625186,104252420,27200,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thiamphenicol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836361,"",625186,104252420,27200,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thiamphenicol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836362,"",625186,160708999,7010,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valethamate bromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836363,"",625186,160708999,7010,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valethamate bromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836364,"",625186,103189409,3415,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Foscarnet,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836365,"",625186,103189409,3415,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Foscarnet,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836366,"",625186,103168230,3767,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Isoniazid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836367,"",625186,103168230,3767,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Isoniazid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836368,"",625186,103682056,27447,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cephalexin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836369,"",625186,103682056,27447,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cephalexin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836370,"",625186,103166445,3463,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gemfibrozil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836371,"",625186,160693281,6419941,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Homatropine hydrobromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836372,"",625186,160693281,6419941,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Homatropine hydrobromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836373,"",625186,103228261,14969,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vancomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836755,"",625186,103228261,14969,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vancomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836756,"",625186,103198031,4917,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prochlorperazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836757,"",625186,103198031,4917,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prochlorperazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836758,"",625186,103370406,5029,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rabeprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836759,"",625186,103370406,5029,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rabeprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836760,"",625186,104246526,78386,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-(2-Thienyl)butyric acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836761,"",625186,104246526,78386,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-(2-Thienyl)butyric acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836762,"",625186,123090165,2769,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propulsid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836763,"",625186,103174523,4496,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nimetazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836764,"",625186,103174523,4496,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nimetazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836765,"",625186,103206766,5311309,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nateglinide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836766,"",625186,103206766,5311309,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nateglinide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836767,"",625186,103293043,3478,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glipizide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836768,"",625186,103293043,3478,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glipizide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836769,"",625186,103543150,3333,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Felodipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836770,"",625186,103543150,3333,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Felodipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836771,"",625186,103572434,7057919,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diethylhexylphthalate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836772,"",625186,103572434,7057919,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diethylhexylphthalate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836773,"",625186,103202464,9904,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nandrolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836774,"",625186,103202464,9904,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nandrolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254836775,"",625186,123084851,9794806,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",CID 9794806,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837176,"",625186,123084851,9794806,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",CID 9794806,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837177,"",625186,103557046,4485,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nifedipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837178,"",625186,103557046,4485,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nifedipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837179,"",625186,104234151,43815,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Paroxetine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837180,"",625186,104234151,43815,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Paroxetine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837181,"",625186,103252336,26757,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Selegiline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837182,"",625186,103252336,26757,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Selegiline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837183,"",625186,103219164,5472,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ticlopidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837184,"",625186,103219164,5472,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ticlopidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837185,"",625186,103195217,135398745,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Olanzapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837186,"",625186,103195217,135398745,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Olanzapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837187,"",625186,103771134,6291,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mestranol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837188,"",625186,103771134,6291,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mestranol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837189,"",625186,103533730,135401907,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Allopurinol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837190,"",625186,103533730,135401907,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Allopurinol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837191,"",625186,103543151,3476,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glimepiride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837192,"",625186,103543151,3476,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glimepiride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837193,"",625186,103567590,17134,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfadoxine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837194,"",625186,103567590,17134,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfadoxine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837195,"",625186,103174500,3672,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ibuprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837196,"",625186,103174500,3672,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ibuprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837557,"",625186,103456563,1981,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acemetacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837558,"",625186,103456563,1981,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acemetacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837559,"",625186,103179087,3825,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ketoprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837560,"",625186,103179087,3825,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ketoprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837561,"",625186,103167089,38853,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methyldopa,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837562,"",625186,103167089,38853,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methyldopa,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837563,"",625186,103558584,5284613,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Proscillaridin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837564,"",625186,103558584,5284613,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Proscillaridin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837565,"",625186,103282209,564,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aminocaproic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837566,"",625186,103282209,564,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aminocaproic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837567,"",625186,103618143,4728,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",5-Hydroxy-4-methoxy-5-(1-methylethenyl)-2-furanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837568,"",625186,103618143,4728,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",5-Hydroxy-4-methoxy-5-(1-methylethenyl)-2-furanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837569,"",625186,103168744,5253,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sotalol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837570,"",625186,103168744,5253,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sotalol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837571,"",625186,124971557,2893,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyclandelate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837572,"",625186,124971557,2893,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyclandelate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837573,"",625186,123096749,11080,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-Naphthyl isothiocyanate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837574,"",625186,103288149,5897,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",2-Acetylaminofluorene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837575,"",625186,103288149,5897,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",2-Acetylaminofluorene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837576,"",625186,103588113,522325,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dipyrone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254837577,"",625186,103588113,522325,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dipyrone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838003,"",625186,103196311,5147,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salicylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838004,"",625186,103196311,5147,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salicylamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838005,"",625186,103242469,4495,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nimesulide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838006,"",625186,103242469,4495,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nimesulide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838007,"",625186,103166445,3463,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gemfibrozil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838008,"",625186,123099348,10635,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Androstanolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838009,"",625186,123099348,10635,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Androstanolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838010,"",625186,103589702,7516,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenylhydrazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838011,"",625186,103589702,7516,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenylhydrazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838012,"",625186,103706605,14049689,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trappsol Cyclo,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838013,"",625186,103706605,14049689,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trappsol Cyclo,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838014,"",625186,103225961,14052,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethambutol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838015,"",625186,103225961,14052,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethambutol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838016,"",625186,103201243,72172,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ubenimex,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838017,"",625186,103201243,72172,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ubenimex,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838018,"",625186,103504725,135398513,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acyclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838019,"",625186,103504725,135398513,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acyclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838020,"",625186,103188975,35370,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zidovudine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838021,"",625186,103188975,35370,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zidovudine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838022,"",625186,160677133,5978,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vincristine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838023,"",625186,160677133,5978,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vincristine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838423,"",625186,103274172,4855,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Piromidic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838424,"",625186,103274172,4855,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Piromidic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838425,"",625186,104234163,43672,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Piperacillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838426,"",625186,104234163,43672,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Piperacillin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838427,"",625186,123094713,446598,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clindamycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838428,"",625186,123094713,446598,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clindamycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838429,"",625186,160693426,969491,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dieldrin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838430,"",625186,160693426,969491,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dieldrin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838431,"",625186,131283791,5360515,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Naltrexone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838432,"",625186,131283791,5360515,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Naltrexone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838433,"",625186,174510203,9838675,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Astemisinin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838434,"",625186,174510203,9838675,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Astemisinin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838435,"",625186,103199382,3878,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lamotrigine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838436,"",625186,103199382,3878,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lamotrigine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838437,"",625186,103163765,4893,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prazosin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838438,"",625186,103163765,4893,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prazosin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838439,"",625186,103288373,2732,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorthalidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838440,"",625186,103189011,1978,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acebutolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838441,"",625186,103189011,1978,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acebutolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838442,"",625186,103189246,2803,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clonidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838443,"",625186,103189246,2803,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clonidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838866,"",625186,136944588,443495,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sodium arsenite,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838867,"",625186,136944588,443495,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sodium arsenite,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838868,"",625186,103199419,941361,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flunarizine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838869,"",625186,103199419,941361,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flunarizine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838870,"",625186,103555920,9444,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azacitidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838871,"",625186,103555920,9444,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azacitidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838872,"",625186,103170037,5284596,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Naloxone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838873,"",625186,103170037,5284596,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Naloxone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838874,"",625186,103211583,3397,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flutamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838875,"",625186,103211583,3397,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flutamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838876,"",625186,103513016,2333,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzbromarone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838877,"",625186,103513016,2333,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzbromarone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838878,"",625186,103164548,5284616,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sirolimus,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838879,"",625186,103164548,5284616,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sirolimus,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838880,"",625186,104234273,38945,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tocainide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838881,"",625186,104234273,38945,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tocainide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838882,"",625186,374263482,11643449,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Desacetylvinblastine amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838883,"",625186,374263482,11643449,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Desacetylvinblastine amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838884,"",625186,103558466,1349907,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methimazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838885,"",625186,103558466,1349907,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methimazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254838886,"",625186,103401015,44112,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bopindolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839271,"",625186,103401015,44112,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bopindolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839272,"",625186,124968171,186907,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aflatoxin B1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839273,"",625186,124968171,186907,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aflatoxin B1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839274,"",625186,131279814,4411,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Solgol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839275,"",625186,131279814,4411,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Solgol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839276,"",625186,103173431,4037,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Meclofenamic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839277,"",625186,103173431,4037,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Meclofenamic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839279,"",625186,103176241,2812,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clotrimazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839281,"",625186,103203986,2336,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzo[a]pyrene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839282,"",625186,103207442,5281040,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Montelukast,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839283,"",625186,103207442,5281040,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Montelukast,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839284,"",625186,103348651,6197,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cycloheximide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839285,"",625186,103348651,6197,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cycloheximide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839286,"",625186,103288373,2732,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlorthalidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839287,"",625186,103163873,3357,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fleroxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839288,"",625186,103163873,3357,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fleroxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839289,"",625186,103168637,6228,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","N,N-Dimethylformamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839290,"",625186,103168637,6228,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","N,N-Dimethylformamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839291,"",625186,123096749,11080,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-Naphthyl isothiocyanate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839674,"",625186,103770568,5281034,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxymetholone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839675,"",625186,103770568,5281034,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxymetholone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839676,"",625186,103172254,5983,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Physostigmine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839677,"",625186,103172254,5983,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Physostigmine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839678,"",625186,103190907,2797,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clofibric acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839679,"",625186,103190907,2797,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clofibric acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839680,"",625186,103508277,5852,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Penicillamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839681,"",625186,103508277,5852,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Penicillamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839682,"",625186,123090165,2769,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propulsid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839683,"",625186,103771007,49800046,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","[(1S,2R,4S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;bromide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839684,"",625186,103171247,3598,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hexachlorophene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839687,"",625186,103212333,3198,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Econazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839688,"",625186,103172458,53232,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lovastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839689,"",625186,103172458,53232,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lovastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839690,"",625186,103455384,5281004,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Budesonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839691,"",625186,103455384,5281004,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Budesonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839692,"",625186,103770692,688020,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2-Butenamide, N-ethyl-N-(2-methylphenyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839693,"",625186,103770692,688020,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2-Butenamide, N-ethyl-N-(2-methylphenyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254839694,"",625186,103164873,2249,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Atenolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840160,"",625186,103164873,2249,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Atenolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840161,"",625186,103163782,89594,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nicotine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840162,"",625186,103163782,89594,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nicotine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840163,"",625186,136933682,2264,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azasetron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840164,"",625186,136933682,2264,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azasetron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840165,"",625186,103165163,5904,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Penicillin G,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840166,"",625186,103165163,5904,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Penicillin G,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840167,"",625186,103568173,2265,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azathioprine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840168,"",625186,103164874,2244,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aspirin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840169,"",625186,103164874,2244,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aspirin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840170,"",625186,103716863,5311067,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Desoximetasone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840171,"",625186,103716863,5311067,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Desoximetasone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840172,"",625186,124972228,3158,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zonalon,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840173,"",625186,124972228,3158,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zonalon,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840174,"",625186,103399575,3561,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Haloprogin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840175,"",625186,103399575,3561,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Haloprogin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840176,"",625186,103503975,3151,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Domperidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840177,"",625186,103503975,3151,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Domperidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840178,"",625186,103340603,688095,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(S)-(-)-pindolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840179,"",625186,103340603,688095,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(S)-(-)-pindolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840180,"",625186,103167216,3559,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Haloperidol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840562,"",625186,103167216,3559,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Haloperidol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840564,"",625186,103224052,2247,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Astemizole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840565,"",625186,103305836,3168,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Droperidol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840566,"",625186,103305836,3168,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Droperidol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840567,"",625186,103183749,4810,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Moxonidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840568,"",625186,103183749,4810,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Moxonidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840569,"",625186,103189345,4011,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Maprotiline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840570,"",625186,103189345,4011,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Maprotiline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840571,"",625186,103262836,18283,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Stavudine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840572,"",625186,103262836,18283,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Stavudine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840573,"",625186,103164806,5702063,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Guanabenz,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840574,"",625186,103164806,5702063,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Guanabenz,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840575,"",625186,103321248,18343,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxifluridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840576,"",625186,103321248,18343,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxifluridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840577,"",625186,131279812,688272,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levosulpiride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840578,"",625186,131279812,688272,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levosulpiride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840579,"",625186,103589714,5311217,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lacidipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840580,"",625186,103589714,5311217,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lacidipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840581,"",625186,103288539,7577,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","4,4'-Methylenedianiline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840582,"",625186,103288539,7577,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","4,4'-Methylenedianiline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840918,"",625186,103179319,5388962,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Enalapril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840919,"",625186,103179319,5388962,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Enalapril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840920,"",625186,103241784,64715,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mevastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840921,"",625186,103241784,64715,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mevastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840922,"",625186,103174569,4506,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nitrazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840923,"",625186,103174569,4506,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nitrazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840924,"",625186,103771007,49800046,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","[(1S,2R,4S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;bromide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840925,"",625186,160671902,2176,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ampiroxicam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840926,"",625186,160671902,2176,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ampiroxicam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840927,"",625186,103212991,2196,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aniracetam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840928,"",625186,103212991,2196,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aniracetam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840929,"",625186,134453344,68911,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Artemether,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840930,"",625186,134453344,68911,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Artemether,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840931,"",625186,103558716,66265,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexfenfluramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840932,"",625186,103558716,66265,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexfenfluramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840933,"",625186,103194429,3157,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxazosin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840934,"",625186,103194429,3157,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxazosin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840935,"",625186,103590286,54892,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Quinapril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840936,"",625186,103590286,54892,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Quinapril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840937,"",625186,103213021,4843,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Piracetam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254840938,"",625186,103213021,4843,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Piracetam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841341,"",625186,103266539,3191,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ebastine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841342,"",625186,103166132,5280961,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Genistein,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841343,"",625186,103166132,5280961,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Genistein,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841344,"",625186,103164546,1775,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenytoin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841345,"",625186,103164546,1775,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenytoin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841346,"",625186,103680984,4499,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nisoldipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841347,"",625186,103680984,4499,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nisoldipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841348,"",625186,103358193,4935,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Proparacaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841349,"",625186,103770379,64737,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bupivacaine hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841350,"",625186,103770379,64737,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bupivacaine hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841351,"",625186,103568173,2265,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azathioprine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841352,"",625186,103194851,2197,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Anisindione,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841353,"",625186,103194851,2197,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Anisindione,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841354,"",625186,103171902,5280965,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amphotericin B,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841355,"",625186,103171902,5280965,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amphotericin B,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841356,"",625186,103191130,4030,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mebendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841357,"",625186,103191130,4030,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mebendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841358,"",625186,103171590,4828,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pindolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841359,"",625186,103171590,4828,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pindolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841360,"",625186,103200972,135399235,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zaprinast,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841742,"",625186,103200972,135399235,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zaprinast,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841743,"",625186,103385271,253602,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Anisomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841744,"",625186,103478231,2187,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Anastrozole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841745,"",625186,103478231,2187,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Anastrozole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841746,"",625186,103557047,4679,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pantoprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841747,"",625186,103557047,4679,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pantoprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841748,"",625186,103163813,4583,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ofloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841749,"",625186,103163813,4583,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ofloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841750,"",625186,103164951,4946,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propranolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841751,"",625186,123083191,1201549,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benztropine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841752,"",625186,123083191,1201549,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benztropine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841753,"",625186,123086577,55245,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mifepristone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841754,"",625186,123086577,55245,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mifepristone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841755,"",625186,103219212,4021,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Edaravone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841756,"",625186,103219212,4021,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Edaravone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841757,"",625186,103183767,4680,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Papaverine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841758,"",625186,103183767,4680,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Papaverine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841759,"",625186,103385271,253602,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Anisomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841760,"",625186,103482708,92142,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(-)-Thalidomide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841761,"",625186,103482708,92142,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(-)-Thalidomide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254841762,"",625186,103176152,77918,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-Benzylimidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842164,"",625186,103176152,77918,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-Benzylimidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842165,"",625186,103230651,5284373,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",cyclosporin A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842166,"",625186,103230651,5284373,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",cyclosporin A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842167,"",625186,103520217,2153,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Theophylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842168,"",625186,103520217,2153,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Theophylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842169,"",625186,242586088,4513,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nizatidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842170,"",625186,242586088,4513,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nizatidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842171,"",625186,103242914,3108,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dipyridamole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842172,"",625186,103242914,3108,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dipyridamole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842173,"",625186,103207636,5905,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Idoxuridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842174,"",625186,103207636,5905,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Idoxuridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842175,"",625186,103589812,16574,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azaribine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842176,"",625186,103589812,16574,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azaribine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842178,"",625186,103293005,3728,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Iodoquinol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842179,"",625186,103163840,3715,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Indomethacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842180,"",625186,103181943,4829,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pioglitazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842181,"",625186,103181943,4829,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pioglitazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842182,"",625186,103204055,15625,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2,3,7,8-Tetrachlorodibenzo-P-dioxin",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842183,"",625186,103204055,15625,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2,3,7,8-Tetrachlorodibenzo-P-dioxin",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842184,"",625186,103165830,5193,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Secobarbital,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842674,"",625186,103165830,5193,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Secobarbital,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842675,"",625186,103618328,44575838,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","dipotassium;[(2R,3R,4R,5R,6R)-2-[[(1R,4R,5R,7R,9R,13R,15R)-5-carboxy-15-hydroxy-9-methyl-14-methylidene-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)-3-(3-methylbutanoyloxy)-5-sulfonatooxyoxan-4-yl] sulfate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842676,"",625186,103618328,44575838,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","dipotassium;[(2R,3R,4R,5R,6R)-2-[[(1R,4R,5R,7R,9R,13R,15R)-5-carboxy-15-hydroxy-9-methyl-14-methylidene-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)-3-(3-methylbutanoyloxy)-5-sulfonatooxyoxan-4-yl] sulfate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842677,"",625186,103589735,4507,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nitrendipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842678,"",625186,103589735,4507,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nitrendipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842679,"",625186,103556420,5901,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",6-Azauridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842680,"",625186,103556420,5901,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",6-Azauridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842681,"",625186,103707721,3156,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxapram,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842682,"",625186,103707721,3156,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxapram,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842683,"",625186,103707694,3182,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dyphylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842684,"",625186,103707694,3182,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dyphylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842685,"",625186,103176204,996,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842686,"",625186,103176204,996,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842687,"",625186,103223807,60464,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sparfloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842688,"",625186,103223807,60464,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sparfloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842689,"",625186,103164951,4946,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propranolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842690,"",625186,103407502,6366,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vinylidene chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842691,"",625186,103407502,6366,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vinylidene chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842692,"",625186,103215995,1549008,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terbinafine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842693,"",625186,103770374,6503,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tromethamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254842694,"",625186,103770374,6503,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tromethamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843119,"",625186,103249489,1548953,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Enclomiphene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843120,"",625186,103164922,5355,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulpiride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843121,"",625186,103164922,5355,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulpiride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843122,"",625186,103770612,39764,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vecuronium Bromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843123,"",625186,103770612,39764,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Vecuronium Bromide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843124,"",625186,103770528,71414,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diflorasone Diacetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843125,"",625186,103770528,71414,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diflorasone Diacetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843126,"",625186,103282519,7594,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","1,3-Diphenylguanidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843127,"",625186,103282519,7594,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","1,3-Diphenylguanidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843128,"",625186,103164872,39186,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diltiazem,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843129,"",625186,103164872,39186,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diltiazem,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843130,"",625186,103172204,60490,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zileuton,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843131,"",625186,103172204,60490,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zileuton,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843132,"",625186,103275455,1057,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pyrogallol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843133,"",625186,103275455,1057,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pyrogallol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843134,"",625186,103227365,1853,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",6(5H)-Phenanthridinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843135,"",625186,103227365,1853,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",6(5H)-Phenanthridinone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843136,"",625186,103331451,41781,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Torsemide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843137,"",625186,103331451,41781,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Torsemide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843138,"",625186,103358193,4935,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Proparacaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843584,"",625186,103770542,612,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lactic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843585,"",625186,103770542,612,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lactic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843586,"",625186,104242266,6918276,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",CID 6918276,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843587,"",625186,104242266,6918276,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",CID 6918276,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843588,"",625186,103188158,5533,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trazodone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843589,"",625186,103188158,5533,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trazodone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843590,"",625186,103164678,4114,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methoxsalen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843591,"",625186,103164678,4114,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methoxsalen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843592,"",625186,124963552,3033538,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dapiprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843593,"",625186,124963552,3033538,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dapiprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843594,"",625186,103250959,3117,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Disulfiram,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843595,"",625186,103250959,3117,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Disulfiram,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843596,"",625186,103175608,5994,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Progesterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843597,"",625186,103175608,5994,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Progesterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843598,"",625186,103215995,1549008,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terbinafine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843599,"",625186,103189187,6726,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyclizine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843600,"",625186,103189187,6726,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyclizine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843601,"",625186,103543149,28417,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Danazol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843602,"",625186,103543149,28417,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Danazol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843603,"",625186,103401161,5161,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salsalate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843604,"",625186,103401161,5161,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salsalate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843984,"",625186,103646320,9570327,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salfuride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843985,"",625186,103646320,9570327,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salfuride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843986,"",625186,123083206,5523,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ultram,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843987,"",625186,123083206,5523,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ultram,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843988,"",625186,103250420,119584,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mosapride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843989,"",625186,103250420,119584,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mosapride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843990,"",625186,103163840,3715,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Indomethacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843991,"",625186,136928378,667750,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)(2-methoxyphenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843992,"",625186,136928378,667750,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)(2-methoxyphenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843993,"",625186,123097006,8378,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Framycetin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843994,"",625186,103504084,3019,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diazoxide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843995,"",625186,103504084,3019,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diazoxide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843996,"",625186,103181781,5405,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terfenadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843997,"",625186,103181781,5405,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terfenadine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843998,"",625186,103558703,5719,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zaleplon,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254843999,"",625186,103558703,5719,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zaleplon,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844000,"",625186,124971685,71851,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Myrtecaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844001,"",625186,124971685,71851,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Myrtecaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844002,"",625186,103221520,5694,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pirinixic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844003,"",625186,124963825,3510,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Granisetronum,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844004,"",625186,124963825,3510,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Granisetronum,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844542,"",625186,103244854,392622,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ritonavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844543,"",625186,103244854,392622,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ritonavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844544,"",625186,103631353,71815,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Secnidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844545,"",625186,103631353,71815,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Secnidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844546,"",625186,103557069,6436,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Triamcinolone Acetonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844547,"",625186,103557069,6436,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Triamcinolone Acetonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844548,"",625186,103579573,457193,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dactinomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844549,"",625186,103579573,457193,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dactinomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844550,"",625186,103233471,60750,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gemcitabine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844551,"",625186,103233471,60750,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gemcitabine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844552,"",625186,103203421,3518,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Guanethidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844553,"",625186,103203421,3518,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Guanethidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844554,"",625186,103169156,3883,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lansoprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844555,"",625186,103169156,3883,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lansoprazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844556,"",625186,103512866,54675776,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tetracycline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844557,"",625186,103512866,54675776,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tetracycline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844558,"",625186,103189031,5755,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prednisolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844559,"",625186,103189031,5755,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prednisolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844560,"",625186,103557025,757,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glycolic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844561,"",625186,103557025,757,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glycolic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254844562,"",625186,103226142,5943,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carbon Tetrachloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845055,"",625186,103540543,5585,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trioxsalen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845056,"",625186,103540543,5585,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trioxsalen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845057,"",625186,104234255,439530,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Puromycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845058,"",625186,104234255,439530,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Puromycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845059,"",625186,136921833,667590,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)(2-chlorophenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845060,"",625186,136921833,667590,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)(2-chlorophenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845061,"",625186,124958057,73453,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ergocornine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845062,"",625186,124958057,73453,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ergocornine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845063,"",625186,103164726,41867,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Epirubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845064,"",625186,103164726,41867,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Epirubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845065,"",625186,103541455,446156,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cerivastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845066,"",625186,103541455,446156,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cerivastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845067,"",625186,103602769,20279,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cladribine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845068,"",625186,103602769,20279,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cladribine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845069,"",625186,103611913,8447,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2,2'-Dithiobisbenzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845070,"",625186,103611913,8447,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2,2'-Dithiobisbenzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845071,"",625186,103173757,5198,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Semustine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845072,"",625186,103173757,5198,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Semustine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845073,"",625186,103498411,5210,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sibutramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845074,"",625186,103498411,5210,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sibutramine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845075,"",625186,103301334,3675,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenelzine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845480,"",625186,103301334,3675,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenelzine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845481,"",625186,103215362,5503,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tolazamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845482,"",625186,103215362,5503,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tolazamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845483,"",625186,103165167,2756,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cimetidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845484,"",625186,103165167,2756,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cimetidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845485,"",625186,103556931,222786,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cortisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845486,"",625186,103556931,222786,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cortisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845487,"",625186,103221520,5694,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pirinixic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845488,"",625186,103168388,24360,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Camptothecin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845489,"",625186,103168388,24360,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Camptothecin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845490,"",625186,123092444,92253,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levobupivacaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845491,"",625186,123092444,92253,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levobupivacaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845492,"",625186,123097006,8378,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Framycetin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845493,"",625186,103649168,31072,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carbimazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845494,"",625186,103649168,31072,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carbimazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845495,"",625186,103231281,5526,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tranexamic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845496,"",625186,103231281,5526,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tranexamic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845497,"",625186,103292372,54454,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Simvastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845498,"",625186,103292372,54454,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Simvastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845499,"",625186,103204298,750,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glycine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845500,"",625186,103204298,750,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Glycine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845965,"",625186,103566848,3652,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydroxychloroquine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845966,"",625186,103566848,3652,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydroxychloroquine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845967,"",625186,103532317,54678486,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Warfarin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845968,"",625186,103532317,54678486,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Warfarin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845969,"",625186,103170619,60700,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Topotecan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845970,"",625186,103170619,60700,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Topotecan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845971,"",625186,103544522,2082,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Albendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845972,"",625186,103544522,2082,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Albendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845973,"",625186,103288110,5510,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tolnaftate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845974,"",625186,103288110,5510,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tolnaftate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845975,"",625186,103165609,5340,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfathiazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845976,"",625186,103165609,5340,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfathiazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845977,"",625186,103292415,9681,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methysergide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845978,"",625186,103292415,9681,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methysergide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845979,"",625186,123096753,68869,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flunoxaprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845980,"",625186,123096753,68869,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flunoxaprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845981,"",625186,103272743,667550,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexketoprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845982,"",625186,103272743,667550,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexketoprofen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845983,"",625186,123092331,9321,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydrazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845984,"",625186,103567639,135398748,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Penciclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254845985,"",625186,103567639,135398748,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Penciclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846386,"",625186,103466522,6032,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Kanamycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846387,"",625186,103466522,6032,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Kanamycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846388,"",625186,103189029,4927,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Promethazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846389,"",625186,103189029,4927,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Promethazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846390,"",625186,103210093,2753,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cilostamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846391,"",625186,103210093,2753,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cilostamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846392,"",625186,103602152,54680783,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Citrinin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846393,"",625186,103602152,54680783,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Citrinin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846394,"",625186,103226142,5943,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carbon Tetrachloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846395,"",625186,103182298,5775,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phentolamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846396,"",625186,103176346,702,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846397,"",625186,103176346,702,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846398,"",625186,103175300,47811,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pergolide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846399,"",625186,103175300,47811,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pergolide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846400,"",625186,103210094,2754,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cilostazol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846401,"",625186,103210094,2754,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cilostazol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846402,"",625186,103304486,5323714,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Furoxone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846403,"",625186,103304486,5323714,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Furoxone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846404,"",625186,103637704,108068,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",CID 108068,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846405,"",625186,103637704,108068,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",CID 108068,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846406,"",625186,103469610,6010,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methyltestosterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846834,"",625186,103469610,6010,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methyltestosterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846835,"",625186,103174641,4943,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propofol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846836,"",625186,103174641,4943,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propofol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846837,"",625186,104234228,6013,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Testosterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846838,"",625186,104234228,6013,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Testosterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846839,"",625186,123097261,31703,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxorubicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846842,"",625186,103188875,2157,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amiodarone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846843,"",625186,160693300,4678,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Panthenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846844,"",625186,160693300,4678,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Panthenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846845,"",625186,103176185,6421,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trichloroacetic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846846,"",625186,103176185,6421,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trichloroacetic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846847,"",625186,103225393,119607,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valdecoxib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846848,"",625186,136920451,5541,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Triacetin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846849,"",625186,136920451,5541,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Triacetin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846850,"",625186,103770639,5284447,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Natamycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846851,"",625186,103770639,5284447,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Natamycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846852,"",625186,103333818,9324,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlormadinone acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846853,"",625186,103333818,9324,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlormadinone acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254846854,"",625186,103171825,3637,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydralazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847324,"",625186,103171825,3637,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydralazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847325,"",625186,103216614,7108,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenothiazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847326,"",625186,103216614,7108,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenothiazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847327,"",625186,103188808,4932,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propafenone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847328,"",625186,103188808,4932,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propafenone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847329,"",625186,494428864,3033924,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847330,"",625186,494428864,3033924,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847331,"",625186,103185469,1046,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pyrazinamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847332,"",625186,103185469,1046,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pyrazinamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847333,"",625186,103545170,5284557,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethisterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847334,"",625186,103545170,5284557,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethisterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847335,"",625186,103182595,54677470,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Meloxicam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847336,"",625186,103182595,54677470,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Meloxicam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847337,"",625186,103178054,5517,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tosufloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847338,"",625186,103178054,5517,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tosufloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847339,"",625186,103256288,3516,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Guaifenesin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847340,"",625186,103256288,3516,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Guaifenesin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847341,"",625186,103176635,5282379,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Isotretinoin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847342,"",625186,103176635,5282379,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Isotretinoin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847343,"",625186,103168044,3657,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydroxyurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847344,"",625186,103168044,3657,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydroxyurea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847726,"",625186,103203075,1030,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propylene Glycol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847727,"",625186,103203075,1030,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propylene Glycol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847728,"",625186,103616777,1549041,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",cis-Isoeugenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847729,"",625186,103616777,1549041,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",cis-Isoeugenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847730,"",625186,103482102,21109,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trimetazidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847731,"",625186,103482102,21109,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trimetazidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847732,"",625186,103225393,119607,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valdecoxib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847733,"",625186,103248360,1548943,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Capsaicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847734,"",625186,103248360,1548943,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Capsaicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847735,"",625186,103724173,60606,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clopidogrel,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847736,"",625186,103724173,60606,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clopidogrel,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847737,"",625186,103164520,5831,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carbachol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847738,"",625186,103164520,5831,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Carbachol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847739,"",625186,103224449,3519,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Guanfacine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847740,"",625186,103224449,3519,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Guanfacine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847741,"",625186,103164549,445643,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tacrolimus,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847742,"",625186,103164549,445643,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tacrolimus,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847743,"",625186,103163858,130313,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulbactam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847744,"",625186,103163858,130313,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulbactam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847745,"",625186,103570000,5920,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Liothyronine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254847746,"",625186,103570000,5920,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Liothyronine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848217,"",625186,103165644,5215,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfadiazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848218,"",625186,103165644,5215,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfadiazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848219,"",625186,103422115,3039,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dichlorvos,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848220,"",625186,103422115,3039,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dichlorvos,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848221,"",625186,103419062,5921,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",N-Nitrosodiethylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848222,"",625186,103419062,5921,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",N-Nitrosodiethylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848223,"",625186,103227652,5944,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cantharidin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848224,"",625186,103227652,5944,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cantharidin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848225,"",625186,103771129,5832,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Norethindrone Acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848226,"",625186,103771129,5832,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Norethindrone Acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848227,"",625186,103165561,3639,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydrochlorothiazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848228,"",625186,103165561,3639,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydrochlorothiazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848229,"",625186,194183610,444294,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(-)-Camphor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848230,"",625186,194183610,444294,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(-)-Camphor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848231,"",625186,103532939,7858,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Allyl alcohol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848232,"",625186,103532939,7858,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Allyl alcohol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848233,"",625186,103618726,2758,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Eucalyptol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848234,"",625186,103618726,2758,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Eucalyptol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848235,"",625186,103188807,5358,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sumatriptan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848236,"",625186,103188807,5358,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sumatriptan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848237,"",625186,103220466,5742832,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aztreonam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848617,"",625186,103220466,5742832,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aztreonam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848618,"",625186,103771100,4107,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methocarbamol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848619,"",625186,103771100,4107,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methocarbamol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848620,"",625186,103246205,16231,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amiloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848621,"",625186,103246205,16231,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amiloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848622,"",625186,103558436,82153,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flunisolide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848623,"",625186,103558436,82153,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flunisolide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848624,"",625186,103737203,5511,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tolperisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848625,"",625186,103737203,5511,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tolperisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848626,"",625186,103293849,60726,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromfenac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848627,"",625186,103293849,60726,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromfenac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848628,"",625186,174494812,73348316,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(1S,2R,19R,22R,34S,37R,40R,52S)-2,64-bis[[(2R,3S,4R,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-22-amino-5,15-dichloro-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848629,"",625186,174494812,73348316,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(1S,2R,19R,22R,34S,37R,40R,52S)-2,64-bis[[(2R,3S,4R,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-22-amino-5,15-dichloro-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848630,"",625186,103182298,5775,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phentolamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848631,"",625186,103545435,440473,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mimosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848632,"",625186,103545435,440473,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mimosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848633,"",625186,160671983,60712,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tenidap,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848634,"",625186,160671983,60712,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tenidap,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848635,"",625186,123092331,9321,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydrazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848636,"",625186,103165086,2750,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ciglitazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254848637,"",625186,103165086,2750,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ciglitazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849037,"",625186,103770662,3007855,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zincchloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849038,"",625186,103770662,3007855,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zincchloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849039,"",625186,103503926,667490,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mercaptopurine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849040,"",625186,103503926,667490,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mercaptopurine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849041,"",625186,123099352,39468,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levobunolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849042,"",625186,123099352,39468,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levobunolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849043,"",625186,103469419,5833,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Spironolactone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849044,"",625186,103469419,5833,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Spironolactone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849045,"",625186,103469360,15730,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-Octylphenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849046,"",625186,103469360,15730,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-Octylphenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849047,"",625186,194179209,5284517,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Astromicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849048,"",625186,194179209,5284517,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Astromicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849049,"",625186,103228757,2088,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alendronic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849050,"",625186,103228757,2088,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alendronic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849051,"",625186,242084623,11286230,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nystatin A1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849052,"",625186,242084623,11286230,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nystatin A1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849053,"",625186,103183701,5352624,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulindac sulfide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849054,"",625186,103183701,5352624,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulindac sulfide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849055,"",625186,494429426,3000261,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","Ajmalan-17,21-diol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849056,"",625186,494429426,3000261,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","Ajmalan-17,21-diol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849057,"",625186,103469357,5756,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Estriol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849435,"",625186,103469357,5756,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Estriol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849436,"",625186,103191369,3033,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diclofenac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849437,"",625186,103515892,441071,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Strychnine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849438,"",625186,103556242,3686,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Idebenone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849439,"",625186,103556242,3686,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Idebenone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849440,"",625186,104234146,62959,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trovafloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849441,"",625186,104234146,62959,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trovafloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849442,"",625186,136925223,3236,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Eperisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849443,"",625186,136925223,3236,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Eperisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849444,"",625186,104234199,54687,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pravastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849445,"",625186,103524732,5144,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Safrole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849446,"",625186,103524732,5144,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Safrole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849447,"",625186,103191605,6251,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mannitol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849448,"",625186,103191605,6251,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mannitol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849449,"",625186,103291875,6238,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydroxyprogesterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849450,"",625186,103291875,6238,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Hydroxyprogesterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849452,"",625186,194161898,76322320,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxybutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide;N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxybutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849453,"",625186,103303946,3748,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Iproniazid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849454,"",625186,103303946,3748,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Iproniazid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849455,"",625186,103534218,6075,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pecazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849900,"",625186,103534218,6075,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pecazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849901,"",625186,103179212,2337,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzocaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849902,"",625186,103179212,2337,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzocaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849903,"",625186,136928510,2810,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clorprenaline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849904,"",625186,136928510,2810,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clorprenaline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849905,"",625186,103191369,3033,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diclofenac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849906,"",625186,103306382,2099,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alosetron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849907,"",625186,103306382,2099,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Alosetron,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849908,"",625186,103555930,5572,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trihexyphenidyl,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849909,"",625186,103555930,5572,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trihexyphenidyl,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849911,"",625186,103507191,8478,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benzethonium Chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849912,"",625186,103755607,460129,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azaserine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849913,"",625186,103755607,460129,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azaserine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849914,"",625186,103279849,5280795,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cholecalciferol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849915,"",625186,103279849,5280795,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cholecalciferol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849916,"",625186,103532383,54676038,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dicumarol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849917,"",625186,103532383,54676038,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dicumarol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849918,"",625186,103332887,10917,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levocarnitine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849919,"",625186,103332887,10917,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levocarnitine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254849920,"",625186,103529091,135398739,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Didanosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850453,"",625186,103529091,135398739,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Didanosine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850454,"",625186,103250329,3899,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Leflunomide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850455,"",625186,103250329,3899,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Leflunomide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850456,"",625186,103175312,12560,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Erythromycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850457,"",625186,103175312,12560,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Erythromycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850458,"",625186,164141688,2733335,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","1-methyl-1-nitroso-3-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850459,"",625186,164141688,2733335,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","1-methyl-1-nitroso-3-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850460,"",625186,103189214,6741,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methylprednisolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850461,"",625186,103189214,6741,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methylprednisolone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850462,"",625186,103164917,5566,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trifluoperazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850463,"",625186,103164917,5566,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trifluoperazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850464,"",625186,103484622,221493,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cholic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850465,"",625186,103484622,221493,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cholic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850467,"",625186,103163913,176155,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850468,"",625186,103687860,75792,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(+)-Thalidomide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850469,"",625186,103169151,5452,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thioridazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850470,"",625186,103169151,5452,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thioridazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850471,"",625186,103183576,5717,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zafirlukast,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850472,"",625186,103183576,5717,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Zafirlukast,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850473,"",625186,103165933,2712,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlordiazepoxide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850876,"",625186,103165933,2712,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlordiazepoxide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850877,"",625186,103371832,5318,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850878,"",625186,103371832,5318,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850879,"",625186,103174312,51081,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pefloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850880,"",625186,103174312,51081,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pefloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850881,"",625186,103398356,1752,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-Nonylphenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850882,"",625186,103398356,1752,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",4-Nonylphenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850883,"",625186,123094719,54585,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Balsalazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850884,"",625186,123094719,54585,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Balsalazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850885,"",625186,104234199,54687,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pravastatin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850886,"",625186,103177857,8969,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Yohimbine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850887,"",625186,103177857,8969,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Yohimbine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850888,"",625186,103377543,5624,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2-((4-(2,6-Di(pyrrolidin-1-yl)pyrimidin-4-yl)piperazin-1-yl)methyl)-2,5,7,8-tetramethylchroman-6-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850889,"",625186,103377543,5624,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2-((4-(2,6-Di(pyrrolidin-1-yl)pyrimidin-4-yl)piperazin-1-yl)methyl)-2,5,7,8-tetramethylchroman-6-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850890,"",625186,103255183,4891,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Praziquantel,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850891,"",625186,103255183,4891,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Praziquantel,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850892,"",625186,103164735,1986,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acetazolamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850893,"",625186,103164735,1986,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acetazolamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850894,"",625186,103217150,19099,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","10,11-Dihydrocarbamazepine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850895,"",625186,103217150,19099,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","10,11-Dihydrocarbamazepine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254850896,"",625186,103277459,2052,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tyrphostin A23,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851375,"",625186,103277459,2052,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tyrphostin A23,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851376,"",625186,174489643,54675777,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlortetracycline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851377,"",625186,174489643,54675777,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chlortetracycline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851378,"",625186,103188847,9782,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betamethasone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851379,"",625186,103588726,5641,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Urethane,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851380,"",625186,103588726,5641,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Urethane,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851381,"",625186,103287107,5467,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tiapride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851382,"",625186,103287107,5467,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tiapride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851383,"",625186,103250362,5323,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfadimethoxine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851384,"",625186,103250362,5323,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfadimethoxine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851385,"",625186,103504457,4497,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nimodipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851386,"",625186,103504457,4497,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nimodipine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851387,"",625186,103684622,10531,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dihydroergotamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851388,"",625186,103684622,10531,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dihydroergotamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851389,"",625186,103240106,4753,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenacemide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851390,"",625186,103240106,4753,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenacemide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851391,"",625186,103179006,4754,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenacetin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851392,"",625186,103179006,4754,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Phenacetin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851393,"",625186,103165713,444795,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tretinoin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851394,"",625186,103165713,444795,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tretinoin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851395,"",625186,103637443,4211,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mitotane,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851781,"",625186,103637443,4211,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mitotane,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851782,"",625186,103257884,22475,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Succinylcholine Chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851783,"",625186,103257884,22475,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Succinylcholine Chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851784,"",625186,103189263,5757,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Estradiol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851785,"",625186,103189263,5757,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Estradiol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851786,"",625186,242501998,644020,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sparteine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851787,"",625186,242501998,644020,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sparteine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851788,"",625186,103556997,9642,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluocinonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851789,"",625186,103556997,9642,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluocinonide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851790,"",625186,103189275,9651,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Galantamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851791,"",625186,103189275,9651,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Galantamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851792,"",625186,136930151,5597,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Troxipide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851793,"",625186,136930151,5597,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Troxipide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851794,"",625186,103469393,10631,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Medroxyprogesterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851795,"",625186,103469393,10631,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Medroxyprogesterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851796,"",625186,312468102,148123,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Docetaxel trihydrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851797,"",625186,312468102,148123,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Docetaxel trihydrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851798,"",625186,103231964,3324,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Famciclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851799,"",625186,103231964,3324,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Famciclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851800,"",625186,103770993,225609,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fludrocortisone Acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254851801,"",625186,103770993,225609,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fludrocortisone Acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852303,"",625186,103544139,667749,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)(2-fluorophenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852304,"",625186,103544139,667749,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)(2-fluorophenyl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852305,"",625186,103245522,5291,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Imatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852306,"",625186,103245522,5291,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Imatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852307,"",625186,103601826,174,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethylene Glycol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852308,"",625186,103601826,174,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethylene Glycol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852309,"",625186,103687860,75792,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(+)-Thalidomide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852310,"",625186,104234176,36462,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Etoposide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852311,"",625186,104234176,36462,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Etoposide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852312,"",625186,136925133,17683252,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)-[2-(trifluoromethyl)phenyl]methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852313,"",625186,136925133,17683252,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",(4-Benzylpiperidin-1-yl)-[2-(trifluoromethyl)phenyl]methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852314,"",625186,103516887,3000540,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lincomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852315,"",625186,103516887,3000540,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lincomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852316,"",625186,103515892,441071,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Strychnine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852317,"",625186,103165317,3869,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Labetalol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852318,"",625186,103165317,3869,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Labetalol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852319,"",625186,103770587,5593,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tropicamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852320,"",625186,103770587,5593,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tropicamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852321,"",625186,103174787,54676228,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Piroxicam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852322,"",625186,103174787,54676228,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Piroxicam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852323,"",625186,103164301,5591,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Troglitazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852799,"",625186,103164301,5591,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Troglitazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852800,"",625186,103193303,5411,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tetracaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852801,"",625186,103193303,5411,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tetracaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852802,"",625186,103193092,5576,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trimethadione,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852803,"",625186,103193092,5576,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trimethadione,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852804,"",625186,103770995,15209,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flurandrenolide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852805,"",625186,103770995,15209,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Flurandrenolide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852806,"",625186,103188847,9782,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betamethasone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852807,"",625186,103181002,2662,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Celecoxib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852808,"",625186,103181002,2662,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Celecoxib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852809,"",625186,103188954,5656,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Venlafaxine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852810,"",625186,103204244,5770,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Reserpine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852811,"",625186,103204244,5770,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Reserpine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852812,"",625186,136926966,135398735,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rifampin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852813,"",625186,136926966,135398735,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Rifampin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852814,"",625186,103226686,446541,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mycophenolic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852815,"",625186,103226686,446541,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mycophenolic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852816,"",625186,103259583,445154,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Resveratrol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852817,"",625186,103259583,445154,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Resveratrol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852818,"",625186,103170197,31101,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromocriptine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254852819,"",625186,103170197,31101,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromocriptine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853294,"",625186,124958489,104903,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tirilazad,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853295,"",625186,124958489,104903,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tirilazad,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853296,"",625186,103273527,5509,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tolmetin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853297,"",625186,103273527,5509,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tolmetin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853298,"",625186,103304594,32176,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",6-Methoxy-2-naphthylacetic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853299,"",625186,103304594,32176,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",6-Methoxy-2-naphthylacetic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853300,"",625186,103164353,3016,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853301,"",625186,103164353,3016,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Diazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853302,"",625186,103188912,5865,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prednisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853303,"",625186,103188912,5865,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Prednisone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853304,"",625186,103165964,2802,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clonazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853305,"",625186,103165964,2802,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clonazepam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853306,"",625186,103188337,5430,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thiabendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853307,"",625186,103188337,5430,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thiabendazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853308,"",625186,103380806,5319,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfabenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853309,"",625186,103380806,5319,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfabenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853310,"",625186,103165643,5325,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfamerazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853311,"",625186,103165643,5325,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfamerazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853312,"",625186,103770583,9878,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluorometholone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853313,"",625186,103770583,9878,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluorometholone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853314,"",625186,103190535,5816,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Epinephrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853747,"",625186,103190535,5816,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Epinephrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853748,"",625186,103219083,5342,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfinpyrazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853749,"",625186,103219083,5342,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfinpyrazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853750,"",625186,103195118,2083,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Albuterol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853751,"",625186,103195118,2083,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Albuterol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853752,"",625186,103164821,5339,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfasalazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853753,"",625186,103164821,5339,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfasalazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853754,"",625186,103339774,5362129,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ramipril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853755,"",625186,103339774,5362129,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ramipril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853756,"",625186,103177883,3121,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valproic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853757,"",625186,103177883,3121,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valproic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853758,"",625186,103254526,11057,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gentian Violet,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853759,"",625186,103254526,11057,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gentian Violet,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853760,"",625186,103558530,54675779,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxytetracycline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853761,"",625186,103558530,54675779,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxytetracycline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853762,"",625186,103188954,5656,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Venlafaxine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853763,"",625186,103220490,5362124,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benazepril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853764,"",625186,103220490,5362124,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Benazepril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853765,"",625186,103240093,5790,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Floxuridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254853766,"",625186,103240093,5790,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Floxuridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854176,"",625186,103167833,4212,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mitoxantrone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854177,"",625186,136928379,196129,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cygro,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854178,"",625186,136928379,196129,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cygro,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854179,"",625186,103172426,12456,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Berberine chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854180,"",625186,103183978,28693,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metergoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854181,"",625186,103183978,28693,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metergoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854182,"",625186,103558443,3749,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Irbesartan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854183,"",625186,103558443,3749,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Irbesartan,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854184,"",625186,103170100,2733526,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tamoxifen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854186,"",625186,103169867,3676,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lidocaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854187,"",625186,103169867,3676,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lidocaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854188,"",625186,103405309,441383,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854189,"",625186,103405309,441383,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Terconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854190,"",625186,103178971,1983,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acetaminophen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854191,"",625186,103178971,1983,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Acetaminophen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854192,"",625186,103245064,3446,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gabapentin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854193,"",625186,103245064,3446,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Gabapentin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854194,"",625186,103408740,28864,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lisuride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854195,"",625186,103408740,28864,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lisuride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854196,"",625186,103382993,9880,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyproterone acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854745,"",625186,103382993,9880,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyproterone acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854746,"",625186,103696081,84029,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clarithromycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854747,"",625186,103696081,84029,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clarithromycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854748,"",625186,103176475,3365,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854749,"",625186,103176475,3365,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fluconazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854750,"",625186,103226170,6212,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chloroform,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854751,"",625186,103226170,6212,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Chloroform,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854752,"",625186,123094738,159055,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Camphor (synthetic),ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854753,"",625186,123094738,159055,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Camphor (synthetic),ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854754,"",625186,136939962,36119,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sisomicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854755,"",625186,136939962,36119,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sisomicin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854756,"",625186,103274161,4746,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Perhexiline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854757,"",625186,103274161,4746,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Perhexiline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854758,"",625186,103245564,2391,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bisacodyl,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854759,"",625186,103245564,2391,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bisacodyl,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854760,"",625186,103770541,10909430,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bacitracin A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854761,"",625186,103770541,10909430,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bacitracin A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854762,"",625186,103177051,2771,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Citalopram,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854763,"",625186,103177051,2771,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Citalopram,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854764,"",625186,103589983,54766,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bambuterol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254854765,"",625186,103589983,54766,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bambuterol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855176,"",625186,312365533,13690207,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",H-D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-D-aThr-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855177,"",625186,312365533,13690207,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",H-D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-D-aThr-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855178,"",625186,104247295,47866,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyromazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855179,"",625186,104247295,47866,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Cyromazine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855180,"",625186,103303791,71771,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aceclofenac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855181,"",625186,103303791,71771,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aceclofenac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855182,"",625186,103178942,2796,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clofibrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855183,"",625186,103166463,896,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Melatonin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855184,"",625186,103166463,896,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Melatonin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855185,"",625186,124966219,15032,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pregnenolone carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855186,"",625186,103494075,14957,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Antimycin A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855187,"",625186,103494075,14957,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Antimycin A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855188,"",625186,103184643,4912,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Probucol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855189,"",625186,103184643,4912,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Probucol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855190,"",625186,103166129,3278,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethacrynic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855191,"",625186,103512892,169371,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aminopterin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855192,"",625186,103512892,169371,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aminopterin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855193,"",625186,103418150,3747,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ipriflavone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855194,"",625186,103418150,3747,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ipriflavone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855195,"",625186,104247004,444913,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",alpha-CYCLODEXTRIN,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855196,"",625186,104247004,444913,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",alpha-CYCLODEXTRIN,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855644,"",625186,103168084,10607,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Podofilox,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855645,"",625186,103168084,10607,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Podofilox,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855646,"",625186,103284327,1923,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxyquinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855647,"",625186,103284327,1923,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxyquinoline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855648,"",625186,494430630,24832676,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aconitin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855649,"",625186,494430630,24832676,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aconitin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855650,"",625186,103179013,1548887,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulindac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855651,"",625186,103179013,1548887,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulindac,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855652,"",625186,103288166,5560,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trichlormethiazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855653,"",625186,103288166,5560,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Trichlormethiazide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855654,"",625186,103654274,9917490,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pharmakon1600-01500602,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855655,"",625186,103654274,9917490,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pharmakon1600-01500602,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855656,"",625186,103770606,13765,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethylestrenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855657,"",625186,103770606,13765,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethylestrenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855658,"",625186,103179607,5362440,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Indinavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855659,"",625186,103179607,5362440,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Indinavir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855660,"",625186,103172426,12456,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Berberine chloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855661,"",625186,103193099,3291,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethosuximide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855662,"",625186,103168755,12124,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metacetamol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855663,"",625186,103168755,12124,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metacetamol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254855664,"",625186,103195252,5002,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Quetiapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856101,"",625186,103195252,5002,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Quetiapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856102,"",625186,103170049,5035,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Raloxifene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856103,"",625186,103170049,5035,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Raloxifene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856104,"",625186,103358404,4886,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pramoxine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856105,"",625186,103358404,4886,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pramoxine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856106,"",625186,103210632,4201,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Minoxidil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856107,"",625186,103210632,4201,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Minoxidil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856108,"",625186,104234169,126941,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methotrexate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856109,"",625186,104234169,126941,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methotrexate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856110,"",625186,103406603,71335,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Danofloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856111,"",625186,103406603,71335,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Danofloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856112,"",625186,136926996,657272,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Choline Alfoscerate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856113,"",625186,136926996,657272,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Choline Alfoscerate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856114,"",625186,103533189,44431027,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",gamma-Cyclodextrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856115,"",625186,103533189,44431027,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",gamma-Cyclodextrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856116,"",625186,103462008,275196,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Noscapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856117,"",625186,103462008,275196,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Noscapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856118,"",625186,103231282,4170,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metolazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856119,"",625186,103231282,4170,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Metolazone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856120,"",625186,103166129,3278,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethacrynic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856121,"",625186,103228758,3305,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Etidronic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856595,"",625186,103228758,3305,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Etidronic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856596,"",625186,103188732,4740,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pentoxifylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856597,"",625186,103188732,4740,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pentoxifylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856598,"",625186,103165765,135398737,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clozapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856599,"",625186,103165765,135398737,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clozapine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856600,"",625186,103504490,135398740,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ganciclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856601,"",625186,103504490,135398740,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ganciclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856603,"",625186,124974065,36314,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Paclitaxel,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856604,"",625186,103240839,5245,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Risedronic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856605,"",625186,103240839,5245,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Risedronic Acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856606,"",625186,124974125,2447,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromisoval,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856607,"",625186,124974125,2447,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Bromisoval,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856609,"",625186,103173154,42574,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Closantel,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856610,"",625186,103224659,442292,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Picrotoxinin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856611,"",625186,103224659,442292,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Picrotoxinin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856612,"",625186,136920460,7000,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",O-Anisidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856613,"",625186,136920460,7000,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",O-Anisidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856614,"",625186,103376533,4634,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxybutynin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254856615,"",625186,103376533,4634,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Oxybutynin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857116,"",625186,103770607,9270,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethynodiol diacetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857117,"",625186,103770607,9270,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethynodiol diacetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857118,"",625186,103336971,9819053,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2-(4-Fluorophenyl)-4-methoxy-3-(pyridin-4-YL)-1H-pyrrolo[2,3-B]pyridin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857119,"",625186,103336971,9819053,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","2-(4-Fluorophenyl)-4-methoxy-3-(pyridin-4-YL)-1H-pyrrolo[2,3-B]pyridin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857120,"",625186,242566490,5353627,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857121,"",625186,242566490,5353627,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857122,"",625186,103179077,4914,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Procaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857123,"",625186,103179077,4914,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Procaine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857124,"",625186,103253261,4488,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Niflumic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857125,"",625186,103253261,4488,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Niflumic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857126,"",625186,103165982,5344,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfisoxazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857127,"",625186,103165982,5344,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sulfisoxazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857128,"",625186,123100913,4284720,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-[5-(thiophen-2-ylmethoxy)-1H-indol-3-yl]propan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857129,"",625186,123100913,4284720,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",1-[5-(thiophen-2-ylmethoxy)-1H-indol-3-yl]propan-2-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857130,"",625186,103605085,26987,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clemastine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857131,"",625186,103605085,26987,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clemastine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857132,"",625186,103193099,3291,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ethosuximide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857133,"",625186,103168313,5426,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thalidomide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857134,"",625186,103173542,4992,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pyrilamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857135,"",625186,103173542,4992,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pyrilamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857136,"",625186,103172304,1935,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tacrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857747,"",625186,103172304,1935,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tacrine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857748,"",625186,103232332,2783,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clenbuterol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857749,"",625186,103232332,2783,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Clenbuterol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857750,"",625186,103200429,222757,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Estradiol Benzoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857751,"",625186,103200429,222757,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Estradiol Benzoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857752,"",625186,103378026,5362119,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lisinopril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857753,"",625186,103378026,5362119,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Lisinopril,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857754,"",625186,103355081,1720,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","4-Amino-1,8-naphthalimide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857755,"",625186,103355081,1720,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))","4-Amino-1,8-naphthalimide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857756,"",625186,103179819,5546,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Triamterene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857757,"",625186,103179819,5546,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Triamterene,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857758,"",625186,103167313,4735,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pentamidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857759,"",625186,103167313,4735,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Pentamidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857760,"",625186,103268014,6047,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levodopa,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857761,"",625186,103268014,6047,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Levodopa,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857762,"",625186,103329683,4133,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methyl Salicylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857763,"",625186,103329683,4133,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Methyl Salicylate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857764,"",625186,103175236,447043,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azithromycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857765,"",625186,103175236,447043,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Azithromycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857766,"",625186,124966244,50942,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxofylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254857767,"",625186,124966244,50942,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Doxofylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858203,"",625186,242430918,5282435,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Irsogladine maleate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858204,"",625186,242430918,5282435,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Irsogladine maleate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858205,"",625186,136944590,6101868,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Strontium Chloride Hexahydrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858206,"",625186,136944590,6101868,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Strontium Chloride Hexahydrate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858207,"",625186,103245600,1549120,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Epalrestat,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858208,"",625186,103245600,1549120,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Epalrestat,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858209,"",625186,103165562,3440,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Furosemide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858210,"",625186,103165562,3440,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Furosemide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858211,"",625186,160703994,54677971,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tenoxicam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858212,"",625186,160703994,54677971,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Tenoxicam,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858213,"",625186,103173037,21138,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexpropranolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858214,"",625186,103173037,21138,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dexpropranolol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858215,"",625186,103178134,71188,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Enrofloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858216,"",625186,103178134,71188,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Enrofloxacin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858217,"",625186,103588722,657237,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fludarabine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858218,"",625186,103588722,657237,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Fludarabine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858219,"",625186,123084917,119020,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Arcaine sulfate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858220,"",625186,123084917,119020,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Arcaine sulfate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858221,"",625186,103440109,135398742,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valacyclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858222,"",625186,103440109,135398742,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Valacyclovir,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858223,"",625186,103548420,135398744,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sildenafil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858727,"",625186,103548420,135398744,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Sildenafil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858728,"",625186,103168783,4122,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nocodazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858729,"",625186,103168783,4122,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Nocodazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858730,"",625186,103221475,3314,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Eugenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858731,"",625186,103221475,3314,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Eugenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858732,"",625186,103524891,5281078,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mycophenolate Mofetil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858733,"",625186,103524891,5281078,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Mycophenolate Mofetil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858734,"",625186,103224166,4909,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Primidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858735,"",625186,103241510,36811,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dobutamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858736,"",625186,103241510,36811,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dobutamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858737,"",625186,103175725,3827,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ketotifen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858738,"",625186,103175725,3827,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ketotifen,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858739,"",625186,103511767,439501,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ouabain,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858740,"",625186,103511767,439501,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Ouabain,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858741,"",625186,124966204,107782,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betamethasone phosphate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858742,"",625186,124966204,107782,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Betamethasone phosphate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858744,"",625186,103323115,5281787,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Caffeic acid phenethyl ester,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858745,"",625186,160671847,9433,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aminophylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858746,"",625186,160671847,9433,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Aminophylline,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254858747,"",625186,103224166,4909,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Primidone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859210,"",625186,103558581,657298,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propylthiouracil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859211,"",625186,103558581,657298,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Propylthiouracil,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859212,"",625186,103168313,5426,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Thalidomide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859213,"",625186,123100235,3085092,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salinomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859214,"",625186,123100235,3085092,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Salinomycin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859215,"",625186,103291064,5879,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Androsterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859216,"",625186,103291064,5879,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Androsterone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859217,"",625186,103590644,656516,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amygdalin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859218,"",625186,103590644,656516,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Amygdalin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859219,"",625186,103513368,3902,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Letrozole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859220,"",625186,103513368,3902,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Letrozole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859221,"",625186,103318016,3042,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,IC50,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dicyclomine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
254859222,"",625186,103318016,3042,2064,"",Confirmatory,20240503,0,0,Unspecified,P04626,Ki,"",ChEMBL,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Dicyclomine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304124,"",651424,103176259,15872391,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-{4-[5-(4-Fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidin-2-yloxy}-benzonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304125,"",651424,103176260,15872388,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-Phenoxy-4-[1-(piperidine-4-yl)-4-(4-fluorophenyl)-5-imidazolyl]pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304126,"",651424,103176495,15872404,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(3-Fluoro-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304127,"",651424,103259940,9604970,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"1-(3-methoxyphenyl)-3-methyl-N-[(E)-1-pyridin-4-ylethylideneamino]pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304128,"",651424,103310961,22464113,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[5-(4-Fluoro-phenyl)-3-(1-methyl-piperidin-4-yl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304129,"",651424,103316127,5329404,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N,5-diphenyl-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304130,"",651424,103407492,6539453,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Arylmaleimide deriv. 6c,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304131,"",651424,103456911,599038,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(1-Ethyl-1H-benzimidazol-2-yl)-1,2,5-oxadiazol-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304132,"",651424,103465517,5329850,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[(5-Phenyl-1,3-oxazol-2-yl)amino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304133,"",651424,103503437,44418556,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],5-[(E)-2-(2-chlorophenyl)ethenyl]-N-methylpyridine-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304134,"",651424,103503456,44418572,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-3,5-Dimethyl-4-(2-(5-(methylcarbamoyl)pyridin-3-yl)vinyl)phenyl methylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304135,"",651424,103504657,11247002,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(3,4-dichlorophenyl)-N-1H-indazol-5-yl-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304136,"",651424,103566727,6539567,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[6-(4-methoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304137,"",651424,103610164,44571453,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],EGFR/ErbB-2 inhibitor-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304138,"",651424,103610848,9826308,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(5,6-Dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304139,"",651424,103623535,44578255,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"6-Methyl-biphenyl-3,4''-dicarboxylic acid 3-cyclobutylamide 4''-cyclopropylmethyl-amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304140,"",651424,103627932,10308522,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(4-Pyrazolo[1,5-b]pyridazin-3-yl-2-pyrimidinyl)amino]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304141,"",651424,103629585,25218573,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-((2-((5-(2-(Dimethylamino)-N-methylacetamido)-2-methoxy-4-methylphenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304142,"",651424,103176292,9885504,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-{3-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-imidazol-1-yl]-propyl}-morpholine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304143,"",651424,103176408,9890357,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-{4-[5-(4-Fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidin-2-yloxy}-benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304144,"",651424,103310794,17892742,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],{4-[5-(4-Fluoro-phenyl)-3-(1-methyl-piperidin-4-yl)-3H-imidazol-4-yl]-pyrimidin-2-yl}-phenyl-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304145,"",651424,103407728,6539466,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Arylmaleimide deriv. 6p,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304146,"",651424,103454620,11473228,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(3-Chlorophenyl)-5-(1,5-naphthyridin-2-yl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304147,"",651424,103454721,6539418,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 76",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304148,"",651424,103455206,6539424,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[2-(4-chlorophenyl)pyrazolo[1,5-b]pyridazin-3-yl]-N-phenylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304149,"",651424,103456492,44396990,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(4-Ethoxy-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304150,"",651424,103486307,11669455,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(4-aminophenyl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304151,"",651424,103534542,766948,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-Cyano-4,5,6,7-Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304152,"",651424,103536614,9927432,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Methyl-3-{[6-(Methylsulfonyl)quinolin-4-Yl]amino}phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304153,"",651424,103552592,10113568,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],TIE-2/VEGFR-2 kinase-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304154,"",651424,103566730,135435015,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(5-bromo-6-(4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-1-methylpiperidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304283,"",651424,103575285,10200651,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-Cyanophenyl)-2'-Methyl-5'-(5-Methyl-1,3,4-Oxadiazol-2-Yl)-4-Biphenylcarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304284,"",651424,103592466,5329489,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(3-Ethynylphenyl)-6-(4-((2-(methylsulfonyl)ethyl)amino)butoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304285,"",651424,103176271,15872400,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[5-(4-Fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-2-(4-phenoxy-phenoxy)-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304286,"",651424,103176382,15872407,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-[3-(Trifluoromethyl)phenoxy]-4-[1-(piperidine-4-yl)-4-(4-fluorophenyl)-5-imidazolyl]pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304287,"",651424,103311248,44329036,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-{4-[5-(4-Fluoro-phenyl)-3-(1-methyl-piperidin-4-yl)-3H-imidazol-4-yl]-pyrimidin-2-ylamino}-ethanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304288,"",651424,103449269,11290221,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(4-Fluorophenyl)-5-(1,5-naphthyridin-2-yl)thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304289,"",651424,103466885,5329801,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(4-Methoxyphenyl)furo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304290,"",651424,103522255,16048303,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-Amino-5-(4-fluorophenyl)-3-(pyridin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304291,"",651424,103527603,10160775,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"methyl N-[6-(4-{[(3-ethylphenyl)carbamoyl]amino}phenoxy)-1H-1,3-benzodiazol-2-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304292,"",651424,103577755,135434965,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Oxindole-Based Inhibitor 20,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304293,"",651424,103577937,135435007,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Oxindole-Based Inhibitor 81,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304294,"",651424,103610354,25263115,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-N-methyl-3-{[2-(trifluoromethyl)phenyl]methoxy}thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304295,"",651424,103611131,25263099,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-[5,6-bis(methyloxy)-1H-benzimidazol-1-yl]-3-[(2-phenylethyl)oxy]-2-thiophenecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304296,"",651424,103612574,25263117,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(1S)-1-(2-chlorophenyl)ethoxy]-5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304297,"",651424,134437918,25263123,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-{6-[(1-methylpiperidin-4-yl)methoxy]-1H-1,3-benzodiazol-1-yl}-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304298,"",651424,134449559,3805075,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-Methoxy-4-hydroxybenzaldehyde [1-(phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]hydrazone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304299,"",651424,136920479,16236469,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-y",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304300,"",651424,136932136,57396353,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[2-(dimethylamino)ethyl]-4-[(E)-[[1-(3-methoxyphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]hydrazinylidene]methyl]benzamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304301,"",651424,136938729,56603973,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],CID 56603973,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304302,"",651424,103441529,5329860,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-Anilino-5-aryloxazole 27,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304303,"",651424,103457523,44397710,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[1-(3-Dimethylamino-propyl)-1H-imidazo[4,5-c]pyridin-2-yl]-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304304,"",651424,103484113,11604319,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-{2-[(4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]-pyridin-2-yl}-phenyl)oxy]ethyl}morpholine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304305,"",651424,103498517,9873849,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(((5-(4-(4-(3-Fluorobenzyloxy)-3-chlorophenylamino)quinazolin-6-yl)furan-2-yl)methyl)(2-(methylsulfonyl)ethyl)amino)acetonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304306,"",651424,103508344,11957417,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-[5,6-Bis(Methyloxy)-1h-Benzimidazol-1-Yl]-3-{[1-(2-Chlorophenyl)ethyl]oxy}-2-Thiophenecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304307,"",651424,103575696,10158653,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[(4-methoxyphenyl)methyl]-4-[2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304308,"",651424,103610291,25263114,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"1-[5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-3-{[2-(trifluoromethyl)phenyl]methoxy}thiophen-2-yl]ethan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304309,"",651424,103631934,25218601,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-fluoro-2-[(2-{[2-methoxy-4-(1-propylpiperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304310,"",651424,134441817,135421144,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[[(Z)-(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methyl]amino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304311,"",651424,134441818,53239978,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(3,5-dichloro-4-hydroxyphenyl)methylidene]-5-(furan-2-carbonyl)-1H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304312,"",651424,134445610,136026030,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[5-(2-piperidin-4-yl-5-pyridin-4-yl-1H-imidazol-4-yl)-2,3-dihydroinden-1-ylidene]hydroxylamine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304313,"",651424,136920477,57390087,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-chloro-4-fluorophenyl)-6-[2-[(2-methylsulfonylethylamino)methyl]-1,3-thiazol-4-yl]quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304314,"",651424,136928917,56603987,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[4-[2-(4-fluorophenyl)-6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-yl]-N',N'-dimethylpropane-1,3-diamine;methanesulfonic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304443,"",651424,136938726,136126596,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[[2-hydroxy-4-(2-pyridin-4-ylethyl)-1H-indol-3-yl]diazenyl]benzenesulfonamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304444,"",651424,136938728,57399802,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[5-(4-Fluorophenyl)-3-piperidin-4-ylimidazol-4-yl]pyrimidin-2-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304445,"",651424,136938728,57399802,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[5-(4-Fluorophenyl)-3-piperidin-4-ylimidazol-4-yl]pyrimidin-2-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304446,"",651424,136945094,57403317,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]benzamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304447,"",651424,103260679,135778713,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-methoxy-4-[(2-{5H-pyrazolo[3,4-d]pyrimidin-4-yl}hydrazin-1-ylidene)methyl]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304448,"",651424,103435091,9827373,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-Bromo-3-(5-bromo-6-hydroxy-2''-methoxy-biphenyl-3-ylmethylene)-1,3-dihydro-pyrrolo[2,3-b]pyridin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304449,"",651424,103455179,6539414,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-[2-(4-methoxyphenyl)pyrazolo[1,5-b]pyridazin-3-yl]pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304450,"",651424,103456549,44397032,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(1-cyclohexyl-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304451,"",651424,103457167,44397453,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[1-(4-Aminomethyl-phenyl)-1H-imidazo[4,5-c]pyridin-2-yl]-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304452,"",651424,103176311,9910722,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(4-Fluoro-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304453,"",651424,103260592,9604948,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Pyrazolopyrimidine 2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304454,"",651424,103408579,6539502,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Arylmaleimide deriv. 6cc,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304455,"",651424,103454690,6539369,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304456,"",651424,103454806,6539417,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 75",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304457,"",651424,103454856,6539390,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 48",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304458,"",651424,103455041,11163861,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3,5-Dimethoxyphenyl)-4-(pyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304459,"",651424,103455105,6539422,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 80",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304460,"",651424,103455340,6539361,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Pyrazolopyridazine 1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304461,"",651424,103485758,9604915,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],(E)-9-(3-Methoxyphenyl)-6-(2-(pyridin-4-ylmethylene)hydrazinyl)-9H-purine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304462,"",651424,103486358,11502866,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-phenylethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304463,"",651424,103504676,11751266,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(7-chloro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304464,"",651424,103534541,579429,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304465,"",651424,103567065,6539611,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[5-bromo-6-(furan-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304466,"",651424,103610915,25263092,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(2-chlorophenyl)methoxy]-5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304467,"",651424,103624339,24856364,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-{4'-[(Cyclopropylmethyl)carbamoyl]-6-Methylbiphenyl-3-Yl}-2-Morpholin-4-Ylpyridine-4-Carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304468,"",651424,103629652,25218584,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-fluoro-6-({2-[(5-methoxy-1-{2-[4-(propan-2-yl)piperazin-1-yl]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304469,"",651424,103652214,42618163,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Benzyloxyisoquinoline, 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304470,"",651424,131281196,15872408,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-(3,4-difluorophenoxy)-4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304471,"",651424,134461029,56681565,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(2-amino-1,3-thiazol-4-yl)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-1H-indol-2-one;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304472,"",651424,136941925,57401572,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"methyl N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-1,3-benzothiazol-2-yl]carbamate;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304473,"",651424,103455205,6539409,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 67",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304474,"",651424,103486524,44410704,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304571,"",651424,103504607,16099859,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-((2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl)oxy)phenyl)-4-(dimethylamino)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304572,"",651424,103504644,11233873,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(4-fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304573,"",651424,103504658,11269477,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(1H-indazol-5-yl)-2-methyl-4-(naphthalen-2-yl)-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304574,"",651424,103508251,11626927,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],IKK-3 Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304575,"",651424,103534539,44431824,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-fluoronaphthalene-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304576,"",651424,103577474,135434987,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(3z)-N-[2-(1h-Imidazol-4-Yl)ethyl]-2-Oxo-3-[2-(4-Sulfamoylphenyl)hydrazinylidene]-2,3-Dihydro-1h-Indole-5-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304577,"",651424,103606906,11273032,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304578,"",651424,103610115,44571435,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(furan-2-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304579,"",651424,103631371,25218621,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[(2R)-2,3-dihydroxypropyl]-5-fluoro-2-{[2-({2-methoxy-4-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304580,"",651424,103648686,44589696,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-Methyl-N-(3-morpholinopropyl)-7-phenylimidazo[5,1-f][1,2,4]triazin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304581,"",651424,103659231,44536036,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304582,"",651424,131273123,53239984,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-(2-(4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)pyrimidin-2-yloxy)phenyl)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304583,"",651424,136927822,5034,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304584,"",651424,136932134,57396351,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],methyl N-[6-[4-[(3-bromophenyl)carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304585,"",651424,136932135,57396352,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],methyl N-[6-[4-(phenylcarbamoylamino)phenoxy]-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304586,"",651424,136935591,57398147,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],methyl N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenyl]sulfonyl-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304587,"",651424,136935592,57398148,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(1-benzylindazol-5-yl)-6,7-dimethoxyquinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304588,"",651424,136935593,57398149,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-[[4-(3-Fluoroanilino)pyrimidin-2-yl]amino]benzamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304589,"",651424,103176330,15872409,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[5-(4-Fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-2-(4-methanesulfonyl-phenoxy)-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304590,"",651424,103176455,15872406,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[4-(4-Fluorophenyl)-1-(Piperidin-4-Yl)-1h-Imidazol-5-Yl]-2-(2-Methoxyphenoxy)pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304591,"",651424,103176489,18536613,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(4-tert-Butyl-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304592,"",651424,103448885,6539751,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[6-(4-methylphenyl)furo[2,3-d]pyrimidin-4-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304593,"",651424,103455235,6539439,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 97",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304594,"",651424,103456457,5329829,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],1-[4-[methyl-[2-[(3-Sulfamoylphenyl)amino]pyrimidin-4-Yl]amino]phenyl]-3-[4-(Trifluoromethyloxy)phenyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304595,"",651424,103456873,11680113,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(1-Methyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304596,"",651424,103465338,5329868,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"1-[3-(2-{[5-(Ethylsulfonyl)-2-methoxyphenyl]amino}-1,3-oxazol-5-yl)phenyl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304597,"",651424,103503410,44418532,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Methyl (E)-5-(4-hydroxy-2,6-dimethylstyryl)nicotinate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304598,"",651424,103575499,25093474,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(cyclopropylmethyl)-4-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304599,"",651424,103577712,135418490,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Oxindole-Based Inhibitor 22,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304600,"",651424,103577939,135421144,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[[(Z)-(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methyl]amino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304601,"",651424,103610059,44571414,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)thiophen-3-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304602,"",651424,103627809,10469531,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-cyclopropyl-3-(1H-indazol-5-yl)-4-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304731,"",651424,103629529,25218571,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-{[2-({4-chloro-2-methoxy-5-[(1-propylpiperidin-4-yl)oxy]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304732,"",651424,134449557,24949545,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[[4-[(1,3-Dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]benzenesulfonamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304733,"",651424,134453396,135398493,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-{[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-methyl]amino}benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304734,"",651424,134453403,136091540,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[[(1-Benzylpyrazolo[3,4-d]pyrimidin-4-yl)hydrazinylidene]methyl]-2-methoxyphenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304735,"",651424,134461030,135506564,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[[4-(1,2,4-triazol-1-yl)phenyl]iminomethyl]-1H-indol-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304736,"",651424,136922442,57391092,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[4-[[2-[3-(4-methylpiperazin-1-yl)propylamino]-3H-benzimidazol-5-yl]oxy]phenyl]urea;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304737,"",651424,136922444,57391094,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(3-bromo-4-phenylmethoxyphenyl)-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304738,"",651424,136925695,9947709,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[2-(4-Fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304739,"",651424,136930182,57395310,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-N-(5-ethylsulfonyl-2-methoxyphenyl)-4-N-methyl-4-N-(3-methyl-2H-indazol-6-yl)pyrimidine-2,4-diamine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304740,"",651424,136936843,57398861,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[5-(2,3-difluorophenyl)-1H-pyrazolo[3,4-c]pyridazin-3-yl]-1-ethylpiperidine-4-carboxamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304741,"",651424,136940024,21701565,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"6,7-Dimethoxy-4-(3-hydroxy-4-methylanilino)quinazoline hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304742,"",651424,103163917,453216,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Imidazo(2,1-b)thiazole, 5-(4-fluorophenyl)-2,3-dihydro-6-(4-pyridinyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304743,"",651424,103176501,15872403,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-(Benzo[1,3]dioxol-5-yloxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304744,"",651424,103321097,6539599,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-[6-(3-methanesulfonamidophenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304745,"",651424,103454731,6539385,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 43",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304746,"",651424,103457339,5329831,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Urea deriv. 25,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304747,"",651424,103486315,11656050,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)phenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304748,"",651424,103610608,25263078,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],5-(1H-benzimidazol-1-yl)-3-[(3-methoxybenzyl)oxy]-2-thiophenecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304749,"",651424,103610773,25263088,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-[(2-Bromophenyl)methoxy]-5-[6-(trifluoromethyl)benzimidazol-1-yl]thiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304750,"",651424,103624112,44578563,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Biphenyl-3,4''-dicarboxylic acid 3-cyclopropylamide 4''-cyclopropylmethyl-amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304751,"",651424,103624279,44578672,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(4'-{[(Cyclopropylmethyl)amino]carbonyl}-6-methyl-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304752,"",651424,103663384,22727427,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-N-(2-benzyl-3H-benzimidazol-5-yl)-6-N,6-N-dimethylpyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304753,"",651424,136927026,136068093,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[5-bromo-6-(4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-1-methylpiperidine-4-carboxamide;(Z)-but-2-enedioic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304754,"",651424,136935600,56603997,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Lithium;4-[4-[5-(4-fluorophenyl)-3-piperidin-4-ylimidazol-4-yl]pyrimidin-2-yl]oxybenzoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304755,"",651424,136938727,10272700,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-(4-Fluorophenyl)-3-(2-((3-hydroxypropyl)amino)pyrimidin-4-yl)pyrazolo[1,5-a]pyridine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304756,"",651424,136943221,10133732,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-Cyclopropyl-4-[6-cyano-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304757,"",651424,136945093,57403316,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],1-[2-(Dimethylamino)ethyl]-3-[4-[methyl-[2-[4-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]amino]phenyl]urea;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304758,"",651424,103321813,6539592,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[6-(furan-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304759,"",651424,103322222,6539600,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-[6-(4-methanesulfonamidophenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304760,"",651424,103441550,5329861,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[5-(ethanesulfonyl)-2-methoxyphenyl]-5-(3-fluorophenyl)-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304761,"",651424,103455079,6539412,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 70",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304762,"",651424,103456490,10236195,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-(1-Ethyl-6-fluoro-1H-benzoimidazol-2-yl)-furazan-3-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304891,"",651424,103486529,11605761,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)benzyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304892,"",651424,103498929,22609796,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],(4-Benzyloxy-phenyl)-(6-furan-2-yl-quinazolin-4-yl)-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304893,"",651424,103503427,44418546,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-[(E)-2-(2,6-diethylphenyl)ethenyl]-N-methylpyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304894,"",651424,103503436,44418555,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-methyl-5-[(E)-2-(2-methylphenyl)ethenyl]pyridine-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304895,"",651424,103551407,24896610,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-[[4-(1H-indazol-4-ylamino)pyrimidin-2-yl]amino]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304896,"",651424,134437917,135418262,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(4-{[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}phenyl)methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304897,"",651424,136922445,57391095,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],6-[5-[[2-(benzenesulfonyl)ethylamino]methyl]furan-2-yl]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304898,"",651424,136925696,56604000,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-but-2-enedioic acid;3-[[4-[2-(4-fluorophenyl)-6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-yl]amino]propan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304899,"",651424,136940025,57400542,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3,5-dimethyl-4-[(E)-2-[5-(2H-tetrazol-5-yl)pyridin-3-yl]ethenyl]phenol;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304900,"",651424,136943844,5482344,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"12,13-Dihydro-3,9-dimethoxy-5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304901,"",651424,136945096,57403319,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-chloro-4-phenylmethoxyphenyl)-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304902,"",651424,103176254,9800117,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[5-(4-Fluoro-phenyl)-3-(3-morpholin-4-yl-propyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304903,"",651424,103311544,10475737,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[5-(4-Fluoro-phenyl)-3-(2,2,6,6-tetramethyl-piperidin-4-yl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304904,"",651424,103408167,6539482,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Arylmaleimide deriv. 6-g,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304905,"",651424,103441505,5329857,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-Anilino-5-aryloxazole 24,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304906,"",651424,103456856,44397250,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(1-Cyclopropyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304907,"",651424,103456856,44397250,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(1-Cyclopropyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304908,"",651424,103534538,766949,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],TCS JNK 5a,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304909,"",651424,103536424,44433173,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-{5-(6-Methoxynaphthalen-2-Yl)-1-Methyl-2-[2-Methyl-4-(Methylsulfonyl)phenyl]-1h-Imidazol-4-Yl}pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304910,"",651424,103567703,11617559,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304911,"",651424,103577470,135434988,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Oxindole-Based Inhibitor 59,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304912,"",651424,103163933,9951300,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"[4-(4-Benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)-phenyl]-methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304913,"",651424,103318338,135435019,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Anilinopyrazole deriv. 1f,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304914,"",651424,103408120,6539487,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Arylmaleimide deriv. 6-l,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304915,"",651424,103436813,44386338,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-(5-Hydroxy-indan-1-ylidene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304916,"",651424,103455401,6539413,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 71",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304917,"",651424,103577836,3323623,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Oxindole-Based Inhibitor 43,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304918,"",651424,103610024,25263103,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-3-(thiophen-2-ylmethoxy)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304919,"",651424,103610156,44571449,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((4-methylpiperazin-1-yl)methyl)furan-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304920,"",651424,103610156,44571449,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((4-methylpiperazin-1-yl)methyl)furan-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304921,"",651424,103610222,25263110,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"methyl 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[(2-trifluoromethylbenzyl)-oxy]thiophene-2-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301304922,"",651424,103623911,44593640,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(4'-{[(Cyclopropylmethyl)amino]carbonyl}-6-methyl-1,1'-biphenyl-3-yl)-3-furamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305019,"",651424,103631933,25218600,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-Fluoro-2-((2-((2-methoxy-4-(1-propylpiperidin-3-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305020,"",651424,103648995,11155941,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-methyl-7-(3-phenoxyphenyl)-N-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305021,"",651424,134449556,56604005,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[7-(3-Aminopropoxy)-4-(3-aminoprop-1-ynyl)-1-ethylimidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305022,"",651424,134453399,25263120,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-{6-[(2S)-2,3-dihydroxypropoxy]-1H-1,3-benzodiazol-1-yl}thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305023,"",651424,134457207,11244488,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3,4-dimethoxyphenyl)-5-phenyl-1,3-oxazol-2-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305024,"",651424,134457209,25263124,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-{6-[(1-methylpiperidin-4-yl)methoxy]-1H-1,3-benzodiazol-1-yl}thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305025,"",651424,136933712,10215776,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[4-(diethylaminomethyl)phenyl]-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305026,"",651424,136938725,57399800,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-fluoro-4-phenylmethoxyphenyl)-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305027,"",651424,136943220,56604034,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-[(1R)-2-amino-1-phenylethoxy]-1-ethylimidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305028,"",651424,160669476,70682205,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[5-(2,3-difluorophenyl)-1H-pyrazolo[3,4-c]pyridazin-3-yl]-2-(1-ethylpiperidin-4-yl)acetamide;2,3-dihydroxybutanedioic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305029,"",651424,103176506,10321190,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(4-Ethyl-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305030,"",651424,103260120,135778714,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-methoxy-4-[(E)-[(1-propan-2-ylpyrazolo[3,4-d]pyrimidin-4-yl)hydrazinylidene]methyl]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305031,"",651424,103260370,9604958,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-1-(3-Methoxyphenyl)-4-(2-(4-methylbenzylidene)hydrazinyl)-1H-pyrazolo[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305032,"",651424,103318335,6539620,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Anilinopyrazole deriv. 1k,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305033,"",651424,103408351,6539451,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Arylmaleimide deriv. 6a,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305034,"",651424,103441489,5329855,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-Anilino-5-aryloxazole 20,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305035,"",651424,103522295,25190924,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-Methoxy-5-(pyridin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305036,"",651424,103552595,23646936,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[3,5-bis(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305037,"",651424,103606995,25263274,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305038,"",651424,103624548,9822610,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N~4~-(3-Methyl-1h-Indazol-6-Yl)-N~2~-(3,4,5-Trimethoxyphenyl)pyrimidine-2,4-Diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305039,"",651424,103648509,9857146,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-(4-Fluorophenyl)-3-(4-pyridinyl)pyrazolo[1,5-a]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305040,"",651424,136925694,56603975,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]quinazolin-4-amine;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305041,"",651424,136935588,57398144,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[[4-[(2,3-Dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]benzenesulfonamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305042,"",651424,136935595,57398151,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-(4-phenylmethoxyphenyl)quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305043,"",651424,136938721,56604030,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],methyl N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenyl]sulfanyl-1H-benzimidazol-2-yl]carbamate;sulfuric acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305044,"",651424,103456717,44397147,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(1,4-Diethyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305045,"",651424,103498556,21951965,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305046,"",651424,103503411,44418533,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-[(E)-2-(4-hydroxy-2,6-dimethylphenyl)ethenyl]-N,N-dimethylpyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305047,"",651424,103566590,6539603,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[6-(2,5-difluorophenyl)-1H-indazol-3-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305048,"",651424,103566685,6539593,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(6-phenyl-1H-indazol-3-yl)cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305049,"",651424,103577597,135409809,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Oxindole-Based Inhibitor 29,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305050,"",651424,103577938,135434994,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Oxindole-Based Inhibitor 66,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305147,"",651424,103610678,25263083,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(1H-1,3-benzodiazol-1-yl)-3-[(2-bromophenyl)methoxy]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305148,"",651424,103612791,25263119,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(6-methoxy-1H-1,3-benzodiazol-1-yl)-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305149,"",651424,103750103,11959682,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(S)-4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-(2-amino-2-phenylethoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305150,"",651424,134437919,16051023,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-[6-(1-methylpiperidin-4-yl)oxybenzimidazol-1-yl]thiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305151,"",651424,134453395,135482293,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-{[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}-1,3-dihydro-2H-benzimidazol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305152,"",651424,134461031,11392350,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(5-Phenyl-1,3-oxazol-2-yl)amino]benzonitrile;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305153,"",651424,136922443,57391093,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-[4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305154,"",651424,136923783,57391875,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-6-[2-(methylamino)ethoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305155,"",651424,136928913,57394599,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],methyl N-[6-[4-[(3-chlorophenyl)carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305156,"",651424,136938732,136126597,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],SB-590885Aad,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305157,"",651424,103408052,6539478,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(3-Chloro-4-Hydroxyphenyl)amino]-4-(3-Chlorophenyl)-1h-Pyrrole-2,5-Dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305158,"",651424,103454865,6539430,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 88",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305159,"",651424,103485748,9604912,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-7-(3-Methoxyphenyl)-4-(2-(pyridin-4-ylmethylene)hydrazinyl)-5H-pyrrolo[3,2-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305160,"",651424,103504666,11453116,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Dihydropyridone indazole amide 13,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305161,"",651424,103522249,25190921,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-amino-5-(4-fluorophenyl)-N-methyl-3-[4-(pyrrolidine-1-sulfonyl)phenyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305162,"",651424,103522281,16048194,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-Amino-3-(4-methanesulfonamidophenyl)-5-phenylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305163,"",651424,103522297,25190926,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],5-(4-Chlorophenyl)-2-methoxy-3-(4-sulfamoylphenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305164,"",651424,103628926,10193464,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-cyclopropyl-4-(6-morpholinopyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305165,"",651424,103629175,25210972,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(2-{[1-(N,N-Dimethylglycyl)-6-Methoxy-4,4-Dimethyl-1,2,3,4-Tetrahydroquinolin-7-Yl]amino}-7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)amino]thiophene-2-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305166,"",651424,103630045,44581765,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N2-(4-(4-isopropylpiperazin-1-yl)-2-methoxyphenyl)-N4-(quinolin-5-yl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305167,"",651424,134453397,11231939,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(2-methoxyphenyl)-5-phenyl-1,3-oxazol-2-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305168,"",651424,136922447,57391097,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"[(3R,5S)-5-[2-[4-[(1-benzylindazol-5-yl)amino]thieno[3,2-d]pyrimidin-6-yl]ethynyl]pyrrolidin-3-yl] morpholine-4-carboxylate;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305169,"",651424,136930185,57395317,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"6-[2-[(2-methylsulfonylethylamino)methyl]-1,3-thiazol-4-yl]-N-[4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305170,"",651424,136935601,57398154,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-[4-(benzyloxy)phenyl]-6-methoxyquinazolin-4-amine hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305171,"",651424,136945095,57403318,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305172,"",651424,103604269,25023715,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(2-(methylamino)ethyl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305173,"",651424,103628930,10286242,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(pyrazolo[1,5-b]pyridazin-3-yl)-N-(2,2,2-trifluoroethyl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305174,"",651424,103629171,44581245,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-Fluoro-6-((2-((4-(4-isopropylpiperazin-1-yl)-2-methoxyphenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305175,"",651424,134445607,56667992,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-pyridin-3-yl-1H-indol-2-one;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305176,"",651424,136935590,57398146,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],GSK269962 hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305177,"",651424,136935597,57398153,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[2-methylsulfonylethyl(propyl)amino]methyl]furan-2-yl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305178,"",651424,136940027,57400544,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(4-phenoxyphenyl)-5-phenyl-1,3-oxazol-2-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305275,"",651424,136943217,22464120,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[5-(2-Azanylpyrimidin-4-yl)-4-(4-fluorophenyl)imidazol-1-yl]cyclohexan-1-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305276,"",651424,103203007,6603857,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305277,"",651424,103261167,9604926,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-N-Propyl-3-(4-(2-(pyridin-4-ylmethylene)hydrazinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305278,"",651424,103407399,6539521,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Arylmaleimide deriv. 8f,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305279,"",651424,103455016,6539440,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[2-(4-fluorophenyl)-6-methylpyrazolo[1,5-b]pyridazin-3-yl]-N-phenylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305280,"",651424,103455050,6539382,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305281,"",651424,103465244,5329849,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-methylphenyl)-5-phenyl-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305282,"",651424,103465361,5329875,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-Anilino-5-aryloxazole 44,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305283,"",651424,103483591,9901964,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-[4-methoxyphenyl]-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305284,"",651424,103483994,10294883,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(4-(2-(1H-imidazol-1-yl)ethoxy)phenyl)-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305285,"",651424,103536421,44433171,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-(5-(6-methoxynaphthalen-2-yl)-1-methyl-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305286,"",651424,103536423,24180608,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[5-(6-Methoxynaphthalen-2-yl)-1-methyl-2-(2-methyl-4-methylsulfinylphenyl)imidazol-4-yl]pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305287,"",651424,103546381,11281930,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-(4-Amino-3-(3-chloro-4-fluorophenyl)thieno[3,2-c]pyridin-7-yl)benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305288,"",651424,103566437,135435011,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(5-bromo-6-(4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305289,"",651424,103575697,10295475,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[(4-chlorophenyl)methyl]-4-[2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305290,"",651424,103610355,25263116,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-N,N-dimethyl-3-{[2-(trifluoromethyl)phenyl]methoxy}thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305291,"",651424,103623777,44578401,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(4'-{[(Cyclopropylmethyl)amino]carbonyl}-6-methyl-1,1'-biphenyl-3-yl)propionamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305292,"",651424,103629174,25210971,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-(2-(1-(2-(dimethylamino)acetyl)-6-methoxy-1,2,3,4-tetrahydroquinolin-7-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305293,"",651424,103646103,11569498,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(4-fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-(6-(trifluoromethyl)pyridin-3-yl)-1,4-dihydropyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305294,"",651424,103750021,11959377,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-6-(pyrrolidin-1-ylmethyl)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305295,"",651424,134445609,56603995,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-4-ylmethoxy)imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305296,"",651424,134453398,56604013,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-piperidin-4-yloxyimidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305297,"",651424,136928914,57394600,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-(1,3-benzodioxol-5-yl)-2-pyridin-2-yl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305298,"",651424,136928915,57394601,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],6-[4-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-(4-phenylmethoxyphenyl)quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305299,"",651424,136928916,57394602,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-[4-phenylmethoxy-3-(trifluoromethyl)phenyl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305300,"",651424,136935599,56604024,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-(2,3-Dimethylphenoxy)-4-[5-(4-fluorophenyl)-3-piperidin-4-ylimidazol-4-yl]pyrimidine;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305301,"",651424,136940028,57400545,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"1-methyl-N-(5-phenyl-1H-pyrazolo[3,4-c]pyridazin-3-yl)piperidine-4-carboxamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305302,"",651424,103176430,18536627,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(4-Chloro-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305303,"",651424,103260821,9604922,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-4-(2-(3-Fluorobenzylidene)hydrazinyl)-1-(3-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305304,"",651424,103261287,9604940,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-4-(2-(3-Methoxybenzylidene)hydrazinyl)-1-(3-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305305,"",651424,103321312,6539607,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-[6-(4-fluorophenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305306,"",651424,103408023,448008,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-Chloro-5-[4-(3-chloro-phenyl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-ylamino]-benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305403,"",651424,103448962,449054,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],RepSox,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305404,"",651424,103454835,6539364,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(4-propan-2-ylphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305405,"",651424,103455078,6539397,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 55",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305406,"",651424,103456516,44397010,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(3-Ethyl-3H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305407,"",651424,103498514,9917474,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(phenylsulfonyl)ethoxy)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305408,"",651424,103503419,44418539,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-5-(2,6-Dimethylstyryl)-N-methylnicotinamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305409,"",651424,103552601,23646938,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[3-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305410,"",651424,103577662,135421139,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-[[5-(dimethylamino)-2-hydroxy-1H-indol-3-yl]methylideneamino]benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305411,"",651424,103610772,25263087,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(2-bromophenyl)methoxy]-5-[5-(trifluoromethyl)-1H-1,3-benzodiazol-1-yl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305412,"",651424,103663107,44532204,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Methyl-3-[(7-pyridin-2-ylquinolin-4-yl)amino]phenol;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305413,"",651424,136922446,57391096,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],CID 57391096,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305414,"",651424,136925693,57392873,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-[[4-(3-Hydroxy-4-methylanilino)pyrimidin-2-yl]amino]benzamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305415,"",651424,136938724,56603966,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(2S)-pyrrolidin-2-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305416,"",651424,136938731,57399804,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)phenol;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305417,"",651424,136945097,135434997,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-[2-(7-Methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-hydrazino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305418,"",651424,103321208,6539597,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-[6-(4-sulfamoylphenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305419,"",651424,103455274,6539411,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 69",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305420,"",651424,103466756,5329802,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"6-(4-Methoxyphenyl)furo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305421,"",651424,103486443,11640889,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(2-aminopyrimidin-4-yl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305422,"",651424,103486476,11627264,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(6-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)pyridin-2-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305423,"",651424,103522291,16048415,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-Amino-3-phenyl-5-(pyridin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305424,"",651424,103623533,44578253,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"6-Methyl-biphenyl-3,4''-dicarboxylic acid 3-cyclohexylamide 4''-cyclopropylmethyl-amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305425,"",651424,103623534,44578254,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"6-Methyl-biphenyl-3,4''-dicarboxylic acid 4''-cyclopropylmethyl-amide 3-isopropylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305426,"",651424,103628799,10171618,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-Cyclopropyl-4-(2-ethylpyrazolo[1,5-b]pyridazin-3-yl)-2-pyrimidinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305427,"",651424,103629015,10193482,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3-morpholinopropyl)-4-(pyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305428,"",651424,103629016,10173796,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305429,"",651424,103629116,44581222,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-(dimethylamino)-1-(6-(4-(indolin-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-5-methoxyindolin-1-yl)ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305430,"",651424,103629583,25211574,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-((2-((5-(2-(Dimethylamino)acetamido)-2-methoxy-4-methylphenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305431,"",651424,103643942,44587530,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"1-(4-(benzyloxy)phenyl)-3-(3-(1-ethyl-4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-1H-pyrazol-3-yl)phenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305432,"",651424,103652215,42618164,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"Benzyloxyisoquinoline, 7",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305433,"",651424,136925697,56604049,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"[(3R,5S)-5-[2-[4-[[1-[(2,5-difluorophenyl)methyl]indol-5-yl]amino]thieno[3,2-d]pyrimidin-6-yl]ethynyl]pyrrolidin-3-yl] morpholine-4-carboxylate;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305434,"",651424,136932133,57396350,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]furan-2-carboxamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305531,"",651424,136935594,57398150,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-7-yl]-[(3S)-3-aminopyrrolidin-1-yl]methanone;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305532,"",651424,136941926,57401573,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-7-yl]-piperazin-1-ylmethanone;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305533,"",651424,103503420,44418540,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-5-(4-Hydroxy-2,6-dimethylstyryl)nicotinamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305534,"",651424,103629014,10125875,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(4-chlorobenzyl)-4-(pyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305535,"",651424,136932766,53239988,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[[2-[[1-[2-(dimethylamino)acetyl]-6-methoxy-3,4-dihydro-2H-quinolin-7-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-N-methylpyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305536,"",651424,136938723,57399799,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-[[4-[[2-(methoxycarbonylamino)-3H-benzimidazol-5-yl]oxy]phenyl]carbamoylamino]benzoic acid;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305537,"",651424,136938730,57399803,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],5-[2-[4-(aminomethyl)phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2-chlorophenol;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305538,"",651424,136945098,57403320,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"6-(4-Fluorophenyl)-5-pyridin-4-yl-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305539,"",651424,160706968,70696859,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(5-bromo-6-thiophen-2-yl-1H-pyrazolo[3,4-b]pyridin-3-yl)-2-(1-ethylpiperidin-4-yl)acetamide;2,3-dihydroxybutanedioic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305540,"",651424,103631756,25218593,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-((2-((2-Methyl-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305541,"",651424,103658212,44532523,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(3-chloro-4-phenylmethoxyphenyl)-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305542,"",651424,134434070,136207967,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[5-[5-[4-[2-(dimethylamino)ethoxy]phenyl]-2-pyridin-4-ylfuran-3-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305543,"",651424,136922441,57391091,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],1-[4-[Methyl-[2-[4-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]amino]phenyl]-3-(2-morpholin-4-ylethyl)urea;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305544,"",651424,136927020,57393604,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],3-[[5-(4-fluorophenyl)-1H-pyrazol-3-yl]amino]benzenesulfonamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305545,"",651424,136936845,57398866,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(E)-2-(2,6-dimethyl-4-pyridin-2-ylphenyl)ethenyl]-5-(2H-tetrazol-5-yl)pyridine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305546,"",651424,103260746,9604911,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"1-(3-methoxyphenyl)-N-[(E)-pyridin-4-ylmethylideneamino]pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305547,"",651424,103441474,5329854,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-phenyl-N-(3,4,5-trimethoxyphenyl)-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305548,"",651424,103456789,44397201,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(1-Ethyl-4-pyrrolidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305549,"",651424,103483599,9858084,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(4-fluorophenyl)-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305550,"",651424,103566682,6539598,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-[6-(3-sulfamoylphenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305551,"",651424,103577394,135434990,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Oxindole-Based Inhibitor 62,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305552,"",651424,103577437,135434989,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-oxo-N-(pyridin-4-ylmethyl)-3-[2-(4-sulfamoylphenyl)hydrazinyl]indole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305553,"",651424,103577553,135421141,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"2-Oxo-3-(4-sulfamoyl-phenylamino-methylene)-2,3-dihydro-1H-indole-5-carboxylic acid isobutyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305554,"",651424,103577757,135421134,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],(Z)-4-((1-(2-Oxoindolin-3-ylidene)ethyl)amino)benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305555,"",651424,103593129,11284937,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305556,"",651424,103648992,11328632,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-methyl-7-[3-(trifluoromethyl)phenyl]-N-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305557,"",651424,136935598,135434999,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],Oxindole-Based Inhibitor 72,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305558,"",651424,136938722,57399798,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],methyl N-[6-[3-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305559,"",651424,103612637,25263118,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-(6-methoxy-1H-1,3-benzodiazol-1-yl)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305560,"",651424,103623835,44578425,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],5''-(2-Cyclopropyl-acetylamino)-2''-methyl-biphenyl-4-carboxylic acid cyclopropylmethyl-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305561,"",651424,103629234,25218614,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-fluoro-2-{[2-({2-methoxy-4-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301305562,"",651424,103750063,11959683,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((R)-2-amino-2-phenylethoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306113,"",651425,103163917,453216,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Imidazo(2,1-b)thiazole, 5-(4-fluorophenyl)-2,3-dihydro-6-(4-pyridinyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306114,"",651425,103176501,15872403,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-(Benzo[1,3]dioxol-5-yloxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306115,"",651425,103321097,6539599,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-[6-(3-methanesulfonamidophenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306116,"",651425,103454731,6539385,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 43",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306117,"",651425,103457339,5329831,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Urea deriv. 25,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306118,"",651425,103486315,11656050,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)phenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306119,"",651425,103610608,25263078,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],5-(1H-benzimidazol-1-yl)-3-[(3-methoxybenzyl)oxy]-2-thiophenecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306120,"",651425,103610773,25263088,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-[(2-Bromophenyl)methoxy]-5-[6-(trifluoromethyl)benzimidazol-1-yl]thiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306121,"",651425,103624112,44578563,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Biphenyl-3,4''-dicarboxylic acid 3-cyclopropylamide 4''-cyclopropylmethyl-amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306122,"",651425,103624279,44578672,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(4'-{[(Cyclopropylmethyl)amino]carbonyl}-6-methyl-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306123,"",651425,103663384,22727427,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-N-(2-benzyl-3H-benzimidazol-5-yl)-6-N,6-N-dimethylpyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306124,"",651425,136927026,136068093,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[5-bromo-6-(4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-1-methylpiperidine-4-carboxamide;(Z)-but-2-enedioic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306125,"",651425,136935600,56603997,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Lithium;4-[4-[5-(4-fluorophenyl)-3-piperidin-4-ylimidazol-4-yl]pyrimidin-2-yl]oxybenzoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306126,"",651425,136938727,10272700,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-(4-Fluorophenyl)-3-(2-((3-hydroxypropyl)amino)pyrimidin-4-yl)pyrazolo[1,5-a]pyridine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306127,"",651425,136943221,10133732,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-Cyclopropyl-4-[6-cyano-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306128,"",651425,136945093,57403316,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],1-[2-(Dimethylamino)ethyl]-3-[4-[methyl-[2-[4-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]amino]phenyl]urea;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306129,"",651425,103176506,10321190,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(4-Ethyl-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306130,"",651425,103260120,135778714,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-methoxy-4-[(E)-[(1-propan-2-ylpyrazolo[3,4-d]pyrimidin-4-yl)hydrazinylidene]methyl]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306131,"",651425,103260370,9604958,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-1-(3-Methoxyphenyl)-4-(2-(4-methylbenzylidene)hydrazinyl)-1H-pyrazolo[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306132,"",651425,103318335,6539620,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Anilinopyrazole deriv. 1k,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306133,"",651425,103408351,6539451,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Arylmaleimide deriv. 6a,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306134,"",651425,103441489,5329855,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-Anilino-5-aryloxazole 20,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306135,"",651425,103522295,25190924,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-Methoxy-5-(pyridin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306136,"",651425,103552595,23646936,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[3,5-bis(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306137,"",651425,103606995,25263274,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(3S,5R)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306138,"",651425,103624548,9822610,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N~4~-(3-Methyl-1h-Indazol-6-Yl)-N~2~-(3,4,5-Trimethoxyphenyl)pyrimidine-2,4-Diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306171,"",651425,103648509,9857146,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-(4-Fluorophenyl)-3-(4-pyridinyl)pyrazolo[1,5-a]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306172,"",651425,136925694,56603975,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]quinazolin-4-amine;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306173,"",651425,136935588,57398144,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[[4-[(2,3-Dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]benzenesulfonamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306174,"",651425,136935595,57398151,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-(4-phenylmethoxyphenyl)quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306175,"",651425,136938721,56604030,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],methyl N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenyl]sulfanyl-1H-benzimidazol-2-yl]carbamate;sulfuric acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306176,"",651425,103260487,9604943,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-4-(2-(4-Fluorobenzylidene)hydrazinyl)-1-(3-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306177,"",651425,103407373,6539522,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Arylmaleimide deriv. 8g,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306178,"",651425,103441467,5329853,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3,5-dimethoxyphenyl)-5-phenyl-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306179,"",651425,103449085,9922527,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(1,5-Naphthyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306180,"",651425,103483604,11717091,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(4-Isopropylphenyl)-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306181,"",651425,103503426,44418545,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"tert-Butyl (E)-5-(4-hydroxy-2,6-dimethylstyryl)nicotinate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306182,"",651425,103503428,44418547,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-[(E)-2-(2,6-dichlorophenyl)ethenyl]-N-methylpyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306183,"",651425,103534555,16664858,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"1-Naphthalenecarboxamide, N-[3-cyano-7-(cyclopropylcarbonyl)-4,5,6,7-tetrahydrothieno[2,3-b]pyridin-2-yl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306184,"",651425,103606835,11307581,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306185,"",651425,131277124,53239985,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(2-(4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)pyrimidin-2-yloxy)phenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306186,"",651425,134445608,53239955,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"methyl 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-2-oxo-1H-indole-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306187,"",651425,136935589,57398145,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],1-[4-[Methyl-[2-[4-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]amino]phenyl]-3-[4-(4-methylpiperazine-1-carbonyl)phenyl]urea;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306188,"",651425,136935596,57398152,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],6-[3-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-(4-phenylmethoxyphenyl)quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306189,"",651425,103407399,6539521,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Arylmaleimide deriv. 8f,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306190,"",651425,103455016,6539440,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[2-(4-fluorophenyl)-6-methylpyrazolo[1,5-b]pyridazin-3-yl]-N-phenylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306191,"",651425,103455050,6539382,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 40",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306192,"",651425,103465244,5329849,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-methylphenyl)-5-phenyl-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306193,"",651425,103465361,5329875,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-Anilino-5-aryloxazole 44,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306194,"",651425,103483591,9901964,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-[4-methoxyphenyl]-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306195,"",651425,103483994,10294883,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(4-(2-(1H-imidazol-1-yl)ethoxy)phenyl)-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306196,"",651425,103536421,44433171,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-(5-(6-methoxynaphthalen-2-yl)-1-methyl-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306197,"",651425,103536423,24180608,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[5-(6-Methoxynaphthalen-2-yl)-1-methyl-2-(2-methyl-4-methylsulfinylphenyl)imidazol-4-yl]pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306198,"",651425,103546381,11281930,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-(4-Amino-3-(3-chloro-4-fluorophenyl)thieno[3,2-c]pyridin-7-yl)benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306199,"",651425,103566437,135435011,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(5-bromo-6-(4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306200,"",651425,103575697,10295475,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[(4-chlorophenyl)methyl]-4-[2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306201,"",651425,103610355,25263116,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-N,N-dimethyl-3-{[2-(trifluoromethyl)phenyl]methoxy}thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306202,"",651425,103623777,44578401,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(4'-{[(Cyclopropylmethyl)amino]carbonyl}-6-methyl-1,1'-biphenyl-3-yl)propionamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306235,"",651425,103629174,25210971,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-(2-(1-(2-(dimethylamino)acetyl)-6-methoxy-1,2,3,4-tetrahydroquinolin-7-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306236,"",651425,103646103,11569498,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(4-fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-(6-(trifluoromethyl)pyridin-3-yl)-1,4-dihydropyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306237,"",651425,103750021,11959377,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-6-(pyrrolidin-1-ylmethyl)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306238,"",651425,134445609,56603995,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-4-ylmethoxy)imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306239,"",651425,134453398,56604013,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-piperidin-4-yloxyimidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306240,"",651425,136928914,57394600,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-(1,3-benzodioxol-5-yl)-2-pyridin-2-yl-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306241,"",651425,136928915,57394601,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],6-[4-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-(4-phenylmethoxyphenyl)quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306242,"",651425,136928916,57394602,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-[4-phenylmethoxy-3-(trifluoromethyl)phenyl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306243,"",651425,136935599,56604024,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-(2,3-Dimethylphenoxy)-4-[5-(4-fluorophenyl)-3-piperidin-4-ylimidazol-4-yl]pyrimidine;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306244,"",651425,136940028,57400545,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"1-methyl-N-(5-phenyl-1H-pyrazolo[3,4-c]pyridazin-3-yl)piperidine-4-carboxamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306245,"",651425,136935601,57398154,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-[4-(benzyloxy)phenyl]-6-methoxyquinazolin-4-amine hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306246,"",651425,136945095,57403318,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306247,"",651425,103176254,9800117,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[5-(4-Fluoro-phenyl)-3-(3-morpholin-4-yl-propyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306248,"",651425,103311544,10475737,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[5-(4-Fluoro-phenyl)-3-(2,2,6,6-tetramethyl-piperidin-4-yl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306249,"",651425,103408167,6539482,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Arylmaleimide deriv. 6-g,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306250,"",651425,103441505,5329857,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-Anilino-5-aryloxazole 24,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306251,"",651425,103456856,44397250,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(1-Cyclopropyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306252,"",651425,103456856,44397250,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(1-Cyclopropyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306253,"",651425,103534538,766949,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],TCS JNK 5a,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306254,"",651425,103536424,44433173,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-{5-(6-Methoxynaphthalen-2-Yl)-1-Methyl-2-[2-Methyl-4-(Methylsulfonyl)phenyl]-1h-Imidazol-4-Yl}pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306255,"",651425,103567703,11617559,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306256,"",651425,103577470,135434988,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Oxindole-Based Inhibitor 59,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306257,"",651425,103604269,25023715,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-N-(2-(methylamino)ethyl)-1H-imidazo[4,5-c]pyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306258,"",651425,103628930,10286242,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(pyrazolo[1,5-b]pyridazin-3-yl)-N-(2,2,2-trifluoroethyl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306259,"",651425,103629171,44581245,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-Fluoro-6-((2-((4-(4-isopropylpiperazin-1-yl)-2-methoxyphenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306260,"",651425,134445607,56667992,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-pyridin-3-yl-1H-indol-2-one;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306261,"",651425,136935590,57398146,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],GSK269962 hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306262,"",651425,136935597,57398153,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[2-methylsulfonylethyl(propyl)amino]methyl]furan-2-yl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306263,"",651425,136940027,57400544,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(4-phenoxyphenyl)-5-phenyl-1,3-oxazol-2-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306264,"",651425,136943217,22464120,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[5-(2-Azanylpyrimidin-4-yl)-4-(4-fluorophenyl)imidazol-1-yl]cyclohexan-1-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306265,"",651425,103163933,9951300,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"[4-(4-Benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)-phenyl]-methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306266,"",651425,103318338,135435019,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Anilinopyrazole deriv. 1f,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306299,"",651425,103408120,6539487,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Arylmaleimide deriv. 6-l,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306300,"",651425,103436813,44386338,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-(5-Hydroxy-indan-1-ylidene)-1,3-dihydro-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306301,"",651425,103455401,6539413,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 71",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306302,"",651425,103577836,3323623,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Oxindole-Based Inhibitor 43,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306303,"",651425,103610024,25263103,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-3-(thiophen-2-ylmethoxy)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306304,"",651425,103610156,44571449,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((4-methylpiperazin-1-yl)methyl)furan-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306305,"",651425,103610156,44571449,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((4-methylpiperazin-1-yl)methyl)furan-2-yl)thieno[3,2-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306306,"",651425,103610222,25263110,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"methyl 5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[(2-trifluoromethylbenzyl)-oxy]thiophene-2-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306307,"",651425,103623911,44593640,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(4'-{[(Cyclopropylmethyl)amino]carbonyl}-6-methyl-1,1'-biphenyl-3-yl)-3-furamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306308,"",651425,103631933,25218600,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-Fluoro-2-((2-((2-methoxy-4-(1-propylpiperidin-3-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306309,"",651425,103648995,11155941,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-methyl-7-(3-phenoxyphenyl)-N-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306310,"",651425,134449556,56604005,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[7-(3-Aminopropoxy)-4-(3-aminoprop-1-ynyl)-1-ethylimidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306311,"",651425,134453399,25263120,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-{6-[(2S)-2,3-dihydroxypropoxy]-1H-1,3-benzodiazol-1-yl}thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306312,"",651425,134457207,11244488,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3,4-dimethoxyphenyl)-5-phenyl-1,3-oxazol-2-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306313,"",651425,134457209,25263124,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-{6-[(1-methylpiperidin-4-yl)methoxy]-1H-1,3-benzodiazol-1-yl}thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306314,"",651425,136933712,10215776,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[4-(diethylaminomethyl)phenyl]-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306315,"",651425,136938725,57399800,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-fluoro-4-phenylmethoxyphenyl)-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306316,"",651425,136943220,56604034,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-[(1R)-2-amino-1-phenylethoxy]-1-ethylimidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306317,"",651425,160669476,70682205,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[5-(2,3-difluorophenyl)-1H-pyrazolo[3,4-c]pyridazin-3-yl]-2-(1-ethylpiperidin-4-yl)acetamide;2,3-dihydroxybutanedioic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306318,"",651425,103260679,135778713,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-methoxy-4-[(2-{5H-pyrazolo[3,4-d]pyrimidin-4-yl}hydrazin-1-ylidene)methyl]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306319,"",651425,103435091,9827373,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-Bromo-3-(5-bromo-6-hydroxy-2''-methoxy-biphenyl-3-ylmethylene)-1,3-dihydro-pyrrolo[2,3-b]pyridin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306320,"",651425,103455179,6539414,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-[2-(4-methoxyphenyl)pyrazolo[1,5-b]pyridazin-3-yl]pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306321,"",651425,103456549,44397032,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(1-cyclohexyl-1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306322,"",651425,103457167,44397453,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[1-(4-Aminomethyl-phenyl)-1H-imidazo[4,5-c]pyridin-2-yl]-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306323,"",651425,103503420,44418540,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-5-(4-Hydroxy-2,6-dimethylstyryl)nicotinamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306324,"",651425,103629014,10125875,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(4-chlorobenzyl)-4-(pyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306325,"",651425,136932766,53239988,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[[2-[[1-[2-(dimethylamino)acetyl]-6-methoxy-3,4-dihydro-2H-quinolin-7-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-N-methylpyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306326,"",651425,136938723,57399799,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-[[4-[[2-(methoxycarbonylamino)-3H-benzimidazol-5-yl]oxy]phenyl]carbamoylamino]benzoic acid;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306327,"",651425,136938730,57399803,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],5-[2-[4-(aminomethyl)phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2-chlorophenol;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306328,"",651425,136945098,57403320,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"6-(4-Fluorophenyl)-5-pyridin-4-yl-2,3-dihydroimidazo[2,1-b][1,3]thiazole;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306329,"",651425,160706968,70696859,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(5-bromo-6-thiophen-2-yl-1H-pyrazolo[3,4-b]pyridin-3-yl)-2-(1-ethylpiperidin-4-yl)acetamide;2,3-dihydroxybutanedioic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306330,"",651425,136932135,57396352,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],methyl N-[6-[4-(phenylcarbamoylamino)phenoxy]-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306363,"",651425,136935591,57398147,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],methyl N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenyl]sulfonyl-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306364,"",651425,136935592,57398148,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(1-benzylindazol-5-yl)-6,7-dimethoxyquinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306365,"",651425,136935593,57398149,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-[[4-(3-Fluoroanilino)pyrimidin-2-yl]amino]benzamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306366,"",651425,103176311,9910722,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(4-Fluoro-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306367,"",651425,103260592,9604948,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Pyrazolopyrimidine 2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306368,"",651425,103408579,6539502,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Arylmaleimide deriv. 6cc,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306369,"",651425,103203007,6603857,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306370,"",651425,103261167,9604926,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-N-Propyl-3-(4-(2-(pyridin-4-ylmethylene)hydrazinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306371,"",651425,103455205,6539409,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 67",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306372,"",651425,103486524,44410704,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306373,"",651425,103504607,16099859,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-((2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl)oxy)phenyl)-4-(dimethylamino)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306374,"",651425,103504644,11233873,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(4-fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306375,"",651425,103504658,11269477,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(1H-indazol-5-yl)-2-methyl-4-(naphthalen-2-yl)-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306376,"",651425,103508251,11626927,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],IKK-3 Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306377,"",651425,103534539,44431824,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-fluoronaphthalene-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306378,"",651425,103577474,135434987,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(3z)-N-[2-(1h-Imidazol-4-Yl)ethyl]-2-Oxo-3-[2-(4-Sulfamoylphenyl)hydrazinylidene]-2,3-Dihydro-1h-Indole-5-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306379,"",651425,103606906,11273032,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N,N-dimethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306380,"",651425,103610115,44571435,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(furan-2-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306381,"",651425,103631371,25218621,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[(2R)-2,3-dihydroxypropyl]-5-fluoro-2-{[2-({2-methoxy-4-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306382,"",651425,103648686,44589696,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-Methyl-N-(3-morpholinopropyl)-7-phenylimidazo[5,1-f][1,2,4]triazin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306383,"",651425,103659231,44536036,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306384,"",651425,131273123,53239984,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-(2-(4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)pyrimidin-2-yloxy)phenyl)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306385,"",651425,136927822,5034,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306386,"",651425,136932134,57396351,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],methyl N-[6-[4-[(3-bromophenyl)carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306387,"",651425,103408052,6539478,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(3-Chloro-4-Hydroxyphenyl)amino]-4-(3-Chlorophenyl)-1h-Pyrrole-2,5-Dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306388,"",651425,103454865,6539430,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 88",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306389,"",651425,103485748,9604912,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-7-(3-Methoxyphenyl)-4-(2-(pyridin-4-ylmethylene)hydrazinyl)-5H-pyrrolo[3,2-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306390,"",651425,103504666,11453116,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Dihydropyridone indazole amide 13,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306391,"",651425,103522249,25190921,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-amino-5-(4-fluorophenyl)-N-methyl-3-[4-(pyrrolidine-1-sulfonyl)phenyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306392,"",651425,103522281,16048194,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-Amino-3-(4-methanesulfonamidophenyl)-5-phenylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306393,"",651425,103522297,25190926,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],5-(4-Chlorophenyl)-2-methoxy-3-(4-sulfamoylphenyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306394,"",651425,103628926,10193464,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-cyclopropyl-4-(6-morpholinopyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306427,"",651425,103629175,25210972,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(2-{[1-(N,N-Dimethylglycyl)-6-Methoxy-4,4-Dimethyl-1,2,3,4-Tetrahydroquinolin-7-Yl]amino}-7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)amino]thiophene-2-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306428,"",651425,103630045,44581765,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N2-(4-(4-isopropylpiperazin-1-yl)-2-methoxyphenyl)-N4-(quinolin-5-yl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306429,"",651425,134453397,11231939,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(2-methoxyphenyl)-5-phenyl-1,3-oxazol-2-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306430,"",651425,136922447,57391097,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"[(3R,5S)-5-[2-[4-[(1-benzylindazol-5-yl)amino]thieno[3,2-d]pyrimidin-6-yl]ethynyl]pyrrolidin-3-yl] morpholine-4-carboxylate;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306431,"",651425,136930185,57395317,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"6-[2-[(2-methylsulfonylethylamino)methyl]-1,3-thiazol-4-yl]-N-[4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306432,"",651425,103176430,18536627,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(4-Chloro-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306433,"",651425,103260821,9604922,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-4-(2-(3-Fluorobenzylidene)hydrazinyl)-1-(3-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306434,"",651425,103261287,9604940,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-4-(2-(3-Methoxybenzylidene)hydrazinyl)-1-(3-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306435,"",651425,103321312,6539607,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-[6-(4-fluorophenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306436,"",651425,103408023,448008,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-Chloro-5-[4-(3-chloro-phenyl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-ylamino]-benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306437,"",651425,103448962,449054,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],RepSox,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306438,"",651425,103454835,6539364,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(4-propan-2-ylphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306439,"",651425,103455078,6539397,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 55",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306440,"",651425,103456516,44397010,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(3-Ethyl-3H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306441,"",651425,103498514,9917474,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(phenylsulfonyl)ethoxy)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306442,"",651425,103503419,44418539,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-5-(2,6-Dimethylstyryl)-N-methylnicotinamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306443,"",651425,103552601,23646938,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[3-(trifluoromethyl)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306444,"",651425,103577662,135421139,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[[5-(dimethylamino)-2-hydroxy-1H-indol-3-yl]methylideneamino]benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306445,"",651425,103610772,25263087,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(2-bromophenyl)methoxy]-5-[5-(trifluoromethyl)-1H-1,3-benzodiazol-1-yl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306446,"",651425,103663107,44532204,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Methyl-3-[(7-pyridin-2-ylquinolin-4-yl)amino]phenol;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306447,"",651425,136922446,57391096,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],CID 57391096,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306448,"",651425,136925693,57392873,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-[[4-(3-Hydroxy-4-methylanilino)pyrimidin-2-yl]amino]benzamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306449,"",651425,136938724,56603966,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(2S)-pyrrolidin-2-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306450,"",651425,136938731,57399804,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)phenol;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306451,"",651425,136945097,135434997,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[2-(7-Methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-hydrazino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306452,"",651425,103321208,6539597,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-[6-(4-sulfamoylphenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306453,"",651425,103455274,6539411,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 69",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306454,"",651425,103466756,5329802,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"6-(4-Methoxyphenyl)furo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306455,"",651425,103486443,11640889,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(2-aminopyrimidin-4-yl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306456,"",651425,103486476,11627264,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(6-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)pyridin-2-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306457,"",651425,103522291,16048415,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-Amino-3-phenyl-5-(pyridin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306458,"",651425,103623533,44578253,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"6-Methyl-biphenyl-3,4''-dicarboxylic acid 3-cyclohexylamide 4''-cyclopropylmethyl-amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306491,"",651425,103623534,44578254,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"6-Methyl-biphenyl-3,4''-dicarboxylic acid 4''-cyclopropylmethyl-amide 3-isopropylamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306492,"",651425,103628799,10171618,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-Cyclopropyl-4-(2-ethylpyrazolo[1,5-b]pyridazin-3-yl)-2-pyrimidinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306493,"",651425,103629015,10193482,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-morpholinopropyl)-4-(pyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306494,"",651425,103629016,10173796,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306495,"",651425,103629116,44581222,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-(dimethylamino)-1-(6-(4-(indolin-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-5-methoxyindolin-1-yl)ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306496,"",651425,103629583,25211574,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-((2-((5-(2-(Dimethylamino)acetamido)-2-methoxy-4-methylphenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306497,"",651425,103643942,44587530,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"1-(4-(benzyloxy)phenyl)-3-(3-(1-ethyl-4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-1H-pyrazol-3-yl)phenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306498,"",651425,103652215,42618164,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Benzyloxyisoquinoline, 7",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306499,"",651425,136925697,56604049,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"[(3R,5S)-5-[2-[4-[[1-[(2,5-difluorophenyl)methyl]indol-5-yl]amino]thieno[3,2-d]pyrimidin-6-yl]ethynyl]pyrrolidin-3-yl] morpholine-4-carboxylate;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306500,"",651425,136932133,57396350,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]furan-2-carboxamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306501,"",651425,136935594,57398150,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-7-yl]-[(3S)-3-aminopyrrolidin-1-yl]methanone;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306502,"",651425,136941926,57401573,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-7-yl]-piperazin-1-ylmethanone;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306503,"",651425,103176330,15872409,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[5-(4-Fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-2-(4-methanesulfonyl-phenoxy)-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306504,"",651425,103176455,15872406,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[4-(4-Fluorophenyl)-1-(Piperidin-4-Yl)-1h-Imidazol-5-Yl]-2-(2-Methoxyphenoxy)pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306505,"",651425,103176489,18536613,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(4-tert-Butyl-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306506,"",651425,103448885,6539751,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[6-(4-methylphenyl)furo[2,3-d]pyrimidin-4-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306507,"",651425,103455235,6539439,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 97",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306508,"",651425,103456457,5329829,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],1-[4-[methyl-[2-[(3-Sulfamoylphenyl)amino]pyrimidin-4-Yl]amino]phenyl]-3-[4-(Trifluoromethyloxy)phenyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306509,"",651425,103456873,11680113,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(1-Methyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306510,"",651425,103465338,5329868,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"1-[3-(2-{[5-(Ethylsulfonyl)-2-methoxyphenyl]amino}-1,3-oxazol-5-yl)phenyl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306511,"",651425,103503410,44418532,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Methyl (E)-5-(4-hydroxy-2,6-dimethylstyryl)nicotinate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306512,"",651425,103575499,25093474,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(cyclopropylmethyl)-4-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306513,"",651425,103577712,135418490,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Oxindole-Based Inhibitor 22,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306514,"",651425,103577939,135421144,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[[(Z)-(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methyl]amino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306515,"",651425,103610059,44571414,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)thiophen-3-yl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306516,"",651425,103627809,10469531,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-cyclopropyl-3-(1H-indazol-5-yl)-4-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306517,"",651425,103629529,25218571,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-{[2-({4-chloro-2-methoxy-5-[(1-propylpiperidin-4-yl)oxy]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-6-fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306518,"",651425,134449557,24949545,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[[4-[(1,3-Dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]benzenesulfonamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306519,"",651425,134453396,135398493,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-{[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-methyl]amino}benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306520,"",651425,134453403,136091540,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[[(1-Benzylpyrazolo[3,4-d]pyrimidin-4-yl)hydrazinylidene]methyl]-2-methoxyphenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306521,"",651425,134461030,135506564,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[[4-(1,2,4-triazol-1-yl)phenyl]iminomethyl]-1H-indol-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306522,"",651425,136922442,57391092,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[4-[[2-[3-(4-methylpiperazin-1-yl)propylamino]-3H-benzimidazol-5-yl]oxy]phenyl]urea;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306555,"",651425,136922444,57391094,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(3-bromo-4-phenylmethoxyphenyl)-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306556,"",651425,136925695,9947709,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[2-(4-Fluorophenyl)-6-trifluoromethylpyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306557,"",651425,136930182,57395310,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-N-(5-ethylsulfonyl-2-methoxyphenyl)-4-N-methyl-4-N-(3-methyl-2H-indazol-6-yl)pyrimidine-2,4-diamine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306558,"",651425,136936843,57398861,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[5-(2,3-difluorophenyl)-1H-pyrazolo[3,4-c]pyridazin-3-yl]-1-ethylpiperidine-4-carboxamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306559,"",651425,136940024,21701565,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"6,7-Dimethoxy-4-(3-hydroxy-4-methylanilino)quinazoline hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306560,"",651425,103176259,15872391,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-{4-[5-(4-Fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidin-2-yloxy}-benzonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306561,"",651425,103176260,15872388,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-Phenoxy-4-[1-(piperidine-4-yl)-4-(4-fluorophenyl)-5-imidazolyl]pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306562,"",651425,103176495,15872404,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(3-Fluoro-phenoxy)-4-[5-(4-fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306563,"",651425,103259940,9604970,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"1-(3-methoxyphenyl)-3-methyl-N-[(E)-1-pyridin-4-ylethylideneamino]pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306564,"",651425,103310961,22464113,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[5-(4-Fluoro-phenyl)-3-(1-methyl-piperidin-4-yl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306565,"",651425,103316127,5329404,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N,5-diphenyl-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306566,"",651425,103407492,6539453,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Arylmaleimide deriv. 6c,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306567,"",651425,103456911,599038,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(1-Ethyl-1H-benzimidazol-2-yl)-1,2,5-oxadiazol-3-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306568,"",651425,103465517,5329850,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[(5-Phenyl-1,3-oxazol-2-yl)amino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306569,"",651425,103503437,44418556,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],5-[(E)-2-(2-chlorophenyl)ethenyl]-N-methylpyridine-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306570,"",651425,103503456,44418572,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-3,5-Dimethyl-4-(2-(5-(methylcarbamoyl)pyridin-3-yl)vinyl)phenyl methylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306571,"",651425,103504657,11247002,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(3,4-dichlorophenyl)-N-1H-indazol-5-yl-2-methyl-6-oxo-1,4,5,6-tetrahydropyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306572,"",651425,103566727,6539567,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[6-(4-methoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306573,"",651425,103610164,44571453,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],EGFR/ErbB-2 inhibitor-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306574,"",651425,103610848,9826308,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(5,6-Dimethoxy-1-benzimidazolyl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306575,"",651425,103623535,44578255,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"6-Methyl-biphenyl-3,4''-dicarboxylic acid 3-cyclobutylamide 4''-cyclopropylmethyl-amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306576,"",651425,103627932,10308522,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(4-Pyrazolo[1,5-b]pyridazin-3-yl-2-pyrimidinyl)amino]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306577,"",651425,103629585,25218573,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-((2-((5-(2-(Dimethylamino)-N-methylacetamido)-2-methoxy-4-methylphenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-6-fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306578,"",651425,103631756,25218593,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-((2-((2-Methyl-4-(1-propyl-1,2,5,6-tetrahydropyridin-3-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306579,"",651425,103658212,44532523,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(3-chloro-4-phenylmethoxyphenyl)-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306580,"",651425,134434070,136207967,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[5-[5-[4-[2-(dimethylamino)ethoxy]phenyl]-2-pyridin-4-ylfuran-3-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306581,"",651425,136922441,57391091,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],1-[4-[Methyl-[2-[4-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]amino]phenyl]-3-(2-morpholin-4-ylethyl)urea;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306582,"",651425,136927020,57393604,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-[[5-(4-fluorophenyl)-1H-pyrazol-3-yl]amino]benzenesulfonamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306583,"",651425,136936845,57398866,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(E)-2-(2,6-dimethyl-4-pyridin-2-ylphenyl)ethenyl]-5-(2H-tetrazol-5-yl)pyridine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306584,"",651425,103176292,9885504,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-{3-[4-(4-Fluoro-phenyl)-5-pyridin-4-yl-imidazol-1-yl]-propyl}-morpholine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306585,"",651425,103176408,9890357,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-{4-[5-(4-Fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-pyrimidin-2-yloxy}-benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306586,"",651425,103310794,17892742,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],{4-[5-(4-Fluoro-phenyl)-3-(1-methyl-piperidin-4-yl)-3H-imidazol-4-yl]-pyrimidin-2-yl}-phenyl-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306619,"",651425,103407728,6539466,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Arylmaleimide deriv. 6p,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306620,"",651425,103454620,11473228,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(3-Chlorophenyl)-5-(1,5-naphthyridin-2-yl)-1,3-thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306621,"",651425,103454721,6539418,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 76",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306622,"",651425,103455206,6539424,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[2-(4-chlorophenyl)pyrazolo[1,5-b]pyridazin-3-yl]-N-phenylpyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306623,"",651425,103456492,44396990,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(4-Ethoxy-1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306624,"",651425,103486307,11669455,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-(4-aminophenyl)ethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306625,"",651425,103534542,766948,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-Cyano-4,5,6,7-Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306626,"",651425,103536614,9927432,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-Methyl-3-{[6-(Methylsulfonyl)quinolin-4-Yl]amino}phenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306627,"",651425,103552592,10113568,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],TIE-2/VEGFR-2 kinase-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306628,"",651425,103566730,135435015,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(5-bromo-6-(4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-1-methylpiperidine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306629,"",651425,103575285,10200651,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-Cyanophenyl)-2'-Methyl-5'-(5-Methyl-1,3,4-Oxadiazol-2-Yl)-4-Biphenylcarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306630,"",651425,103592466,5329489,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(3-Ethynylphenyl)-6-(4-((2-(methylsulfonyl)ethyl)amino)butoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306631,"",651425,103612637,25263118,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-(6-methoxy-1H-1,3-benzodiazol-1-yl)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306632,"",651425,103623835,44578425,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],5''-(2-Cyclopropyl-acetylamino)-2''-methyl-biphenyl-4-carboxylic acid cyclopropylmethyl-amide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306633,"",651425,103629234,25218614,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-fluoro-2-{[2-({2-methoxy-4-[4-(propan-2-yl)piperazin-1-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306634,"",651425,103750063,11959683,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((R)-2-amino-2-phenylethoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306635,"",651425,136930146,16219401,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(1-methyl-3-indolyl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306636,"",651425,136936846,57398867,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(E)-2-[4-(furan-2-yl)-2,6-dimethylphenyl]ethenyl]-5-(2H-tetrazol-5-yl)pyridine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306637,"",651425,136940023,57400541,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridazin-3-yl)cyclopropanecarboxamide;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306638,"",651425,136941927,57401574,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(2-benzyl-3H-benzimidazol-5-yl)quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306639,"",651425,136941928,57401575,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-(1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306640,"",651425,103260746,9604911,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"1-(3-methoxyphenyl)-N-[(E)-pyridin-4-ylmethylideneamino]pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306641,"",651425,103441474,5329854,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-phenyl-N-(3,4,5-trimethoxyphenyl)-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306642,"",651425,103456789,44397201,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(1-Ethyl-4-pyrrolidin-1-yl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306643,"",651425,103483599,9858084,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(4-fluorophenyl)-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306644,"",651425,103566682,6539598,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-[6-(3-sulfamoylphenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306645,"",651425,103577394,135434990,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Oxindole-Based Inhibitor 62,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306646,"",651425,103577437,135434989,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-oxo-N-(pyridin-4-ylmethyl)-3-[2-(4-sulfamoylphenyl)hydrazinyl]indole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306647,"",651425,103577553,135421141,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-Oxo-3-(4-sulfamoyl-phenylamino-methylene)-2,3-dihydro-1H-indole-5-carboxylic acid isobutyl ester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306648,"",651425,103577757,135421134,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],(Z)-4-((1-(2-Oxoindolin-3-ylidene)ethyl)amino)benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306649,"",651425,103593129,11284937,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl morpholine-4-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306650,"",651425,103648992,11328632,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-methyl-7-[3-(trifluoromethyl)phenyl]-N-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306683,"",651425,136935598,135434999,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Oxindole-Based Inhibitor 72,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306684,"",651425,136938722,57399798,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],methyl N-[6-[3-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306685,"",651425,103176271,15872400,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[5-(4-Fluoro-phenyl)-3-piperidin-4-yl-3H-imidazol-4-yl]-2-(4-phenoxy-phenoxy)-pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306686,"",651425,103176382,15872407,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-[3-(Trifluoromethyl)phenoxy]-4-[1-(piperidine-4-yl)-4-(4-fluorophenyl)-5-imidazolyl]pyrimidine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306687,"",651425,103311248,44329036,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-{4-[5-(4-Fluoro-phenyl)-3-(1-methyl-piperidin-4-yl)-3H-imidazol-4-yl]-pyrimidin-2-ylamino}-ethanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306688,"",651425,103449269,11290221,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(4-Fluorophenyl)-5-(1,5-naphthyridin-2-yl)thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306689,"",651425,103466885,5329801,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(4-Methoxyphenyl)furo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306690,"",651425,103522255,16048303,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-Amino-5-(4-fluorophenyl)-3-(pyridin-4-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306691,"",651425,103527603,10160775,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"methyl N-[6-(4-{[(3-ethylphenyl)carbamoyl]amino}phenoxy)-1H-1,3-benzodiazol-2-yl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306692,"",651425,103577755,135434965,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Oxindole-Based Inhibitor 20,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306693,"",651425,103577937,135435007,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Oxindole-Based Inhibitor 81,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306694,"",651425,103610354,25263115,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-N-methyl-3-{[2-(trifluoromethyl)phenyl]methoxy}thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306695,"",651425,103611131,25263099,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-[5,6-bis(methyloxy)-1H-benzimidazol-1-yl]-3-[(2-phenylethyl)oxy]-2-thiophenecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306696,"",651425,103612574,25263117,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(1S)-1-(2-chlorophenyl)ethoxy]-5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306697,"",651425,134437918,25263123,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-{6-[(1-methylpiperidin-4-yl)methoxy]-1H-1,3-benzodiazol-1-yl}-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306698,"",651425,134449559,3805075,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-Methoxy-4-hydroxybenzaldehyde [1-(phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]hydrazone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306699,"",651425,136920479,16236469,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-y",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306700,"",651425,136932136,57396353,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[2-(dimethylamino)ethyl]-4-[(E)-[[1-(3-methoxyphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]hydrazinylidene]methyl]benzamide;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306701,"",651425,136938729,56603973,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],CID 56603973,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306702,"",651425,103454690,6539369,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 27",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306703,"",651425,103454806,6539417,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 75",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306704,"",651425,103454856,6539390,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 48",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306705,"",651425,103455041,11163861,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3,5-Dimethoxyphenyl)-4-(pyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306706,"",651425,103455105,6539422,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 80",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306707,"",651425,103455340,6539361,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Pyrazolopyridazine 1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306708,"",651425,103485758,9604915,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],(E)-9-(3-Methoxyphenyl)-6-(2-(pyridin-4-ylmethylene)hydrazinyl)-9H-purine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306709,"",651425,103486358,11502866,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-5-(2-phenylethynyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306710,"",651425,103504676,11751266,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(7-chloro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306711,"",651425,103534541,579429,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306712,"",651425,103567065,6539611,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[5-bromo-6-(furan-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306713,"",651425,103610915,25263092,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(2-chlorophenyl)methoxy]-5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306714,"",651425,103624339,24856364,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-{4'-[(Cyclopropylmethyl)carbamoyl]-6-Methylbiphenyl-3-Yl}-2-Morpholin-4-Ylpyridine-4-Carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306747,"",651425,103629652,25218584,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-fluoro-6-({2-[(5-methoxy-1-{2-[4-(propan-2-yl)piperazin-1-yl]acetyl}-2,3-dihydro-1H-indol-6-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306748,"",651425,103652214,42618163,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Benzyloxyisoquinoline, 6",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306749,"",651425,131281196,15872408,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"2-(3,4-difluorophenoxy)-4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306750,"",651425,134461029,56681565,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(2-amino-1,3-thiazol-4-yl)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-1H-indol-2-one;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306751,"",651425,136941925,57401572,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"methyl N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-1,3-benzothiazol-2-yl]carbamate;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306752,"",651425,103321813,6539592,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[6-(furan-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306753,"",651425,103322222,6539600,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-[6-(4-methanesulfonamidophenyl)-1H-indazol-3-yl]cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306754,"",651425,103441550,5329861,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[5-(ethanesulfonyl)-2-methoxyphenyl]-5-(3-fluorophenyl)-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306755,"",651425,103455079,6539412,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"Pyrazolo[1,5-b]pyridazine deriv. 70",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306756,"",651425,103456490,10236195,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-(1-Ethyl-6-fluoro-1H-benzoimidazol-2-yl)-furazan-3-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306757,"",651425,103486529,11605761,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(3-(2-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)pyrimidin-5-yl)ethynyl)benzyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306758,"",651425,103498929,22609796,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],(4-Benzyloxy-phenyl)-(6-furan-2-yl-quinazolin-4-yl)-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306759,"",651425,103503427,44418546,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-[(E)-2-(2,6-diethylphenyl)ethenyl]-N-methylpyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306760,"",651425,103503436,44418555,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-methyl-5-[(E)-2-(2-methylphenyl)ethenyl]pyridine-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306761,"",651425,103551407,24896610,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-[[4-(1H-indazol-4-ylamino)pyrimidin-2-yl]amino]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306762,"",651425,134437917,135418262,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(4-{[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}phenyl)methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306763,"",651425,136922445,57391095,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],6-[5-[[2-(benzenesulfonyl)ethylamino]methyl]furan-2-yl]-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306764,"",651425,136925696,56604000,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(E)-but-2-enedioic acid;3-[[4-[2-(4-fluorophenyl)-6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-yl]amino]propan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306765,"",651425,136940025,57400542,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3,5-dimethyl-4-[(E)-2-[5-(2H-tetrazol-5-yl)pyridin-3-yl]ethenyl]phenol;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306766,"",651425,136943844,5482344,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"12,13-Dihydro-3,9-dimethoxy-5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306767,"",651425,136945096,57403319,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-chloro-4-phenylmethoxyphenyl)-6-[5-[(1-oxo-1,4-thiazinan-4-yl)methyl]furan-2-yl]quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306768,"",651425,103456717,44397147,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-(1,4-Diethyl-1H-imidazo[4,5-c]pyridin-2-yl)-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306769,"",651425,103498556,21951965,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(4-(3-fluorobenzyloxy)-3-(trifluoromethyl)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306770,"",651425,103503411,44418533,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-[(E)-2-(4-hydroxy-2,6-dimethylphenyl)ethenyl]-N,N-dimethylpyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306771,"",651425,103566590,6539603,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[6-(2,5-difluorophenyl)-1H-indazol-3-yl]cyclopropanecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306772,"",651425,103566685,6539593,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-(6-phenyl-1H-indazol-3-yl)cyclopropanecarboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306773,"",651425,103577597,135409809,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Oxindole-Based Inhibitor 29,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306774,"",651425,103577938,135434994,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],Oxindole-Based Inhibitor 66,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306775,"",651425,103610678,25263083,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(1H-1,3-benzodiazol-1-yl)-3-[(2-bromophenyl)methoxy]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306776,"",651425,103612791,25263119,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-(6-methoxy-1H-1,3-benzodiazol-1-yl)-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306777,"",651425,103750103,11959682,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"(S)-4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-(2-amino-2-phenylethoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301306778,"",651425,134437919,16051023,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-[6-(1-methylpiperidin-4-yl)oxybenzimidazol-1-yl]thiophene-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311470,"",651424,136930146,16219401,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(1-methyl-3-indolyl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311471,"",651424,136936846,57398867,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"3-[(E)-2-[4-(furan-2-yl)-2,6-dimethylphenyl]ethenyl]-5-(2H-tetrazol-5-yl)pyridine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311472,"",651424,136940023,57400541,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(5-pyridin-3-yl-1H-pyrazolo[3,4-c]pyridazin-3-yl)cyclopropanecarboxamide;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311473,"",651424,136941927,57401574,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],N-(2-benzyl-3H-benzimidazol-5-yl)quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311474,"",651424,136941928,57401575,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-(1H-pyrrol-2-yl)thieno[3,2-d]pyrimidin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311475,"",651424,103260487,9604943,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(E)-4-(2-(4-Fluorobenzylidene)hydrazinyl)-1-(3-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311476,"",651424,103407373,6539522,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],4-Arylmaleimide deriv. 8g,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311477,"",651424,103441467,5329853,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"N-(3,5-dimethoxyphenyl)-5-phenyl-1,3-oxazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311478,"",651424,103449085,9922527,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-(1,5-Naphthyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311479,"",651424,103483604,11717091,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(4-Isopropylphenyl)-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311480,"",651424,103503426,44418545,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"tert-Butyl (E)-5-(4-hydroxy-2,6-dimethylstyryl)nicotinate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311481,"",651424,103503428,44418547,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"5-[(E)-2-(2,6-dichlorophenyl)ethenyl]-N-methylpyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311482,"",651424,103534555,16664858,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"1-Naphthalenecarboxamide, N-[3-cyano-7-(cyclopropylcarbonyl)-4,5,6,7-tetrahydrothieno[2,3-b]pyridin-2-yl]-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311483,"",651424,103606835,11307581,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"(3R,5S)-5-{2-[4-({3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}amino)thieno[3,2-d]pyrimidin-6-yl]ethynyl}pyrrolidin-3-yl N-ethylcarbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311484,"",651424,131277124,53239985,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],2-(2-(4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)pyrimidin-2-yloxy)phenyl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311485,"",651424,134445608,53239955,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],"methyl 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-2-oxo-1H-indole-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311486,"",651424,136935589,57398145,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],1-[4-[Methyl-[2-[4-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]amino]phenyl]-3-[4-(4-methylpiperazine-1-carbonyl)phenyl]urea;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301311487,"",651424,136935596,57398152,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn],6-[3-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-(4-phenylmethoxyphenyl)quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320743,"",651425,134453395,135482293,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-{[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}-1,3-dihydro-2H-benzimidazol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320744,"",651425,134461031,11392350,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(5-Phenyl-1,3-oxazol-2-yl)amino]benzonitrile;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320745,"",651425,136922443,57391093,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-[4-[[3-(trifluoromethyl)phenyl]methoxy]phenyl]quinazolin-4-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320746,"",651425,136923783,57391875,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-6-[2-(methylamino)ethoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320747,"",651425,136928913,57394599,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],methyl N-[6-[4-[(3-chlorophenyl)carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]carbamate;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320748,"",651425,136938732,136126597,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],SB-590885Aad,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320749,"",651425,103441529,5329860,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-Anilino-5-aryloxazole 27,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320750,"",651425,103457523,44397710,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[1-(3-Dimethylamino-propyl)-1H-imidazo[4,5-c]pyridin-2-yl]-furazan-3-ylamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320751,"",651425,103484113,11604319,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-{2-[(4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]-pyridin-2-yl}-phenyl)oxy]ethyl}morpholine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320752,"",651425,103498517,9873849,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],2-(((5-(4-(4-(3-Fluorobenzyloxy)-3-chlorophenylamino)quinazolin-6-yl)furan-2-yl)methyl)(2-(methylsulfonyl)ethyl)amino)acetonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320753,"",651425,103508344,11957417,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"5-[5,6-Bis(Methyloxy)-1h-Benzimidazol-1-Yl]-3-{[1-(2-Chlorophenyl)ethyl]oxy}-2-Thiophenecarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320754,"",651425,103575696,10158653,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[(4-methoxyphenyl)methyl]-4-[2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320755,"",651425,103610291,25263114,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"1-[5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-3-{[2-(trifluoromethyl)phenyl]methoxy}thiophen-2-yl]ethan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320756,"",651425,103631934,25218601,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-fluoro-2-[(2-{[2-methoxy-4-(1-propylpiperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320757,"",651425,134441817,135421144,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"4-[[(Z)-(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methyl]amino]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320758,"",651425,134441818,53239978,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"3-[(3,5-dichloro-4-hydroxyphenyl)methylidene]-5-(furan-2-carbonyl)-1H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320759,"",651425,134445610,136026030,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[5-(2-piperidin-4-yl-5-pyridin-4-yl-1H-imidazol-4-yl)-2,3-dihydroinden-1-ylidene]hydroxylamine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320760,"",651425,136920477,57390087,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-(3-chloro-4-fluorophenyl)-6-[2-[(2-methylsulfonylethylamino)methyl]-1,3-thiazol-4-yl]quinazolin-4-amine;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320761,"",651425,136928917,56603987,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],"N-[4-[2-(4-fluorophenyl)-6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-yl]-N',N'-dimethylpropane-1,3-diamine;methanesulfonic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320762,"",651425,136938726,136126596,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[[2-hydroxy-4-(2-pyridin-4-ylethyl)-1H-indol-3-yl]diazenyl]benzenesulfonamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320763,"",651425,136938728,57399802,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[5-(4-Fluorophenyl)-3-piperidin-4-ylimidazol-4-yl]pyrimidin-2-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320764,"",651425,136938728,57399802,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],4-[5-(4-Fluorophenyl)-3-piperidin-4-ylimidazol-4-yl]pyrimidin-2-amine;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
301320765,"",651425,136945094,57403317,2064,"",Other,20200626,0,0,Unspecified,P04626,"","",ChEMBL,GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn],N-[6-[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-1H-benzimidazol-2-yl]benzamide;hydrochloride,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321397321,"",655489,160693696,54613080,2064,22335895,Literature-derived,20180921,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 at 10 uM,"4-(7-Methoxy-1-(Trifluoromethyl)-9h-Pyrido[3,4-B]indol-9-Yl)butan-1-Amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321410983,"",664737,160678864,53341082,2064,22372864,Literature-derived,20180921,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human SKBR3 cells at 1 uM measured immediately by Western blot analysis relative to control,"N-[[2-[4-amino-6-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]pyrimidin-5-yl]-1,3-oxazol-4-yl]methyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
321411198,"",664739,160678864,53341082,2064,22372864,Literature-derived,20180921,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human SKBR3 cells at 1 uM measured 8 hrs following wash out by Western blot analysis relative to control,"N-[[2-[4-amino-6-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]pyrimidin-5-yl]-1,3-oxazol-4-yl]methyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
321457046,"",662490,160673040,57341660,2064,22339342,Literature-derived,20200626,0,0,Active,P04626,"","",ChEMBL,Binding affinity to ErbB2 at 100 nM,"N-[3-[3-benzyl-7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321465942,"",666201,160679350,25229528,2064,24900237,Literature-derived,20200627,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747 to E749 deletion, A750P mutant at 1 uM","(1S,2S,3R,4R)-3-[5-Chloro-2-(1-ethyl-6-methoxy-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-ylamino)-pyrimidin-4-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321465964,"",666200,160679350,25229528,2064,24900237,Literature-derived,20200627,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747 to E749 deletion, A750P mutant at 0.1 uM","(1S,2S,3R,4R)-3-[5-Chloro-2-(1-ethyl-6-methoxy-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-ylamino)-pyrimidin-4-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321495940,"",682901,103226312,65064,2064,22559865,Literature-derived,20200630,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human SK-BR-3 cells after 6 hrs by Western blot analysis,Epigallocatechin Gallate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
321495941,"",682901,160707819,25110597,2064,22559865,Literature-derived,20200630,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human SK-BR-3 cells after 6 hrs by Western blot analysis,"4,4'-Bis[(3,4,5-trihydroxybenzoyl)oxy]-1,1'-biphenyl",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
321502900,"",662509,160689092,57341490,2064,22339342,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant Y1068 autophosphorylation in human HCC827 cells after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-3-phenyl-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321502924,"",662580,103244983,123631,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Erk phosphorylation in human HCC827 cells up to 125 nM after 24 hrs by Western blot analysis,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321502949,"",662581,160673040,57341660,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Erk phosphorylation in human HCC827 cells up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[3-benzyl-7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321502989,"",662588,104245790,44607530,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in Akt level up to 125 nM after 24 hrs by Western blot analysis,N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503078,"",662579,160689092,57341490,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Akt phosphorylation in human HCC827 cells up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-3-phenyl-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503082,"",662579,160673040,57341660,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Akt phosphorylation in human HCC827 cells up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[3-benzyl-7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503144,"",662584,104245790,44607530,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in EGFR level up to 125 nM after 24 hrs by Western blot analysis,N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503148,"",662584,160668080,57343703,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in EGFR level up to 125 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503213,"",661572,160700159,46239453,2064,22280453,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ErbB2 up to 10 uM by time-resolved fluorometry,N-[4-(3-bromoanilino)quinazolin-6-yl]-3-(dimethylamino)propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503227,"",662509,104245790,44607530,2064,22339342,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant Y1068 autophosphorylation in human HCC827 cells after 24 hrs by Western blot analysis,N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503231,"",662509,160668080,57343703,2064,22339342,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant Y1068 autophosphorylation in human HCC827 cells after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503235,"",662509,160673040,57341660,2064,22339342,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant Y1068 autophosphorylation in human HCC827 cells after 24 hrs by Western blot analysis,"N-[3-[3-benzyl-7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503245,"",662580,104245790,44607530,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Erk phosphorylation in human HCC827 cells up to 125 nM after 24 hrs by Western blot analysis,N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503249,"",662580,160668080,57343703,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Erk phosphorylation in human HCC827 cells up to 125 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503285,"",662581,160689092,57341490,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Erk phosphorylation in human HCC827 cells up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-3-phenyl-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503292,"",662585,160689092,57341490,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in EGFR level up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-3-phenyl-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503296,"",662585,160673040,57341660,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in EGFR level up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[3-benzyl-7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503297,"",662592,104245790,44607530,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in Erk level up to 125 nM after 24 hrs by Western blot analysis,N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503301,"",662592,160668080,57343703,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in Erk level up to 125 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503380,"",662589,160689092,57341490,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in Akt level up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-3-phenyl-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503384,"",662589,160673040,57341660,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in Akt level up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[3-benzyl-7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503512,"",662593,160689092,57341490,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in Erk level up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-3-phenyl-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503516,"",662593,160673040,57341660,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in Erk level up to 50 nM after 24 hrs by Western blot analysis,"N-[3-[3-benzyl-7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503519,"",662617,103244983,123631,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant Y1068 autophosphorylation in human HCC827 cells up to 125 nM after 24 hrs by Western blot analysis,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503758,"",662578,103244983,123631,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Akt phosphorylation in human HCC827 cells up to 125 nM after 24 hrs by Western blot analysis,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503762,"",662578,104245790,44607530,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Akt phosphorylation in human HCC827 cells up to 125 nM after 24 hrs by Western blot analysis,N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503766,"",662578,160668080,57343703,2064,22339342,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant-mediated Akt phosphorylation in human HCC827 cells up to 125 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321503841,"",662588,160668080,57343703,2064,22339342,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of EGFR del E746-A750 mutant in human HCC827 cells assessed as change in Akt level up to 125 nM after 24 hrs by Western blot analysis,"N-[3-[7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-3-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-1-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504638,"",670128,160674380,57415416,2064,22439974,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"5-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-1,3-dihydroindol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504639,"",670128,160701254,57415418,2064,22439974,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"4-(2-chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino}phenoxy)isoindolin-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504640,"",670128,160706531,57415536,2064,22439974,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"7-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-1,3-dihydroindol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504641,"",670128,160679731,57415537,2064,22439974,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"2-[4-[3-Chloro-4-(1-methylindazol-4-yl)oxyanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504642,"",670128,160674391,25026281,2064,22439974,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"2-[4-[3-chloro-4-(1H-indazol-4-yloxy)anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504643,"",670128,160669074,57415414,2064,22439974,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"6-(2-chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino}phenoxy)isoindolin-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504644,"",670128,160669075,25026085,2064,22439974,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"2-[4-[4-(1-Benzothiophen-4-yloxy)-3-chloroanilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504645,"",670128,160679719,57415415,2064,22439974,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"5-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-2,3-dihydroisoindol-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504646,"",670128,160679720,57415417,2064,22439974,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"6-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-1,3-dihydroindol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504647,"",670128,160690494,57415535,2064,22439974,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"7-[2-Chloro-4-[[5-(2-hydroxyethyl)pyrrolo[3,2-d]pyrimidin-4-yl]amino]phenoxy]-2,3-dihydroisoindol-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504648,"",670128,160690508,44205208,2064,22439974,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"2-(4-{[4-(1,2-benzoisothiazol-4-yloxy)-3-chlorophenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504649,"",670128,160695907,25025888,2064,22439974,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"2-(4-{[3-chloro-4-(1H-indol-4-yloxy)phenyl]amino}-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321504900,"",670128,160679721,25026082,2064,22439974,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillat,"4-(2-chloro-4-{[5-(2-hydroxyethyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino}phenoxy)-1,3-dihydro-2H-indol-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
321506635,"",678137,160675461,70684700,2064,22868229,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of full-lenght/His-tagged ERBB2 overexpressed in human MCF7 cells assessed as inhibition of AKT phosphorylation at 0.2 to 6 uM after 12 hrs by Western blot analysis,N-benzyl-6-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
321508074,"",678140,160675461,70684700,2064,22868229,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of truncated soluble ERBB2 expressed in human MCF7 cell lysate at 1 to 10 uM after mCherry fluorescence assay pretreated with canertinib before lysis,N-benzyl-6-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
321508075,"",678141,160675461,70684700,2064,22868229,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of truncated soluble ERBB2 expressed in human MCF7 cell lysate at 1 to 10 uM after mCherry fluorescence assay,N-benzyl-6-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
321508173,"",683035,160707819,25110597,2064,22559865,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 signaling in human SK-BR-3 cells up to 24 hrs,"4,4'-Bis[(3,4,5-trihydroxybenzoyl)oxy]-1,1'-biphenyl",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
321508222,"",683031,160707819,25110597,2064,22559865,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of FASN/HER2 in human SK-BR-3 cells assessed as reduction in p-ERK1/2 levels after 6 hrs by Western blot analysis,"4,4'-Bis[(3,4,5-trihydroxybenzoyl)oxy]-1,1'-biphenyl",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
321508316,"",682883,160707819,25110597,2064,22559865,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human SK-BR-3 cells after 2 hrs by Western blot analysis,"4,4'-Bis[(3,4,5-trihydroxybenzoyl)oxy]-1,1'-biphenyl",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
321508683,"",683032,160707819,25110597,2064,22559865,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of FASN/HER2 in human SK-BR-3 cells assessed as reduction in p-AKT levels after 6 hrs by Western blot analysis,"4,4'-Bis[(3,4,5-trihydroxybenzoyl)oxy]-1,1'-biphenyl",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
323651604,"",686974,96079542,1572025,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",3-bromo-N-(3-butoxyphenyl)-2-oxo-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651605,"",686974,96079540,1417940,2064,"",Other,20130724,0,0,Inactive,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",3-bromo-N-{4-[(4-methoxyphenyl)carbamoyl]phenyl}-2-oxo-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651606,"",686974,96079536,929904,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",3-bromo-N-(4-methoxyphenyl)-2-oxo-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651607,"",686974,115001723,930700,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",3-bromo-N-(furan-2-ylmethyl)-2-oxo-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651608,"",686974,96079541,935372,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",3-bromo-N-(4-fluorophenyl)-2-oxo-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651609,"",686974,85267043,4988879,2064,"",Other,20130724,0,0,Inactive,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT","Methyl 2-(cyclopropanecarbonylamino)-1,3-benzothiazole-6-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651611,"",686974,115001717,1872661,2064,"",Other,20130724,0,0,Inactive,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",5-bromo-N-(3-methyl-4-propan-2-ylphenyl)-6-oxopyran-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651612,"",686974,115001721,929897,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",3-bromo-N-(6-methylpyridin-2-yl)-2-oxo-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651695,"",686974,96079537,949725,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",N-(4-acetylphenyl)-3-bromo-2-oxo-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651696,"",686974,115001720,921568,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",5-bromo-N-[2-(4-fluorophenyl)ethyl]-6-oxopyran-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651700,"",686974,85267040,16190663,2064,"",Other,20130724,0,0,Inactive,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT","1-{[2-(4-ethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-2-[2-(1H-pyrazol-1-yl)ethyl]piperidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651707,"",686974,115001722,930325,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",3-bromo-2-oxo-N-(pyridin-3-ylmethyl)-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323651708,"",686974,115001718,3781338,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",5-bromo-N-(2-methylpropyl)-6-oxopyran-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323909249,"",686974,115001719,3945091,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT","3-bromo-N-[1-(octahydro-1H-2,5-methanoinden-4-yl)ethyl]-2-oxo-2H-pyran-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323909250,"",686974,96079539,1417406,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",3-bromo-N-(2-iodophenyl)-2-oxo-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
323909254,"",686974,96079538,1565171,2064,"",Other,20130724,0,0,Active,AAO18082,"","",The Scripps Research Institute Molecular Screening Center,"Late stage assay provider results from the probe development effort to identify selective inhibitors of heat shock protein 90 (HSP90): Western blot analysis of Hsp90-dependent client proteins, Her2 and AKT",3-bromo-N-(4-(octyloxy)phenyl)-2-oxo-2H-pyran-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,"",AAO18082,9606,"","","",""
325855530,"",710534,163332075,71459220,2064,23098137,Literature-derived,20180923,0,0,Inconclusive,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","5-bromo-N-[(4-fluorophenyl)methyl]-8-piperazin-1-yl-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855531,"",710534,163328524,45376580,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-[(4-aminocyclohexyl)amino]-5-bromo-N-[(4-methoxyphenyl)methyl]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855532,"",710534,163325079,45376447,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","5-bromo-N-[(4-fluorophenyl)methyl]-8-(piperidin-4-ylamino)-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855533,"",710534,163328525,45376710,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-[(4-aminocyclohexyl)amino]-5-bromo-N-[(4-chlorophenyl)methyl]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855534,"",710534,163335513,45376708,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-[(4-aminocyclohexyl)amino]-5-bromo-N-[(3-methoxyphenyl)methyl]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855535,"",710534,163314778,71450209,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-[(4-aminocyclohexyl)amino]-5-bromo-N-[(2,4-dichlorophenyl)methyl]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855536,"",710534,163338923,45376308,2064,23098137,Literature-derived,20180923,0,0,Inconclusive,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","5-bromo-8-[3-(dimethylamino)propylamino]-N-[(4-fluorophenyl)methyl]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855537,"",710534,163332077,71459222,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","N-[(4-fluorophenyl)methyl]-5-(6-formamidohexylamino)-8-hydroxy-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855538,"",710534,163321668,45377110,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","N-(4-aminocyclohexyl)-5-bromo-8-[(4-fluorophenyl)methylamino]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855539,"",710534,163338883,45376709,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-[(4-aminocyclohexyl)amino]-5-bromo-N-phenyl-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855905,"",710534,163335515,45376448,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-[(4-aminocyclohexyl)amino]-5-bromo-N-[(4-fluorophenyl)methyl]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855906,"",710534,103177479,208908,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA",Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855907,"",710534,163318244,45376579,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-[(4-aminocyclohexyl)amino]-N-(1,3-benzodioxol-5-ylmethyl)-5-bromo-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855908,"",710534,163325078,45376312,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-(4-aminoanilino)-5-bromo-N-[(4-fluorophenyl)methyl]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855909,"",710534,163328523,45376578,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-[(4-aminocyclohexyl)amino]-N-benzyl-5-bromo-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855910,"",710534,163328483,45376707,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-[(4-aminocyclohexyl)amino]-5-bromo-N-(2-phenylethyl)-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855911,"",710534,163328528,45376183,2064,23098137,Literature-derived,20180923,0,0,Inconclusive,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-(3-aminopropylamino)-N-[(4-fluorophenyl)methyl]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855912,"",710534,163332074,45376446,2064,23098137,Literature-derived,20180923,0,0,Inconclusive,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","8-(6-aminohexylamino)-5-bromo-N-[(4-fluorophenyl)methyl]-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325855913,"",710534,103470636,457930,2064,23098137,Literature-derived,20180923,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","5-(1,1-dioxido-1,2-thiazinan-2-yl)-N-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325949388,"",691105,163313276,53378051,2064,22672799,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 at 1 uM,"2-(1-{[2-(5-Fluoro-1h-Indol-4-Yl)-4-(Morpholin-4-Yl)pyrido[3,2-D]pyrimidin-6-Yl]methyl}piperidin-4-Yl)propan-2-Ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325988073,"",714348,163325435,68107965,2064,22863203,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-T751del, Sins mutant assessed as residual activity at 10 uM relative to control",2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325988088,"",714349,163325435,68107965,2064,22863203,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-S752del, P753S mutant assessed as residual activity at 10 uM relative to control",2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325988114,"",714328,163325435,68107965,2064,22863203,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 assessed as residual activity at 10 uM relative to control,2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325988115,"",714548,163325435,68107965,2064,22863203,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR E746-A750del mutant assessed as residual activity at 10 uM relative to control,2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325988288,"",714545,163325435,68107965,2064,22863203,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of EGFR L747-E749del, A750P mutant assessed as residual activity at 10 uM relative to control",2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325988396,"",714344,163325435,68107965,2064,22863203,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR S752-I759del mutant assessed as residual activity at 10 uM relative to control,2-(benzyloxy)-5-(2-fluoropyridin-4-yl)-N-(pyridin-3-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325993690,"",718822,103768626,10184653,2064,23099099,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 100 uM,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
325993691,"",718822,163325861,71456067,2064,23099099,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 at 100 uM,"5-[(2-Nitrophenyl)methyl]-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943677,"",723354,164142322,10071409,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,Nakijiquinone C,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943678,"",723354,164145090,71519172,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2S,3S)-3-hydroxy-2-[[6-hydroxy-5-[(E)-3-methyl-5-[(1R,2S)-1,2,3-trimethylcyclohex-3-en-1-yl]pent-2-enyl]-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]butanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943679,"",723354,103583085,10473589,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,Metachromin A,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943680,"",723354,103618644,6440837,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,Metachromin C,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943681,"",723354,164131117,71532907,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,Metachromin O,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943682,"",723354,164131115,24766873,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,Metachromin M,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943683,"",723354,164136694,71519009,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2S,3S)-2-[[5-[(E)-5-[(1R,3R)-1,3-dimethyl-2-methylidenecyclohexyl]-3-methylpent-2-enyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-hydroxybutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943684,"",723354,164142289,71519007,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2R,3S)-2-[[5-[(E)-5-[(1R,3R)-1,3-dimethyl-2-methylidenecyclohexyl]-3-methylpent-2-enyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-hydroxybutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943685,"",723354,164147923,71519338,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2S)-2-[[5-[(E)-5-[(1R,3R)-1,3-dimethyl-2-methylidenecyclohexyl]-3-methylpent-2-enyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-methylbutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943686,"",723354,164133894,71519008,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2R,3S)-3-hydroxy-2-[[6-hydroxy-5-[(E)-3-methyl-5-[(1R,2S)-1,2,3-trimethylcyclohex-3-en-1-yl]pent-2-enyl]-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]butanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943687,"",723354,164133933,24766872,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,Metachromin L,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333943688,"",723354,164133932,71519340,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2R)-2-[[5-[(E)-5-[(1R,3R)-1,3-dimethyl-2-methylidenecyclohexyl]-3-methylpent-2-enyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-methylbutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333944239,"",723354,164133895,71519173,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2R,3R)-2-[[5-[(E)-5-[(1R,3R)-1,3-dimethyl-2-methylidenecyclohexyl]-3-methylpent-2-enyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-hydroxybutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333944240,"",723354,164131066,71532908,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,Metachromin P,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333944241,"",723354,164142321,71519339,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2S)-2-[[6-hydroxy-5-[(E)-3-methyl-5-[(1R,2S)-1,2,3-trimethylcyclohex-3-en-1-yl]pent-2-enyl]-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-methylbutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333944242,"",723354,164131116,71532857,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,Metachromin N,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333944243,"",723354,164136723,71519493,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2R)-3-hydroxy-2-[[6-hydroxy-5-[(E)-3-methyl-5-[(1R,2S)-1,2,3-trimethylcyclohex-3-en-1-yl]pent-2-enyl]-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]propanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333944244,"",723354,164133896,71519175,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2R)-2-[[5-[(E)-5-[(1R,3R)-1,3-dimethyl-2-methylidenecyclohexyl]-3-methylpent-2-enyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-hydroxypropanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333944245,"",723354,164145133,71519341,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2R)-2-[[6-hydroxy-5-[(E)-3-methyl-5-[(1R,2S)-1,2,3-trimethylcyclohex-3-en-1-yl]pent-2-enyl]-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]-3-methylbutanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333944246,"",723354,164131067,71519174,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,"(2R,3R)-3-hydroxy-2-[[6-hydroxy-5-[(E)-3-methyl-5-[(1R,2S)-1,2,3-trimethylcyclohex-3-en-1-yl]pent-2-enyl]-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]butanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333944247,"",723354,164139525,71532909,2064,23219324,Literature-derived,20180925,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) by Z-LYTE assay,Metachromin Q,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333962477,"",738835,164146106,71568837,2064,22819505,Literature-derived,20180926,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR L861R/T790M double mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM,"8-(4-Ethylphenyl)-5-Methyl-2,5-Dihydropyrazolo[4,3-C][2,1]benzothiazine 4,4-Dioxide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333962783,"",739777,164146106,71568837,2064,22819505,Literature-derived,20180926,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM,"8-(4-Ethylphenyl)-5-Methyl-2,5-Dihydropyrazolo[4,3-C][2,1]benzothiazine 4,4-Dioxide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333966930,"",739427,164149848,71571535,2064,23611691,Literature-derived,20180926,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR T766M mutant (unknown origin) at 1 uM relative to control,"N-[3-(4-{[(1s)-2-Hydroxy-1-Phenylethyl]amino}-6-Phenylfuro[2,3-D]pyrimidin-5-Yl)phenyl]-N~3~,N~3~-Dimethyl-Beta-Alaninamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333967093,"",739690,164149848,71571535,2064,23611691,Literature-derived,20180926,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR L834R mutant (unknown origin) at 1 uM relative to control,"N-[3-(4-{[(1s)-2-Hydroxy-1-Phenylethyl]amino}-6-Phenylfuro[2,3-D]pyrimidin-5-Yl)phenyl]-N~3~,N~3~-Dimethyl-Beta-Alaninamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333967276,"",739429,164149848,71571535,2064,23611691,Literature-derived,20180926,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR L837Q mutant (unknown origin) at 1 uM relative to control,"N-[3-(4-{[(1s)-2-Hydroxy-1-Phenylethyl]amino}-6-Phenylfuro[2,3-D]pyrimidin-5-Yl)phenyl]-N~3~,N~3~-Dimethyl-Beta-Alaninamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333968052,"",739428,164149848,71571535,2064,23611691,Literature-derived,20180926,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR T766M/L834R mutant (unknown origin) at 1 uM relative to control,"N-[3-(4-{[(1s)-2-Hydroxy-1-Phenylethyl]amino}-6-Phenylfuro[2,3-D]pyrimidin-5-Yl)phenyl]-N~3~,N~3~-Dimethyl-Beta-Alaninamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333980993,"",725963,103769006,49799240,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"3-(3,4-Dichlorophenyl)-5-(4-hydroxyphenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333980997,"",725963,164148465,71524964,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Methoxyphenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981001,"",725963,164128796,71524917,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Chlorophenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981005,"",725963,164131627,71524870,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Bromophenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981009,"",725963,164145692,11617204,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(2-Naphthalenyl)-1,3-diphenyl-2-pyrazoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981013,"",725963,164140100,71524918,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Bromophenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981017,"",725963,164140102,71524871,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Methoxyphenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981021,"",725963,164134471,71524916,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Fluorophenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981025,"",725963,164140103,71524872,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(Naphthalene-1-yl)-3-p-tolyl-4,5-dihydro-1h-pyrazole-1-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981029,"",725963,164142896,71524868,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Fluorophenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981033,"",725963,164142897,71524869,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Chlorophenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981037,"",725963,164140101,71524961,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Fluorophenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981041,"",725963,164148501,71525006,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(3,4-Dichlorophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981045,"",725963,164148502,71525007,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Bromophenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981049,"",725963,103177459,176870,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981053,"",725963,164131628,71524873,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(3,4-Dichlorophenyl)-3-naphthalen-1-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981057,"",725963,164137328,2802451,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(1-Naphthalenyl)-1,3-diphenyl-2-pyrazoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981061,"",725963,164145691,71524960,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(3,4-Dichlorophenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981065,"",725963,103769191,46842884,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"3-(3,4-Dimethylphenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1h-pyrazole-1-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981069,"",725963,164131599,71524962,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Chlorophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981073,"",725963,164134472,2725645,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Methylphenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981077,"",725963,164137305,71524965,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Methylphenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981081,"",725963,164134473,71524914,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"3-Naphthalen-2-yl-5-phenyl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981085,"",725963,164137331,14246200,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Methylphenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981089,"",725963,164140104,71524915,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Fluorophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981093,"",725963,164148464,71524963,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Bromophenyl)-3-naphthalen-2-yl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981097,"",725963,164137329,14246203,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Chlorophenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981101,"",725963,164142895,71524919,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Methoxyphenyl)-3-naphthalen-1-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981105,"",725963,164137330,71525008,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(4-Methoxyphenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981109,"",725963,164148503,71525009,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"5-(3,4-Dichlorophenyl)-3-naphthalen-2-yl-2-phenyl-3,4-dihydropyrazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333981113,"",725963,164148504,71524867,2064,23391364,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human HER2 cytoplasmic domain (676 to 1245) to IC50 for recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin),"3-Naphthalen-1-yl-5-phenyl-3,4-dihydropyrazole-2-carbothioamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333984145,"",729978,164129461,71578377,2064,23047001,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 100 uM after 60 mins by ELISA relative to control,"2-Benzyl-5-[(2-nitrophenyl)methyl]-2,3-dihydro-1,5-benzothiazepin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333984146,"",729978,103768626,10184653,2064,23047001,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 100 uM after 60 mins by ELISA relative to control,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333997014,"",734771,103698494,16079040,2064,23550937,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay,"3,5-Bis(2-pyridylmethylene)piperidine-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333999167,"",737502,164130246,66699750,2064,23414803,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as remaining activity at 10 uM relative to control,"6-(4-(1H-1,2,4-Triazol-5-yl)phenyl)-1-(2-(tetrahydro-2H-pyran-4-yl)ethyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
333999168,"",737502,164147064,58298312,2064,23414803,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as remaining activity at 10 uM relative to control,"6-(6-(2-Hydroxypropan-2-yl)pyridin-3-yl)-4-((tetrahydro-2H-pyran-4-yl)methyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334000213,"",741052,164147064,58298312,2064,23414803,Literature-derived,20200626,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as remaining activity at 1 uM relative to control,"6-(6-(2-Hydroxypropan-2-yl)pyridin-3-yl)-4-((tetrahydro-2H-pyran-4-yl)methyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334006657,"",722487,164147423,71508798,2064,23245802,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human MCF6 cells assessed as down regulation of HEr2 protein levels after 24 hrs by Western blotting method,"2-[3-(1,3-Benzodioxol-5-yl)-5-(4-bromophenyl)-3,4-dihydropyrazol-2-yl]-4-(4-bromophenyl)-1,3-thiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334010992,"",739687,164130185,71583657,2064,23490150,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Pseudo-irreversible inhibition of human N-terminal DYKDDDD-tagged HER2 cytoplasmic domain (676 to 1255) expressed in baculovirus expression system at 10 times IC50 preincubated for 15 mins followed by 100 fold dilution measured after 16 hrs by Alphascreen,"4-{[4-(1-Benzothiophen-4-Yloxy)-3-Chlorophenyl]amino}-N-(2-Hydroxyethyl)-8,9-Dihydro-7h-Pyrimido[4,5-B]azepine-6-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
334046123,"",730878,164135163,71578588,2064,23107515,Confirmatory,20220830,0,0,Inactive,P04626,Activity,"",ChEMBL,Binding affinity to synthetic peptide mimicking HER2 subdomain 4 (unknown origin) by fluorescence spectroscopic analysis,Ac-Cys-Ser-Arg-Trp-Gly-Gly-Asp-Gly-Phe-Tyr-Ala-Met-Asp-Tyr-Trp-Gly-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339859718,"",749648,174511827,70654642,2064,23618709,Literature-derived,20180926,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM,"N-[5-[4-[[(5-tert-butyl-1,2-oxazol-3-yl)carbamoylamino]methyl]phenyl]-1H-pyrazol-3-yl]-4-(2-morpholin-4-ylethoxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339859719,"",749648,174506691,60198892,2064,23618709,Literature-derived,20180926,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM,"N-[3-(4-{[(5-Tert-Butyl-1,2-Oxazol-3-Yl)carbamoyl]amino}-3-Methylphenyl)-1h-Pyrazol-5-Yl]-4-[(4-Methylpiperazin-1-Yl)methyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339890080,"",769358,174513990,24823665,2064,23352510,Literature-derived,20180927,0,0,Unspecified,P04626,"","",ChEMBL,Competitive binding affinity to ERBB2 (unknown origin) at 10 uM in presence of ATP relative to control,trans-4-(4-Benzotriazol-1-yl-pyrimidin-2-ylamino)-cyclohexanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339890081,"",769358,174518997,24823964,2064,23352510,Literature-derived,20180927,0,0,Unspecified,P04626,"","",ChEMBL,Competitive binding affinity to ERBB2 (unknown origin) at 10 uM in presence of ATP relative to control,[4-[[4-(Benzotriazol-1-yl)pyrimidin-2-yl]amino]cyclohexyl]-morpholin-4-ylmethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339890082,"",769358,174513989,24957308,2064,23352510,Literature-derived,20180927,0,0,Unspecified,P04626,"","",ChEMBL,Competitive binding affinity to ERBB2 (unknown origin) at 10 uM in presence of ATP relative to control,4-[(4-Indol-1-ylpyrimidin-2-yl)amino]cyclohexan-1-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339890083,"",769358,174518996,24957306,2064,23352510,Literature-derived,20180927,0,0,Unspecified,P04626,"","",ChEMBL,Competitive binding affinity to ERBB2 (unknown origin) at 10 uM in presence of ATP relative to control,Trans-4-{[4-(1h-Indazol-1-Yl)pyrimidin-2-Yl]amino}cyclohexanol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339890084,"",769358,174493269,24960635,2064,23352510,Literature-derived,20180927,0,0,Unspecified,P04626,"","",ChEMBL,Competitive binding affinity to ERBB2 (unknown origin) at 10 uM in presence of ATP relative to control,4-[[4-(1H-indazol-3-yl)pyrimidin-2-yl]amino]cyclohexan-1-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339890085,"",769358,174488240,24824104,2064,23352510,Literature-derived,20180927,0,0,Unspecified,P04626,"","",ChEMBL,Competitive binding affinity to ERBB2 (unknown origin) at 10 uM in presence of ATP relative to control,"4-N-[4-(benzotriazol-1-yl)pyrimidin-2-yl]cyclohexane-1,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339901166,"",775618,174509527,72202732,2064,24053674,Literature-derived,20180928,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 1 uM after 1 hr relative to control,N-[3-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-7-oxopteridin-8-yl]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339938306,"",757279,174502250,53261846,2064,23522834,Literature-derived,20200629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM relative to control,(7R)-7-ethyl-2-[2-(4-fluorophenyl)imidazol-1-yl]-5-methyl-8-(1-methylpyrazol-3-yl)-7H-pteridin-6-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
339989257,"",752170,174511943,846018,2064,23567961,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs,N-[5-(4-fluorophenyl)-1H-pyrazol-3-yl]-3-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,147,"","",""
339989258,"",752170,103418044,819077,2064,23567961,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs,4-methoxy-N-(3-phenyl-1H-pyrazol-5-yl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,147,"","",""
339989259,"",752170,174511942,846007,2064,23567961,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs,4-fluoro-N-[5-(4-methylphenyl)-1H-pyrazol-3-yl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,147,"","",""
339989352,"",752146,174511944,51588297,2064,23567961,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs,4-[5-(3-chloro-4-fluorophenyl)-1H-pyrazol-4-yl]pyridine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,147,"","",""
339989353,"",752146,174511945,1389797,2064,23567961,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs,4-methyl-N-[1-(4-methylphenyl)-1H-benzimidazol-5-yl]phthalazin-1-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,147,"","",""
339989958,"",757478,174512631,73353571,2064,23688700,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 extracellular domain in human SKBR3 cells assessed as inhibition of EGFR binding,H-Arg-bAla(3-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
339990016,"",757483,174512631,73353571,2064,23688700,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 kinase domain phosphorylation in human SKBR3 cells at 0.4 uM by Western blot analysis,H-Arg-bAla(3-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
339990017,"",757484,174512631,73353571,2064,23688700,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 extracellular domain in human SKBR3 cells assessed as inhibition of HER3 binding at 0.8 uM after 24 hrs by confocal microscopy-based proximity ligation assay,H-Arg-bAla(3-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
339990032,"",757480,174512631,73353571,2064,23688700,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 kinase domain phosphorylation in human BT474 cells at 0.4 uM after 18 hrs by Western blot analysis,H-Arg-bAla(3-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
339990084,"",757485,174512631,73353571,2064,23688700,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Binding affinity to HER2 extracellular domain in human SKBR3 cells assessed as inhibition of HER3 binding at 0.5 uM after 24 hrs by confocal microscopy-based proximity ligation assay,H-Arg-bAla(3-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
339990437,"",757481,174512631,73353571,2064,23688700,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 kinase domain phosphorylation in human SKBR3 cells at 0.4 uM after 18 hrs by Western blot analysis,H-Arg-bAla(3-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
339990438,"",757482,174512631,73353571,2064,23688700,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 kinase domain phosphorylation in human BT474 cells at 0.4 uM by Western blot analysis,H-Arg-bAla(3-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
340012195,"",748805,174491209,67219275,2064,23566514,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of human EGFR extracellular domain/TIE2 intracellular domain transfected in mouse NIH/3T3 cells assessed as phosphotyrosine level preincubated for 60 mins followed by EGF stimulation by DELFIA assay,"N-[3-[(4-amino-7-cyclopentylpyrrolo[2,3-d]pyrimidin-5-yl)methyl]phenyl]-2,6-difluorobenzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,566,"","",""
340957500,"",1053580,194172520,72712897,2064,24124898,Literature-derived,20180928,0,0,Active,P04626,"","",ChEMBL,Binding affinity to ERBB2 (unknown origin),"7-[3-methyl-4-(4-methylpiperazin-1-yl)anilino]-3-phenyl-1-[(3S)-1-prop-2-enoylpyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
340974340,"",1066537,103226312,65064,2064,24456004,Literature-derived,20180929,0,0,Active,P04626,"","",ChEMBL,Induction of ErbB2 internalization in lysosome/endosome of human A431 cells in serum free medium at 200 uM after 30 mins by by immunofluorescence staining-based confocal microscopic analysis,Epigallocatechin Gallate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,37,"","",""
340974354,"",1066538,103226312,65064,2064,24456004,Literature-derived,20180929,0,0,Active,P04626,"","",ChEMBL,Induction of ErbB2 internalization in lysosome/endosome of human SKBR3 cells in serum free medium at 200 uM after 30 mins by immunofluorescence staining-based confocal microscopic analysis,Epigallocatechin Gallate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
341006561,"",1061307,194152613,135914522,2064,24326279,Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as residual activity at 10 uM relative to control,"2-(2-hydroxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrrolo[2,3-b]pyridin-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341006752,"",1061338,194152613,135914522,2064,24326279,Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as residual activity at 1 uM relative to control,"2-(2-hydroxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrrolo[2,3-b]pyridin-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
341071762,"",1056133,194165981,72725139,2064,24900620,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of Her2 phosphorylation at Tyr1221/1222 in human A549 cells at 10 uM after 3 hrs followed by 10 mins incubation in 10% FBS by Western blotting analysis,"2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-N-[(3Z)-2-oxo-3-(thiophen-2-ylmethylidene)-1H-indol-5-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,23,"","",""
341071763,"",1056133,194186498,72725140,2064,24900620,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of Her2 phosphorylation at Tyr1221/1222 in human A549 cells at 10 uM after 3 hrs followed by 10 mins incubation in 10% FBS by Western blotting analysis,"2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-N-[(3E)-3-[(1-methylimidazol-2-yl)methylidene]-2-oxo-1H-indol-5-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,23,"","",""
341073138,"",1062005,194148013,331313,2064,24355130,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells at 10 uM after 2 hrs by Western blotting,CID 331313,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341073139,"",1062005,103177479,208908,2064,24355130,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells at 10 uM after 2 hrs by Western blotting,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341073140,"",1062005,103222017,10205,2064,24355130,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells at 10 uM after 2 hrs by Western blotting,Plumbagin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341073141,"",1062005,194166433,823103,2064,24355130,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells at 10 uM after 2 hrs by Western blotting,"5-Acetoxy-8-hydroxy-1,4-naphthoquinone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341073142,"",1062005,194168807,313371,2064,24355130,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells at 10 uM after 2 hrs by Western blotting,"5,8-Dihydroxy-2,3-bis(hydroxymethyl)naphthoquinone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341073265,"",1062006,194148013,331313,2064,24355130,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells expressing pcDNA3 at 10 uM after 2 hrs by Western blotting,CID 331313,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341073266,"",1062006,103177479,208908,2064,24355130,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells expressing pcDNA3 at 10 uM after 2 hrs by Western blotting,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341073267,"",1062006,103222017,10205,2064,24355130,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells expressing pcDNA3 at 10 uM after 2 hrs by Western blotting,Plumbagin,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341073268,"",1062006,194166433,823103,2064,24355130,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells expressing pcDNA3 at 10 uM after 2 hrs by Western blotting,"5-Acetoxy-8-hydroxy-1,4-naphthoquinone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
341073269,"",1062006,194168807,313371,2064,24355130,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation at Y1248 in human MCF7 cells expressing pcDNA3 at 10 uM after 2 hrs by Western blotting,"5,8-Dihydroxy-2,3-bis(hydroxymethyl)naphthoquinone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
342537347,"",1117579,242614149,90666398,2064,"",Literature-derived,20181002,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"N-(3-chlorophenyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537348,"",1117579,103568709,3794,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,Janex-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537349,"",1117579,164140666,19963206,2064,"",Literature-derived,20181002,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"N1-(6,7-Dimethoxyquinazolin-4-yl)benzene-1,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537350,"",1117579,242613059,90665697,2064,"",Literature-derived,20181002,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,[4-(3-Chloroanilino)quinazolin-6-yl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537351,"",1117579,242615054,85784051,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"Methyl 4-[(6,7-dimethoxyquinazolin-4-yl)amino]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537352,"",1117579,242614151,90666400,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,[4-(3-Chloro-4-fluoroanilino)quinazolin-6-yl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537353,"",1117579,242614152,90666401,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,[4-(3-Chloroanilino)-7-methoxyquinazolin-6-yl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537354,"",1117579,242614154,90666403,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"[3-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenyl]boronic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537355,"",1117579,242615055,49816177,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"4-[(6,7-Dimethoxyquinazolin-4-yl)amino]benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537356,"",1117579,242615056,11779327,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"4-[3-Aminophenylamino]-6,7-dimethoxyquinazoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537357,"",1117579,103358612,5687,2064,"",Literature-derived,20181002,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"4-[3-Hydroxyanilino]-6,7-dimethoxyquinazoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537358,"",1117579,242614158,90666407,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"[4-[[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]boronic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537359,"",1117579,242615053,1637524,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"4-[(6,7-Dimethoxyquinazolin-4-yl)amino]benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537360,"",1117579,103177459,176870,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537361,"",1117579,242614147,23729145,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"N-(3-chlorophenyl)-7-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537362,"",1117579,242614160,18004876,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"[3-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenyl]methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537363,"",1117579,242614155,90666404,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"[3-[[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]boronic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537364,"",1117579,103401044,6398883,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,2-(Pyridin-4-Ylmethylamino)-~{n}-[3-(Trifluoromethyl)phenyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537441,"",1117579,242614156,90666405,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,[3-[[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537442,"",1117579,242614159,90666408,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,[4-[[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537443,"",1117579,164149065,11312797,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"3-(6,7-Dimethoxyquinazolin-4-ylamino)benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537444,"",1117579,242615051,1637521,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"3-[(6,7-Dimethoxyquinazolin-4-yl)amino]benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537445,"",1117579,242614148,90666397,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537446,"",1117579,242614150,90666399,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"N-(3-chloro-4-fluorophenyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537447,"",1117579,242614157,90666406,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"[4-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenyl]boronic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537448,"",1117579,242614153,90666402,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,[4-(3-Chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]boronic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342537449,"",1117579,242615052,85767535,2064,"",Literature-derived,20181002,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA,"Methyl 3-[(6,7-dimethoxyquinazolin-4-yl)amino]benzoate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342594334,"",1137591,242637203,86288869,2064,24900830,Literature-derived,20181003,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ErbB2 (unknown origin) at 1 uM,N-[3-fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-3-thiophen-3-ylbenzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342598359,"",1140718,242637347,86580016,2064,24742150,Literature-derived,20181003,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM,N-[3-[[ethoxy(ethyl)phosphoryl]methyl]phenyl]-6-(2-methoxyphenyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342598360,"",1140718,242637348,86580017,2064,24742150,Literature-derived,20181003,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM,N-[3-[[ethoxy(propyl)phosphoryl]methyl]phenyl]-6-(2-methoxyphenyl)pyrimidin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342731025,"",1138435,242635123,86276126,2064,24580635,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of human HER2/ErbB2 kinase at 10 uM,4-(2-chlorophenyl)-N-ethyl-N-[(4-methylphenyl)methyl]quinazoline-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342731222,"",1138434,242635123,86276126,2064,24580635,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of human HER2/ErbB2 kinase at 1 uM,4-(2-chlorophenyl)-N-ethyl-N-[(4-methylphenyl)methyl]quinazoline-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342733741,"",1128940,242621523,25118036,2064,24588073,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM by KINOMEscan assay,"N-[3-(Trifluoromethyl)-4-[(4-methyl-1-piperazinyl)methyl]phenyl]-3-[[[1H-pyrrolo[2,3-b]pyridine-5-yl]carbonyl]amino]-4-methylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
342737914,"",1118817,242613373,90665892,2064,21887403,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,"Displacement of (10S,13S,17S)-17-benzyl-1-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-ylamino)-10-(3-guanidinopropyl)-13-(naphthalen-1-yl)-8,11,15-trioxo-1-thioxo-2,9,12,16-tetraazaoctadecan-18-oic acid from HER2 in human BT474 cells at",Ac-Cit-bAla(3R-naphth-1-yl)-Phe-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
342737915,"",1118817,242613173,90665784,2064,21887403,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,"Displacement of (10S,13S,17S)-17-benzyl-1-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-ylamino)-10-(3-guanidinopropyl)-13-(naphthalen-1-yl)-8,11,15-trioxo-1-thioxo-2,9,12,16-tetraazaoctadecan-18-oic acid from HER2 in human BT474 cells at",H-Arg-bAla(3R-naphth-1-yl)-Phe-Asp-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
342737947,"",1118818,242613173,90665784,2064,21887403,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,"Displacement of (10S,13S,17S)-17-benzyl-1-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-ylamino)-10-(3-guanidinopropyl)-13-(naphthalen-1-yl)-8,11,15-trioxo-1-thioxo-2,9,12,16-tetraazaoctadecan-18-oic acid from HER2 in human SKBR3 cells at",H-Arg-bAla(3R-naphth-1-yl)-Phe-Asp-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
342737948,"",1118818,242613374,90665893,2064,21887403,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,"Displacement of (10S,13S,17S)-17-benzyl-1-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-ylamino)-10-(3-guanidinopropyl)-13-(naphthalen-1-yl)-8,11,15-trioxo-1-thioxo-2,9,12,16-tetraazaoctadecan-18-oic acid from HER2 in human SKBR3 cells at",Ac-Cit-bAla(3S-naphth-1-yl)-Phe-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
342737949,"",1118818,242613373,90665892,2064,21887403,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,"Displacement of (10S,13S,17S)-17-benzyl-1-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-ylamino)-10-(3-guanidinopropyl)-13-(naphthalen-1-yl)-8,11,15-trioxo-1-thioxo-2,9,12,16-tetraazaoctadecan-18-oic acid from HER2 in human SKBR3 cells at",Ac-Cit-bAla(3R-naphth-1-yl)-Phe-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
342737950,"",1118818,242613372,90665891,2064,21887403,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,"Displacement of (10S,13S,17S)-17-benzyl-1-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-ylamino)-10-(3-guanidinopropyl)-13-(naphthalen-1-yl)-8,11,15-trioxo-1-thioxo-2,9,12,16-tetraazaoctadecan-18-oic acid from HER2 in human SKBR3 cells at","2-[3-[(13S,19S,22S,26S)-26-benzyl-22-naphthalen-1-yl-11,14,20,24,27-pentaoxo-2-oxa-12,15,21,25,28-pentazapentacyclo[29.4.0.03,8.04,35.015,19]pentatriaconta-1(31),3(8),4,6,32,34-hexaen-13-yl]propyl]guanidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,33,"","",""
342738222,"",1118817,242613374,90665893,2064,21887403,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,"Displacement of (10S,13S,17S)-17-benzyl-1-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-ylamino)-10-(3-guanidinopropyl)-13-(naphthalen-1-yl)-8,11,15-trioxo-1-thioxo-2,9,12,16-tetraazaoctadecan-18-oic acid from HER2 in human BT474 cells at",Ac-Cit-bAla(3S-naphth-1-yl)-Phe-NH2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
342738223,"",1118817,242613372,90665891,2064,21887403,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,"Displacement of (10S,13S,17S)-17-benzyl-1-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-ylamino)-10-(3-guanidinopropyl)-13-(naphthalen-1-yl)-8,11,15-trioxo-1-thioxo-2,9,12,16-tetraazaoctadecan-18-oic acid from HER2 in human BT474 cells at","2-[3-[(13S,19S,22S,26S)-26-benzyl-22-naphthalen-1-yl-11,14,20,24,27-pentaoxo-2-oxa-12,15,21,25,28-pentazapentacyclo[29.4.0.03,8.04,35.015,19]pentatriaconta-1(31),3(8),4,6,32,34-hexaen-13-yl]propyl]guanidine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
345240857,"",1223927,242651273,86298673,2064,24813737,Literature-derived,20181004,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 100 nM,"(S)-N-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-2-(tetrahydro-2H-pyran-4-ylamino)-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345248589,"",1163298,312357179,118713258,2064,25200979,Literature-derived,20181005,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of purified ErbB2 (unknown origin) at 1 uM after 60 mins by ELISA kinase assay,"[2-[[5-Chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepin-6-yl]-(oxan-4-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345258244,"",1173106,312373675,44545901,2064,25453805,Literature-derived,20181005,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 0.1 uM,"3-[4-(4-Methylpiperazin-1-Yl)phenyl]-9h-Pyrrolo[2,3-B:5,4-C']dipyridine-6-Carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345258248,"",1173172,312373675,44545901,2064,25453805,Literature-derived,20181005,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 1 uM,"3-[4-(4-Methylpiperazin-1-Yl)phenyl]-9h-Pyrrolo[2,3-B:5,4-C']dipyridine-6-Carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345272200,"",1184141,312352516,71763463,2064,25036791,Literature-derived,20181006,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 1 uM by radioisotope-based P81 filter-binding assay,5-(2-fluorophenyl)-4-oxo-N-[(3Z)-2-oxo-3-(1H-pyrrol-2-ylmethylidene)-1H-indol-6-yl]-1H-pyridine-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345274724,"",1186631,312356011,71816087,2064,25089810,Literature-derived,20181006,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2/Her2 (unknown origin) at 1 uM,"5-[(Z)-[6-[(2-fluoro-4-methoxybenzoyl)carbamoylamino]-2-oxo-1H-indol-3-ylidene]methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345276809,"",1187673,312352917,91666638,2064,25124116,Literature-derived,20181006,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 1 uM,N-(4-chloro-2-fluorophenyl)-6-methoxy-7-(morpholin-2-ylmethoxy)quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345280349,"",1190998,312377553,25021112,2064,25619636,Literature-derived,20181006,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human full length HER2 assessed as phosphorylation state at 10 uM by ELISA assay,"N-phenyl-N'-{[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)sulfanyl]acetyl}urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345280350,"",1190998,242176229,135461535,2064,25619636,Literature-derived,20181006,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human full length HER2 assessed as phosphorylation state at 10 uM by ELISA assay,"2-[(4,7-dimethylquinazolin-2-yl)amino]-6-{[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]methyl}pyrimidin-4(1H)-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345280351,"",1190998,242514647,9617884,2064,25619636,Literature-derived,20181006,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human full length HER2 assessed as phosphorylation state at 10 uM by ELISA assay,"2-{[(5-{4-Chloro-3-nitrophenyl}-2-furyl)methylene]amino}-3-(2-furyl)imidazo[1,2-a]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345280352,"",1190998,312377554,4464708,2064,25619636,Literature-derived,20181006,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human full length HER2 assessed as phosphorylation state at 10 uM by ELISA assay,"4-(1,3-benzoxazol-2-yl)-N-[(3-bromophenyl)methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345280353,"",1190998,312377561,135435923,2064,25619636,Literature-derived,20181006,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human full length HER2 assessed as phosphorylation state at 10 uM by ELISA assay,3-benzyl-8-{[2-(2-fluorophenoxy)ethyl]sulfanyl}-3H-purin-6-ylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345280354,"",1190998,312377557,1979873,2064,25619636,Literature-derived,20181006,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human full length HER2 assessed as phosphorylation state at 10 uM by ELISA assay,1-(4-Methylphenyl)-2-[3-(2-quinoxalinyl)phenoxy]ethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345463056,"",1190103,312377849,101896447,2064,25537530,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of purified ErbB2 (unknown origin) at 1 uM after 60 mins by ELISA,"1-N'-[4-(3-amino-1H-indazol-4-yl)-3-fluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345495303,"",1205023,312393816,90479825,2064,25699576,Literature-derived,20200625,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2/HER2 using poly[Glu:Tyr] (4:1) peptide substrate at 1 uM by 33P Hotspot assay,"5-chloro-N~2~-[4-(4-methylpiperazin-1-yl)phenyl]-N~4~-{[(2R)-oxolan-2-yl]methyl}pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345537398,"",1190133,312377849,101896447,2064,25537530,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of purified ErbB2 (unknown origin) at 0.01 uM after 60 mins by ELISA,"1-N'-[4-(3-amino-1H-indazol-4-yl)-3-fluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345537491,"",1190118,312377849,101896447,2064,25537530,Literature-derived,20220318,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of purified ErbB2 (unknown origin) at 0.1 uM after 60 mins by ELISA,"1-N'-[4-(3-amino-1H-indazol-4-yl)-3-fluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
345543749,"",1168544,312363556,46865125,2064,25305330,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) expressed in human BT474 cells assessed as reduction in AKT phosphorylation at 0.001 to 1 uM incubated for 2 hrs by Western blot method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1S)-1-(dimethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
345543773,"",1168550,103177479,208908,2064,25305330,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) expressed in human BT474 cells assessed as reduction in AKT phosphorylation at 0.001 to 10 uM incubated for 2 hrs by Western blot method,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
345543786,"",1168540,312363556,46865125,2064,25305330,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation (unknown origin) expressed in human BT474 cells at 0.001 to 1 uM incubated for 2 hrs by Western blot method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1S)-1-(dimethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
345543841,"",1168549,103177479,208908,2064,25305330,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) expressed in human BT474 cells assessed as reduction in ERK1/2 phosphorylation at 0.001 to 10 uM incubated for 2 hrs by Western blot method,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
345543877,"",1168546,103177479,208908,2064,25305330,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation (unknown origin) expressed in human BT474 cells at 0.001 to 10 uM incubated for 2 hrs by Western blot method,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
345543908,"",1168543,312363556,46865125,2064,25305330,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) expressed in human BT474 cells assessed as reduction in ERK1/2 phosphorylation at 0.001 to 1 uM incubated for 2 hrs by Western blot method,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(1S)-1-(dimethylamino)-2-methylsulfonylethyl]furan-2-yl]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
345669995,"",1170851,312367907,68672618,2064,25383627,Confirmatory,20220830,0,0,Unspecified,P04626,Inhibition,"",ChEMBL,Inhibition of EGFR del746 to 750 mutant (unknown origin) by high-throughput biochemical screening,"2,6-Dichloro-N-{2-[(2-{[(2s)-1-Hydroxypropan-2-Yl]amino}-6-Methylpyrimidin-4-Yl)amino]pyridin-4-Yl}benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
346893596,"",1234750,318377710,88876355,2064,26081023,Literature-derived,20181008,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human HER2 at 0.1 uM relative to control,"1-(5-Ethyl-1,2-oxazol-3-yl)-3-[4-[2-[[6-(4-ethylpiperazin-1-yl)-2-methylpyrimidin-4-yl]amino]-1,3-thiazol-5-yl]phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
346897721,"",1238464,318382194,122184946,2064,26112437,Literature-derived,20181009,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant ERBB2 (unknown origin) at 1 uM after 3 hrs,"N-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
346915671,"",1253273,318394791,91936970,2064,26431428,Literature-derived,20181009,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 1 uM by FRET method,2-[[1-Cyclopentyl-5-[1-(Oxetan-3-Yl)piperidin-4-Yl]pyrazol-3-Yl]amino]pyridine-4-Carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
346915941,"",1253401,318395400,10422105,2064,26442778,Literature-derived,20181009,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control,"Benz[b]indeno[1,2-e]pyran-6,11-dione",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
346969290,"",1253732,318394401,91971264,2064,26455654,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,"2,6-Bis(Fluoranyl)-N-[3-[5-[2-[(3-Methylsulfonylphenyl)amino]pyrimidin-4-Yl]-2-Morpholin-4-Yl-1,3-Thiazol-4-Yl]phenyl]benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
346969291,"",1253732,103420204,9819877,2064,26455654,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,"1-(5-Tert-butyl-1,2-oxazol-3-YL)-3-(4-pyridin-4-yloxyphenyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
346969292,"",1253732,318394402,53475688,2064,26455654,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,"2-(2-(4-Chlorophenyl)-1h-Imidazol-5-Yl)-N,1-Bis(2-Methoxyethyl)-1h-Benzo[d]imidazole-5-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353432552,"",1268701,336890317,58540422,2064,26675441,Literature-derived,20180904,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 1 uM,"N-(6-Fluoro-2-Methyl-3-{5-[(5-Methyl-4,5,6,7-Tetrahydropyrazolo[1,5-A]pyrazin-2-Yl)amino]-6-Oxo-1,6-Dihydropyridazin-3-Yl}phenyl)-1-Benzothiophene-2-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439345,"",1273665,336865161,127024862,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"N-[2-(dimethylamino)ethyl]-4-methoxy-3-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439346,"",1273665,336866946,127026081,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"N-[2-(dimethylamino)ethyl]-4-[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439347,"",1273665,336868343,78319176,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"[3-methoxy-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]phenyl]methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439348,"",1273665,336869640,127027985,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"[4-[4-(3-Chloro-4-fluoroanilino)thieno[2,3-d]pyrimidin-6-yl]-3-methoxyphenyl]methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439349,"",1273665,336868345,117803686,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"[4-(4-Anilinothieno[2,3-d]pyrimidin-6-yl)-3-methoxyphenyl]methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439350,"",1273665,336866947,127026082,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"4-[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]-3-methoxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439351,"",1273665,336868344,78319174,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"(2S)-2-[[6-[4-(hydroxymethyl)-2-methoxyphenyl]thieno[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439352,"",1273665,336866520,127025789,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"N-[2-(dimethylamino)ethyl]-4-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439353,"",1273665,336867799,127026690,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"2-[4-[[(1R)-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439354,"",1273665,336868346,127027074,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,"[4-[4-(3-Ethynylanilino)thieno[2,3-d]pyrimidin-6-yl]-3-methoxyphenyl]methanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439355,"",1273665,103177459,176870,2064,26599532,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 500 nM,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439529,"",1274116,336869239,127027694,2064,26639762,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) at 100 nM,"N-(1H-indazol-3-yl)-7,7-dimethyl-2-(1H-pyrazol-4-yl)-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353439533,"",1274116,336870589,92132732,2064,26639762,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) at 100 nM,"N-(7-chloro-1H-indazol-3-yl)-7,7-dimethyl-2-(1H-pyrazol-4-yl)-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353440209,"",1274133,336869239,127027694,2064,26639762,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 100 nM,"N-(1H-indazol-3-yl)-7,7-dimethyl-2-(1H-pyrazol-4-yl)-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353440336,"",1274362,336870998,127028959,2064,26639762,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1000 nM,"N-(7-chloro-1H-indazol-3-yl)-2-[5-(difluoromethyl)-1H-pyrazol-4-yl]-7,7-dimethyl-5H-furo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353443906,"",1279303,336869852,127028127,2064,"",Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human recombinant ERBB2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control,"6-amino-N-(3-chloro-2-methylphenyl)-10-oxo-4-thia-2-azatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraene-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353444224,"",1279301,336869852,127028127,2064,"",Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human recombinant EGFR L858R mutant assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control,"6-amino-N-(3-chloro-2-methylphenyl)-10-oxo-4-thia-2-azatricyclo[7.3.0.03,7]dodeca-1(9),2,5,7-tetraene-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353447569,"",1283723,336875656,127032020,2064,26852363,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of N-terminal His6-tagged recombinant human EGFR L858R mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,[3-[[4-(1-methylpyrazol-4-yl)phenyl]methyl]-2H-indazol-5-yl]-morpholin-4-ylmethanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
353447804,"",1283723,336877070,118960044,2064,26852363,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of N-terminal His6-tagged recombinant human EGFR L858R mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,[(3R)-3-hydroxypyrrolidin-1-yl]-[3-[[4-(1-methylpyrazol-4-yl)phenyl]methyl]-2H-indazol-5-yl]methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
353447808,"",1283723,336873889,118960212,2064,26852363,Literature-derived,20180905,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of N-terminal His6-tagged recombinant human EGFR L858R mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,N-methyl-3-[(1-methylindazol-5-yl)methyl]-2H-indazole-5-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
353557991,"",1297810,336897720,127045762,2064,27061987,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant ERBB2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control","6-[Difluoro-[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazin-3-yl]methyl]quinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629298,"",1263984,336887549,127038480,2064,"",Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for wild type human recombinant EGFR to IC50 for human recombinant VEGFR2,6-[2-[3-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]oxy-N-phenylnaphthalene-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629429,"",1263987,336887549,127038480,2064,"",Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R mutant to IC50 for human recombinant VEGFR2,6-[2-[3-(methylsulfonylmethyl)anilino]pyrimidin-4-yl]oxy-N-phenylnaphthalene-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629627,"",1264290,336888888,127039518,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,"N-[3-[[5-chloro-2-[(2E)-2-[(2,4-difluorophenyl)methylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629631,"",1264290,336889290,127039812,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,(E)-N-[3-[[2-[(2E)-2-[(1-benzylindol-3-yl)methylidene]hydrazinyl]-5-chloropyrimidin-4-yl]amino]phenyl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629635,"",1264290,336888861,127039495,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,N-[3-[[5-chloro-2-[(2E)-2-[1-(4-fluorophenyl)ethylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629639,"",1264290,336889313,127039835,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,"(E)-N-[3-[[5-chloro-2-[(2E)-2-[(2,4-difluorophenyl)methylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629643,"",1264290,336889747,127040181,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,(E)-N-[3-[[5-chloro-2-[(2E)-2-(1-pyridin-3-ylethylidene)hydrazinyl]pyrimidin-4-yl]amino]phenyl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629843,"",1264290,336888863,127039497,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,N-[3-[[5-chloro-2-[(2E)-2-[1-(4-methylphenyl)ethylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629847,"",1264290,336889311,127039833,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,(E)-N-[3-[[5-chloro-2-[(2E)-2-[(2-fluorophenyl)methylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629851,"",1264290,336889312,127039834,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,(E)-N-[3-[[5-chloro-2-[(2E)-2-[(4-fluorophenyl)methylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629855,"",1264290,336888862,127039496,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,"N-[3-[[5-chloro-2-[(2E)-2-[1-(2,4-difluorophenyl)ethylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629859,"",1264290,336889746,127040180,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,(E)-N-[3-[[5-chloro-2-[(2E)-2-(1-pyridin-2-ylethylidene)hydrazinyl]pyrimidin-4-yl]amino]phenyl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629905,"",1264290,336889291,127039813,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,(E)-N-[3-[[5-chloro-2-[(2E)-2-[1-(4-fluorophenyl)ethylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]-4-(dimethylamino)but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629909,"",1264290,336891893,127041787,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,N-[3-[[5-chloro-2-[(2E)-2-[(2-fluorophenyl)methylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629913,"",1264290,336891475,127041488,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,N-[3-[[5-chloro-2-[(2E)-2-[(4-fluorophenyl)methylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629917,"",1264290,336889292,127039814,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,"(E)-N-[3-[[5-chloro-2-[(2E)-2-[1-(2,4-difluorophenyl)ethylidene]hydrazinyl]pyrimidin-4-yl]amino]phenyl]-4-(dimethylamino)but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353629921,"",1264290,104245790,44607530,2064,26451770,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of IC50 for human recombinant EGFR T790M/L858R double mutant to IC50 for wild type recombinant human EGFR,N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640153,"",1269030,336893337,127042853,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM,"6-(2,4-Difluorophenoxy)-2-[4-(4-hydroxypiperidin-1-yl)anilino]-8-methylpyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640154,"",1269030,336890784,127040991,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM,"6-(2,4-Difluorophenoxy)-8-methyl-2-(2-pyridin-2-ylethylamino)pyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640155,"",1269030,336893339,127042855,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM,"6-(2,4-Difluorophenoxy)-8-methyl-2-[3-(4-methylpiperazin-1-yl)propylamino]pyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640156,"",1269030,336891589,127041569,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM,"6-(2,4-Difluorophenoxy)-2-[2-(dimethylamino)ethylamino]-8-methylpyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640157,"",1269030,336887301,127038294,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM,"6-(2,4-Difluorophenoxy)-8-methyl-2-[4-(4-methylpiperazin-1-yl)anilino]pyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640158,"",1269030,336888650,127039333,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM,"6-(2,6-Dichlorophenoxy)-8-methyl-2-(oxan-4-ylamino)pyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640159,"",1269030,336889507,127040001,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM,"6-(2,6-Dichlorophenoxy)-8-methyl-2-[4-(4-methylpiperazin-1-yl)anilino]pyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640160,"",1269030,336890785,127040992,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM,"6-(2,4-Difluorophenoxy)-8-methyl-2-(4-piperidin-1-ylanilino)pyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640161,"",1269030,336892907,20626909,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM,"6-(2,4-Difluorophenoxy)-8-methyl-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrido[2,3-d]pyrimidin-7-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353640581,"",1269064,336887300,127038293,2064,26704265,Literature-derived,20200623,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM,"4-[[6-(2,4-Difluorophenoxy)-8-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl]amino]piperidine-1-sulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
353674053,"",1291332,312468158,57335384,2064,26968253,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity ratio of Kinact/Ki for recombinant EGFR T790M/L858R double mutant (unknown origin ) to Kinact/Ki for recombinant wild type EGFR (unknown origin),Rociletinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354577615,"",1287300,336878567,122516793,2064,26898335,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of partial length human EGFR L858R mutant expressed in bacterial system at 1 uM,"3-(2-Amino-5-methylpyrimidin-4-yl)oxy-2,2-dimethylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354578021,"",1287302,336878567,122516793,2064,26898335,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of partial length human ERBB2 expressed in mammalian system at 1 uM,"3-(2-Amino-5-methylpyrimidin-4-yl)oxy-2,2-dimethylpropan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354611846,"",1266268,103420820,216239,2064,26706113,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of EGFR tyrosine kinase L858R mutant (unknown origin) assessed as ATP level by luminescence analysis,Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354611850,"",1266268,336887985,124197588,2064,26706113,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of EGFR tyrosine kinase L858R mutant (unknown origin) assessed as ATP level by luminescence analysis,1-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-3-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354696428,"",1301744,336895118,68796885,2064,27010810,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of His-tagged human recombinant ERBB2 (676 to 1225 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,"5-[[[2-methyl-5-[[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzoyl]amino]phenyl]methyl]amino]-1H-pyrrolo[2,3-b]pyridine-2-carboxylicacid,methylester",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354699124,"",1305078,336907755,57384863,2064,27096040,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged cytoplasmic ERBB2 (676 to 1255 residues) expressed in baculovirus expression system at 1 uM relative to control,Gdc-0084,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354699672,"",1305820,336903000,52933152,2064,27246618,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 at 1 uM using poly[Glu:Tyr] (4:1) as substrate,"3-((6,7-dimethoxyquinazolin-4-yl)amino)-4-(dimethylamino)-N-methylbenzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354709931,"",1315988,374321006,134146542,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,N-[4-[4-(3-fluorophenoxy)anilino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354709932,"",1315988,374309244,134143257,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,"N-[4-[4-(1,3-benzodioxol-5-yloxy)anilino]-7-methoxyquinazolin-6-yl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354709933,"",1315988,374335050,134150452,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,N-[7-methoxy-4-[4-(pyridin-4-ylmethoxy)anilino]quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354709934,"",1315988,374319030,134145988,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,N-[4-[4-(benzenesulfonamido)-3-fluoroanilino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354710364,"",1315983,374351652,134155220,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of ERBB2 (unknown origin) autophosphorylation transfected in EGF-stimulated mouse T24 NIH/3T3 cells with extracellular binding domain of ERBB1 at 0.5 uM incubated for 2 hrs followed by stimulation with EGF for 10 mins,N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,526,"","",""
354710365,"",1315983,374296246,134139647,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of ERBB2 (unknown origin) autophosphorylation transfected in EGF-stimulated mouse T24 NIH/3T3 cells with extracellular binding domain of ERBB1 at 0.5 uM incubated for 2 hrs followed by stimulation with EGF for 10 mins,(E)-N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]but-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,526,"","",""
354710366,"",1315983,374323175,134147150,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of ERBB2 (unknown origin) autophosphorylation transfected in EGF-stimulated mouse T24 NIH/3T3 cells with extracellular binding domain of ERBB1 at 0.5 uM incubated for 2 hrs followed by stimulation with EGF for 10 mins,N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]cyclopentene-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,526,"","",""
354710367,"",1315983,374348571,134154342,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of ERBB2 (unknown origin) autophosphorylation transfected in EGF-stimulated mouse T24 NIH/3T3 cells with extracellular binding domain of ERBB1 at 0.5 uM incubated for 2 hrs followed by stimulation with EGF for 10 mins,N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]-2-methylprop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,526,"","",""
354710418,"",1315988,374315912,134145160,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,N-[7-methoxy-4-(4-pyridin-3-yloxyanilino)quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354710419,"",1315988,374291109,134138222,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,N-[4-(benzylamino)-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354710420,"",1315988,374347070,134153922,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,N-[7-methoxy-4-[[(1R)-1-phenylethyl]amino]quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354710421,"",1315988,374343894,134153017,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,N-[4-[4-[hydroxy(phenyl)methyl]anilino]-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354710422,"",1315988,374295601,134139490,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,N-[7-methoxy-4-[[1-(pyridin-2-ylmethyl)indazol-5-yl]amino]quinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354710423,"",1315988,374295377,134139430,2064,27491023,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Irreversible inhibition of GST-tagged ERBB2 (unknown origin) (Ile-675 to Val-1256 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation at 1 uM after 6 mins by ELISA,N-[4-(1H-indazol-5-ylamino)-7-methoxyquinazolin-6-yl]propanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
354710852,"",1317490,374334495,69412987,2064,27187860,Literature-derived,20180906,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human ERBB2 expressed in insect cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay,"3-Methyl-1-[[5-methyl-6-[4-[2-(methylamino)ethoxy]phenyl]-2-thiophen-2-ylthieno[2,3-d]pyrimidin-4-yl]amino]pyrrole-2,5-dione;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850410,"",1345653,223365982,10437018,2064,19821562,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),"(S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850411,"",1345653,178102295,10184653,2064,18408761,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850412,"",1345653,178102633,6444692,2064,16771730,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Mubritinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850413,"",1345653,178103994,11511120,2064,22621397,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Dacomitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850681,"",1345653,249565825,71556703,2064,24915291,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),2-methyl-N-[2-({3-[2-(prop-2-enamido)acetamido]phenyl}amino)pyrimidin-5-yl]-5-[3-(trifluoromethyl)benzamido]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850682,"",1345653,178102313,9915743,2064,15173008,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850683,"",1345653,178102313,9915743,2064,22037378,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Neratinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850684,"",1345653,223366050,11488320,2064,24900741,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Sapitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850685,"",1345653,178102302,156414,2064,10753475,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Canertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850686,"",1345653,223366212,9874913,2064,18500794,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850687,"",1345653,249565627,10458325,2064,17575237,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Tesevatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850688,"",1345653,178102319,208908,2064,12467226,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850689,"",1345653,178102319,208908,2064,22037378,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850690,"",1345653,223365981,6918508,2064,15199094,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Falnidamol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850691,"",1345653,223366208,11349170,2064,20166197,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),"(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850692,"",1345653,310264693,71226662,2064,26641137,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Acalabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850693,"",1345653,178103494,24821094,2064,26641137,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850694,"",1345653,178102587,9843206,2064,11378364,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),EGFR/ErbB-2 Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850695,"",1345653,348353621,51039030,2064,28115222,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Pyrotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850696,"",1345653,223365978,10297043,2064,15256466,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),"(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850698,"",1345653,363894213,51348455,2064,24121234,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Selatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850699,"",1345653,310264675,24756910,2064,20143778,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Cudc-101,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850700,"",1345653,363894206,24739943,2064,21789172,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Allitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850701,"",1345653,249565586,25127713,2064,21306821,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),Poziotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
354850703,"",1345653,178102588,11566580,2064,16480284,Literature-derived,20181109,0,0,Active,NP_001005862,"","",IUPHAR/BPS Guide to PHARMACOLOGY,Human erb-b2 receptor tyrosine kinase 2 (Type I RTKs: ErbB (epidermal growth factor) receptor family),EGFR/ErbB-2/ErbB-4 Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355526328,"",1303500,194148013,331313,2064,27173800,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human EGFR L858R mutant (669 to 1011 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay,CID 331313,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355526639,"",1303502,194148013,331313,2064,27173800,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 (646 to 1225 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay,CID 331313,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355526658,"",1303549,336897123,135464244,2064,27173802,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of c-erbB2 (unknown origin),[4-hydroxy-5-[(Z)-(6-hydroxyindol-3-ylidene)methyl]-1H-imidazol-2-yl]-(1H-indol-3-yl)methanone,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355545955,"",1317884,103177459,176870,2064,27235841,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of His tagged recombinant human ErbB2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355545956,"",1317884,374283721,134136269,2064,27235841,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of His tagged recombinant human ErbB2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay,"N-[(1R)-1-phenylethyl]-6-[4-(2-piperidin-1-ylethylamino)phenyl]furo[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355545957,"",1317884,374278757,134134898,2064,27235841,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of His tagged recombinant human ErbB2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay,"N',N'-dimethyl-N-[4-[4-[[(1R)-1-phenylethyl]amino]furo[2,3-d]pyrimidin-6-yl]phenyl]ethane-1,2-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355574721,"",1330968,374292238,132495274,2064,27769671,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as suppression of HER2 phosphorylation at Tyr1221/1222 residue at 25 uM measured after 24 hrs by Western blot analysis,7-[4-[4-(3-chloro-2-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
355574887,"",1330969,374292238,132495274,2064,27769671,Literature-derived,20200624,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as suppression of HER2 phosphorylation at Tyr1248 residue at 1 uM measured after 24 hrs by Western blot analysis,7-[4-[4-(3-chloro-2-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
355606259,"",1307365,336905296,127051255,2064,"",Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/ERK signalling in human Ca9-22 cells assessed as reduction in MMP9 mRNA expression at 2 uM preincubated for 2 hrs followed by 0.5 Jcm'-2 UVA irradiation measured after 8 hrs by qRT-PCR method,"2-[4-(Benzotriazol-1-yl)phenyl]-6-methoxy-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3565,"","",""
355606372,"",1307368,336905679,127051561,2064,"",Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/ERK signalling in human Ca9-22 cells assessed as reduction in MMP2 expression at 2 uM preincubated for 2 hrs followed by 0.5 Jcm'-2 UVA irradiation by Western blot analysis,"2-[4-(Benzotriazol-1-yl)-3-methylphenyl]-6-ethyl-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3565,"","",""
355606412,"",1307364,336905296,127051255,2064,"",Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/ERK signalling in human Ca9-22 cells assessed as reduction in MMP2 mRNA expression at 2 uM preincubated for 2 hrs followed by 0.5 Jcm'-2 UVA irradiation measured after 8 hrs by qRT-PCR method,"2-[4-(Benzotriazol-1-yl)phenyl]-6-methoxy-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3565,"","",""
355606428,"",1307369,336905296,127051255,2064,"",Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/ERK signalling in human Ca9-22 cells assessed as reduction in MMP9 expression at 2 uM preincubated for 2 hrs followed by 0.5 Jcm'-2 UVA irradiation by Western blot analysis,"2-[4-(Benzotriazol-1-yl)phenyl]-6-methoxy-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3565,"","",""
355606432,"",1307369,336905679,127051561,2064,"",Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/ERK signalling in human Ca9-22 cells assessed as reduction in MMP9 expression at 2 uM preincubated for 2 hrs followed by 0.5 Jcm'-2 UVA irradiation by Western blot analysis,"2-[4-(Benzotriazol-1-yl)-3-methylphenyl]-6-ethyl-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3565,"","",""
355606436,"",1307369,336906056,127051829,2064,"",Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/ERK signalling in human Ca9-22 cells assessed as reduction in MMP9 expression at 2 uM preincubated for 2 hrs followed by 0.5 Jcm'-2 UVA irradiation by Western blot analysis,"2-[4-(Benzotriazol-1-yl)-3-methylphenyl]-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3565,"","",""
355606603,"",1307368,336906056,127051829,2064,"",Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/ERK signalling in human Ca9-22 cells assessed as reduction in MMP2 expression at 2 uM preincubated for 2 hrs followed by 0.5 Jcm'-2 UVA irradiation by Western blot analysis,"2-[4-(Benzotriazol-1-yl)-3-methylphenyl]-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3565,"","",""
355606607,"",1307368,336905296,127051255,2064,"",Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/ERK signalling in human Ca9-22 cells assessed as reduction in MMP2 expression at 2 uM preincubated for 2 hrs followed by 0.5 Jcm'-2 UVA irradiation by Western blot analysis,"2-[4-(Benzotriazol-1-yl)phenyl]-6-methoxy-1,3-benzothiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3565,"","",""
355611072,"",1330953,374292238,132495274,2064,27769671,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as suppression of HER2 phosphorylation at Tyr1248 residue measured after 24 hrs by Western blot analysis,7-[4-[4-(3-chloro-2-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
355611086,"",1330952,374292238,132495274,2064,27769671,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as suppression of HER2 phosphorylation at Tyr1221/1222 residue measured after 24 hrs by Western blot analysis,7-[4-[4-(3-chloro-2-fluoroanilino)quinazolin-6-yl]triazol-1-yl]-N-hydroxyheptanamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,165,"","",""
355632715,"",1306577,336902099,127048980,2064,27288180,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(3-Bromoanilino)quinazolin-6-yl]-3-(2-morpholin-4-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355633174,"",1306577,336902098,127048979,2064,27288180,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355633182,"",1306577,336902100,127048981,2064,27288180,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,1-[4-(3-Bromoanilino)quinazolin-6-yl]-3-(2-piperidin-1-ylethyl)urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654687,"",1315425,374303628,134141689,2064,27187856,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[4-(Morpholine-4-carbonylamino)anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654689,"",1315425,374341708,134152381,2064,27187856,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[2-Oxo-8-(4-phenylmethoxyanilino)-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654690,"",1315425,374266932,134131685,2064,27187856,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-(3-Ethynylanilino)-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355654693,"",1315425,374313982,134144632,2064,27187856,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus after 1 hr by Z-lyte assay,"2-[8-[4-(Cyclopentylcarbamoylamino)anilino]-2-oxo-[1,3]oxazolo[4,5-g]quinazolin-1-yl]ethyl 2-bromoacetate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688211,"",1330925,103174146,5311,2064,27769671,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,Vorinostat,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
355688213,"",1330925,103244983,123631,2064,27769671,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HER2 (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362980551,"",1358754,404655252,145951771,2064,29684708,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM by [33P]-ATP radiometric assay,"7-chloro-2-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methylamino]-3H-pyrimido[4,5-b]quinolin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362980552,"",1358754,404655590,145952021,2064,29684708,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM by [33P]-ATP radiometric assay,7-methoxy-2-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methylamino]-3H-benzo[g]pteridin-4-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362980553,"",1358754,404664434,145958133,2064,29684708,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM by [33P]-ATP radiometric assay,"2-[[4-(piperidin-1-ylmethyl)phenyl]methylamino]-3H-pyrimido[4,5-b]quinolin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362980554,"",1358754,103245522,5291,2064,29684708,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM by [33P]-ATP radiometric assay,Imatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362980555,"",1358754,404658590,145954079,2064,29684708,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM by [33P]-ATP radiometric assay,2-[[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]amino]-7-methyl-3H-benzo[g]pteridin-4-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362980556,"",1358754,404662521,145956798,2064,29684708,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM by [33P]-ATP radiometric assay,"7-methyl-2-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]methylamino]-3H-pyrimido[4,5-b]quinolin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362987505,"",1360966,404653945,117803897,2064,29909341,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control,"(2S)-2-[[6-[4-(hydroxymethyl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362987506,"",1360966,404658604,145954089,2064,29909341,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control,"N-[4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362987507,"",1360966,404664043,145957844,2064,29909341,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control,"3-[4-Amino-7-[2-(dimethylamino)ethyl]pyrrolo[2,3-d]pyrimidin-5-yl]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362987508,"",1360966,404684899,145972007,2064,29909341,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 cytoplasmic domain expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control,"4-[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]thieno[2,3-d]pyrimidin-6-yl]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
362990419,"",1361889,404655466,137333450,2064,30053721,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control,Chmfl-PI3KD-317,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363013718,"",1371628,404694825,129900111,2064,28818446,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control,Aurora kinase inhibitor-8,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363013719,"",1371628,374345460,134153498,2064,28818446,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control,"4-(prop-2-enoylamino)-N-[4-[(5,8,11-trimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363016559,"",1373083,404691561,145976421,2064,29289448,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control,"N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-9-(3,5-difluorophenyl)-2-morpholin-4-ylpurin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363025576,"",1376531,404693403,145977670,2064,28131712,Literature-derived,20200618,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human ErbB2 (676 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method","1-(4-methylsulfonylphenyl)-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363083806,"",1393610,404702416,132275094,2064,29407977,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERB-B2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control,"1-(propan-2-yl)-3-({3-[3-(trifluoromethyl)phenyl]isoquinolin-8-yl}ethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363083807,"",1393610,336880269,127034964,2064,29407977,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERB-B2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control,"N-[3-[2-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)ethynyl]phenyl]-3-(trifluoromethyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363085262,"",1394225,404704493,129318936,2064,29544149,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,PDGFRalpha kinase inhibitor 1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363090289,"",1396419,404705177,145985555,2064,29921474,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control,"N-(2-methylpropyl)-N-(11-oxo-5H-benzimidazolo[1,2-b]isoquinolin-6-yl)pyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106011,"",1402427,404696334,129202507,2064,29247857,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 cytoplasmic domain expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control,CDK4/6/1 Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106235,"",1402509,404696334,129202507,2064,29247857,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,CDK4/6/1 Inhibitor,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106621,"",1402964,404714405,145991542,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"Ethyl 6-methyl-4-[4-[(4-methylphenyl)methoxy]anilino]furo[2,3-d]pyrimidine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106622,"",1402964,404705945,145986089,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"Ethyl 4-[4-[(3-chlorophenyl)methoxy]anilino]-6-methylfuro[2,3-d]pyrimidine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106928,"",1402964,404715747,145992414,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"Ethyl 4-[3-chloro-4-[(4-fluoropyridin-2-yl)methoxy]anilino]-6-methylfuro[2,3-d]pyrimidine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106929,"",1402964,404716545,145992924,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"Ethyl 6-methyl-4-[4-[(3-methylphenyl)methoxy]anilino]furo[2,3-d]pyrimidine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106930,"",1402964,404718519,145994119,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"Ethyl 6-methyl-4-(4-phenylmethoxyanilino)furo[2,3-d]pyrimidine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106931,"",1402964,404698058,145980690,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"Ethyl 4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-methylfuro[2,3-d]pyrimidine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106932,"",1402964,404712858,145990551,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"Ethyl 4-[4-[(3-fluorophenyl)methoxy]anilino]-6-methylfuro[2,3-d]pyrimidine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106933,"",1402964,404700427,145982225,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-N-(2-hydroxyethyl)-6-methylfuro[2,3-d]pyrimidine-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106934,"",1402964,404711474,145989676,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"Ethyl 4-[4-[(3,4-dichlorophenyl)methoxy]anilino]-6-methylfuro[2,3-d]pyrimidine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106935,"",1402964,404695336,145978917,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"Ethyl 4-[4-[(4-chlorophenyl)methoxy]anilino]-6-methylfuro[2,3-d]pyrimidine-5-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363106936,"",1402964,404707972,145987445,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,"4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-6-methylfuro[2,3-d]pyrimidine-5-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363107661,"",1402965,123092436,44259,2064,29275232,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 100 nM using poly[Glu:Tyr] (4:1) as substrate after 40 mins by Kinase-Glo plus luminescence assay relative to control,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363108281,"",1403296,404699700,145981755,2064,29288948,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,1-(3-Chlorophenyl)-3-[4-[2-(ethylamino)pyridin-4-yl]-3-(trifluoromethyl)phenyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112338,"",1404898,404711098,145989431,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-benzyl-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112339,"",1404898,404711573,145989746,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-(3-ethynylphenyl)-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112340,"",1404898,404697087,145980052,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","6-(4-aminophenyl)-N-[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112341,"",1404898,404697807,145980530,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-[4-chloro-3-(trifluoromethyl)phenyl]-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112342,"",1404898,404709296,145988274,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112343,"",1404898,404711368,145989612,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","6-(4-aminophenyl)-N-benzylthieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112424,"",1404982,123092436,44259,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 1 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control",Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112721,"",1404898,404712376,145990245,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","1-[4-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]-3-cyclopropylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112722,"",1404898,404696451,145979641,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","6-(4-aminophenyl)-N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112723,"",1404898,404716437,145992857,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-[3-chloro-4-[(3,4-dichlorophenyl)methoxy]phenyl]-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112724,"",1404898,404717864,145993746,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","ethyl N-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112725,"",1404898,404711767,145989871,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112726,"",1404898,404715268,145992117,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-(3-bromophenyl)-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112727,"",1404898,404696965,145979976,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-[4-(1,3-benzothiazol-2-ylsulfanyl)-3-chlorophenyl]-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112728,"",1404898,404717996,145993817,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-(3-chloro-4-fluorophenyl)-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112729,"",1404898,404713355,145990878,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112730,"",1404898,404699666,145981733,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112731,"",1404898,404696686,145979807,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-[3-chloro-4-[(3-chlorophenyl)methoxy]phenyl]-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112732,"",1404898,404713618,145991044,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363112733,"",1404898,404715426,145992216,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control",Egfr/her2-IN-12,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363113080,"",1404898,404716385,145992825,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","(E)-N-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]-4-methylpent-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363113081,"",1404898,404708677,145987885,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","6-(4-nitrophenyl)-N-(2-phenylethyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363113082,"",1404898,123092436,44259,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control",Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363113083,"",1404898,404695299,145978889,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","N-(1-benzylindazol-5-yl)-6-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363113084,"",1404898,404699260,145981459,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","(Z)-4-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]anilino]-4-oxobut-2-enoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363113085,"",1404898,404714888,145991881,2064,29902719,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human N-terminal GST-tagged HER2 (679 to 1255 residues) expressed in baculovirus infected Sf9 cells at 10 uM using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay relative to control","1-[4-[4-[3-Chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]-3-(2-morpholin-4-ylethyl)urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363130775,"",1414229,404715460,145992239,2064,30314880,Literature-derived,20200619,0,0,Inactive,P04626,"","",ChEMBL,Binding affinity to HER2 extracellular domain (unknown origin) at 25 to 100 uM by SPR analysis,"(2S)-2-[3-[2-[[(2S)-2,6-diaminohexanoyl]amino]-6-phenylphenyl]propanoylamino]-3-phenylpropanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363130789,"",1414232,404718320,145994001,2064,30314880,Literature-derived,20200619,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 in human BT474 cells assessed as receptor internalization at 0.5 uM after 2 hrs by DAPI/Lysotracker staining based microscopic method,"(2S)-2-[[2-[[2-[[2-[[(2S)-2-[[(2S)-2-[[(3S)-3-[[(2S)-5-carbamimidamido-2-[[2-(octadecanoylamino)acetyl]amino]pentanoyl]amino]-3-naphthalen-1-ylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-6-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]hexanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363130790,"",1414232,404715492,145992259,2064,30314880,Literature-derived,20200619,0,0,Inactive,P04626,"","",ChEMBL,Binding affinity to HER2 in human BT474 cells assessed as receptor internalization at 0.5 uM after 2 hrs by DAPI/Lysotracker staining based microscopic method,"(2S)-2-[[2-[[2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(octadecanoylamino)acetyl]amino]pentanoyl]amino]propanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-6-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]hexanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363130864,"",1414231,404718320,145994001,2064,30314880,Literature-derived,20200619,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 in human BT474 cells at 0.5 uM after 30 mins by DAPI staining based microscopic method,"(2S)-2-[[2-[[2-[[2-[[(2S)-2-[[(2S)-2-[[(3S)-3-[[(2S)-5-carbamimidamido-2-[[2-(octadecanoylamino)acetyl]amino]pentanoyl]amino]-3-naphthalen-1-ylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-6-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]hexanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363130865,"",1414231,404715492,145992259,2064,30314880,Literature-derived,20200619,0,0,Inactive,P04626,"","",ChEMBL,Binding affinity to HER2 in human BT474 cells at 0.5 uM after 30 mins by DAPI staining based microscopic method,"(2S)-2-[[2-[[2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(octadecanoylamino)acetyl]amino]pentanoyl]amino]propanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-6-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]hexanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363135229,"",1417374,404699876,118664938,2064,30227946,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERB-B2 (unknown origin) at 1 uM relative to control,"4-[6-[4-(1-Aminocyclobutyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-1-naphthalenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363136065,"",1417860,404696536,134814484,2064,30253346,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control,4-(((4-(5-Chloro-2-((trans-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363141813,"",1419936,404696751,145979845,2064,29398441,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ErbB2 at 1 uM relative to control,"1-[4-[4-[(5-Propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl)amino]cyclohexyl]piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363141814,"",1419936,404700244,133107904,2064,29398441,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ErbB2 at 1 uM relative to control,"4-[4-[[4-(dimethylamino)cyclohexyl]amino]-7~{H}-pyrrolo[2,3-d]pyrimidin-5-yl]cyclohexane-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363141815,"",1419936,404708857,138728749,2064,29398441,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ErbB2 at 1 uM relative to control,"1-[4-[4-[[5-(Oxan-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]cyclohexyl]piperazin-1-yl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363142464,"",1420283,404712452,145990292,2064,30143423,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 10 uM,2-(Methylcarbamoylamino)-7-propan-2-yl-5-(thiophen-2-ylsulfonylamino)-1-benzothiophene-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363143515,"",1420641,404717314,145993414,2064,30195240,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of N-terminal His-tagged human HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,5-[[6-(3-Methoxyanilino)pyrimidin-4-yl]amino]-5-oxopentanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363144532,"",1420641,404716669,145993006,2064,30195240,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of N-terminal His-tagged human HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,5-[(6-Morpholin-4-ylpyrimidin-4-yl)amino]-5-oxopentanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363144533,"",1420641,404698017,145980662,2064,30195240,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of N-terminal His-tagged human HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,5-[[6-(3-Chloroanilino)pyrimidin-4-yl]amino]-5-oxopentanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363144534,"",1420641,404708896,145988025,2064,30195240,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of N-terminal His-tagged human HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,5-[[6-(4-Ethoxycarbonylanilino)pyrimidin-4-yl]amino]-5-oxopentanoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363144535,"",1420641,404712840,145990537,2064,30195240,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of N-terminal His-tagged human HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,N-[6-(4-methoxyanilino)pyrimidin-4-yl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363144536,"",1420641,404715580,112866175,2064,30195240,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of N-terminal His-tagged human HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control,"N4-(2,5-Dimethoxyphenyl)-N6-(3-methoxyphenyl)pyrimidine-4,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363146676,"",1421411,404700085,145982003,2064,30241010,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human Erbb2 at 1000 nM after 60 mins by ELISA relative to control,"4-[6-Methyl-9-(4-methylphenyl)-2,4,5,8,12,14-hexazatricyclo[8.4.0.03,7]tetradeca-1(14),3,6,8,10,12-hexaen-13-yl]morpholine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363146677,"",1421411,103175813,5329102,2064,30241010,Literature-derived,20200619,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of recombinant human Erbb2 at 1000 nM after 60 mins by ELISA relative to control,Sunitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363146678,"",1421411,103768626,10184653,2064,30241010,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human Erbb2 at 1000 nM after 60 mins by ELISA relative to control,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363147209,"",1421412,404700085,145982003,2064,30241010,Literature-derived,20200619,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human Erbb2 at 100 nM after 60 mins by ELISA relative to control,"4-[6-Methyl-9-(4-methylphenyl)-2,4,5,8,12,14-hexazatricyclo[8.4.0.03,7]tetradeca-1(14),3,6,8,10,12-hexaen-13-yl]morpholine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363163387,"",1428032,381842917,137635615,2064,27839788,Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control,"1-(5-Tert-butyl-1,2-oxazol-3-yl)-3-[2-methyl-4-[6-(methylamino)pyrimidin-4-yl]oxyphenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363166704,"",1428887,381887285,137661906,2064,28088086,Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human HER2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [33P]ATP by Hotspot assay relative to control,"1-[4-Chloro-3-(trifluoromethyl)phenyl]-3-[4-(6,7-dimethoxy-2-methylquinolin-3-yl)oxyphenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363171391,"",1430982,381841939,11515536,2064,"",Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control,"6-Methyl-4-phenylsulfanylpyrimido[4,5-b][1,4]benzothiazepine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363180006,"",1434203,381861855,137648413,2064,28006668,Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human wild type partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system at 10 uM by KinomeScan method relative to control,"1-(6-Methyl-3-phenylsulfanylpyrido[2,3-b]pyrazin-7-yl)-3-phenylurea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363185769,"",1436458,381837558,134397453,2064,28049589,Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human ErbB2 using poly(Glu, Tyr) as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method","2-N-[(1R,2S)-2-aminocyclohexyl]-6-N-(3-chlorophenyl)-9-propan-2-ylpurine-2,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363185770,"",1436458,381856276,134397451,2064,28049589,Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human ErbB2 using poly(Glu, Tyr) as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method","2-N-[(1S,2S)-2-aminocyclohexyl]-6-N-(3-chlorophenyl)-9-propan-2-ylpurine-2,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363185771,"",1436458,381864334,134397387,2064,28049589,Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human ErbB2 using poly(Glu, Tyr) as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method","6-N-(3-amino-5-chlorophenyl)-2-N-[(1R,2S)-2-aminocyclohexyl]-9-propan-2-ylpurine-2,6-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363205884,"",1443482,103244983,123631,2064,28291344,Literature-derived,20200620,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 0.5 uM,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363253881,"",1461146,381869691,135317791,2064,28521156,Literature-derived,20200621,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control,"3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[1-[(E)-4-(dimethylamino)but-2-enoyl]piperidin-4-yl]-7-(4-fluoroanilino)-4H-pyrimido[4,5-d]pyrimidin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,45,"","",""
363258431,"",1463376,381886260,117605934,2064,28802632,Literature-derived,20200621,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 1 uM relative to control,3-Methyl-4-(4-pyridinyl)-1H-pyrrole-2-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363272811,"",1468764,381839160,86567195,2064,29457982,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human cytoplasmic His-tagged ERBB2 expressed in baculovirus at 1 uM by Z'-LYTE assay,Fenebrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363272812,"",1468764,318464585,71226662,2064,29457982,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human cytoplasmic His-tagged ERBB2 expressed in baculovirus at 1 uM by Z'-LYTE assay,Acalabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363272813,"",1468764,381849777,54755438,2064,29457982,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human cytoplasmic His-tagged ERBB2 expressed in baculovirus at 1 uM by Z'-LYTE assay,Tirabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363272814,"",1468764,242651825,59174488,2064,29457982,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human cytoplasmic His-tagged ERBB2 expressed in baculovirus at 1 uM by Z'-LYTE assay,Spebrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363272815,"",1468764,136940589,24821094,2064,29457982,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human cytoplasmic His-tagged ERBB2 expressed in baculovirus at 1 uM by Z'-LYTE assay,Ibrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363273398,"",1468764,381847098,71479709,2064,29457982,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human cytoplasmic His-tagged ERBB2 expressed in baculovirus at 1 uM by Z'-LYTE assay,Evobrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363273399,"",1468764,374313890,86580692,2064,29457982,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human cytoplasmic His-tagged ERBB2 expressed in baculovirus at 1 uM by Z'-LYTE assay,"(7R)-3-fluoro-4-[3-(8-fluoro-1-methyl-2,4-dioxoquinazolin-3-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-6,7,8,9-tetrahydro-5H-carbazole-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363275385,"",1470082,381866647,129896681,2064,28315597,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,Chmfl-btk-01,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363292543,"",1478929,381860900,137647779,2064,28408219,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 activation loop (unknown origin) at 10 uM,"3-pyridin-4-yl-1H-pyrrolo[2,3-c]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363292644,"",1478930,381860900,137647779,2064,28408219,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 Lysine 1 labelling site (unknown origin) at 10 uM,"3-pyridin-4-yl-1H-pyrrolo[2,3-c]pyridine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363296779,"",1481335,381839686,127264586,2064,28282122,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human ERBB2 expressed in mammalian system assessed as control score at 1 uM by KINOMEScan assay,Chmfl-egfr-202,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363301609,"",1483392,381848123,137639118,2064,28482151,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant wild-type human N-terminally GST-His6 tagged ERBB2 (Q679 to V1255 residues) C-terminal fragment harboring thrombin cleavage site expressed in Baculovirus infected Sf9 cells assessed as residual activity at 1 uM in presence of [33,"N-[3-[4-[4-(4-fluorophenyl)-2-(3-hydroxypropyl)-1H-imidazol-5-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363304701,"",1484494,381878204,118514811,2064,28426996,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (HER2) (unknown origin) at 1 uM relative to control,"N-[5-[[4-(1-azatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraen-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363305870,"",1484890,381859635,137646902,2064,28460311,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control","N-[1-(4-ethyl-3-oxo-1,4-benzothiazine-2-carbonyl)piperidin-4-yl]pentadecanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363305952,"",1484891,103768626,10184653,2064,28460311,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA relative to control",Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363307342,"",1485623,381871712,117769575,2064,28539220,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,"4-{[(1r,3s)-3-Amino-2,2,3-Trimethylcyclopentyl]amino}-6-Phenylpyrrolo[1,2-B]pyridazine-3-Carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363307343,"",1485623,381860306,86707711,2064,28539220,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,"4-((1R,3S)-3-amino-2,2,3-trimethylcyclopentylamino)-6-(6-methoxypyridin-3-yl)pyrrolo[1,2-b]pyridazine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363318860,"",1490129,374266435,131801160,2064,28038940,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2/ErbB2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled GIWIPDGENVKIPVAIKVLR probe by mass-spectrometric analysis relative to control,CID 131801160,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363318861,"",1490129,103743338,9863776,2064,28038940,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2/ErbB2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled GIWIPDGENVKIPVAIKVLR probe by mass-spectrometric analysis relative to control,5Z-7-Oxozeaenol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363318862,"",1490129,374265964,131801161,2064,28038940,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2/ErbB2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled GIWIPDGENVKIPVAIKVLR probe by mass-spectrometric analysis relative to control,N-[2-[5-chloro-2-[[1-(2-methoxyethyl)pyrazol-4-yl]amino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363323407,"",1491830,336861399,90292823,2064,28929759,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant His-tagged human ErbB2 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control,Dlk-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363323408,"",1491830,336863575,90292687,2064,28929759,Literature-derived,20200622,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant His-tagged human ErbB2 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control,example 152 [WO2014111496],ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363436058,"",1412464,242303136,1257937,2064,30108917,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of human ErbB2 using poly(Glu-Tyr) as substrate at 100 uM after 40 mins in presence of [gamma-33P-ATP] by scintillation counting analysis,"3,4-dichloro-2-ethoxy-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzenesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363436190,"",1412705,404697020,145331341,2064,30108960,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 (unknown origin) at 100 nM using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA relative to control","N-[3-[2-[3-methoxy-4-(4-methylpiperazin-1-yl)anilino]-6,7-dioxo-5-propan-2-ylpteridin-8-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363436191,"",1412705,404707250,132597737,2064,30108960,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 (unknown origin) at 100 nM using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA relative to control","N-[3-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-6,7-dioxo-5-propan-2-ylpteridin-8-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363436192,"",1412705,404715602,145331319,2064,30108960,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ErbB2 (unknown origin) at 100 nM using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA relative to control","N-[3-[2-[3-methyl-4-(4-methylpiperazin-1-yl)anilino]-6,7-dioxo-5-propan-2-ylpteridin-8-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363440617,"",1414226,404715460,145992239,2064,30314880,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of FITC-aminocaproic acid-Arg-(S)Anapa-Phe-OH binding to HER2 domain-4 in human BT474 cells at 0.5 to 200 uM after 45 mins by fluorescence assay,"(2S)-2-[3-[2-[[(2S)-2,6-diaminohexanoyl]amino]-6-phenylphenyl]propanoylamino]-3-phenylpropanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363440799,"",1414230,404702549,145983688,2064,30314880,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 in human BT474 cells assessed as inhibition of HER2:HER3 heterodimerization at 1 to 5 uM after 48 hrs by DAPI staining based proximity ligation assay,stearoyl-Arg-bAla(3R-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363440856,"",1414225,404702549,145983688,2064,30314880,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of Stearic acid-Gly-Arg-(S)Anapa-Phe-Asp-Gly-Gly-Gly-Lys-OH (FAM Lys side chain) binding to HER2 domain-4 in human BT474 cells after 45 mins by fluorescence assay,stearoyl-Arg-bAla(3R-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363440857,"",1414227,404702549,145983688,2064,30314880,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of Stearic acid-Gly-Arg-(S)Anapa-Phe-Asp-Gly-Gly-Gly-Lys-OH (FAM Lys side chain) binding to HER2 domain-4 in human BT474 cells at 0.5 to 100 uM after 1 hr by DAPI staining based microscopic method,stearoyl-Arg-bAla(3R-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363441283,"",1414224,404702549,145983688,2064,30314880,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of FITC-aminocaproic acid-Arg-(S)Anapa-Phe-OH binding to HER2 domain-4 in human BT474 cells after 45 mins by fluorescence assay,stearoyl-Arg-bAla(3R-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363448860,"",1404970,404709296,145988274,2064,29902719,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 signalling in HER2 over-expressing human SKBR3 cells assessed as reduction in mTOR phosphorylation at S2448 residue at 2.5 to 10 uM after 72 hrs by Western blot analysis,"N-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363448912,"",1404971,404709296,145988274,2064,29902719,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 signalling in HER2 over-expressing human SKBR3 cells assessed as reduction in S6 phosphorylation at S235/236 residue at 2.5 to 10 uM after 72 hrs by Western blot analysis,"N-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363448959,"",1404969,404709296,145988274,2064,29902719,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 signalling in HER2 over-expressing human SKBR3 cells assessed as reduction in AKT phosphorylation at S473 residue at 2.5 to 10 uM after 72 hrs by Western blot analysis,"N-[4-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]thieno[2,3-d]pyrimidin-6-yl]phenyl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363454545,"",1441926,381839661,137633473,2064,28225269,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM by Z'-LYTE assay,N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[6-(3-fluoroanilino)-1H-indazol-3-yl]amino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363660908,"",1414228,404718320,145994001,2064,30314880,Confirmatory,20220830,0,0,Unspecified,P04626,Activity,"",ChEMBL,Binding affinity to HER2 extracellular domain (unknown origin) by SPR analysis,"(2S)-2-[[2-[[2-[[2-[[(2S)-2-[[(2S)-2-[[(3S)-3-[[(2S)-5-carbamimidamido-2-[[2-(octadecanoylamino)acetyl]amino]pentanoyl]amino]-3-naphthalen-1-ylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-6-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]hexanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363660910,"",1414228,404702549,145983688,2064,30314880,Confirmatory,20220830,0,0,Unspecified,P04626,Activity,"",ChEMBL,Binding affinity to HER2 extracellular domain (unknown origin) by SPR analysis,stearoyl-Arg-bAla(3R-naphth-1-yl)-Phe-OH,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363691135,"",1407103,103177479,208908,2064,30096580,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of recombinant human GST-tagged HER2 (676-end) expressed in baculovirus infected Sf9 insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363691137,"",1407103,103244983,123631,2064,30096580,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of recombinant human GST-tagged HER2 (676-end) expressed in baculovirus infected Sf9 insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363798911,"",1428363,381855489,137644097,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(4-methylphenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363798914,"",1428363,381851384,137641315,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-[5-(1H-benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363798915,"",1428363,381844252,137636527,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"4-[5-(1H-benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363798916,"",1428363,381854682,137643535,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(4-fluorophenyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363798918,"",1428363,381867167,137652014,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-pyridin-2-yl-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363798920,"",1428363,381856991,137645121,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-pyridin-3-yl-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799230,"",1428363,381870931,137654543,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-[(2-methylphenyl)methyl]-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799232,"",1428363,381853807,137642950,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(2,7a-dihydro-1H-indol-3-ylmethyl)-5-(1H-benzimidazol-2-ylmethyl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799237,"",1428363,381839680,137633488,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"1-[2-[5-(1H-benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]phenyl]ethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799238,"",1428363,381869816,137653795,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"4-amino-2-[5-(1H-benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]phenol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799240,"",1428363,381841053,137634412,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-[(6-chloro-1H-benzimidazol-2-yl)methyl]-5-phenyl-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799241,"",1428363,381864482,137650197,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-thiophen-2-yl-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799244,"",1428363,381869283,137653418,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-benzyl-5-[(6-chloro-1H-benzimidazol-2-yl)methyl]-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799481,"",1428363,381839315,137633245,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-[5-(1H-benzimidazol-2-ylmethyl)-1,3,4-oxadiazol-2-yl]acetonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
363799482,"",1428363,381844061,137636403,2064,27987485,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of HRG stimulated erbB2 phosphorylation in human MCF-7 cells preincubated for 90 mins followed by HRG addition for 5 mins by ELISA method,"2-(1H-benzimidazol-2-ylmethyl)-5-(furan-2-yl)-1,3,4-oxadiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
364895629,"",1511609,440174964,155547726,2064,31531196,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,"3-[3-(Dimethylamino)propylamino]-4-(1-methylindol-3-yl)-1-propan-2-ylpyrrole-2,5-dione;hydrochloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
364899001,"",1513294,440112060,155512053,2064,30006168,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control,"1-[3,5-Bis(trifluoromethyl)phenyl]-3-[3-[3-(3-chloro-5-methoxyphenyl)-4-pyridin-4-ylpyrazol-1-yl]phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
364910806,"",1517012,440200871,155558046,2064,31520926,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control,"1-[3,5-Bis(trifluoromethyl)phenyl]-3-[3-[3-(3-chloro-4-methoxyphenyl)-4-pyridin-4-ylpyrazol-1-yl]phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
364910807,"",1517012,440109256,155510358,2064,31520926,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control,N-[3-[3-(3-chloro-4-methoxyphenyl)-4-pyridin-4-ylpyrazol-1-yl]phenyl]-3-(trifluoromethyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
364913660,"",1517625,440125028,155520510,2064,31550660,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant His-tagged human HER2 (676 to 1255 residues) expressed in baculovirus expression system at 0.5 uM using tyr 06 as substrate in presence of ATP at Km concentration after 1 hr by Z'-LYTE assay relative to control,"4-[[4-(2-dimethylphosphorylanilino)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-methoxy-N-piperidin-4-ylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365259478,"",1508708,440158620,138454798,2064,30998353,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system at 1 uM by Kinomescan method,MD2-Tlr4-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365288063,"",1518286,440192342,155554609,2064,31610375,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human ErbB2 G778D mutant (676 to end residues) assessed as residual activity at 10 uM using poly (Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method","3-[[(2-chloro-9-cyclopentylpurin-6-yl)amino]methyl]-4,6-dimethyl-1H-pyridin-2-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365310101,"",1529021,440216742,145996526,2064,31934767,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant Erbb2 (unknown origin) at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control",3-((2-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)ethynyl)-N-(4-chlorophenyl)-4-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365310439,"",1528997,440216742,145996526,2064,31934767,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant Erbb2 (unknown origin) at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control",3-((2-Amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)ethynyl)-N-(4-chlorophenyl)-4-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365313625,"",1530959,440113239,14740251,2064,30384048,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control,"1-[(E)-4-chlorobut-2-enyl]-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane;chloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365313964,"",1530959,440122138,155518723,2064,30384048,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control,"1-[(E)-3-phenylprop-2-enyl]-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane;chloride",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365314425,"",1531319,123092436,44259,2064,30384048,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control,Staurosporine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365325876,"",1536530,440204431,47001335,2064,30626559,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,4-Amino-5-(5-chlorothiophene-2-carbonyl)-2-(propan-2-ylamino)thiophene-3-carbonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365328458,"",1538076,440131700,155524866,2064,30925338,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human ERBB2 G778D mutant (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to contr","(5E)-2-imino-5-[[5-(3-nitrophenyl)furan-2-yl]methylidene]-1,3-thiazolidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365328459,"",1538076,440207612,5919090,2064,30925338,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human ERBB2 G778D mutant (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to contr",prop-2-en-1-yl 2-chloro-5-{5-[(E)-(5-oxo-2-thioxoimidazolidin-4-ylidene)methyl]furan-2-yl}benzoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365333916,"",1539903,440148146,154853229,2064,31400941,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human ERBB2 G778D mutant (676 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to cont","1-[(1S)-1-phenylethyl]-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)triazolo[4,5-c]quinoline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365359365,"",1550222,440165745,138377596,2064,30901208,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human ERBB2 at 200 nM using biotinyl-beta amyloid-beta amyloid-beta AAEEEEYFELVAKKK after 10 mins by HTRF method relative to control,Jak/hdac-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365359594,"",1550221,440165745,138377596,2064,30901208,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human ERBB2 at 20 nM using biotinyl-beta amyloid-beta amyloid-beta AAEEEEYFELVAKKK after 10 mins by HTRF method relative to control,Jak/hdac-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365372413,"",1555845,440127759,155522293,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 1 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-1H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372414,"",1555845,440166470,155544349,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 1 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-(furan-2-yl)-1H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372415,"",1555845,440180654,155550014,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 1 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-fluoro-2-(furan-2-yl)-3H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372416,"",1555845,440116135,155514744,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 1 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-(furan-2-yl)-1H-imidazo[4,5-b]pyridin-7-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372417,"",1555845,440141542,155531311,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 1 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-1H-imidazo[4,5-b]pyridin-7-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372418,"",1555845,103177479,208908,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 1 uM incubated for 60 mins by ELISA relative to control",Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372419,"",1555845,440191860,155554429,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 1 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-fluoro-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-3H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372588,"",1555844,440127759,155522293,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 10 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-1H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372589,"",1555844,440166470,155544349,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 10 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-(furan-2-yl)-1H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372590,"",1555844,440116135,155514744,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 10 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-(furan-2-yl)-1H-imidazo[4,5-b]pyridin-7-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372591,"",1555844,440180654,155550014,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 10 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-fluoro-2-(furan-2-yl)-3H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372592,"",1555844,103177479,208908,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 10 uM incubated for 60 mins by ELISA relative to control",Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372593,"",1555844,440191860,155554429,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 10 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-fluoro-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-3H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372594,"",1555844,440141542,155531311,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 10 uM incubated for 60 mins by ELISA relative to control","N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-1H-imidazo[4,5-b]pyridin-7-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372595,"",1555844,440206007,155560076,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 10 uM incubated for 60 mins by ELISA relative to control",N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-8-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-7H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372596,"",1555844,440132704,155525531,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 10 uM incubated for 60 mins by ELISA relative to control",N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-8-(furan-2-yl)-7H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372811,"",1555845,440206007,155560076,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 1 uM incubated for 60 mins by ELISA relative to control",N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-8-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-7H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365372812,"",1555845,440132704,155525531,2064,31125894,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of human recombinant GST-tagged HER2 (catalytic domain 676 to end residues) autophosphorylation expressed in baculovirus infected Sf9 cells using poly( Glu, Tyr) 4:1 as substrate at 1 uM incubated for 60 mins by ELISA relative to control",N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-8-(furan-2-yl)-7H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,521,"","",""
365380391,"",1560181,440155362,154573782,2064,31935084,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,CID 154573782,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365397286,"",1567779,440112164,118959080,2064,31212132,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control,Erk5-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365397991,"",1568453,440167916,148564044,2064,31228810,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,PI3K/mTOR Inhibitor-4,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365421344,"",1579452,440178668,138911336,2064,31376566,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human ErbB2 (676 to end residues) G778D mutant at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control",Cdk9-IN-7,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365429702,"",1584042,440149221,155536330,2064,28528303,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,N-[5-[[5-chloro-4-(2-propan-2-ylsulfonylanilino)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365435403,"",1585973,440116376,155514902,2064,30472599,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 expressed in baculovirus expression system at 1 uM Z'-Lyte assay relative to control,[4-(3-Chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl] 2-chloroacetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365435404,"",1585973,440110981,155511317,2064,30472599,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 expressed in baculovirus expression system at 1 uM Z'-Lyte assay relative to control,[4-(3-Chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl] prop-2-enoate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365435405,"",1585973,440165827,155544107,2064,30472599,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 expressed in baculovirus expression system at 1 uM Z'-Lyte assay relative to control,[4-(3-chloro-4-fluoroanilino)-7-ethoxyquinazolin-6-yl] 2-(1H-imidazol-2-ylsulfanyl)acetate,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365441642,"",1588693,242651810,46220502,2064,31307887,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control,Abemaciclib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365441643,"",1588693,440188045,138911331,2064,31307887,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 catalytic domain (676 to 1255 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control,Cdk4/6-IN-3,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365447915,"",1590583,440199183,67972044,2064,31138459,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control,"1-(2-pyrrolidin-1-ylphenyl)-3-[3-[(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365448130,"",1591060,440205153,138393376,2064,31138459,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control,"N-[2-fluoro-6-(pyrrolidin-1-yl)phenyl]-N'-{3-[(2R)-1-(2-hydroxyethyl)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazin-2-yl]phenyl}urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365453125,"",1592609,440109419,155510425,2064,30798053,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,"1-(6-oxo-2,3,4,10b-tetrahydro-1H-pyrido[2,1-a]isoindol-10-yl)-3-[4-[1-[2-(1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]triazol-4-yl]pyridin-2-yl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365474117,"",1599796,440118990,146180717,2064,31223440,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 100 nM relative to control,"2-(2,5-difluorophenyl)-N-[3-fluoro-4-[[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-yl]amino]phenyl]-2-(3-oxo-1H-isoindol-2-yl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365474145,"",1599962,440150574,155537212,2064,31254923,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM using peptide as substrate incubated for 10 mins by caliper assay relative to control,N-[6-[(4-chlorophenyl)methylamino]-7H-purin-2-yl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365490566,"",1606174,440131035,146585662,2064,32212730,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control,4-[[[2-[(1S)-1-[(2-amino-5-cyano-6-methylpyrimidin-4-yl)amino]propyl]-4-oxo-3-phenylquinazolin-5-yl]amino]methyl]-N-hydroxybenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365495454,"",1608670,440120678,155517777,2064,31382120,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human ERBB2 (676 to end residues) at 1 uM using poly (Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control","1-N'-[4-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]phenyl]-1-N-(4-methylphenyl)cyclopropane-1,1-dicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365531746,"",1629485,440139432,46209051,2064,27544589,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 1 uM,4-[[1-(4-Cyanophenyl)piperidin-4-yl]amino]-6-[(2-methylpyrimidin-4-yl)amino]pyridine-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365538420,"",1632328,440211394,155562219,2064,27524312,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant ERBB2 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA",N-[4-(2-amino-3-chloropyridin-4-yl)oxy-3-fluorophenyl]-2-oxo-1-phenylquinoline-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
365538421,"",1632328,103591700,24794418,2064,27524312,Literature-derived,20210302,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant ERBB2 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA","N-(4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366241703,"",1554268,440215847,138105961,2064,30998845,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,"Inhibition of recombinant human ErbB2 G778D mutant (676 to end residues) at 10 uM using poly (Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method",Brd-IN-3,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366242257,"",1554776,440161920,122703613,2064,31013427,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of human ERBB2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP,"2,2-dimethyl-1-[(3S)-3-phenyl-3,4-dihydropyrazol-2-yl]propan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366242630,"",1555846,440132704,155525531,2064,31125894,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation in human HCC1954 cells overexpressing HER2 at 0.02 to 2 uM incubated for 1 hr by Western blot analysis,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-8-(furan-2-yl)-7H-purin-6-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3722,"","",""
366242631,"",1555846,440127759,155522293,2064,31125894,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation in human HCC1954 cells overexpressing HER2 at 0.02 to 2 uM incubated for 1 hr by Western blot analysis,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-1H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3722,"","",""
366242632,"",1555846,440141542,155531311,2064,31125894,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation in human HCC1954 cells overexpressing HER2 at 0.02 to 2 uM incubated for 1 hr by Western blot analysis,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-1H-imidazo[4,5-b]pyridin-7-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3722,"","",""
366242633,"",1555846,103177479,208908,2064,31125894,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation in human HCC1954 cells overexpressing HER2 at 0.02 to 2 uM incubated for 1 hr by Western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3722,"","",""
366242634,"",1555846,440191860,155554429,2064,31125894,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 autophosphorylation in human HCC1954 cells overexpressing HER2 at 0.02 to 2 uM incubated for 1 hr by Western blot analysis,"N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-7-fluoro-2-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-3H-imidazo[4,5-c]pyridin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,3722,"","",""
366249106,"",1573253,440225037,52914647,2064,29928803,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay,N-[3-fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-2-(trifluoromethyl)benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366249242,"",1573255,440225037,52914647,2064,29928803,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Binding affinity to ERBB2 (unknown origin) at 10 uM,N-[3-fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-2-(trifluoromethyl)benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366249741,"",1573254,440225037,52914647,2064,29928803,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay,N-[3-fluoro-4-[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yl]oxyphenyl]-2-(trifluoromethyl)benzenesulfonamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366272376,"",1612960,440175594,138454761,2064,30572178,Literature-derived,20220329,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 100 nM relative to control,FGFR1/DDR2 inhibitor 1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366272581,"",1612990,440175594,138454761,2064,30572178,Literature-derived,20220329,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 10 nM relative to control,FGFR1/DDR2 inhibitor 1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366272978,"",1612930,440175594,138454761,2064,30572178,Literature-derived,20220329,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 1000 nM relative to control,FGFR1/DDR2 inhibitor 1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366277179,"",1614743,440160507,7328982,2064,30689946,Literature-derived,20220329,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human His-tagged ERBB2 expressed in baculovirus expression system assessed as reduction in enzyme activity at 5 uM in presence of ATP relative to control,"2-hydroxy-4-[(4-naphthalen-2-yl-1,3-thiazol-2-yl)amino]benzoic Acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366281466,"",1616565,440162455,46212971,2064,31560541,Literature-derived,20220329,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual binding level at 10000 nM by Kinomescan method relative to control,"(E)-4-(dimethylamino)-N-[3-[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-6-phenylfuro[2,3-d]pyrimidin-5-yl]phenyl]but-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366291046,"",1627100,404707250,132597737,2064,27396610,Literature-derived,20220329,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 expressed in mammalian system assessed as remaining enzyme activity at 1000 nM relative to untreated control,"N-[3-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-6,7-dioxo-5-propan-2-ylpteridin-8-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366291518,"",1627693,440204884,145925651,2064,27460209,Literature-derived,20220329,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM relative to control,"2-[1-[2-(5-Chloro-2-fluorophenyl)-5-methylpyridin-4-yl]-2-oxoimidazo[4,5-c]pyridin-3-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366319119,"",1532892,103244983,123631,2064,30508379,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of wild type human N-terminal His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,Gefitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366319123,"",1532892,440203800,155559201,2064,30508379,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of wild type human N-terminal His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,"N-(3-bromo-4-fluorophenyl)-7-methoxy-6-[3-(1,4,7-triazonan-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366319212,"",1532892,440173051,155546954,2064,30508379,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of wild type human N-terminal His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,"N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(1,4,7,10-tetrazacyclododec-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366319213,"",1532892,440111356,155511571,2064,30508379,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of wild type human N-terminal His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,"N-(4-bromo-2-fluorophenyl)-7-methoxy-6-[3-(1,4,7-triazonan-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
366319214,"",1532892,440223449,155566973,2064,30508379,Confirmatory,20220830,0,0,Inconclusive,P04626,IC50,"",ChEMBL,Inhibition of wild type human N-terminal His-tagged HER2 cytoplasmic domain (676 to 1255 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,"N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(1,4,7-triazonan-1-yl)propoxy]quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367404401,"",1650615,442050666,154708216,2064,31859027,Literature-derived,20210802,0,0,Unspecified,P04626,"","",ChEMBL,Induction of HER2 destabilization in human MCF7 cells assessed as half life at 10 uM measured up to 24 hrs by immunoblotting assay (Rvb > 24 hrs),Hsp90-IN-12,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,31,"","",""
367436704,"",1664201,103177479,208908,2064,32631510,Literature-derived,20210802,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of recombinant human wild type partial length HER2 (646 to 1225 residues) expressed in mammalian expression system by competitive binding assay,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367436705,"",1664201,442060512,135236945,2064,32631510,Literature-derived,20210802,0,0,Inconclusive,P04626,"","",ChEMBL,Inhibition of recombinant human wild type partial length HER2 (646 to 1225 residues) expressed in mammalian expression system by competitive binding assay,"US10246444, Example 92",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367447537,"",1667593,442062324,78322295,2064,32139324,Literature-derived,20210802,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of gefitinib IC50 to test compound IC50 for inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobili","(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(diethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367447538,"",1667593,442053645,78322298,2064,32139324,Literature-derived,20210802,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of gefitinib IC50 to test compound IC50 for inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobili","(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-pyrrolidin-1-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367447678,"",1667594,442062324,78322295,2064,32139324,Literature-derived,20210802,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of erlotinib IC50 to test compound IC50 for inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobili","(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(diethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367447679,"",1667594,442053645,78322298,2064,32139324,Literature-derived,20210802,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of erlotinib IC50 to test compound IC50 for inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobili","(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-pyrrolidin-1-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367447680,"",1667595,442053645,78322298,2064,32139324,Literature-derived,20210802,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of lapatinib IC50 to test compound IC50 for inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobili","(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-pyrrolidin-1-ylbut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
367447681,"",1667595,442062324,78322295,2064,32139324,Literature-derived,20210802,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of lapatinib IC50 to test compound IC50 for inhibition of HER2 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobili","(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-(diethylamino)but-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371786111,"",1672577,461522480,135200194,2064,30981576,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system using Tyr 06 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control,"US11155557, Example 1",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371786112,"",1672577,461519771,118522410,2064,30981576,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system using Tyr 06 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control,"N-{5-[5-chloro-2-(difluoromethoxy)phenyl]-1H-pyrazol-4-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371786113,"",1672577,461515515,66847152,2064,30981576,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system using Tyr 06 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control,"N-{3-[5-chloro-2-(difluoromethoxy)phenyl]-1-methyl-1H-pyrazol-4-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371786245,"",1672730,461549298,124178749,2064,31000154,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system using Tyr 06 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control,"N-[(3S)-5-Methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-(perfluoroethyl)-2H-pyrazolo[3,4-b]pyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371789074,"",1673833,461537426,162659093,2064,31620235,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin),"4-tert-butyl-N-[2-methyl-3-[5-[[methyl(prop-2-enoyl)amino]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371795559,"",1676527,461549771,162667731,2064,32931277,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human H1781 cells assessed as reduction in HER2 phosphorylation at Y1221/1222 residues after 1 hrs by Western blot analysis,"N-[3-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371795560,"",1676527,461556894,162672776,2064,32931277,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human H1781 cells assessed as reduction in HER2 phosphorylation at Y1221/1222 residues after 1 hrs by Western blot analysis,"N-[3-[4-[4-[(1,3-dioxoisoindol-2-yl)methyl]anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371795583,"",1676526,461556894,162672776,2064,32931277,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human H1781 cells assessed as reduction in HER2 phosphorylation at Y1248 residues after 1 hrs by Western blot analysis,"N-[3-[4-[4-[(1,3-dioxoisoindol-2-yl)methyl]anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371795584,"",1676526,461549771,162667731,2064,32931277,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human H1781 cells assessed as reduction in HER2 phosphorylation at Y1248 residues after 1 hrs by Western blot analysis,"N-[3-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371795659,"",1676521,461532895,162655895,2064,32931277,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human H1781 cells assessed as reduction in HER2 phosphorylation at Y1248 residues at 100 to 500 nM after 1 hrs by Western blot analysis,"N-[5-[4-[(1-benzylindazol-5-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-(2-hydroxyethoxy)phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371795660,"",1676521,461533508,162656328,2064,32931277,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human H1781 cells assessed as reduction in HER2 phosphorylation at Y1248 residues at 100 to 500 nM after 1 hrs by Western blot analysis,"N-[5-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-[2-(dimethylamino)ethoxy]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371795839,"",1676522,461532895,162655895,2064,32931277,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human H1781 cells assessed as reduction in HER2 phosphorylation at Y1221/1222 residues at 100 to 500 nM after 1 hrs by Western blot analysis,"N-[5-[4-[(1-benzylindazol-5-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-(2-hydroxyethoxy)phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371795840,"",1676522,461533508,162656328,2064,32931277,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human H1781 cells assessed as reduction in HER2 phosphorylation at Y1221/1222 residues at 100 to 500 nM after 1 hrs by Western blot analysis,"N-[5-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-[2-(dimethylamino)ethoxy]phenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371805185,"",1679743,461526466,122197569,2064,29636220,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control,Hpk1-IN-26,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371805186,"",1679743,461549981,162667877,2064,29636220,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control,"3-Cyclohexyloxy-5-(2-piperidin-4-yl-1,3-thiazol-5-yl)pyridin-2-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371835920,"",1690318,461522141,162648400,2064,32097841,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of His-tagged human recombinant ERBB2 (676 to 1255 residues) expressed in baculovirus expression system at 100 nM using Tyr 06 as substrate preincubated for 1 hr in presence of ATP by Z'-LYTE assay relative to control,Jak3-IN-11,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371942113,"",1696943,461544615,72950266,2064,32897703,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 at 1 uM using fluorescently labeled peptide substrate measured after 3 hrs by microfluidic mobility shift assay relative to control,"4-[[4-(2-amino-1,3-thiazol-5-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]-N,N-dimethylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371951312,"",1699945,103389515,3001118,2064,33130288,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM by ELISA,"Thiourea, N-(3-bromo-2-pyridinyl)-N'-(2-phenylethyl)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371951313,"",1699945,461553063,162670042,2064,33130288,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM by ELISA,"1-(3-Bromopyridin-2-yl)-3-(2,4-dichlorophenyl)thiourea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371951314,"",1699945,461540538,162661278,2064,33130288,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM by ELISA,1-(2-Bromo-4-chlorophenyl)-3-(3-bromopyridin-2-yl)thiourea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371957103,"",1702628,461562019,162512901,2064,31869655,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human recombinant His-tagged HER2 (676 to 1255 residues) expressed in baculovirus expression system at 1 uM by Z-lyte assay relative to control,"N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-[3-(4-fluorophenyl)-5-methylsulfanyl-1,2,4-triazol-4-yl]pyridin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371987720,"",1713470,461524582,162650080,2064,27614407,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system at 500 nM using Tyr 06 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contr,"(2S)-2-[[6-[4-[[2-(dimethylamino)ethylamino]methyl]-3-fluorophenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371987721,"",1713470,461546276,117804364,2064,27614407,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system at 500 nM using Tyr 06 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contr,"(2S)-2-[[6-(2-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371987722,"",1713470,461542575,117779877,2064,27614407,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system at 500 nM using Tyr 06 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contr,"(2S)-2-phenyl-2-[(6-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]ethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371988158,"",1713470,461549453,162667501,2064,27614407,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system at 500 nM using Tyr 06 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contr,"(3R)-3-phenyl-3-[(6-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]propan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371988159,"",1713470,461515564,162643734,2064,27614407,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system at 500 nM using Tyr 06 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contr,"(2S)-2-[[6-(2-ethoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2-phenylethanol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371988160,"",1713470,103177459,176870,2064,27614407,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human His-tagged ERBB2 (676 to 1255 residues) expressed in baculovirus expression system at 500 nM using Tyr 06 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contr,Erlotinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371989264,"",1713706,461532019,162655285,2064,27681240,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant His-tagged human Erbb2 (676 to 1255 residues) expressed in baculovirus expression system at 10 uM by TR-FRET assay relative to control,"[(1R,2E,6E,10S,11E,13S)-13-hydroxy-3,7,13-trimethyl-10-propan-2-ylcyclotetradeca-2,6,11-trien-1-yl] N-[3,5-bis(trifluoromethyl)phenyl]carbamate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371993345,"",1715710,461526241,162651224,2064,29523467,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control,N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]-2-fluoro-5-nitrobenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371993923,"",1715992,461558575,118286428,2064,29588215,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,LRRK2 inhibitor 1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998353,"",1718828,461544522,162624257,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Erk1/2 phosphorylation at 0.1 IC50 incubated for 24 to 48 hrs by western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998354,"",1718830,461544522,162624257,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.1 IC50 incubated for 24 to 48 hrs by western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998372,"",1718835,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in Akt phosphorylation at 0.1 IC50 incubated for 24 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998373,"",1718835,461541674,162662079,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in Akt phosphorylation at 0.1 IC50 incubated for 24 hrs by western blot analysis,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998374,"",1718835,461557934,162673523,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in Akt phosphorylation at 0.1 IC50 incubated for 24 hrs by western blot analysis,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998375,"",1718842,461557934,162673523,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in Akt phosphorylation at IC50 incubated after 24 to 72 hrs by Western blot analysis,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998376,"",1718842,461541674,162662079,2064,33314925,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in Akt phosphorylation at IC50 incubated after 24 to 72 hrs by Western blot analysis,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998377,"",1718842,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in Akt phosphorylation at IC50 incubated after 24 to 72 hrs by Western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998378,"",1718842,461544318,162663928,2064,33314925,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in Akt phosphorylation at IC50 incubated after 24 to 72 hrs by Western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-2-(dimethylamino)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998396,"",1718829,461544522,162624257,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.5 IC50 incubated for 24 to 48 hrs by western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998411,"",1718832,461544522,162624257,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.5 IC50 after 24 to 48 hrs by Western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998472,"",1718822,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.5 IC50 incubated for 72 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998473,"",1718822,461557934,162673523,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.5 IC50 incubated for 72 hrs by western blot analysis,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998503,"",1718819,461557934,162673523,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in ERK1/2 phosphorylation at 0.1 IC50 incubated for 72 hrs by western blot analysis,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998504,"",1718819,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in ERK1/2 phosphorylation at 0.1 IC50 incubated for 72 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998505,"",1718821,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.1 IC50 incubated for 72 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998506,"",1718821,461557934,162673523,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.1 IC50 incubated for 72 hrs by western blot analysis,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998561,"",1718824,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in HER2 expression at IC50 incubated for 24 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998562,"",1718824,461541674,162662079,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in HER2 expression at IC50 incubated for 24 hrs by western blot analysis,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998588,"",1718823,461541674,162662079,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at IC50 incubated for 72 hrs by western blot analysis,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998589,"",1718823,461531469,162654900,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at IC50 incubated for 72 hrs by western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998590,"",1718823,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at IC50 incubated for 72 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998591,"",1718827,461544522,162624257,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Erk1/2 phosphorylation at 0.5 IC50 incubated for 24 to 48 hrs by western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998592,"",1718841,461541674,162662079,2064,33314925,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in ERK phosphorylation at IC50 incubated for 72 hrs by western blot analysis,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998593,"",1718841,461544318,162663928,2064,33314925,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in ERK phosphorylation at IC50 incubated for 72 hrs by western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-2-(dimethylamino)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998594,"",1718841,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in ERK phosphorylation at IC50 incubated for 72 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998621,"",1718820,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in ERK1/2 phosphorylation at 0.5 IC50 incubated for 72 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998622,"",1718820,461557934,162673523,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in ERK1/2 phosphorylation at 0.5 IC50 incubated for 72 hrs by western blot analysis,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998623,"",1718836,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in expression of ERK phosphorylation at 0.5 IC50 incubated for 24 to 72 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998624,"",1718836,461541674,162662079,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in expression of ERK phosphorylation at 0.5 IC50 incubated for 24 to 72 hrs by western blot analysis,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998704,"",1718882,461541674,162662079,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.01 to 25 uM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998705,"",1718882,461544522,162624257,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.01 to 25 uM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998706,"",1718882,461547108,162624208,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.01 to 25 uM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-2-(2-hydroxyethylamino)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998746,"",1718884,103420820,216239,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Effect on human recombinant N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay rela,Sorafenib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998747,"",1718884,461547108,162624208,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Effect on human recombinant N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay rela,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-2-(2-hydroxyethylamino)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998748,"",1718884,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Effect on human recombinant N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay rela,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998773,"",1718826,461557934,162673523,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in Akt expression level at 0.5 IC50 incubated for 72 hrs by western blot analysis,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998774,"",1718826,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in Akt expression level at 0.5 IC50 incubated for 72 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998775,"",1718840,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in ERK phosphorylation at IC50 incubated for 24 hrs by western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998776,"",1718840,461541674,162662079,2064,33314925,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in ERK phosphorylation at IC50 incubated for 24 hrs by western blot analysis,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998777,"",1718840,461544318,162663928,2064,33314925,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of HER2 in human AU565 cells assessed as reduction in ERK phosphorylation at IC50 incubated for 24 hrs by western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-2-(dimethylamino)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998781,"",1718831,461544522,162624257,2064,33314925,Literature-derived,20220318,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in Akt phosphorylation at 0.1 IC50 after 24 to 48 hrs by Western blot analysis,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998808,"",1718892,461541674,162662079,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.5 nM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998809,"",1718892,461557934,162673523,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.5 nM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998810,"",1718892,461544522,162624257,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.5 nM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998811,"",1718892,461557889,162673490,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.5 nM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998812,"",1718892,461547108,162624208,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.5 nM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-2-(2-hydroxyethylamino)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998926,"",1718884,461533548,162624239,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Effect on human recombinant N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay rela,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-2-morpholin-4-ylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998927,"",1718884,461529723,162624246,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Effect on human recombinant N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay rela,N-[4-[3-chloro-4-(3-methylphenoxy)anilino]quinazolin-6-yl]-2-(2-hydroxyethylamino)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998928,"",1718884,318398282,122196556,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Effect on human recombinant N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay rela,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-2-morpholin-4-ylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998929,"",1718884,461527313,162624277,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Effect on human recombinant N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay rela,N-[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998930,"",1718884,461515729,162624225,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Effect on human recombinant N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay rela,N-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]quinazolin-6-yl]-2-morpholin-4-ylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371998931,"",1718884,461544522,162624257,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Effect on human recombinant N-terminal GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay rela,N-[4-[3-chloro-4-(3-fluorophenoxy)anilino]quinazolin-6-yl]-4-[(2-hydroxyethylamino)methyl]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371999261,"",1718885,461557934,162673523,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 100 nM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371999434,"",1718882,103177479,208908,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.01 to 25 uM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371999435,"",1718882,461515621,162643774,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.01 to 25 uM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[3-chloro-4-(3-fluorophenoxy)phenyl]-6-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-amine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
371999436,"",1718882,461557889,162673490,2064,33314925,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type HER2 (unknown origin) at 0.01 to 25 uM in presence of substrate incubated for 30 mins by ADP-Glo assay relative to control,N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]-2-(4-methylpiperazin-1-yl)acetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372002604,"",1720106,461558717,162674051,2064,32320239,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 ug/ml using biotinylated peptide as substrate in presence of ATP relative to control,"(E)-3-[4-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]-N-hydroxyprop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372010955,"",1723354,461525222,154025206,2064,32787110,Literature-derived,20220318,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system at 1 uM by Kinomescan method,"(1S,2S)-2-[[4-methoxy-6-[[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]methoxy]-1,3-benzothiazol-2-yl]amino]cyclohexan-1-ol",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372039855,"",1731396,461530261,162654057,2064,33545637,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM relative to control,"6-[2-[(5E)-3-(4-chlorophenyl)-5-[(4-methoxyphenyl)methylidene]-6-oxo-1H-1,2,4-triazin-2-yl]-2-oxoethyl]-3-methyl-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372039856,"",1731396,461555295,162671604,2064,33545637,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM relative to control,"6-[2-[(5E)-5-benzylidene-6-oxo-3-phenyl-1H-1,2,4-triazin-2-yl]-2-oxoethyl]-3-methyl-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372039857,"",1731396,461544210,162663842,2064,33545637,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM relative to control,"6-[(5Z)-5-[(4-chlorophenyl)methylidene]-3-(4-methylphenyl)-6-oxo-1H-1,2,4-triazine-2-carbonyl]-3-methyl-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372039858,"",1731396,461535100,162657456,2064,33545637,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM relative to control,"6-[2-[(5E)-5-[(4-chlorophenyl)methylidene]-3-(4-methylphenyl)-6-oxo-1H-1,2,4-triazin-2-yl]-2-oxoethyl]-3-methyl-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372039859,"",1731396,103177479,208908,2064,33545637,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 uM relative to control,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372053383,"",1735370,461558472,162673880,2064,29133048,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human ERBB2 (676 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to contro","1-(5-Tert-butyl-1,2-oxazol-3-yl)-3-[4-(6,7,8,9-tetrahydropyrimido[5,4-b][1,4]oxazepin-4-ylamino)phenyl]urea",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059852,"",1737848,461545260,162664615,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyridine-4-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059853,"",1737848,461546907,162665741,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[5-[(11-benzyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]-2-(dimethylamino)phenyl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059854,"",1737848,461554218,162670861,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-pyrimidin-2-yl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059855,"",1737848,461515670,162643805,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]pyridine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059856,"",1737848,461543789,162663532,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyrimidine-2-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059857,"",1737848,461549671,162667660,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyridine-4-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]furan-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059858,"",1737848,461553981,162670675,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-(8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-ylamino)phenyl]pyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059859,"",1737848,461558095,162673630,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-[3-(4-methylpiperazin-1-yl)propyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059860,"",1737848,461559331,162674483,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372059861,"",1737848,461552771,162669848,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060125,"",1737848,461553689,162670472,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyrazine-2-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]furan-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060126,"",1737848,461558876,162674150,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-[3-(4-methylpiperazin-1-yl)propyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]furan-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060127,"",1737848,461560463,162675277,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyrazine-2-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060128,"",1737848,461560480,162675292,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyridine-3-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060129,"",1737848,461554967,162671372,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-(8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-ylamino)phenyl]-4-methylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060130,"",1737848,461557734,162673381,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyridine-2-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060131,"",1737848,461553350,162670239,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]naphthalene-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060132,"",1737848,461557060,162672895,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-[3-(dimethylamino)propyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060133,"",1737848,461543046,162663008,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-(8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-ylamino)phenyl]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060134,"",1737848,461545233,162664594,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-(8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-ylamino)phenyl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060135,"",1737848,461561822,162676264,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-(8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-ylamino)phenyl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060136,"",1737848,461514695,162643127,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]furan-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060137,"",1737848,461553418,162670283,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]pyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060326,"",1737848,461553872,162670603,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyridine-2-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]furan-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060327,"",1737848,461554924,162671342,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-(8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-ylamino)phenyl]furan-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060328,"",1737848,461561615,162676109,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-[3-(dimethylamino)propyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]furan-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060329,"",1737848,461558498,162673900,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-[4-(trifluoromethyl)benzoyl]-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060330,"",1737848,461558667,162674021,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]thiophene-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060331,"",1737848,461554022,162670707,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-methyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]-4-methylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060332,"",1737848,461543871,162663589,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[(11-ethyl-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl)amino]phenyl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060333,"",1737848,461515022,162643339,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-(8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-ylamino)phenyl]naphthalene-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060334,"",1737848,461515575,162643742,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyridine-3-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]furan-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060335,"",1737848,461547276,162665995,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(pyrimidine-2-carbonyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]furan-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060336,"",1737848,461553462,162670310,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-(8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-ylamino)phenyl]pyridine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
372060337,"",1737848,461550199,162668023,2064,32344181,Literature-derived,20220318,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of recombinant human HER2 (676 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control","N-[2-(dimethylamino)-5-[[11-(3-morpholin-4-ylpropyl)-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6-tetraen-3-yl]amino]phenyl]propanamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373769575,"",1746487,469823909,146403432,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,Senexin C,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373770872,"",1747075,469817308,164622418,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control,"2-N-cyclopropyl-6,7-dimethoxy-4-N-(1-propan-2-ylpiperidin-4-yl)quinazoline-2,4-diamine;2,2,2-trifluoroacetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373771129,"",1747460,103721758,126274,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of DNA-tagged human ERBB2 assessed as percent of control at 50000 nM by qPCR analysis relative to control,Meisoindigo,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373771572,"",1747906,469828901,139600338,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 10 uM relative to control,"N-((5,6-dichloro-1H-benzo[d]imidazol-2-yl)methyl)-9-(1-methyl-1H-pyrazol-4-yl)-2-morpholino-9H-purin-6-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373771804,"",1748092,164141461,11532220,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,"3-Amino-4-[4-[4-(dimethylcarbamoyl)phenyl]-1,4-diazepan-1-yl]thieno[2,3-b]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373771805,"",1748092,164141461,11532220,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human ERBB2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,"3-Amino-4-[4-[4-(dimethylcarbamoyl)phenyl]-1,4-diazepan-1-yl]thieno[2,3-b]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373774456,"",1749171,103501621,3062316,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as residual activity at 1 uM,Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373774457,"",1749171,469808183,164615805,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as residual activity at 1 uM,"N-(4-chloro-2-methylpyridin-3-yl)-2-[[6-[[4-(2-hydroxyethyl)piperazin-1-yl]amino]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373775679,"",1749397,103501621,3062316,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as residual activity measured at 1 uM,Dasatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373775680,"",1749397,469812395,146500970,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as residual activity measured at 1 uM,"N-(2-chloro-4-methylthiophen-3-yl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373775681,"",1749397,469808183,164615805,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as residual activity measured at 1 uM,"N-(4-chloro-2-methylpyridin-3-yl)-2-[[6-[[4-(2-hydroxyethyl)piperazin-1-yl]amino]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373828711,"",1757234,469810920,164617795,2064,33667849,Literature-derived,20220830,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 (unknown origin) assessed as reduction in heterodimerization of HER2/EGFR by competitive based SPR analysis,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373828712,"",1757237,469810920,164617795,2064,33667849,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2/EGFR dimerization in human Calu-3 cells incubated for 48 hrs by proximity ligation assay,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373828719,"",1757233,469810920,164617795,2064,33667849,Confirmatory,20220830,0,0,Unspecified,P04626,Activity,"",ChEMBL,Binding affinity to HER2 domain IV (unknown origin) by SPR analysis,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373828798,"",1757263,469810920,164617795,2064,33667849,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2/HER3 dimerization in human Calu-3 cells incubated for 48 hrs by proximity ligation assay,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829093,"",1757232,469810920,164617795,2064,33667849,Confirmatory,20220830,0,0,Unspecified,P04626,Activity,"",ChEMBL,Binding affinity to HER2 ECD (unknown origin) by SPR analysis,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829094,"",1757239,103177479,208908,2064,33667849,Literature-derived,20220830,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 ECD in human A549 cells assessed as reduction in HER2 intracellular kinase domain phosphorylation at 2 uM incubated for 40 hrs by Western blot analysis,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829095,"",1757241,469810920,164617795,2064,33667849,Literature-derived,20220830,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 ECD in human A549 cells assessed as reduction in Akt phosphorylation at 1 uM incubated for 40 hrs by Western blot analysis,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829113,"",1757236,469810920,164617795,2064,33667849,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2/HER3 dimerization in human A549 cells incubated for 48 hrs by proximity ligation assay,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829115,"",1757238,469810920,164617795,2064,33667849,Literature-derived,20220830,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 ECD in human A549 cells assessed as reduction in HER2 intracellular kinase domain phosphorylation at 1 uM incubated for 40 hrs by Western blot analysis,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829142,"",1757410,469816341,141483825,2064,33689932,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM by ELISA,"2-methoxy-3-methyl-N-[2-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]sulfanyl-1,3-benzothiazol-6-yl]-4-pentan-2-yloxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829143,"",1757410,103768626,10184653,2064,33689932,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM by ELISA,Afatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829144,"",1757410,469799380,141483850,2064,33689932,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM by ELISA,"2-methoxy-N-[2-[2-[[(1S)-1-(4-methoxyphenyl)ethyl]amino]-2-oxoethyl]sulfanyl-1,3-benzothiazol-6-yl]-3-methyl-4-pentan-2-yloxybenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373829267,"",1757235,469810920,164617795,2064,33667849,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2/EGFR dimerization in human A549 cells incubated for 48 hrs by proximity ligation assay,"2-[(1R,5S,8S,11S,17S,22S,26S,30S,34R,37S,40S,44S,47S,53S)-37,53-dibenzyl-22-[(2S)-butan-2-yl]-8,26-bis(3-carbamimidamidopropyl)-40-(carboxymethyl)-5,30-dinaphthalen-1-yl-3,7,10,16,23,25,28,32,35,38,41,43,46,52,55-pentadecaoxo-57,58-dithia-2,6,9,15,21,24,27,31,33,36,39,42,45,51,54-pentadecazapentacyclo[32.21.4.011,15.017,21.047,51]nonapentacontan-44-yl]acetic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373892920,"",1769047,469819849,150237192,2064,34515481,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of wild-type human partial length ERBB2 (K646 to V1225 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control,Mnk/pim-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373914178,"",1772901,469816858,155811287,2064,34237622,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 10 uM incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method relative to control,"6-[3-[(4-Fluorophenyl)methoxy]phenyl]-5-(2-methylsulfonylpyrimidin-4-yl)imidazo[2,1-b][1,3]thiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373914179,"",1772901,469802269,155804973,2064,34237622,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 10 uM incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method relative to control,"5-(2-Methylsulfonylpyrimidin-4-yl)-6-(3-phenylmethoxyphenyl)imidazo[2,1-b][1,3]thiazole",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373958901,"",1782067,103628628,135398510,2064,34694800,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 1000 nM relative to control,Dovitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373958902,"",1782067,469811285,162679262,2064,34694800,Literature-derived,20220830,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 1000 nM relative to control,Pomalidomide-C5-Dovitinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373979514,"",1785951,440151760,129284334,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ErbB2 Kinase panel,"N-{2-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-(morpholin-4-yl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373982650,"",1786388,440164983,23652660,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 Invitrogen Lab (UK) kinase screen (BI),"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373982651,"",1786388,440164983,23652660,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 Invitrogen Lab (UK) kinase screen (BI),"3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373983686,"",1787318,461563592,155884467,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ErbB2(h) Millipore kinase panel,"(2~{R})-2-[[3-cyano-2-[4-(2-fluoranyl-3-methyl-phenyl)phenyl]-1,7-naphthyridin-4-yl]amino]butanoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373983898,"",1787626,461558359,122668091,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 (HER2) SelectScreen Kinase panel (LifeTechnologies),Borussertib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373986450,"",1789269,440120698,134128280,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ErbB2(h) Eurofins Kinase panel,"(2-Amino-4-(trifluoromethoxy)phenyl)(4-(7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl)piperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373987811,"",1790180,312390293,66764813,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 Invitrogen selectivity data (BI),"2-[4-[3-[(1R)-1-[4-(2-aminopyrimidin-5-yl)phenyl]-1-cyclopropylethyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373988450,"",1790655,136929043,45376872,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 Invitrogen selectivity data (BI),4-[[[5-(2-ethoxycarbonyl-1H-indol-5-yl)-1-methylpyrazole-3-carbonyl]amino]methyl]benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373988882,"",1791001,381885815,78319901,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 (HER2) Kinase screen,MLi-2-Bio-X,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373989339,"",1791592,440171575,132585205,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 (HER2) Kinase activity screen,Clk-IN-T3,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373989340,"",1791592,440171575,132585205,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 (HER2) Kinase activity screen,Clk-IN-T3,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373990194,"",1792283,163327014,45279963,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 ProQinase selectivity panel,Skepinone-L,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
373990455,"",1792671,440218803,134817183,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,ErbB2(h) Eurofins kinase panel,"N-[5-(3,5-dicyano-1,2,6-trimethyl-4H-pyridin-4-yl)-6-fluoro-7-methyl-1H-indazol-3-yl]-2-ethylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007360,"",1794079,103349868,5310991,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007361,"",1794079,134461578,51346964,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,S2JB42Bbp5,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007362,"",1794079,318374355,122179556,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,MSD-CYP11B2-Negative-control,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007363,"",1794079,336900042,89794927,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,(R)-1-(4-Methyl-5-(6-(trifluoromethyl)-1H-indazol-4-yl)pyrimidin-2-yl)pyrrolidin-3-ol,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007364,"",1794079,440225117,59126962,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(1S,4R,7Z,14S,18R)-14-(cyclopentyloxycarbonylamino)-18-[7-methoxy-8-methyl-2-[2-(2-methylpropanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxy-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007365,"",1794079,136929043,45376872,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,4-[[[5-(2-ethoxycarbonyl-1H-indol-5-yl)-1-methylpyrazole-3-carbonyl]amino]methyl]benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007366,"",1794079,461542924,162662928,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,N-pyridazin-3-yl-3-[(E)-3-[6-[5-(trifluoromethyl)pyridin-2-yl]oxypyrazin-2-yl]prop-2-enyl]azetidine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007367,"",1794079,124963756,24771824,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007368,"",1794079,312359683,11525848,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"4-(((2-((3-Methoxybenzyl)carbamoyl)-4-oxo-1,4-dihydrothieno[2,3-d]pyrimidin-5-yl)methoxy)methyl)benzoic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007369,"",1794079,381842065,137635074,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"3-Chloro-4-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)benzonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007370,"",1794079,440162068,138973681,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,BAY 293 Negative Control,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007371,"",1794079,440174202,101933292,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(2S,3S,4R)-4-(1,3-benzodioxol-5-yl)-1-[2-(2,6-diethylanilino)-2-oxoethyl]-2-(4-propoxyphenyl)pyrrolidine-3-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007372,"",1794079,440228548,155568985,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(5R)-N-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-5H-1,6-naphthyridine-6-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007373,"",1794079,312361687,59447577,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007374,"",1794079,318459881,87522699,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,(NE)-N-[(E)-1-(4-fluoro-3-methylphenyl)-2-methylpent-1-en-3-ylidene]hydroxylamine,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007375,"",1794079,404696611,118958122,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-(4-Fluorobenzyl)-2-((R)-5-(3-methylureido)-2',4'-dioxo-2,3-dihydrospiro[indene-1,5'-oxazolidin]-3'-yl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007376,"",1794079,440132040,154701643,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"[2-Amino-4-(trifluoromethoxy)phenyl]-[4-[2-methyl-7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007377,"",1794079,134451810,42611190,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,4-((Piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007378,"",1794079,242510763,11524200,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"6-Chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374007379,"",1794079,381863071,131801156,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,BCL6-IN-8c,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008429,"",1794079,440164595,155543618,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(4R)-2-(4-chlorophenyl)-6-methyl-4-(3-methyl-2H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008430,"",1794079,440207296,155560620,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Nvs-malt1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008431,"",1794079,163339280,49821991,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"[2-(6-chloropyridin-3-yl)-4-(2-methoxyethoxy)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-imidazo[1,5-a]pyridin-1-ylmethanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008432,"",1794079,381887626,137662140,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"5-[4-Methyl-2-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazol-5-yl]pyridine-2-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008433,"",1794079,404679711,49846946,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Bcl2-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008434,"",1794079,440159327,11996298,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyrimidin-4-yl]methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008435,"",1794079,440198624,155557179,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,ERKi-NC,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008436,"",1794079,440226684,155568238,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-[[4-[[(2S)-4-cyclohexyl-1-[(1-methylsulfonylpiperidin-3-yl)amino]-1-oxobutan-2-yl]carbamoyl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008437,"",1794079,103478702,11386747,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,CB1 inverse agonist 1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008438,"",1794079,440162092,124125214,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008439,"",1794079,134447941,25229646,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008440,"",1794079,318372032,60195662,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,(R)-3-((N-(1-(4-fluorophenyl)ethyl)quinoline-3-carboxamido)methyl)benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008441,"",1794079,440120698,134128280,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(2-Amino-4-(trifluoromethoxy)phenyl)(4-(7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl)piperidin-1-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008442,"",1794079,440170404,155545891,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,MRL-SYKi-NC,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008443,"",1794079,440174729,137322663,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008444,"",1794079,440192898,155554839,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(2-methylpyrimidin-4-yl)methyl (1R,5S)-6-[(2H-benzotriazole-5-carbonylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008445,"",1794079,440218803,134817183,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-[5-(3,5-dicyano-1,2,6-trimethyl-4H-pyridin-4-yl)-6-fluoro-7-methyl-1H-indazol-3-yl]-2-ethylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008446,"",1794079,103277752,5025739,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,2-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-1H-benzimidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008447,"",1794079,242645573,25114442,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,1-(4-Fluorobenzoyl)-3-[(6-methoxynaphthalen-2-yl)oxymethyl]azetidine-3-carboxylic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008448,"",1794079,318374372,56645363,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Cyp11B2-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008449,"",1794079,440170635,58026161,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"2-[(4S)-4-[(5-ethylsulfonyl-1H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl]-5-fluorobenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008450,"",1794079,440175882,145925685,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008451,"",1794079,440210612,155561913,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Nvs-malt1-C,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008452,"",1794079,440132255,52916803,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,CCR1 antagonist 8,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008453,"",1794079,440157493,57861407,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,1-(2-ethoxyethyl)-6-oxo-N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridin-2-yl]pyridine-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008454,"",1794079,440177378,137332060,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-[(4-fluorophenyl)methyl]-2-[(3R)-5-(methylcarbamoylamino)-2',4'-dioxospiro[1,2-dihydroindene-3,5'-1,3-oxazolidine]-3'-yl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]acetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008455,"",1794079,103683319,45268455,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"Pyrido(1,2-a)indole-10-acetic acid, 7-(((4-fluorophenyl)sulfonyl)methylamino)-6,7,8,9-tetrahydro-, (7R)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008456,"",1794079,134457814,56678756,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(1S,3R)-N-[4-(1,3-benzoxazol-2-yl)phenyl]-N-methyl-3-propanamidocyclopentane-1-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008457,"",1794079,381872584,121301295,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,CFTR corrector 4,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008458,"",1794079,440124631,118191391,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N4-[1-[(4-cyanophenyl)methyl]-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-2,4-Quinolinedicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008459,"",1794079,440190963,155554081,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(5R)-5-[(4-cyanophenyl)methyl]-N-[1-(3-cyclobutyl-1,2,4-oxadiazol-5-yl)cyclopropyl]-7-(3,5-dichlorophenyl)-5-methyl-6-oxoimidazo[1,2-a]imidazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008460,"",1794079,440202897,155558842,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"2-Pyridin-2-yl-2,3-dihydro-1,3-benzothiazin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008461,"",1794079,194175385,25117126,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Defactinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008462,"",1794079,381840647,121301422,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,CFTR corrector 8,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008463,"",1794079,404661187,131953432,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"[3,5-bis(trifluoromethyl)phenyl]methyl (1~{S},5~{R})-6-[(1~{H}-benzotriazol-5-ylcarbonylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008883,"",1794079,440157481,155540682,2064,"",Other,20220830,0,0,Unspecified,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-1-(2-chlorophenyl)cyclopropane-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008884,"",1794079,440165585,10278851,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,4-[(2R)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008885,"",1794079,440202169,56849304,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"2-[4-[3-[1-[4-(2-aminopyrimidin-5-yl)phenyl]cyclopropyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008886,"",1794079,318390136,23728722,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"5-[(6r)-5-Ethanoyl-4-Methyl-2-Oxidanylidene-3-[3-(Trifluoromethyl)phenyl]-1,6-Dihydropyrimidin-6-Yl]pyridine-2-Carbonitrile",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008887,"",1794079,440112062,139030333,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,5-amino-N-[[4-(3-cyclohexylpropylcarbamoyl)phenyl]methyl]-1-phenylpyrazole-4-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008888,"",1794079,440156611,155540255,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(1S,4R,7Z,14S,18R)-14-(cyclopentyloxycarbonylamino)-2,15-dioxo-18-pyridin-4-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008889,"",1794079,440175888,85469632,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Unii-66vrx9TN9T,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008890,"",1794079,440179305,137479135,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"1-[4-[[2-[[6-[5-chloro-6-(dimethylamino)pyrimidin-4-yl]-1H-benzimidazol-2-yl]amino]pyridin-4-yl]methyl]piperazin-1-yl]-3,3,3-trifluoropropan-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008891,"",1794079,440208510,155561056,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Pptn-NC,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008892,"",1794079,440217259,11364870,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-(3-Acetyl-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-1-methyl-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)methanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008893,"",1794079,442046237,156009445,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(1,1-dioxo-1,3-thiazolidin-3-yl)-[(3S,5S)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008894,"",1794079,381885815,78319901,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,MLi-2-Bio-X,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008895,"",1794079,440134679,139600336,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,CID 139600336,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008896,"",1794079,440180707,155550034,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"4-(1-acetylpiperidin-4-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)-3-(trifluoromethyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008897,"",1794079,440205039,118877194,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,CID 118877194,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008898,"",1794079,440207046,155560522,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-[(2S)-4-cyclohexyl-1-[(1-methylsulfonylpiperidin-3-yl)amino]-1-oxobutan-2-yl]-4-[[(3-phenyltriazolo[4,5-d]pyrimidin-7-yl)amino]methyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008899,"",1794079,442046235,11772152,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,2-[[4-(3-methylsulfanylpyridin-2-yl)piperazin-1-yl]methyl]-1H-benzimidazole,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008900,"",1794079,312390293,66764813,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"2-[4-[3-[(1R)-1-[4-(2-aminopyrimidin-5-yl)phenyl]-1-cyclopropylethyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008901,"",1794079,336898977,44470113,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,ADRA1D receptor antagonist 1 free base,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008902,"",1794079,442046238,154701640,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"[(3S,5S)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]-(1,1-dioxo-1,4-thiazinan-4-yl)methanone",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008903,"",1794079,103333158,9915028,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,A-216546 free base,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008904,"",1794079,318456509,42641861,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"1-Penten-3-one, 1-(4-fluorophenyl)-2-methyl-, oxime, (1E,3E)-",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008905,"",1794079,374280463,71623052,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"[3-Cyano-5-[[[2,4-dimethyl-5-[6-(3-pyridinyl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl]amino]carbonyl]phenyl]pentafluorosulfur",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008906,"",1794079,440170924,58431184,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(5R)-5-[(4-cyanophenyl)methyl]-7-(3,5-dichloro-4-fluorophenyl)-5-methyl-6-oxo-N-[(2S)-1-oxo-1-[(1-pyridin-2-ylcyclopropyl)amino]propan-2-yl]imidazo[1,2-a]imidazole-3-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008907,"",1794079,440171401,155546287,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,N-[[4-(3-cyclohexylpropylcarbamoyl)phenyl]methyl]-1-phenyl-5-(trifluoromethyl)pyrazole-4-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008908,"",1794079,440178405,145925680,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,ERK-IN-2 (free base),ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008909,"",1794079,103745040,11577204,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008910,"",1794079,163325400,71455782,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Msd-M1pam-NC,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008911,"",1794079,318376732,118430456,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Dhodh-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008912,"",1794079,318444609,53251189,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Syk-IN-3,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008913,"",1794079,336898978,127046693,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,5-chloro-1-[(1S)-1-(3-cyanophenyl)ethyl]-2-iminopyridine-3-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008914,"",1794079,440131550,91885570,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Mgat2-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008915,"",1794079,440153796,91827581,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(2R,3S,4R)-1-[2-(dibutylamino)-2-oxoethyl]-2-(2,2-dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)pyrrolidine-3-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008916,"",1794079,440186768,155552454,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"6-chloro-4-N-[4-(3-chloro-1-methylpyrrolo[2,3-b]pyridin-4-yl)oxy-3,5-difluorophenyl]pyrimidine-2,4-diamine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374008917,"",1794079,440201576,155558331,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,MLi-2-NC,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009352,"",1794079,440223918,140309892,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"1-(5-aminopyrimidin-2-yl)-N-(4-chloro-2,6-difluorophenyl)-7-(2-oxopyrrolidin-1-yl)-2,3-dihydroindole-5-sulfonamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009353,"",1794079,124976534,53326879,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,CRTH2-negative-control,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009354,"",1794079,312372725,44543970,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Unii-KQ33evh4KU,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009355,"",1794079,440172743,155546818,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Gsm-NC,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009356,"",1794079,440193399,155555047,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"4-[4-[[2-(4-Chlorophenyl)-4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009357,"",1794079,440194870,124203924,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"4-N-[1-[(4-tert-butylphenyl)methyl]-5-methyl-3-(trifluoromethyl)pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009358,"",1794079,136938862,56850410,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,4-[[[5-(1H-indol-5-yl)-1-methylpyrazole-3-carbonyl]amino]methyl]benzoic acid,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009359,"",1794079,440159052,155541355,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Thpp-1-NC,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009360,"",1794079,440165545,155544007,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-[3-methyl-5-(6-pyridin-3-ylimidazo[1,2-b]pyrazol-1-yl)phenyl]-3-(pentafluoro-lambda6-sulfanyl)benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009361,"",1794079,440224957,6451154,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,4-[(2S)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009362,"",1794079,163338225,51031001,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,4-(1-Acetylpiperidin-4-yl)-N-carbamimidoyl-3-(trifluoromethyl)benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009363,"",1794079,318386330,59472574,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,gamma-Secretase modulator 2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009364,"",1794079,381861468,56649300,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,Ftbmt,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009365,"",1794079,440156172,9837640,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"2-(pyridin-2-yl)-4H-benzo[e][1,3]thiazin-4-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009366,"",1794079,440179852,155549686,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(1R,2R,5S)-2-[4-[2-(oxan-4-yl)ethoxy]benzoyl]-5-[(4-oxo-1,2,3-benzotriazin-3-yl)methyl]cyclopentane-1-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009367,"",1794079,440180856,155550101,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"1-(4-fluorophenyl)-N-[(1S)-3-(methanesulfonamido)-1-(2-methylsulfonylpyridin-4-yl)propyl]pyrazolo[3,4-c]pyridine-4-carboxamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009368,"",1794079,440217121,118425786,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"(1S,2S,5R)-2-[4-[2-(oxan-4-yl)ethoxy]benzoyl]-5-[(4-oxo-1,2,3-benzotriazin-3-yl)methyl]cyclopentane-1-carboxylic acid",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374009369,"",1794079,442046236,156009444,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,KinomeScan assay: inhibition of ERBB2,"N-[5-(3,5-dicyano-2,6-dimethyl-1,4-dihydropyridin-4-yl)-1-methylindazol-3-yl]-2-methylbenzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
374059495,"",1794554,440175888,85469632,2064,"",Other,20220830,0,0,Inactive,P04626,"","",ChEMBL,"Protein Tyrosine Kinase, ERBB2 (HER2) Eurofins-Panlabs enzyme assay",Unii-66vrx9TN9T,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380251362,"",1807881,475989183,166630876,2064,34757216,Literature-derived,20230314,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) assessed as residual activity at 1 uM relative to control,N-methyl-2-[[2-[4-[4-[2-(prop-2-enoylamino)propanoyl]piperazin-1-yl]anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380251363,"",1807881,475986765,163322241,2064,34757216,Literature-derived,20230314,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) assessed as residual activity at 1 uM relative to control,Fak-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380251364,"",1807881,475980348,166626457,2064,34757216,Literature-derived,20230314,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) assessed as residual activity at 1 uM relative to control,2-[[5-chloro-2-[4-[4-[2-(prop-2-enoylamino)acetyl]piperazin-1-yl]anilino]pyrimidin-4-yl]amino]-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380251365,"",1807881,476000719,166636611,2064,34757216,Literature-derived,20230314,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) assessed as residual activity at 1 uM relative to control,N-methyl-2-[[2-[4-[4-[2-(prop-2-enoylamino)acetyl]piperazin-1-yl]anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]benzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380251366,"",1807881,475998215,166635362,2064,34757216,Literature-derived,20230314,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) assessed as residual activity at 1 uM relative to control,2-[[5-chloro-2-[4-[4-[3-(prop-2-enoylamino)propanoyl]piperazin-1-yl]anilino]pyrimidin-4-yl]amino]-N-methylbenzamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380263287,"",1810742,475999566,166636029,2064,34129329,Literature-derived,20230314,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 1000 nM relative to control,"(E)-1-[4-[5-[4-amino-3-(3,5-dimethoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]pentyl]piperazin-1-yl]-4,4,4-trifluorobut-2-en-1-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380356703,"",1830162,475998190,166635350,2064,34506131,Literature-derived,20230314,0,0,Inactive,P04626,"","",ChEMBL,Induction of endolysosomal trafficking of HER2 in human SK-BR-3 cells assessed as EGF-induced degradation of HER2 at 2 uM measured up to 24 hrs post-EGF stimulation by western blot analysis,CID 166635350,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380356746,"",1830135,475998190,166635350,2064,34506131,Literature-derived,20230314,0,0,Active,P04626,"","",ChEMBL,Induction of endolysosomal trafficking of HER2 in human SK-BR-3 cells assessed as EGF-induced degradation of HER2 at 20 to 40 uM measured after 24 hrs post-EGF stimulation by western blot analysis,CID 166635350,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380356747,"",1830137,475982432,166627490,2064,34506131,Literature-derived,20230314,0,0,Unspecified,P04626,"","",ChEMBL,Induction of endolysosomal trafficking of HER2 in human SK-BR-3 cells assessed as EGF-induced degradation of HER2 at 2 uM measured after 15 hrs post-EGF stimulation by western blot analysis relative to control,CID 166627490,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380357335,"",1830136,475982432,166627490,2064,34506131,Literature-derived,20230314,0,0,Unspecified,P04626,"","",ChEMBL,Induction of endolysosomal trafficking of HER2 in human SK-BR-3 cells assessed as EGF-induced degradation of HER2 at 2 uM measured after 24 hrs post-EGF stimulation by western blot analysis relative to control,CID 166627490,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380357640,"",1830558,475994316,163408822,2064,34583130,Literature-derived,20230314,0,0,Unspecified,P04626,"","",ChEMBL,"Inhibition of ERBB2 (unknown origin) at 0.1 uM using Poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA relative to control",Flt3/itd-IN-3,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380370916,"",1834126,475992945,141755881,2064,34854662,Literature-derived,20230314,0,0,Inactive,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 1 uM,Ido1/2-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380499769,"",1834961,475988416,162760083,2064,"",Other,20230314,0,0,Inactive,P04626,"","",ChEMBL,ErbB2(h) Kinase panel,"2-(5-fluoropyridin-2-yl)-3-(1H-pyrazolo[3,4-b]pyridin-4-yl)-6,6-bis(trideuteriomethyl)-4,7-dihydropyrazolo[5,1-c][1,4]oxazine",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380500638,"",1835712,475995198,118958833,2064,"",Other,20230314,0,0,Inactive,P04626,"","",ChEMBL,ERBB2 DiscoveRx kinase panel,1891087-61-8,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380510077,"",1845160,160701240,11203294,2064,"",Other,20230314,0,0,Inactive,P04626,"","",ChEMBL,"Protein Tyrosine Kinase, ERBB2 (HER2) Eurofins-Panlabs enzyme assay",CID 11203294,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522350,"",1849135,482086698,168297032,2064,36351049,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR/HER2 heterodimerization in human SK-BR-3 cells at 1 uM preincubated for 4 hrs followed by EGF addition for 20 mins by immunoprecipitation analysis,CID 168297032,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522521,"",1849108,482069273,168285231,2064,36351049,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 in HER-positive human SK-BR-3 cells assessed as increase in fluorescence intensity at 25 uM by Hoechst 33342 staining based confocal microscopic analysis,CID 168285231,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522522,"",1849108,482073042,168287947,2064,36351049,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 in HER-positive human SK-BR-3 cells assessed as increase in fluorescence intensity at 25 uM by Hoechst 33342 staining based confocal microscopic analysis,CID 168287947,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522523,"",1849108,482086698,168297032,2064,36351049,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 in HER-positive human SK-BR-3 cells assessed as increase in fluorescence intensity at 25 uM by Hoechst 33342 staining based confocal microscopic analysis,CID 168297032,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522524,"",1849108,482049106,168270628,2064,36351049,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Binding affinity to HER2 in HER-positive human SK-BR-3 cells assessed as increase in fluorescence intensity at 25 uM by Hoechst 33342 staining based confocal microscopic analysis,CID 168270628,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522619,"",1849135,482049106,168270628,2064,36351049,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of EGFR/HER2 heterodimerization in human SK-BR-3 cells at 1 uM preincubated for 4 hrs followed by EGF addition for 20 mins by immunoprecipitation analysis,CID 168270628,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522732,"",1849136,482086698,168297032,2064,36351049,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/HER2 heterodimerization in human SK-BR-3 cells at 10 uM preincubated for 4 hrs followed by EGF addition for 20 mins by immunoprecipitation analysis,CID 168297032,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522734,"",1849136,482049106,168270628,2064,36351049,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Inhibition of EGFR/HER2 heterodimerization in human SK-BR-3 cells at 10 uM preincubated for 4 hrs followed by EGF addition for 20 mins by immunoprecipitation analysis,CID 168270628,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522878,"",1849109,482073042,168287947,2064,36351049,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to HER2 in HER-negative human MDA-MB-231 cells assessed as increase in fluorescence intensity at 25 uM by Hoechst 33342 staining based confocal microscopic analysis,CID 168287947,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380522958,"",1849109,482069273,168285231,2064,36351049,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Binding affinity to HER2 in HER-negative human MDA-MB-231 cells assessed as increase in fluorescence intensity at 25 uM by Hoechst 33342 staining based confocal microscopic analysis,CID 168285231,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380564546,"",1858634,461558717,162674051,2064,33143937,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of GST-fused HER2 (unknown origin) assessed as inhibition ratio at 10 ug/ml using biotinylated peptide substrate in presence of ATP by DELFIA assay relative to control,"(E)-3-[4-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]-N-hydroxyprop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380582378,"",1861970,482055922,168275513,2064,35764033,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 1 uM relative to control,N-[4-chloro-3-(trifluoromethyl)phenyl]-4-[4-[3-(3-hydroxyphenyl)-1-phenylpyrazol-4-yl]pyridin-2-yl]piperazine-1-carboxamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380582379,"",1861970,482065515,168282482,2064,35764033,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ErbB2 (unknown origin) at 1 uM relative to control,1-(4-Fluorophenyl)-3-[3-[[4-[3-(3-methoxyphenyl)-1-phenylpyrazol-4-yl]pyridin-2-yl]amino]propyl]urea,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597646,"",1865641,381884390,134959408,2064,36518696,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 wild type (679 to 1255 residues) expressed in baculovirus infected Sf9 insect cells assessed as Kinact/Ki ratio using AQT0794 measured up to 240 mins by fluorescence assay,N-[3-[[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1H-imidazol-4-yl]pyridin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597647,"",1865641,312367127,71496458,2064,36518696,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 wild type (679 to 1255 residues) expressed in baculovirus infected Sf9 insect cells assessed as Kinact/Ki ratio using AQT0794 measured up to 240 mins by fluorescence assay,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597648,"",1865641,440199298,121269225,2064,36518696,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 wild type (679 to 1255 residues) expressed in baculovirus infected Sf9 insect cells assessed as Kinact/Ki ratio using AQT0794 measured up to 240 mins by fluorescence assay,Lazertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597760,"",1865639,381884390,134959408,2064,36518696,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 wild type (679 to 1255 residues) expressed in baculovirus infected Sf9 insect cells assessed as Kinact using AQT0794 as substrate measured up to 240 mins by fluorescence assay,N-[3-[[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1H-imidazol-4-yl]pyridin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597761,"",1865639,440199298,121269225,2064,36518696,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 wild type (679 to 1255 residues) expressed in baculovirus infected Sf9 insect cells assessed as Kinact using AQT0794 as substrate measured up to 240 mins by fluorescence assay,Lazertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597762,"",1865639,312367127,71496458,2064,36518696,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 wild type (679 to 1255 residues) expressed in baculovirus infected Sf9 insect cells assessed as Kinact using AQT0794 as substrate measured up to 240 mins by fluorescence assay,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597772,"",1865640,312367127,71496458,2064,36518696,Confirmatory,20230629,0,0,Unspecified,P04626,Ki,"",ChEMBL,Inhibition of recombinant human N-terminal GST-tagged HER2 wild type (679 to 1255 residues) expressed in baculovirus infected Sf9 insect cells using AQT0794 measured up to 240 mins by fluorescence assay,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597912,"",1865646,312367127,71496458,2064,36518696,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in autophosphorylation at Y1221/1222 residue at 5 to 100 nM after 6 hrs by Western blot analysis,Osimertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597913,"",1865646,381884390,134959408,2064,36518696,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in autophosphorylation at Y1221/1222 residue at 5 to 100 nM after 6 hrs by Western blot analysis,N-[3-[[4-[5-(4-fluorophenyl)-2-methylsulfanyl-1H-imidazol-4-yl]pyridin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380597914,"",1865646,440199298,121269225,2064,36518696,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 in human BT474 cells assessed as reduction in autophosphorylation at Y1221/1222 residue at 5 to 100 nM after 6 hrs by Western blot analysis,Lazertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380604890,"",1867618,160682577,6444692,2064,35452936,Literature-derived,20230629,0,0,Active,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human SK-BR-3 cells overexpressing HER2 at 60 nM incubated for 24 hrs by Western blot analysis,Mubritinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605328,"",1867616,482066547,156768728,2064,35452936,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human SK-BR-3 cells overexpressing HER2 incubated for 24 hrs by Western blot analysis,"4-bromo-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380605381,"",1867617,482066547,156768728,2064,35452936,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 in human SK-BR-3 cells overexpressing HER2 at 20 to 60 nM incubated for 24 hrs by Western blot analysis,"4-bromo-N-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methyl]aniline",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380679618,"",1885485,482074202,164887513,2064,35860875,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 0.5 uM assessed as competition rate relative to control,Jak3-IN-13,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380679649,"",1885438,482074202,164887513,2064,35860875,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 0.5 uM relative to control,Jak3-IN-13,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380735183,"",1898681,482060756,163228652,2064,34668706,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) assessed as residual activity at 1 uM by radiometric 33 PanQuinase assay relative to control,"2-[(1,3-dioxoisoindol-2-yl)methyl]-6-fluoro-3-hydroxy-N-[3-[5-[2-[2-methoxy-5-(prop-2-enoylamino)anilino]pyridin-4-yl]-2-methylsulfanyl-1H-imidazol-4-yl]phenyl]benzamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380740336,"",1899712,482047892,163196370,2064,34952433,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 0.3 uM relative to control,Blk-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751638,"",1902390,482072809,168287779,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,2-[6-[[(3S)-selenolan-3-yl]amino]-7H-purin-2-yl]-3H-isoindol-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751639,"",1902390,482062392,141656145,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,"2-[6-(cyclohexylamino)-7H-purin-2-yl]-1,2-benzoselenazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751640,"",1902390,482065906,168282788,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,2-[6-[5-(diethylamino)pentan-2-ylamino]-7H-purin-2-yl]-3H-isoindol-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751641,"",1902390,482066292,132051414,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,2-[6-(cyclohexylamino)-7H-purin-2-yl]-3H-isoindol-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751642,"",1902390,482086630,168296990,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,"2-[6-[[(3S)-oxolan-3-yl]amino]-7H-purin-2-yl]-1,2-benzoselenazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751643,"",1902390,482074420,141656143,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,"2-[6-[[(1R,2R,4S)-2-bicyclo[2.2.1]heptanyl]amino]-7H-purin-2-yl]-1,2-benzoselenazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751644,"",1902390,482048222,168270019,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,2-[6-(cyclopentylamino)-7H-purin-2-yl]-3H-isoindol-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751645,"",1902390,482067488,168283926,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,"2-(6-anilino-7H-purin-2-yl)-1,2-benzoselenazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751646,"",1902390,482066016,168282877,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,"2-[6-(propylamino)-7H-purin-2-yl]-1,2-benzoselenazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751647,"",1902390,482078616,141656152,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,"2-[6-[[(3S)-selenolan-3-yl]amino]-7H-purin-2-yl]-1,2-benzoselenazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751648,"",1902390,482083754,141656148,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,"2-[6-[[(1R,2R,3R,5S)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]amino]-7H-purin-2-yl]-1,2-benzoselenazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380751649,"",1902390,482067959,168284264,2064,35167283,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of ERBB2 (unknown origin) at 50 nM by Z'LYTE screening method relative to control,"2-[6-[5-(diethylamino)pentan-2-ylamino]-7H-purin-2-yl]-1,2-benzoselenazol-3-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380764865,"",1904515,482060429,163408815,2064,35259690,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human SKOV3 cells measured after 2 hrs by western blot analysis,pan-HER-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380764866,"",1904515,482086360,153253814,2064,35259690,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human SKOV3 cells measured after 2 hrs by western blot analysis,pan-HER-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380767878,"",1905799,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of neratinib IC50 to test compound IC50 for inhibition of HER2 R896C mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768207,"",1905802,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of pyrotinib IC50 to test compound IC50 for inhibition of HER2 V777L mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768294,"",1905736,482063465,137535295,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768295,"",1905736,482070557,168286132,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768296,"",1905736,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768297,"",1905736,482052977,137376670,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-3-[(2R)-1-methylpyrrolidin-2-yl]-N-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768298,"",1905736,482050668,168271684,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768299,"",1905736,482080846,168293608,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-b]pyridazin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768412,"",1905798,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of neratinib IC50 to test compound IC50 for inhibition of HER2 V777L mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768671,"",1905736,482062866,137376693,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoroprop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768672,"",1905736,482057379,168276568,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768673,"",1905736,482049765,168271074,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768674,"",1905736,482052398,168272889,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768675,"",1905736,482057295,168276509,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768676,"",1905736,482067535,168283966,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-(3-methyl-4-pyrazolo[1,5-a]pyrimidin-6-yloxyanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768677,"",1905736,482076065,168290131,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768678,"",1905736,482079077,168292331,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-(4-imidazo[1,2-a]pyridin-6-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768679,"",1905736,482056533,168275958,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to pyrotinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768683,"",1905803,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of pyrotinib IC50 to test compound IC50 for inhibition of HER2 R896C mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768941,"",1904516,482086360,153253814,2064,35259690,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human BT-474 cells measured after 2 hrs by western blot analysis,pan-HER-IN-2,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380768942,"",1904516,482060429,163408815,2064,35259690,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 phosphorylation in human BT-474 cells measured after 2 hrs by western blot analysis,pan-HER-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380769757,"",1905796,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of neratinib IC50 to test compound IC50 for inhibition of HER2 D769H mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773054,"",1905735,482063465,137535295,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773055,"",1905735,482052398,168272889,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773056,"",1905735,482057295,168276509,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773057,"",1905735,482076065,168290131,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773058,"",1905735,482049765,168271074,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773059,"",1905735,482057379,168276568,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2S)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773060,"",1905735,482062866,137376693,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoroprop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773669,"",1905800,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of pyrotinib IC50 to test compound IC50 for inhibition of HER2 D769H mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773727,"",1905735,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773728,"",1905735,482079077,168292331,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-(4-imidazo[1,2-a]pyridin-6-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773729,"",1905735,482070557,168286132,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773730,"",1905735,482050668,168271684,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-(4-imidazo[1,2-c]pyrimidin-7-yloxy-3-methylanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773731,"",1905735,482067535,168283966,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-(3-methyl-4-pyrazolo[1,5-a]pyrimidin-6-yloxyanilino)quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773732,"",1905735,482052977,137376670,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-3-[(2R)-1-methylpyrrolidin-2-yl]-N-[4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773733,"",1905735,482080846,168293608,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-b]pyridazin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773734,"",1905735,482056533,168275958,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of test compound IC50 to neratinib IC50 for inhibition of wild type human GST-tagged HER2 (676 to end residues) expressed in baculovirus infected Sf9 cells incubated for 30 mins in presence of ATP by HTRF analysis","(E)-N-[7-hydroxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380773739,"",1905801,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of pyrotinib IC50 to test compound IC50 for inhibition of HER2 D769Y mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380775630,"",1905797,482056461,168275910,2064,35319895,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,"Potency index, ratio of neratinib IC50 to test compound IC50 for inhibition of HER2 D769Y mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography","(Z)-N-[7-ethoxy-4-[3-methyl-4-([1,2,4]triazolo[4,3-c]pyrimidin-7-yloxy)anilino]quinazolin-6-yl]-2-fluoro-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380820743,"",1915536,461558717,162674051,2064,33077264,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 ug/ml using synthetic biotinylated peptide as substrate by Wallac Victor II 1420 microplate reader method relative to control,"(E)-3-[4-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]-N-hydroxyprop-2-enamide",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380820744,"",1915536,103177479,208908,2064,33077264,Literature-derived,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 10 ug/ml using synthetic biotinylated peptide as substrate by Wallac Victor II 1420 microplate reader method relative to control,Lapatinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
380835628,"",1913677,318464585,71226662,2064,"",Other,20230629,0,0,Unspecified,P04626,"","",ChEMBL,Selectivity interaction (KinomeScan (DiscoverX)) EUB0000638a ERBB2,Acalabrutinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407951388,"",1935465,442046297,118607832,2064,36423823,Literature-derived,20240503,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of human HER2 at 1 uM by hotspot assay relative to control,Mobocertinib,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
407996297,"",1946521,494404842,146180757,2064,36279692,Literature-derived,20240503,0,0,Active,P04626,"","",ChEMBL,Binding affinity to ERRB2 (unknown origin) assessed as strong interaction at 100 nM,Egfr/C797S-IN-1,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408017699,"",1951303,494406819,171349813,2064,36804726,Literature-derived,20240503,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 500 nM relative to control,1-[4-[4-(3-chloro-2-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one,ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
408035697,"",1955944,494397787,171344284,2064,37127101,Literature-derived,20240503,0,0,Unspecified,P04626,"","",ChEMBL,Inhibition of HER2 (unknown origin) at 1 uM relative to control,"(3R)-3-ethyl-6-fluorospiro[10-oxa-2,13,17,21,22-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15,17,19-heptaene-12,1'-cyclopropane]-14-one",ERBB2 - erb-b2 receptor tyrosine kinase 2 (human),/gene/2064,2.7.10.1,P04626,9606,"","","",""
